data_1hov_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hov _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.375 0.607 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.539 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -57.89 134.57 56.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 109.238 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -175.87 74.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.458 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' NZ ' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -164.01 139.94 6.37 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.338 -0.851 . . . . 0.0 109.905 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 4.2 p-10 -53.98 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 5.1 mt-30 47.67 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.959 -1.088 . . . . 0.0 110.305 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.463 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -115.25 149.96 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.7 132.51 56.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.852 -1.155 . . . . 0.0 109.383 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CB ' HG13 ' A' ' 61' ' ' ILE . 44.0 p90 -140.49 151.92 45.2 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.252 -0.905 . . . . 0.0 109.902 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 18.4 tpt180 -150.75 119.71 6.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.759 . . . . 0.0 109.372 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.444 ' HA ' ' HB ' ' A' ' 63' ' ' ILE . 2.7 mp -70.51 138.82 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 27.8 mm -82.89 -5.47 9.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.79 105.67 0.19 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.668 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 3.8 m-30 -51.91 168.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.334 -1.098 . . . . 0.0 109.306 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 26' ' ' ASP . 5.3 t -109.89 148.75 38.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.974 . . . . 0.0 109.762 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.469 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.3 Cg_endo -82.06 -36.39 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.883 2.389 . . . . 0.0 111.622 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 24' ' ' THR . 0.7 OUTLIER -42.43 -26.59 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.208 -0.933 . . . . 0.0 110.007 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' CD2' ' HB ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.89 168.35 17.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.017 -1.052 . . . . 0.0 109.272 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CB ' ' OG1' ' A' ' 31' ' ' THR . 0.5 OUTLIER -57.4 147.79 57.29 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 108.787 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 29.6 Cg_endo -70.25 -45.85 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -69.61 -21.12 63.6 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.532 ' OG1' ' CB ' ' A' ' 28' ' ' ASP . 47.8 m -76.78 -50.06 14.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.138 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.668 ' CG1' ' CD2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -55.33 -34.4 33.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.39 -39.88 92.31 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.043 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -44.43 27.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.33 -29.34 33.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.172 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.61 -44.09 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.305 -0.872 . . . . 0.0 108.96 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -61.01 -52.78 63.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -51.37 -58.56 5.91 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -45.32 -51.14 11.43 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -46.17 -50.23 15.91 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.327 -0.858 . . . . 0.0 110.003 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG13 ' N ' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -64.71 -32.82 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.9 -1.125 . . . . 0.0 108.915 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.533 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.7 m95 -100.54 -25.15 14.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -77.82 -18.25 56.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.094 -1.004 . . . . 0.0 108.39 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 43.7 t0 -71.46 -14.27 62.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.081 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 43' ' ' TRP . 3.7 p -102.92 10.7 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.284 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 9.2 t -178.13 148.15 0.63 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 109.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 34.6 Cg_endo -76.01 56.84 4.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.551 2.167 . . . . 0.0 110.393 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 162' ' ' TYR . 9.2 tp -85.89 147.7 26.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.362 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -113.05 110.88 21.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 49' ' ' LEU . 39.7 m-85 -97.01 141.78 29.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 109.478 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -132.42 125.09 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.27 140.35 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.534 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.518 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.38 -168.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.77 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -176.15 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -163.31 -32.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 110.199 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.54 27.9 17.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.9 OUTLIER 58.04 170.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -1.193 . . . . 0.0 109.161 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 54' ' ' ILE . . . -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.04 -1.038 . . . . 0.0 110.672 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CG ' ' CZ2' ' A' ' 11' ' ' TRP . 79.1 m-20 -58.91 -47.86 83.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.527 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -102.15 126.42 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 6.9 mtp -116.48 125.17 51.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 109.567 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 64' ' ' ASN . 2.6 mp -105.09 158.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.715 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.528 ' ND2' ' HB ' ' A' ' 21' ' ' ILE . 3.2 t-20 178.85 -138.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.141 -0.974 . . . . 0.0 109.816 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.77 -174.77 2.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.875 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 67' ' ' ARG . . . -106.63 -19.34 9.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 37.8 mtt180 60.75 170.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -1.211 . . . . 0.0 110.46 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 75' ' ' PRO . 41.0 m0 -81.33 -42.81 19.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 0.0 109.15 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 44.9 mt-10 -75.85 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.839 . . . . 0.0 109.077 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 1.5 t-80 78.17 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 72' ' ' ASP . . . 120.68 -22.51 8.18 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 71' ' ' GLY . 7.3 m-20 -37.72 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.591 -0.947 . . . . 0.0 110.017 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.95 31.18 0.08 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -179.67 74.32 0.18 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.447 -1.031 . . . . 0.0 108.405 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 76' ' ' PHE . 32.5 Cg_endo -73.21 134.43 21.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.612 2.208 . . . . 0.0 111.847 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.5 p90 50.53 158.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.332 1.063 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 1.4 p-10 178.56 -29.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 51.74 -156.84 3.42 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 78' ' ' GLY . 3.5 mttp 43.56 -173.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.229 1.014 . . . . 0.0 110.517 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.473 ' O ' HD22 ' A' ' 83' ' ' LEU . 1.5 m-20 -67.15 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 41.06 -139.18 1.55 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.529 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -49.86 123.38 7.94 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 108.646 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 81' ' ' GLY . 16.5 mt -111.74 -22.11 11.32 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 99' ' ' PHE . . . 169.4 -178.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 7.6 p-80 179.05 175.86 0.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.979 -1.075 . . . . 0.0 110.253 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.66 166.26 28.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 109.39 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.99 159.51 15.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.676 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -48.55 172.78 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.631 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 88' ' ' ALA . 32.4 Cg_endo -73.69 137.98 25.76 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.119 1.879 . . . . 0.0 110.874 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.518 ' N ' ' HA3' ' A' ' 94' ' ' GLY . . . 175.77 -168.34 40.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.0 p -99.1 134.5 41.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 110.041 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.24 -82.46 0.66 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.475 ' HA ' ' OD2' ' A' ' 96' ' ' ASP . 0.9 OUTLIER -69.54 -41.37 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 110.205 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 90' ' ' GLY . . . -71.3 111.05 3.49 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.808 -1.186 . . . . 0.0 110.191 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.527 ' HA3' HG23 ' A' ' 61' ' ' ILE . . . 121.44 2.79 10.64 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.739 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 62' ' ' MET . 3.9 m-20 -95.96 140.02 31.32 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.415 -1.638 . . . . 0.0 109.865 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -121.3 142.62 49.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.487 ' ND1' ' NE2' ' A' ' 70' ' ' HIS . 59.5 m170 -114.76 130.71 56.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.809 . . . . 0.0 109.971 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 46.7 m-85 -103.89 152.03 22.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -60.09 138.98 57.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.952 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -76.29 -78.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 8.5 t70 -66.04 91.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.016 -1.053 . . . . 0.0 110.672 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -159.81 -170.34 2.86 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -138.38 82.69 1.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.705 -1.247 . . . . 0.0 110.867 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.32 130.62 42.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.08 -1.013 . . . . 0.0 109.449 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 113' ' ' SER . 1.1 p -154.45 154.16 32.73 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.723 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.527 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 7.7 t30 -82.76 4.56 24.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 109' ' ' SER . 1.9 p -91.89 -145.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 108' ' ' THR . 6.3 t -89.9 37.99 0.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . -64.14 -97.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 109.831 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 23.0 t-20 -178.31 -46.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.061 -1.024 . . . . 0.0 109.639 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' OH ' ' CG ' ' A' ' 80' ' ' ASP . 94.4 m-85 -85.42 -36.32 20.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 109.176 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.0 OUTLIER 62.2 110.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -0.76 . . . . 0.0 110.591 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.534 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -50.86 -36.47 37.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 109.677 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.9 t80 -65.63 -35.9 82.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 142' ' ' TYR . 2.1 tm? -80.58 -57.1 3.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.625 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -50.42 -40.82 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.864 -1.148 . . . . 0.0 108.94 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -69.23 -49.52 55.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.857 . . . . 0.0 109.622 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -42.45 -59.78 1.74 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -49.18 -56.53 8.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.179 -0.95 . . . . 0.0 108.744 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 69.3 mm-40 -66.53 -11.99 55.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.53 -15.17 57.35 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.534 ' HA3' ' CE ' ' A' ' 138' ' ' MET . . . -94.95 -42.04 3.91 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.525 ' NE2' ' NE2' ' A' ' 130' ' ' HIS . 5.0 m-70 -63.56 -49.16 74.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.11 . . . . 0.0 109.389 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -41.89 -26.39 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 124' ' ' HIS . 26.2 mmt -78.99 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.928 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . -157.91 -35.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.255 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.508 ' CD1' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -46.25 149.72 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 109.579 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -129.29 163.06 26.5 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.525 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 25.5 m170 -44.28 137.41 3.56 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.064 -1.022 . . . . 0.0 109.228 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -112.89 11.9 19.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.23 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 0.5 OUTLIER 82.48 -24.8 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.21 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.492 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -66.49 124.89 89.43 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.67 -1.269 . . . . 0.0 109.737 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.456 ' HA ' HD13 ' A' ' 141' ' ' ILE . 31.2 Cg_endo -72.58 -36.55 4.91 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.248 1.965 . . . . 0.0 110.555 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.49 11.07 47.17 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 133' ' ' ASP . . . -92.23 174.69 7.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.999 -1.295 . . . . 0.0 109.936 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.7 tp -88.17 -35.81 17.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.534 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -83.81 7.25 18.52 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' ASP . . . -55.39 154.7 11.19 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.839 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.97 21.66 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.906 2.404 . . . . 0.0 112.246 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -134.91 133.72 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.595 -1.316 . . . . 0.0 109.532 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.432 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 75.8 t80 -73.21 121.88 21.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 110.122 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -125.05 111.43 15.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.388 -0.82 . . . . 0.0 108.919 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -59.93 160.43 7.81 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.091 -1.006 . . . . 0.0 110.209 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 148' ' ' PHE . 2.8 p -99.09 83.0 2.81 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.659 -0.651 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -3.47 30.49 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.854 -1.154 . . . . 0.0 108.275 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -160.0 20.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.526 -0.734 . . . . 0.0 109.113 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 3.3 t80 36.24 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.463 -0.773 . . . . 0.0 110.529 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.65 132.57 56.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.334 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.8 mt -88.65 -163.41 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.384 -0.822 . . . . 0.0 109.838 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.0 p -167.12 131.43 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 109.648 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.624 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 2.7 pt20 -59.63 -29.57 68.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 152' ' ' GLN . 4.0 m-20 -43.48 -37.62 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 107.956 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.42 -46.05 11.28 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.624 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.9 OUTLIER -51.95 -33.69 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.681 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -75.55 -56.77 4.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.83 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 128' ' ' LEU . . . -57.04 -39.46 89.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.403 HG22 HG21 ' A' ' 46' ' ' VAL . 9.0 tp -78.17 -18.78 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -1.23 . . . . 0.0 109.788 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -72.78 -48.12 40.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.88 . . . . 0.0 108.925 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -74.37 -21.65 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -85.25 -15.86 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.784 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.57 ' CD2' HD12 ' A' ' 49' ' ' LEU . 6.0 m-85 -140.11 -93.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.42 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.75 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.568 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -163.0 44.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.914 -1.116 . . . . 0.0 108.73 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.04 85.27 6.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -141.63 101.95 4.08 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 13' ' ' LYS . 7.7 m-20 -34.18 -85.71 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.894 -0.504 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -51.88 106.97 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 109.216 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.521 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 3.3 mt -104.29 162.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 0.0 109.526 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -135.53 135.85 40.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -142.59 162.5 35.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.343 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.74 120.39 9.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.483 -0.76 . . . . 0.0 109.057 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.479 HD12 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -83.17 112.95 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.0 109.46 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HD13 ' HG2' ' A' ' 62' ' ' MET . 7.7 mt -89.51 17.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 166.5 96.21 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.61 ' CG ' HG12 ' A' ' 32' ' ' VAL . 20.3 m-85 -58.07 -114.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -1.074 . . . . 0.0 108.853 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.639 HG23 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -112.58 178.29 1.0 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.502 -1.374 . . . . 0.0 108.102 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' A' ' 24' ' ' THR . 33.0 Cg_endo -76.57 -34.85 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.745 1.63 . . . . 0.0 112.324 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 26' ' ' ASP . 5.6 t70 -158.64 81.73 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.768 -1.208 . . . . 0.0 112.191 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.597 ' CD2' HG22 ' A' ' 24' ' ' THR . 0.3 OUTLIER -155.68 -178.98 7.68 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.184 -0.948 . . . . 0.0 108.737 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 1.3 m-20 -72.16 136.45 81.91 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' ASP . 26.8 Cg_endo -69.68 -30.88 21.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 106.444 -2.175 . . . . 0.0 106.444 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.17 -32.84 63.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.477 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 2.9 m -70.6 -62.65 1.31 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG12 ' CG ' ' A' ' 23' ' ' TYR . 1.3 p -49.64 -43.28 18.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 3.0 t70 -64.85 -22.08 66.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.733 . . . . 0.0 109.109 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.3 t0 -78.38 -40.99 34.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.015 . . . . 0.0 110.174 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -57.52 -44.05 84.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.967 -1.083 . . . . 0.0 109.145 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 40' ' ' PHE . 75.2 m-85 -71.35 -48.57 49.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.27 -0.894 . . . . 0.0 108.637 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.31 -51.12 63.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.552 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 61.3 mtp180 -67.18 -48.85 66.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.438 -0.789 . . . . 0.0 108.899 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.601 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . . . -41.98 -43.28 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.551 ' O ' ' CB ' ' A' ' 44' ' ' SER . 58.1 m-85 -68.52 -39.16 81.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ARG . 3.3 tt0 -71.56 -60.54 2.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.132 -0.98 . . . . 0.0 109.026 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 39' ' ' ALA . 1.7 m -46.18 -29.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.589 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 11.6 m95 -101.98 -19.0 15.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 11.2 t -88.7 -23.35 22.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.016 -1.053 . . . . 0.0 108.25 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -59.77 -12.56 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.716 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 7.7 p -110.62 19.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.003 . . . . 0.0 109.69 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.512 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 5.1 t -179.33 149.32 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.002 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 32.4 Cg_endo -76.0 57.82 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 110.486 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 162' ' ' TYR . 18.8 mt -100.76 121.3 41.45 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.81 112.66 25.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 109.094 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.547 ' CD2' ' CE1' ' A' ' 40' ' ' PHE . 56.3 m-85 -88.52 143.65 26.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.57 138.75 52.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.526 -0.734 . . . . 0.0 109.341 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -89.28 129.66 35.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.077 -1.014 . . . . 0.0 108.862 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 59' ' ' ALA . 2.5 pt -122.12 131.95 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 54' ' ' ILE . 4.4 p80 -60.32 -147.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.306 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -70.05 169.31 13.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.043 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.37 -147.29 18.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.91 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.253 . . . . 0.0 109.595 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . . . -160.91 150.4 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.555 ' OD2' ' CE2' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -77.88 -70.19 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 109.268 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -82.13 126.26 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.477 ' HG2' HD13 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -120.96 115.83 23.94 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.62 145.33 12.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.89 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 63.8 t30 -168.67 172.64 7.84 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 65' ' ' PHE . 31.2 p90 -119.94 160.77 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 109.842 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.71 128.87 1.73 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -96.9 -135.15 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 67' ' ' ARG . 1.6 t90 -49.92 -41.64 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.511 -1.368 . . . . 0.0 107.852 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' HIS . 2.8 tt0 -73.86 55.22 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 76' ' ' PHE . 4.1 t-160 -44.16 -50.63 8.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.175 -0.953 . . . . 0.0 109.27 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 18.11 44.98 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 72' ' ' ASP . 41.2 p-10 -151.47 28.04 0.65 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.349 -1.089 . . . . 0.0 109.892 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . 93.19 154.0 30.76 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.38 -0.914 . . . . 0.0 110.901 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 58.6 m-85 55.14 164.36 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 110.049 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 34.4 Cg_endo -76.45 -159.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.004 1.803 . . . . 0.0 108.555 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.673 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 69.0 t80 177.54 168.86 0.65 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.9 -1.125 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 24.1 t70 50.63 40.61 24.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.705 -0.622 . . . . 0.0 110.345 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . -49.06 173.05 0.05 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.3 -2.32 . . . . 0.0 107.3 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 80' ' ' ASP . 1.1 ptmt -51.46 141.75 15.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.762 -1.434 . . . . 0.0 107.253 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 79' ' ' LYS . 21.2 t70 39.55 -111.21 0.11 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.495 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 25.85 -132.54 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 CA-C-O 121.432 0.462 . . . . 0.0 112.226 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -26.94 123.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.975 0.893 . . . . 0.0 111.914 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 73.5 mt -118.84 -28.6 5.54 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 172.51 146.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.511 -0.743 . . . . 0.0 109.343 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 24.4 p-80 -144.92 149.25 34.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.339 -0.851 . . . . 0.0 109.262 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 97' ' ' SER . . . -123.61 159.44 29.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.892 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.41 151.8 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.075 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.494 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -57.17 168.96 0.78 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 109.624 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.6 152.23 25.89 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.773 2.315 . . . . 0.0 110.569 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.58 -103.1 0.17 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -162.59 78.51 0.48 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -1.093 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.06 -103.1 0.29 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.87 -2.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -1.168 . . . . 0.0 109.32 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -75.6 143.2 29.99 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 76.34 -4.4 49.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 1.6 m-20 -101.03 134.8 43.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.942 -1.328 . . . . 0.0 108.68 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.495 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 16.4 t -130.86 127.64 38.98 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.561 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 46.0 m80 -89.78 145.27 25.31 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.422 -0.799 . . . . 0.0 109.109 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -116.58 160.29 20.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.001 -1.062 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 3.5 m-20 -52.85 121.36 7.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 109.854 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 65' ' ' PHE . 18.6 t0 -44.58 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' GLU . 35.3 m-20 -77.22 -128.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 83.92 -29.86 0.08 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp 68.81 74.56 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.185 -0.947 . . . . 0.0 111.137 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.583 ' O ' ' HB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -94.0 163.19 13.59 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.712 HG21 ' CG2' ' A' ' 108' ' ' THR . 9.7 t 171.48 -173.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.096 -1.002 . . . . 0.0 110.308 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.586 ' O ' ' OG1' ' A' ' 108' ' ' THR . 6.8 p-10 -50.19 -31.17 13.1 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.712 ' CG2' HG21 ' A' ' 106' ' ' THR . 1.8 p 73.31 -110.89 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER 61.24 23.14 13.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 100.99 -3.707 . . . . 0.0 100.99 -168.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.446 ' N ' ' C ' ' A' ' 108' ' ' THR . . . -135.78 -45.26 0.66 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.318 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -158.39 -86.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.775 -0.578 . . . . 0.0 110.277 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.567 ' O ' ' CG2' ' A' ' 108' ' ' THR . 9.0 m-85 -121.16 126.64 50.21 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.3 OUTLIER -76.58 129.59 36.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 111.557 -178.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.585 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -57.09 -24.23 52.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.653 -0.654 . . . . 0.0 110.479 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 1.7 t80 -73.64 -54.75 7.42 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.498 -1.376 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.569 HD23 ' CD1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -63.26 -51.0 67.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.926 -1.108 . . . . 0.0 109.144 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 21.0 m -54.82 -53.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 109.907 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -66.91 -39.99 87.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.735 -1.228 . . . . 0.0 108.828 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.429 ' HB1' ' CE1' ' A' ' 115' ' ' PHE . . . -47.6 -58.37 4.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.496 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 34.1 t60 -54.49 -42.6 70.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.157 . . . . 0.0 108.53 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 117' ' ' VAL . 54.2 mm-40 -71.73 -10.5 59.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.5 OUTLIER -87.28 -15.67 37.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.589 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -89.51 -45.6 4.59 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.496 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 1.5 m-70 -62.02 -45.97 91.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.475 -1.015 . . . . 0.0 108.417 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.68 -19.11 2.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.315 -0.865 . . . . 0.0 109.162 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.1 mtt -100.97 -5.51 25.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 113.21 -35.57 4.5 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.522 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 127' ' ' GLY . 1.8 mt -37.0 146.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.494 -1.003 . . . . 0.0 110.237 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 138' ' ' MET . 0.3 OUTLIER -113.08 -179.48 3.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 109.713 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.43 151.31 20.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -96.71 -177.73 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 0.0 109.519 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -13.24 6.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -101.05 142.36 24.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.94 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.467 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 32.5 Cg_endo -76.84 116.7 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.8 2.333 . . . . 0.0 109.564 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.81 -3.56 24.41 Favored Glycine 0 C--N 1.272 -2.989 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.77 -177.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.192 . . . . 0.0 109.772 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.408 ' CD2' ' CZ2' ' A' ' 43' ' ' TRP . 8.6 tp -96.06 -28.86 14.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 109.681 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -94.6 3.01 55.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -46.19 148.14 1.63 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.274 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -78.04 12.0 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.565 2.176 . . . . 0.0 111.021 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mm -133.64 155.69 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 0.0 110.262 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER -76.0 95.29 3.56 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.96 92.93 5.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 108.637 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 146' ' ' LYS . 7.8 t80 -60.07 155.38 17.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -143.49 8.83 1.58 Allowed 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.626 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 144' ' ' TYR . 21.3 mtpt 52.6 -106.75 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.305 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 4.9 p-10 -56.94 -47.22 81.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.716 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 5.8 t80 68.01 125.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.808 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.493 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -100.77 -70.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 4.0 tp 169.29 172.15 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -143.45 130.68 20.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.021 -1.049 . . . . 0.0 109.654 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.641 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 46.9 tt0 -54.63 -30.31 54.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 152' ' ' GLN . 51.5 m-20 -46.9 -41.61 16.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.577 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.552 ' OD1' ' CZ3' ' A' ' 43' ' ' TRP . 21.5 t0 -83.53 -36.14 24.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.641 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -63.57 -31.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 108.908 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.461 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -78.71 -44.72 22.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 128' ' ' LEU . . . -75.55 -20.29 78.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 1.6 tp -93.9 -17.87 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 155' ' ' ILE . 2.9 pt20 -90.94 -31.48 16.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.081 . . . . 0.0 108.446 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.412 ' HG2' ' HG3' ' A' ' 159' ' ' GLN . 2.0 mm-40 -86.94 -29.94 21.69 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -95.66 -28.11 14.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.559 ' CD1' HD21 ' A' ' 49' ' ' LEU . 2.1 m-85 -122.38 -91.28 0.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.452 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 158' ' ' ILE . . . . . . . . 0 N--CA 1.492 2.383 0 CA-C-O 118.036 -1.425 . . . . 0.0 109.756 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HG3' ' HG3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -95.98 106.76 18.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.808 -1.182 . . . . 0.0 110.022 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.05 81.58 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.093 . . . . 0.0 110.102 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.75 153.1 48.54 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.261 -0.9 . . . . 0.0 109.309 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -79.44 -89.21 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.46 111.27 1.33 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.275 -0.891 . . . . 0.0 108.948 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.531 HD13 ' CE1' ' A' ' 51' ' ' PHE . 73.7 mt -119.59 145.67 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.444 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.559 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 22.8 p -121.06 140.06 52.46 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.591 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.507 ' HB3' HG13 ' A' ' 61' ' ' ILE . 34.0 p90 -139.28 -179.44 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' CD ' ' HB1' ' A' ' 59' ' ' ALA . 1.9 ptm180 -159.34 140.45 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.27 145.18 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 64' ' ' ASN . 28.0 mt -90.19 -5.53 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 65' ' ' PHE . . . 147.54 109.79 0.57 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.566 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -66.29 -163.3 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.047 -1.267 . . . . 0.0 108.812 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.476 ' CG2' ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -108.49 146.8 34.4 Favored Pre-proline 0 C--N 1.293 -1.853 0 O-C-N 121.51 -0.744 . . . . 0.0 109.257 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 26' ' ' ASP . 29.9 Cg_endo -73.13 -26.15 15.21 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.441 2.094 . . . . 0.0 110.42 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 10.0 p-10 -35.23 -35.43 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.414 0.626 . . . . 0.0 109.976 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -133.04 171.66 13.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.988 -1.07 . . . . 0.0 110.245 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 5.5 m-20 -51.63 148.16 10.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.559 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 32.3 Cg_endo -69.98 -32.44 17.68 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 N-CA-C 105.688 -2.466 . . . . 0.0 105.688 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -78.33 -31.26 48.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.586 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 21.4 m -73.7 -52.62 12.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.883 -1.136 . . . . 0.0 108.45 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.566 ' CG1' ' CG ' ' A' ' 23' ' ' TYR . 1.8 p -47.74 -41.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 5.3 m-20 -61.43 -39.12 89.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.693 -0.63 . . . . 0.0 109.669 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -61.21 -37.5 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.206 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.93 -28.6 38.06 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.908 . . . . 0.0 109.074 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.19 -24.95 19.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 108.892 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.36 63.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -39.21 73.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.434 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -57.32 -40.58 78.22 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -60.61 -45.72 92.94 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -74.95 -15.85 60.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.685 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' ' OD2' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -84.3 -27.95 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.811 -1.181 . . . . 0.0 109.057 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -104.96 -25.2 12.67 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.709 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' THR . 9.7 t -85.11 -23.27 28.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.396 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 3.4 p30 -60.04 -22.39 62.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.16 -0.962 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.453 HG11 ' OD1' ' A' ' 45' ' ' ASP . 10.8 m -99.07 16.63 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.999 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t -173.52 152.74 2.16 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.093 -1.004 . . . . 0.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 33.8 Cg_endo -74.91 45.65 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.985 2.457 . . . . 0.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.443 HD21 ' CD2' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -87.3 144.14 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.231 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 99.03 5.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.309 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.531 ' CE1' HD13 ' A' ' 16' ' ' ILE . 15.9 m-85 -93.38 133.16 36.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.884 -1.135 . . . . 0.0 110.047 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 17' ' ' THR . 1.0 OUTLIER -115.54 164.98 13.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 2.3 mtp-105 -111.17 137.62 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 108.808 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.559 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 7.2 pt -145.34 134.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.017 -1.052 . . . . 0.0 109.658 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.31 42.53 2.72 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.21 -67.24 0.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.3 -0.875 . . . . 0.0 110.049 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . -99.16 50.25 1.19 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 68.09 162.72 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.299 -1.118 . . . . 0.0 109.932 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' A' ' 54' ' ' ILE . . . -129.49 173.17 10.82 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -84.9 -57.08 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.12 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -95.87 148.42 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 0.0 109.874 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.524 ' CG ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -123.52 116.9 23.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.502 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 97' ' ' SER . 46.9 mt -115.62 140.51 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 108.908 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HB3' HD13 ' A' ' 21' ' ' ILE . 7.9 p-10 -154.49 -148.67 0.25 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.686 -1.258 . . . . 0.0 110.36 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -136.59 174.98 10.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.896 -1.127 . . . . 0.0 110.604 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 101' ' ' ASP . . . -122.77 99.27 0.64 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.524 ' HA ' ' CB ' ' A' ' 101' ' ' ASP . 5.4 mtm180 -90.08 -6.96 54.91 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -1.072 . . . . 0.0 110.459 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.452 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 177.46 -162.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' O ' ' O ' ' A' ' 70' ' ' HIS . 5.8 pt-20 -83.76 67.27 9.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.741 -1.224 . . . . 0.0 111.033 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -49.74 -172.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.0 109.136 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . -64.58 -9.49 38.32 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.66 ' CB ' ' CE1' ' A' ' 70' ' ' HIS . 11.5 t0 -54.89 -169.99 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.021 -1.282 . . . . 0.0 108.396 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.37 -8.95 26.3 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.344 -1.407 . . . . 0.0 110.095 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.533 ' CD1' HD13 ' A' ' 82' ' ' LEU . 11.7 m-85 -110.67 118.33 48.87 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.206 -1.173 . . . . 0.0 108.652 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -75.47 -176.43 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.045 1.83 . . . . 0.0 110.31 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 68' ' ' TRP . 38.3 p90 -78.69 140.86 38.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.552 -0.718 . . . . 0.0 109.107 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 9.5 p-10 -115.55 6.66 14.69 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.24 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 62.75 -167.68 19.95 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.265 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -43.16 167.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -1.064 . . . . 0.0 109.874 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' LYS . 71.6 m-20 41.15 -162.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.277 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 -146.94 50.77 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.302 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -47.77 107.1 0.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.481 -1.011 . . . . 0.0 108.997 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 84' ' ' ALA . 15.4 mt -91.23 -15.37 29.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.023 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . 169.5 158.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.524 -0.735 . . . . 0.0 109.024 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -156.83 146.38 20.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.981 -1.075 . . . . 0.0 109.915 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 97' ' ' SER . . . -128.86 161.55 29.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.357 -0.839 . . . . 0.0 109.714 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.1 166.0 10.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -79.41 166.93 38.16 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.515 -0.74 . . . . 0.0 109.084 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HG3' ' HG3' ' A' ' 10' ' ' LYS . 33.1 Cg_endo -76.87 157.54 34.94 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.51 2.14 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.41 -102.32 0.16 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -150.87 90.95 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.255 . . . . 0.0 110.038 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.83 -73.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.5 t -77.41 -1.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -1.209 . . . . 0.0 110.026 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -76.39 139.91 24.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 73.82 67.78 1.71 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' OD1' ' CG ' ' A' ' 62' ' ' MET . 14.9 m-20 -160.8 117.02 2.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 109.01 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -117.02 157.39 25.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.466 -0.771 . . . . 0.0 109.861 -179.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -129.79 146.81 51.52 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m-85 -111.19 144.24 40.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.123 -0.986 . . . . 0.0 110.022 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.504 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -44.7 167.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.586 -1.321 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 5.1 t0 -97.43 -25.39 15.21 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -99.42 -144.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 178.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.4 OUTLIER 75.24 136.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.0 109.643 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 90.63 6.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.327 -0.858 . . . . 0.0 110.55 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.533 ' CB ' ' CD2' ' A' ' 114' ' ' LEU . 13.0 m0 -96.38 153.53 17.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 113' ' ' SER . 55.3 p -138.16 159.61 41.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.586 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 9.4 t30 -112.73 4.37 17.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 0.0 109.148 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 108' ' ' THR . 9.7 t -139.6 48.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.6 p 45.62 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.89 -1.131 . . . . 0.0 109.874 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.13 -42.11 0.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.909 -1.119 . . . . 0.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -137.48 -77.31 0.39 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.5 m-30 -107.98 -102.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER 165.43 98.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.835 -1.166 . . . . 0.0 110.633 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.533 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -52.12 -35.24 47.59 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.106 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 2.2 t80 -66.33 -43.25 86.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 110.005 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.579 ' CD1' ' HA ' ' A' ' 144' ' ' TYR . 1.2 mt -59.41 -60.96 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.004 -1.06 . . . . 0.0 109.566 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 114' ' ' LEU . 19.7 m -52.66 -38.19 26.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -61.74 -51.03 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -53.15 -49.5 66.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.493 -0.754 . . . . 0.0 109.144 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -46.44 -68.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 65.6 mm-40 -56.97 -21.14 28.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.217 -0.927 . . . . 0.0 108.834 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.575 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -74.4 -12.2 60.45 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.89 -47.43 2.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.631 ' NE2' ' CE1' ' A' ' 130' ' ' HIS . 0.6 OUTLIER -59.6 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -1.1 . . . . 0.0 109.57 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.48 22.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -0.754 . . . . 0.0 110.286 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 7.7 mtt -103.79 -10.65 18.11 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.692 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.459 ' HA2' ' CD ' ' A' ' 10' ' ' LYS . . . 128.75 -64.28 0.6 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.013 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 127' ' ' GLY . 15.0 mt -49.35 176.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -169.54 -172.64 1.48 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.719 0.771 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.631 ' CE1' ' NE2' ' A' ' 124' ' ' HIS . 23.0 m80 -49.82 114.01 0.97 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.763 0.792 . . . . 0.0 109.99 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.537 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 11.2 t -84.86 -77.53 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 131' ' ' SER . 52.3 tt0 161.03 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -57.88 133.1 83.28 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.715 -0.616 . . . . 0.0 109.632 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.407 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 29.2 Cg_endo -75.69 113.33 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.555 2.17 . . . . 0.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.53 -13.77 20.61 Favored Glycine 0 C--N 1.272 -2.983 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.74 158.82 12.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.884 -1.362 . . . . 0.0 109.706 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 11.7 tp -70.47 -20.41 62.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.024 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -100.05 2.06 42.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.376 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.19 156.69 91.44 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.232 -0.918 . . . . 0.0 110.015 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.442 ' C ' ' CG1' ' A' ' 141' ' ' ILE . 34.3 Cg_endo -77.14 64.65 7.85 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.858 2.372 . . . . 0.0 110.986 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' CG1' ' C ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -159.53 -157.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.261 -0.9 . . . . 0.0 109.625 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -165.69 119.03 1.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 109.823 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' TYR . 52.8 m -138.26 95.87 3.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 109.259 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.579 ' HA ' ' CD1' ' A' ' 116' ' ' LEU . 21.8 t80 -45.39 158.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.793 -1.192 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 146' ' ' LYS . 1.3 t -152.01 123.92 8.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -48.52 122.46 5.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.195 . . . . 0.0 108.578 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 7.5 m-20 58.96 -95.34 0.05 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.253 -0.905 . . . . 0.0 108.56 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 1.2 p90 177.72 142.88 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.088 -1.007 . . . . 0.0 109.657 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -107.82 -10.83 15.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.892 -1.13 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.432 HD11 ' CG1' ' A' ' 46' ' ' VAL . 1.5 mt 66.57 139.34 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.61 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.74 122.76 48.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.573 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 tt0 -50.01 -53.11 28.89 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.09 0.471 . . . . 0.0 109.954 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -42.32 -29.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -90.62 -29.29 17.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 151' ' ' SER . 0.9 OUTLIER -73.49 -30.43 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -88.25 -43.3 11.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -64.24 -25.62 69.88 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -85.45 -47.47 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.379 . . . . 0.0 109.078 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -52.02 -31.22 28.74 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 109.624 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.02 -28.71 22.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.264 -0.897 . . . . 0.0 109.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -89.35 -16.08 31.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.443 ' CD2' HD21 ' A' ' 49' ' ' LEU . 1.8 m-85 -126.54 -47.37 1.57 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.812 -1.18 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.503 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 140.37 58.23 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 109.79 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -61.46 165.53 4.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 108.549 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HD2' ' CD1' ' A' ' 162' ' ' TYR . 5.6 mmtp -118.75 -175.7 2.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.536 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.9 m120 61.96 141.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.336 -0.852 . . . . 0.0 109.175 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . 2.5 mt-30 45.04 76.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.859 -1.151 . . . . 0.0 109.683 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.6 mt -110.73 136.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 108.886 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.489 ' O ' ' OD2' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -120.09 136.56 54.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.409 -0.807 . . . . 0.0 111.382 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 53' ' ' ARG . 34.3 p90 -149.61 153.07 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.969 . . . . 0.0 110.304 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.53 ' HD2' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.77 138.9 44.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.523 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -80.24 121.4 33.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.53 ' CD1' ' HD2' ' A' ' 19' ' ' ARG . 33.8 mm -67.33 -2.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.469 -0.769 . . . . 0.0 109.77 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 23' ' ' TYR . . . 144.15 84.44 0.07 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.586 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -51.19 169.42 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 1.2 t -85.31 149.07 51.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.059 -1.651 . . . . 0.0 109.276 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' LEU . 36.2 Cg_endo -79.09 -21.5 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.331 2.021 . . . . 0.0 109.85 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' HD12 ' A' ' 104' ' ' LEU . 74.4 m-20 -40.64 -25.06 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.133 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.559 HD21 ' CG2' ' A' ' 32' ' ' VAL . 1.4 pt? -133.76 173.83 11.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.675 -1.266 . . . . 0.0 110.798 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 3.0 m-20 -48.66 138.3 12.11 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 108.862 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.459 ' O ' HG13 ' A' ' 32' ' ' VAL . 31.3 Cg_endo -69.03 -33.66 18.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 N-CA-C 107.331 -1.834 . . . . 0.0 107.331 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -79.01 -26.88 43.22 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 20.8 m -74.15 -50.83 17.68 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG12 ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.66 -36.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.993 0.901 . . . . 0.0 108.643 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.506 ' N ' HG13 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -73.87 -24.72 59.78 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.66 -41.66 68.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -53.19 -38.89 63.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CZ ' HG23 ' A' ' 63' ' ' ILE . 26.9 m-85 -74.12 -26.75 60.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -52.66 9.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -34.47 72.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.603 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . . . -62.9 -46.78 86.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.44 -0.788 . . . . 0.0 109.206 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.594 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -53.39 -34.72 58.79 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -83.01 -12.3 57.37 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.572 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -73.38 -32.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.603 ' CH2' ' HB2' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -102.82 -51.02 3.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.599 -0.688 . . . . 0.0 109.718 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 10.0 t -53.76 -33.17 54.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 109.157 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 41' ' ' GLN . 1.2 t70 -54.78 -33.3 61.22 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.599 -0.688 . . . . 0.0 109.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 46' ' ' VAL . 12.1 p -106.06 23.42 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.036 -1.04 . . . . 0.0 110.694 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -173.13 153.87 2.54 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.665 -1.272 . . . . 0.0 110.115 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' CD ' ' OXT' ' A' ' 163' ' ' GLY . 37.3 Cg_endo -79.77 12.78 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.89 3.06 . . . . 0.0 110.723 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.637 HD12 ' CD2' ' A' ' 162' ' ' TYR . 4.2 tt -64.37 148.72 49.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.96 138.93 45.64 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.77 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.561 ' CE2' HD22 ' A' ' 49' ' ' LEU . 26.6 m-85 -116.72 135.62 53.63 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.183 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.4 t -128.59 118.67 23.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.059 -1.025 . . . . 0.0 110.322 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 18' ' ' TYR . 6.0 mtm180 -92.16 131.43 37.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.977 -1.077 . . . . 0.0 108.15 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 58' ' ' GLU . 15.5 pt -126.6 148.31 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 109.536 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -109.38 -14.58 14.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.996 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -135.44 -167.39 2.0 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.953 -1.092 . . . . 0.0 109.941 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.86 -170.94 2.0 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 54' ' ' ILE . 1.9 tp10 -79.07 158.43 27.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.251 -1.146 . . . . 0.0 110.358 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HA ' HD13 ' A' ' 54' ' ' ILE . . . -136.44 -160.38 1.05 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.447 -0.783 . . . . 0.0 108.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -134.22 -57.03 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.584 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 2.5 mt -98.77 152.05 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.361 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.412 ' HB2' ' OD2' ' A' ' 96' ' ' ASP . 67.0 mtt -119.21 123.19 43.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.948 -1.095 . . . . 0.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' A' ' 18' ' ' TYR . 1.6 mp -117.78 142.21 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.634 -1.291 . . . . 0.0 109.968 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' OD1' ' C ' ' A' ' 63' ' ' ILE . 2.7 p-10 175.3 -174.69 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.439 -0.788 . . . . 0.0 110.189 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -89.96 -167.3 1.81 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.001 -1.062 . . . . 0.0 111.052 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 99' ' ' PHE . . . -149.3 49.66 0.57 Allowed Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -56.05 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -49.95 -57.28 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.981 . . . . 0.0 109.886 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 124.75 24.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.693 -0.63 . . . . 0.0 110.146 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.09 -70.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 133.74 -20.0 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -46.33 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.517 -0.99 . . . . 0.0 111.601 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.77 -2.02 65.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.88 77.59 18.51 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.967 -1.314 . . . . 0.0 110.172 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.27 139.33 18.65 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.51 2.14 . . . . 0.0 109.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.24 159.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.384 -0.822 . . . . 0.0 109.605 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.9 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.495 -0.753 . . . . 0.0 109.112 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.86 -154.92 19.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -69.4 167.28 16.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -1.068 . . . . 0.0 111.128 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER 41.42 -150.41 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.42 -134.88 45.52 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 4.7 tt -50.68 98.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.594 -0.945 . . . . 0.0 109.012 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 1.3 mt -110.31 -28.45 8.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 108.934 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -177.94 155.34 0.97 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.508 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 4.8 p80 -152.21 174.48 13.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.768 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -144.76 144.11 31.01 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.428 -0.795 . . . . 0.0 109.874 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.6 156.91 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 108.739 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.537 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -65.67 173.32 2.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 110.195 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 88' ' ' ALA . 37.5 Cg_endo -82.51 155.54 16.21 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.201 2.601 . . . . 0.0 110.67 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.52 -128.76 1.18 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.7 60.09 1.7 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.207 -1.173 . . . . 0.0 110.475 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.18 -67.8 0.44 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.86 1.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.281 . . . . 0.0 108.36 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -78.89 134.82 14.46 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 84.04 91.95 0.72 Allowed Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.55 -0.97 . . . . 0.0 110.68 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.3 m-20 -160.99 120.33 2.61 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.975 -1.309 . . . . 0.0 108.754 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 3.1 p -110.25 130.01 55.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.052 0.93 . . . . 0.0 110.505 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.508 ' ND1' ' NE2' ' A' ' 85' ' ' HIS . 29.5 m170 -119.36 148.9 42.67 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 109.333 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.7 m-30 -112.48 147.05 37.35 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 0.0 109.833 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 82' ' ' LEU . 3.6 t70 -81.13 114.92 20.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 102' ' ' ASP . 18.5 t70 -57.37 -95.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.75 -0.78 . . . . 0.0 108.92 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 101' ' ' ASP . 47.2 m-20 21.67 -93.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 120.706 0.288 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 102' ' ' ASP . 2.5 mp0 -41.95 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.933 -1.104 . . . . 0.0 110.094 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 2.0 tp -106.2 101.08 10.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.883 . . . . 0.0 109.696 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.522 ' O ' HG23 ' A' ' 106' ' ' THR . 12.1 m95 -103.11 147.27 27.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.363 -0.835 . . . . 0.0 110.034 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 2.2 p -159.02 -159.68 0.79 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.315 -0.866 . . . . 0.0 110.02 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.1 70.0 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -168.2 -99.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.413 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -142.67 59.82 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.774 -1.204 . . . . 0.0 109.613 178.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.93 -24.13 0.76 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.246 -0.908 . . . . 0.0 110.972 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -169.57 -153.66 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.739 -1.226 . . . . 0.0 108.968 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -67.74 -167.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.798 -1.189 . . . . 0.0 108.436 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.5 t -105.36 117.61 34.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.904 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -53.24 -22.51 6.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.86 0.838 . . . . 0.0 108.753 179.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -76.07 -38.49 57.02 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 142' ' ' TYR . 2.3 tm? -64.72 -55.13 21.88 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.409 -0.807 . . . . 0.0 109.716 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.67 -51.06 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -57.29 -51.48 69.2 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.938 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.4 -58.25 3.47 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.953 0.882 . . . . 0.0 109.333 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.436 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 84.9 t60 -42.81 -67.62 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 44.1 mm-40 -62.25 -21.95 65.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CG ' ' CZ2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -74.43 -5.54 43.07 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -98.08 -48.54 1.88 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.436 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 97.0 m-70 -60.79 -42.61 97.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.53 -16.5 38.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.922 . . . . 0.0 109.209 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.508 ' HE1' ' CG ' ' A' ' 43' ' ' TRP . 44.2 mtt -84.62 15.82 3.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 100.95 -73.26 0.39 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.788 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' GLY . 15.7 mt -32.44 145.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.997 -0.708 . . . . 0.0 111.184 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.85 -179.66 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.815 -1.178 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -49.08 135.47 16.13 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.2 p -93.35 -152.16 0.32 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.16 -4.66 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.746 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.97 134.44 49.75 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.93 113.15 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.465 2.11 . . . . 0.0 111.007 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.07 -5.32 42.06 Favored Glycine 0 C--N 1.268 -3.199 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.13 162.04 1.12 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.682 -0.893 . . . . 0.0 109.64 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 19.0 tp -67.32 -34.3 77.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.547 -0.721 . . . . 0.0 109.085 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.34 28.09 8.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.514 -0.741 . . . . 0.0 110.398 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.19 164.27 57.61 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.773 -1.204 . . . . 0.0 109.112 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -73.5 15.74 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.269 2.646 . . . . 0.0 112.39 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 139.59 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.853 -1.155 . . . . 0.0 109.507 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.599 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 62.9 t80 -76.79 129.58 36.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 144' ' ' TYR . 6.2 m -150.06 84.77 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.982 -1.074 . . . . 0.0 108.472 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.549 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 75.4 t80 -42.37 164.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.633 -0.667 . . . . 0.0 109.339 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.507 ' O ' ' CE2' ' A' ' 144' ' ' TYR . 1.7 t -111.5 119.05 37.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 110.604 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -44.83 104.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.825 . . . . 0.0 108.848 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 146' ' ' LYS . 70.1 m-20 68.81 -79.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.521 ' CE1' HD22 ' A' ' 150' ' ' LEU . 24.1 t80 171.14 113.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.037 -1.039 . . . . 0.0 108.95 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.448 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 14.1 ttt85 -133.02 -20.7 2.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 110.214 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER 71.98 -160.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -163.42 126.71 2.71 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.731 -1.231 . . . . 0.0 108.985 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.602 ' HA ' HG21 ' A' ' 155' ' ' ILE . 4.7 mm-40 -45.51 -44.07 12.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.25 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' GLN . 41.9 t0 -45.57 -36.4 4.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.654 -1.218 . . . . 0.0 108.357 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -86.51 -30.89 21.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.634 -0.667 . . . . 0.0 109.479 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.602 HG21 ' HA ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -70.48 -37.56 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 108.805 178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.51 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -72.82 -43.1 63.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.84 48.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.562 HG22 ' N ' ' A' ' 159' ' ' GLN . 0.5 OUTLIER -54.47 -42.95 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.365 . . . . 0.0 109.534 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.562 ' N ' HG22 ' A' ' 158' ' ' ILE . 7.3 mm-40 -65.4 -43.15 91.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 109.589 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 69.3 mm-40 -57.73 -22.98 49.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.741 -1.225 . . . . 0.0 108.468 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.509 ' N ' HD21 ' A' ' 161' ' ' LEU . 3.8 mm? -98.96 -64.5 1.03 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.584 0.707 . . . . 0.0 109.318 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.639 ' CD1' ' HD2' ' A' ' 13' ' ' LYS . 21.9 p90 -151.64 85.27 1.3 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.45 ' OXT' ' CD ' ' A' ' 48' ' ' PRO . . . . . . . . 0 N--CA 1.494 2.543 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.662 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 9.8 mttp . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.483 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.0 m95 -71.54 130.99 42.61 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 11.8 p-10 167.92 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.36 -0.837 . . . . 0.0 109.383 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.64 32.0 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 72.28 -62.97 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.146 -0.971 . . . . 0.0 108.951 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 50' ' ' ARG . 21.3 mt-30 -78.94 103.23 8.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.517 -0.739 . . . . 0.0 109.297 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -101.06 162.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 108.577 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.45 133.96 48.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 110.043 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 7.3 p90 -145.99 157.69 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.475 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . 3.4 tmm_? -148.76 136.82 20.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 0.0 109.927 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 HD12 ' OH ' ' A' ' 23' ' ' TYR . 5.8 mt -86.6 144.97 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' HG2' ' A' ' 62' ' ' MET . 11.6 mm -107.67 -38.85 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 0.0 110.074 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.02 96.23 0.14 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.613 ' CG ' HG13 ' A' ' 32' ' ' VAL . 2.5 m-85 -55.31 179.02 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.353 -1.086 . . . . 0.0 109.1 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 5.0 t -105.05 150.59 38.93 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 109.437 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.2 Cg_endo -81.27 -33.04 0.79 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.727 2.285 . . . . 0.0 111.238 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' PRO . 36.5 m-20 -39.48 -27.16 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.68 -0.637 . . . . 0.0 110.105 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.523 ' CD1' ' HB ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -135.16 -178.15 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 110.04 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 1.1 m-20 -73.62 151.97 89.37 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.511 -0.743 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.7 Cg_endo -74.1 -30.12 9.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 N-CA-C 106.254 -2.248 . . . . 0.0 106.254 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 2.6 mm-40 -78.11 -30.41 49.45 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 107' ' ' ASN . 2.4 m -76.45 -50.68 13.46 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.613 HG13 ' CG ' ' A' ' 23' ' ' TYR . 1.4 p -54.92 -41.43 57.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.26 -23.97 62.08 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 2.7 t70 -81.39 -34.5 31.61 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.528 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.8 m-85 -73.21 -47.95 39.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -46.24 -51.15 14.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.993 . . . . 0.0 108.609 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -55.19 -50.44 69.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.013 -1.054 . . . . 0.0 108.439 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -53.41 -44.36 68.68 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 44' ' ' SER . 49.6 t80 -51.25 -40.25 58.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 108.732 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 3.0 tt0 -86.77 -24.03 25.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -68.74 -33.33 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.147 -0.97 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.592 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 1.9 m95 -103.22 -22.3 13.75 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.208 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 27.5 t -85.9 -19.61 30.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.8 m-20 -64.6 -15.12 60.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.516 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 46' ' ' VAL . 7.1 p -113.65 17.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.404 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -173.04 147.56 1.53 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 120.466 -1.396 . . . . 0.0 111.037 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 36.4 Cg_endo -78.52 46.78 2.23 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.773 2.316 . . . . 0.0 110.067 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mp -76.55 160.16 29.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -130.41 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.534 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 5.4 m-30 -66.57 139.41 57.91 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' THR . 8.1 t -130.89 101.66 5.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.244 -0.91 . . . . 0.0 109.835 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -81.03 144.08 32.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -113.29 158.87 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 43.1 m-70 -106.75 -14.65 14.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.04 -175.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.046 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.34 63.65 0.83 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 177.35 153.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.482 -1.01 . . . . 0.0 109.527 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.513 ' HB2' ' CG1' ' A' ' 54' ' ' ILE . . . 176.45 143.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -62.53 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 22.9 mt -87.59 156.51 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.565 ' HG2' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -165.83 136.05 3.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.126 -0.984 . . . . 0.0 109.931 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.39 144.56 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 109.668 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -164.19 -167.14 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.325 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -117.2 166.73 11.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.74 -24.99 7.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HD2' ' CD1' ' A' ' 65' ' ' PHE . 54.1 mtp180 47.91 -150.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.177 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -91.12 -72.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 0.0 109.412 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -62.42 99.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.621 -0.675 . . . . 0.0 110.481 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.418 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -127.29 -160.28 0.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.418 ' H ' ' CG ' ' A' ' 70' ' ' HIS . . . -113.86 -33.26 1.89 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.74 72.18 10.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.431 -1.04 . . . . 0.0 108.492 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' TYR . . . 112.95 -113.29 3.15 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.543 ' N ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER 163.33 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.21 -1.17 . . . . 0.0 109.827 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 74' ' ' TYR . 36.8 Cg_endo -79.26 137.69 13.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.246 1.964 . . . . 0.0 110.235 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 24.7 p90 -71.63 138.05 48.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.617 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 p-10 -75.31 -2.29 27.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.555 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 57.41 -114.91 5.99 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.5 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 78' ' ' GLY . 5.4 mttt -41.65 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.057 -0.673 . . . . 0.0 110.78 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 79' ' ' LYS . 10.1 m-20 -25.18 -93.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 80' ' ' ASP . . . 38.6 -130.35 1.79 Allowed Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 9.7 tt -54.51 109.37 0.49 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 81' ' ' GLY . 1.1 mt -107.94 -29.29 9.1 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 83' ' ' LEU . . . 171.77 155.93 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.903 -1.123 . . . . 0.0 110.899 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' SER . 1.9 p80 -146.36 -162.74 1.59 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 97' ' ' SER . . . -160.73 145.81 14.36 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.456 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -92.77 156.29 17.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.841 -1.162 . . . . 0.0 109.976 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.499 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -79.8 164.01 55.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 36.1 Cg_endo -79.35 154.55 24.68 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.002 2.468 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.49 60.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.78 92.56 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -1.084 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.82 -62.81 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.19 153.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.267 . . . . 0.0 109.748 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 98.2 141.08 11.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 95.83 -45.78 1.96 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 62' ' ' MET . 4.1 p30 -73.26 125.22 27.27 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.188 -1.183 . . . . 0.0 109.724 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.511 ' OG ' ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -131.65 136.28 47.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.314 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 9.5 m80 -98.93 143.38 29.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.557 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . 13.8 m-85 -113.9 141.83 46.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.565 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' CZ3' ' A' ' 105' ' ' TRP . 5.4 t70 -51.91 135.43 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -98.23 -16.86 19.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.871 -1.143 . . . . 0.0 109.592 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.83 -16.92 60.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 158.23 32.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 111' ' ' ASN . 8.4 tp -109.09 95.61 5.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.557 ' CZ3' ' HB3' ' A' ' 99' ' ' PHE . 10.3 m0 -102.33 141.51 35.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.216 -0.927 . . . . 0.0 110.222 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 105' ' ' TRP . 1.5 p -133.51 -160.28 1.04 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.972 -1.08 . . . . 0.0 110.006 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.514 ' HB2' ' CG2' ' A' ' 31' ' ' THR . 0.2 OUTLIER -134.59 2.25 3.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.826 . . . . 0.0 109.99 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.08 -60.5 1.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.098 . . . . 0.0 109.359 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.6 p -165.26 -91.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.324 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 43.6 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.865 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' SER . 60.8 t30 -110.55 -104.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.95 -124.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.794 -1.191 . . . . 0.0 109.456 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 117.24 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.356 -1.465 . . . . 0.0 111.219 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 HD21 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -45.95 -43.48 14.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.643 -0.66 . . . . 0.0 110.078 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.91 -44.52 91.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.388 -0.82 . . . . 0.0 109.862 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.625 HD13 ' CD2' ' A' ' 144' ' ' TYR . 0.5 OUTLIER -59.2 -67.14 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.422 -0.798 . . . . 0.0 109.766 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 114' ' ' LEU . 19.1 m -51.08 -42.93 25.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.435 -0.791 . . . . 0.0 108.985 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.64 -46.94 67.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.861 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -54.48 -59.02 5.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.376 -0.828 . . . . 0.0 110.007 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 124' ' ' HIS . 77.3 t60 -43.55 -65.05 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.655 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 99' ' ' PHE . 68.1 mm-40 -62.84 -12.95 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 0.0 109.341 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 39' ' ' ALA . 1.1 m-85 -80.92 -10.8 59.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.108 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.592 ' CA ' ' CZ2' ' A' ' 43' ' ' TRP . . . -103.68 -41.29 2.19 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 120' ' ' HIS . 9.5 m80 -61.02 -42.93 99.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -1.117 . . . . 0.0 109.104 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -37.56 -32.36 0.05 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.391 0.615 . . . . 0.0 109.532 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.532 ' HE2' ' CD1' ' A' ' 158' ' ' ILE . 4.1 mtm -69.89 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.87 . . . . 0.0 109.476 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.47 -30.87 0.05 OUTLIER Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.9 153.82 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.538 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 130' ' ' HIS . 4.0 mt-10 -113.44 -177.53 3.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.157 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 129' ' ' GLU . 18.6 m170 -44.72 172.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 110.142 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 p -123.58 -152.23 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 -17.36 2.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.321 -0.862 . . . . 0.0 110.99 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 151.32 54.21 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.72 -1.237 . . . . 0.0 109.251 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.8 -38.7 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.398 2.065 . . . . 0.0 110.686 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.09 6.81 69.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.57 163.31 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 110.03 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.494 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 16.7 tp -89.12 -28.5 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 110.233 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.508 ' HE2' ' ND1' ' A' ' 124' ' ' HIS . 37.0 mtp -101.53 15.01 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.909 -1.119 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -43.15 153.72 0.34 Allowed Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.401 ' O ' ' CD1' ' A' ' 141' ' ' ILE . 35.2 Cg_endo -79.09 -1.11 11.32 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.205 1.937 . . . . 0.0 110.21 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 140' ' ' PRO . 5.5 mm -131.28 154.46 40.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.66 139.36 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 110.16 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 144' ' ' TYR . 1.9 m -129.52 -41.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 110.37 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.625 ' CD2' HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER 68.42 147.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 t -120.65 138.13 54.09 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -83.11 0.15 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.119 -0.988 . . . . 0.0 111.003 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 1.5 p-10 -88.19 21.43 2.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.824 -1.173 . . . . 0.0 109.391 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 148' ' ' PHE . 1.6 t80 60.14 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.112 -0.993 . . . . 0.0 109.133 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -121.06 -10.8 8.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.437 -0.789 . . . . 0.0 109.247 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 155' ' ' ILE . 1.5 tp 59.32 -144.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 109.274 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 155' ' ' ILE . 1.1 p -178.41 129.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.644 ' HA ' HG23 ' A' ' 155' ' ' ILE . 23.3 mm-40 -53.76 -35.17 61.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.896 -0.502 . . . . 0.0 110.053 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 152' ' ' GLN . 2.9 m-20 -42.87 -47.7 5.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 109.304 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -79.37 -45.26 19.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.454 -0.779 . . . . 0.0 109.177 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.644 HG23 ' HA ' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -50.86 -28.47 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.0 108.661 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -57.44 3.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 0.0 109.553 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.41 -36.41 53.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.532 ' CD1' ' HE2' ' A' ' 126' ' ' MET . 6.7 tp -75.28 -30.09 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.378 -1.072 . . . . 0.0 109.1 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.57 67.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.479 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 -28.38 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.406 0.622 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -95.02 -19.62 20.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.658 -0.651 . . . . 0.0 110.136 -178.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 12' ' ' ASP . 41.6 m-85 -140.3 -75.05 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.406 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.795 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HE3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 121.384 0.612 . . . . 0.0 111.936 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.55 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 176.0 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.462 -0.774 . . . . 0.0 109.24 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HB2' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -44.57 158.39 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -114.81 144.65 43.17 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.471 -0.768 . . . . 0.0 109.448 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.499 ' HA ' HD21 ' A' ' 49' ' ' LEU . 68.0 m-80 43.26 -82.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' LYS . 2.9 mt-30 -71.4 106.89 4.08 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 12' ' ' ASP . 2.2 mm -114.05 -178.33 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.034 -1.041 . . . . 0.0 110.133 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.576 ' HB ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -140.33 137.83 34.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.52 ' CB ' HG13 ' A' ' 61' ' ' ILE . 43.2 p90 -145.38 162.89 36.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.115 -0.99 . . . . 0.0 109.569 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' NH2' ' HA ' ' A' ' 58' ' ' GLU . 19.9 ttp85 -159.42 124.33 4.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -0.896 . . . . 0.0 109.684 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.457 ' CG2' ' CD1' ' A' ' 23' ' ' TYR . 4.0 mt -85.25 116.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 3.7 mt -73.62 0.3 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.981 -1.074 . . . . 0.0 109.836 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.64 103.64 0.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -68.74 -153.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -1.178 . . . . 0.0 109.365 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -105.13 147.63 34.84 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.202 -0.936 . . . . 0.0 110.521 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 37.5 Cg_endo -78.89 -32.91 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.157 2.571 . . . . 0.0 111.178 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' PRO . 71.7 m-20 -41.1 -34.73 0.47 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.698 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -121.03 176.95 5.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.967 -1.083 . . . . 0.0 109.231 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 4.6 m-20 -63.04 154.49 77.06 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.012 -1.055 . . . . 0.0 108.348 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.9 Cg_endo -72.3 -33.33 9.22 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.1 -26.41 33.62 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 1.4 m -71.79 -51.84 20.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -56.6 -33.74 40.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.578 ' N ' HG12 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -70.35 -24.23 62.94 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -73.7 -39.19 64.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.296 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.478 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.25 -60.83 2.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE2' HD23 ' A' ' 114' ' ' LEU . 78.3 m-85 -53.42 -42.5 67.12 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.96 27.74 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' VAL . 1.2 mtp180 -74.48 -46.84 36.99 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.35 -36.15 68.46 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -65.61 -40.99 93.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 1.3 mt-30 -81.69 -9.42 59.65 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -94.26 -27.84 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.133 -0.979 . . . . 0.0 109.63 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.501 ' CZ3' ' HG3' ' A' ' 126' ' ' MET . 1.7 m95 -102.67 -21.16 14.16 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 109.887 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' THR . 6.2 t -95.2 -26.25 16.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.255 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -67.43 -4.54 11.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.488 ' CG2' HG22 ' A' ' 47' ' ' THR . 15.1 m -108.1 -8.2 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.705 -1.247 . . . . 0.0 109.614 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' CG1' ' A' ' 158' ' ' ILE . 0.6 OUTLIER -153.16 163.53 23.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.999 -1.063 . . . . 0.0 108.424 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.2 Cg_endo -76.66 57.16 5.47 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.067 1.845 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.554 HD13 ' CE2' ' A' ' 162' ' ' TYR . 2.6 mt -93.66 125.5 38.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.546 -0.721 . . . . 0.0 109.241 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 4.9 mmm180 -112.26 90.81 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 89.4 m-85 -77.05 148.83 35.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.953 -1.092 . . . . 0.0 109.842 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 17' ' ' THR . 51.5 m -132.11 111.85 11.82 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.84 138.44 54.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.352 -0.843 . . . . 0.0 108.998 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -133.58 164.99 33.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.608 ' O ' ' N ' ' A' ' 57' ' ' GLY . 87.7 m-70 -132.03 165.35 24.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.258 -0.901 . . . . 0.0 109.697 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER 55.36 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 55' ' ' HIS . . . -46.3 156.53 0.52 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 1.7 mt-10 -66.55 161.2 23.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.92 -1.341 . . . . 0.0 110.47 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.47 148.57 47.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.587 -0.696 . . . . 0.0 109.381 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' CD2' ' A' ' 11' ' ' TRP . 10.3 t0 -70.03 -54.48 13.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.996 -1.065 . . . . 0.0 109.398 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.52 HG13 ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -103.54 122.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.195 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.456 ' HG3' ' OD1' ' A' ' 96' ' ' ASP . 3.5 mtt -105.49 139.82 39.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.959 -1.088 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.32 128.61 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.023 -1.048 . . . . 0.0 108.616 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.95 -147.1 0.21 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.101 -0.999 . . . . 0.0 109.782 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.595 ' CD2' ' HA ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -177.85 -178.55 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.899 -1.126 . . . . 0.0 110.314 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 101' ' ' ASP . . . 139.21 178.95 16.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -160.87 161.74 31.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.286 -1.126 . . . . 0.0 109.786 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 57.04 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 108.517 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.5 pp20? -61.65 124.53 20.95 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-80 173.45 -57.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 77.55 -12.76 13.82 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 71' ' ' GLY . 6.0 m-20 -42.18 -24.68 0.05 Allowed 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.016 -1.285 . . . . 0.0 110.274 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 128.31 13.14 2.67 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.548 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 14.8 p90 -154.76 90.85 3.04 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 120.834 -1.392 . . . . 0.0 109.287 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.35 -171.88 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.598 2.199 . . . . 0.0 110.957 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 26.6 m-85 61.08 170.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 0.0 109.235 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 78' ' ' GLY . 1.3 t70 172.63 -34.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . 31.72 -157.77 0.0 OUTLIER Glycine 0 N--CA 1.5 2.957 0 CA-C-O 121.682 0.601 . . . . 0.0 111.933 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 80' ' ' ASP . 6.3 mttt -72.8 162.45 29.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.688 -0.889 . . . . 0.0 110.957 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 79' ' ' LYS . 9.7 p-10 27.96 -138.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.199 0.523 . . . . 0.0 111.208 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 83' ' ' LEU . . . 44.51 -116.93 1.84 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -42.68 97.53 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 81' ' ' GLY . 1.7 mt -114.3 -21.41 10.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.567 -1.333 . . . . 0.0 109.392 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.09 150.09 0.94 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.143 -0.973 . . . . 0.0 110.178 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.588 ' CE1' ' CE1' ' A' ' 74' ' ' TYR . 1.1 p80 -144.04 -179.98 6.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.81 162.06 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.115 -0.99 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.07 168.7 10.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.673 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.8 148.32 64.72 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.547 -0.721 . . . . 0.0 109.357 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.414 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 28.8 Cg_endo -75.87 136.73 19.03 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.709 2.272 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.511 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 145.21 122.79 1.56 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.387 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER 56.25 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.704 . . . . 0.0 110.954 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 33.14 -92.21 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -45.65 160.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -1.124 . . . . 0.0 108.743 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 96' ' ' ASP . . . 126.58 151.1 7.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.479 ' O ' HG21 ' A' ' 61' ' ' ILE . . . 60.82 13.41 32.67 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.651 -1.499 . . . . 0.0 109.434 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 94' ' ' GLY . 1.6 m-20 -97.09 116.2 28.86 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.552 -1.558 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.614 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 33.8 m -114.65 156.36 24.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.724 -0.61 . . . . 0.0 109.941 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 97' ' ' SER . 1.9 m80 -148.79 139.01 22.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 32.6 m-85 -104.61 179.24 4.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.172 0.987 . . . . 0.0 112.165 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.553 ' OD2' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -58.64 161.98 4.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.866 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.595 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 13.2 t0 -94.02 -4.83 48.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -170.12 79.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.0 109.023 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -137.09 -8.54 1.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.476 -1.39 . . . . 0.0 111.599 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.535 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER 76.66 141.5 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.188 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.576 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 26.0 m-90 -149.01 -50.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.017 -1.052 . . . . 0.0 110.288 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.585 ' CA ' ' HB3' ' A' ' 110' ' ' ALA . 35.8 p -138.13 -89.21 0.24 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 117.905 -1.518 . . . . 0.0 113.171 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.577 ' HB2' HD21 ' A' ' 27' ' ' LEU . 28.8 t-20 52.92 19.26 1.28 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -175.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 106' ' ' THR . 30.3 p 50.49 37.63 16.35 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.356 1.074 . . . . 0.0 110.039 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -168.07 31.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.585 ' HB3' ' CA ' ' A' ' 106' ' ' THR . . . -98.12 179.97 4.58 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.463 0.649 . . . . 0.0 111.967 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -120.98 -13.31 8.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.523 ' O ' ' CB ' ' A' ' 113' ' ' SER . 1.2 m-85 -107.59 -42.4 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.939 -1.101 . . . . 0.0 108.475 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.537 ' HA ' HG22 ' A' ' 106' ' ' THR . 0.3 OUTLIER 81.01 93.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.927 0.87 . . . . 0.0 110.925 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 36' ' ' PHE . 13.2 tp -37.67 -41.83 0.52 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.739 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.527 ' CZ ' HG22 ' A' ' 42' ' ' VAL . 1.5 t80 -55.29 -45.1 76.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.893 . . . . 0.0 109.9 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.42 HD12 ' HH ' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -68.66 -58.69 3.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.448 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 118' ' ' ALA . 32.9 m -59.08 -42.37 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.006 -1.059 . . . . 0.0 109.432 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 114' ' ' LEU . . . -59.06 -41.55 88.23 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.384 0.612 . . . . 0.0 109.4 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.32 69.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.492 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -54.64 -33.61 60.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 0.0 108.821 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -86.04 -24.61 26.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.167 -0.958 . . . . 0.0 109.151 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 118' ' ' ALA . 1.4 m-85 -71.91 -10.92 60.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -101.71 -37.92 3.33 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -63.54 -50.23 70.37 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.21 -1.171 . . . . 0.0 108.597 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.45 18.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.739 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 22.9 mmm -81.26 10.87 4.85 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.089 -1.007 . . . . 0.0 108.985 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 88.64 -54.96 4.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 127' ' ' GLY . 14.7 mt -42.8 142.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.343 -1.093 . . . . 0.0 110.166 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' HIS . 19.6 pt-20 -108.98 175.61 5.4 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' GLU . 45.4 m80 -44.24 167.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.143 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 m -115.6 -80.53 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.005 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 177.11 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.44 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -68.53 145.79 97.36 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 -179.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -75.83 -35.44 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.256 1.971 . . . . 0.0 108.567 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.34 13.7 62.97 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.65 149.43 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -1.081 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 137' ' ' LEU . 14.3 tp -72.93 -16.16 61.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.47 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 7.3 mmt -112.45 27.87 9.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 133' ' ' ASP . . . -67.95 154.49 93.62 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.743 -0.598 . . . . 0.0 109.477 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.25 4.14 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.79 2.327 . . . . 0.0 111.413 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.99 151.06 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.887 -1.133 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 144' ' ' TYR . 30.1 t80 -63.96 120.96 12.96 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 144' ' ' TYR . 7.6 m -124.07 53.61 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.042 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.618 ' CD2' ' N ' ' A' ' 145' ' ' THR . 75.2 t80 -44.39 170.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.393 -0.817 . . . . 0.0 109.318 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.618 ' N ' ' CD2' ' A' ' 144' ' ' TYR . 1.6 t 179.64 113.3 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.064 -1.022 . . . . 0.0 109.455 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 23.0 ttpt -59.7 167.31 2.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.907 -1.121 . . . . 0.0 108.943 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 3.9 t-20 71.3 -54.83 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.086 . . . . 0.0 110.591 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 68.74 143.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.165 -0.96 . . . . 0.0 109.58 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 80.1 mtp85 -134.11 -86.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 108.922 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 2.1 mt 160.29 152.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.987 -1.071 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.482 ' O ' HG21 ' A' ' 155' ' ' ILE . 10.4 p -119.83 129.02 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 109.885 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.5 mt-30 -65.39 -32.55 74.25 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -44.46 -38.28 3.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.413 ' O ' ' CG2' ' A' ' 158' ' ' ILE . 0.9 OUTLIER -86.54 -38.41 17.22 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.542 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.629 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -62.7 -29.77 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 108.718 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -63.9 1.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 110.236 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -51.64 -39.97 47.05 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.507 ' CG1' HG23 ' A' ' 47' ' ' THR . 9.9 tp -70.17 -40.98 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.612 -0.934 . . . . 0.0 109.461 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 1.8 mm-40 -70.6 -20.55 62.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.257 -0.902 . . . . 0.0 108.809 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -87.14 -27.91 22.79 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.176 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.438 ' CD1' ' HD3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -93.53 -19.99 20.69 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 109.808 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.554 ' CE2' HD13 ' A' ' 49' ' ' LEU . 25.6 m-85 -113.59 -8.06 13.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HD3' ' HG2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CH2' ' OD2' ' A' ' 60' ' ' ASP . 5.9 m95 -107.6 -105.58 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.0 109.199 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 61.34 22.95 13.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.81 -1.181 . . . . 0.0 109.548 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HD2' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -94.3 166.74 11.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 109.709 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' ILE . 4.2 m120 -82.54 -88.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 110.262 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 15' ' ' GLN . 3.5 pt20 -52.45 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.772 -1.205 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 17' ' ' THR . 10.9 mt -102.72 167.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.342 -0.849 . . . . 0.0 110.602 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -131.64 131.51 43.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.159 -0.963 . . . . 0.0 109.837 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.505 ' HA ' HG13 ' A' ' 61' ' ' ILE . 9.3 p90 -133.7 163.93 28.34 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.996 . . . . 0.0 110.53 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' A' ' 55' ' ' HIS . 19.1 ttt180 -159.05 132.4 7.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 109.754 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.541 ' CD1' ' OD1' ' A' ' 33' ' ' ASP . 6.0 mt -93.26 131.25 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.75 -20.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.76 113.15 0.32 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -84.27 -168.36 2.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.409 -1.054 . . . . 0.0 108.225 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.54 HG22 ' CD2' ' A' ' 27' ' ' LEU . 0.7 OUTLIER -105.1 149.66 37.89 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.817 -1.177 . . . . 0.0 109.475 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -78.31 -28.75 4.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.67 2.247 . . . . 0.0 110.061 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD2' ' CG2' ' A' ' 24' ' ' THR . 1.8 p30 -38.88 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 24' ' ' THR . 2.0 pt? -129.11 157.45 41.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.109 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 1.6 m-20 -40.75 138.89 1.23 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.602 -0.687 . . . . 0.0 109.169 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.87 -39.91 4.0 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 N-CA-C 107.021 -1.953 . . . . 0.0 107.021 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.4 pt-20 -72.88 -22.55 60.74 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 28' ' ' ASP . 5.7 m -80.01 -51.36 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.357 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.581 HG13 ' CG ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -55.71 -39.14 53.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.541 ' OD1' ' CD1' ' A' ' 20' ' ' ILE . 4.8 m-20 -78.76 -29.9 45.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 11.6 t70 -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.727 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -43.28 -55.37 4.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.468 -0.77 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -54.99 -42.58 72.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.65 -0.656 . . . . 0.0 109.42 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.88 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.865 . . . . 0.0 109.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HB3' ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -47.93 -37.68 14.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.57 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . . . -63.14 -47.71 81.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.612 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -52.4 -33.04 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 2.1 tt0 -82.39 -16.03 50.58 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.601 -0.687 . . . . 0.0 109.348 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -72.54 -36.43 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.921 -1.112 . . . . 0.0 110.167 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.635 ' CD1' ' CG1' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.29 -24.52 12.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 28.2 t -77.63 -17.67 57.53 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.176 -0.952 . . . . 0.0 108.964 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 8.0 t70 -65.77 -17.67 64.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 110.097 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 43' ' ' TRP . 13.6 p -110.31 19.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 3.8 t -173.74 149.79 1.62 Allowed Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.069 -1.02 . . . . 0.0 108.805 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -81.03 47.12 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.885 2.39 . . . . 0.0 110.811 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 51' ' ' PHE . 0.6 OUTLIER -81.25 147.2 30.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.405 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -122.78 124.06 42.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.353 -0.842 . . . . 0.0 108.93 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.644 ' CZ ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 m-85 -102.23 144.37 30.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.662 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -118.9 119.68 35.07 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -87.84 141.9 28.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 109.159 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 4.5 pt -141.22 -169.01 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 109.778 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.421 ' O ' ' CZ ' ' A' ' 19' ' ' ARG . 4.6 p80 -159.08 -33.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 109.191 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -115.31 157.86 23.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.18 -0.95 . . . . 0.0 109.18 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.18 11.26 78.82 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.16 158.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.419 -1.048 . . . . 0.0 109.066 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . . . -128.13 143.66 51.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.88 -1.138 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 11' ' ' TRP . 1.6 m-20 -51.58 -59.24 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 109.072 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -98.6 129.66 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.062 . . . . 0.0 108.583 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.459 ' SD ' ' OD1' ' A' ' 96' ' ' ASP . 1.5 mtp -125.1 116.61 22.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.563 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 64' ' ' ASN . 3.7 mp -104.95 155.4 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.51 -0.744 . . . . 0.0 109.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.573 ' N ' HG23 ' A' ' 63' ' ' ILE . 22.5 p30 179.3 -172.15 0.16 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.014 -1.054 . . . . 0.0 109.986 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -134.07 170.54 15.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.472 -0.768 . . . . 0.0 109.108 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -179.64 114.73 0.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -55.14 -149.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.722 -0.87 . . . . 0.0 110.894 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.513 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.4 p90 -48.96 -51.13 32.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.813 -1.179 . . . . 0.0 109.792 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 1.1 mt-10 -43.69 -69.21 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 15.1 t60 73.32 -73.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.43 -0.793 . . . . 0.0 110.608 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.33 9.96 9.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -170.66 68.5 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.252 -1.146 . . . . 0.0 109.971 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.47 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 117.59 179.25 17.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.81 76.29 14.03 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.431 -1.04 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 82' ' ' LEU . 29.7 Cg_endo -74.78 -84.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.39 2.06 . . . . 0.0 108.425 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 68' ' ' TRP . 24.1 t80 59.52 -100.12 0.1 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.435 -0.791 . . . . 0.0 110.567 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 75.69 -53.96 0.63 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.989 -1.07 . . . . 0.0 108.357 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 77' ' ' ASP . . . 101.83 -148.23 17.71 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.467 ' HA ' ' OE2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -57.66 161.75 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 108.972 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 39.05 -147.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.434 -0.791 . . . . 0.0 110.028 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 51.46 -146.21 12.16 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.606 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 3.5 tp -40.56 112.93 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.927 . . . . 0.0 109.71 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 84' ' ' ALA . 10.1 mt -108.63 -19.26 13.49 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.344 -0.848 . . . . 0.0 109.891 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.572 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . 163.98 163.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.503 ' NE2' ' HB2' ' A' ' 98' ' ' HIS . 6.3 p-80 -153.92 177.4 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.935 -1.103 . . . . 0.0 109.979 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.47 156.39 48.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.08 163.2 12.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.066 -1.022 . . . . 0.0 109.609 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.546 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -83.67 157.34 64.26 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.102 -0.999 . . . . 0.0 109.706 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HG2' ' HD3' ' A' ' 10' ' ' LYS . 37.6 Cg_endo -76.81 147.56 27.56 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.462 2.108 . . . . 0.0 109.597 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 161.26 45.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.261 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 71.3 142.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -1.129 . . . . 0.0 109.72 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 35.97 -102.53 0.02 OUTLIER Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.73 119.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.158 -1.201 . . . . 0.0 108.171 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 133.15 146.1 5.5 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.49 ' HA3' HG22 ' A' ' 61' ' ' ILE . . . 79.18 2.98 88.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.459 ' OD1' ' SD ' ' A' ' 62' ' ' MET . 1.3 m-20 -107.85 130.41 55.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.197 -1.178 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 85' ' ' HIS . 0.7 OUTLIER -122.67 133.53 54.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 109.535 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 5.8 m80 -111.89 134.21 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 109.065 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.625 ' HB2' ' CD2' ' A' ' 65' ' ' PHE . 6.1 m-85 -103.76 141.95 35.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 110.63 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.82 146.03 53.61 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 66' ' ' GLY . 16.6 m-20 -89.64 -112.27 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 101' ' ' ASP . 5.1 m-20 36.03 -160.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER 34.97 -124.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.437 -0.789 . . . . 0.0 110.349 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 15.1 tp -177.62 134.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.047 -1.033 . . . . 0.0 108.713 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -126.25 124.51 40.53 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.971 -1.081 . . . . 0.0 110.449 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 4.1 p -147.03 -160.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.145 -0.972 . . . . 0.0 111.275 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 107' ' ' ASN . 36.7 t30 -108.21 18.81 20.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.391 -0.818 . . . . 0.0 110.782 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -37.15 2.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.435 -1.416 . . . . 0.0 110.168 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -178.68 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 36.26 -94.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.699 -0.626 . . . . 0.0 109.821 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.1 m-20 -85.23 -80.98 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 108.597 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 116' ' ' LEU . 40.8 m-85 -157.42 40.44 0.3 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.0 OUTLIER 61.92 108.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.414 -0.804 . . . . 0.0 109.863 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.601 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -40.14 -39.39 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 109.848 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 57.4 t80 -59.44 -46.51 88.54 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.146 -0.971 . . . . 0.0 109.803 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.503 HD11 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -67.6 -54.44 19.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.569 -0.707 . . . . 0.0 109.814 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 14.2 m -58.78 -50.25 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.837 -1.164 . . . . 0.0 109.499 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -55.82 -43.29 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.505 -0.747 . . . . 0.0 110.07 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.17 -51.02 63.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.608 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -55.75 -61.37 2.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.954 -1.091 . . . . 0.0 109.234 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 67.1 mm-40 -63.9 -11.21 25.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.545 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -88.16 -18.76 28.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.776 -1.203 . . . . 0.0 108.032 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.38 -43.8 9.18 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.82 -43.24 72.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 121' ' ' GLU . . . -46.31 -32.07 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 64.9 mtt -72.97 -80.65 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.03 -40.32 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.46 HD11 ' HA3' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -56.77 155.96 7.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.377 -1.072 . . . . 0.0 111.019 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -173.4 2.24 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 138' ' ' MET . 45.7 m170 -52.39 144.19 13.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.55 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -123.75 20.17 9.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 1.2 tp60 54.07 -156.17 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.6 OUTLIER 66.37 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -72.72 -41.17 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.311 2.007 . . . . 0.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.86 9.44 52.44 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 133' ' ' ASP . . . -75.73 153.73 36.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.051 -1.264 . . . . 0.0 110.14 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.449 ' HB3' ' OD2' ' A' ' 154' ' ' ASP . 14.4 tp -85.6 -21.64 28.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -111.97 28.3 8.88 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.76 76.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.32 9.29 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.933 1.755 . . . . 0.0 110.719 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.75 -99.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.008 -1.057 . . . . 0.0 109.366 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.503 ' CE2' HD11 ' A' ' 116' ' ' LEU . 1.3 t80 179.46 144.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 0.0 110.158 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -137.46 84.47 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 0.0 109.32 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -55.28 161.09 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.82 137.62 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.643 -0.661 . . . . 0.0 110.28 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.086 -1.009 . . . . 0.0 108.595 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 148' ' ' PHE . 42.8 t-20 -51.69 -29.91 19.99 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.496 ' O ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 59.45 134.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 1.8 tpt180 -113.45 -15.49 12.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.069 -1.019 . . . . 0.0 110.454 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER 84.13 -24.84 0.14 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 150' ' ' LEU . 97.6 p 55.99 132.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.937 0.875 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.611 ' O ' HG13 ' A' ' 155' ' ' ILE . 55.8 mt-30 -73.31 -24.4 60.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -49.76 -40.83 42.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.504 ' OD2' ' CE ' ' A' ' 138' ' ' MET . 1.4 t70 -83.18 -43.64 15.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 152' ' ' GLN . 1.2 pp -51.08 -34.23 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 157' ' ' GLY . 8.2 tmtt? -73.15 -48.02 38.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.113 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.543 ' N ' ' HD3' ' A' ' 156' ' ' LYS . . . -72.11 -53.95 8.62 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 159' ' ' GLN . 10.3 tp -45.61 -51.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -1.183 . . . . 0.0 110.181 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.488 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 5.4 mt-30 -57.61 -56.93 15.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.681 -1.262 . . . . 0.0 109.144 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.53 -25.92 0.31 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.644 -0.66 . . . . 0.0 110.402 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.02 -56.53 2.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 109.42 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.467 ' CD2' HD11 ' A' ' 158' ' ' ILE . 15.7 m-30 -77.9 -77.38 0.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.901 -1.124 . . . . 0.0 108.682 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.466 ' OXT' ' HG2' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.635 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mttt . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 13.0 m95 -84.4 72.58 10.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 5.9 m-20 -122.58 62.94 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 109.558 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.471 ' O ' HD21 ' A' ' 49' ' ' LEU . 5.0 mtmt -124.63 -163.55 1.18 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.998 -1.064 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -109.77 -34.9 6.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.83 . . . . 0.0 108.82 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -94.14 97.7 10.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.497 0.665 . . . . 0.0 109.844 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.94 169.04 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.758 -1.214 . . . . 0.0 108.63 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -138.79 134.61 33.66 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.162 -0.961 . . . . 0.0 108.503 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 18.0 p90 -135.28 145.18 47.28 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.077 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HB2' HG13 ' A' ' 54' ' ' ILE . 2.2 tpt180 -151.21 125.37 9.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.56 124.04 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.874 -1.141 . . . . 0.0 109.049 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 64' ' ' ASN . 24.0 mm -53.76 -27.29 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.911 -1.118 . . . . 0.0 109.261 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 162.38 86.24 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.908 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.593 ' CE2' ' OD2' ' A' ' 33' ' ' ASP . 1.3 p90 -46.73 177.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.567 -0.961 . . . . 0.0 109.203 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.94 140.72 31.1 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 0.0 109.941 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -80.09 -23.5 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.632 2.221 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . 12.0 t0 -39.83 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.894 -0.504 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -132.51 170.85 14.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.768 -1.207 . . . . 0.0 110.34 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 65.7 m-20 -42.64 133.93 2.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.371 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.508 ' O ' HG13 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -68.67 -31.03 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 30' ' ' GLU . 5.6 mm-40 -76.02 -34.49 59.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 17.5 m -69.69 -52.55 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.422 -1.311 . . . . 0.0 108.038 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.596 HG22 ' CD2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -55.66 -38.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -74.22 -31.27 62.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 22.7 t70 -64.36 -33.77 76.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' N ' ' A' ' 115' ' ' PHE . . . -50.52 -47.91 57.27 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -71.36 -25.71 62.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 34' ' ' ASP . . . -63.9 -64.55 0.86 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -53.76 -39.93 65.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 43' ' ' TRP . . . -58.9 -51.12 71.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.4 t80 -44.19 -49.22 9.21 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 22.4 tt0 -70.49 -26.27 63.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.672 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -60.9 -33.83 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 108.509 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.701 ' CH2' ' CD1' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -103.04 -55.36 2.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.725 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -49.08 -35.12 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 3.6 t0 -62.96 -28.77 70.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.401 -0.812 . . . . 0.0 110.596 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 43' ' ' TRP . 7.8 p -108.72 9.68 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -149.74 133.63 8.84 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.52 29.96 0.46 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.764 2.309 . . . . 0.0 111.358 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.511 HD12 ' CG ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -85.57 141.39 29.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.652 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -101.38 121.7 42.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.854 -1.154 . . . . 0.0 109.44 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -94.78 143.2 26.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.741 -0.599 . . . . 0.0 109.449 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -124.47 141.39 52.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.852 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -99.43 162.39 13.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.942 -1.099 . . . . 0.0 108.847 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.564 ' CD1' ' CB ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.86 164.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.707 -1.197 . . . . 0.0 110.02 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.563 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.1 p80 -145.97 38.64 1.09 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.415 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 55' ' ' HIS . 0.4 OUTLIER 169.04 166.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.427 -0.795 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . 75.2 -81.14 0.94 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 54' ' ' ILE . 1.3 tp10 178.33 166.24 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -1.004 . . . . 0.0 108.856 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . . . -138.89 146.78 41.55 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 109.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.59 -57.76 6.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.02 -1.05 . . . . 0.0 108.745 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 18' ' ' TYR . 0.6 OUTLIER -93.46 116.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 120.839 -1.163 . . . . 0.0 109.223 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 4.8 mtm -113.06 114.01 26.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.582 -0.699 . . . . 0.0 109.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.77 153.14 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.139 -0.975 . . . . 0.0 109.839 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 97' ' ' SER . 20.8 p-10 -174.64 -171.47 0.57 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 34.5 p90 -116.21 -171.9 2.08 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.49 ' HA3' ' CD2' ' A' ' 98' ' ' HIS . . . -164.64 116.2 0.69 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HD3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.73 -169.65 2.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -1.171 . . . . 0.0 108.876 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -16.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.472 -0.767 . . . . 0.0 109.92 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' ' 67' ' ' ARG . 12.9 mt-10 -76.55 -105.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.05 . . . . 0.0 110.813 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 1.2 t-80 56.28 -158.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.862 -1.149 . . . . 0.0 108.751 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.57 38.11 0.23 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD1' ' CD2' ' A' ' 70' ' ' HIS . 1.3 m-20 -75.86 4.19 8.58 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.468 -1.019 . . . . 0.0 110.283 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.6 -42.4 2.32 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 16.0 p90 -103.19 160.61 25.64 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.303 . . . . 0.0 110.601 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -78.85 142.05 17.39 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.974 2.45 . . . . 0.0 111.287 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 67' ' ' ARG . 9.1 m-85 -58.34 146.76 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 109.654 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 80' ' ' ASP . 10.9 p-10 -74.23 2.66 8.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.641 -0.662 . . . . 0.0 109.953 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.04 -161.58 41.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 163.72 13.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.016 -1.285 . . . . 0.0 109.438 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.462 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 61.1 m-20 53.72 -170.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 108.698 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 66.71 -144.32 45.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.487 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -38.25 127.02 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.722 -0.869 . . . . 0.0 110.461 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -23.98 9.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 121' ' ' GLU . . . -179.65 162.74 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.717 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.442 ' CD2' ' HD1' ' A' ' 98' ' ' HIS . 2.9 p80 -149.45 167.81 25.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.98 48.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -0.903 . . . . 0.0 110.039 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -81.83 169.68 16.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.951 -1.093 . . . . 0.0 109.858 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 11' ' ' TRP . 35.6 Cg_endo -79.47 140.62 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.078 2.519 . . . . 0.0 111.009 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.54 -43.19 1.54 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.9 p -73.17 159.06 34.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.416 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 -16.86 63.28 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 93' ' ' VAL . 74.4 t -103.66 0.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -1.23 . . . . 0.0 109.168 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.52 159.4 20.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 77.91 -6.37 48.7 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -91.14 130.05 37.07 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.712 -1.463 . . . . 0.0 108.607 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 17.8 m -122.13 142.55 50.28 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.53 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.49 ' CD2' ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -116.13 122.24 44.49 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 108.856 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 26.8 m-85 -98.39 145.22 26.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' OE1' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -46.91 163.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 108.933 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 105' ' ' TRP . 34.3 t70 -117.61 -18.1 9.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.982 -1.074 . . . . 0.0 108.924 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -81.84 -31.41 31.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.127 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.436 ' OE1' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -67.13 161.58 24.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 110.651 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -106.02 106.58 17.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.722 -0.611 . . . . 0.0 109.465 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -116.15 122.74 45.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.0 108.908 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 113' ' ' SER . 1.2 p -149.13 151.3 34.14 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.803 -1.186 . . . . 0.0 110.574 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.457 ' C ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER -111.78 68.59 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.058 . . . . 0.0 110.174 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -172.63 77.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.459 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 108' ' ' THR . 2.4 p 45.67 75.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.464 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.434 ' CB ' ' OG1' ' A' ' 106' ' ' THR . . . -155.77 -158.19 0.79 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -73.47 -114.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 110.471 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -62.15 146.45 50.57 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.067 -1.021 . . . . 0.0 109.843 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 106' ' ' THR . 3.5 m -110.02 110.34 21.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 110.448 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.596 ' CD2' HG22 ' A' ' 32' ' ' VAL . 2.1 tp -39.42 -45.62 1.53 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 110.521 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.555 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 3.7 t80 -54.83 -46.17 74.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -62.65 -72.12 0.14 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 17.4 m -45.21 -49.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.08 -46.31 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.04 -1.038 . . . . 0.0 109.888 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -50.72 -58.82 4.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.721 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 37.6 t60 -42.68 -57.52 2.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.502 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 75.4 mm-40 -71.4 -16.4 62.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.954 -1.091 . . . . 0.0 109.546 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.701 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -81.98 -3.46 54.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 108.24 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.13 -41.38 1.41 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 31.4 m-70 -64.09 -32.01 73.42 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.38 -26.7 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 109.36 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 6.84 46.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 109.747 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.67 -8.65 78.7 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.476 HD23 ' HA3' ' A' ' 157' ' ' GLY . 5.7 mt -44.73 151.36 0.29 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 110.438 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -111.6 176.05 5.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -80.46 169.95 17.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.152 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.547 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -115.07 -22.97 9.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 131' ' ' SER . 9.3 mm100 82.99 -21.72 0.27 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.691 -0.631 . . . . 0.0 110.707 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -74.66 152.41 87.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.877 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.26 -39.54 3.82 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.5 2.134 . . . . 0.0 110.356 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.33 2.14 62.95 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.99 149.09 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -1.214 . . . . 0.0 110.18 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.403 ' HA ' HD13 ' A' ' 137' ' ' LEU . 18.1 tp -80.38 -23.25 40.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.188 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.421 ' HA ' ' CE1' ' A' ' 120' ' ' HIS . 1.1 mpt? -109.87 26.22 10.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.479 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . . . -58.73 164.85 3.68 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.178 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 139' ' ' ALA . 34.4 Cg_endo -78.69 17.18 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.465 2.11 . . . . 0.0 111.195 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 142' ' ' TYR . 15.5 mt -140.66 162.11 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.787 -1.196 . . . . 0.0 110.07 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 141' ' ' ILE . 16.7 t80 -91.68 118.84 31.02 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -108.8 -48.81 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.584 ' CG ' ' N ' ' A' ' 145' ' ' THR . 58.7 t80 60.93 165.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.067 -1.021 . . . . 0.0 109.999 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.584 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 152.6 30.12 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.659 -0.651 . . . . 0.0 109.271 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 6.8 tptm -92.03 -11.62 35.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 148' ' ' PHE . 12.2 m-80 -126.53 -91.98 0.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 150' ' ' LEU . 6.2 t80 156.93 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.13 -0.981 . . . . 0.0 109.724 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -150.95 -40.53 0.12 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.288 -0.883 . . . . 0.0 110.364 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 148' ' ' PHE . 9.6 tp 65.6 144.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.018 -1.051 . . . . 0.0 109.495 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -114.84 131.56 56.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.597 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 12.3 tt0 -48.95 -22.66 0.9 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -48.6 78.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.888 -1.132 . . . . 0.0 108.088 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -73.58 -33.77 64.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.597 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -70.17 -27.53 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.365 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -76.56 -46.62 25.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 110.455 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.476 ' HA3' HD23 ' A' ' 128' ' ' LEU . . . -71.64 -23.12 78.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.517 HG21 ' N ' ' A' ' 159' ' ' GLN . 6.5 tp -81.0 -39.74 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.838 -1.389 . . . . 0.0 108.449 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.517 ' N ' HG21 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -68.61 -22.45 64.44 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -86.13 -25.06 25.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -22.23 42.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.511 ' CG ' HD12 ' A' ' 49' ' ' LEU . 30.3 m-85 -120.3 -69.05 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 108.999 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 9.1 mtpt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER 174.86 45.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.929 -1.107 . . . . 0.0 110.354 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' HB3' ' CE1' ' A' ' 162' ' ' TYR . 12.9 p-10 -144.57 84.52 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.467 -1.395 . . . . 0.0 111.329 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -115.95 49.11 1.14 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 9.8 m-20 65.34 -69.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' LYS . 4.2 mt-30 -80.67 110.35 16.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.995 -1.066 . . . . 0.0 109.103 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.1 mm -104.18 164.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -128.2 137.55 52.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.595 ' CB ' HG13 ' A' ' 61' ' ' ILE . 13.2 p90 -149.15 154.3 38.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.043 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -147.53 125.43 11.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.847 . . . . 0.0 109.865 -178.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 ' CE2' ' A' ' 36' ' ' PHE . 3.4 mt -86.02 124.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 64' ' ' ASN . 2.8 mt -74.18 3.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.89 -1.131 . . . . 0.0 110.43 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.42 112.56 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -61.63 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.113 -1.228 . . . . 0.0 107.788 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.619 HG22 ' CZ ' ' A' ' 65' ' ' PHE . 1.8 t -106.84 137.38 19.48 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.858 -1.151 . . . . 0.0 108.121 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.59 -24.74 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.206 1.938 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.26 -24.83 3.14 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.763 -0.586 . . . . 0.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' CD1' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -138.47 177.0 8.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.878 -1.139 . . . . 0.0 111.002 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 74.8 m-20 -53.87 129.51 56.45 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.649 -0.657 . . . . 0.0 110.436 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.636 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . 27.0 Cg_endo -73.79 -33.65 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 N-CA-C 105.394 -2.579 . . . . 0.0 105.394 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.72 -36.24 82.36 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.7 m -66.27 -71.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.636 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -41.32 -28.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 0.0 108.981 178.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -72.47 -38.37 68.23 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' THR . 24.2 t0 -79.89 -58.57 3.11 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 34' ' ' ASP . . . -36.77 -39.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.642 0.734 . . . . 0.0 109.034 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 37' ' ' ALA . 3.6 m-85 -68.26 -65.78 0.65 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -44.52 -51.02 9.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.773 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -59.26 -52.5 65.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 38' ' ' ARG . . . -43.91 -52.57 6.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -46.38 -40.91 12.79 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -71.56 -20.33 62.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.546 -0.721 . . . . 0.0 110.591 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -86.47 -32.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.259 -1.526 . . . . 0.0 109.196 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.6 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 3.7 m95 -91.13 -19.01 23.56 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.605 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 28.9 t -91.37 -23.04 20.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 8.4 m-20 -65.34 -5.55 7.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.245 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.64 ' CG2' ' HB ' ' A' ' 155' ' ' ILE . 12.2 p -120.49 4.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 7.9 t -159.08 149.05 15.16 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.598 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -79.11 49.59 3.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.337 2.025 . . . . 0.0 109.856 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.556 HD21 ' CE2' ' A' ' 162' ' ' TYR . 4.8 tp -93.67 150.56 20.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.3 -0.875 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -122.95 136.79 54.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 109.073 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 51' ' ' PHE . 6.7 m-85 -112.56 149.72 32.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.929 -1.107 . . . . 0.0 110.183 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -125.11 126.68 45.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.208 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 6.0 mtm-85 -77.97 126.73 31.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 108.481 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -113.64 141.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.223 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 55' ' ' HIS . 4.5 m170 -72.44 -145.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.53 -174.13 4.1 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 108.636 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 58' ' ' GLU . . . 93.63 42.64 4.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 64.43 160.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -1.041 . . . . 0.0 109.203 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -153.46 148.94 27.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -53.55 -59.97 3.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 108.802 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.595 HG13 ' CB ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -104.57 124.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 74.9 mtp -111.96 113.88 26.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 110.987 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 64' ' ' ASN . 1.6 mp -102.71 159.7 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.8 p-10 174.99 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.445 -0.784 . . . . 0.0 109.397 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.619 ' CZ ' HG22 ' A' ' 24' ' ' THR . 32.4 m-85 -115.41 175.67 5.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.63 90.88 0.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -71.87 -145.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 108.059 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 67' ' ' ARG . 5.4 m95 -63.22 -147.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.485 -1.385 . . . . 0.0 108.648 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 47.79 -143.54 0.4 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.03 -1.044 . . . . 0.0 109.927 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 0.1 OUTLIER 68.02 156.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -130.72 23.94 4.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.3 74.95 0.09 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.462 -1.022 . . . . 0.0 108.99 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 63.48 -87.51 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 3.1 m-85 -108.71 117.98 52.87 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.294 -1.121 . . . . 0.0 108.713 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.52 158.38 40.19 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.68 1.586 . . . . 0.0 109.916 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 17.8 t80 62.64 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 80.95 -46.17 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.15 -157.56 23.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -57.31 165.5 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -1.163 . . . . 0.0 108.826 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 3.3 m-20 43.69 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.229 -0.919 . . . . 0.0 111.135 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 61.17 -142.32 48.4 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.461 ' HB3' ' OD2' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -40.08 106.83 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.655 -0.909 . . . . 0.0 109.347 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 84' ' ' ALA . 1.8 mt -111.21 -26.92 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 83' ' ' LEU . . . 165.05 152.93 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.385 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -152.24 177.05 10.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.411 -0.806 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.471 ' HB1' ' OE1' ' A' ' 121' ' ' GLU . . . -140.22 155.92 46.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 108.775 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 156.22 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 110.078 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.27 162.47 73.58 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.75 136.76 23.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.807 2.338 . . . . 0.0 111.112 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.66 -165.82 28.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -86.48 117.96 25.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -1.086 . . . . 0.0 110.339 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.64 -89.81 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.32 119.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.082 -1.246 . . . . 0.0 109.065 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.39 158.65 8.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 61' ' ' ILE . . . 67.27 6.9 42.42 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' MET . 2.7 m-20 -97.98 140.83 31.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -1.194 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.8 131.15 25.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.02 . . . . 0.0 109.769 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 1.9 m170 -106.32 135.5 47.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.029 -1.044 . . . . 0.0 109.309 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 58.9 m-85 -96.52 158.83 15.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.457 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -55.43 129.42 38.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.698 -0.627 . . . . 0.0 109.683 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.14 -70.27 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 22.3 p-10 -60.7 86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 110.592 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -179.48 179.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.532 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 63.8 tp -119.32 100.77 7.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.906 -1.121 . . . . 0.0 109.385 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.506 ' C ' ' CG2' ' A' ' 106' ' ' THR . 24.4 m0 -112.45 173.91 6.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.246 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 113' ' ' SER . 0.5 OUTLIER 179.62 162.65 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.969 -1.082 . . . . 0.0 110.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 115' ' ' PHE . 2.1 t-20 -104.84 21.74 16.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 109.869 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -124.01 -179.7 4.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.512 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 108' ' ' THR . 8.1 t -66.69 69.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.377 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -160.41 115.96 2.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.424 -0.798 . . . . 0.0 109.104 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t-20 64.96 -150.3 0.26 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.443 -0.786 . . . . 0.0 108.984 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HD2' ' CD1' ' A' ' 105' ' ' TRP . 42.3 m-85 -67.88 -147.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.094 . . . . 0.0 108.4 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 106' ' ' THR . 22.4 t -148.71 98.64 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.061 -1.024 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -35.69 -57.97 0.63 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.384 -0.822 . . . . 0.0 111.286 -179.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -49.66 -40.57 40.25 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.168 -0.958 . . . . 0.0 109.792 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 115' ' ' PHE . 3.0 tm? -70.36 -55.14 9.83 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 110.521 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 114' ' ' LEU . 35.7 m -58.36 -48.63 84.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 O-C-N 120.437 -1.414 . . . . 0.0 108.057 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -46.56 -52.37 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.94 -1.1 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.03 -54.53 6.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 108.605 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 138' ' ' MET . 43.8 t60 -46.48 -64.63 0.71 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.102 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 66.3 mm-40 -63.23 -15.34 56.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.772 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.6 m-85 -82.12 -10.61 59.13 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.6 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -99.31 -48.38 1.71 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.44 ' CD2' ' NE2' ' A' ' 120' ' ' HIS . 12.8 m-70 -55.93 -40.54 73.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -1.07 . . . . 0.0 108.856 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.31 -4.66 18.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.465 -0.772 . . . . 0.0 109.554 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.495 ' HG2' ' OH ' ' A' ' 162' ' ' TYR . 26.7 mtt -103.04 -14.84 16.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 0.0 110.902 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.22 -11.67 12.91 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.677 -1.264 . . . . 0.0 110.678 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.498 ' CD1' ' OD1' ' A' ' 154' ' ' ASP . 30.9 mt -81.07 138.53 35.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.897 -1.355 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.39 178.27 4.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 138' ' ' MET . 50.4 m170 -55.53 148.28 16.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 0.0 110.247 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.4 p -112.39 -173.14 2.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -108.03 -14.46 14.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.004 -1.06 . . . . 0.0 109.715 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -70.04 134.72 87.46 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 133' ' ' ASP . 33.2 Cg_endo -79.51 109.84 2.55 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 123.056 2.504 . . . . 0.0 110.115 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.78 -2.77 17.48 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.11 170.7 1.53 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.353 -1.086 . . . . 0.0 109.406 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 137' ' ' LEU . 8.3 tp -84.68 -25.86 28.15 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.782 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.597 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 2.9 mmt -97.79 4.23 49.84 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.989 -1.069 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 141' ' ' ILE . . . -41.69 156.75 0.22 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.13 2.37 7.71 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.426 2.084 . . . . 0.0 111.574 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 139' ' ' ALA . 0.4 OUTLIER -129.46 160.94 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.915 -1.116 . . . . 0.0 108.196 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.557 ' O ' ' CB ' ' A' ' 143' ' ' THR . 75.0 t80 -56.52 -82.28 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.563 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.557 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 3.2 m 81.59 -33.56 0.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.039 -1.038 . . . . 0.0 111.792 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CB ' ' O ' ' A' ' 143' ' ' THR . 3.0 t80 71.59 175.23 0.29 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.686 -1.259 . . . . 0.0 109.426 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.619 ' OG1' ' N ' ' A' ' 148' ' ' PHE . 4.6 p -85.34 4.28 35.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 109.119 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.602 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 46.99 47.73 15.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.232 -0.917 . . . . 0.0 110.435 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.4 t30 89.16 21.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.619 ' N ' ' OG1' ' A' ' 145' ' ' THR . 48.7 t80 52.34 164.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 109.938 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.567 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 165.2 -22.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.61 -178.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.605 HD22 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 69.01 123.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 108.881 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.571 ' O ' HG22 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.62 134.99 49.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.032 -1.042 . . . . 0.0 110.668 -178.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.59 ' HA ' HG22 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -50.61 -19.99 1.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.38 -56.06 26.78 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.688 -1.257 . . . . 0.0 108.055 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.587 ' OD2' ' CZ2' ' A' ' 43' ' ' TRP . 4.2 t0 -68.46 -32.13 71.91 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.64 ' HB ' ' CG2' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -69.29 -37.39 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.603 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 155' ' ' ILE . 8.4 tmtt? -61.73 -49.32 76.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.304 -0.873 . . . . 0.0 109.39 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -68.25 -39.83 87.84 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.467 HG23 ' HB ' ' A' ' 47' ' ' THR . 2.7 tp -66.17 -17.65 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.841 -1.388 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 163' ' ' GLY . 66.0 mt-30 -87.82 -49.02 7.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.092 . . . . 0.0 109.282 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -13.63 62.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 0.0 109.278 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -101.76 -42.3 6.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.839 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.556 ' CE2' HD21 ' A' ' 49' ' ' LEU . 21.8 m-30 -107.17 -13.21 15.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.794 -1.191 . . . . 0.0 110.312 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.497 ' HE2' ' CG ' ' A' ' 89' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' LYS . 14.6 m95 -37.5 110.64 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.56 -0.712 . . . . 0.0 110.338 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.7 p-10 -128.81 54.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -108.84 -167.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.287 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -108.57 -41.7 4.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.023 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 19.3 mt-30 -92.92 116.77 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.071 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -111.45 161.07 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.039 -1.038 . . . . 0.0 109.595 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.3 p -131.69 126.07 33.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.397 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 34.1 p90 -137.05 148.53 46.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -144.33 140.85 29.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.075 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.551 HD13 ' CZ ' ' A' ' 23' ' ' TYR . 2.2 mp -92.89 161.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -108.38 -39.72 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . -161.58 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.222 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.551 ' CZ ' HD13 ' A' ' 20' ' ' ILE . 15.5 m-85 -45.74 172.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -1.183 . . . . 0.0 108.962 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.529 ' CG2' HD13 ' A' ' 27' ' ' LEU . 9.9 t -97.98 145.41 29.74 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 34.2 Cg_endo -78.29 -28.69 4.47 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.313 2.009 . . . . 0.0 111.22 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD2' HG21 ' A' ' 106' ' ' THR . 3.9 t70 -41.56 -28.49 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.868 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -133.33 179.68 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.037 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.548 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -73.6 152.27 89.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.245 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.686 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . 26.5 Cg_endo -67.08 -32.61 34.02 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.872 2.381 . . . . 0.0 105.971 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.48 -31.95 71.6 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.4 m -72.84 -69.39 0.42 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.686 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -40.97 -31.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.452 -0.78 . . . . 0.0 109.052 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 4.6 t0 -79.84 -33.05 40.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 31' ' ' THR . 21.7 t70 -78.93 -44.88 21.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 108.589 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -44.62 -48.9 10.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -71.44 -44.99 63.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.405 -0.81 . . . . 0.0 108.934 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -51.37 -54.17 29.09 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -53.32 -42.47 66.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -56.54 -49.67 74.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 44' ' ' SER . 10.1 t80 -47.22 -33.76 5.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -86.81 -24.05 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.712 -0.617 . . . . 0.0 109.72 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.648 ' CG2' ' CE1' ' A' ' 148' ' ' PHE . 0.3 OUTLIER -59.59 -35.34 58.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.258 -0.902 . . . . 0.0 108.851 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.628 ' NE1' ' CG1' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -105.96 -49.66 3.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.454 -0.779 . . . . 0.0 110.104 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 48.2 t -53.83 -21.7 8.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.178 -0.951 . . . . 0.0 110.639 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 6.2 m-20 -67.12 -13.89 62.38 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG23 HG23 ' A' ' 47' ' ' THR . 32.8 m -122.01 -20.83 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 0.0 110.434 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.466 ' CG2' HG21 ' A' ' 158' ' ' ILE . 54.0 p -122.58 143.8 40.77 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 109.405 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.05 57.99 4.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.097 1.864 . . . . 0.0 108.945 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 162' ' ' TYR . 3.0 mm? -84.64 144.84 28.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.904 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 50' ' ' ARG . 9.3 tpm_? -116.6 66.64 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 108.778 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 47.2 m-85 -59.5 148.68 32.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 108.92 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 16' ' ' ILE . 3.4 t -139.32 106.65 5.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.522 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 2.3 ptt85 -76.6 126.57 31.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 108.752 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 58' ' ' GLU . 6.3 pt -117.95 166.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.937 -1.102 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 55' ' ' HIS . 9.7 p80 -154.01 70.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.071 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.44 6.01 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.725 -1.235 . . . . 0.0 109.824 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 58' ' ' GLU . . . 106.76 32.72 3.5 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 172.18 158.35 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.178 -1.189 . . . . 0.0 109.701 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 54' ' ' ILE . . . 178.95 143.04 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.764 . . . . 0.0 109.034 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.56 -57.38 9.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.077 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 9.8 mt -90.51 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.169 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.517 ' CB ' ' HB3' ' A' ' 96' ' ' ASP . 2.7 mtt -147.35 118.2 7.62 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.813 . . . . 0.0 109.776 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 2.0 mp -105.82 148.95 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' N ' HG22 ' A' ' 63' ' ' ILE . 5.8 t30 176.44 -156.25 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.225 -0.922 . . . . 0.0 109.274 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -127.43 171.21 11.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.905 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.52 86.52 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.016 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 68' ' ' TRP . 1.4 ptt85 -78.26 -160.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.099 -1.236 . . . . 0.0 109.686 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.541 ' C ' ' CE3' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -42.95 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.256 -0.903 . . . . 0.0 110.562 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -36.74 95.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.58 -0.7 . . . . 0.0 110.374 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' TRP . 2.2 t-80 -168.57 -61.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 76.77 -2.66 58.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 74' ' ' TYR . 4.1 p-10 -56.1 83.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.155 -1.203 . . . . 0.0 110.13 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 61.18 -75.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 72' ' ' ASP . 24.3 m-85 -100.69 137.11 19.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.274 . . . . 0.0 110.146 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.15 -157.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.576 2.184 . . . . 0.0 109.221 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -80.63 140.66 35.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.134 . . . . 0.0 109.153 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 40.2 p-10 -116.19 -15.6 11.05 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.05 -154.43 33.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' ASP . 1.1 mttt -47.25 154.6 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -1.171 . . . . 0.0 110.843 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' LYS . 15.6 m-20 49.5 -177.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.621 -0.674 . . . . 0.0 110.18 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 76.39 -144.97 31.24 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 28.6 tp -40.27 116.61 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.493 -1.004 . . . . 0.0 110.022 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' GLY . 57.8 mt -112.02 -28.16 8.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB1' ' OE2' ' A' ' 121' ' ' GLU . . . 176.47 147.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 109.771 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -150.16 179.52 8.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -148.13 158.23 43.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.0 108.993 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.46 155.73 18.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.226 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -55.51 155.14 10.75 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.579 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.497 ' CG ' ' HE2' ' A' ' 10' ' ' LYS . 33.5 Cg_endo -75.2 141.41 26.03 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.761 2.307 . . . . 0.0 110.436 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.9 177.48 48.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.96 114.18 15.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.237 . . . . 0.0 109.236 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.78 -85.51 0.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.16 156.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -1.131 . . . . 0.0 108.928 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 109.69 156.22 16.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.559 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 74.83 -0.54 57.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -98.83 137.83 36.84 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.872 -1.369 . . . . 0.0 109.118 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -132.26 130.85 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.905 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -111.66 133.79 53.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.312 -0.867 . . . . 0.0 108.828 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 3.7 m-30 -95.95 159.8 14.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.544 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CB ' ' OE1' ' A' ' 103' ' ' GLU . 1.6 t70 -58.83 136.81 57.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 109.359 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.92 -9.2 58.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.229 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.5 -42.19 12.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.786 . . . . 0.0 109.742 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.483 ' OE1' ' CB ' ' A' ' 100' ' ' ASP . 3.1 mp0 -72.7 140.93 48.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.74 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.21 128.18 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.427 -0.795 . . . . 0.0 109.277 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 99' ' ' PHE . 1.9 m-90 -101.01 166.56 10.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 114' ' ' LEU . 82.6 p -149.46 -168.3 3.07 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.056 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.521 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 2.6 p30 -135.2 6.33 3.32 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.128 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 109' ' ' SER . 11.1 t -139.22 -152.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.237 -0.915 . . . . 0.0 109.98 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' HG21 ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.91 108.77 18.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.4 -0.813 . . . . 0.0 108.87 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.8 -97.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.262 -0.899 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.79 -78.05 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.069 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.467 ' HB3' ' HA ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -100.92 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.127 -0.983 . . . . 0.0 109.073 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -164.61 114.63 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 106' ' ' THR . 8.4 tp -50.16 -70.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.5 -0.75 . . . . 0.0 110.318 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' LEU . 8.0 t80 -39.5 -27.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.427 -0.795 . . . . 0.0 110.173 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -78.57 -71.6 0.42 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.836 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 118' ' ' ALA . 14.6 m -52.46 -42.43 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.917 -1.115 . . . . 0.0 109.154 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 114' ' ' LEU . . . -55.88 -45.92 78.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.69 68.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.229 -0.919 . . . . 0.0 108.87 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -60.52 -54.06 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 124' ' ' HIS . 73.5 mm-40 -69.05 -53.36 20.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.133 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.622 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 13.4 m-85 -49.59 -24.09 1.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.955 -1.091 . . . . 0.0 108.47 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.45 -27.53 24.74 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 2.1 m-70 -76.3 -48.23 20.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.689 -0.889 . . . . 0.0 109.183 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -42.88 -27.49 0.19 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.609 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -71.9 -98.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.782 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.58 29.14 0.19 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.76 144.84 24.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.742 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -119.96 151.78 38.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 138' ' ' MET . 12.2 m-70 -51.29 117.6 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 110.015 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -88.76 -80.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.082 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 131' ' ' SER . 5.6 tt0 177.03 -34.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' HB1' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -43.0 139.6 2.13 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.105 -0.997 . . . . 0.0 110.138 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.54 -38.86 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.431 2.088 . . . . 0.0 109.812 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.15 17.48 53.36 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 133' ' ' ASP . . . -85.09 149.42 25.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.066 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.45 ' O ' HD13 ' A' ' 137' ' ' LEU . 0.0 OUTLIER -75.76 -10.99 59.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.583 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 0.8 OUTLIER -106.42 11.96 30.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.83 84.96 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.913 -1.117 . . . . 0.0 108.955 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . 0.403 ' HD2' HD13 ' A' ' 141' ' ' ILE . 33.6 Cg_endo -76.78 9.19 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.755 2.303 . . . . 0.0 111.477 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.403 HD13 ' HD2' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -134.63 137.79 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 109.307 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.583 ' OH ' ' CD1' ' A' ' 144' ' ' TYR . 2.9 t80 -84.78 128.72 34.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.424 -0.798 . . . . 0.0 110.186 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' TYR . 96.2 m -122.16 100.26 6.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CD1' ' OH ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -40.21 149.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -0.808 . . . . 0.0 110.26 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.1 t -149.56 102.88 3.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -16.93 32.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.442 -0.786 . . . . 0.0 110.269 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 148' ' ' PHE . 1.1 t30 -95.25 -19.62 19.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.766 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.648 ' CE1' ' CG2' ' A' ' 42' ' ' VAL . 9.4 t80 49.2 104.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.701 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -121.32 -20.69 6.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 109.209 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 149' ' ' ARG . 15.5 tp 66.47 147.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.555 ' CB ' ' OD1' ' A' ' 153' ' ' ASP . 3.7 m -114.97 138.58 50.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 109.889 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.637 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 19.6 tt0 -49.09 -31.42 7.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 110.533 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.555 ' OD1' ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -46.3 -50.03 16.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.565 -1.334 . . . . 0.0 108.638 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -75.17 -31.33 60.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.474 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.637 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -69.69 -26.05 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 108.991 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -74.85 -53.57 8.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.252 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -59.32 -41.07 96.71 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.486 HG23 ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -75.78 -22.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -1.232 . . . . 0.0 109.751 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 163' ' ' GLY . 36.6 mt-30 -79.25 -42.21 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 108.931 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.17 -22.86 15.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.537 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 17.6 m-85 -130.61 -24.99 2.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.589 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.537 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 172.05 42.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 16.1 p-10 -130.35 99.76 5.13 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLN . 2.4 mtmt -120.92 34.52 5.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.43 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.9 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.097 -1.002 . . . . 0.0 108.586 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt-30 -86.94 104.93 16.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.277 -0.89 . . . . 0.0 108.672 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 mt -112.84 153.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 52' ' ' SER . 0.0 OUTLIER -115.19 148.41 39.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.565 ' CB ' HG13 ' A' ' 61' ' ' ILE . 15.9 p90 -151.94 155.24 37.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.932 . . . . 0.0 109.797 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -148.84 133.48 17.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.746 -179.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -96.17 124.85 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.917 -1.114 . . . . 0.0 108.834 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 64' ' ' ASN . 2.8 mp -76.74 -1.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 0.0 109.474 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.71 100.81 0.17 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.438 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.587 ' CG ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.88 -163.52 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -94.58 148.35 34.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.94 -1.1 . . . . 0.0 108.94 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' LEU . 35.1 Cg_endo -83.59 -29.11 1.16 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.559 2.839 . . . . 0.0 110.603 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -41.96 -26.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.57 -0.706 . . . . 0.0 109.528 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.4 166.03 20.36 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.266 -0.896 . . . . 0.0 109.613 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -58.63 147.95 68.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.492 -0.755 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' O ' HG11 ' A' ' 32' ' ' VAL . 28.9 Cg_endo -67.64 -34.85 24.04 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 106.131 -2.296 . . . . 0.0 106.131 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.58 -28.33 60.88 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.579 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 2.9 m -72.88 -63.42 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.587 HG12 ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -45.92 -39.54 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.557 -0.714 . . . . 0.0 109.354 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 19.5 t0 -67.56 -29.84 69.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.1 t70 -61.39 -50.52 72.55 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.84 -39.38 5.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 109.317 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 85.5 m-85 -73.11 -36.2 66.7 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.687 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -56.0 -57.59 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 108.516 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' ALA . 2.7 mtm180 -61.34 -51.61 68.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -45.23 -48.99 12.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.584 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 28.6 t80 -49.99 -44.74 51.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 108.879 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 8.1 tt0 -79.87 -19.13 49.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 109.912 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.645 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -62.58 -36.08 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.028 -1.045 . . . . 0.0 108.502 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.645 ' CD1' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -108.42 -46.67 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.725 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -51.33 -20.3 1.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.053 . . . . 0.0 110.042 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.2 m-20 -64.92 -10.31 27.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 110.473 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.15 -18.88 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.991 -1.068 . . . . 0.0 109.861 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.552 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -131.67 155.03 81.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 108.846 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.552 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 31.8 Cg_endo -77.84 49.15 2.85 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.748 2.298 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.38 162.5 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.932 0.873 . . . . 0.0 111.182 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 1.1 tpt180 -138.4 116.73 11.92 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 40' ' ' PHE . 3.3 m-85 -99.9 136.66 39.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.749 -1.219 . . . . 0.0 109.399 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -123.05 100.84 7.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.1 tmt_? -80.39 135.79 36.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.882 -1.136 . . . . 0.0 109.451 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -111.12 163.47 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.506 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -119.75 -29.33 5.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -0.962 . . . . 0.0 108.961 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.65 98.65 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.41 -173.31 32.92 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.68 161.96 25.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.271 . . . . 0.0 110.394 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 19' ' ' ARG . . . -143.71 153.11 42.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 108.978 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -77.12 -49.35 15.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.931 -1.106 . . . . 0.0 109.313 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.578 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.99 131.28 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.53 ' CB ' ' CG ' ' A' ' 96' ' ' ASP . 4.3 ttm -116.35 115.81 26.58 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.149 -0.969 . . . . 0.0 109.2 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 9.3 mt -108.5 148.38 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.085 -1.01 . . . . 0.0 109.689 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 29.3 t30 177.93 159.79 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CE1' ' HG3' ' A' ' 67' ' ' ARG . 35.7 p90 -83.32 175.16 10.09 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 108.665 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 68' ' ' TRP . . . -113.39 -27.17 3.71 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 62.7 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -1.228 . . . . 0.0 109.813 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TRP . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 36.1 t-105 -165.35 -56.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.843 -1.16 . . . . 0.0 109.331 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.55 74.16 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.645 -0.66 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -106.86 -66.39 1.02 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 84.96 -10.39 63.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 3.2 m-20 -62.65 73.4 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.509 -0.995 . . . . 0.0 108.893 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 59.84 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -86.28 138.25 34.42 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.122 -1.223 . . . . 0.0 109.644 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -175.06 2.54 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.405 2.07 . . . . 0.0 110.29 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -76.35 150.87 36.8 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.12 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' OD2' ' HA3' ' A' ' 81' ' ' GLY . 20.3 p-10 -115.07 -14.18 11.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 72.33 -92.12 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 80' ' ' ASP . 5.0 mttt -45.75 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.56 -0.964 . . . . 0.0 109.379 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -25.69 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.436 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 33.26 -139.24 0.1 Allowed Glycine 0 N--CA 1.502 3.093 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 81' ' ' GLY . 33.8 tp -37.18 118.67 0.63 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.885 . . . . 0.0 110.098 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' CE2' ' A' ' 112' ' ' TYR . 6.9 mt -105.2 -26.44 12.05 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.609 ' CB ' ' CD1' ' A' ' 99' ' ' PHE . . . 170.5 175.94 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 109.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.438 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 55.5 p-80 -177.62 149.08 0.6 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.898 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -132.35 175.62 9.12 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.63 156.87 26.29 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.602 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . . . -57.09 -178.98 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 88' ' ' ALA . 38.1 Cg_endo -80.57 144.36 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 11' ' ' TRP . . . -174.16 -172.2 39.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 92' ' ' GLY . 21.3 m -67.13 -96.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -1.04 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.435 ' N ' HG21 ' A' ' 91' ' ' THR . . . -70.09 -81.21 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.9 172.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -1.143 . . . . 0.0 108.888 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 96.92 150.94 27.46 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.578 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 62.07 9.67 22.95 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.343 -1.093 . . . . 0.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.53 ' CG ' ' CB ' ' A' ' 62' ' ' MET . 32.5 m-20 -102.37 134.52 45.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.082 -1.834 . . . . 0.0 109.248 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -112.36 120.66 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.948 . . . . 0.0 110.523 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 8.1 m80 -95.23 129.11 42.47 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.609 ' CD1' ' CB ' ' A' ' 84' ' ' ALA . 8.3 m-30 -108.89 147.38 32.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.0 110.088 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 76' ' ' PHE . 9.3 t70 -76.88 112.16 13.18 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 103' ' ' GLU . 46.9 t0 -55.48 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.217 -0.927 . . . . 0.0 111.204 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' ASP . 1.9 m-20 -40.03 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 110.439 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 175.09 156.9 0.17 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.0 124.83 50.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.975 -1.078 . . . . 0.0 111.68 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 112' ' ' TYR . 6.8 m0 -122.35 172.3 8.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 6.4 p -145.19 141.3 28.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.579 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 4.9 t-20 -103.26 27.99 6.76 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' SER . 8.8 t -142.05 25.89 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.468 -1.395 . . . . 0.0 110.626 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 0.9 OUTLIER 70.68 89.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.815 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.541 ' O ' ' CG2' ' A' ' 106' ' ' THR . . . 174.87 137.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.471 -0.768 . . . . 0.0 109.156 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.59 -149.04 0.27 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.859 -1.151 . . . . 0.0 108.651 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.618 ' CE2' ' CD2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -65.17 -34.71 79.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.81 -1.181 . . . . 0.0 108.097 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 112' ' ' TYR . 0.7 OUTLIER 75.38 124.73 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 110.393 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -66.55 -35.02 79.2 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.158 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -68.69 -43.29 76.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -178.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.522 HD13 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -64.58 -62.46 1.57 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.771 -1.205 . . . . 0.0 109.562 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.462 HG12 ' NE1' ' A' ' 105' ' ' TRP . 18.1 m -44.12 -46.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.209 -0.932 . . . . 0.0 109.61 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -62.49 -47.85 82.17 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.955 -1.091 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -48.36 -63.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.583 -0.698 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -46.62 -54.18 10.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.206 -0.934 . . . . 0.0 109.521 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.34 -18.81 65.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.963 -1.086 . . . . 0.0 108.254 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -81.89 -8.22 59.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -97.03 -37.89 4.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . 0.468 ' CE1' ' CD2' ' A' ' 130' ' ' HIS . 55.3 m-70 -74.19 -47.41 35.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.33 -27.09 0.95 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.173 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 10.8 mtt -79.29 7.99 6.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.271 -0.893 . . . . 0.0 109.822 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' HIS . . . 92.79 -23.75 27.22 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -53.54 141.57 25.04 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.337 -1.096 . . . . 0.0 108.986 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.04 -176.43 2.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 109.528 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CD2' ' CE1' ' A' ' 124' ' ' HIS . 24.6 m170 -63.75 132.59 51.45 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -90.25 -115.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -159.41 -48.64 0.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.696 -1.253 . . . . 0.0 109.261 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 132' ' ' GLN . 0.9 OUTLIER -42.38 124.83 2.85 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.979 . . . . 0.0 109.718 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -78.37 108.01 2.4 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.093 1.862 . . . . 0.0 109.386 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 124.27 -13.83 7.87 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.33 157.66 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.379 -1.071 . . . . 0.0 110.352 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.459 ' HA ' HD12 ' A' ' 137' ' ' LEU . 14.2 tp -63.13 -24.77 68.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.44 ' CE ' ' HG ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -102.7 12.92 35.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.57 149.2 84.87 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.702 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -77.27 21.11 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.959 2.44 . . . . 0.0 110.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.46 145.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.888 -1.133 . . . . 0.0 110.396 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -69.34 148.07 50.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 m -161.97 -33.46 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.634 ' CD1' ' N ' ' A' ' 145' ' ' THR . 42.9 t80 59.24 166.06 0.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.4 -0.813 . . . . 0.0 109.057 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.634 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 1.2 t -150.13 115.31 5.41 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.844 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -39.94 42.92 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.092 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 44.6 t-20 -73.25 -48.38 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.076 -1.015 . . . . 0.0 108.511 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.616 ' CZ ' ' HG ' ' A' ' 150' ' ' LEU . 39.7 t80 75.45 139.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.39 0.614 . . . . 0.0 109.68 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 1.6 tpt180 -155.65 -25.06 0.11 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.316 -0.865 . . . . 0.0 110.889 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.616 ' HG ' ' CZ ' ' A' ' 148' ' ' PHE . 6.2 mt 65.66 83.36 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -53.87 140.36 30.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.611 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 mt-30 -55.23 -35.3 64.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.355 -0.84 . . . . 0.0 108.994 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -47.01 -33.81 5.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.531 -1.356 . . . . 0.0 108.889 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' HE2' ' A' ' 138' ' ' MET . 34.1 t70 -89.1 -28.42 20.11 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ILE . . . . . 0.611 ' CG2' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -71.03 -34.48 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 2.2 ttmt -73.29 -56.86 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -51.0 -37.29 36.06 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 155' ' ' ILE . 1.0 OUTLIER -83.49 -14.9 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -70.34 -57.13 5.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 13.1 mm-40 -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.759 -0.588 . . . . 0.0 109.474 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.461 ' N ' HD22 ' A' ' 161' ' ' LEU . 0.8 OUTLIER -73.4 -29.43 62.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -0.779 . . . . 0.0 111.024 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 126' ' ' MET . 42.4 m-85 -131.24 -51.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.471 -1.393 . . . . 0.0 109.174 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' ASN . 1.5 mmm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 53.48 -89.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 108.937 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.6 m-20 -148.45 -178.54 6.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.124 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -74.96 150.18 39.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.467 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.3 m-85 -127.87 165.55 29.52 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 35.0 Cg_endo -76.03 41.86 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.841 2.36 . . . . 0.0 112.031 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 71.79 -49.23 0.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.837 -1.165 . . . . 0.0 111.236 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -78.13 117.06 63.7 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.743 -1.223 . . . . 0.0 109.964 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 10' ' ' LYS . 32.2 Cg_endo -73.04 80.67 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.152 1.902 . . . . 0.0 108.84 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -30.88 134.05 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.375 0.607 . . . . 0.0 110.704 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.539 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -57.89 134.57 56.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 109.238 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -175.87 74.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.458 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' NZ ' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -164.01 139.94 6.37 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.338 -0.851 . . . . 0.0 109.905 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 4.2 p-10 -53.98 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 5.1 mt-30 47.67 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.959 -1.088 . . . . 0.0 110.305 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.463 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -115.25 149.96 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.7 132.51 56.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.852 -1.155 . . . . 0.0 109.383 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' CB ' HG13 ' A' ' 61' ' ' ILE . 44.0 p90 -140.49 151.92 45.2 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.252 -0.905 . . . . 0.0 109.902 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 18.4 tpt180 -150.75 119.71 6.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.759 . . . . 0.0 109.372 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.444 ' HA ' ' HB ' ' A' ' 63' ' ' ILE . 2.7 mp -70.51 138.82 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 27.8 mm -82.89 -5.47 9.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.79 105.67 0.19 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.657 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.668 ' CD2' ' CG1' ' A' ' 32' ' ' VAL . 3.8 m-30 -51.91 168.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.334 -1.098 . . . . 0.0 109.306 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 26' ' ' ASP . 5.3 t -109.89 148.75 38.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.974 . . . . 0.0 109.762 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.469 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.3 Cg_endo -82.06 -36.39 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.883 2.389 . . . . 0.0 111.622 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 24' ' ' THR . 0.7 OUTLIER -42.43 -26.59 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.208 -0.933 . . . . 0.0 110.007 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' CD2' ' HB ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.89 168.35 17.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.017 -1.052 . . . . 0.0 109.272 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CB ' ' OG1' ' A' ' 31' ' ' THR . 0.5 OUTLIER -57.4 147.79 57.29 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 108.787 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 29.6 Cg_endo -70.25 -45.85 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -69.61 -21.12 63.6 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.532 ' OG1' ' CB ' ' A' ' 28' ' ' ASP . 47.8 m -76.78 -50.06 14.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.138 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.668 ' CG1' ' CD2' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -55.33 -34.4 33.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.39 -39.88 92.31 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.043 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -44.43 27.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.534 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.33 -29.34 33.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.172 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.61 -44.09 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.305 -0.872 . . . . 0.0 108.96 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -61.01 -52.78 63.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -51.37 -58.56 5.91 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -45.32 -51.14 11.43 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -46.17 -50.23 15.91 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.327 -0.858 . . . . 0.0 110.003 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG13 ' N ' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -64.71 -32.82 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.9 -1.125 . . . . 0.0 108.915 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.533 ' N ' HG13 ' A' ' 42' ' ' VAL . 4.7 m95 -100.54 -25.15 14.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -77.82 -18.25 56.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.094 -1.004 . . . . 0.0 108.39 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 43.7 t0 -71.46 -14.27 62.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.081 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 43' ' ' TRP . 3.7 p -102.92 10.7 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.284 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 9.2 t -178.13 148.15 0.63 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 109.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 34.6 Cg_endo -76.01 56.84 4.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.551 2.167 . . . . 0.0 110.393 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 162' ' ' TYR . 9.2 tp -85.89 147.7 26.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.362 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -113.05 110.88 21.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.549 ' CE1' HD23 ' A' ' 49' ' ' LEU . 39.7 m-85 -97.01 141.78 29.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 109.478 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -132.42 125.09 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.27 140.35 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.534 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.518 ' CD1' ' HB1' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.38 -168.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.77 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -176.15 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -163.31 -32.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 110.199 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.54 27.9 17.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.9 OUTLIER 58.04 170.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -1.193 . . . . 0.0 109.161 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 54' ' ' ILE . . . -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.04 -1.038 . . . . 0.0 110.672 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CG ' ' CZ2' ' A' ' 11' ' ' TRP . 79.1 m-20 -58.91 -47.86 83.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.527 HG23 ' HA3' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -102.15 126.42 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 6.9 mtp -116.48 125.17 51.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 109.567 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.506 HG21 ' N ' ' A' ' 64' ' ' ASN . 2.6 mp -105.09 158.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.715 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.528 ' ND2' ' HB ' ' A' ' 21' ' ' ILE . 3.2 t-20 178.85 -138.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.141 -0.974 . . . . 0.0 109.816 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.77 -174.77 2.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.875 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 67' ' ' ARG . . . -106.63 -19.34 9.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 37.8 mtt180 60.75 170.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -1.211 . . . . 0.0 110.46 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 75' ' ' PRO . 41.0 m0 -81.33 -42.81 19.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 0.0 109.15 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 44.9 mt-10 -75.85 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.839 . . . . 0.0 109.077 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 1.5 t-80 78.17 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 72' ' ' ASP . . . 120.68 -22.51 8.18 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 71' ' ' GLY . 7.3 m-20 -37.72 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.591 -0.947 . . . . 0.0 110.017 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.95 31.18 0.08 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -179.67 74.32 0.18 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.447 -1.031 . . . . 0.0 108.405 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 76' ' ' PHE . 32.5 Cg_endo -73.21 134.43 21.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.612 2.208 . . . . 0.0 111.847 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.5 p90 50.53 158.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.332 1.063 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 1.4 p-10 178.56 -29.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 51.74 -156.84 3.42 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 78' ' ' GLY . 3.5 mttp 43.56 -173.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.229 1.014 . . . . 0.0 110.517 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.473 ' O ' HD22 ' A' ' 83' ' ' LEU . 1.5 m-20 -67.15 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.486 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 41.06 -139.18 1.55 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -49.86 123.38 7.94 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 108.646 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 81' ' ' GLY . 16.5 mt -111.74 -22.11 11.32 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 99' ' ' PHE . . . 169.4 -178.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 7.6 p-80 179.05 175.86 0.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.979 -1.075 . . . . 0.0 110.253 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.66 166.26 28.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 109.39 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.99 159.51 15.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.676 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.491 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . . . -48.55 172.78 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.631 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 88' ' ' ALA . 32.4 Cg_endo -73.69 137.98 25.76 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.119 1.879 . . . . 0.0 110.874 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.518 ' N ' ' HA3' ' A' ' 94' ' ' GLY . . . 175.77 -168.34 40.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.0 p -99.1 134.5 41.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 110.041 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.24 -82.46 0.66 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.475 ' HA ' ' OD2' ' A' ' 96' ' ' ASP . 0.9 OUTLIER -69.54 -41.37 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 110.205 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.518 ' HA3' ' N ' ' A' ' 90' ' ' GLY . . . -71.3 111.05 3.49 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.808 -1.186 . . . . 0.0 110.191 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.527 ' HA3' HG23 ' A' ' 61' ' ' ILE . . . 121.44 2.79 10.64 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.739 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 62' ' ' MET . 3.9 m-20 -95.96 140.02 31.32 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.415 -1.638 . . . . 0.0 109.865 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -121.3 142.62 49.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 59.5 m170 -114.76 130.71 56.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.809 . . . . 0.0 109.971 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' HA ' ' HB3' ' A' ' 84' ' ' ALA . 46.7 m-85 -103.89 152.03 22.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.49 ' OD1' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -60.09 138.98 57.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.952 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -76.29 -78.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 8.5 t70 -66.04 91.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.016 -1.053 . . . . 0.0 110.672 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -159.81 -170.34 2.86 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -138.38 82.69 1.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.705 -1.247 . . . . 0.0 110.867 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.32 130.62 42.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.08 -1.013 . . . . 0.0 109.449 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 113' ' ' SER . 1.1 p -154.45 154.16 32.73 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.723 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.527 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 7.7 t30 -82.76 4.56 24.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 109' ' ' SER . 1.9 p -91.89 -145.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 108' ' ' THR . 6.3 t -89.9 37.99 0.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 111' ' ' ASN . . . -64.14 -97.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 109.831 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 110' ' ' ALA . 23.0 t-20 -178.31 -46.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.061 -1.024 . . . . 0.0 109.639 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' OH ' ' CG ' ' A' ' 80' ' ' ASP . 94.4 m-85 -85.42 -36.32 20.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 109.176 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 106' ' ' THR . 1.0 OUTLIER 62.2 110.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -0.76 . . . . 0.0 110.591 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.534 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -50.86 -36.47 37.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 109.677 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.9 t80 -65.63 -35.9 82.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.432 HD12 ' CZ ' ' A' ' 142' ' ' TYR . 2.1 tm? -80.58 -57.1 3.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.625 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 0.2 OUTLIER -50.42 -40.82 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.864 -1.148 . . . . 0.0 108.94 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -69.23 -49.52 55.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.857 . . . . 0.0 109.622 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.469 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -42.45 -59.78 1.74 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -49.18 -56.53 8.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.179 -0.95 . . . . 0.0 108.744 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.438 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 69.3 mm-40 -66.53 -11.99 55.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.53 -15.17 57.35 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.534 ' HA3' ' CE ' ' A' ' 138' ' ' MET . . . -94.95 -42.04 3.91 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.466 ' O ' ' N ' ' A' ' 126' ' ' MET . 5.0 m-70 -63.56 -49.16 74.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.11 . . . . 0.0 109.389 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -41.89 -26.39 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 124' ' ' HIS . 26.2 mmt -78.99 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.928 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . -157.91 -35.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.255 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.508 ' CD1' ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -46.25 149.72 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 109.579 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -129.29 163.06 26.5 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 129' ' ' GLU . 25.5 m170 -44.28 137.41 3.56 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.064 -1.022 . . . . 0.0 109.228 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -112.89 11.9 19.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.23 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 0.5 OUTLIER 82.48 -24.8 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.21 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.492 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -66.49 124.89 89.43 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.67 -1.269 . . . . 0.0 109.737 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.456 ' HA ' HD13 ' A' ' 141' ' ' ILE . 31.2 Cg_endo -72.58 -36.55 4.91 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.248 1.965 . . . . 0.0 110.555 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.49 11.07 47.17 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.492 ' HB1' ' HB3' ' A' ' 133' ' ' ASP . . . -92.23 174.69 7.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.999 -1.295 . . . . 0.0 109.936 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.7 tp -88.17 -35.81 17.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.534 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -83.81 7.25 18.52 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 133' ' ' ASP . . . -55.39 154.7 11.19 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.839 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.97 21.66 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.906 2.404 . . . . 0.0 112.246 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -134.91 133.72 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.595 -1.316 . . . . 0.0 109.532 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.432 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 75.8 t80 -73.21 121.88 21.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 110.122 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -125.05 111.43 15.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.388 -0.82 . . . . 0.0 108.919 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -59.93 160.43 7.81 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.091 -1.006 . . . . 0.0 110.209 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.68 ' CG2' H392 ' A' ' 800' ' ' I52 . 2.8 p -99.09 83.0 2.81 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.659 -0.651 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -3.47 30.49 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.854 -1.154 . . . . 0.0 108.275 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -160.0 20.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.526 -0.734 . . . . 0.0 109.113 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 3.3 t80 36.24 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.463 -0.773 . . . . 0.0 110.529 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.509 ' O ' H381 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -118.65 132.57 56.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.334 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 50.8 mt -88.65 -163.41 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.384 -0.822 . . . . 0.0 109.838 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.0 p -167.12 131.43 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 109.648 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.624 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 2.7 pt20 -59.63 -29.57 68.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 152' ' ' GLN . 4.0 m-20 -43.48 -37.62 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 107.956 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -85.42 -46.05 11.28 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.624 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.9 OUTLIER -51.95 -33.69 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.681 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -75.55 -56.77 4.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.83 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.508 ' HA3' ' CD1' ' A' ' 128' ' ' LEU . . . -57.04 -39.46 89.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.403 HG22 HG21 ' A' ' 46' ' ' VAL . 9.0 tp -78.17 -18.78 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -1.23 . . . . 0.0 109.788 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -72.78 -48.12 40.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.88 . . . . 0.0 108.925 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -74.37 -21.65 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -85.25 -15.86 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.784 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.57 ' CD2' HD12 ' A' ' 49' ' ' LEU . 6.0 m-85 -140.11 -93.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.42 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.75 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.958 H243 ' H72' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.49 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.352 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.21 98.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -116.35 176.26 5.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.451 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -83.02 165.84 38.9 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 0.0 108.802 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 32.2 Cg_endo -74.18 -161.09 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.386 2.057 . . . . 0.0 109.919 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 14.9 ttp180 77.44 54.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.573 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 7' ' ' ARG . 6.0 mttp 60.52 144.59 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 36.3 Cg_endo -79.11 55.33 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.096 1.864 . . . . 0.0 108.965 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -62.34 -137.11 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.568 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -163.0 44.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.914 -1.116 . . . . 0.0 108.73 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.04 85.27 6.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -141.63 101.95 4.08 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 13' ' ' LYS . 7.7 m-20 -34.18 -85.71 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.894 -0.504 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -51.88 106.97 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 109.216 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.521 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 3.3 mt -104.29 162.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 0.0 109.526 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -135.53 135.85 40.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.512 ' C ' ' CD1' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -142.59 162.5 35.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.343 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.74 120.39 9.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.483 -0.76 . . . . 0.0 109.057 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.479 HD12 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -83.17 112.95 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.0 109.46 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HD13 ' HG2' ' A' ' 62' ' ' MET . 7.7 mt -89.51 17.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 166.5 96.21 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.61 ' CG ' HG12 ' A' ' 32' ' ' VAL . 20.3 m-85 -58.07 -114.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -1.074 . . . . 0.0 108.853 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.639 HG23 ' HD2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -112.58 178.29 1.0 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.502 -1.374 . . . . 0.0 108.102 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' A' ' 24' ' ' THR . 33.0 Cg_endo -76.57 -34.85 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.745 1.63 . . . . 0.0 112.324 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 26' ' ' ASP . 5.6 t70 -158.64 81.73 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.768 -1.208 . . . . 0.0 112.191 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.597 ' CD2' HG22 ' A' ' 24' ' ' THR . 0.3 OUTLIER -155.68 -178.98 7.68 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.184 -0.948 . . . . 0.0 108.737 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 1.3 m-20 -72.16 136.45 81.91 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' ASP . 26.8 Cg_endo -69.68 -30.88 21.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 106.444 -2.175 . . . . 0.0 106.444 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.17 -32.84 63.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.477 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 2.9 m -70.6 -62.65 1.31 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG12 ' CG ' ' A' ' 23' ' ' TYR . 1.3 p -49.64 -43.28 18.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 3.0 t70 -64.85 -22.08 66.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.733 . . . . 0.0 109.109 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.3 t0 -78.38 -40.99 34.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.015 . . . . 0.0 110.174 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -57.52 -44.05 84.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.967 -1.083 . . . . 0.0 109.145 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' O ' ' CD2' ' A' ' 40' ' ' PHE . 75.2 m-85 -71.35 -48.57 49.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.27 -0.894 . . . . 0.0 108.637 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.31 -51.12 63.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.552 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 61.3 mtp180 -67.18 -48.85 66.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.438 -0.789 . . . . 0.0 108.899 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.601 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . . . -41.98 -43.28 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.551 ' O ' ' CB ' ' A' ' 44' ' ' SER . 58.1 m-85 -68.52 -39.16 81.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ARG . 3.3 tt0 -71.56 -60.54 2.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.132 -0.98 . . . . 0.0 109.026 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.601 ' CG2' ' HA ' ' A' ' 39' ' ' ALA . 1.7 m -46.18 -29.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.589 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 11.6 m95 -101.98 -19.0 15.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 11.2 t -88.7 -23.35 22.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.016 -1.053 . . . . 0.0 108.25 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -59.77 -12.56 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.716 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 7.7 p -110.62 19.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.003 . . . . 0.0 109.69 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.512 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 5.1 t -179.33 149.32 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.002 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.512 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 32.4 Cg_endo -76.0 57.82 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 110.486 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 162' ' ' TYR . 18.8 mt -100.76 121.3 41.45 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.81 112.66 25.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 109.094 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.547 ' CD2' ' CE1' ' A' ' 40' ' ' PHE . 56.3 m-85 -88.52 143.65 26.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.57 138.75 52.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.526 -0.734 . . . . 0.0 109.341 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -89.28 129.66 35.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.077 -1.014 . . . . 0.0 108.862 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 59' ' ' ALA . 2.5 pt -122.12 131.95 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 54' ' ' ILE . 4.4 p80 -60.32 -147.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.306 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -70.05 169.31 13.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.043 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.37 -147.29 18.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.03 150.91 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.253 . . . . 0.0 109.595 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB3' ' CD1' ' A' ' 54' ' ' ILE . . . -160.91 150.4 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.555 ' OD2' ' CE2' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -77.88 -70.19 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 109.268 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -82.13 126.26 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.477 ' HG2' HD13 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -120.96 115.83 23.94 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.6 mp -103.62 145.33 12.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.89 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 63.8 t30 -168.67 172.64 7.84 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' C ' ' CD1' ' A' ' 65' ' ' PHE . 31.2 p90 -119.94 160.77 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 109.842 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.71 128.87 1.73 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -96.9 -135.15 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 67' ' ' ARG . 1.6 t90 -49.92 -41.64 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.511 -1.368 . . . . 0.0 107.852 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' HIS . 2.8 tt0 -73.86 55.22 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 76' ' ' PHE . 4.1 t-160 -44.16 -50.63 8.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.175 -0.953 . . . . 0.0 109.27 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 18.11 44.98 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 72' ' ' ASP . 41.2 p-10 -151.47 28.04 0.65 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.349 -1.089 . . . . 0.0 109.892 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . 93.19 154.0 30.76 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.38 -0.914 . . . . 0.0 110.901 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 58.6 m-85 55.14 164.36 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 110.049 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 34.4 Cg_endo -76.45 -159.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.004 1.803 . . . . 0.0 108.555 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.673 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 69.0 t80 177.54 168.86 0.65 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.9 -1.125 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 24.1 t70 50.63 40.61 24.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.705 -0.622 . . . . 0.0 110.345 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . -49.06 173.05 0.05 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.3 -2.32 . . . . 0.0 107.3 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 80' ' ' ASP . 1.1 ptmt -51.46 141.75 15.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.762 -1.434 . . . . 0.0 107.253 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 79' ' ' LYS . 21.2 t70 39.55 -111.21 0.11 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.495 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 25.85 -132.54 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 CA-C-O 121.432 0.462 . . . . 0.0 112.226 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.1 OUTLIER -26.94 123.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.975 0.893 . . . . 0.0 111.914 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 73.5 mt -118.84 -28.6 5.54 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 172.51 146.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.511 -0.743 . . . . 0.0 109.343 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 24.4 p-80 -144.92 149.25 34.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.339 -0.851 . . . . 0.0 109.262 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.495 ' CB ' ' HB2' ' A' ' 97' ' ' SER . . . -123.61 159.44 29.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.892 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.41 151.8 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.075 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.494 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -57.17 168.96 0.78 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 109.624 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.6 152.23 25.89 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.773 2.315 . . . . 0.0 110.569 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 9' ' ' PRO . . . 179.58 -103.1 0.17 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -162.59 78.51 0.48 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -1.093 . . . . 0.0 109.357 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.06 -103.1 0.29 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.87 -2.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -1.168 . . . . 0.0 109.32 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -75.6 143.2 29.99 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 76.34 -4.4 49.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 1.6 m-20 -101.03 134.8 43.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.942 -1.328 . . . . 0.0 108.68 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.495 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 16.4 t -130.86 127.64 38.98 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.561 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 46.0 m80 -89.78 145.27 25.31 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.422 -0.799 . . . . 0.0 109.109 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -116.58 160.29 20.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.001 -1.062 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.476 ' OD2' ' HA ' ' A' ' 83' ' ' LEU . 3.5 m-20 -52.85 121.36 7.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 109.854 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 65' ' ' PHE . 18.6 t0 -44.58 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' GLU . 35.3 m-20 -77.22 -128.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 83.92 -29.86 0.08 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 16.0 tp 68.81 74.56 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.185 -0.947 . . . . 0.0 111.137 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.583 ' O ' ' HB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -94.0 163.19 13.59 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.712 HG21 ' CG2' ' A' ' 108' ' ' THR . 9.7 t 171.48 -173.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.096 -1.002 . . . . 0.0 110.308 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.586 ' O ' ' OG1' ' A' ' 108' ' ' THR . 6.8 p-10 -50.19 -31.17 13.1 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.712 ' CG2' HG21 ' A' ' 106' ' ' THR . 1.8 p 73.31 -110.89 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER 61.24 23.14 13.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 100.99 -3.707 . . . . 0.0 100.99 -168.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.446 ' N ' ' C ' ' A' ' 108' ' ' THR . . . -135.78 -45.26 0.66 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.318 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -158.39 -86.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.775 -0.578 . . . . 0.0 110.277 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.567 ' O ' ' CG2' ' A' ' 108' ' ' THR . 9.0 m-85 -121.16 126.64 50.21 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.3 OUTLIER -76.58 129.59 36.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 111.557 -178.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.585 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -57.09 -24.23 52.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.653 -0.654 . . . . 0.0 110.479 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 1.7 t80 -73.64 -54.75 7.42 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.498 -1.376 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.569 HD23 ' CD1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -63.26 -51.0 67.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.926 -1.108 . . . . 0.0 109.144 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.526 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 21.0 m -54.82 -53.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 109.907 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -66.91 -39.99 87.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.735 -1.228 . . . . 0.0 108.828 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.429 ' HB1' ' CE1' ' A' ' 115' ' ' PHE . . . -47.6 -58.37 4.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.4 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 34.1 t60 -54.49 -42.6 70.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.157 . . . . 0.0 108.53 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 117' ' ' VAL . 54.2 mm-40 -71.73 -10.5 59.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.5 OUTLIER -87.28 -15.67 37.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.589 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -89.51 -45.6 4.59 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.02 -45.97 91.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.475 -1.015 . . . . 0.0 108.417 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.68 -19.11 2.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.315 -0.865 . . . . 0.0 109.162 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.1 mtt -100.97 -5.51 25.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 113.21 -35.57 4.5 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.522 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 127' ' ' GLY . 1.8 mt -37.0 146.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.494 -1.003 . . . . 0.0 110.237 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 138' ' ' MET . 0.3 OUTLIER -113.08 -179.48 3.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 109.713 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.765 ' CE1' H132 ' A' ' 800' ' ' I52 . 62.5 m170 -58.43 151.31 20.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -96.71 -177.73 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 0.0 109.519 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -13.24 6.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.467 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -101.05 142.36 24.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.94 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.467 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 32.5 Cg_endo -76.84 116.7 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.8 2.333 . . . . 0.0 109.564 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.81 -3.56 24.41 Favored Glycine 0 C--N 1.272 -2.989 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.794 ' O ' H351 ' A' ' 800' ' ' I52 . . . -67.77 -177.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.192 . . . . 0.0 109.772 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.578 ' CD1' H362 ' A' ' 800' ' ' I52 . 8.6 tp -96.06 -28.86 14.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 109.681 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -94.6 3.01 55.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.51 ' O ' ' H34' ' A' ' 800' ' ' I52 . . . -46.19 148.14 1.63 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.274 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.418 ' O ' ' H19' ' A' ' 800' ' ' I52 . 36.5 Cg_endo -78.04 12.0 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.565 2.176 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.4 mm -133.64 155.69 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 0.0 110.262 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER -76.0 95.29 3.56 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.482 ' O ' H372 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -100.96 92.93 5.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 108.637 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.574 ' CZ ' ' HA ' ' A' ' 146' ' ' LYS . 7.8 t80 -60.07 155.38 17.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.512 HG23 H371 ' A' ' 800' ' ' I52 . 0.1 OUTLIER -143.49 8.83 1.58 Allowed 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.626 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.574 ' HA ' ' CZ ' ' A' ' 144' ' ' TYR . 21.3 mtpt 52.6 -106.75 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.305 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 4.9 p-10 -56.94 -47.22 81.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.716 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.702 ' CG ' H391 ' A' ' 800' ' ' I52 . 5.8 t80 68.01 125.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.808 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.493 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -100.77 -70.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 149' ' ' ARG . 4.0 tp 169.29 172.15 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.463 ' O ' HG21 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -143.45 130.68 20.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.021 -1.049 . . . . 0.0 109.654 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.641 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 46.9 tt0 -54.63 -30.31 54.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 152' ' ' GLN . 51.5 m-20 -46.9 -41.61 16.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.577 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.552 ' OD1' ' CZ3' ' A' ' 43' ' ' TRP . 21.5 t0 -83.53 -36.14 24.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.641 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -63.57 -31.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 108.908 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.461 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -78.71 -44.72 22.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.445 ' HA3' HD22 ' A' ' 128' ' ' LEU . . . -75.55 -20.29 78.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.506 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 1.6 tp -93.9 -17.87 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 155' ' ' ILE . 2.9 pt20 -90.94 -31.48 16.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.081 . . . . 0.0 108.446 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' HG2' ' HG3' ' A' ' 159' ' ' GLN . 2.0 mm-40 -86.94 -29.94 21.69 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.471 ' O ' ' CD1' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -95.66 -28.11 14.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.559 ' CD1' HD21 ' A' ' 49' ' ' LEU . 2.1 m-85 -122.38 -91.28 0.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.452 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 158' ' ' ILE . . . . . . . . 0 N--CA 1.492 2.383 0 CA-C-O 118.036 -1.425 . . . . 0.0 109.756 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.794 H351 ' O ' ' A' ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.485 ' O ' ' HB2' ' A' ' 2' ' ' TYR . 24.8 mtm . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.18 0.514 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 75.17 123.0 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.981 0.896 . . . . 0.0 108.978 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -116.83 39.3 3.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' PHE . 9.4 m-85 -107.0 176.19 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.446 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.597 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 171.11 -54.46 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.456 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.597 ' HD3' ' CB ' ' A' ' 5' ' ' PHE . 39.1 Cg_endo -82.23 108.2 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.314 2.009 . . . . 0.0 111.846 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.01 44.37 1.03 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 148.69 34.84 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.729 -0.607 . . . . 0.0 109.88 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.7 Cg_endo -74.64 58.02 4.5 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.13 1.886 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' HG3' ' HG3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 40.45 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -95.98 106.76 18.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.808 -1.182 . . . . 0.0 110.022 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.05 81.58 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.093 . . . . 0.0 110.102 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.75 153.1 48.54 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.261 -0.9 . . . . 0.0 109.309 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -79.44 -89.21 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.46 111.27 1.33 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.275 -0.891 . . . . 0.0 108.948 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.531 HD13 ' CE1' ' A' ' 51' ' ' PHE . 73.7 mt -119.59 145.67 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.444 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.559 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 22.8 p -121.06 140.06 52.46 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.591 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.507 ' HB3' HG13 ' A' ' 61' ' ' ILE . 34.0 p90 -139.28 -179.44 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' CD ' ' HB1' ' A' ' 59' ' ' ALA . 1.9 ptm180 -159.34 140.45 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mt -95.27 145.18 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 64' ' ' ASN . 28.0 mt -90.19 -5.53 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.578 ' O ' ' CD2' ' A' ' 65' ' ' PHE . . . 147.54 109.79 0.57 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.566 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -66.29 -163.3 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.047 -1.267 . . . . 0.0 108.812 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.476 ' CG2' ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -108.49 146.8 34.4 Favored Pre-proline 0 C--N 1.293 -1.853 0 O-C-N 121.51 -0.744 . . . . 0.0 109.257 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 26' ' ' ASP . 29.9 Cg_endo -73.13 -26.15 15.21 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.441 2.094 . . . . 0.0 110.42 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 10.0 p-10 -35.23 -35.43 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.414 0.626 . . . . 0.0 109.976 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -133.04 171.66 13.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.988 -1.07 . . . . 0.0 110.245 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 5.5 m-20 -51.63 148.16 10.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.559 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 32.3 Cg_endo -69.98 -32.44 17.68 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 N-CA-C 105.688 -2.466 . . . . 0.0 105.688 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -78.33 -31.26 48.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.586 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 21.4 m -73.7 -52.62 12.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.883 -1.136 . . . . 0.0 108.45 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.566 ' CG1' ' CG ' ' A' ' 23' ' ' TYR . 1.8 p -47.74 -41.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 5.3 m-20 -61.43 -39.12 89.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.693 -0.63 . . . . 0.0 109.669 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -61.21 -37.5 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.206 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.93 -28.6 38.06 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.908 . . . . 0.0 109.074 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.19 -24.95 19.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 108.892 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.36 63.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -39.21 73.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.434 ' O ' HG11 ' A' ' 42' ' ' VAL . . . -57.32 -40.58 78.22 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -60.61 -45.72 92.94 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -74.95 -15.85 60.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.685 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.442 ' O ' ' OD2' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -84.3 -27.95 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.811 -1.181 . . . . 0.0 109.057 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -104.96 -25.2 12.67 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.709 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' THR . 9.7 t -85.11 -23.27 28.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.396 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 41' ' ' GLN . 3.4 p30 -60.04 -22.39 62.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.16 -0.962 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.453 HG11 ' OD1' ' A' ' 45' ' ' ASP . 10.8 m -99.07 16.63 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.999 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.562 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t -173.52 152.74 2.16 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.093 -1.004 . . . . 0.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 33.8 Cg_endo -74.91 45.65 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.985 2.457 . . . . 0.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.443 HD21 ' CD2' ' A' ' 162' ' ' TYR . 0.9 OUTLIER -87.3 144.14 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.231 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 99.03 5.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.309 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.531 ' CE1' HD13 ' A' ' 16' ' ' ILE . 15.9 m-85 -93.38 133.16 36.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.884 -1.135 . . . . 0.0 110.047 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB3' HG21 ' A' ' 17' ' ' THR . 1.0 OUTLIER -115.54 164.98 13.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.795 179.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.56 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 2.3 mtp-105 -111.17 137.62 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 108.808 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.559 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 7.2 pt -145.34 134.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.017 -1.052 . . . . 0.0 109.658 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.31 42.53 2.72 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.21 -67.24 0.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.3 -0.875 . . . . 0.0 110.049 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . -99.16 50.25 1.19 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 68.09 162.72 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.299 -1.118 . . . . 0.0 109.932 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.494 ' HB2' HG13 ' A' ' 54' ' ' ILE . . . -129.49 173.17 10.82 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -84.9 -57.08 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.12 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -95.87 148.42 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 0.0 109.874 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.524 ' CG ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -123.52 116.9 23.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.502 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 97' ' ' SER . 46.9 mt -115.62 140.51 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 108.908 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.47 ' HB3' HD13 ' A' ' 21' ' ' ILE . 7.9 p-10 -154.49 -148.67 0.25 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.686 -1.258 . . . . 0.0 110.36 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 22' ' ' GLY . 0.2 OUTLIER -136.59 174.98 10.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.896 -1.127 . . . . 0.0 110.604 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 101' ' ' ASP . . . -122.77 99.27 0.64 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.524 ' HA ' ' CB ' ' A' ' 101' ' ' ASP . 5.4 mtm180 -90.08 -6.96 54.91 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -1.072 . . . . 0.0 110.459 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.452 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 177.46 -162.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' O ' ' O ' ' A' ' 70' ' ' HIS . 5.8 pt-20 -83.76 67.27 9.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.741 -1.224 . . . . 0.0 111.033 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -49.74 -172.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.0 109.136 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . -64.58 -9.49 38.32 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.66 ' CB ' ' CE1' ' A' ' 70' ' ' HIS . 11.5 t0 -54.89 -169.99 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.021 -1.282 . . . . 0.0 108.396 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.37 -8.95 26.3 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.344 -1.407 . . . . 0.0 110.095 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.533 ' CD1' HD13 ' A' ' 82' ' ' LEU . 11.7 m-85 -110.67 118.33 48.87 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.206 -1.173 . . . . 0.0 108.652 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -75.47 -176.43 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.045 1.83 . . . . 0.0 110.31 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 68' ' ' TRP . 38.3 p90 -78.69 140.86 38.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.552 -0.718 . . . . 0.0 109.107 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 9.5 p-10 -115.55 6.66 14.69 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.24 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 62.75 -167.68 19.95 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.265 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -43.16 167.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -1.064 . . . . 0.0 109.874 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' LYS . 71.6 m-20 41.15 -162.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.277 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 -146.94 50.77 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.302 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -47.77 107.1 0.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.481 -1.011 . . . . 0.0 108.997 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 84' ' ' ALA . 15.4 mt -91.23 -15.37 29.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.023 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.534 ' O ' ' H4 ' ' A' ' 800' ' ' I52 . . . 169.5 158.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.524 -0.735 . . . . 0.0 109.024 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -156.83 146.38 20.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.981 -1.075 . . . . 0.0 109.915 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 97' ' ' SER . . . -128.86 161.55 29.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.357 -0.839 . . . . 0.0 109.714 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.1 166.0 10.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.463 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -79.41 166.93 38.16 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.515 -0.74 . . . . 0.0 109.084 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.513 ' HG3' ' HG3' ' A' ' 10' ' ' LYS . 33.1 Cg_endo -76.87 157.54 34.94 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.51 2.14 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.41 -102.32 0.16 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -150.87 90.95 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.255 . . . . 0.0 110.038 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.83 -73.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 93' ' ' VAL . 5.5 t -77.41 -1.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -1.209 . . . . 0.0 110.026 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -76.39 139.91 24.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 73.82 67.78 1.71 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' OD1' ' CG ' ' A' ' 62' ' ' MET . 14.9 m-20 -160.8 117.02 2.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 109.01 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -117.02 157.39 25.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.466 -0.771 . . . . 0.0 109.861 -179.209 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -129.79 146.81 51.52 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m-85 -111.19 144.24 40.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.123 -0.986 . . . . 0.0 110.022 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.504 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -44.7 167.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.586 -1.321 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 5.1 t0 -97.43 -25.39 15.21 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -99.42 -144.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 178.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.504 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.4 OUTLIER 75.24 136.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.0 109.643 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 90.63 6.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.327 -0.858 . . . . 0.0 110.55 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.533 ' CB ' ' CD2' ' A' ' 114' ' ' LEU . 13.0 m0 -96.38 153.53 17.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 113' ' ' SER . 55.3 p -138.16 159.61 41.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.586 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 9.4 t30 -112.73 4.37 17.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 0.0 109.148 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 108' ' ' THR . 9.7 t -139.6 48.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.6 p 45.62 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.89 -1.131 . . . . 0.0 109.874 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.13 -42.11 0.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.909 -1.119 . . . . 0.0 109.974 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -137.48 -77.31 0.39 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.5 m-30 -107.98 -102.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.572 ' OG ' ' CE1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER 165.43 98.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.835 -1.166 . . . . 0.0 110.633 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.533 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -52.12 -35.24 47.59 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.106 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.438 ' O ' ' CD1' ' A' ' 115' ' ' PHE . 2.2 t80 -66.33 -43.25 86.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 110.005 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.71 ' CD2' H382 ' A' ' 800' ' ' I52 . 1.2 mt -59.41 -60.96 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.004 -1.06 . . . . 0.0 109.566 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 114' ' ' LEU . 19.7 m -52.66 -38.19 26.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -61.74 -51.03 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -53.15 -49.5 66.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.493 -0.754 . . . . 0.0 109.144 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -46.44 -68.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 65.6 mm-40 -56.97 -21.14 28.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.217 -0.927 . . . . 0.0 108.834 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.575 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -74.4 -12.2 60.45 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.89 -47.43 2.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.535 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 0.6 OUTLIER -59.6 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -1.1 . . . . 0.0 109.57 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.48 22.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -0.754 . . . . 0.0 110.286 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 7.7 mtt -103.79 -10.65 18.11 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.692 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.459 ' HA2' ' CD ' ' A' ' 10' ' ' LYS . . . 128.75 -64.28 0.6 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.013 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 127' ' ' GLY . 15.0 mt -49.35 176.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -169.54 -172.64 1.48 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.719 0.771 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -49.82 114.01 0.97 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.763 0.792 . . . . 0.0 109.99 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.537 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 11.2 t -84.86 -77.53 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.537 ' HB2' ' O ' ' A' ' 131' ' ' SER . 52.3 tt0 161.03 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.407 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -57.88 133.1 83.28 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.715 -0.616 . . . . 0.0 109.632 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 29.2 Cg_endo -75.69 113.33 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.555 2.17 . . . . 0.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.53 -13.77 20.61 Favored Glycine 0 C--N 1.272 -2.983 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.74 158.82 12.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.884 -1.362 . . . . 0.0 109.706 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.792 HD11 H381 ' A' ' 800' ' ' I52 . 11.7 tp -70.47 -20.41 62.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.024 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -100.05 2.06 42.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.376 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -70.19 156.69 91.44 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.232 -0.918 . . . . 0.0 110.015 -179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.503 ' HB3' ' H92' ' A' ' 800' ' ' I52 . 34.3 Cg_endo -77.14 64.65 7.85 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.858 2.372 . . . . 0.0 110.986 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.539 ' O ' ' N27' ' A' ' 800' ' ' I52 . 0.0 OUTLIER -159.53 -157.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.261 -0.9 . . . . 0.0 109.625 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -165.69 119.03 1.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 109.823 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' TYR . 52.8 m -138.26 95.87 3.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 109.259 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.579 ' HA ' ' CD1' ' A' ' 116' ' ' LEU . 21.8 t80 -45.39 158.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.793 -1.192 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.406 ' O ' ' C ' ' A' ' 146' ' ' LYS . 1.3 t -152.01 123.92 8.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -48.52 122.46 5.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.195 . . . . 0.0 108.578 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.503 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 7.5 m-20 58.96 -95.34 0.05 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.253 -0.905 . . . . 0.0 108.56 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 1.2 p90 177.72 142.88 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.088 -1.007 . . . . 0.0 109.657 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -107.82 -10.83 15.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.892 -1.13 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.432 HD11 ' CG1' ' A' ' 46' ' ' VAL . 1.5 mt 66.57 139.34 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.61 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.74 122.76 48.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.573 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 tt0 -50.01 -53.11 28.89 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.09 0.471 . . . . 0.0 109.954 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -42.32 -29.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -90.62 -29.29 17.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.024 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 151' ' ' SER . 0.9 OUTLIER -73.49 -30.43 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.425 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -88.25 -43.3 11.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -64.24 -25.62 69.88 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -85.45 -47.47 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.379 . . . . 0.0 109.078 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -52.02 -31.22 28.74 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 109.624 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.02 -28.71 22.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.264 -0.897 . . . . 0.0 109.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.453 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -89.35 -16.08 31.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.443 ' CD2' HD21 ' A' ' 49' ' ' LEU . 1.8 m-85 -126.54 -47.37 1.57 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.812 -1.18 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.503 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.792 H381 HD11 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.278 0.561 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.593 ' CD1' ' HB2' ' A' ' 3' ' ' ASN . 46.7 p90 -84.44 -173.1 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.49 -0.756 . . . . 0.0 109.524 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.593 ' HB2' ' CD1' ' A' ' 2' ' ' TYR . 1.5 t30 49.59 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.04 -33.79 16.2 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.02 -1.05 . . . . 0.0 110.259 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.551 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER 178.83 -55.96 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.909 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 5' ' ' PHE . 32.7 Cg_endo -79.45 159.32 25.76 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.087 1.858 . . . . 0.0 110.67 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -71.4 0.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.693 -0.629 . . . . 0.0 109.348 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -99.04 141.87 23.63 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 109.891 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.62 82.24 2.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.913 1.742 . . . . 0.0 108.784 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -51.99 175.6 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.195 -0.941 . . . . 0.0 108.843 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -66.1 140.37 58.23 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 109.79 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -61.46 165.53 4.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 108.549 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.639 ' HD2' ' CD1' ' A' ' 162' ' ' TYR . 5.6 mmtp -118.75 -175.7 2.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.536 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' LYS . 1.9 m120 61.96 141.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.336 -0.852 . . . . 0.0 109.175 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . 2.5 mt-30 45.04 76.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.859 -1.151 . . . . 0.0 109.683 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.6 mt -110.73 136.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 108.886 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.489 ' O ' ' OD2' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -120.09 136.56 54.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.409 -0.807 . . . . 0.0 111.382 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 53' ' ' ARG . 34.3 p90 -149.61 153.07 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.969 . . . . 0.0 110.304 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.53 ' HD2' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.77 138.9 44.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.523 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -80.24 121.4 33.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.53 ' CD1' ' HD2' ' A' ' 19' ' ' ARG . 33.8 mm -67.33 -2.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.469 -0.769 . . . . 0.0 109.77 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 23' ' ' TYR . . . 144.15 84.44 0.07 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.586 ' CB ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -51.19 169.42 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.479 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 1.2 t -85.31 149.07 51.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.059 -1.651 . . . . 0.0 109.276 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' LEU . 36.2 Cg_endo -79.09 -21.5 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.331 2.021 . . . . 0.0 109.85 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' HB3' HD12 ' A' ' 104' ' ' LEU . 74.4 m-20 -40.64 -25.06 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.133 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.559 HD21 ' CG2' ' A' ' 32' ' ' VAL . 1.4 pt? -133.76 173.83 11.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.675 -1.266 . . . . 0.0 110.798 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 3.0 m-20 -48.66 138.3 12.11 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 108.862 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.459 ' O ' HG13 ' A' ' 32' ' ' VAL . 31.3 Cg_endo -69.03 -33.66 18.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 N-CA-C 107.331 -1.834 . . . . 0.0 107.331 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -79.01 -26.88 43.22 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 20.8 m -74.15 -50.83 17.68 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.586 HG12 ' CB ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.66 -36.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.993 0.901 . . . . 0.0 108.643 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.506 ' N ' HG13 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -73.87 -24.72 59.78 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.171 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.66 -41.66 68.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -53.19 -38.89 63.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CZ ' HG23 ' A' ' 63' ' ' ILE . 26.9 m-85 -74.12 -26.75 60.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -52.66 9.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -34.47 72.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.603 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . . . -62.9 -46.78 86.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.44 -0.788 . . . . 0.0 109.206 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.594 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -53.39 -34.72 58.79 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -83.01 -12.3 57.37 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.572 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -73.38 -32.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.603 ' CH2' ' HB2' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -102.82 -51.02 3.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.599 -0.688 . . . . 0.0 109.718 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 10.0 t -53.76 -33.17 54.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 109.157 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 41' ' ' GLN . 1.2 t70 -54.78 -33.3 61.22 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.599 -0.688 . . . . 0.0 109.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 46' ' ' VAL . 12.1 p -106.06 23.42 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.036 -1.04 . . . . 0.0 110.694 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.509 HG21 ' O ' ' A' ' 43' ' ' TRP . 0.1 OUTLIER -173.13 153.87 2.54 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.665 -1.272 . . . . 0.0 110.115 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' CD ' ' OXT' ' A' ' 163' ' ' GLY . 37.3 Cg_endo -79.77 12.78 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.89 3.06 . . . . 0.0 110.723 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.637 HD12 ' CD2' ' A' ' 162' ' ' TYR . 4.2 tt -64.37 148.72 49.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.96 138.93 45.64 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.77 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.561 ' CE2' HD22 ' A' ' 49' ' ' LEU . 26.6 m-85 -116.72 135.62 53.63 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.183 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 17' ' ' THR . 9.4 t -128.59 118.67 23.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.059 -1.025 . . . . 0.0 110.322 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 18' ' ' TYR . 6.0 mtm180 -92.16 131.43 37.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.977 -1.077 . . . . 0.0 108.15 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.542 ' CD1' ' O ' ' A' ' 58' ' ' GLU . 15.5 pt -126.6 148.31 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 109.536 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -109.38 -14.58 14.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.996 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -135.44 -167.39 2.0 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.953 -1.092 . . . . 0.0 109.941 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.86 -170.94 2.0 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 54' ' ' ILE . 1.9 tp10 -79.07 158.43 27.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.251 -1.146 . . . . 0.0 110.358 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HA ' HD13 ' A' ' 54' ' ' ILE . . . -136.44 -160.38 1.05 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.447 -0.783 . . . . 0.0 108.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -134.22 -57.03 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.584 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 2.5 mt -98.77 152.05 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.361 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.412 ' HB2' ' OD2' ' A' ' 96' ' ' ASP . 67.0 mtt -119.21 123.19 43.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.948 -1.095 . . . . 0.0 110.274 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' A' ' 18' ' ' TYR . 1.6 mp -117.78 142.21 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.634 -1.291 . . . . 0.0 109.968 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' OD1' ' C ' ' A' ' 63' ' ' ILE . 2.7 p-10 175.3 -174.69 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.439 -0.788 . . . . 0.0 110.189 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -89.96 -167.3 1.81 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.001 -1.062 . . . . 0.0 111.052 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 99' ' ' PHE . . . -149.3 49.66 0.57 Allowed Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -56.05 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -49.95 -57.28 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.981 . . . . 0.0 109.886 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 124.75 24.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.693 -0.63 . . . . 0.0 110.146 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.09 -70.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 133.74 -20.0 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -46.33 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.517 -0.99 . . . . 0.0 111.601 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.77 -2.02 65.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.88 77.59 18.51 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.967 -1.314 . . . . 0.0 110.172 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.27 139.33 18.65 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.51 2.14 . . . . 0.0 109.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.24 159.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.384 -0.822 . . . . 0.0 109.605 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.9 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.495 -0.753 . . . . 0.0 109.112 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.86 -154.92 19.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -69.4 167.28 16.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -1.068 . . . . 0.0 111.128 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER 41.42 -150.41 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 54.42 -134.88 45.52 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' O ' ' CB ' ' A' ' 100' ' ' ASP . 4.7 tt -50.68 98.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.594 -0.945 . . . . 0.0 109.012 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 100' ' ' ASP . 1.3 mt -110.31 -28.45 8.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 108.934 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -177.94 155.34 0.97 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.438 ' CD2' ' HB2' ' A' ' 98' ' ' HIS . 4.8 p80 -152.21 174.48 13.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.768 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -144.76 144.11 31.01 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.428 -0.795 . . . . 0.0 109.874 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.6 156.91 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 108.739 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.537 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -65.67 173.32 2.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 110.195 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.5 ' CD ' ' CB ' ' A' ' 88' ' ' ALA . 37.5 Cg_endo -82.51 155.54 16.21 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.201 2.601 . . . . 0.0 110.67 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.52 -128.76 1.18 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.7 60.09 1.7 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.207 -1.173 . . . . 0.0 110.475 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.18 -67.8 0.44 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 61.7 t -79.86 1.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.281 . . . . 0.0 108.36 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -78.89 134.82 14.46 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.571 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 84.04 91.95 0.72 Allowed Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.55 -0.97 . . . . 0.0 110.68 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.3 m-20 -160.99 120.33 2.61 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.975 -1.309 . . . . 0.0 108.754 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 3.1 p -110.25 130.01 55.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.052 0.93 . . . . 0.0 110.505 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 85' ' ' HIS . 29.5 m170 -119.36 148.9 42.67 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 109.333 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.7 m-30 -112.48 147.05 37.35 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 0.0 109.833 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' HB3' ' HA ' ' A' ' 83' ' ' LEU . 3.6 t70 -81.13 114.92 20.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.541 ' O ' ' C ' ' A' ' 102' ' ' ASP . 18.5 t70 -57.37 -95.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.75 -0.78 . . . . 0.0 108.92 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 101' ' ' ASP . 47.2 m-20 21.67 -93.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 120.706 0.288 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 102' ' ' ASP . 2.5 mp0 -41.95 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.933 -1.104 . . . . 0.0 110.094 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 2.0 tp -106.2 101.08 10.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.883 . . . . 0.0 109.696 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.522 ' O ' HG23 ' A' ' 106' ' ' THR . 12.1 m95 -103.11 147.27 27.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.363 -0.835 . . . . 0.0 110.034 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.543 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 2.2 p -159.02 -159.68 0.79 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.315 -0.866 . . . . 0.0 110.02 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.1 70.0 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -168.2 -99.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.413 ' N ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -142.67 59.82 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.774 -1.204 . . . . 0.0 109.613 178.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.93 -24.13 0.76 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.246 -0.908 . . . . 0.0 110.972 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -169.57 -153.66 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.739 -1.226 . . . . 0.0 108.968 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -67.74 -167.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.798 -1.189 . . . . 0.0 108.436 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.5 t -105.36 117.61 34.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.904 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.463 ' HG ' HG22 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -53.24 -22.51 6.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.86 0.838 . . . . 0.0 108.753 179.107 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -76.07 -38.49 57.02 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.599 HD13 ' CZ ' ' A' ' 142' ' ' TYR . 2.3 tm? -64.72 -55.13 21.88 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.409 -0.807 . . . . 0.0 109.716 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.4 m -53.67 -51.06 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -57.29 -51.48 69.2 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.938 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.427 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.4 -58.25 3.47 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.953 0.882 . . . . 0.0 109.333 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.795 ' HB2' ' H34' ' A' ' 800' ' ' I52 . 84.9 t60 -42.81 -67.62 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.456 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 44.1 mm-40 -62.25 -21.95 65.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CG ' ' CZ2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -74.43 -5.54 43.07 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -98.08 -48.54 1.88 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.471 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 97.0 m-70 -60.79 -42.61 97.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.53 -16.5 38.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.922 . . . . 0.0 109.209 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.508 ' HE1' ' CG ' ' A' ' 43' ' ' TRP . 44.2 mtt -84.62 15.82 3.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 100.95 -73.26 0.39 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.788 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' GLY . 15.7 mt -32.44 145.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.997 -0.708 . . . . 0.0 111.184 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.85 -179.66 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.815 -1.178 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -49.08 135.47 16.13 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.2 p -93.35 -152.16 0.32 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.16 -4.66 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.746 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.97 134.44 49.75 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.905 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.93 113.15 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.465 2.11 . . . . 0.0 111.007 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.07 -5.32 42.06 Favored Glycine 0 C--N 1.268 -3.199 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -54.13 162.04 1.12 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.682 -0.893 . . . . 0.0 109.64 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.69 HD12 H362 ' A' ' 800' ' ' I52 . 19.0 tp -67.32 -34.3 77.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.547 -0.721 . . . . 0.0 109.085 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -107.34 28.09 8.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.514 -0.741 . . . . 0.0 110.398 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -78.19 164.27 57.61 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.773 -1.204 . . . . 0.0 109.112 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -73.5 15.74 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.269 2.646 . . . . 0.0 112.39 -179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 139.59 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.853 -1.155 . . . . 0.0 109.507 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.599 ' CZ ' HD13 ' A' ' 116' ' ' LEU . 62.9 t80 -76.79 129.58 36.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 144' ' ' TYR . 6.2 m -150.06 84.77 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.982 -1.074 . . . . 0.0 108.472 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.549 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 75.4 t80 -42.37 164.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.633 -0.667 . . . . 0.0 109.339 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.839 ' HB ' H372 ' A' ' 800' ' ' I52 . 1.7 t -111.5 119.05 37.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 110.604 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -44.83 104.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.825 . . . . 0.0 108.848 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 146' ' ' LYS . 70.1 m-20 68.81 -79.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.521 ' CE1' HD22 ' A' ' 150' ' ' LEU . 24.1 t80 171.14 113.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.037 -1.039 . . . . 0.0 108.95 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.448 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 14.1 ttt85 -133.02 -20.7 2.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 110.214 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.532 ' HA ' H381 ' A' ' 800' ' ' I52 . 0.2 OUTLIER 71.98 -160.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -163.42 126.71 2.71 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.731 -1.231 . . . . 0.0 108.985 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.602 ' HA ' HG21 ' A' ' 155' ' ' ILE . 4.7 mm-40 -45.51 -44.07 12.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.25 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' GLN . 41.9 t0 -45.57 -36.4 4.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.654 -1.218 . . . . 0.0 108.357 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -86.51 -30.89 21.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.634 -0.667 . . . . 0.0 109.479 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.602 HG21 ' HA ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -70.48 -37.56 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 108.805 178.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.51 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -72.82 -43.1 63.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.84 48.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.562 HG22 ' N ' ' A' ' 159' ' ' GLN . 0.5 OUTLIER -54.47 -42.95 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.365 . . . . 0.0 109.534 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.562 ' N ' HG22 ' A' ' 158' ' ' ILE . 7.3 mm-40 -65.4 -43.15 91.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 109.589 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 69.3 mm-40 -57.73 -22.98 49.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.741 -1.225 . . . . 0.0 108.468 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.509 ' N ' HD21 ' A' ' 161' ' ' LEU . 3.8 mm? -98.96 -64.5 1.03 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.584 0.707 . . . . 0.0 109.318 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.639 ' CD1' ' HD2' ' A' ' 13' ' ' LYS . 21.9 p90 -151.64 85.27 1.3 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.45 ' OXT' ' CD ' ' A' ' 48' ' ' PRO . . . . . . . . 0 N--CA 1.494 2.543 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.662 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.956 H251 H131 ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.259 0.552 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 2' ' ' TYR . 0.7 OUTLIER -153.27 83.16 1.19 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -102.94 31.28 4.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.151 -0.968 . . . . 0.0 109.849 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -79.72 125.35 29.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 109.577 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -68.13 155.74 91.43 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.164 -0.96 . . . . 0.0 108.984 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -79.26 157.3 26.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.452 2.102 . . . . 0.0 110.131 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 9.0 mmt180 -88.95 -1.67 58.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 62.43 144.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.998 . . . . 0.0 108.979 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.51 82.63 2.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.058 1.839 . . . . 0.0 108.848 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 9.8 mttp -54.33 164.45 0.68 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.483 ' O ' ' HB3' ' A' ' 12' ' ' ASP . 3.0 m95 -71.54 130.99 42.61 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 11.8 p-10 167.92 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.36 -0.837 . . . . 0.0 109.383 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.64 32.0 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 72.28 -62.97 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.146 -0.971 . . . . 0.0 108.951 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 50' ' ' ARG . 21.3 mt-30 -78.94 103.23 8.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.517 -0.739 . . . . 0.0 109.297 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.9 OUTLIER -101.06 162.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 108.577 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.45 133.96 48.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 110.043 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 7.3 p90 -145.99 157.69 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.475 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . 3.4 tmm_? -148.76 136.82 20.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 0.0 109.927 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 HD12 ' OH ' ' A' ' 23' ' ' TYR . 5.8 mt -86.6 144.97 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.565 ' CD1' ' HG2' ' A' ' 62' ' ' MET . 11.6 mm -107.67 -38.85 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 0.0 110.074 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.02 96.23 0.14 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.613 ' CG ' HG13 ' A' ' 32' ' ' VAL . 2.5 m-85 -55.31 179.02 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.353 -1.086 . . . . 0.0 109.1 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.517 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 5.0 t -105.05 150.59 38.93 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 109.437 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.517 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.2 Cg_endo -81.27 -33.04 0.79 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.727 2.285 . . . . 0.0 111.238 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' PRO . 36.5 m-20 -39.48 -27.16 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.68 -0.637 . . . . 0.0 110.105 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.523 ' CD1' ' HB ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -135.16 -178.15 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 110.04 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 1.1 m-20 -73.62 151.97 89.37 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.511 -0.743 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.7 Cg_endo -74.1 -30.12 9.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 N-CA-C 106.254 -2.248 . . . . 0.0 106.254 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 2.6 mm-40 -78.11 -30.41 49.45 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.514 ' CG2' ' HB2' ' A' ' 107' ' ' ASN . 2.4 m -76.45 -50.68 13.46 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.613 HG13 ' CG ' ' A' ' 23' ' ' TYR . 1.4 p -54.92 -41.43 57.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.26 -23.97 62.08 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 2.7 t70 -81.39 -34.5 31.61 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.528 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.8 m-85 -73.21 -47.95 39.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -46.24 -51.15 14.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.993 . . . . 0.0 108.609 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -55.19 -50.44 69.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.013 -1.054 . . . . 0.0 108.439 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.55 ' HB3' ' CE2' ' A' ' 122' ' ' PHE . . . -53.41 -44.36 68.68 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 44' ' ' SER . 49.6 t80 -51.25 -40.25 58.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 108.732 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 3.0 tt0 -86.77 -24.03 25.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.524 HG11 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -68.74 -33.33 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.147 -0.97 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.592 ' CZ2' ' CA ' ' A' ' 123' ' ' GLY . 1.9 m95 -103.22 -22.3 13.75 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.208 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 27.5 t -85.9 -19.61 30.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.8 m-20 -64.6 -15.12 60.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.516 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 46' ' ' VAL . 7.1 p -113.65 17.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.404 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.474 HG21 ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -173.04 147.56 1.53 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 120.466 -1.396 . . . . 0.0 111.037 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 36.4 Cg_endo -78.52 46.78 2.23 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.773 2.316 . . . . 0.0 110.067 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 mp -76.55 160.16 29.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -130.41 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.534 ' HB3' ' CE1' ' A' ' 18' ' ' TYR . 5.4 m-30 -66.57 139.41 57.91 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' THR . 8.1 t -130.89 101.66 5.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.244 -0.91 . . . . 0.0 109.835 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -81.03 144.08 32.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -113.29 158.87 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 43.1 m-70 -106.75 -14.65 14.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.04 -175.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.046 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.34 63.65 0.83 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 177.35 153.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.482 -1.01 . . . . 0.0 109.527 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.513 ' HB2' ' CG1' ' A' ' 54' ' ' ILE . . . 176.45 143.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -62.53 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.529 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 22.9 mt -87.59 156.51 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.565 ' HG2' ' CD1' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -165.83 136.05 3.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.126 -0.984 . . . . 0.0 109.931 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.39 144.56 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 109.668 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -164.19 -167.14 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.325 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.458 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -117.2 166.73 11.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.74 -24.99 7.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HD2' ' CD1' ' A' ' 65' ' ' PHE . 54.1 mtp180 47.91 -150.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.177 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -91.12 -72.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 0.0 109.412 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -62.42 99.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.621 -0.675 . . . . 0.0 110.481 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.418 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.8 OUTLIER -127.29 -160.28 0.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.418 ' H ' ' CG ' ' A' ' 70' ' ' HIS . . . -113.86 -33.26 1.89 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.74 72.18 10.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.431 -1.04 . . . . 0.0 108.492 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' TYR . . . 112.95 -113.29 3.15 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.543 ' N ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER 163.33 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.21 -1.17 . . . . 0.0 109.827 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 74' ' ' TYR . 36.8 Cg_endo -79.26 137.69 13.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.246 1.964 . . . . 0.0 110.235 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 24.7 p90 -71.63 138.05 48.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.617 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 p-10 -75.31 -2.29 27.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.555 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 57.41 -114.91 5.99 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.5 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 78' ' ' GLY . 5.4 mttt -41.65 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.057 -0.673 . . . . 0.0 110.78 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 79' ' ' LYS . 10.1 m-20 -25.18 -93.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 80' ' ' ASP . . . 38.6 -130.35 1.79 Allowed Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 9.7 tt -54.51 109.37 0.49 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.466 HD12 ' S14' ' A' ' 800' ' ' I52 . 1.1 mt -107.94 -29.29 9.1 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.628 ' O ' ' H4 ' ' A' ' 800' ' ' I52 . . . 171.77 155.93 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.903 -1.123 . . . . 0.0 110.899 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.47 ' HB3' H253 ' A' ' 800' ' ' I52 . 1.9 p80 -146.36 -162.74 1.59 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 97' ' ' SER . . . -160.73 145.81 14.36 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.456 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -92.77 156.29 17.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.841 -1.162 . . . . 0.0 109.976 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.499 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -79.8 164.01 55.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.525 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 36.1 Cg_endo -79.35 154.55 24.68 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.002 2.468 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.49 60.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.78 92.56 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -1.084 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.82 -62.81 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.4 t -58.19 153.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.267 . . . . 0.0 109.748 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 98.2 141.08 11.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 95.83 -45.78 1.96 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.529 ' HA ' ' O ' ' A' ' 62' ' ' MET . 4.1 p30 -73.26 125.22 27.27 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.188 -1.183 . . . . 0.0 109.724 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.511 ' OG ' ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -131.65 136.28 47.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.314 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 9.5 m80 -98.93 143.38 29.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.557 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . 13.8 m-85 -113.9 141.83 46.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.565 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' CZ3' ' A' ' 105' ' ' TRP . 5.4 t70 -51.91 135.43 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -98.23 -16.86 19.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.871 -1.143 . . . . 0.0 109.592 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.83 -16.92 60.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.49 158.23 32.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 111' ' ' ASN . 8.4 tp -109.09 95.61 5.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.557 ' CZ3' ' HB3' ' A' ' 99' ' ' PHE . 10.3 m0 -102.33 141.51 35.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.216 -0.927 . . . . 0.0 110.222 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.446 HG22 ' C ' ' A' ' 105' ' ' TRP . 1.5 p -133.51 -160.28 1.04 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.972 -1.08 . . . . 0.0 110.006 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.514 ' HB2' ' CG2' ' A' ' 31' ' ' THR . 0.2 OUTLIER -134.59 2.25 3.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.826 . . . . 0.0 109.99 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.08 -60.5 1.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.098 . . . . 0.0 109.359 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.6 p -165.26 -91.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.324 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 43.6 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.865 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 109' ' ' SER . 60.8 t30 -110.55 -104.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.95 -124.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.794 -1.191 . . . . 0.0 109.456 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -171.99 117.24 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.356 -1.465 . . . . 0.0 111.219 -179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 HD21 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -45.95 -43.48 14.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.643 -0.66 . . . . 0.0 110.078 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.91 -44.52 91.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.388 -0.82 . . . . 0.0 109.862 -179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.625 HD13 ' CD2' ' A' ' 144' ' ' TYR . 0.5 OUTLIER -59.2 -67.14 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.422 -0.798 . . . . 0.0 109.766 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 114' ' ' LEU . 19.1 m -51.08 -42.93 25.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.435 -0.791 . . . . 0.0 108.985 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -52.64 -46.94 67.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.861 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -54.48 -59.02 5.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.376 -0.828 . . . . 0.0 110.007 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.73 ' HB2' ' H34' ' A' ' 800' ' ' I52 . 77.3 t60 -43.55 -65.05 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.655 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 99' ' ' PHE . 68.1 mm-40 -62.84 -12.95 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 0.0 109.341 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 39' ' ' ALA . 1.1 m-85 -80.92 -10.8 59.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.108 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.592 ' CA ' ' CZ2' ' A' ' 43' ' ' TRP . . . -103.68 -41.29 2.19 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 120' ' ' HIS . 9.5 m80 -61.02 -42.93 99.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -1.117 . . . . 0.0 109.104 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -37.56 -32.36 0.05 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.391 0.615 . . . . 0.0 109.532 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.532 ' HE2' ' CD1' ' A' ' 158' ' ' ILE . 4.1 mtm -69.89 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.87 . . . . 0.0 109.476 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.47 -30.87 0.05 OUTLIER Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -49.9 153.82 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.538 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 130' ' ' HIS . 4.0 mt-10 -113.44 -177.53 3.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.157 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 129' ' ' GLU . 18.6 m170 -44.72 172.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 110.142 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 p -123.58 -152.23 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 -17.36 2.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.321 -0.862 . . . . 0.0 110.99 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 151.32 54.21 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.72 -1.237 . . . . 0.0 109.251 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.8 -38.7 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.398 2.065 . . . . 0.0 110.686 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.09 6.81 69.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.57 163.31 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 110.03 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.798 HD11 H362 ' A' ' 800' ' ' I52 . 16.7 tp -89.12 -28.5 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 110.233 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.508 ' HE2' ' ND1' ' A' ' 124' ' ' HIS . 37.0 mtp -101.53 15.01 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.909 -1.119 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -43.15 153.72 0.34 Allowed Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.401 ' O ' ' CD1' ' A' ' 141' ' ' ILE . 35.2 Cg_endo -79.09 -1.11 11.32 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.205 1.937 . . . . 0.0 110.21 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.401 ' CD1' ' O ' ' A' ' 140' ' ' PRO . 5.5 mm -131.28 154.46 40.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.66 139.36 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 110.16 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.644 ' HB ' ' H31' ' A' ' 800' ' ' I52 . 1.9 m -129.52 -41.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 110.37 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.625 ' CD2' HD13 ' A' ' 116' ' ' LEU . 0.5 OUTLIER 68.42 147.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.568 ' HB ' H372 ' A' ' 800' ' ' I52 . 6.4 t -120.65 138.13 54.09 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -83.11 0.15 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.119 -0.988 . . . . 0.0 111.003 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 1.5 p-10 -88.19 21.43 2.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.824 -1.173 . . . . 0.0 109.391 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 148' ' ' PHE . 1.6 t80 60.14 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.112 -0.993 . . . . 0.0 109.133 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -121.06 -10.8 8.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.437 -0.789 . . . . 0.0 109.247 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.448 HD22 HG21 ' A' ' 155' ' ' ILE . 1.5 tp 59.32 -144.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 109.274 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 155' ' ' ILE . 1.1 p -178.41 129.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.644 ' HA ' HG23 ' A' ' 155' ' ' ILE . 23.3 mm-40 -53.76 -35.17 61.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.896 -0.502 . . . . 0.0 110.053 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 152' ' ' GLN . 2.9 m-20 -42.87 -47.7 5.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 109.304 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -79.37 -45.26 19.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.454 -0.779 . . . . 0.0 109.177 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.644 HG23 ' HA ' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -50.86 -28.47 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.0 108.661 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -57.44 3.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 0.0 109.553 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.41 -36.41 53.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.532 ' CD1' ' HE2' ' A' ' 126' ' ' MET . 6.7 tp -75.28 -30.09 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.378 -1.072 . . . . 0.0 109.1 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.57 67.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.479 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 -28.38 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.406 0.622 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.429 HD11 ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -95.02 -19.62 20.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.658 -0.651 . . . . 0.0 110.136 -178.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.422 ' OH ' ' HA ' ' A' ' 12' ' ' ASP . 41.6 m-85 -140.3 -75.05 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.406 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.798 H362 HD11 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 59.65 53.93 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.437 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -127.18 132.85 50.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.815 . . . . 0.0 110.477 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.532 ' CE1' HD22 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -100.73 113.35 65.63 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 110.38 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 33.0 Cg_endo -76.45 155.52 36.36 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.909 2.406 . . . . 0.0 110.904 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.546 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 13.7 mtp85 72.68 -109.09 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 89' ' ' PRO . 0.6 OUTLIER -83.73 109.74 20.42 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 109.516 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 31.7 Cg_endo -72.15 58.76 2.93 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.809 1.673 . . . . 0.0 110.261 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER 22.17 -94.25 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.384 0.612 . . . . 0.0 111.936 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.55 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 176.0 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.462 -0.774 . . . . 0.0 109.24 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HB2' HG22 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -44.57 158.39 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -114.81 144.65 43.17 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.471 -0.768 . . . . 0.0 109.448 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.499 ' HA ' HD21 ' A' ' 49' ' ' LEU . 68.0 m-80 43.26 -82.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' LYS . 2.9 mt-30 -71.4 106.89 4.08 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.427 HG22 ' HB2' ' A' ' 12' ' ' ASP . 2.2 mm -114.05 -178.33 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.034 -1.041 . . . . 0.0 110.133 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.576 ' HB ' HD13 ' A' ' 54' ' ' ILE . 0.5 OUTLIER -140.33 137.83 34.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.52 ' CB ' HG13 ' A' ' 61' ' ' ILE . 43.2 p90 -145.38 162.89 36.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.115 -0.99 . . . . 0.0 109.569 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' NH2' ' HA ' ' A' ' 58' ' ' GLU . 19.9 ttp85 -159.42 124.33 4.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -0.896 . . . . 0.0 109.684 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.457 ' CG2' ' CD1' ' A' ' 23' ' ' TYR . 4.0 mt -85.25 116.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.524 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 3.7 mt -73.62 0.3 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.981 -1.074 . . . . 0.0 109.836 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 151.64 103.64 0.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.577 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -68.74 -153.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -1.178 . . . . 0.0 109.365 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 t -105.13 147.63 34.84 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.202 -0.936 . . . . 0.0 110.521 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 37.5 Cg_endo -78.89 -32.91 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.157 2.571 . . . . 0.0 111.178 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' PRO . 71.7 m-20 -41.1 -34.73 0.47 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.698 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -121.03 176.95 5.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.967 -1.083 . . . . 0.0 109.231 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 4.6 m-20 -63.04 154.49 77.06 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.012 -1.055 . . . . 0.0 108.348 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' A' ' 33' ' ' ASP . 30.9 Cg_endo -72.3 -33.33 9.22 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.1 -26.41 33.62 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 28' ' ' ASP . 1.4 m -71.79 -51.84 20.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG12 ' N ' ' A' ' 33' ' ' ASP . 0.3 OUTLIER -56.6 -33.74 40.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.578 ' N ' HG12 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -70.35 -24.23 62.94 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -73.7 -39.19 64.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.296 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.478 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.25 -60.83 2.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.581 ' CE2' HD23 ' A' ' 114' ' ' LEU . 78.3 m-85 -53.42 -42.5 67.12 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.2 -38.96 27.74 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' VAL . 1.2 mtp180 -74.48 -46.84 36.99 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.35 -36.15 68.46 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -65.61 -40.99 93.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 1.3 mt-30 -81.69 -9.42 59.65 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.527 HG22 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -94.26 -27.84 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.133 -0.979 . . . . 0.0 109.63 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.501 ' CZ3' ' HG3' ' A' ' 126' ' ' MET . 1.7 m95 -102.67 -21.16 14.16 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 109.887 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' THR . 6.2 t -95.2 -26.25 16.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.255 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -67.43 -4.54 11.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.488 ' CG2' HG22 ' A' ' 47' ' ' THR . 15.1 m -108.1 -8.2 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.705 -1.247 . . . . 0.0 109.614 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' CG1' ' A' ' 158' ' ' ILE . 0.6 OUTLIER -153.16 163.53 23.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.999 -1.063 . . . . 0.0 108.424 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.2 Cg_endo -76.66 57.16 5.47 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.067 1.845 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.554 HD13 ' CE2' ' A' ' 162' ' ' TYR . 2.6 mt -93.66 125.5 38.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.546 -0.721 . . . . 0.0 109.241 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 4.9 mmm180 -112.26 90.81 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 89.4 m-85 -77.05 148.83 35.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.953 -1.092 . . . . 0.0 109.842 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 17' ' ' THR . 51.5 m -132.11 111.85 11.82 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.84 138.44 54.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.352 -0.843 . . . . 0.0 108.998 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -133.58 164.99 33.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.608 ' O ' ' N ' ' A' ' 57' ' ' GLY . 87.7 m-70 -132.03 165.35 24.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.258 -0.901 . . . . 0.0 109.697 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 0.3 OUTLIER 55.36 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 55' ' ' HIS . . . -46.3 156.53 0.52 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.406 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 1.7 mt-10 -66.55 161.2 23.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.92 -1.341 . . . . 0.0 110.47 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -124.47 148.57 47.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.587 -0.696 . . . . 0.0 109.381 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' CD2' ' A' ' 11' ' ' TRP . 10.3 t0 -70.03 -54.48 13.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.996 -1.065 . . . . 0.0 109.398 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.52 HG13 ' CB ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -103.54 122.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.195 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.456 ' HG3' ' OD1' ' A' ' 96' ' ' ASP . 3.5 mtt -105.49 139.82 39.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.959 -1.088 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.9 mt -123.32 128.61 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.023 -1.048 . . . . 0.0 108.616 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.95 -147.1 0.21 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.101 -0.999 . . . . 0.0 109.782 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.595 ' CD2' ' HA ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -177.85 -178.55 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.899 -1.126 . . . . 0.0 110.314 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 101' ' ' ASP . . . 139.21 178.95 16.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -160.87 161.74 31.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.286 -1.126 . . . . 0.0 109.786 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 57.04 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 108.517 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.5 pp20? -61.65 124.53 20.95 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-80 173.45 -57.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 77.55 -12.76 13.82 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 71' ' ' GLY . 6.0 m-20 -42.18 -24.68 0.05 Allowed 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.016 -1.285 . . . . 0.0 110.274 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 128.31 13.14 2.67 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.548 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 14.8 p90 -154.76 90.85 3.04 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 120.834 -1.392 . . . . 0.0 109.287 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.35 -171.88 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.598 2.199 . . . . 0.0 110.957 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 26.6 m-85 61.08 170.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 0.0 109.235 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 78' ' ' GLY . 1.3 t70 172.63 -34.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . 31.72 -157.77 0.0 OUTLIER Glycine 0 N--CA 1.5 2.957 0 CA-C-O 121.682 0.601 . . . . 0.0 111.933 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 80' ' ' ASP . 6.3 mttt -72.8 162.45 29.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.688 -0.889 . . . . 0.0 110.957 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 79' ' ' LYS . 9.7 p-10 27.96 -138.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.199 0.523 . . . . 0.0 111.208 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 83' ' ' LEU . . . 44.51 -116.93 1.84 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.2 OUTLIER -42.68 97.53 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 81' ' ' GLY . 1.7 mt -114.3 -21.41 10.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.567 -1.333 . . . . 0.0 109.392 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.09 150.09 0.94 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.143 -0.973 . . . . 0.0 110.178 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.588 ' CE1' ' CE1' ' A' ' 74' ' ' TYR . 1.1 p80 -144.04 -179.98 6.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.81 162.06 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.115 -0.99 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.07 168.7 10.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.673 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.8 148.32 64.72 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.547 -0.721 . . . . 0.0 109.357 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.43 ' O ' ' HE2' ' A' ' 8' ' ' LYS . 28.8 Cg_endo -75.87 136.73 19.03 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.709 2.272 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.511 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 145.21 122.79 1.56 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.387 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER 56.25 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.704 . . . . 0.0 110.954 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 33.14 -92.21 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -45.65 160.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -1.124 . . . . 0.0 108.743 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.478 ' N ' ' CG2' ' A' ' 93' ' ' VAL . . . 126.58 151.1 7.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.479 ' O ' HG21 ' A' ' 61' ' ' ILE . . . 60.82 13.41 32.67 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.651 -1.499 . . . . 0.0 109.434 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 62' ' ' MET . 1.6 m-20 -97.09 116.2 28.86 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.552 -1.558 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.614 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 33.8 m -114.65 156.36 24.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.724 -0.61 . . . . 0.0 109.941 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 97' ' ' SER . 1.9 m80 -148.79 139.01 22.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 32.6 m-85 -104.61 179.24 4.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.172 0.987 . . . . 0.0 112.165 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' OD2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -58.64 161.98 4.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.866 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.595 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 13.2 t0 -94.02 -4.83 48.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -170.12 79.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.0 109.023 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -137.09 -8.54 1.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.476 -1.39 . . . . 0.0 111.599 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.535 ' CB ' ' O ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER 76.66 141.5 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.188 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.576 ' O ' ' CB ' ' A' ' 110' ' ' ALA . 26.0 m-90 -149.01 -50.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.017 -1.052 . . . . 0.0 110.288 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.585 ' CA ' ' HB3' ' A' ' 110' ' ' ALA . 35.8 p -138.13 -89.21 0.24 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 117.905 -1.518 . . . . 0.0 113.171 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.577 ' HB2' HD21 ' A' ' 27' ' ' LEU . 28.8 t-20 52.92 19.26 1.28 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -175.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 106' ' ' THR . 30.3 p 50.49 37.63 16.35 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.356 1.074 . . . . 0.0 110.039 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -168.07 31.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.585 ' HB3' ' CA ' ' A' ' 106' ' ' THR . . . -98.12 179.97 4.58 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.463 0.649 . . . . 0.0 111.967 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -120.98 -13.31 8.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.523 ' O ' ' CB ' ' A' ' 113' ' ' SER . 1.2 m-85 -107.59 -42.4 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.939 -1.101 . . . . 0.0 108.475 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.537 ' HA ' HG22 ' A' ' 106' ' ' THR . 0.3 OUTLIER 81.01 93.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.927 0.87 . . . . 0.0 110.925 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 36' ' ' PHE . 13.2 tp -37.67 -41.83 0.52 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.739 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.527 ' CZ ' HG22 ' A' ' 42' ' ' VAL . 1.5 t80 -55.29 -45.1 76.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.893 . . . . 0.0 109.9 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.726 HD23 H351 ' A' ' 800' ' ' I52 . 1.0 OUTLIER -68.66 -58.69 3.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.448 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.495 ' CG2' ' N ' ' A' ' 118' ' ' ALA . 32.9 m -59.08 -42.37 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.006 -1.059 . . . . 0.0 109.432 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 114' ' ' LEU . . . -59.06 -41.55 88.23 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.384 0.612 . . . . 0.0 109.4 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.32 69.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.492 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -54.64 -33.61 60.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 0.0 108.821 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -86.04 -24.61 26.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.167 -0.958 . . . . 0.0 109.151 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 118' ' ' ALA . 1.4 m-85 -71.91 -10.92 60.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -101.71 -37.92 3.33 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -63.54 -50.23 70.37 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.21 -1.171 . . . . 0.0 108.597 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -61.18 -13.45 18.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.739 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.51 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 22.9 mmm -81.26 10.87 4.85 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.089 -1.007 . . . . 0.0 108.985 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 88.64 -54.96 4.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' A' ' 127' ' ' GLY . 14.7 mt -42.8 142.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.343 -1.093 . . . . 0.0 110.166 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' HIS . 19.6 pt-20 -108.98 175.61 5.4 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' GLU . 45.4 m80 -44.24 167.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.143 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 m -115.6 -80.53 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.005 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 177.11 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.44 ' O ' ' HB1' ' A' ' 139' ' ' ALA . 0.1 OUTLIER -68.53 145.79 97.36 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 -179.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -75.83 -35.44 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.256 1.971 . . . . 0.0 108.567 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.34 13.7 62.97 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.65 149.43 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -1.081 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.897 ' CD1' H352 ' A' ' 800' ' ' I52 . 14.3 tp -72.93 -16.16 61.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.47 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 7.3 mmt -112.45 27.87 9.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 133' ' ' ASP . . . -67.95 154.49 93.62 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.743 -0.598 . . . . 0.0 109.477 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.25 4.14 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.79 2.327 . . . . 0.0 111.413 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -131.99 151.06 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.887 -1.133 . . . . 0.0 109.747 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.567 ' CE2' ' HB2' ' A' ' 144' ' ' TYR . 30.1 t80 -63.96 120.96 12.96 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 144' ' ' TYR . 7.6 m -124.07 53.61 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.042 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.618 ' CD2' ' N ' ' A' ' 145' ' ' THR . 75.2 t80 -44.39 170.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.393 -0.817 . . . . 0.0 109.318 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.701 HG23 H382 ' A' ' 800' ' ' I52 . 1.6 t 179.64 113.3 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.064 -1.022 . . . . 0.0 109.455 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 23.0 ttpt -59.7 167.31 2.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.907 -1.121 . . . . 0.0 108.943 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 3.9 t-20 71.3 -54.83 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.086 . . . . 0.0 110.591 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 68.74 143.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.165 -0.96 . . . . 0.0 109.58 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 80.1 mtp85 -134.11 -86.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 108.922 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 2.1 mt 160.29 152.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.987 -1.071 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.482 ' O ' HG21 ' A' ' 155' ' ' ILE . 10.4 p -119.83 129.02 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 109.885 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.629 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.5 mt-30 -65.39 -32.55 74.25 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.463 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -44.46 -38.28 3.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.413 ' O ' ' CG2' ' A' ' 158' ' ' ILE . 0.9 OUTLIER -86.54 -38.41 17.22 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.542 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.629 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -62.7 -29.77 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 108.718 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -63.9 1.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 110.236 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -51.64 -39.97 47.05 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.507 ' CG1' HG23 ' A' ' 47' ' ' THR . 9.9 tp -70.17 -40.98 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.612 -0.934 . . . . 0.0 109.461 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 1.8 mm-40 -70.6 -20.55 62.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.257 -0.902 . . . . 0.0 108.809 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -87.14 -27.91 22.79 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.176 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.532 HD22 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -93.53 -19.99 20.69 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 109.808 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.554 ' CE2' HD13 ' A' ' 49' ' ' LEU . 25.6 m-85 -113.59 -8.06 13.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.602 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.897 H352 ' CD1' ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -98.46 38.28 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.59 44.76 2.62 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.234 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.69 38.0 2.37 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.552 ' O ' ' NH1' ' A' ' 7' ' ' ARG . 13.1 m-85 -130.55 84.29 59.57 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 7' ' ' ARG . 36.7 Cg_endo -78.95 0.75 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.533 2.156 . . . . 0.0 110.743 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -54.58 -166.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.126 -0.984 . . . . 0.0 109.682 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 7' ' ' ARG . 2.9 mttt -88.79 158.04 48.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.028 -1.045 . . . . 0.0 109.548 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 8' ' ' LYS . 35.4 Cg_endo -78.01 57.28 6.06 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.501 2.134 . . . . 0.0 108.699 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.479 ' HD3' ' HG2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -64.61 -171.04 0.06 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CH2' ' OD2' ' A' ' 60' ' ' ASP . 5.9 m95 -107.6 -105.58 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.0 109.199 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 61.34 22.95 13.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.81 -1.181 . . . . 0.0 109.548 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HD2' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -94.3 166.74 11.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 109.709 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' ILE . 4.2 m120 -82.54 -88.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 110.262 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 15' ' ' GLN . 3.5 pt20 -52.45 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.772 -1.205 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' CG2' ' N ' ' A' ' 17' ' ' THR . 10.9 mt -102.72 167.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.342 -0.849 . . . . 0.0 110.602 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.549 ' O ' HG13 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -131.64 131.51 43.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.159 -0.963 . . . . 0.0 109.837 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.505 ' HA ' HG13 ' A' ' 61' ' ' ILE . 9.3 p90 -133.7 163.93 28.34 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.996 . . . . 0.0 110.53 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' A' ' 55' ' ' HIS . 19.1 ttt180 -159.05 132.4 7.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 109.754 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.541 ' CD1' ' OD1' ' A' ' 33' ' ' ASP . 6.0 mt -93.26 131.25 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.75 -20.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 159.76 113.15 0.32 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.581 ' CG ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -84.27 -168.36 2.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.409 -1.054 . . . . 0.0 108.225 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.54 HG22 ' CD2' ' A' ' 27' ' ' LEU . 0.7 OUTLIER -105.1 149.66 37.89 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.817 -1.177 . . . . 0.0 109.475 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -78.31 -28.75 4.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.67 2.247 . . . . 0.0 110.061 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD2' ' CG2' ' A' ' 24' ' ' THR . 1.8 p30 -38.88 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.54 ' CD2' HG22 ' A' ' 24' ' ' THR . 2.0 pt? -129.11 157.45 41.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.109 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.531 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 1.6 m-20 -40.75 138.89 1.23 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.602 -0.687 . . . . 0.0 109.169 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -70.87 -39.91 4.0 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 N-CA-C 107.021 -1.953 . . . . 0.0 107.021 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.4 pt-20 -72.88 -22.55 60.74 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.531 ' HB ' ' CB ' ' A' ' 28' ' ' ASP . 5.7 m -80.01 -51.36 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.357 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.581 HG13 ' CG ' ' A' ' 23' ' ' TYR . 0.5 OUTLIER -55.71 -39.14 53.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.541 ' OD1' ' CD1' ' A' ' 20' ' ' ILE . 4.8 m-20 -78.76 -29.9 45.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 11.6 t70 -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.727 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -43.28 -55.37 4.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.468 -0.77 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -54.99 -42.58 72.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.65 -0.656 . . . . 0.0 109.42 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.88 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.865 . . . . 0.0 109.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' HB3' ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -47.93 -37.68 14.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.57 ' HB2' ' CH2' ' A' ' 43' ' ' TRP . . . -63.14 -47.71 81.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.612 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -52.4 -33.04 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 2.1 tt0 -82.39 -16.03 50.58 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.601 -0.687 . . . . 0.0 109.348 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -72.54 -36.43 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.921 -1.112 . . . . 0.0 110.167 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.635 ' CD1' ' CG1' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.29 -24.52 12.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 28.2 t -77.63 -17.67 57.53 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.176 -0.952 . . . . 0.0 108.964 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 8.0 t70 -65.77 -17.67 64.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 110.097 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 43' ' ' TRP . 13.6 p -110.31 19.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 3.8 t -173.74 149.79 1.62 Allowed Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.069 -1.02 . . . . 0.0 108.805 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -81.03 47.12 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.885 2.39 . . . . 0.0 110.811 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 51' ' ' PHE . 0.6 OUTLIER -81.25 147.2 30.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.405 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -122.78 124.06 42.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.353 -0.842 . . . . 0.0 108.93 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.644 ' CZ ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 m-85 -102.23 144.37 30.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.662 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -118.9 119.68 35.07 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -87.84 141.9 28.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 109.159 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 4.5 pt -141.22 -169.01 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 109.778 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.421 ' O ' ' CZ ' ' A' ' 19' ' ' ARG . 4.6 p80 -159.08 -33.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 109.191 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -115.31 157.86 23.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.18 -0.95 . . . . 0.0 109.18 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.18 11.26 78.82 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.16 158.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.419 -1.048 . . . . 0.0 109.066 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . . . -128.13 143.66 51.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.88 -1.138 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 11' ' ' TRP . 1.6 m-20 -51.58 -59.24 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 109.072 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -98.6 129.66 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.062 . . . . 0.0 108.583 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.459 ' SD ' ' OD1' ' A' ' 96' ' ' ASP . 1.5 mtp -125.1 116.61 22.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.563 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.573 HG23 ' N ' ' A' ' 64' ' ' ASN . 3.7 mp -104.95 155.4 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.51 -0.744 . . . . 0.0 109.129 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.573 ' N ' HG23 ' A' ' 63' ' ' ILE . 22.5 p30 179.3 -172.15 0.16 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.014 -1.054 . . . . 0.0 109.986 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -134.07 170.54 15.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.472 -0.768 . . . . 0.0 109.108 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -179.64 114.73 0.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -55.14 -149.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.722 -0.87 . . . . 0.0 110.894 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.4 p90 -48.96 -51.13 32.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.813 -1.179 . . . . 0.0 109.792 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 1.1 mt-10 -43.69 -69.21 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 15.1 t60 73.32 -73.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.43 -0.793 . . . . 0.0 110.608 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.33 9.96 9.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -170.66 68.5 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.252 -1.146 . . . . 0.0 109.971 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.47 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 117.59 179.25 17.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.81 76.29 14.03 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.431 -1.04 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.606 ' HB2' ' CD2' ' A' ' 82' ' ' LEU . 29.7 Cg_endo -74.78 -84.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.39 2.06 . . . . 0.0 108.425 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 68' ' ' TRP . 24.1 t80 59.52 -100.12 0.1 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.435 -0.791 . . . . 0.0 110.567 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 75.69 -53.96 0.63 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.989 -1.07 . . . . 0.0 108.357 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 77' ' ' ASP . . . 101.83 -148.23 17.71 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.467 ' HA ' ' OE2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -57.66 161.75 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 108.972 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 39.05 -147.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.434 -0.791 . . . . 0.0 110.028 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 51.46 -146.21 12.16 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.606 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 3.5 tp -40.56 112.93 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.927 . . . . 0.0 109.71 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' CB ' ' A' ' 84' ' ' ALA . 10.1 mt -108.63 -19.26 13.49 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.344 -0.848 . . . . 0.0 109.891 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.572 ' HB3' ' CG ' ' A' ' 99' ' ' PHE . . . 163.98 163.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.503 ' NE2' ' HB2' ' A' ' 98' ' ' HIS . 6.3 p-80 -153.92 177.4 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.935 -1.103 . . . . 0.0 109.979 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.47 156.39 48.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.08 163.2 12.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.066 -1.022 . . . . 0.0 109.609 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.546 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -83.67 157.34 64.26 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.102 -0.999 . . . . 0.0 109.706 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HG2' ' HD3' ' A' ' 10' ' ' LYS . 37.6 Cg_endo -76.81 147.56 27.56 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.462 2.108 . . . . 0.0 109.597 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 161.26 45.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.261 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 71.3 142.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -1.129 . . . . 0.0 109.72 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 35.97 -102.53 0.02 OUTLIER Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.73 119.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.158 -1.201 . . . . 0.0 108.171 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 133.15 146.1 5.5 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.49 ' HA3' HG22 ' A' ' 61' ' ' ILE . . . 79.18 2.98 88.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.459 ' OD1' ' SD ' ' A' ' 62' ' ' MET . 1.3 m-20 -107.85 130.41 55.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.197 -1.178 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 85' ' ' HIS . 0.7 OUTLIER -122.67 133.53 54.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 109.535 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 5.8 m80 -111.89 134.21 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 109.065 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.625 ' HB2' ' CD2' ' A' ' 65' ' ' PHE . 6.1 m-85 -103.76 141.95 35.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 110.63 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.82 146.03 53.61 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 66' ' ' GLY . 16.6 m-20 -89.64 -112.27 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 101' ' ' ASP . 5.1 m-20 36.03 -160.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER 34.97 -124.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.437 -0.789 . . . . 0.0 110.349 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 15.1 tp -177.62 134.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.047 -1.033 . . . . 0.0 108.713 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -126.25 124.51 40.53 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.971 -1.081 . . . . 0.0 110.449 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.5 ' HA ' ' CD1' ' A' ' 27' ' ' LEU . 4.1 p -147.03 -160.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.145 -0.972 . . . . 0.0 111.275 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 107' ' ' ASN . 36.7 t30 -108.21 18.81 20.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.391 -0.818 . . . . 0.0 110.782 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -37.15 2.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.435 -1.416 . . . . 0.0 110.168 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -178.68 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 36.26 -94.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.699 -0.626 . . . . 0.0 109.821 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 104' ' ' LEU . 1.1 m-20 -85.23 -80.98 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 108.597 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.43 ' O ' ' CB ' ' A' ' 116' ' ' LEU . 40.8 m-85 -157.42 40.44 0.3 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.0 OUTLIER 61.92 108.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.414 -0.804 . . . . 0.0 109.863 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.601 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -40.14 -39.39 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 109.848 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 57.4 t80 -59.44 -46.51 88.54 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.146 -0.971 . . . . 0.0 109.803 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.511 ' CD1' ' H33' ' A' ' 800' ' ' I52 . 0.2 OUTLIER -67.6 -54.44 19.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.569 -0.707 . . . . 0.0 109.814 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.577 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 14.2 m -58.78 -50.25 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.837 -1.164 . . . . 0.0 109.499 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -55.82 -43.29 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.505 -0.747 . . . . 0.0 110.07 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.17 -51.02 63.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.608 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 51.9 t60 -55.75 -61.37 2.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.954 -1.091 . . . . 0.0 109.234 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.477 ' O ' ' HB1' ' A' ' 125' ' ' ALA . 67.1 mm-40 -63.9 -11.21 25.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.545 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -88.16 -18.76 28.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.776 -1.203 . . . . 0.0 108.032 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.38 -43.8 9.18 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.82 -43.24 72.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 121' ' ' GLU . . . -46.31 -32.07 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 64.9 mtt -72.97 -80.65 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.03 -40.32 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.46 HD11 ' HA3' ' A' ' 157' ' ' GLY . 0.4 OUTLIER -56.77 155.96 7.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.377 -1.072 . . . . 0.0 111.019 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -173.4 2.24 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 138' ' ' MET . 45.7 m170 -52.39 144.19 13.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.55 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -123.75 20.17 9.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.484 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 1.2 tp60 54.07 -156.17 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.498 ' O ' ' HB3' ' A' ' 136' ' ' ALA . 0.6 OUTLIER 66.37 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -72.72 -41.17 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.311 2.007 . . . . 0.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.86 9.44 52.44 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.498 ' HB3' ' O ' ' A' ' 133' ' ' ASP . . . -75.73 153.73 36.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.051 -1.264 . . . . 0.0 110.14 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.664 HD12 H382 ' A' ' 800' ' ' I52 . 14.4 tp -85.6 -21.64 28.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -111.97 28.3 8.88 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.76 76.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.32 9.29 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.933 1.755 . . . . 0.0 110.719 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 56.3 mt -122.75 -99.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.008 -1.057 . . . . 0.0 109.366 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.503 ' CE2' HD11 ' A' ' 116' ' ' LEU . 1.3 t80 179.46 144.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 0.0 110.158 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.571 ' O ' H351 ' A' ' 800' ' ' I52 . 1.6 m -137.46 84.47 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 0.0 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -55.28 161.09 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.82 137.62 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.643 -0.661 . . . . 0.0 110.28 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.086 -1.009 . . . . 0.0 108.595 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 148' ' ' PHE . 42.8 t-20 -51.69 -29.91 19.99 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.496 ' O ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 59.45 134.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 1.8 tpt180 -113.45 -15.49 12.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.069 -1.019 . . . . 0.0 110.454 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER 84.13 -24.84 0.14 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 150' ' ' LEU . 97.6 p 55.99 132.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.937 0.875 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.611 ' O ' HG13 ' A' ' 155' ' ' ILE . 55.8 mt-30 -73.31 -24.4 60.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.468 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -49.76 -40.83 42.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.504 ' OD2' ' CE ' ' A' ' 138' ' ' MET . 1.4 t70 -83.18 -43.64 15.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 152' ' ' GLN . 1.2 pp -51.08 -34.23 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.543 ' HD3' ' N ' ' A' ' 157' ' ' GLY . 8.2 tmtt? -73.15 -48.02 38.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.113 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.543 ' N ' ' HD3' ' A' ' 156' ' ' LYS . . . -72.11 -53.95 8.62 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 159' ' ' GLN . 10.3 tp -45.61 -51.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -1.183 . . . . 0.0 110.181 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.488 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 5.4 mt-30 -57.61 -56.93 15.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.681 -1.262 . . . . 0.0 109.144 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.53 -25.92 0.31 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.644 -0.66 . . . . 0.0 110.402 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 16.6 tp -97.02 -56.53 2.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 109.42 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.467 ' CD2' HD11 ' A' ' 158' ' ' ILE . 15.7 m-30 -77.9 -77.38 0.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.901 -1.124 . . . . 0.0 108.682 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.466 ' OXT' ' HG2' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.635 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.664 H382 HD12 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' CB ' ' A' ' 2' ' ' TYR . 5.0 mtm . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.167 0.508 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.469 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 75.71 -177.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.9 23.19 12.22 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' O ' ' CD2' ' A' ' 5' ' ' PHE . 55.4 m-85 55.41 -124.29 2.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.211 -0.931 . . . . 0.0 109.295 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' CD2' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 179.76 -58.57 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.676 -1.265 . . . . 0.0 109.861 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 5' ' ' PHE . 32.2 Cg_endo -72.73 124.2 9.56 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.085 1.857 . . . . 0.0 110.635 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.82 19.53 4.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 108.853 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -96.52 143.74 26.65 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.77 57.16 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 N-CA-C 108.017 -1.571 . . . . 0.0 108.017 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -57.96 165.53 1.8 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 13.0 m95 -84.4 72.58 10.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 5.9 m-20 -122.58 62.94 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 109.558 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.471 ' O ' HD21 ' A' ' 49' ' ' LEU . 5.0 mtmt -124.63 -163.55 1.18 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.998 -1.064 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -109.77 -34.9 6.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.83 . . . . 0.0 108.82 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.526 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -94.14 97.7 10.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.497 0.665 . . . . 0.0 109.844 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.94 169.04 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.758 -1.214 . . . . 0.0 108.63 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -138.79 134.61 33.66 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.162 -0.961 . . . . 0.0 108.503 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 18.0 p90 -135.28 145.18 47.28 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.077 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HB2' HG13 ' A' ' 54' ' ' ILE . 2.2 tpt180 -151.21 125.37 9.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mt -85.56 124.04 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.874 -1.141 . . . . 0.0 109.049 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' CG1' ' HB3' ' A' ' 64' ' ' ASN . 24.0 mm -53.76 -27.29 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.911 -1.118 . . . . 0.0 109.261 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 162.38 86.24 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.908 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.593 ' CE2' ' OD2' ' A' ' 33' ' ' ASP . 1.3 p90 -46.73 177.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.567 -0.961 . . . . 0.0 109.203 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.94 140.72 31.1 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 0.0 109.941 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -80.09 -23.5 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.632 2.221 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . 12.0 t0 -39.83 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.894 -0.504 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD21 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -132.51 170.85 14.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.768 -1.207 . . . . 0.0 110.34 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 65.7 m-20 -42.64 133.93 2.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.371 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.508 ' O ' HG13 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -68.67 -31.03 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 30' ' ' GLU . 5.6 mm-40 -76.02 -34.49 59.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.554 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 17.5 m -69.69 -52.55 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.422 -1.311 . . . . 0.0 108.038 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.596 HG22 ' CD2' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -55.66 -38.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -74.22 -31.27 62.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 22.7 t70 -64.36 -33.77 76.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.555 ' HB2' ' N ' ' A' ' 115' ' ' PHE . . . -50.52 -47.91 57.27 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -71.36 -25.71 62.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 34' ' ' ASP . . . -63.9 -64.55 0.86 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -53.76 -39.93 65.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.593 ' HB2' ' CZ2' ' A' ' 43' ' ' TRP . . . -58.9 -51.12 71.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.511 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.4 t80 -44.19 -49.22 9.21 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 22.4 tt0 -70.49 -26.27 63.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.672 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -60.9 -33.83 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 108.509 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.701 ' CH2' ' CD1' ' A' ' 122' ' ' PHE . 0.8 OUTLIER -103.04 -55.36 2.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.725 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.511 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -49.08 -35.12 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 3.6 t0 -62.96 -28.77 70.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.401 -0.812 . . . . 0.0 110.596 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 43' ' ' TRP . 7.8 p -108.72 9.68 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -149.74 133.63 8.84 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.52 29.96 0.46 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.764 2.309 . . . . 0.0 111.358 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.511 HD12 ' CG ' ' A' ' 162' ' ' TYR . 0.0 OUTLIER -85.57 141.39 29.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.652 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.512 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -101.38 121.7 42.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.854 -1.154 . . . . 0.0 109.44 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -94.78 143.2 26.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.741 -0.599 . . . . 0.0 109.449 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.529 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -124.47 141.39 52.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.852 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -99.43 162.39 13.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.942 -1.099 . . . . 0.0 108.847 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.564 ' CD1' ' CB ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.86 164.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.707 -1.197 . . . . 0.0 110.02 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.563 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.1 p80 -145.97 38.64 1.09 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.415 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.563 ' HB2' ' O ' ' A' ' 55' ' ' HIS . 0.4 OUTLIER 169.04 166.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.427 -0.795 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . 75.2 -81.14 0.94 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 54' ' ' ILE . 1.3 tp10 178.33 166.24 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -1.004 . . . . 0.0 108.856 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . . . -138.89 146.78 41.55 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 109.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.59 -57.76 6.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.02 -1.05 . . . . 0.0 108.745 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.494 HG13 ' HA ' ' A' ' 18' ' ' TYR . 0.6 OUTLIER -93.46 116.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 120.839 -1.163 . . . . 0.0 109.223 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 4.8 mtm -113.06 114.01 26.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.582 -0.699 . . . . 0.0 109.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.77 153.14 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.139 -0.975 . . . . 0.0 109.839 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 97' ' ' SER . 20.8 p-10 -174.64 -171.47 0.57 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 34.5 p90 -116.21 -171.9 2.08 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.49 ' HA3' ' CD2' ' A' ' 98' ' ' HIS . . . -164.64 116.2 0.69 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' HD3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.73 -169.65 2.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -1.171 . . . . 0.0 108.876 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -16.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.472 -0.767 . . . . 0.0 109.92 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HG3' ' HD3' ' A' ' 67' ' ' ARG . 12.9 mt-10 -76.55 -105.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.05 . . . . 0.0 110.813 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 1.2 t-80 56.28 -158.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.862 -1.149 . . . . 0.0 108.751 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.57 38.11 0.23 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD1' ' CD2' ' A' ' 70' ' ' HIS . 1.3 m-20 -75.86 4.19 8.58 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.468 -1.019 . . . . 0.0 110.283 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.6 -42.4 2.32 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.471 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 16.0 p90 -103.19 160.61 25.64 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.303 . . . . 0.0 110.601 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -78.85 142.05 17.39 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.974 2.45 . . . . 0.0 111.287 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.49 ' CE1' ' O ' ' A' ' 67' ' ' ARG . 9.1 m-85 -58.34 146.76 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 109.654 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.23 2.66 8.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.641 -0.662 . . . . 0.0 109.953 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.04 -161.58 41.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 163.72 13.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.016 -1.285 . . . . 0.0 109.438 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 53.72 -170.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 108.698 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 66.71 -144.32 45.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.487 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -38.25 127.02 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.722 -0.869 . . . . 0.0 110.461 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -23.98 9.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.419 ' HB2' ' HG3' ' A' ' 121' ' ' GLU . . . -179.65 162.74 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.717 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.436 ' CD2' ' HD1' ' A' ' 98' ' ' HIS . 2.9 p80 -149.45 167.81 25.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.98 48.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -0.903 . . . . 0.0 110.039 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -81.83 169.68 16.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.951 -1.093 . . . . 0.0 109.858 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.567 ' HB3' ' CD1' ' A' ' 11' ' ' TRP . 35.6 Cg_endo -79.47 140.62 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.078 2.519 . . . . 0.0 111.009 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.54 -43.19 1.54 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.9 p -73.17 159.06 34.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.416 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 -16.86 63.28 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.433 ' O ' HG11 ' A' ' 93' ' ' VAL . 74.4 t -103.66 0.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -1.23 . . . . 0.0 109.168 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.52 159.4 20.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.473 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 77.91 -6.37 48.7 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -91.14 130.05 37.07 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.712 -1.463 . . . . 0.0 108.607 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 17.8 m -122.13 142.55 50.28 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.53 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.49 ' CD2' ' HA3' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -116.13 122.24 44.49 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 108.856 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 26.8 m-85 -98.39 145.22 26.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' OE1' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -46.91 163.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 108.933 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.5 ' HA ' ' CZ2' ' A' ' 105' ' ' TRP . 34.3 t70 -117.61 -18.1 9.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.982 -1.074 . . . . 0.0 108.924 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -81.84 -31.41 31.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.127 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' OE1' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -67.13 161.58 24.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 110.651 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -106.02 106.58 17.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.722 -0.611 . . . . 0.0 109.465 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.584 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -116.15 122.74 45.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.0 108.908 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 113' ' ' SER . 1.2 p -149.13 151.3 34.14 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.803 -1.186 . . . . 0.0 110.574 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.457 ' C ' HG23 ' A' ' 108' ' ' THR . 0.6 OUTLIER -111.78 68.59 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.058 . . . . 0.0 110.174 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.457 HG23 ' C ' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -172.63 77.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.459 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 108' ' ' THR . 2.4 p 45.67 75.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.464 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.434 ' CB ' ' OG1' ' A' ' 106' ' ' THR . . . -155.77 -158.19 0.79 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -73.47 -114.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 110.471 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -62.15 146.45 50.57 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.067 -1.021 . . . . 0.0 109.843 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 106' ' ' THR . 3.5 m -110.02 110.34 21.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 110.448 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.596 ' CD2' HG22 ' A' ' 32' ' ' VAL . 2.1 tp -39.42 -45.62 1.53 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 110.521 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.555 ' N ' ' HB2' ' A' ' 35' ' ' ALA . 3.7 t80 -54.83 -46.17 74.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -62.65 -72.12 0.14 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 17.4 m -45.21 -49.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -54.08 -46.31 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.04 -1.038 . . . . 0.0 109.888 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -50.72 -58.82 4.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.721 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.431 ' CD2' ' CD2' ' A' ' 124' ' ' HIS . 37.6 t60 -42.68 -57.52 2.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.502 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 84' ' ' ALA . 75.4 mm-40 -71.4 -16.4 62.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.954 -1.091 . . . . 0.0 109.546 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.701 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -81.98 -3.46 54.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 108.24 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.13 -41.38 1.41 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.431 ' CD2' ' CD2' ' A' ' 120' ' ' HIS . 31.4 m-70 -64.09 -32.01 73.42 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.38 -26.7 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 109.36 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 6.84 46.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 109.747 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.67 -8.65 78.7 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.476 HD23 ' HA3' ' A' ' 157' ' ' GLY . 5.7 mt -44.73 151.36 0.29 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 110.438 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -111.6 176.05 5.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -80.46 169.95 17.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.152 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.547 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -115.07 -22.97 9.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 131' ' ' SER . 9.3 mm100 82.99 -21.72 0.27 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.691 -0.631 . . . . 0.0 110.707 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -74.66 152.41 87.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.877 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.26 -39.54 3.82 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.5 2.134 . . . . 0.0 110.356 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.33 2.14 62.95 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.99 149.09 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -1.214 . . . . 0.0 110.18 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.784 ' CD1' H362 ' A' ' 800' ' ' I52 . 18.1 tp -80.38 -23.25 40.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.188 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.421 ' HA ' ' CE1' ' A' ' 120' ' ' HIS . 1.1 mpt? -109.87 26.22 10.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.479 ' HB2' ' HD2' ' A' ' 140' ' ' PRO . . . -58.73 164.85 3.68 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.178 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 139' ' ' ALA . 34.4 Cg_endo -78.69 17.18 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.465 2.11 . . . . 0.0 111.195 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 142' ' ' TYR . 15.5 mt -140.66 162.11 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.787 -1.196 . . . . 0.0 110.07 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.423 ' N ' HG23 ' A' ' 141' ' ' ILE . 16.7 t80 -91.68 118.84 31.02 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -108.8 -48.81 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.584 ' CG ' ' N ' ' A' ' 145' ' ' THR . 58.7 t80 60.93 165.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.067 -1.021 . . . . 0.0 109.999 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.584 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 152.6 30.12 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.659 -0.651 . . . . 0.0 109.271 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 6.8 tptm -92.03 -11.62 35.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 148' ' ' PHE . 12.2 m-80 -126.53 -91.98 0.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.635 ' CZ ' ' HB2' ' A' ' 150' ' ' LEU . 6.2 t80 156.93 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.13 -0.981 . . . . 0.0 109.724 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -150.95 -40.53 0.12 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.288 -0.883 . . . . 0.0 110.364 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 148' ' ' PHE . 9.6 tp 65.6 144.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.018 -1.051 . . . . 0.0 109.495 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -114.84 131.56 56.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.597 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 12.3 tt0 -48.95 -22.66 0.9 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -48.6 78.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.888 -1.132 . . . . 0.0 108.088 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -73.58 -33.77 64.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.597 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -70.17 -27.53 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.365 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.458 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -76.56 -46.62 25.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 110.455 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.476 ' HA3' HD23 ' A' ' 128' ' ' LEU . . . -71.64 -23.12 78.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.517 HG21 ' N ' ' A' ' 159' ' ' GLN . 6.5 tp -81.0 -39.74 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.838 -1.389 . . . . 0.0 108.449 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.517 ' N ' HG21 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -68.61 -22.45 64.44 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.495 ' N ' ' HG3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -86.13 -25.06 25.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.465 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.02 -22.23 42.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.511 ' CG ' HD12 ' A' ' 49' ' ' LEU . 30.3 m-85 -120.3 -69.05 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 108.999 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.853 H241 ' H62' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.455 0.645 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 10.5 t80 -101.08 -29.94 11.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.11 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -102.16 -167.04 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 109.001 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -141.02 108.1 5.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.821 -1.174 . . . . 0.0 109.465 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 51.59 81.85 0.25 Allowed Pre-proline 0 C--N 1.303 -1.414 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.491 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.92 41.58 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.229 1.953 . . . . 0.0 110.821 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -142.32 -154.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.046 -1.034 . . . . 0.0 109.845 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 7' ' ' ARG . 5.4 mttt -176.98 163.28 1.54 Allowed Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 109.731 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' LYS . 36.3 Cg_endo -79.87 66.78 8.77 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.149 1.899 . . . . 0.0 108.632 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 9.1 mtpt -41.7 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.562 -0.711 . . . . 0.0 109.615 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER 174.86 45.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.929 -1.107 . . . . 0.0 110.354 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' HB3' ' CE1' ' A' ' 162' ' ' TYR . 12.9 p-10 -144.57 84.52 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.467 -1.395 . . . . 0.0 111.329 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -115.95 49.11 1.14 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.034 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 9.8 m-20 65.34 -69.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' LYS . 4.2 mt-30 -80.67 110.35 16.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.995 -1.066 . . . . 0.0 109.103 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.1 mm -104.18 164.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -128.2 137.55 52.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.595 ' CB ' HG13 ' A' ' 61' ' ' ILE . 13.2 p90 -149.15 154.3 38.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.043 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB3' ' CB ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -147.53 125.43 11.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.847 . . . . 0.0 109.865 -178.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.41 HG12 ' CE2' ' A' ' 36' ' ' PHE . 3.4 mt -86.02 124.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 64' ' ' ASN . 2.8 mt -74.18 3.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.89 -1.131 . . . . 0.0 110.43 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.42 112.56 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -61.63 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.113 -1.228 . . . . 0.0 107.788 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.619 HG22 ' CZ ' ' A' ' 65' ' ' PHE . 1.8 t -106.84 137.38 19.48 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.858 -1.151 . . . . 0.0 108.121 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.59 -24.74 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.206 1.938 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.26 -24.83 3.14 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.763 -0.586 . . . . 0.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' CD1' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -138.47 177.0 8.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.878 -1.139 . . . . 0.0 111.002 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.527 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 74.8 m-20 -53.87 129.51 56.45 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.649 -0.657 . . . . 0.0 110.436 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.636 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . 27.0 Cg_endo -73.79 -33.65 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 N-CA-C 105.394 -2.579 . . . . 0.0 105.394 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.72 -36.24 82.36 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.7 m -66.27 -71.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.636 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -41.32 -28.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 0.0 108.981 178.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -72.47 -38.37 68.23 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' THR . 24.2 t0 -79.89 -58.57 3.11 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 34' ' ' ASP . . . -36.77 -39.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.642 0.734 . . . . 0.0 109.034 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 37' ' ' ALA . 3.6 m-85 -68.26 -65.78 0.65 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -44.52 -51.02 9.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.773 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -59.26 -52.5 65.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.458 ' C ' ' O ' ' A' ' 38' ' ' ARG . . . -43.91 -52.57 6.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -46.38 -40.91 12.79 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.505 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -71.56 -20.33 62.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.546 -0.721 . . . . 0.0 110.591 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.53 HG12 ' N ' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -86.47 -32.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.259 -1.526 . . . . 0.0 109.196 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.6 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 3.7 m95 -91.13 -19.01 23.56 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.605 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 28.9 t -91.37 -23.04 20.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 8.4 m-20 -65.34 -5.55 7.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.245 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.64 ' CG2' ' HB ' ' A' ' 155' ' ' ILE . 12.2 p -120.49 4.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.521 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 7.9 t -159.08 149.05 15.16 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.598 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.521 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -79.11 49.59 3.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.337 2.025 . . . . 0.0 109.856 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.556 HD21 ' CE2' ' A' ' 162' ' ' TYR . 4.8 tp -93.67 150.56 20.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.3 -0.875 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -122.95 136.79 54.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 109.073 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 51' ' ' PHE . 6.7 m-85 -112.56 149.72 32.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.929 -1.107 . . . . 0.0 110.183 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.459 ' HB3' HG22 ' A' ' 17' ' ' THR . 0.4 OUTLIER -125.11 126.68 45.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.208 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 53' ' ' ARG . 6.0 mtm-85 -77.97 126.73 31.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 108.481 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.492 HG23 ' O ' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -113.64 141.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.223 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.509 ' N ' ' CD2' ' A' ' 55' ' ' HIS . 4.5 m170 -72.44 -145.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.53 -174.13 4.1 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 108.636 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 58' ' ' GLU . . . 93.63 42.64 4.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 64.43 160.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -1.041 . . . . 0.0 109.203 -179.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -153.46 148.94 27.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -53.55 -59.97 3.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 108.802 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.595 ' CG1' ' O ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -104.57 124.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 74.9 mtp -111.96 113.88 26.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 110.987 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 64' ' ' ASN . 1.6 mp -102.71 159.7 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.8 p-10 174.99 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.445 -0.784 . . . . 0.0 109.397 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.619 ' CZ ' HG22 ' A' ' 24' ' ' THR . 32.4 m-85 -115.41 175.67 5.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.175 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.63 90.88 0.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -71.87 -145.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 108.059 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 67' ' ' ARG . 5.4 m95 -63.22 -147.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.485 -1.385 . . . . 0.0 108.648 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 47.79 -143.54 0.4 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.03 -1.044 . . . . 0.0 109.927 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.02 156.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -130.72 23.94 4.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.3 74.95 0.09 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.462 -1.022 . . . . 0.0 108.99 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 63.48 -87.51 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 3.1 m-85 -108.71 117.98 52.87 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.294 -1.121 . . . . 0.0 108.713 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.52 158.38 40.19 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.68 1.586 . . . . 0.0 109.916 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 17.8 t80 62.64 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 80.95 -46.17 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.15 -157.56 23.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -57.31 165.5 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -1.163 . . . . 0.0 108.826 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 3.3 m-20 43.69 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.229 -0.919 . . . . 0.0 111.135 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 61.17 -142.32 48.4 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.461 ' HB3' ' OD2' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -40.08 106.83 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.655 -0.909 . . . . 0.0 109.347 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.512 ' O ' ' CB ' ' A' ' 84' ' ' ALA . 1.8 mt -111.21 -26.92 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' A' ' 83' ' ' LEU . . . 165.05 152.93 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.385 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.674 ' HA ' ' H2 ' ' A' ' 800' ' ' I52 . 34.1 p80 -152.24 177.05 10.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.411 -0.806 . . . . 0.0 108.961 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.471 ' HB1' ' OE1' ' A' ' 121' ' ' GLU . . . -140.22 155.92 46.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 108.775 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 156.22 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 110.078 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -72.27 162.47 73.58 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -73.75 136.76 23.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.807 2.338 . . . . 0.0 111.112 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.66 -165.82 28.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -86.48 117.96 25.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -1.086 . . . . 0.0 110.339 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.64 -89.81 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 32.6 m -71.32 119.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.082 -1.246 . . . . 0.0 109.065 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.39 158.65 8.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.534 ' CA ' HG21 ' A' ' 61' ' ' ILE . . . 67.27 6.9 42.42 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 62' ' ' MET . 2.7 m-20 -97.98 140.83 31.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -1.194 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.8 131.15 25.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.02 . . . . 0.0 109.769 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 98' ' ' HIS . 1.9 m170 -106.32 135.5 47.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.029 -1.044 . . . . 0.0 109.309 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 58.9 m-85 -96.52 158.83 15.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.457 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -55.43 129.42 38.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.698 -0.627 . . . . 0.0 109.683 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.14 -70.27 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 22.3 p-10 -60.7 86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 110.592 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -179.48 179.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.532 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 63.8 tp -119.32 100.77 7.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.906 -1.121 . . . . 0.0 109.385 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.506 ' C ' ' CG2' ' A' ' 106' ' ' THR . 24.4 m0 -112.45 173.91 6.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.246 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.623 ' O ' ' HA ' ' A' ' 113' ' ' SER . 0.5 OUTLIER 179.62 162.65 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.969 -1.082 . . . . 0.0 110.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 115' ' ' PHE . 2.1 t-20 -104.84 21.74 16.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 109.869 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -124.01 -179.7 4.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.512 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 108' ' ' THR . 8.1 t -66.69 69.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.377 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 108' ' ' THR . . . -160.41 115.96 2.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.424 -0.798 . . . . 0.0 109.104 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t-20 64.96 -150.3 0.26 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.443 -0.786 . . . . 0.0 108.984 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.469 ' HD2' ' CD1' ' A' ' 105' ' ' TRP . 42.3 m-85 -67.88 -147.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.094 . . . . 0.0 108.4 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 106' ' ' THR . 22.4 t -148.71 98.64 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.061 -1.024 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.484 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -35.69 -57.97 0.63 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.384 -0.822 . . . . 0.0 111.286 -179.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -49.66 -40.57 40.25 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.168 -0.958 . . . . 0.0 109.792 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.769 HD22 H372 ' A' ' 800' ' ' I52 . 3.0 tm? -70.36 -55.14 9.83 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 110.521 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 114' ' ' LEU . 35.7 m -58.36 -48.63 84.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 O-C-N 120.437 -1.414 . . . . 0.0 108.057 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -46.56 -52.37 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.94 -1.1 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.03 -54.53 6.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 108.605 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.473 ' CE1' ' HA ' ' A' ' 138' ' ' MET . 43.8 t60 -46.48 -64.63 0.71 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.102 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 66.3 mm-40 -63.23 -15.34 56.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.772 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.471 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.6 m-85 -82.12 -10.61 59.13 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.6 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -99.31 -48.38 1.71 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.435 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 12.8 m-70 -55.93 -40.54 73.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -1.07 . . . . 0.0 108.856 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.31 -4.66 18.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.465 -0.772 . . . . 0.0 109.554 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.495 ' HG2' ' OH ' ' A' ' 162' ' ' TYR . 26.7 mtt -103.04 -14.84 16.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 0.0 110.902 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.22 -11.67 12.91 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.677 -1.264 . . . . 0.0 110.678 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.498 ' CD1' ' OD1' ' A' ' 154' ' ' ASP . 30.9 mt -81.07 138.53 35.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.897 -1.355 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.39 178.27 4.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 138' ' ' MET . 50.4 m170 -55.53 148.28 16.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 0.0 110.247 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.4 p -112.39 -173.14 2.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -108.03 -14.46 14.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.004 -1.06 . . . . 0.0 109.715 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -70.04 134.72 87.46 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 133' ' ' ASP . 33.2 Cg_endo -79.51 109.84 2.55 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 123.056 2.504 . . . . 0.0 110.115 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.78 -2.77 17.48 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.11 170.7 1.53 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.353 -1.086 . . . . 0.0 109.406 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.828 ' CD1' H362 ' A' ' 800' ' ' I52 . 8.3 tp -84.68 -25.86 28.15 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.782 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.597 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 2.9 mmt -97.79 4.23 49.84 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.989 -1.069 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.485 ' HB3' HD12 ' A' ' 141' ' ' ILE . . . -41.69 156.75 0.22 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.13 2.37 7.71 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.426 2.084 . . . . 0.0 111.574 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 139' ' ' ALA . 0.4 OUTLIER -129.46 160.94 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.915 -1.116 . . . . 0.0 108.196 179.101 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.557 ' O ' ' CB ' ' A' ' 143' ' ' THR . 75.0 t80 -56.52 -82.28 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.563 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.557 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 3.2 m 81.59 -33.56 0.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.039 -1.038 . . . . 0.0 111.792 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.507 ' O ' H351 ' A' ' 800' ' ' I52 . 3.0 t80 71.59 175.23 0.29 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.686 -1.259 . . . . 0.0 109.426 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.855 ' HA ' H371 ' A' ' 800' ' ' I52 . 4.6 p -85.34 4.28 35.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 109.119 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.602 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 46.99 47.73 15.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.232 -0.917 . . . . 0.0 110.435 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.4 t30 89.16 21.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.619 ' N ' ' OG1' ' A' ' 145' ' ' THR . 48.7 t80 52.34 164.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 109.938 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.567 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 165.2 -22.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.61 -178.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.605 HD22 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 69.01 123.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 108.881 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.571 ' O ' HG22 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.62 134.99 49.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.032 -1.042 . . . . 0.0 110.668 -178.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.59 ' HA ' HG22 ' A' ' 155' ' ' ILE . 0.4 OUTLIER -50.61 -19.99 1.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.38 -56.06 26.78 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.688 -1.257 . . . . 0.0 108.055 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.587 ' OD2' ' CZ2' ' A' ' 43' ' ' TRP . 4.2 t0 -68.46 -32.13 71.91 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.64 ' HB ' ' CG2' ' A' ' 46' ' ' VAL . 0.5 OUTLIER -69.29 -37.39 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.603 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.509 ' N ' HG13 ' A' ' 155' ' ' ILE . 8.4 tmtt? -61.73 -49.32 76.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.304 -0.873 . . . . 0.0 109.39 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -68.25 -39.83 87.84 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.467 HG23 ' HB ' ' A' ' 47' ' ' THR . 2.7 tp -66.17 -17.65 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.841 -1.388 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 163' ' ' GLY . 66.0 mt-30 -87.82 -49.02 7.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.092 . . . . 0.0 109.282 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -13.63 62.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 0.0 109.278 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -101.76 -42.3 6.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.839 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.556 ' CE2' HD21 ' A' ' 49' ' ' LEU . 21.8 m-30 -107.17 -13.21 15.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.794 -1.191 . . . . 0.0 110.312 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.855 H371 ' HA ' ' A' ' 145' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptt? . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.16 132.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.321 -0.862 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.66 -161.59 1.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 5' ' ' PHE . 4.3 t80 -102.12 26.76 7.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.114 -0.991 . . . . 0.0 108.697 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 4' ' ' PHE . 25.5 m-85 42.86 84.31 0.19 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 109.32 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.33 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.569 2.179 . . . . 0.0 110.364 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER 44.35 -165.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.247 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -44.74 161.86 0.22 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.441 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 10' ' ' LYS . 36.7 Cg_endo -80.49 55.09 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.378 2.052 . . . . 0.0 107.58 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.1 OUTLIER 60.35 128.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' LYS . 14.6 m95 -37.5 110.64 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.56 -0.712 . . . . 0.0 110.338 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.7 p-10 -128.81 54.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -108.84 -167.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.287 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -108.57 -41.7 4.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.023 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 19.3 mt-30 -92.92 116.77 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.071 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -111.45 161.07 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.039 -1.038 . . . . 0.0 109.595 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.3 p -131.69 126.07 33.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.397 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 34.1 p90 -137.05 148.53 46.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -144.33 140.85 29.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.075 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.551 HD13 ' CZ ' ' A' ' 23' ' ' TYR . 2.2 mp -92.89 161.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -108.38 -39.72 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . -161.58 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.222 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.551 ' CZ ' HD13 ' A' ' 20' ' ' ILE . 15.5 m-85 -45.74 172.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -1.183 . . . . 0.0 108.962 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.529 ' CG2' HD13 ' A' ' 27' ' ' LEU . 9.9 t -97.98 145.41 29.74 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.428 ' O ' ' N ' ' A' ' 27' ' ' LEU . 34.2 Cg_endo -78.29 -28.69 4.47 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.313 2.009 . . . . 0.0 111.22 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.485 ' OD2' HG21 ' A' ' 106' ' ' THR . 3.9 t70 -41.56 -28.49 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.868 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 32' ' ' VAL . 0.4 OUTLIER -133.33 179.68 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.037 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.548 ' O ' ' CG2' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -73.6 152.27 89.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.245 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.686 ' HA ' ' CG2' ' A' ' 32' ' ' VAL . 26.5 Cg_endo -67.08 -32.61 34.02 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.872 2.381 . . . . 0.0 105.971 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.48 -31.95 71.6 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.577 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.4 m -72.84 -69.39 0.42 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.686 ' CG2' ' HA ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -40.97 -31.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.452 -0.78 . . . . 0.0 109.052 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 4.6 t0 -79.84 -33.05 40.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 31' ' ' THR . 21.7 t70 -78.93 -44.88 21.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 108.589 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -44.62 -48.9 10.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -71.44 -44.99 63.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.405 -0.81 . . . . 0.0 108.934 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -51.37 -54.17 29.09 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -53.32 -42.47 66.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -56.54 -49.67 74.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 44' ' ' SER . 10.1 t80 -47.22 -33.76 5.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -86.81 -24.05 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.712 -0.617 . . . . 0.0 109.72 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.648 ' CG2' ' CE1' ' A' ' 148' ' ' PHE . 0.3 OUTLIER -59.59 -35.34 58.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.258 -0.902 . . . . 0.0 108.851 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.628 ' NE1' ' CG1' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -105.96 -49.66 3.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.454 -0.779 . . . . 0.0 110.104 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 48.2 t -53.83 -21.7 8.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.178 -0.951 . . . . 0.0 110.639 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 6.2 m-20 -67.12 -13.89 62.38 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG23 HG23 ' A' ' 47' ' ' THR . 32.8 m -122.01 -20.83 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 0.0 110.434 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.466 ' CG2' HG21 ' A' ' 158' ' ' ILE . 54.0 p -122.58 143.8 40.77 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 109.405 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.05 57.99 4.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.097 1.864 . . . . 0.0 108.945 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.537 ' CD2' ' HB3' ' A' ' 162' ' ' TYR . 3.0 mm? -84.64 144.84 28.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.904 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 50' ' ' ARG . 9.3 tpm_? -116.6 66.64 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 108.778 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.509 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 47.2 m-85 -59.5 148.68 32.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 108.92 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 16' ' ' ILE . 3.4 t -139.32 106.65 5.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.522 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 2.3 ptt85 -76.6 126.57 31.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 108.752 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 58' ' ' GLU . 6.3 pt -117.95 166.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.937 -1.102 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 55' ' ' HIS . 9.7 p80 -154.01 70.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.071 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.44 6.01 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.725 -1.235 . . . . 0.0 109.824 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 58' ' ' GLU . . . 106.76 32.72 3.5 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 172.18 158.35 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.178 -1.189 . . . . 0.0 109.701 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' HD13 ' A' ' 54' ' ' ILE . . . 178.95 143.04 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.764 . . . . 0.0 109.034 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.56 -57.38 9.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.077 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 9.8 mt -90.51 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.169 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.517 ' CB ' ' HB3' ' A' ' 96' ' ' ASP . 2.7 mtt -147.35 118.2 7.62 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.813 . . . . 0.0 109.776 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 2.0 mp -105.82 148.95 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' N ' HG22 ' A' ' 63' ' ' ILE . 5.8 t30 176.44 -156.25 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.225 -0.922 . . . . 0.0 109.274 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -127.43 171.21 11.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.905 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.52 86.52 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.016 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 68' ' ' TRP . 1.4 ptt85 -78.26 -160.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.099 -1.236 . . . . 0.0 109.686 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.541 ' C ' ' CE3' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -42.95 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.256 -0.903 . . . . 0.0 110.562 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -36.74 95.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.58 -0.7 . . . . 0.0 110.374 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' TRP . 2.2 t-80 -168.57 -61.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 76.77 -2.66 58.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 74' ' ' TYR . 4.1 p-10 -56.1 83.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.155 -1.203 . . . . 0.0 110.13 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 61.18 -75.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 72' ' ' ASP . 24.3 m-85 -100.69 137.11 19.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.274 . . . . 0.0 110.146 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.15 -157.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.576 2.184 . . . . 0.0 109.221 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -80.63 140.66 35.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.134 . . . . 0.0 109.153 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 40.2 p-10 -116.19 -15.6 11.05 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.05 -154.43 33.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' ASP . 1.1 mttt -47.25 154.6 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -1.171 . . . . 0.0 110.843 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' LYS . 15.6 m-20 49.5 -177.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.621 -0.674 . . . . 0.0 110.18 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 76.39 -144.97 31.24 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 28.6 tp -40.27 116.61 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.493 -1.004 . . . . 0.0 110.022 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 81' ' ' GLY . 57.8 mt -112.02 -28.16 8.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB1' ' OE2' ' A' ' 121' ' ' GLU . . . 176.47 147.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 109.771 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -150.16 179.52 8.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -148.13 158.23 43.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.0 108.993 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.46 155.73 18.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.226 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -55.51 155.14 10.75 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.579 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.497 ' CG ' ' HE2' ' A' ' 10' ' ' LYS . 33.5 Cg_endo -75.2 141.41 26.03 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.761 2.307 . . . . 0.0 110.436 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.9 177.48 48.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.96 114.18 15.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.237 . . . . 0.0 109.236 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.78 -85.51 0.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.16 156.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -1.131 . . . . 0.0 108.928 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 109.69 156.22 16.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.559 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 74.83 -0.54 57.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -98.83 137.83 36.84 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.872 -1.369 . . . . 0.0 109.118 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -132.26 130.85 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.905 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -111.66 133.79 53.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.312 -0.867 . . . . 0.0 108.828 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.584 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 3.7 m-30 -95.95 159.8 14.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.544 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CB ' ' OE1' ' A' ' 103' ' ' GLU . 1.6 t70 -58.83 136.81 57.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 109.359 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.92 -9.2 58.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.229 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.5 -42.19 12.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.786 . . . . 0.0 109.742 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.483 ' OE1' ' CB ' ' A' ' 100' ' ' ASP . 3.1 mp0 -72.7 140.93 48.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.74 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.21 128.18 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.427 -0.795 . . . . 0.0 109.277 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.584 ' CZ2' ' HB2' ' A' ' 99' ' ' PHE . 1.9 m-90 -101.01 166.56 10.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.499 ' O ' ' N ' ' A' ' 114' ' ' LEU . 82.6 p -149.46 -168.3 3.07 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.056 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.521 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 2.6 p30 -135.2 6.33 3.32 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.128 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.41 HG21 ' N ' ' A' ' 109' ' ' SER . 11.1 t -139.22 -152.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.237 -0.915 . . . . 0.0 109.98 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.41 ' N ' HG21 ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.91 108.77 18.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.4 -0.813 . . . . 0.0 108.87 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.8 -97.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.262 -0.899 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.79 -78.05 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.069 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.467 ' HB3' ' HA ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -100.92 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.127 -0.983 . . . . 0.0 109.073 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -164.61 114.63 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' A' ' 106' ' ' THR . 8.4 tp -50.16 -70.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.5 -0.75 . . . . 0.0 110.318 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' LEU . 8.0 t80 -39.5 -27.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.427 -0.795 . . . . 0.0 110.173 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.558 ' CD1' ' H31' ' A' ' 800' ' ' I52 . 1.0 OUTLIER -78.57 -71.6 0.42 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.836 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 118' ' ' ALA . 14.6 m -52.46 -42.43 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.917 -1.115 . . . . 0.0 109.154 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 114' ' ' LEU . . . -55.88 -45.92 78.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.69 68.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.229 -0.919 . . . . 0.0 108.87 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -60.52 -54.06 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 110.104 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.5 ' HA ' ' HB2' ' A' ' 124' ' ' HIS . 73.5 mm-40 -69.05 -53.36 20.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.133 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.622 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 13.4 m-85 -49.59 -24.09 1.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.955 -1.091 . . . . 0.0 108.47 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.45 -27.53 24.74 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 2.1 m-70 -76.3 -48.23 20.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.689 -0.889 . . . . 0.0 109.183 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -42.88 -27.49 0.19 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.609 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -71.9 -98.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.782 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.58 29.14 0.19 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.76 144.84 24.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.742 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -119.96 151.78 38.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 138' ' ' MET . 12.2 m-70 -51.29 117.6 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 110.015 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -88.76 -80.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.082 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 131' ' ' SER . 5.6 tt0 177.03 -34.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.485 ' O ' ' HB1' ' A' ' 136' ' ' ALA . 0.2 OUTLIER -43.0 139.6 2.13 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.105 -0.997 . . . . 0.0 110.138 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.54 -38.86 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.431 2.088 . . . . 0.0 109.812 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.15 17.48 53.36 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.485 ' HB1' ' O ' ' A' ' 133' ' ' ASP . . . -85.09 149.42 25.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.066 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.689 HD21 H362 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -75.76 -10.99 59.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.583 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 0.8 OUTLIER -106.42 11.96 30.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -75.92 154.83 84.96 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.913 -1.117 . . . . 0.0 108.955 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . 0.403 ' HD2' HD13 ' A' ' 141' ' ' ILE . 33.6 Cg_endo -76.78 9.19 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.755 2.303 . . . . 0.0 111.477 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.403 HD13 ' HD2' ' A' ' 140' ' ' PRO . 0.1 OUTLIER -134.63 137.79 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 109.307 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.583 ' OH ' ' CD1' ' A' ' 144' ' ' TYR . 2.9 t80 -84.78 128.72 34.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.424 -0.798 . . . . 0.0 110.186 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' TYR . 96.2 m -122.16 100.26 6.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CD1' ' OH ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -40.21 149.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -0.808 . . . . 0.0 110.26 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.416 HG22 H393 ' A' ' 800' ' ' I52 . 6.1 t -149.56 102.88 3.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -16.93 32.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.442 -0.786 . . . . 0.0 110.269 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 148' ' ' PHE . 1.1 t30 -95.25 -19.62 19.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.766 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.648 ' CE1' ' CG2' ' A' ' 42' ' ' VAL . 9.4 t80 49.2 104.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.701 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -121.32 -20.69 6.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 109.209 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 149' ' ' ARG . 15.5 tp 66.47 147.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.555 ' CB ' ' OD1' ' A' ' 153' ' ' ASP . 3.7 m -114.97 138.58 50.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 109.889 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.637 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 19.6 tt0 -49.09 -31.42 7.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 110.533 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.555 ' OD1' ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -46.3 -50.03 16.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.565 -1.334 . . . . 0.0 108.638 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -75.17 -31.33 60.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.474 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.637 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.5 OUTLIER -69.69 -26.05 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 108.991 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -74.85 -53.57 8.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.252 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -59.32 -41.07 96.71 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.486 HG23 ' HA ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -75.78 -22.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -1.232 . . . . 0.0 109.751 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 163' ' ' GLY . 36.6 mt-30 -79.25 -42.21 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 108.931 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.17 -22.86 15.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.537 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 17.6 m-85 -130.61 -24.99 2.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.589 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 0.689 H362 HD21 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.229 0.538 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.24 -33.35 6.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.285 -0.885 . . . . 0.0 109.828 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -61.57 150.09 37.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -114.4 110.58 20.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.534 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.55 106.47 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.343 -0.848 . . . . 0.0 109.474 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.6 136.59 19.41 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.628 2.219 . . . . 0.0 111.187 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.74 -163.74 0.67 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.0 158.48 52.99 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.199 -0.938 . . . . 0.0 110.501 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 8' ' ' LYS . 35.2 Cg_endo -75.51 58.21 5.13 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.283 1.989 . . . . 0.0 108.988 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -55.6 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.537 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 172.05 42.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 16.1 p-10 -130.35 99.76 5.13 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLN . 2.4 mtmt -120.92 34.52 5.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.43 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.9 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.097 -1.002 . . . . 0.0 108.586 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.562 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt-30 -86.94 104.93 16.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.277 -0.89 . . . . 0.0 108.672 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 mt -112.84 153.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.496 HG21 ' HB3' ' A' ' 52' ' ' SER . 0.0 OUTLIER -115.19 148.41 39.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.565 ' CB ' HG13 ' A' ' 61' ' ' ILE . 15.9 p90 -151.94 155.24 37.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.932 . . . . 0.0 109.797 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -148.84 133.48 17.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.746 -179.495 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.3 mt -96.17 124.85 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.917 -1.114 . . . . 0.0 108.834 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB2' ' A' ' 64' ' ' ASN . 2.8 mp -76.74 -1.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 0.0 109.474 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.71 100.81 0.17 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.438 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.587 ' CG ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.88 -163.52 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -94.58 148.35 34.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.94 -1.1 . . . . 0.0 108.94 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' LEU . 35.1 Cg_endo -83.59 -29.11 1.16 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.559 2.839 . . . . 0.0 110.603 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -41.96 -26.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.57 -0.706 . . . . 0.0 109.528 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -129.4 166.03 20.36 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.266 -0.896 . . . . 0.0 109.613 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -58.63 147.95 68.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.492 -0.755 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' O ' HG11 ' A' ' 32' ' ' VAL . 28.9 Cg_endo -67.64 -34.85 24.04 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 106.131 -2.296 . . . . 0.0 106.131 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.58 -28.33 60.88 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.579 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 2.9 m -72.88 -63.42 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.587 HG12 ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -45.92 -39.54 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.557 -0.714 . . . . 0.0 109.354 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 19.5 t0 -67.56 -29.84 69.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.1 t70 -61.39 -50.52 72.55 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.84 -39.38 5.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 109.317 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 85.5 m-85 -73.11 -36.2 66.7 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.687 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -56.0 -57.59 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 108.516 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' ALA . 2.7 mtm180 -61.34 -51.61 68.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -45.23 -48.99 12.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.584 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 28.6 t80 -49.99 -44.74 51.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 108.879 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 8.1 tt0 -79.87 -19.13 49.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 109.912 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.645 ' CG1' ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -62.58 -36.08 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.028 -1.045 . . . . 0.0 108.502 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.645 ' CD1' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -108.42 -46.67 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.725 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -51.33 -20.3 1.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.053 . . . . 0.0 110.042 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.2 m-20 -64.92 -10.31 27.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 110.473 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 m -111.15 -18.88 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.991 -1.068 . . . . 0.0 109.861 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.552 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -131.67 155.03 81.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 108.846 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.552 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 31.8 Cg_endo -77.84 49.15 2.85 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.748 2.298 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.38 162.5 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.932 0.873 . . . . 0.0 111.182 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.562 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 1.1 tpt180 -138.4 116.73 11.92 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.473 ' CD1' ' CE1' ' A' ' 40' ' ' PHE . 3.3 m-85 -99.9 136.66 39.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.749 -1.219 . . . . 0.0 109.399 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.496 ' HB3' HG21 ' A' ' 17' ' ' THR . 0.4 OUTLIER -123.05 100.84 7.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.1 tmt_? -80.39 135.79 36.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.882 -1.136 . . . . 0.0 109.451 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.601 ' N ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -111.12 163.47 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.506 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -119.75 -29.33 5.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -0.962 . . . . 0.0 108.961 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.65 98.65 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.41 -173.31 32.92 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.68 161.96 25.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.271 . . . . 0.0 110.394 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 19' ' ' ARG . . . -143.71 153.11 42.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 108.978 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -77.12 -49.35 15.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.931 -1.106 . . . . 0.0 109.313 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.578 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.99 131.28 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.53 ' CB ' ' CG ' ' A' ' 96' ' ' ASP . 4.3 ttm -116.35 115.81 26.58 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.149 -0.969 . . . . 0.0 109.2 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.473 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 9.3 mt -108.5 148.38 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.085 -1.01 . . . . 0.0 109.689 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 29.3 t30 177.93 159.79 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.59 ' CE1' ' HG3' ' A' ' 67' ' ' ARG . 35.7 p90 -83.32 175.16 10.09 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 108.665 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 68' ' ' TRP . . . -113.39 -27.17 3.71 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.59 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 62.7 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -1.228 . . . . 0.0 109.813 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 36.1 t-105 -165.35 -56.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.843 -1.16 . . . . 0.0 109.331 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.55 74.16 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.645 -0.66 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -106.86 -66.39 1.02 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 84.96 -10.39 63.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.469 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 3.2 m-20 -62.65 73.4 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.509 -0.995 . . . . 0.0 108.893 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 59.84 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -86.28 138.25 34.42 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.122 -1.223 . . . . 0.0 109.644 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.66 -175.06 2.54 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.405 2.07 . . . . 0.0 110.29 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -76.35 150.87 36.8 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.12 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' OD2' ' HA3' ' A' ' 81' ' ' GLY . 20.3 p-10 -115.07 -14.18 11.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 72.33 -92.12 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 80' ' ' ASP . 5.0 mttt -45.75 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.56 -0.964 . . . . 0.0 109.379 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -25.69 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.436 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.519 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 33.26 -139.24 0.1 Allowed Glycine 0 N--CA 1.502 3.093 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 81' ' ' GLY . 33.8 tp -37.18 118.67 0.63 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.885 . . . . 0.0 110.098 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' CE2' ' A' ' 112' ' ' TYR . 6.9 mt -105.2 -26.44 12.05 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.609 ' CB ' ' CD1' ' A' ' 99' ' ' PHE . . . 170.5 175.94 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 109.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.524 ' HB3' H252 ' A' ' 800' ' ' I52 . 55.5 p-80 -177.62 149.08 0.6 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.898 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -132.35 175.62 9.12 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.63 156.87 26.29 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.602 ' CB ' ' CD ' ' A' ' 89' ' ' PRO . . . -57.09 -178.98 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.602 ' CD ' ' CB ' ' A' ' 88' ' ' ALA . 38.1 Cg_endo -80.57 144.36 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 11' ' ' TRP . . . -174.16 -172.2 39.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.435 HG21 ' N ' ' A' ' 92' ' ' GLY . 21.3 m -67.13 -96.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -1.04 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.435 ' N ' HG21 ' A' ' 91' ' ' THR . . . -70.09 -81.21 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.9 172.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -1.143 . . . . 0.0 108.888 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 96.92 150.94 27.46 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.578 ' O ' ' CG2' ' A' ' 61' ' ' ILE . . . 62.07 9.67 22.95 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.343 -1.093 . . . . 0.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.53 ' CG ' ' CB ' ' A' ' 62' ' ' MET . 32.5 m-20 -102.37 134.52 45.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.082 -1.834 . . . . 0.0 109.248 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.5 m -112.36 120.66 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.948 . . . . 0.0 110.523 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 8.1 m80 -95.23 129.11 42.47 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.609 ' CD1' ' CB ' ' A' ' 84' ' ' ALA . 8.3 m-30 -108.89 147.38 32.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.0 110.088 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 76' ' ' PHE . 9.3 t70 -76.88 112.16 13.18 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 103' ' ' GLU . 46.9 t0 -55.48 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.217 -0.927 . . . . 0.0 111.204 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' ASP . 1.9 m-20 -40.03 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 110.439 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 175.09 156.9 0.17 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.0 124.83 50.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.975 -1.078 . . . . 0.0 111.68 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TRP . . . . . 0.592 ' CD1' ' HB3' ' A' ' 112' ' ' TYR . 6.8 m0 -122.35 172.3 8.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 6.4 p -145.19 141.3 28.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.579 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 4.9 t-20 -103.26 27.99 6.76 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' SER . 8.8 t -142.05 25.89 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.468 -1.395 . . . . 0.0 110.626 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 0.9 OUTLIER 70.68 89.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.815 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.541 ' O ' ' CG2' ' A' ' 106' ' ' THR . . . 174.87 137.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.471 -0.768 . . . . 0.0 109.156 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.59 -149.04 0.27 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.859 -1.151 . . . . 0.0 108.651 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.618 ' CE2' ' CD2' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -65.17 -34.71 79.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.81 -1.181 . . . . 0.0 108.097 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 112' ' ' TYR . 0.7 OUTLIER 75.38 124.73 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 110.393 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -66.55 -35.02 79.2 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.158 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -68.69 -43.29 76.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -178.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD13 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -64.58 -62.46 1.57 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.771 -1.205 . . . . 0.0 109.562 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.462 HG12 ' NE1' ' A' ' 105' ' ' TRP . 18.1 m -44.12 -46.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.209 -0.932 . . . . 0.0 109.61 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -62.49 -47.85 82.17 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.955 -1.091 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -48.36 -63.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.583 -0.698 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -46.62 -54.18 10.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.206 -0.934 . . . . 0.0 109.521 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.34 -18.81 65.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.963 -1.086 . . . . 0.0 108.254 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -81.89 -8.22 59.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -97.03 -37.89 4.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.468 ' CE1' ' CD2' ' A' ' 130' ' ' HIS . 55.3 m-70 -74.19 -47.41 35.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.33 -27.09 0.95 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.173 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 10.8 mtt -79.29 7.99 6.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.271 -0.893 . . . . 0.0 109.822 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 124' ' ' HIS . . . 92.79 -23.75 27.22 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -53.54 141.57 25.04 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.337 -1.096 . . . . 0.0 108.986 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.04 -176.43 2.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 109.528 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CD2' ' CE1' ' A' ' 124' ' ' HIS . 24.6 m170 -63.75 132.59 51.45 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -90.25 -115.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -159.41 -48.64 0.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.696 -1.253 . . . . 0.0 109.261 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 132' ' ' GLN . 0.9 OUTLIER -42.38 124.83 2.85 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.979 . . . . 0.0 109.718 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -78.37 108.01 2.4 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.093 1.862 . . . . 0.0 109.386 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 124.27 -13.83 7.87 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.593 ' O ' ' H33' ' A' ' 800' ' ' I52 . . . -57.33 157.66 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.379 -1.071 . . . . 0.0 110.352 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.873 HD12 H372 ' A' ' 800' ' ' I52 . 14.2 tp -63.13 -24.77 68.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.44 ' CE ' ' HG ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -102.7 12.92 35.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -61.57 149.2 84.87 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.702 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -77.27 21.11 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.959 2.44 . . . . 0.0 110.917 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.1 mt -142.46 145.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.888 -1.133 . . . . 0.0 110.396 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -69.34 148.07 50.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.9 m -161.97 -33.46 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.634 ' CD1' ' N ' ' A' ' 145' ' ' THR . 42.9 t80 59.24 166.06 0.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.4 -0.813 . . . . 0.0 109.057 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.634 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 1.2 t -150.13 115.31 5.41 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.844 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -39.94 42.92 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.092 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 44.6 t-20 -73.25 -48.38 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.076 -1.015 . . . . 0.0 108.511 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.616 ' CZ ' ' HG ' ' A' ' 150' ' ' LEU . 39.7 t80 75.45 139.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.39 0.614 . . . . 0.0 109.68 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 1.6 tpt180 -155.65 -25.06 0.11 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.316 -0.865 . . . . 0.0 110.889 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.616 ' HG ' ' CZ ' ' A' ' 148' ' ' PHE . 6.2 mt 65.66 83.36 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -53.87 140.36 30.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.611 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 mt-30 -55.23 -35.3 64.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.355 -0.84 . . . . 0.0 108.994 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -47.01 -33.81 5.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.531 -1.356 . . . . 0.0 108.889 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.403 ' OD1' ' HE2' ' A' ' 138' ' ' MET . 34.1 t70 -89.1 -28.42 20.11 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ILE . . . . . 0.611 ' CG2' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -71.03 -34.48 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 2.2 ttmt -73.29 -56.86 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -51.0 -37.29 36.06 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 155' ' ' ILE . 1.0 OUTLIER -83.49 -14.9 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 163' ' ' GLY . 0.6 OUTLIER -70.34 -57.13 5.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.334 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 13.1 mm-40 -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.759 -0.588 . . . . 0.0 109.474 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.461 ' N ' HD22 ' A' ' 161' ' ' LEU . 0.8 OUTLIER -73.4 -29.43 62.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -0.779 . . . . 0.0 111.024 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.49 ' CZ ' ' HG2' ' A' ' 126' ' ' MET . 42.4 m-85 -131.24 -51.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.471 -1.393 . . . . 0.0 109.174 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' I52 . . . . . 1.058 ' H20' ' H72' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.375 0.607 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.549 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -57.89 134.57 56.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 109.238 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.594 ' OD1' HD13 ' A' ' 161' ' ' LEU . 8.5 t70 -175.87 74.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -164.01 139.94 6.37 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.338 -0.851 . . . . 0.0 109.905 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 4.2 p-10 -53.98 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 5.1 mt-30 47.67 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.959 -1.088 . . . . 0.0 110.305 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.478 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -115.25 149.96 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.7 132.51 56.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.852 -1.155 . . . . 0.0 109.383 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CB ' HG13 ' A' ' 61' ' ' ILE . 44.0 p90 -140.49 151.92 45.2 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.252 -0.905 . . . . 0.0 109.902 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 18.4 tpt180 -150.75 119.71 6.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.759 . . . . 0.0 109.372 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.827 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -70.51 138.82 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 21' ' ' ILE . 27.8 mm -82.89 -5.47 9.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 172.79 105.67 0.19 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.827 ' CE1' HD13 ' A' ' 20' ' ' ILE . 3.8 m-30 -51.91 168.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.334 -1.098 . . . . 0.0 109.306 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.81 ' CG2' HD22 ' A' ' 27' ' ' LEU . 5.3 t -109.89 148.75 38.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.974 . . . . 0.0 109.762 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.3 Cg_endo -82.06 -36.39 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.883 2.389 . . . . 0.0 111.622 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 24' ' ' THR . 0.7 OUTLIER -42.43 -26.59 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.208 -0.933 . . . . 0.0 110.007 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.89 168.35 17.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.017 -1.052 . . . . 0.0 109.272 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CB ' ' OG1' ' A' ' 31' ' ' THR . 0.5 OUTLIER -57.4 147.79 57.29 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 108.787 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 29.6 Cg_endo -70.25 -45.85 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -69.61 -21.12 63.6 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 47.8 m -76.78 -50.06 14.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.138 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.05 ' HB ' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -55.33 -34.4 33.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.39 -39.88 92.31 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.043 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -44.43 27.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.33 -29.34 33.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.172 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.61 -44.09 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.305 -0.872 . . . . 0.0 108.96 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -61.01 -52.78 63.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -51.37 -58.56 5.91 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -45.32 -51.14 11.43 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -46.17 -50.23 15.91 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.327 -0.858 . . . . 0.0 110.003 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.71 -32.82 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.9 -1.125 . . . . 0.0 108.915 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.688 ' O ' HG12 ' A' ' 46' ' ' VAL . 4.7 m95 -100.54 -25.15 14.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -77.82 -18.25 56.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.094 -1.004 . . . . 0.0 108.39 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 43.7 t0 -71.46 -14.27 62.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.081 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 46' ' ' VAL . 3.7 p -102.92 10.7 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.284 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 9.2 t -178.13 148.15 0.63 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 109.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 34.6 Cg_endo -76.01 56.84 4.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.551 2.167 . . . . 0.0 110.393 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.965 HD23 ' CE1' ' A' ' 51' ' ' PHE . 9.2 tp -85.89 147.7 26.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.362 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -113.05 110.88 21.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.965 ' CE1' HD23 ' A' ' 49' ' ' LEU . 39.7 m-85 -97.01 141.78 29.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 109.478 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -132.42 125.09 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.27 140.35 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.534 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.38 -168.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.77 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -176.15 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -163.31 -32.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 110.199 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.54 27.9 17.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.9 OUTLIER 58.04 170.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -1.193 . . . . 0.0 109.161 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 54' ' ' ILE . . . -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.04 -1.038 . . . . 0.0 110.672 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CG ' ' CZ2' ' A' ' 11' ' ' TRP . 79.1 m-20 -58.91 -47.86 83.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -102.15 126.42 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 6.9 mtp -116.48 125.17 51.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 109.567 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' ILE . 2.6 mp -105.09 158.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.715 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.504 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 33.1 t30 178.85 -138.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.141 -0.974 . . . . 0.0 109.816 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.77 -174.77 2.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.875 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' ARG . . . -106.63 -19.34 9.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 37.8 mtt180 60.75 170.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -1.211 . . . . 0.0 110.46 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 75' ' ' PRO . 41.0 m0 -81.33 -42.81 19.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 0.0 109.15 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 44.9 mt-10 -75.85 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.839 . . . . 0.0 109.077 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 1.5 t-80 78.17 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 72' ' ' ASP . . . 120.68 -22.51 8.18 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 71' ' ' GLY . 7.3 m-20 -37.72 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.591 -0.947 . . . . 0.0 110.017 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.95 31.18 0.08 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -179.67 74.32 0.18 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.447 -1.031 . . . . 0.0 108.405 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 76' ' ' PHE . 32.5 Cg_endo -73.21 134.43 21.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.612 2.208 . . . . 0.0 111.847 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.5 p90 50.53 158.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.332 1.063 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 1.4 p-10 178.56 -29.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 51.74 -156.84 3.42 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 78' ' ' GLY . 3.5 mttp 43.56 -173.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.229 1.014 . . . . 0.0 110.517 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 81' ' ' GLY . 1.5 m-20 -67.15 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 41.06 -139.18 1.55 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -49.86 123.38 7.94 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 108.646 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 16.5 mt -111.74 -22.11 11.32 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.4 -178.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 7.6 p-80 179.05 175.86 0.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.979 -1.075 . . . . 0.0 110.253 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.66 166.26 28.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 109.39 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.99 159.51 15.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.676 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -48.55 172.78 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.631 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 32.4 Cg_endo -73.69 137.98 25.76 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.119 1.879 . . . . 0.0 110.874 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' N ' ' HA3' ' A' ' 94' ' ' GLY . . . 175.77 -168.34 40.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.0 p -99.1 134.5 41.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 110.041 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.24 -82.46 0.66 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.481 ' HA ' ' OD2' ' A' ' 96' ' ' ASP . 0.9 OUTLIER -69.54 -41.37 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 110.205 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 90' ' ' GLY . . . -71.3 111.05 3.49 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.808 -1.186 . . . . 0.0 110.191 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 121.44 2.79 10.64 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.739 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 62' ' ' MET . 3.9 m-20 -95.96 140.02 31.32 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.415 -1.638 . . . . 0.0 109.865 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -121.3 142.62 49.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 59.5 m170 -114.76 130.71 56.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.809 . . . . 0.0 109.971 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -103.89 152.03 22.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' OD1' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -60.09 138.98 57.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.952 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -76.29 -78.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 8.5 t70 -66.04 91.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.016 -1.053 . . . . 0.0 110.672 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -159.81 -170.34 2.86 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.56 HD12 ' O ' ' A' ' 104' ' ' LEU . 0.4 OUTLIER -138.38 82.69 1.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.705 -1.247 . . . . 0.0 110.867 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.32 130.62 42.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.08 -1.013 . . . . 0.0 109.449 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 110' ' ' ALA . 1.1 p -154.45 154.16 32.73 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.723 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.551 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 7.7 t30 -82.76 4.56 24.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 109' ' ' SER . 1.9 p -91.89 -145.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 108' ' ' THR . 6.3 t -89.9 37.99 0.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 106' ' ' THR . . . -64.14 -97.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 109.831 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -178.31 -46.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.061 -1.024 . . . . 0.0 109.639 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' OH ' ' CG ' ' A' ' 80' ' ' ASP . 94.4 m-85 -85.42 -36.32 20.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 109.176 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.851 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER 62.2 110.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -0.76 . . . . 0.0 110.591 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -50.86 -36.47 37.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 109.677 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.546 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.9 t80 -65.63 -35.9 82.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.674 HD12 ' OH ' ' A' ' 142' ' ' TYR . 2.1 tm? -80.58 -57.1 3.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.625 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.851 HG22 ' O ' ' A' ' 113' ' ' SER . 0.2 OUTLIER -50.42 -40.82 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.864 -1.148 . . . . 0.0 108.94 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -69.23 -49.52 55.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.857 . . . . 0.0 109.622 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -42.45 -59.78 1.74 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -49.18 -56.53 8.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.179 -0.95 . . . . 0.0 108.744 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 69.3 mm-40 -66.53 -11.99 55.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.53 -15.17 57.35 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CE ' ' A' ' 138' ' ' MET . . . -94.95 -42.04 3.91 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.665 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 5.0 m-70 -63.56 -49.16 74.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.11 . . . . 0.0 109.389 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -41.89 -26.39 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 124' ' ' HIS . 26.2 mmt -78.99 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.928 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . -157.91 -35.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.255 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 1.049 HD11 ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -46.25 149.72 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 109.579 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -129.29 163.06 26.5 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.665 ' CD2' ' HE2' ' A' ' 124' ' ' HIS . 25.5 m170 -44.28 137.41 3.56 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.064 -1.022 . . . . 0.0 109.228 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -112.89 11.9 19.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.23 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 0.5 OUTLIER 82.48 -24.8 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.21 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -66.49 124.89 89.43 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.67 -1.269 . . . . 0.0 109.737 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 141' ' ' ILE . 31.2 Cg_endo -72.58 -36.55 4.91 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.248 1.965 . . . . 0.0 110.555 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.49 11.07 47.17 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.23 174.69 7.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.999 -1.295 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.7 tp -88.17 -35.81 17.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.526 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -83.81 7.25 18.52 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -55.39 154.7 11.19 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.839 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.97 21.66 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.906 2.404 . . . . 0.0 112.246 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -134.91 133.72 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.595 -1.316 . . . . 0.0 109.532 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.674 ' OH ' HD12 ' A' ' 116' ' ' LEU . 75.8 t80 -73.21 121.88 21.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 110.122 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -125.05 111.43 15.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.388 -0.82 . . . . 0.0 108.919 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -59.93 160.43 7.81 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.091 -1.006 . . . . 0.0 110.209 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.8 p -99.09 83.0 2.81 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.659 -0.651 . . . . 0.0 110.493 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -3.47 30.49 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.854 -1.154 . . . . 0.0 108.275 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -160.0 20.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.526 -0.734 . . . . 0.0 109.113 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 3.3 t80 36.24 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.463 -0.773 . . . . 0.0 110.529 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.65 132.57 56.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.334 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 150' ' ' LEU . 50.8 mt -88.65 -163.41 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.384 -0.822 . . . . 0.0 109.838 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.0 p -167.12 131.43 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 109.648 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 155' ' ' ILE . 2.7 pt20 -59.63 -29.57 68.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 152' ' ' GLN . 4.0 m-20 -43.48 -37.62 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 107.956 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 158' ' ' ILE . 3.8 m-20 -85.42 -46.05 11.28 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.698 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.9 OUTLIER -51.95 -33.69 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.681 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -56.77 4.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.83 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 1.049 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -57.04 -39.46 89.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.448 ' HA ' HD12 ' A' ' 158' ' ' ILE . 9.0 tp -78.17 -18.78 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -1.23 . . . . 0.0 109.788 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -72.78 -48.12 40.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.88 . . . . 0.0 108.925 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -74.37 -21.65 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.594 HD13 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -85.25 -15.86 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.784 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.476 ' CD2' HD13 ' A' ' 49' ' ' LEU . 6.0 m-85 -140.11 -93.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.42 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.75 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.582 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -163.0 44.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.914 -1.116 . . . . 0.0 108.73 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.04 85.27 6.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -141.63 101.95 4.08 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 13' ' ' LYS . 7.7 m-20 -34.18 -85.71 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.894 -0.504 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -51.88 106.97 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 109.216 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CG2' HD11 ' A' ' 61' ' ' ILE . 3.3 mt -104.29 162.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 0.0 109.526 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.705 ' HB ' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -135.53 135.85 40.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -142.59 162.5 35.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.343 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.74 120.39 9.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.483 -0.76 . . . . 0.0 109.057 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.879 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -83.17 112.95 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.0 109.46 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' HG2' ' A' ' 62' ' ' MET . 7.7 mt -89.51 17.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 166.5 96.21 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CE1' HD13 ' A' ' 20' ' ' ILE . 20.3 m-85 -58.07 -114.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -1.074 . . . . 0.0 108.853 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.996 ' CG2' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -112.58 178.29 1.0 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.502 -1.374 . . . . 0.0 108.102 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 24' ' ' THR . 33.0 Cg_endo -76.57 -34.85 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.745 1.63 . . . . 0.0 112.324 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 24' ' ' THR . 5.6 t70 -158.64 81.73 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.768 -1.208 . . . . 0.0 112.191 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.996 HD22 ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -155.68 -178.98 7.68 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.184 -0.948 . . . . 0.0 108.737 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 1.3 m-20 -72.16 136.45 81.91 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 33' ' ' ASP . 26.8 Cg_endo -69.68 -30.88 21.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 106.444 -2.175 . . . . 0.0 106.444 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.17 -32.84 63.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.499 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 2.9 m -70.6 -62.65 1.31 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 23' ' ' TYR . 1.3 p -49.64 -43.28 18.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 3.0 t70 -64.85 -22.08 66.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.733 . . . . 0.0 109.109 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.3 t0 -78.38 -40.99 34.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.015 . . . . 0.0 110.174 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.595 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -57.52 -44.05 84.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.967 -1.083 . . . . 0.0 109.145 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 63' ' ' ILE . 75.2 m-85 -71.35 -48.57 49.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.27 -0.894 . . . . 0.0 108.637 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.31 -51.12 63.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 1.036 ' O ' HG22 ' A' ' 42' ' ' VAL . 61.3 mtp180 -67.18 -48.85 66.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.438 -0.789 . . . . 0.0 108.899 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . . . -41.98 -43.28 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.551 ' O ' ' CB ' ' A' ' 44' ' ' SER . 58.1 m-85 -68.52 -39.16 81.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ARG . 29.3 tt0 -71.56 -60.54 2.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.132 -0.98 . . . . 0.0 109.026 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 38' ' ' ARG . 1.7 m -46.18 -29.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.589 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 11.6 m95 -101.98 -19.0 15.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 11.2 t -88.7 -23.35 22.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.016 -1.053 . . . . 0.0 108.25 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -59.77 -12.56 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.716 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.7 p -110.62 19.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.003 . . . . 0.0 109.69 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 5.1 t -179.33 149.32 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.002 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 32.4 Cg_endo -76.0 57.82 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 110.486 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.65 HD11 ' CG ' ' A' ' 162' ' ' TYR . 18.8 mt -100.76 121.3 41.45 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.81 112.66 25.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 109.094 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 16' ' ' ILE . 56.3 m-85 -88.52 143.65 26.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.57 138.75 52.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.526 -0.734 . . . . 0.0 109.341 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -89.28 129.66 35.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.077 -1.014 . . . . 0.0 108.862 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.705 HD13 ' HB ' ' A' ' 17' ' ' THR . 2.5 pt -122.12 131.95 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 54' ' ' ILE . 4.4 p80 -60.32 -147.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.306 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -70.05 169.31 13.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.043 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.37 -147.29 18.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -83.03 150.91 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.253 . . . . 0.0 109.595 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.741 ' HB3' ' SD ' ' A' ' 62' ' ' MET . . . -160.91 150.4 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -77.88 -70.19 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 109.268 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -82.13 126.26 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.751 ' HG2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -120.96 115.83 23.94 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 4.6 mp -103.62 145.33 12.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.89 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 63.8 t30 -168.67 172.64 7.84 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 101' ' ' ASP . 31.2 p90 -119.94 160.77 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 109.842 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.71 128.87 1.73 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -96.9 -135.15 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 67' ' ' ARG . 1.6 t90 -49.92 -41.64 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.511 -1.368 . . . . 0.0 107.852 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' HIS . 2.8 tt0 -73.86 55.22 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 76' ' ' PHE . 4.1 t-160 -44.16 -50.63 8.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.175 -0.953 . . . . 0.0 109.27 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 18.11 44.98 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 41.2 p-10 -151.47 28.04 0.65 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.349 -1.089 . . . . 0.0 109.892 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . 93.19 154.0 30.76 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.38 -0.914 . . . . 0.0 110.901 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.53 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 58.6 m-85 55.14 164.36 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 110.049 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 74' ' ' TYR . 34.4 Cg_endo -76.45 -159.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.004 1.803 . . . . 0.0 108.555 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.673 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 69.0 t80 177.54 168.86 0.65 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.9 -1.125 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 24.1 t70 50.63 40.61 24.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.705 -0.622 . . . . 0.0 110.345 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . -49.06 173.05 0.05 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.3 -2.32 . . . . 0.0 107.3 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 80' ' ' ASP . 1.1 ptmt -51.46 141.75 15.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.762 -1.434 . . . . 0.0 107.253 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 79' ' ' LYS . 21.2 t70 39.55 -111.21 0.11 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 25.85 -132.54 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 CA-C-O 121.432 0.462 . . . . 0.0 112.226 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.58 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -26.94 123.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.975 0.893 . . . . 0.0 111.914 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 73.5 mt -118.84 -28.6 5.54 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 172.51 146.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.511 -0.743 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 24.4 p-80 -144.92 149.25 34.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.339 -0.851 . . . . 0.0 109.262 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 97' ' ' SER . . . -123.61 159.44 29.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.892 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.41 151.8 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.075 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.17 168.96 0.78 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 109.624 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.3 Cg_endo -78.6 152.23 25.89 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.773 2.315 . . . . 0.0 110.569 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 91' ' ' THR . . . 179.58 -103.1 0.17 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -162.59 78.51 0.48 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -1.093 . . . . 0.0 109.357 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.06 -103.1 0.29 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.87 -2.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -1.168 . . . . 0.0 109.32 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -75.6 143.2 29.99 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.843 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 76.34 -4.4 49.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 1.6 m-20 -101.03 134.8 43.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.942 -1.328 . . . . 0.0 108.68 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 16.4 t -130.86 127.64 38.98 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.576 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 46.0 m80 -89.78 145.27 25.31 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.422 -0.799 . . . . 0.0 109.109 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -116.58 160.29 20.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.001 -1.062 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 3.5 m-20 -52.85 121.36 7.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 109.854 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 18.6 t0 -44.58 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' GLU . 35.3 m-20 -77.22 -128.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 83.92 -29.86 0.08 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 103' ' ' GLU . 16.0 tp 68.81 74.56 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.185 -0.947 . . . . 0.0 111.137 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.603 ' O ' ' HB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -94.0 163.19 13.59 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.96 HG23 ' N ' ' A' ' 108' ' ' THR . 9.7 t 171.48 -173.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.096 -1.002 . . . . 0.0 110.308 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.586 ' O ' ' OG1' ' A' ' 108' ' ' THR . 6.8 p-10 -50.19 -31.17 13.1 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.96 ' N ' HG23 ' A' ' 106' ' ' THR . 1.8 p 73.31 -110.89 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER 61.24 23.14 13.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 100.99 -3.707 . . . . 0.0 100.99 -168.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.446 ' N ' ' C ' ' A' ' 108' ' ' THR . . . -135.78 -45.26 0.66 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.318 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -158.39 -86.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.775 -0.578 . . . . 0.0 110.277 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.808 ' O ' HG21 ' A' ' 108' ' ' THR . 9.0 m-85 -121.16 126.64 50.21 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.669 ' OG ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.58 129.59 36.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 111.557 -178.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.595 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -57.09 -24.23 52.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.653 -0.654 . . . . 0.0 110.479 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 42' ' ' VAL . 1.7 t80 -73.64 -54.75 7.42 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.498 -1.376 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.8 HD21 ' CE1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -63.26 -51.0 67.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.926 -1.108 . . . . 0.0 109.144 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 118' ' ' ALA . 21.0 m -54.82 -53.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 109.907 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -66.91 -39.99 87.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.735 -1.228 . . . . 0.0 108.828 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 115' ' ' PHE . . . -47.6 -58.37 4.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.496 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 34.1 t60 -54.49 -42.6 70.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.157 . . . . 0.0 108.53 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 117' ' ' VAL . 54.2 mm-40 -71.73 -10.5 59.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.5 OUTLIER -87.28 -15.67 37.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.589 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -89.51 -45.6 4.59 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.496 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 1.5 m-70 -62.02 -45.97 91.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.475 -1.015 . . . . 0.0 108.417 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.68 -19.11 2.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.315 -0.865 . . . . 0.0 109.162 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.1 mtt -100.97 -5.51 25.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 113.21 -35.57 4.5 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.522 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 127' ' ' GLY . 1.8 mt -37.0 146.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.494 -1.003 . . . . 0.0 110.237 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 138' ' ' MET . 0.3 OUTLIER -113.08 -179.48 3.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 109.713 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.444 ' CD2' ' HE2' ' A' ' 124' ' ' HIS . 62.5 m170 -58.43 151.31 20.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -96.71 -177.73 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 0.0 109.519 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -13.24 6.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -101.05 142.36 24.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.94 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 32.5 Cg_endo -76.84 116.7 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.8 2.333 . . . . 0.0 109.564 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.81 -3.56 24.41 Favored Glycine 0 C--N 1.272 -2.989 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.77 -177.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.192 . . . . 0.0 109.772 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.508 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 8.6 tp -96.06 -28.86 14.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 109.681 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -94.6 3.01 55.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -46.19 148.14 1.63 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.274 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.757 ' O ' HD13 ' A' ' 141' ' ' ILE . 36.5 Cg_endo -78.04 12.0 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.565 2.176 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.4 mm -133.64 155.69 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 0.0 110.262 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER -76.0 95.29 3.56 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.96 92.93 5.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 108.637 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.8 ' CE1' HD21 ' A' ' 116' ' ' LEU . 7.8 t80 -60.07 155.38 17.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -143.49 8.83 1.58 Allowed 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.626 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 144' ' ' TYR . 21.3 mtpt 52.6 -106.75 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.305 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 4.9 p-10 -56.94 -47.22 81.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.716 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.61 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 5.8 t80 68.01 125.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.808 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -100.77 -70.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.61 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 4.0 tp 169.29 172.15 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -143.45 130.68 20.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.021 -1.049 . . . . 0.0 109.654 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.659 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 46.9 tt0 -54.63 -30.31 54.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.43 ' O ' HD21 ' A' ' 128' ' ' LEU . 51.5 m-20 -46.9 -41.61 16.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.577 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.552 ' OD1' ' CZ3' ' A' ' 43' ' ' TRP . 21.5 t0 -83.53 -36.14 24.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.659 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -63.57 -31.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 108.908 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -78.71 -44.72 22.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.55 -20.29 78.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.623 HG22 ' HA ' ' A' ' 155' ' ' ILE . 1.6 tp -93.9 -17.87 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 155' ' ' ILE . 2.9 pt20 -90.94 -31.48 16.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.081 . . . . 0.0 108.446 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 159' ' ' GLN . 2.0 mm-40 -86.94 -29.94 21.69 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.66 ' O ' HD13 ' A' ' 161' ' ' LEU . 0.2 OUTLIER -95.66 -28.11 14.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.65 ' CG ' HD11 ' A' ' 49' ' ' LEU . 2.1 m-85 -122.38 -91.28 0.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.452 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 158' ' ' ILE . . . . . . . . 0 N--CA 1.492 2.383 0 CA-C-O 118.036 -1.425 . . . . 0.0 109.756 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -95.98 106.76 18.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.808 -1.182 . . . . 0.0 110.022 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.05 81.58 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.093 . . . . 0.0 110.102 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.75 153.1 48.54 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.261 -0.9 . . . . 0.0 109.309 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -79.44 -89.21 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.46 111.27 1.33 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.275 -0.891 . . . . 0.0 108.948 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.893 HD12 ' HE1' ' A' ' 51' ' ' PHE . 73.7 mt -119.59 145.67 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.444 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 22.8 p -121.06 140.06 52.46 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.591 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 61' ' ' ILE . 34.0 p90 -139.28 -179.44 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.9 ptm180 -159.34 140.45 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.792 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.7 mt -95.27 145.18 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 64' ' ' ASN . 28.0 mt -90.19 -5.53 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.792 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 147.54 109.79 0.57 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -66.29 -163.3 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.047 -1.267 . . . . 0.0 108.812 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.639 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -108.49 146.8 34.4 Favored Pre-proline 0 C--N 1.293 -1.853 0 O-C-N 121.51 -0.744 . . . . 0.0 109.257 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 26' ' ' ASP . 29.9 Cg_endo -73.13 -26.15 15.21 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.441 2.094 . . . . 0.0 110.42 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 24' ' ' THR . 10.0 p-10 -35.23 -35.43 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.414 0.626 . . . . 0.0 109.976 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -133.04 171.66 13.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.988 -1.07 . . . . 0.0 110.245 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 5.5 m-20 -51.63 148.16 10.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.559 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 32' ' ' VAL . 32.3 Cg_endo -69.98 -32.44 17.68 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 N-CA-C 105.688 -2.466 . . . . 0.0 105.688 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -78.33 -31.26 48.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.617 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 21.4 m -73.7 -52.62 12.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.883 -1.136 . . . . 0.0 108.45 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 23' ' ' TYR . 1.8 p -47.74 -41.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 5.3 m-20 -61.43 -39.12 89.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.693 -0.63 . . . . 0.0 109.669 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -61.21 -37.5 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.206 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.93 -28.6 38.06 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.908 . . . . 0.0 109.074 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.19 -24.95 19.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 108.892 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.36 63.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -39.21 73.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -57.32 -40.58 78.22 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -60.61 -45.72 92.94 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -74.95 -15.85 60.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.685 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 ' HZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -84.3 -27.95 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.811 -1.181 . . . . 0.0 109.057 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -104.96 -25.2 12.67 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.709 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' THR . 9.7 t -85.11 -23.27 28.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.396 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.748 ' OD1' HD11 ' A' ' 150' ' ' LEU . 3.4 p30 -60.04 -22.39 62.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.16 -0.962 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.643 HG13 ' OD1' ' A' ' 45' ' ' ASP . 10.8 m -99.07 16.63 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.999 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.563 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t -173.52 152.74 2.16 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.093 -1.004 . . . . 0.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 33.8 Cg_endo -74.91 45.65 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.985 2.457 . . . . 0.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.861 HD23 ' HZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -87.3 144.14 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.231 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 99.03 5.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.309 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.893 ' HE1' HD12 ' A' ' 16' ' ' ILE . 15.9 m-85 -93.38 133.16 36.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.884 -1.135 . . . . 0.0 110.047 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.54 164.98 13.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.795 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 53' ' ' ARG . 2.3 mtp-105 -111.17 137.62 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 108.808 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 7.2 pt -145.34 134.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.017 -1.052 . . . . 0.0 109.658 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.31 42.53 2.72 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.21 -67.24 0.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.3 -0.875 . . . . 0.0 110.049 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . -99.16 50.25 1.19 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 68.09 162.72 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.299 -1.118 . . . . 0.0 109.932 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . -129.49 173.17 10.82 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -84.9 -57.08 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.12 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -95.87 148.42 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 0.0 109.874 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.524 ' CG ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -123.52 116.9 23.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.502 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' SER . 46.9 mt -115.62 140.51 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 108.908 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.747 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.9 p-10 -154.49 -148.67 0.25 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.686 -1.258 . . . . 0.0 110.36 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -136.59 174.98 10.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.896 -1.127 . . . . 0.0 110.604 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 101' ' ' ASP . . . -122.77 99.27 0.64 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 101' ' ' ASP . 5.4 mtm180 -90.08 -6.96 54.91 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -1.072 . . . . 0.0 110.459 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 177.46 -162.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' PRO . 5.8 pt-20 -83.76 67.27 9.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.741 -1.224 . . . . 0.0 111.033 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -49.74 -172.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.0 109.136 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . -64.58 -9.49 38.32 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.66 ' CB ' ' CE1' ' A' ' 70' ' ' HIS . 11.5 t0 -54.89 -169.99 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.021 -1.282 . . . . 0.0 108.396 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.37 -8.95 26.3 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.344 -1.407 . . . . 0.0 110.095 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CD1' HD11 ' A' ' 82' ' ' LEU . 11.7 m-85 -110.67 118.33 48.87 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.206 -1.173 . . . . 0.0 108.652 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -75.47 -176.43 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.045 1.83 . . . . 0.0 110.31 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 68' ' ' TRP . 38.3 p90 -78.69 140.86 38.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.552 -0.718 . . . . 0.0 109.107 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 9.5 p-10 -115.55 6.66 14.69 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.24 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 62.75 -167.68 19.95 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.265 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -43.16 167.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -1.064 . . . . 0.0 109.874 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' LYS . 71.6 m-20 41.15 -162.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.277 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 -146.94 50.77 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.302 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.485 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -47.77 107.1 0.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.481 -1.011 . . . . 0.0 108.997 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 15.4 mt -91.23 -15.37 29.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.023 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.5 158.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.524 -0.735 . . . . 0.0 109.024 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -156.83 146.38 20.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.981 -1.075 . . . . 0.0 109.915 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 97' ' ' SER . . . -128.86 161.55 29.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.357 -0.839 . . . . 0.0 109.714 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.1 166.0 10.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.759 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.41 166.93 38.16 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.515 -0.74 . . . . 0.0 109.084 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.759 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 33.1 Cg_endo -76.87 157.54 34.94 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.51 2.14 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.41 -102.32 0.16 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -150.87 90.95 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.255 . . . . 0.0 110.038 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.83 -73.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.41 -1.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -1.209 . . . . 0.0 110.026 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -76.39 139.91 24.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 73.82 67.78 1.71 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' OD1' ' CG ' ' A' ' 62' ' ' MET . 14.9 m-20 -160.8 117.02 2.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 109.01 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -117.02 157.39 25.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.466 -0.771 . . . . 0.0 109.861 -179.209 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -129.79 146.81 51.52 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m-85 -111.19 144.24 40.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.123 -0.986 . . . . 0.0 110.022 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -44.7 167.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.586 -1.321 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 5.1 t0 -97.43 -25.39 15.21 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -99.42 -144.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 178.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.4 OUTLIER 75.24 136.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.0 109.643 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -94.91 90.63 6.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.327 -0.858 . . . . 0.0 110.55 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.586 ' CB ' HD22 ' A' ' 114' ' ' LEU . 13.0 m0 -96.38 153.53 17.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.624 HG21 ' HB3' ' A' ' 110' ' ' ALA . 55.3 p -138.16 159.61 41.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.617 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 28.7 t-20 -112.73 4.37 17.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 0.0 109.148 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 108' ' ' THR . 9.7 t -139.6 48.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.6 p 45.62 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.89 -1.131 . . . . 0.0 109.874 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 106' ' ' THR . . . -136.13 -42.11 0.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.909 -1.119 . . . . 0.0 109.974 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -137.48 -77.31 0.39 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.5 m-30 -107.98 -102.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER 165.43 98.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.835 -1.166 . . . . 0.0 110.633 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.586 HD22 ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -52.12 -35.24 47.59 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.106 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HZ ' HG21 ' A' ' 42' ' ' VAL . 2.2 t80 -66.33 -43.25 86.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 110.005 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 144' ' ' TYR . 1.2 mt -59.41 -60.96 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.004 -1.06 . . . . 0.0 109.566 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.445 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.7 m -52.66 -38.19 26.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -61.74 -51.03 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -53.15 -49.5 66.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.493 -0.754 . . . . 0.0 109.144 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -46.44 -68.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 65.6 mm-40 -56.97 -21.14 28.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.217 -0.927 . . . . 0.0 108.834 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -74.4 -12.2 60.45 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.89 -47.43 2.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.982 ' HE2' ' CE1' ' A' ' 130' ' ' HIS . 0.6 OUTLIER -59.6 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -1.1 . . . . 0.0 109.57 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.48 22.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -0.754 . . . . 0.0 110.286 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 7.7 mtt -103.79 -10.65 18.11 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.692 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA3' HD22 ' A' ' 161' ' ' LEU . . . 128.75 -64.28 0.6 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.013 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 127' ' ' GLY . 15.0 mt -49.35 176.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -169.54 -172.64 1.48 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.719 0.771 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.982 ' CE1' ' HE2' ' A' ' 124' ' ' HIS . 23.0 m80 -49.82 114.01 0.97 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.763 0.792 . . . . 0.0 109.99 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 11.2 t -84.86 -77.53 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 131' ' ' SER . 52.3 tt0 161.03 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -57.88 133.1 83.28 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.715 -0.616 . . . . 0.0 109.632 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 29.2 Cg_endo -75.69 113.33 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.555 2.17 . . . . 0.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.53 -13.77 20.61 Favored Glycine 0 C--N 1.272 -2.983 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.74 158.82 12.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.884 -1.362 . . . . 0.0 109.706 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.672 HD21 ' HB1' ' A' ' 119' ' ' ALA . 11.7 tp -70.47 -20.41 62.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.024 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -100.05 2.06 42.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.376 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -70.19 156.69 91.44 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.232 -0.918 . . . . 0.0 110.015 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.442 ' C ' ' CG1' ' A' ' 141' ' ' ILE . 34.3 Cg_endo -77.14 64.65 7.85 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.858 2.372 . . . . 0.0 110.986 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' CG1' ' C ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -159.53 -157.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.261 -0.9 . . . . 0.0 109.625 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -165.69 119.03 1.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 109.823 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' TYR . 52.8 m -138.26 95.87 3.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 109.259 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.615 ' HA ' HD11 ' A' ' 116' ' ' LEU . 21.8 t80 -45.39 158.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.793 -1.192 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 145' ' ' THR . 1.3 t -152.01 123.92 8.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -48.52 122.46 5.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.195 . . . . 0.0 108.578 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.505 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 7.5 m-20 58.96 -95.34 0.05 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.253 -0.905 . . . . 0.0 108.56 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 42' ' ' VAL . 1.2 p90 177.72 142.88 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.088 -1.007 . . . . 0.0 109.657 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -107.82 -10.83 15.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.892 -1.13 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.748 HD11 ' OD1' ' A' ' 45' ' ' ASP . 1.5 mt 66.57 139.34 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.74 122.76 48.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.584 ' HA ' HG23 ' A' ' 155' ' ' ILE . 5.3 tt0 -50.01 -53.11 28.89 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.09 0.471 . . . . 0.0 109.954 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -42.32 -29.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -90.62 -29.29 17.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 151' ' ' SER . 0.9 OUTLIER -73.49 -30.43 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.434 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -88.25 -43.3 11.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -64.24 -25.62 69.88 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -85.45 -47.47 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.379 . . . . 0.0 109.078 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.522 ' N ' HG23 ' A' ' 158' ' ' ILE . 38.2 mt-30 -52.02 -31.22 28.74 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 109.624 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.02 -28.71 22.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.264 -0.897 . . . . 0.0 109.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.504 HD22 ' HA3' ' A' ' 127' ' ' GLY . 0.1 OUTLIER -89.35 -16.08 31.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CZ ' HD21 ' A' ' 49' ' ' LEU . 1.8 m-85 -126.54 -47.37 1.57 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.812 -1.18 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.503 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.408 ' CH2' ' HB3' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -66.1 140.37 58.23 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 109.79 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -61.46 165.53 4.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 108.549 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.641 ' HD2' ' CD1' ' A' ' 162' ' ' TYR . 5.6 mmtp -118.75 -175.7 2.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.536 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' HD12 ' A' ' 49' ' ' LEU . 1.9 m120 61.96 141.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.336 -0.852 . . . . 0.0 109.175 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . 2.5 mt-30 45.04 76.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.859 -1.151 . . . . 0.0 109.683 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 49' ' ' LEU . 20.6 mt -110.73 136.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 108.886 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 52' ' ' SER . 0.2 OUTLIER -120.09 136.56 54.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.409 -0.807 . . . . 0.0 111.382 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CD1' HD11 ' A' ' 63' ' ' ILE . 34.3 p90 -149.61 153.07 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.969 . . . . 0.0 110.304 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HD2' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.77 138.9 44.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.523 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -80.24 121.4 33.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 19' ' ' ARG . 33.8 mm -67.33 -2.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.469 -0.769 . . . . 0.0 109.77 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 23' ' ' TYR . . . 144.15 84.44 0.07 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.791 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -51.19 169.42 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 1.2 t -85.31 149.07 51.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.059 -1.651 . . . . 0.0 109.276 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' LEU . 36.2 Cg_endo -79.09 -21.5 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.331 2.021 . . . . 0.0 109.85 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' PRO . 74.4 m-20 -40.64 -25.06 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.133 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.4 pt? -133.76 173.83 11.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.675 -1.266 . . . . 0.0 110.798 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 3.0 m-20 -48.66 138.3 12.11 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 108.862 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.551 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.3 Cg_endo -69.03 -33.66 18.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 N-CA-C 107.331 -1.834 . . . . 0.0 107.331 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 pt-20 -79.01 -26.88 43.22 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 20.8 m -74.15 -50.83 17.68 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.66 -36.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.993 0.901 . . . . 0.0 108.643 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.87 -24.72 59.78 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.66 -41.66 68.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -53.19 -38.89 63.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' HG21 ' A' ' 63' ' ' ILE . 26.9 m-85 -74.12 -26.75 60.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -52.66 9.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -34.47 72.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -62.9 -46.78 86.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.44 -0.788 . . . . 0.0 109.206 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -53.39 -34.72 58.79 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -83.01 -12.3 57.37 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -73.38 -32.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.828 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -102.82 -51.02 3.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.599 -0.688 . . . . 0.0 109.718 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 10.0 t -53.76 -33.17 54.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 109.157 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 41' ' ' GLN . 1.2 t70 -54.78 -33.3 61.22 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.599 -0.688 . . . . 0.0 109.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 46' ' ' VAL . 12.1 p -106.06 23.42 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.036 -1.04 . . . . 0.0 110.694 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.441 HG22 ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -173.13 153.87 2.54 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.665 -1.272 . . . . 0.0 110.115 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' CD ' ' OXT' ' A' ' 163' ' ' GLY . 37.3 Cg_endo -79.77 12.78 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.89 3.06 . . . . 0.0 110.723 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.2 tt -64.37 148.72 49.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.96 138.93 45.64 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.77 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 49' ' ' LEU . 26.6 m-85 -116.72 135.62 53.63 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.183 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.745 ' HB3' HG23 ' A' ' 17' ' ' THR . 9.4 t -128.59 118.67 23.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.059 -1.025 . . . . 0.0 110.322 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 18' ' ' TYR . 6.0 mtm180 -92.16 131.43 37.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.977 -1.077 . . . . 0.0 108.15 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.699 HD11 ' CB ' ' A' ' 59' ' ' ALA . 15.5 pt -126.6 148.31 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 109.536 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.38 -14.58 14.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.996 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -135.44 -167.39 2.0 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.953 -1.092 . . . . 0.0 109.941 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.86 -170.94 2.0 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 54' ' ' ILE . 1.9 tp10 -79.07 158.43 27.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.251 -1.146 . . . . 0.0 110.358 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.699 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -136.44 -160.38 1.05 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.447 -0.783 . . . . 0.0 108.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -134.22 -57.03 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.584 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.618 HG23 ' C ' ' A' ' 95' ' ' GLY . 2.5 mt -98.77 152.05 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.361 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtt -119.21 123.19 43.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.948 -1.095 . . . . 0.0 110.274 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.636 HD11 ' CD1' ' A' ' 18' ' ' TYR . 1.6 mp -117.78 142.21 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.634 -1.291 . . . . 0.0 109.968 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' OD1' ' C ' ' A' ' 63' ' ' ILE . 2.7 p-10 175.3 -174.69 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.439 -0.788 . . . . 0.0 110.189 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -89.96 -167.3 1.81 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.001 -1.062 . . . . 0.0 111.052 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 99' ' ' PHE . . . -149.3 49.66 0.57 Allowed Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -56.05 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -49.95 -57.28 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.981 . . . . 0.0 109.886 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 124.75 24.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.693 -0.63 . . . . 0.0 110.146 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.09 -70.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 133.74 -20.0 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -46.33 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.517 -0.99 . . . . 0.0 111.601 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.77 -2.02 65.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.88 77.59 18.51 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.967 -1.314 . . . . 0.0 110.172 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.27 139.33 18.65 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.51 2.14 . . . . 0.0 109.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.24 159.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.384 -0.822 . . . . 0.0 109.605 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.9 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.495 -0.753 . . . . 0.0 109.112 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.86 -154.92 19.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -69.4 167.28 16.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -1.068 . . . . 0.0 111.128 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.57 ' HA ' HD21 ' A' ' 83' ' ' LEU . 0.4 OUTLIER 41.42 -150.41 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 83' ' ' LEU . . . 54.42 -134.88 45.52 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 100' ' ' ASP . 4.7 tt -50.68 98.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.594 -0.945 . . . . 0.0 109.012 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 80' ' ' ASP . 1.3 mt -110.31 -28.45 8.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 108.934 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 121' ' ' GLU . . . -177.94 155.34 0.97 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.508 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 4.8 p80 -152.21 174.48 13.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.768 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -144.76 144.11 31.01 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.428 -0.795 . . . . 0.0 109.874 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.6 156.91 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 108.739 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -65.67 173.32 2.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 110.195 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 37.5 Cg_endo -82.51 155.54 16.21 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.201 2.601 . . . . 0.0 110.67 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.52 -128.76 1.18 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.7 60.09 1.7 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.207 -1.173 . . . . 0.0 110.475 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.18 -67.8 0.44 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 93' ' ' VAL . 61.7 t -79.86 1.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.281 . . . . 0.0 108.36 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -78.89 134.82 14.46 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' HG23 ' A' ' 61' ' ' ILE . . . 84.04 91.95 0.72 Allowed Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.55 -0.97 . . . . 0.0 110.68 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.3 m-20 -160.99 120.33 2.61 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.975 -1.309 . . . . 0.0 108.754 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 3.1 p -110.25 130.01 55.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.052 0.93 . . . . 0.0 110.505 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.508 ' ND1' ' NE2' ' A' ' 85' ' ' HIS . 29.5 m170 -119.36 148.9 42.67 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 109.333 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.7 m-30 -112.48 147.05 37.35 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 0.0 109.833 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.684 ' HB2' HD23 ' A' ' 82' ' ' LEU . 3.6 t70 -81.13 114.92 20.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 67' ' ' ARG . 18.5 t70 -57.37 -95.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.75 -0.78 . . . . 0.0 108.92 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 101' ' ' ASP . 47.2 m-20 21.67 -93.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 120.706 0.288 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 102' ' ' ASP . 2.5 mp0 -41.95 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.933 -1.104 . . . . 0.0 110.094 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.596 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.0 tp -106.2 101.08 10.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.883 . . . . 0.0 109.696 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' THR . 12.1 m95 -103.11 147.27 27.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.363 -0.835 . . . . 0.0 110.034 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.655 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 p -159.02 -159.68 0.79 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.315 -0.866 . . . . 0.0 110.02 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -149.1 70.0 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -168.2 -99.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.467 ' H ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -142.67 59.82 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.774 -1.204 . . . . 0.0 109.613 178.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.93 -24.13 0.76 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.246 -0.908 . . . . 0.0 110.972 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 104' ' ' LEU . 2.6 t-20 -169.57 -153.66 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.739 -1.226 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -67.74 -167.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.798 -1.189 . . . . 0.0 108.436 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.5 t -105.36 117.61 34.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.904 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -53.24 -22.51 6.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.86 0.838 . . . . 0.0 108.753 179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.543 ' C ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -76.07 -38.49 57.02 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.595 HD12 ' CZ ' ' A' ' 142' ' ' TYR . 2.3 tm? -64.72 -55.13 21.88 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.409 -0.807 . . . . 0.0 109.716 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 118' ' ' ALA . 2.4 m -53.67 -51.06 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 117' ' ' VAL . . . -57.29 -51.48 69.2 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.938 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.4 -58.25 3.47 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.953 0.882 . . . . 0.0 109.333 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.436 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 84.9 t60 -42.81 -67.62 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 84' ' ' ALA . 44.1 mm-40 -62.25 -21.95 65.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CG ' ' CZ2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -74.43 -5.54 43.07 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -98.08 -48.54 1.88 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.436 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 97.0 m-70 -60.79 -42.61 97.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.53 -16.5 38.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.922 . . . . 0.0 109.209 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.5 ' SD ' ' OH ' ' A' ' 162' ' ' TYR . 44.2 mtt -84.62 15.82 3.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 100.95 -73.26 0.39 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.788 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' GLY . 15.7 mt -32.44 145.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.997 -0.708 . . . . 0.0 111.184 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.85 -179.66 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.815 -1.178 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -49.08 135.47 16.13 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.2 p -93.35 -152.16 0.32 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.16 -4.66 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.746 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -81.97 134.44 49.75 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.905 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.93 113.15 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.465 2.11 . . . . 0.0 111.007 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.07 -5.32 42.06 Favored Glycine 0 C--N 1.268 -3.199 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . . . -54.13 162.04 1.12 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.682 -0.893 . . . . 0.0 109.64 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD23 ' OD2' ' A' ' 154' ' ' ASP . 19.0 tp -67.32 -34.3 77.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.547 -0.721 . . . . 0.0 109.085 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.416 ' HE1' ' OD1' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -107.34 28.09 8.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.514 -0.741 . . . . 0.0 110.398 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -78.19 164.27 57.61 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.773 -1.204 . . . . 0.0 109.112 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 35.2 Cg_endo -73.5 15.74 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.269 2.646 . . . . 0.0 112.39 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 139.59 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.853 -1.155 . . . . 0.0 109.507 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.595 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 62.9 t80 -76.79 129.58 36.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 144' ' ' TYR . 6.2 m -150.06 84.77 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.982 -1.074 . . . . 0.0 108.472 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.565 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 75.4 t80 -42.37 164.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.633 -0.667 . . . . 0.0 109.339 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.507 ' O ' ' CE2' ' A' ' 144' ' ' TYR . 1.7 t -111.5 119.05 37.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 110.604 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -44.83 104.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.825 . . . . 0.0 108.848 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 146' ' ' LYS . 70.1 m-20 68.81 -79.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.854 ' CE1' HD23 ' A' ' 150' ' ' LEU . 24.1 t80 171.14 113.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.037 -1.039 . . . . 0.0 108.95 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 14.1 ttt85 -133.02 -20.7 2.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 110.214 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.854 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 71.98 -160.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -163.42 126.71 2.71 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.731 -1.231 . . . . 0.0 108.985 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.585 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 4.7 mm-40 -45.51 -44.07 12.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.25 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' GLN . 41.9 t0 -45.57 -36.4 4.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.654 -1.218 . . . . 0.0 108.357 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.416 ' OD1' ' HE1' ' A' ' 138' ' ' MET . 29.2 t0 -86.51 -30.89 21.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.634 -0.667 . . . . 0.0 109.479 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -70.48 -37.56 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 108.805 178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -72.82 -43.1 63.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.84 48.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.687 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -54.47 -42.95 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.365 . . . . 0.0 109.534 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.425 ' N ' HG23 ' A' ' 158' ' ' ILE . 7.3 mm-40 -65.4 -43.15 91.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 109.589 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 69.3 mm-40 -57.73 -22.98 49.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.741 -1.225 . . . . 0.0 108.468 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.469 ' HB3' ' HD1' ' A' ' 162' ' ' TYR . 3.8 mm? -98.96 -64.5 1.03 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.584 0.707 . . . . 0.0 109.318 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.792 ' CE2' HD13 ' A' ' 49' ' ' LEU . 21.9 p90 -151.64 85.27 1.3 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.45 ' OXT' ' CD ' ' A' ' 48' ' ' PRO . . . . . . . . 0 N--CA 1.494 2.543 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.662 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 9.8 mttp . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 3.0 m95 -71.54 130.99 42.61 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 11.8 p-10 167.92 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.36 -0.837 . . . . 0.0 109.383 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.64 32.0 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 4.6 t-20 72.28 -62.97 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.146 -0.971 . . . . 0.0 108.951 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 50' ' ' ARG . 21.3 mt-30 -78.94 103.23 8.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.517 -0.739 . . . . 0.0 109.297 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.9 OUTLIER -101.06 162.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 108.577 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.45 133.96 48.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 110.043 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 7.3 p90 -145.99 157.69 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . 3.4 tmm_? -148.76 136.82 20.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 0.0 109.927 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 23' ' ' TYR . 5.8 mt -86.6 144.97 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 62' ' ' MET . 11.6 mm -107.67 -38.85 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 0.0 110.074 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.02 96.23 0.14 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.755 ' CG ' HG11 ' A' ' 32' ' ' VAL . 2.5 m-85 -55.31 179.02 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.353 -1.086 . . . . 0.0 109.1 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.563 HG22 HD11 ' A' ' 27' ' ' LEU . 5.0 t -105.05 150.59 38.93 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 109.437 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.2 Cg_endo -81.27 -33.04 0.79 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.727 2.285 . . . . 0.0 111.238 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' PRO . 36.5 m-20 -39.48 -27.16 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.68 -0.637 . . . . 0.0 110.105 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' HB ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -135.16 -178.15 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 110.04 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 1.1 m-20 -73.62 151.97 89.37 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.511 -0.743 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.557 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.7 Cg_endo -74.1 -30.12 9.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 N-CA-C 106.254 -2.248 . . . . 0.0 106.254 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 2.6 mm-40 -78.11 -30.41 49.45 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 107' ' ' ASN . 2.4 m -76.45 -50.68 13.46 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.755 HG11 ' CG ' ' A' ' 23' ' ' TYR . 1.4 p -54.92 -41.43 57.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.26 -23.97 62.08 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 2.7 t70 -81.39 -34.5 31.61 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.528 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.8 m-85 -73.21 -47.95 39.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -46.24 -51.15 14.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.993 . . . . 0.0 108.609 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' VAL . 9.3 mtm180 -55.19 -50.44 69.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.013 -1.054 . . . . 0.0 108.439 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -53.41 -44.36 68.68 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 44' ' ' SER . 49.6 t80 -51.25 -40.25 58.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 108.732 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 3.0 tt0 -86.77 -24.03 25.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -68.74 -33.33 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.147 -0.97 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.787 ' HE1' HD21 ' A' ' 137' ' ' LEU . 1.9 m95 -103.22 -22.3 13.75 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.208 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 27.5 t -85.9 -19.61 30.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.8 m-20 -64.6 -15.12 60.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.516 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.1 p -113.65 17.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.404 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -173.04 147.56 1.53 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 120.466 -1.396 . . . . 0.0 111.037 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' THR . 36.4 Cg_endo -78.52 46.78 2.23 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.773 2.316 . . . . 0.0 110.067 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD23 ' HE1' ' A' ' 51' ' ' PHE . 1.7 mp -76.55 160.16 29.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -130.41 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.866 ' HE1' HD23 ' A' ' 49' ' ' LEU . 5.4 m-30 -66.57 139.41 57.91 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' THR . 8.1 t -130.89 101.66 5.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.244 -0.91 . . . . 0.0 109.835 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -81.03 144.08 32.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.745 ' N ' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -113.29 158.87 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 43.1 m-70 -106.75 -14.65 14.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.04 -175.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.046 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.34 63.65 0.83 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 177.35 153.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.482 -1.01 . . . . 0.0 109.527 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 54' ' ' ILE . . . 176.45 143.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -62.53 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.793 HG23 ' O ' ' A' ' 95' ' ' GLY . 22.9 mt -87.59 156.51 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.983 ' HG2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -165.83 136.05 3.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.126 -0.984 . . . . 0.0 109.931 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.39 144.56 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 109.668 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -164.19 -167.14 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.325 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.464 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -117.2 166.73 11.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.74 -24.99 7.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 65' ' ' PHE . 54.1 mtp180 47.91 -150.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.177 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -91.12 -72.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 0.0 109.412 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -62.42 99.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.621 -0.675 . . . . 0.0 110.481 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.29 -160.28 0.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.86 -33.26 1.89 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.74 72.18 10.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.431 -1.04 . . . . 0.0 108.492 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' TYR . . . 112.95 -113.29 3.15 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER 163.33 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.21 -1.17 . . . . 0.0 109.827 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 74' ' ' TYR . 36.8 Cg_endo -79.26 137.69 13.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.246 1.964 . . . . 0.0 110.235 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 24.7 p90 -71.63 138.05 48.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.617 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 p-10 -75.31 -2.29 27.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.555 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 57.41 -114.91 5.99 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.5 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 78' ' ' GLY . 5.4 mttt -41.65 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.057 -0.673 . . . . 0.0 110.78 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 79' ' ' LYS . 10.1 m-20 -25.18 -93.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 80' ' ' ASP . . . 38.6 -130.35 1.79 Allowed Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 9.7 tt -54.51 109.37 0.49 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.1 mt -107.94 -29.29 9.1 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 171.77 155.93 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.903 -1.123 . . . . 0.0 110.899 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.427 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 1.9 p80 -146.36 -162.74 1.59 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 97' ' ' SER . . . -160.73 145.81 14.36 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -92.77 156.29 17.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.841 -1.162 . . . . 0.0 109.976 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.8 164.01 55.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.1 Cg_endo -79.35 154.55 24.68 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.002 2.468 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.49 60.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.78 92.56 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -1.084 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.82 -62.81 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 93' ' ' VAL . 2.4 t -58.19 153.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.267 . . . . 0.0 109.748 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 98.2 141.08 11.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.793 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 95.83 -45.78 1.96 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' MET . 4.1 p30 -73.26 125.22 27.27 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.188 -1.183 . . . . 0.0 109.724 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.511 ' OG ' ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -131.65 136.28 47.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.314 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 9.5 m80 -98.93 143.38 29.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . 13.8 m-85 -113.9 141.83 46.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.565 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' CZ3' ' A' ' 105' ' ' TRP . 5.4 t70 -51.91 135.43 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -98.23 -16.86 19.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.871 -1.143 . . . . 0.0 109.592 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.83 -16.92 60.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.534 ' OE2' HD23 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -75.49 158.23 32.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 111' ' ' ASN . 8.4 tp -109.09 95.61 5.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 99' ' ' PHE . 10.3 m0 -102.33 141.51 35.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.216 -0.927 . . . . 0.0 110.222 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.805 HG21 ' HB3' ' A' ' 110' ' ' ALA . 1.5 p -133.51 -160.28 1.04 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.972 -1.08 . . . . 0.0 110.006 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 31' ' ' THR . 0.2 OUTLIER -134.59 2.25 3.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.826 . . . . 0.0 109.99 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.08 -60.5 1.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.098 . . . . 0.0 109.359 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.6 p -165.26 -91.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.324 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.805 ' HB3' HG21 ' A' ' 106' ' ' THR . . . 43.6 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.865 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' A' ' 104' ' ' LEU . 60.8 t30 -110.55 -104.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.95 -124.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.794 -1.191 . . . . 0.0 109.456 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -171.99 117.24 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.356 -1.465 . . . . 0.0 111.219 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -45.95 -43.48 14.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.643 -0.66 . . . . 0.0 110.078 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.6 t80 -58.91 -44.52 91.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.388 -0.82 . . . . 0.0 109.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.5 OUTLIER -59.2 -67.14 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.422 -0.798 . . . . 0.0 109.766 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.5 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.1 m -51.08 -42.93 25.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.435 -0.791 . . . . 0.0 108.985 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -52.64 -46.94 67.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.861 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -54.48 -59.02 5.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.376 -0.828 . . . . 0.0 110.007 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 124' ' ' HIS . 49.6 t-80 -43.55 -65.05 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.655 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 99' ' ' PHE . 68.1 mm-40 -62.84 -12.95 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 0.0 109.341 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.1 m-85 -80.92 -10.8 59.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.108 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.597 ' HA3' ' CZ2' ' A' ' 43' ' ' TRP . . . -103.68 -41.29 2.19 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.618 ' CE1' ' CE1' ' A' ' 120' ' ' HIS . 9.5 m80 -61.02 -42.93 99.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -1.117 . . . . 0.0 109.104 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -37.56 -32.36 0.05 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.391 0.615 . . . . 0.0 109.532 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.867 ' HE1' HD12 ' A' ' 158' ' ' ILE . 4.1 mtm -69.89 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.87 . . . . 0.0 109.476 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.47 -30.87 0.05 OUTLIER Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' O ' ' HE1' ' A' ' 138' ' ' MET . 0.5 OUTLIER -49.9 153.82 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.538 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 130' ' ' HIS . 4.0 mt-10 -113.44 -177.53 3.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.157 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 129' ' ' GLU . 0.3 OUTLIER -44.72 172.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 110.142 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 p -123.58 -152.23 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 -17.36 2.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.321 -0.862 . . . . 0.0 110.99 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 151.32 54.21 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.72 -1.237 . . . . 0.0 109.251 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.8 -38.7 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.398 2.065 . . . . 0.0 110.686 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.09 6.81 69.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.57 163.31 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 110.03 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.787 HD21 ' HE1' ' A' ' 43' ' ' TRP . 16.7 tp -89.12 -28.5 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 110.233 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 139' ' ' ALA . 37.0 mtp -101.53 15.01 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.909 -1.119 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -43.15 153.72 0.34 Allowed Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.934 ' O ' HD13 ' A' ' 141' ' ' ILE . 35.2 Cg_endo -79.09 -1.11 11.32 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.205 1.937 . . . . 0.0 110.21 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.5 mm -131.28 154.46 40.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.66 139.36 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 110.16 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 144' ' ' TYR . 1.9 m -129.52 -41.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 110.37 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.849 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.5 OUTLIER 68.42 147.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 t -120.65 138.13 54.09 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -83.11 0.15 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.119 -0.988 . . . . 0.0 111.003 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 1.5 p-10 -88.19 21.43 2.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.824 -1.173 . . . . 0.0 109.391 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 148' ' ' PHE . 1.6 t80 60.14 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.112 -0.993 . . . . 0.0 109.133 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -121.06 -10.8 8.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.437 -0.789 . . . . 0.0 109.247 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 tp 59.32 -144.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 109.274 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 155' ' ' ILE . 1.1 p -178.41 129.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.563 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.7 mm100 -53.76 -35.17 61.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.896 -0.502 . . . . 0.0 110.053 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 152' ' ' GLN . 2.9 m-20 -42.87 -47.7 5.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 109.304 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -79.37 -45.26 19.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.454 -0.779 . . . . 0.0 109.177 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 151' ' ' SER . 0.5 OUTLIER -50.86 -28.47 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.0 108.661 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -57.44 3.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 0.0 109.553 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.41 -36.41 53.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' HE1' ' A' ' 126' ' ' MET . 6.7 tp -75.28 -30.09 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.378 -1.072 . . . . 0.0 109.1 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.57 67.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.479 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 -28.38 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.406 0.622 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -19.62 20.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.658 -0.651 . . . . 0.0 110.136 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 49' ' ' LEU . 41.6 m-85 -140.3 -75.05 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.406 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.795 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 121.384 0.612 . . . . 0.0 111.936 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.568 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 176.0 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.462 -0.774 . . . . 0.0 109.24 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -44.57 158.39 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -114.81 144.65 43.17 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.471 -0.768 . . . . 0.0 109.448 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.43 ' O ' HD23 ' A' ' 49' ' ' LEU . 68.0 m-80 43.26 -82.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' LYS . 2.9 mt-30 -71.4 106.89 4.08 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 17' ' ' THR . 2.2 mm -114.05 -178.33 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.034 -1.041 . . . . 0.0 110.133 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -140.33 137.83 34.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CB ' HG13 ' A' ' 61' ' ' ILE . 43.2 p90 -145.38 162.89 36.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.115 -0.99 . . . . 0.0 109.569 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 58' ' ' GLU . 19.9 ttp85 -159.42 124.33 4.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -0.896 . . . . 0.0 109.684 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.892 HG21 ' CD1' ' A' ' 23' ' ' TYR . 4.0 mt -85.25 116.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.7 mt -73.62 0.3 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.981 -1.074 . . . . 0.0 109.836 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 151.64 103.64 0.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.892 ' CD1' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.74 -153.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -1.178 . . . . 0.0 109.365 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.528 HG22 HG21 ' A' ' 32' ' ' VAL . 1.4 t -105.13 147.63 34.84 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.202 -0.936 . . . . 0.0 110.521 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 37.5 Cg_endo -78.89 -32.91 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.157 2.571 . . . . 0.0 111.178 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' PRO . 71.7 m-20 -41.1 -34.73 0.47 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.698 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -121.03 176.95 5.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.967 -1.083 . . . . 0.0 109.231 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 4.6 m-20 -63.04 154.49 77.06 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.012 -1.055 . . . . 0.0 108.348 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.9 Cg_endo -72.3 -33.33 9.22 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.1 -26.41 33.62 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.885 HG21 ' HA ' ' A' ' 107' ' ' ASN . 1.4 m -71.79 -51.84 20.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.6 -33.74 40.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -70.35 -24.23 62.94 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 55.2 t0 -73.7 -39.19 64.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.296 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.726 ' HB3' HD23 ' A' ' 114' ' ' LEU . . . -53.25 -60.83 2.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.477 ' CE2' HD21 ' A' ' 114' ' ' LEU . 78.3 m-85 -53.42 -42.5 67.12 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -49.2 -38.96 27.74 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' VAL . 1.2 mtp180 -74.48 -46.84 36.99 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -56.35 -36.15 68.46 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -65.61 -40.99 93.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 1.3 mt-30 -81.69 -9.42 59.65 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -94.26 -27.84 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.133 -0.979 . . . . 0.0 109.63 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.804 ' HZ3' HD13 ' A' ' 158' ' ' ILE . 1.7 m95 -102.67 -21.16 14.16 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 109.887 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' THR . 6.2 t -95.2 -26.25 16.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.255 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -67.43 -4.54 11.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.918 HG23 HG22 ' A' ' 47' ' ' THR . 15.1 m -108.1 -8.2 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.705 -1.247 . . . . 0.0 109.614 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -153.16 163.53 23.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.999 -1.063 . . . . 0.0 108.424 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.2 Cg_endo -76.66 57.16 5.47 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.067 1.845 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.805 HD11 ' CE2' ' A' ' 162' ' ' TYR . 2.6 mt -93.66 125.5 38.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.546 -0.721 . . . . 0.0 109.241 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 4.9 mmm180 -112.26 90.81 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 89.4 m-85 -77.05 148.83 35.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.953 -1.092 . . . . 0.0 109.842 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' THR . 51.5 m -132.11 111.85 11.82 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.84 138.44 54.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.352 -0.843 . . . . 0.0 108.998 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -133.58 164.99 33.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.608 ' O ' ' N ' ' A' ' 57' ' ' GLY . 87.7 m-70 -132.03 165.35 24.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.258 -0.901 . . . . 0.0 109.697 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER 55.36 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 55' ' ' HIS . . . -46.3 156.53 0.52 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 1.7 mt-10 -66.55 161.2 23.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.92 -1.341 . . . . 0.0 110.47 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -124.47 148.57 47.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.587 -0.696 . . . . 0.0 109.381 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' CD2' ' A' ' 11' ' ' TRP . 10.3 t0 -70.03 -54.48 13.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.996 -1.065 . . . . 0.0 109.398 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.802 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -103.54 122.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.195 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 3.5 mtt -105.49 139.82 39.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.959 -1.088 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.438 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 2.9 mt -123.32 128.61 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.023 -1.048 . . . . 0.0 108.616 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -153.95 -147.1 0.21 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.101 -0.999 . . . . 0.0 109.782 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -177.85 -178.55 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.899 -1.126 . . . . 0.0 110.314 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 101' ' ' ASP . . . 139.21 178.95 16.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -160.87 161.74 31.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.286 -1.126 . . . . 0.0 109.786 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 57.04 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 108.517 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.5 pp20? -61.65 124.53 20.95 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-80 173.45 -57.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 77.55 -12.76 13.82 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 71' ' ' GLY . 6.0 m-20 -42.18 -24.68 0.05 Allowed 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.016 -1.285 . . . . 0.0 110.274 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 128.31 13.14 2.67 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.548 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 14.8 p90 -154.76 90.85 3.04 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 120.834 -1.392 . . . . 0.0 109.287 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 36.0 Cg_endo -78.35 -171.88 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.598 2.199 . . . . 0.0 110.957 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 26.6 m-85 61.08 170.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 0.0 109.235 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 78' ' ' GLY . 1.3 t70 172.63 -34.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . 31.72 -157.77 0.0 OUTLIER Glycine 0 N--CA 1.5 2.957 0 CA-C-O 121.682 0.601 . . . . 0.0 111.933 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 80' ' ' ASP . 6.3 mttt -72.8 162.45 29.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.688 -0.889 . . . . 0.0 110.957 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 79' ' ' LYS . 9.7 p-10 27.96 -138.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.199 0.523 . . . . 0.0 111.208 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 83' ' ' LEU . . . 44.51 -116.93 1.84 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -42.68 97.53 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 81' ' ' GLY . 1.7 mt -114.3 -21.41 10.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.567 -1.333 . . . . 0.0 109.392 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.09 150.09 0.94 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.143 -0.973 . . . . 0.0 110.178 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.588 ' CE1' ' CE1' ' A' ' 74' ' ' TYR . 1.1 p80 -144.04 -179.98 6.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.81 162.06 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.115 -0.99 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.07 168.7 10.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.673 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.8 148.32 64.72 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.547 -0.721 . . . . 0.0 109.357 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 28.8 Cg_endo -75.87 136.73 19.03 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.709 2.272 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.505 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 145.21 122.79 1.56 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.387 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER 56.25 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.704 . . . . 0.0 110.954 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 33.14 -92.21 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -45.65 160.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -1.124 . . . . 0.0 108.743 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 96' ' ' ASP . . . 126.58 151.1 7.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 60.82 13.41 32.67 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.651 -1.499 . . . . 0.0 109.434 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 62' ' ' MET . 1.6 m-20 -97.09 116.2 28.86 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.552 -1.558 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.614 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 33.8 m -114.65 156.36 24.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.724 -0.61 . . . . 0.0 109.941 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 97' ' ' SER . 1.9 m80 -148.79 139.01 22.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 32.6 m-85 -104.61 179.24 4.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.172 0.987 . . . . 0.0 112.165 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.553 ' OD2' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -58.64 161.98 4.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.866 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.611 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 13.2 t0 -94.02 -4.83 48.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -170.12 79.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.0 109.023 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -137.09 -8.54 1.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.476 -1.39 . . . . 0.0 111.599 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD13 ' H ' ' A' ' 105' ' ' TRP . 0.2 OUTLIER 76.66 141.5 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.188 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.608 ' H ' HD13 ' A' ' 104' ' ' LEU . 26.0 m-90 -149.01 -50.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.017 -1.052 . . . . 0.0 110.288 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 114' ' ' LEU . 35.8 p -138.13 -89.21 0.24 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 117.905 -1.518 . . . . 0.0 113.171 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.885 ' HA ' HG21 ' A' ' 31' ' ' THR . 28.8 t-20 52.92 19.26 1.28 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -175.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 106' ' ' THR . 30.3 p 50.49 37.63 16.35 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.356 1.074 . . . . 0.0 110.039 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -168.07 31.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 105' ' ' TRP . . . -98.12 179.97 4.58 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.463 0.649 . . . . 0.0 111.967 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -120.98 -13.31 8.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.523 ' O ' ' CB ' ' A' ' 113' ' ' SER . 1.2 m-85 -107.59 -42.4 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.939 -1.101 . . . . 0.0 108.475 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 105' ' ' TRP . 0.3 OUTLIER 81.01 93.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.927 0.87 . . . . 0.0 110.925 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.743 ' H ' HG23 ' A' ' 106' ' ' THR . 13.2 tp -37.67 -41.83 0.52 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.739 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.5 t80 -55.29 -45.1 76.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.893 . . . . 0.0 109.9 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD12 ' CE1' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -68.66 -58.69 3.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.448 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 118' ' ' ALA . 32.9 m -59.08 -42.37 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.006 -1.059 . . . . 0.0 109.432 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.645 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -59.06 -41.55 88.23 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.384 0.612 . . . . 0.0 109.4 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.32 69.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.492 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -54.64 -33.61 60.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 0.0 108.821 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -86.04 -24.61 26.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.167 -0.958 . . . . 0.0 109.151 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 118' ' ' ALA . 1.4 m-85 -71.91 -10.92 60.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -101.71 -37.92 3.33 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -63.54 -50.23 70.37 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.21 -1.171 . . . . 0.0 108.597 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 95' ' ' GLY . . . -61.18 -13.45 18.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.739 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 22.9 mmm -81.26 10.87 4.85 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.089 -1.007 . . . . 0.0 108.985 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 88.64 -54.96 4.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 128' ' ' LEU . 14.7 mt -42.8 142.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.343 -1.093 . . . . 0.0 110.166 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' HIS . 19.6 pt-20 -108.98 175.61 5.4 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' GLU . 45.4 m80 -44.24 167.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.143 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 m -115.6 -80.53 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.005 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 177.11 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 145.79 97.36 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -75.83 -35.44 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.256 1.971 . . . . 0.0 108.567 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.34 13.7 62.97 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.65 149.43 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -1.081 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 137' ' ' LEU . 14.3 tp -72.93 -16.16 61.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 7.3 mmt -112.45 27.87 9.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.95 154.49 93.62 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.743 -0.598 . . . . 0.0 109.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.25 4.14 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.79 2.327 . . . . 0.0 111.413 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 141' ' ' ILE . 1.0 OUTLIER -131.99 151.06 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.887 -1.133 . . . . 0.0 109.747 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 144' ' ' TYR . 30.1 t80 -63.96 120.96 12.96 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 144' ' ' TYR . 7.6 m -124.07 53.61 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.042 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.618 ' CD2' ' N ' ' A' ' 145' ' ' THR . 75.2 t80 -44.39 170.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.393 -0.817 . . . . 0.0 109.318 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.618 ' N ' ' CD2' ' A' ' 144' ' ' TYR . 1.6 t 179.64 113.3 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.064 -1.022 . . . . 0.0 109.455 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 23.0 ttpt -59.7 167.31 2.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.907 -1.121 . . . . 0.0 108.943 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 3.9 t-20 71.3 -54.83 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.086 . . . . 0.0 110.591 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 68.74 143.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.165 -0.96 . . . . 0.0 109.58 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 80.1 mtp85 -134.11 -86.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 108.922 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 2.1 mt 160.29 152.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.987 -1.071 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 155' ' ' ILE . 10.4 p -119.83 129.02 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 109.885 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.636 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.5 mt-30 -65.39 -32.55 74.25 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -44.46 -38.28 3.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -86.54 -38.41 17.22 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.542 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -62.7 -29.77 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 108.718 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -63.9 1.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 110.236 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -51.64 -39.97 47.05 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.804 HD13 ' HZ3' ' A' ' 43' ' ' TRP . 9.9 tp -70.17 -40.98 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.612 -0.934 . . . . 0.0 109.461 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 1.8 mm-40 -70.6 -20.55 62.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.257 -0.902 . . . . 0.0 108.809 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -87.14 -27.91 22.79 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.176 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.457 ' CD1' ' HD3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -93.53 -19.99 20.69 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 109.808 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 49' ' ' LEU . 25.6 m-85 -113.59 -8.06 13.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HD3' ' HG2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CH2' ' OD2' ' A' ' 60' ' ' ASP . 5.9 m95 -107.6 -105.58 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.0 109.199 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' OD1' HD11 ' A' ' 161' ' ' LEU . 13.5 m-20 61.34 22.95 13.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.81 -1.181 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HD2' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -94.3 166.74 11.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 109.709 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' ILE . 4.2 m120 -82.54 -88.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 110.262 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.5 pt20 -52.45 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.772 -1.205 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 17' ' ' THR . 10.9 mt -102.72 167.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.342 -0.849 . . . . 0.0 110.602 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.611 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.64 131.51 43.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.159 -0.963 . . . . 0.0 109.837 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.521 ' HA ' HG13 ' A' ' 61' ' ' ILE . 9.3 p90 -133.7 163.93 28.34 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.996 . . . . 0.0 110.53 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' A' ' 55' ' ' HIS . 19.1 ttt180 -159.05 132.4 7.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 109.754 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.671 HD13 ' OD1' ' A' ' 33' ' ' ASP . 6.0 mt -93.26 131.25 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.75 -20.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 159.76 113.15 0.32 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -84.27 -168.36 2.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.409 -1.054 . . . . 0.0 108.225 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 27' ' ' LEU . 0.7 OUTLIER -105.1 149.66 37.89 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.817 -1.177 . . . . 0.0 109.475 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -78.31 -28.75 4.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.67 2.247 . . . . 0.0 110.061 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.671 ' OD1' HG22 ' A' ' 106' ' ' THR . 1.8 p30 -38.88 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.017 HD13 ' HA ' ' A' ' 106' ' ' THR . 2.0 pt? -129.11 157.45 41.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.109 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 1.6 m-20 -40.75 138.89 1.23 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.602 -0.687 . . . . 0.0 109.169 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -70.87 -39.91 4.0 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 N-CA-C 107.021 -1.953 . . . . 0.0 107.021 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.4 pt-20 -72.88 -22.55 60.74 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.553 ' HB ' ' CB ' ' A' ' 28' ' ' ASP . 5.7 m -80.01 -51.36 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.357 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.787 ' CG2' HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 -39.14 53.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.671 ' OD1' HD13 ' A' ' 20' ' ' ILE . 4.8 m-20 -78.76 -29.9 45.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 11.6 t70 -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.727 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.622 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -43.28 -55.37 4.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.468 -0.77 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 25.1 m-85 -54.99 -42.58 72.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.65 -0.656 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.88 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.865 . . . . 0.0 109.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -47.93 -37.68 14.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.788 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -63.14 -47.71 81.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.6 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -52.4 -33.04 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 2.1 tt0 -82.39 -16.03 50.58 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.601 -0.687 . . . . 0.0 109.348 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.795 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -72.54 -36.43 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.921 -1.112 . . . . 0.0 110.167 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.795 ' CD1' HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.29 -24.52 12.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 28.2 t -77.63 -17.67 57.53 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.176 -0.952 . . . . 0.0 108.964 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 8.0 t70 -65.77 -17.67 64.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 110.097 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 46' ' ' VAL . 13.6 p -110.31 19.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 3.8 t -173.74 149.79 1.62 Allowed Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.069 -1.02 . . . . 0.0 108.805 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -81.03 47.12 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.885 2.39 . . . . 0.0 110.811 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 51' ' ' PHE . 0.6 OUTLIER -81.25 147.2 30.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.405 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -122.78 124.06 42.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.353 -0.842 . . . . 0.0 108.93 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.644 ' CZ ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 m-85 -102.23 144.37 30.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.662 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -118.9 119.68 35.07 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -87.84 141.9 28.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 109.159 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 ' CB ' ' A' ' 59' ' ' ALA . 4.5 pt -141.22 -169.01 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 109.778 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.421 ' O ' ' CZ ' ' A' ' 19' ' ' ARG . 16.4 p-80 -159.08 -33.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 109.191 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -115.31 157.86 23.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.18 -0.95 . . . . 0.0 109.18 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.18 11.26 78.82 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.16 158.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.419 -1.048 . . . . 0.0 109.066 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.867 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -128.13 143.66 51.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.88 -1.138 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 11' ' ' TRP . 1.6 m-20 -51.58 -59.24 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 109.072 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -98.6 129.66 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.062 . . . . 0.0 108.583 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.459 ' SD ' ' OD1' ' A' ' 96' ' ' ASP . 1.5 mtp -125.1 116.61 22.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.563 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.95 155.4 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.51 -0.744 . . . . 0.0 109.129 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.5 p30 179.3 -172.15 0.16 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.014 -1.054 . . . . 0.0 109.986 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -134.07 170.54 15.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.472 -0.768 . . . . 0.0 109.108 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -179.64 114.73 0.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -55.14 -149.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.722 -0.87 . . . . 0.0 110.894 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.4 p90 -48.96 -51.13 32.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.813 -1.179 . . . . 0.0 109.792 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 1.1 mt-10 -43.69 -69.21 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 15.1 t60 73.32 -73.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.43 -0.793 . . . . 0.0 110.608 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.33 9.96 9.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -170.66 68.5 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.252 -1.146 . . . . 0.0 109.971 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.49 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 117.59 179.25 17.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.81 76.29 14.03 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.431 -1.04 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HB2' ' CD2' ' A' ' 82' ' ' LEU . 29.7 Cg_endo -74.78 -84.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.39 2.06 . . . . 0.0 108.425 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 68' ' ' TRP . 24.1 t80 59.52 -100.12 0.1 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.435 -0.791 . . . . 0.0 110.567 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 75.69 -53.96 0.63 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.989 -1.07 . . . . 0.0 108.357 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 77' ' ' ASP . . . 101.83 -148.23 17.71 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HA ' ' OE2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -57.66 161.75 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 108.972 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 39.05 -147.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.434 -0.791 . . . . 0.0 110.028 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 51.46 -146.21 12.16 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.639 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 3.5 tp -40.56 112.93 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.927 . . . . 0.0 109.71 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 10.1 mt -108.63 -19.26 13.49 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.344 -0.848 . . . . 0.0 109.891 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 163.98 163.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 98' ' ' HIS . 6.3 p-80 -153.92 177.4 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.935 -1.103 . . . . 0.0 109.979 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.47 156.39 48.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.08 163.2 12.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.066 -1.022 . . . . 0.0 109.609 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -83.67 157.34 64.26 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.102 -0.999 . . . . 0.0 109.706 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' A' ' 10' ' ' LYS . 37.6 Cg_endo -76.81 147.56 27.56 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.462 2.108 . . . . 0.0 109.597 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 161.26 45.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.261 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 71.3 142.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -1.129 . . . . 0.0 109.72 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 35.97 -102.53 0.02 OUTLIER Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.73 119.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.158 -1.201 . . . . 0.0 108.171 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . 133.15 146.1 5.5 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.736 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 79.18 2.98 88.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.459 ' OD1' ' SD ' ' A' ' 62' ' ' MET . 1.3 m-20 -107.85 130.41 55.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.197 -1.178 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 85' ' ' HIS . 0.7 OUTLIER -122.67 133.53 54.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 109.535 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.537 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 5.8 m80 -111.89 134.21 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 109.065 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.651 ' HB2' ' CD2' ' A' ' 65' ' ' PHE . 6.1 m-85 -103.76 141.95 35.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 110.63 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.82 146.03 53.61 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 66' ' ' GLY . 16.6 m-20 -89.64 -112.27 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 101' ' ' ASP . 5.1 m-20 36.03 -160.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER 34.97 -124.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.437 -0.789 . . . . 0.0 110.349 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 15.1 tp -177.62 134.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.047 -1.033 . . . . 0.0 108.713 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -126.25 124.51 40.53 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.971 -1.081 . . . . 0.0 110.449 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 1.017 ' HA ' HD13 ' A' ' 27' ' ' LEU . 4.1 p -147.03 -160.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.145 -0.972 . . . . 0.0 111.275 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 107' ' ' ASN . 36.7 t30 -108.21 18.81 20.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.391 -0.818 . . . . 0.0 110.782 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -37.15 2.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.435 -1.416 . . . . 0.0 110.168 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -178.68 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 36.26 -94.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.699 -0.626 . . . . 0.0 109.821 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 105' ' ' TRP . 1.1 m-20 -85.23 -80.98 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 108.597 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.443 ' HB3' ' OH ' ' A' ' 142' ' ' TYR . 40.8 m-85 -157.42 40.44 0.3 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.0 OUTLIER 61.92 108.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.414 -0.804 . . . . 0.0 109.863 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -40.14 -39.39 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 109.848 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 57.4 t80 -59.44 -46.51 88.54 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.146 -0.971 . . . . 0.0 109.803 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.875 HD12 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -67.6 -54.44 19.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.569 -0.707 . . . . 0.0 109.814 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.599 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 14.2 m -58.78 -50.25 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.837 -1.164 . . . . 0.0 109.499 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.82 -43.29 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.505 -0.747 . . . . 0.0 110.07 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.17 -51.02 63.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.608 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.44 ' CE1' ' HE2' ' A' ' 130' ' ' HIS . 51.9 t60 -55.75 -61.37 2.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.954 -1.091 . . . . 0.0 109.234 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HB2' ' HZ ' ' A' ' 99' ' ' PHE . 67.1 mm-40 -63.9 -11.21 25.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.545 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -88.16 -18.76 28.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.776 -1.203 . . . . 0.0 108.032 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.38 -43.8 9.18 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.439 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -69.82 -43.24 72.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.31 -32.07 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 64.9 mtt -72.97 -80.65 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.03 -40.32 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.77 155.96 7.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.377 -1.072 . . . . 0.0 111.019 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -173.4 2.24 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 138' ' ' MET . 45.7 m170 -52.39 144.19 13.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.55 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -123.75 20.17 9.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 1.2 tp60 54.07 -156.17 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER 66.37 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -72.72 -41.17 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.311 2.007 . . . . 0.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.86 9.44 52.44 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -75.73 153.73 36.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.051 -1.264 . . . . 0.0 110.14 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 137' ' ' LEU . 14.4 tp -85.6 -21.64 28.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -111.97 28.3 8.88 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.76 76.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.32 9.29 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.933 1.755 . . . . 0.0 110.719 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 142' ' ' TYR . 56.3 mt -122.75 -99.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.008 -1.057 . . . . 0.0 109.366 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.3 t80 179.46 144.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 0.0 110.158 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -137.46 84.47 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 0.0 109.32 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -55.28 161.09 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.82 137.62 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.643 -0.661 . . . . 0.0 110.28 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.086 -1.009 . . . . 0.0 108.595 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 148' ' ' PHE . 42.8 t-20 -51.69 -29.91 19.99 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.496 ' O ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 59.45 134.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 1.8 tpt180 -113.45 -15.49 12.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.069 -1.019 . . . . 0.0 110.454 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER 84.13 -24.84 0.14 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 155' ' ' ILE . 97.6 p 55.99 132.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.937 0.875 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.64 ' O ' HG13 ' A' ' 155' ' ' ILE . 55.8 mt-30 -73.31 -24.4 60.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -49.76 -40.83 42.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 158' ' ' ILE . 1.4 t70 -83.18 -43.64 15.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 152' ' ' GLN . 1.2 pp -51.08 -34.23 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 157' ' ' GLY . 8.2 tmtt? -73.15 -48.02 38.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.113 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' N ' ' HD3' ' A' ' 156' ' ' LYS . . . -72.11 -53.95 8.62 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.723 HD11 ' CE2' ' A' ' 162' ' ' TYR . 10.3 tp -45.61 -51.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -1.183 . . . . 0.0 110.181 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.613 ' N ' HG23 ' A' ' 158' ' ' ILE . 5.4 mt-30 -57.61 -56.93 15.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.681 -1.262 . . . . 0.0 109.144 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.53 -25.92 0.31 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.644 -0.66 . . . . 0.0 110.402 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 12' ' ' ASP . 16.6 tp -97.02 -56.53 2.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 109.42 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 158' ' ' ILE . 15.7 m-30 -77.9 -77.38 0.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.901 -1.124 . . . . 0.0 108.682 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.452 ' OXT' ' HG2' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.635 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mttt . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 13.0 m95 -84.4 72.58 10.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 5.9 m-20 -122.58 62.94 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 109.558 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 49' ' ' LEU . 5.0 mtmt -124.63 -163.55 1.18 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.998 -1.064 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -109.77 -34.9 6.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.83 . . . . 0.0 108.82 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -94.14 97.7 10.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.497 0.665 . . . . 0.0 109.844 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.94 169.04 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.758 -1.214 . . . . 0.0 108.63 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -138.79 134.61 33.66 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.162 -0.961 . . . . 0.0 108.503 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 18.0 p90 -135.28 145.18 47.28 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.077 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HB2' HG13 ' A' ' 54' ' ' ILE . 2.2 tpt180 -151.21 125.37 9.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' N ' ' HD2' ' A' ' 19' ' ' ARG . 1.2 mt -85.56 124.04 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.874 -1.141 . . . . 0.0 109.049 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 64' ' ' ASN . 24.0 mm -53.76 -27.29 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.911 -1.118 . . . . 0.0 109.261 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 162.38 86.24 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.908 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CG ' HG11 ' A' ' 32' ' ' VAL . 1.3 p90 -46.73 177.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.567 -0.961 . . . . 0.0 109.203 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -87.94 140.72 31.1 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 0.0 109.941 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -80.09 -23.5 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.632 2.221 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . 12.0 t0 -39.83 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.894 -0.504 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -132.51 170.85 14.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.768 -1.207 . . . . 0.0 110.34 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.576 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 65.7 m-20 -42.64 133.93 2.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.371 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -68.67 -31.03 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 5.6 mm-40 -76.02 -34.49 59.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.576 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 17.5 m -69.69 -52.55 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.422 -1.311 . . . . 0.0 108.038 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -55.66 -38.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -74.22 -31.27 62.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 22.7 t70 -64.36 -33.77 76.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -50.52 -47.91 57.27 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -71.36 -25.71 62.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -63.9 -64.55 0.86 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -53.76 -39.93 65.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.919 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -58.9 -51.12 71.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.4 t80 -44.19 -49.22 9.21 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 22.4 tt0 -70.49 -26.27 63.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -60.9 -33.83 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 108.509 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.919 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -103.04 -55.36 2.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.725 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -49.08 -35.12 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 3.6 t0 -62.96 -28.77 70.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.401 -0.812 . . . . 0.0 110.596 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.8 p -108.72 9.68 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -149.74 133.63 8.84 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.52 29.96 0.46 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.764 2.309 . . . . 0.0 111.358 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -85.57 141.39 29.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.652 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -101.38 121.7 42.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.854 -1.154 . . . . 0.0 109.44 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -94.78 143.2 26.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.741 -0.599 . . . . 0.0 109.449 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -124.47 141.39 52.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.852 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -99.43 162.39 13.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.942 -1.099 . . . . 0.0 108.847 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.821 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.86 164.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.707 -1.197 . . . . 0.0 110.02 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 6.1 p-80 -145.97 38.64 1.09 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.415 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 55' ' ' HIS . 0.4 OUTLIER 169.04 166.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.427 -0.795 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . 75.2 -81.14 0.94 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.557 ' O ' HD12 ' A' ' 54' ' ' ILE . 1.3 tp10 178.33 166.24 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -1.004 . . . . 0.0 108.856 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -138.89 146.78 41.55 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 109.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.59 -57.76 6.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.02 -1.05 . . . . 0.0 108.745 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -93.46 116.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 120.839 -1.163 . . . . 0.0 109.223 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 4.8 mtm -113.06 114.01 26.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.582 -0.699 . . . . 0.0 109.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.1 mp -98.77 153.14 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.139 -0.975 . . . . 0.0 109.839 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 97' ' ' SER . 20.8 p-10 -174.64 -171.47 0.57 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 34.5 p90 -116.21 -171.9 2.08 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' A' ' 98' ' ' HIS . . . -164.64 116.2 0.69 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HD3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.73 -169.65 2.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -1.171 . . . . 0.0 108.876 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -16.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.472 -0.767 . . . . 0.0 109.92 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HG3' ' HD3' ' A' ' 67' ' ' ARG . 12.9 mt-10 -76.55 -105.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.05 . . . . 0.0 110.813 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 1.2 t-80 56.28 -158.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.862 -1.149 . . . . 0.0 108.751 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.57 38.11 0.23 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD1' ' CD2' ' A' ' 70' ' ' HIS . 1.3 m-20 -75.86 4.19 8.58 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.468 -1.019 . . . . 0.0 110.283 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.6 -42.4 2.32 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 16.0 p90 -103.19 160.61 25.64 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.303 . . . . 0.0 110.601 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -78.85 142.05 17.39 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.974 2.45 . . . . 0.0 111.287 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.603 ' HE2' ' HE2' ' A' ' 98' ' ' HIS . 9.1 m-85 -58.34 146.76 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 109.654 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 80' ' ' ASP . 10.9 p-10 -74.23 2.66 8.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.641 -0.662 . . . . 0.0 109.953 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.04 -161.58 41.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 163.72 13.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.016 -1.285 . . . . 0.0 109.438 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.462 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 61.1 m-20 53.72 -170.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 108.698 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 66.71 -144.32 45.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.487 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -38.25 127.02 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.722 -0.869 . . . . 0.0 110.461 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -113.59 -23.98 9.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . -179.65 162.74 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.717 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.45 167.81 25.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.98 48.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -0.903 . . . . 0.0 110.039 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -81.83 169.68 16.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.951 -1.093 . . . . 0.0 109.858 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' CD1' ' A' ' 11' ' ' TRP . 35.6 Cg_endo -79.47 140.62 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.078 2.519 . . . . 0.0 111.009 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.54 -43.19 1.54 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.9 p -73.17 159.06 34.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.416 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 -16.86 63.28 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 93' ' ' VAL . 74.4 t -103.66 0.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -1.23 . . . . 0.0 109.168 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.52 159.4 20.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 77.91 -6.37 48.7 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -91.14 130.05 37.07 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.712 -1.463 . . . . 0.0 108.607 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 17.8 m -122.13 142.55 50.28 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.53 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.603 ' HE2' ' HE2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -116.13 122.24 44.49 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 108.856 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 26.8 m-85 -98.39 145.22 26.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' OE1' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -46.91 163.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 108.933 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 105' ' ' TRP . 34.3 t70 -117.61 -18.1 9.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.982 -1.074 . . . . 0.0 108.924 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -81.84 -31.41 31.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.127 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.436 ' OE1' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -67.13 161.58 24.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 110.651 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -106.02 106.58 17.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.722 -0.611 . . . . 0.0 109.465 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -116.15 122.74 45.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.0 108.908 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 110' ' ' ALA . 1.2 p -149.13 151.3 34.14 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.803 -1.186 . . . . 0.0 110.574 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.78 68.59 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.058 . . . . 0.0 110.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -172.63 77.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.459 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 108' ' ' THR . 2.4 p 45.67 75.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.464 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 106' ' ' THR . . . -155.77 -158.19 0.79 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -73.47 -114.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 110.471 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -62.15 146.45 50.57 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.067 -1.021 . . . . 0.0 109.843 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 106' ' ' THR . 3.5 m -110.02 110.34 21.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 110.448 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.69 HD22 ' CG2' ' A' ' 32' ' ' VAL . 2.1 tp -39.42 -45.62 1.53 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 110.521 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 3.7 t80 -54.83 -46.17 74.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -62.65 -72.12 0.14 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 118' ' ' ALA . 17.4 m -45.21 -49.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.528 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -54.08 -46.31 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.04 -1.038 . . . . 0.0 109.888 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -50.72 -58.82 4.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.721 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 37.6 t60 -42.68 -57.52 2.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.502 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.4 -16.4 62.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.954 -1.091 . . . . 0.0 109.546 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.701 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -81.98 -3.46 54.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 108.24 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.13 -41.38 1.41 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 31.4 m-70 -64.09 -32.01 73.42 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.38 -26.7 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 109.36 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 6.84 46.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 109.747 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.67 -8.65 78.7 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.609 HD21 ' HA3' ' A' ' 157' ' ' GLY . 5.7 mt -44.73 151.36 0.29 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 110.438 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -111.6 176.05 5.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -80.46 169.95 17.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.152 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -115.07 -22.97 9.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 131' ' ' SER . 9.3 mm100 82.99 -21.72 0.27 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.691 -0.631 . . . . 0.0 110.707 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -74.66 152.41 87.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.877 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.26 -39.54 3.82 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.5 2.134 . . . . 0.0 110.356 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.33 2.14 62.95 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.99 149.09 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -1.214 . . . . 0.0 110.18 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 137' ' ' LEU . 18.1 tp -80.38 -23.25 40.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.188 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' CE1' ' A' ' 120' ' ' HIS . 1.1 mpt? -109.87 26.22 10.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -58.73 164.85 3.68 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.178 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 34.4 Cg_endo -78.69 17.18 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.465 2.11 . . . . 0.0 111.195 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 142' ' ' TYR . 15.5 mt -140.66 162.11 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.787 -1.196 . . . . 0.0 110.07 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 16.7 t80 -91.68 118.84 31.02 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -108.8 -48.81 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 58.7 t80 60.93 165.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.067 -1.021 . . . . 0.0 109.999 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.584 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 152.6 30.12 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.659 -0.651 . . . . 0.0 109.271 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 6.8 tptm -92.03 -11.62 35.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 148' ' ' PHE . 12.2 m-80 -126.53 -91.98 0.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 150' ' ' LEU . 6.2 t80 156.93 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.13 -0.981 . . . . 0.0 109.724 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -150.95 -40.53 0.12 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.288 -0.883 . . . . 0.0 110.364 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 148' ' ' PHE . 9.6 tp 65.6 144.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.018 -1.051 . . . . 0.0 109.495 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -114.84 131.56 56.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 12.3 tt0 -48.95 -22.66 0.9 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -48.6 78.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.888 -1.132 . . . . 0.0 108.088 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -73.58 -33.77 64.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 155' ' ' ILE . 0.5 OUTLIER -70.17 -27.53 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.365 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -76.56 -46.62 25.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 110.455 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.609 ' HA3' HD21 ' A' ' 128' ' ' LEU . . . -71.64 -23.12 78.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 159' ' ' GLN . 6.5 tp -81.0 -39.74 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.838 -1.389 . . . . 0.0 108.449 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -68.61 -22.45 64.44 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -86.13 -25.06 25.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.465 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -80.02 -22.23 42.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.497 ' CG ' HD11 ' A' ' 49' ' ' LEU . 30.3 m-85 -120.3 -69.05 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 108.999 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 9.1 mtpt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER 174.86 45.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.929 -1.107 . . . . 0.0 110.354 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.485 ' HB3' ' CE1' ' A' ' 162' ' ' TYR . 12.9 p-10 -144.57 84.52 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.467 -1.395 . . . . 0.0 111.329 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -115.95 49.11 1.14 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.034 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 9.8 m-20 65.34 -69.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' LYS . 4.2 mt-30 -80.67 110.35 16.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.995 -1.066 . . . . 0.0 109.103 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.1 mm -104.18 164.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -128.2 137.55 52.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' ILE . 13.2 p90 -149.15 154.3 38.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.043 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.88 ' HB2' HG23 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -147.53 125.43 11.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.847 . . . . 0.0 109.865 -178.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.4 mt -86.02 124.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 64' ' ' ASN . 2.8 mt -74.18 3.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.89 -1.131 . . . . 0.0 110.43 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 145.42 112.56 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -61.63 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.113 -1.228 . . . . 0.0 107.788 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 27' ' ' LEU . 1.8 t -106.84 137.38 19.48 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.858 -1.151 . . . . 0.0 108.121 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.59 -24.74 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.206 1.938 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.26 -24.83 3.14 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.763 -0.586 . . . . 0.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -138.47 177.0 8.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.878 -1.139 . . . . 0.0 111.002 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 32' ' ' VAL . 74.8 m-20 -53.87 129.51 56.45 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.649 -0.657 . . . . 0.0 110.436 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.764 ' HA ' HG23 ' A' ' 32' ' ' VAL . 27.0 Cg_endo -73.79 -33.65 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 N-CA-C 105.394 -2.579 . . . . 0.0 105.394 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.72 -36.24 82.36 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.7 m -66.27 -71.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -41.32 -28.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 0.0 108.981 178.024 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -72.47 -38.37 68.23 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' THR . 24.2 t0 -79.89 -58.57 3.11 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . . . -36.77 -39.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.642 0.734 . . . . 0.0 109.034 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 63' ' ' ILE . 3.6 m-85 -68.26 -65.78 0.65 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -44.52 -51.02 9.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.773 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -59.26 -52.5 65.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -43.91 -52.57 6.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -46.38 -40.91 12.79 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.505 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -71.56 -20.33 62.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.546 -0.721 . . . . 0.0 110.591 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -86.47 -32.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.259 -1.526 . . . . 0.0 109.196 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.6 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 3.7 m95 -91.13 -19.01 23.56 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.626 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 28.9 t -91.37 -23.04 20.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 8.4 m-20 -65.34 -5.55 7.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.245 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' HB ' ' A' ' 155' ' ' ILE . 12.2 p -120.49 4.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.535 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 7.9 t -159.08 149.05 15.16 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.598 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -79.11 49.59 3.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.337 2.025 . . . . 0.0 109.856 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' A' ' 162' ' ' TYR . 4.8 tp -93.67 150.56 20.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.3 -0.875 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -122.95 136.79 54.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 109.073 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 51' ' ' PHE . 6.7 m-85 -112.56 149.72 32.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.929 -1.107 . . . . 0.0 110.183 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -125.11 126.68 45.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.208 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 53' ' ' ARG . 6.0 mtm-85 -77.97 126.73 31.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 108.481 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.88 HG23 ' HB2' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.64 141.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.223 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.405 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -72.44 -145.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.53 -174.13 4.1 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 108.636 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.63 42.64 4.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.43 160.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -1.041 . . . . 0.0 109.203 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.502 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -153.46 148.94 27.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -53.55 -59.97 3.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 108.802 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -104.57 124.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 74.9 mtp -111.96 113.88 26.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 110.987 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 64' ' ' ASN . 1.6 mp -102.71 159.7 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.648 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.8 p-10 174.99 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.445 -0.784 . . . . 0.0 109.397 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -115.41 175.67 5.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.175 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.63 90.88 0.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -71.87 -145.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 108.059 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 67' ' ' ARG . 5.4 m95 -63.22 -147.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.485 -1.385 . . . . 0.0 108.648 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 47.79 -143.54 0.4 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.03 -1.044 . . . . 0.0 109.927 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 0.1 OUTLIER 68.02 156.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -130.72 23.94 4.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.3 74.95 0.09 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.462 -1.022 . . . . 0.0 108.99 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 63.48 -87.51 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 3.1 m-85 -108.71 117.98 52.87 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.294 -1.121 . . . . 0.0 108.713 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.52 158.38 40.19 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.68 1.586 . . . . 0.0 109.916 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 17.8 t80 62.64 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 80.95 -46.17 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.15 -157.56 23.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -57.31 165.5 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -1.163 . . . . 0.0 108.826 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 3.3 m-20 43.69 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.229 -0.919 . . . . 0.0 111.135 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 61.17 -142.32 48.4 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' HB3' ' OD2' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -40.08 106.83 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.655 -0.909 . . . . 0.0 109.347 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 mt -111.21 -26.92 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 165.05 152.93 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.385 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -152.24 177.05 10.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.411 -0.806 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.22 155.92 46.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 108.775 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 156.22 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 110.078 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -72.27 162.47 73.58 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 30.2 Cg_endo -73.75 136.76 23.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.807 2.338 . . . . 0.0 111.112 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.66 -165.82 28.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -86.48 117.96 25.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -1.086 . . . . 0.0 110.339 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.64 -89.81 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 93' ' ' VAL . 32.6 m -71.32 119.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.082 -1.246 . . . . 0.0 109.065 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.39 158.65 8.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.75 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 67.27 6.9 42.42 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' MET . 2.7 m-20 -97.98 140.83 31.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -1.194 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.8 131.15 25.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.02 . . . . 0.0 109.769 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 1.9 m170 -106.32 135.5 47.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.029 -1.044 . . . . 0.0 109.309 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 58.9 m-85 -96.52 158.83 15.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.457 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -55.43 129.42 38.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.698 -0.627 . . . . 0.0 109.683 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.14 -70.27 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 22.3 p-10 -60.7 86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 110.592 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -179.48 179.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.32 100.77 7.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.906 -1.121 . . . . 0.0 109.385 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.761 ' O ' HD23 ' A' ' 27' ' ' LEU . 24.4 m0 -112.45 173.91 6.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.246 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 105' ' ' TRP . 0.5 OUTLIER 179.62 162.65 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.969 -1.082 . . . . 0.0 110.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.565 ' HB3' HG23 ' A' ' 31' ' ' THR . 45.7 t30 -104.84 21.74 16.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 109.869 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -124.01 -179.7 4.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.512 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 108' ' ' THR . 8.1 t -66.69 69.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.377 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 106' ' ' THR . . . -160.41 115.96 2.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.424 -0.798 . . . . 0.0 109.104 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.96 -150.3 0.26 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.443 -0.786 . . . . 0.0 108.984 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HD2' ' CD1' ' A' ' 105' ' ' TRP . 42.3 m-85 -67.88 -147.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.094 . . . . 0.0 108.4 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 106' ' ' THR . 22.4 t -148.71 98.64 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.061 -1.024 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -35.69 -57.97 0.63 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.384 -0.822 . . . . 0.0 111.286 -179.301 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -49.66 -40.57 40.25 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.168 -0.958 . . . . 0.0 109.792 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.566 HD13 ' C ' ' A' ' 116' ' ' LEU . 3.0 tm? -70.36 -55.14 9.83 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 110.521 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 118' ' ' ALA . 35.7 m -58.36 -48.63 84.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 O-C-N 120.437 -1.414 . . . . 0.0 108.057 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -46.56 -52.37 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.94 -1.1 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.03 -54.53 6.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 108.605 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.475 ' CE1' ' HA ' ' A' ' 138' ' ' MET . 43.8 t60 -46.48 -64.63 0.71 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.102 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 66.3 mm-40 -63.23 -15.34 56.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.772 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.6 m-85 -82.12 -10.61 59.13 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.6 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -99.31 -48.38 1.71 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.503 ' CD2' ' HE1' ' A' ' 138' ' ' MET . 12.8 m-70 -55.93 -40.54 73.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -1.07 . . . . 0.0 108.856 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.31 -4.66 18.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.465 -0.772 . . . . 0.0 109.554 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.482 ' HG2' ' OH ' ' A' ' 162' ' ' TYR . 26.7 mtt -103.04 -14.84 16.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 0.0 110.902 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.22 -11.67 12.91 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.677 -1.264 . . . . 0.0 110.678 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.512 HD12 ' CH2' ' A' ' 43' ' ' TRP . 30.9 mt -81.07 138.53 35.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.897 -1.355 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.39 178.27 4.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.506 ' HA ' ' CB ' ' A' ' 138' ' ' MET . 2.5 m-70 -55.53 148.28 16.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 0.0 110.247 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.4 p -112.39 -173.14 2.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -108.03 -14.46 14.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.004 -1.06 . . . . 0.0 109.715 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -70.04 134.72 87.46 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 133' ' ' ASP . 33.2 Cg_endo -79.51 109.84 2.55 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 123.056 2.504 . . . . 0.0 110.115 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.78 -2.77 17.48 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.11 170.7 1.53 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.353 -1.086 . . . . 0.0 109.406 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.7 ' O ' HD12 ' A' ' 137' ' ' LEU . 8.3 tp -84.68 -25.86 28.15 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.782 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.506 ' CB ' ' HA ' ' A' ' 130' ' ' HIS . 2.9 mmt -97.79 4.23 49.84 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.989 -1.069 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -41.69 156.75 0.22 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.13 2.37 7.71 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.426 2.084 . . . . 0.0 111.574 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.46 160.94 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.915 -1.116 . . . . 0.0 108.196 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.557 ' O ' ' CB ' ' A' ' 143' ' ' THR . 75.0 t80 -56.52 -82.28 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.563 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.557 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 3.2 m 81.59 -33.56 0.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.039 -1.038 . . . . 0.0 111.792 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CB ' ' O ' ' A' ' 143' ' ' THR . 3.0 t80 71.59 175.23 0.29 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.686 -1.259 . . . . 0.0 109.426 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.619 ' OG1' ' N ' ' A' ' 148' ' ' PHE . 4.6 p -85.34 4.28 35.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 109.119 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.602 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 46.99 47.73 15.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.232 -0.917 . . . . 0.0 110.435 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.4 t30 89.16 21.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.619 ' N ' ' OG1' ' A' ' 145' ' ' THR . 48.7 t80 52.34 164.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 109.938 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.567 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 165.2 -22.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.61 -178.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.535 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 69.01 123.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 108.881 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.62 134.99 49.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.032 -1.042 . . . . 0.0 110.668 -178.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 0.8 OUTLIER -50.61 -19.99 1.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.38 -56.06 26.78 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.688 -1.257 . . . . 0.0 108.055 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.638 ' OD2' HD23 ' A' ' 137' ' ' LEU . 4.2 t0 -68.46 -32.13 71.91 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.68 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.29 -37.39 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.603 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 155' ' ' ILE . 8.4 tmtt? -61.73 -49.32 76.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.304 -0.873 . . . . 0.0 109.39 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -68.25 -39.83 87.84 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 155' ' ' ILE . 2.7 tp -66.17 -17.65 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.841 -1.388 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 163' ' ' GLY . 66.0 mt-30 -87.82 -49.02 7.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.092 . . . . 0.0 109.282 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -13.63 62.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 0.0 109.278 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -101.76 -42.3 6.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.839 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' A' ' 49' ' ' LEU . 21.8 m-30 -107.17 -13.21 15.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.794 -1.191 . . . . 0.0 110.312 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' A' ' 89' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' LYS . 14.6 m95 -37.5 110.64 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.56 -0.712 . . . . 0.0 110.338 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.7 p-10 -128.81 54.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -108.84 -167.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.287 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -108.57 -41.7 4.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.023 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 19.3 mt-30 -92.92 116.77 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.071 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -111.45 161.07 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.039 -1.038 . . . . 0.0 109.595 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.3 p -131.69 126.07 33.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.397 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 34.1 p90 -137.05 148.53 46.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.768 ' HG2' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.33 140.85 29.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.075 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.2 mp -92.89 161.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -108.38 -39.72 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . -161.58 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.222 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.966 ' CE1' HD13 ' A' ' 20' ' ' ILE . 15.5 m-85 -45.74 172.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -1.183 . . . . 0.0 108.962 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.587 ' CG2' HD11 ' A' ' 27' ' ' LEU . 9.9 t -97.98 145.41 29.74 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 34.2 Cg_endo -78.29 -28.69 4.47 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.313 2.009 . . . . 0.0 111.22 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.496 ' OD2' HG22 ' A' ' 106' ' ' THR . 3.9 t70 -41.56 -28.49 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.868 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -133.33 179.68 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.037 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.722 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -73.6 152.27 89.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.245 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 32' ' ' VAL . 26.5 Cg_endo -67.08 -32.61 34.02 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.872 2.381 . . . . 0.0 105.971 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.48 -31.95 71.6 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 107' ' ' ASN . 1.4 m -72.84 -69.39 0.42 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.97 -31.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.452 -0.78 . . . . 0.0 109.052 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 4.6 t0 -79.84 -33.05 40.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 31' ' ' THR . 21.7 t70 -78.93 -44.88 21.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 108.589 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 114' ' ' LEU . . . -44.62 -48.9 10.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 17.1 m-30 -71.44 -44.99 63.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.405 -0.81 . . . . 0.0 108.934 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -51.37 -54.17 29.09 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -53.32 -42.47 66.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.796 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -56.54 -49.67 74.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' A' ' 44' ' ' SER . 10.1 t80 -47.22 -33.76 5.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -86.81 -24.05 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.712 -0.617 . . . . 0.0 109.72 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -59.59 -35.34 58.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.258 -0.902 . . . . 0.0 108.851 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.796 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -105.96 -49.66 3.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.454 -0.779 . . . . 0.0 110.104 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 48.2 t -53.83 -21.7 8.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.178 -0.951 . . . . 0.0 110.639 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 6.2 m-20 -67.12 -13.89 62.38 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.878 HG23 HG23 ' A' ' 47' ' ' THR . 32.8 m -122.01 -20.83 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 0.0 110.434 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.878 HG23 HG23 ' A' ' 46' ' ' VAL . 54.0 p -122.58 143.8 40.77 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 109.405 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.05 57.99 4.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.097 1.864 . . . . 0.0 108.945 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 162' ' ' TYR . 3.0 mm? -84.64 144.84 28.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.904 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.462 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 9.3 tpm_? -116.6 66.64 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 108.778 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 47.2 m-85 -59.5 148.68 32.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 108.92 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.4 t -139.32 106.65 5.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.522 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 2.3 ptt85 -76.6 126.57 31.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 108.752 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.88 HD11 ' HA ' ' A' ' 59' ' ' ALA . 6.3 pt -117.95 166.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.937 -1.102 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 55' ' ' HIS . 9.7 p80 -154.01 70.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.071 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.44 6.01 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.725 -1.235 . . . . 0.0 109.824 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 58' ' ' GLU . . . 106.76 32.72 3.5 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 172.18 158.35 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.178 -1.189 . . . . 0.0 109.701 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.88 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . 178.95 143.04 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.764 . . . . 0.0 109.034 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.56 -57.38 9.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.077 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 95' ' ' GLY . 9.8 mt -90.51 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.169 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.605 ' C ' HD12 ' A' ' 63' ' ' ILE . 2.7 mtt -147.35 118.2 7.62 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.813 . . . . 0.0 109.776 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.813 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.0 mp -105.82 148.95 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 5.8 t30 176.44 -156.25 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.225 -0.922 . . . . 0.0 109.274 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -127.43 171.21 11.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.905 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.52 86.52 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.016 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 68' ' ' TRP . 1.4 ptt85 -78.26 -160.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.099 -1.236 . . . . 0.0 109.686 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.541 ' CE3' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -42.95 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.256 -0.903 . . . . 0.0 110.562 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -36.74 95.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.58 -0.7 . . . . 0.0 110.374 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' TRP . 2.2 t-80 -168.57 -61.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 76.77 -2.66 58.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 74' ' ' TYR . 4.1 p-10 -56.1 83.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.155 -1.203 . . . . 0.0 110.13 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 61.18 -75.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 72' ' ' ASP . 24.3 m-85 -100.69 137.11 19.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.274 . . . . 0.0 110.146 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.15 -157.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.576 2.184 . . . . 0.0 109.221 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -80.63 140.66 35.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.134 . . . . 0.0 109.153 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 40.2 p-10 -116.19 -15.6 11.05 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.05 -154.43 33.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' ASP . 1.1 mttt -47.25 154.6 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -1.171 . . . . 0.0 110.843 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' LYS . 15.6 m-20 49.5 -177.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.621 -0.674 . . . . 0.0 110.18 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 76.39 -144.97 31.24 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 28.6 tp -40.27 116.61 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.493 -1.004 . . . . 0.0 110.022 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD23 ' OE1' ' A' ' 103' ' ' GLU . 57.8 mt -112.02 -28.16 8.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 176.47 147.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 109.771 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -150.16 179.52 8.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -148.13 158.23 43.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.0 108.993 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.46 155.73 18.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.226 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -55.51 155.14 10.75 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.579 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.514 ' CG ' ' HE2' ' A' ' 10' ' ' LYS . 33.5 Cg_endo -75.2 141.41 26.03 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.761 2.307 . . . . 0.0 110.436 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.9 177.48 48.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.96 114.18 15.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.237 . . . . 0.0 109.236 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.78 -85.51 0.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.16 156.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -1.131 . . . . 0.0 108.928 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 109.69 156.22 16.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 74.83 -0.54 57.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -98.83 137.83 36.84 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.872 -1.369 . . . . 0.0 109.118 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -132.26 130.85 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.905 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -111.66 133.79 53.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.312 -0.867 . . . . 0.0 108.828 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 3.7 m-30 -95.95 159.8 14.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.544 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CB ' ' OE1' ' A' ' 103' ' ' GLU . 1.6 t70 -58.83 136.81 57.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 109.359 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.92 -9.2 58.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.229 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.5 -42.19 12.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.786 . . . . 0.0 109.742 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.612 ' OE1' HD23 ' A' ' 83' ' ' LEU . 3.1 mp0 -72.7 140.93 48.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.74 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 104' ' ' LEU . 1.1 mp -105.21 128.18 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.427 -0.795 . . . . 0.0 109.277 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.609 ' CZ2' ' HB2' ' A' ' 99' ' ' PHE . 1.9 m-90 -101.01 166.56 10.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.847 ' HA ' HD23 ' A' ' 27' ' ' LEU . 82.6 p -149.46 -168.3 3.07 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.056 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.579 ' HB3' HG23 ' A' ' 31' ' ' THR . 8.1 p-10 -135.2 6.33 3.32 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.128 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 109' ' ' SER . 11.1 t -139.22 -152.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.237 -0.915 . . . . 0.0 109.98 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.91 108.77 18.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.4 -0.813 . . . . 0.0 108.87 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.8 -97.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.262 -0.899 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -120.79 -78.05 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.069 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -100.92 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.127 -0.983 . . . . 0.0 109.073 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -164.61 114.63 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 32' ' ' VAL . 8.4 tp -50.16 -70.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.5 -0.75 . . . . 0.0 110.318 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' LEU . 8.0 t80 -39.5 -27.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.427 -0.795 . . . . 0.0 110.173 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -78.57 -71.6 0.42 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.836 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 118' ' ' ALA . 14.6 m -52.46 -42.43 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.917 -1.115 . . . . 0.0 109.154 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.88 -45.92 78.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.69 68.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.229 -0.919 . . . . 0.0 108.87 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 137' ' ' LEU . 24.0 t60 -60.52 -54.06 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 110.104 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 124' ' ' HIS . 73.5 mm-40 -69.05 -53.36 20.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.133 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.622 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 13.4 m-85 -49.59 -24.09 1.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.955 -1.091 . . . . 0.0 108.47 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.45 -27.53 24.74 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 2.1 m-70 -76.3 -48.23 20.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.689 -0.889 . . . . 0.0 109.183 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -42.88 -27.49 0.19 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.609 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -71.9 -98.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.782 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.58 29.14 0.19 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.76 144.84 24.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.742 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -119.96 151.78 38.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 138' ' ' MET . 12.2 m-70 -51.29 117.6 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 110.015 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -88.76 -80.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.082 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 131' ' ' SER . 5.6 tt0 177.03 -34.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.625 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -43.0 139.6 2.13 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.105 -0.997 . . . . 0.0 110.138 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.54 -38.86 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.431 2.088 . . . . 0.0 109.812 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.15 17.48 53.36 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 133' ' ' ASP . . . -85.09 149.42 25.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.066 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -75.76 -10.99 59.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.583 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 0.8 OUTLIER -106.42 11.96 30.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -75.92 154.83 84.96 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.913 -1.117 . . . . 0.0 108.955 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.78 9.19 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.755 2.303 . . . . 0.0 111.477 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 141' ' ' ILE . 0.1 OUTLIER -134.63 137.79 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 109.307 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.583 ' OH ' ' CD1' ' A' ' 144' ' ' TYR . 2.9 t80 -84.78 128.72 34.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.424 -0.798 . . . . 0.0 110.186 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' TYR . 96.2 m -122.16 100.26 6.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CD1' ' OH ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -40.21 149.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -0.808 . . . . 0.0 110.26 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 145' ' ' THR . 6.1 t -149.56 102.88 3.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -16.93 32.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.442 -0.786 . . . . 0.0 110.269 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 148' ' ' PHE . 1.1 t30 -95.25 -19.62 19.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.766 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.648 ' CE1' ' CG2' ' A' ' 42' ' ' VAL . 9.4 t80 49.2 104.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.701 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -121.32 -20.69 6.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 109.209 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 149' ' ' ARG . 15.5 tp 66.47 147.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.555 ' CB ' ' OD1' ' A' ' 153' ' ' ASP . 3.7 m -114.97 138.58 50.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 109.889 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.64 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 19.6 tt0 -49.09 -31.42 7.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 110.533 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.555 ' OD1' ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -46.3 -50.03 16.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.565 -1.334 . . . . 0.0 108.638 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -75.17 -31.33 60.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.474 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.69 -26.05 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 108.991 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -74.85 -53.57 8.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.252 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -59.32 -41.07 96.71 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 47' ' ' THR . 0.6 OUTLIER -75.78 -22.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -1.232 . . . . 0.0 109.751 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.572 ' NE2' HD13 ' A' ' 155' ' ' ILE . 36.6 mt-30 -79.25 -42.21 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 108.931 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.17 -22.86 15.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.805 ' HB3' HD21 ' A' ' 49' ' ' LEU . 17.6 m-85 -130.61 -24.99 2.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.589 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HE3' HD13 ' A' ' 161' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.551 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 172.05 42.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 16.1 p-10 -130.35 99.76 5.13 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLN . 2.4 mtmt -120.92 34.52 5.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.43 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.9 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.097 -1.002 . . . . 0.0 108.586 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.598 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt-30 -86.94 104.93 16.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.277 -0.89 . . . . 0.0 108.672 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 mt -112.84 153.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -115.19 148.41 39.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' A' ' 61' ' ' ILE . 15.9 p90 -151.94 155.24 37.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.932 . . . . 0.0 109.797 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -148.84 133.48 17.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.746 -179.495 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 22' ' ' GLY . 4.3 mt -96.17 124.85 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.917 -1.114 . . . . 0.0 108.834 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 62' ' ' MET . 2.8 mp -76.74 -1.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 0.0 109.474 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.764 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 157.71 100.81 0.17 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.438 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.746 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.88 -163.52 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -94.58 148.35 34.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.94 -1.1 . . . . 0.0 108.94 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' LEU . 35.1 Cg_endo -83.59 -29.11 1.16 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.559 2.839 . . . . 0.0 110.603 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -41.96 -26.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.57 -0.706 . . . . 0.0 109.528 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -129.4 166.03 20.36 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.266 -0.896 . . . . 0.0 109.613 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -58.63 147.95 68.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.492 -0.755 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 32' ' ' VAL . 28.9 Cg_endo -67.64 -34.85 24.04 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 106.131 -2.296 . . . . 0.0 106.131 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.58 -28.33 60.88 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 2.9 m -72.88 -63.42 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.746 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -45.92 -39.54 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.557 -0.714 . . . . 0.0 109.354 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 19.5 t0 -67.56 -29.84 69.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.1 t70 -61.39 -50.52 72.55 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.84 -39.38 5.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 109.317 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 85.5 m-85 -73.11 -36.2 66.7 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.687 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -56.0 -57.59 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 108.516 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' ALA . 2.7 mtm180 -61.34 -51.61 68.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.768 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -45.23 -48.99 12.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 28.6 t80 -49.99 -44.74 51.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 108.879 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 8.1 tt0 -79.87 -19.13 49.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 109.912 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -62.58 -36.08 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.028 -1.045 . . . . 0.0 108.502 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.768 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -108.42 -46.67 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.725 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -51.33 -20.3 1.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.053 . . . . 0.0 110.042 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.2 m-20 -64.92 -10.31 27.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 110.473 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 43' ' ' TRP . 2.6 m -111.15 -18.88 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.991 -1.068 . . . . 0.0 109.861 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.555 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -131.67 155.03 81.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 108.846 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 31.8 Cg_endo -77.84 49.15 2.85 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.748 2.298 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.581 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -76.38 162.5 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.932 0.873 . . . . 0.0 111.182 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 1.1 tpt180 -138.4 116.73 11.92 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HE1' HD22 ' A' ' 49' ' ' LEU . 3.3 m-85 -99.9 136.66 39.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.749 -1.219 . . . . 0.0 109.399 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -123.05 100.84 7.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.1 tmt_? -80.39 135.79 36.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.882 -1.136 . . . . 0.0 109.451 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.691 ' N ' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -111.12 163.47 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.506 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -119.75 -29.33 5.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -0.962 . . . . 0.0 108.961 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.65 98.65 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.41 -173.31 32.92 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.68 161.96 25.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.271 . . . . 0.0 110.394 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . . . -143.71 153.11 42.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 108.978 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -77.12 -49.35 15.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.931 -1.106 . . . . 0.0 109.313 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.99 131.28 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 21' ' ' ILE . 4.3 ttm -116.35 115.81 26.58 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.149 -0.969 . . . . 0.0 109.2 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 9.3 mt -108.5 148.38 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.085 -1.01 . . . . 0.0 109.689 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 29.3 t30 177.93 159.79 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' A' ' 67' ' ' ARG . 35.7 p90 -83.32 175.16 10.09 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 108.665 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 68' ' ' TRP . . . -113.39 -27.17 3.71 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.614 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 62.7 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -1.228 . . . . 0.0 109.813 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TRP . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 36.1 t-105 -165.35 -56.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.843 -1.16 . . . . 0.0 109.331 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.55 74.16 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.645 -0.66 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -106.86 -66.39 1.02 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 84.96 -10.39 63.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 3.2 m-20 -62.65 73.4 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.509 -0.995 . . . . 0.0 108.893 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 59.84 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -86.28 138.25 34.42 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.122 -1.223 . . . . 0.0 109.644 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.66 -175.06 2.54 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.405 2.07 . . . . 0.0 110.29 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -76.35 150.87 36.8 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.12 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD2' ' HA3' ' A' ' 81' ' ' GLY . 20.3 p-10 -115.07 -14.18 11.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 72.33 -92.12 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 80' ' ' ASP . 5.0 mttt -45.75 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.56 -0.964 . . . . 0.0 109.379 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -25.69 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.436 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 33.26 -139.24 0.1 Allowed Glycine 0 N--CA 1.502 3.093 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 81' ' ' GLY . 33.8 tp -37.18 118.67 0.63 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.885 . . . . 0.0 110.098 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' CE2' ' A' ' 112' ' ' TYR . 6.9 mt -105.2 -26.44 12.05 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . 170.5 175.94 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 109.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 55.5 p-80 -177.62 149.08 0.6 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.898 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB2' ' OG ' ' A' ' 97' ' ' SER . . . -132.35 175.62 9.12 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.63 156.87 26.29 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.09 -178.98 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 38.1 Cg_endo -80.57 144.36 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 11' ' ' TRP . . . -174.16 -172.2 39.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.659 HG22 ' N ' ' A' ' 92' ' ' GLY . 21.3 m -67.13 -96.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -1.04 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.659 ' N ' HG22 ' A' ' 91' ' ' THR . . . -70.09 -81.21 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 94' ' ' GLY . 31.6 t -61.9 172.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -1.143 . . . . 0.0 108.888 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 93' ' ' VAL . . . 96.92 150.94 27.46 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 62.07 9.67 22.95 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.343 -1.093 . . . . 0.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.53 ' CG ' ' CB ' ' A' ' 62' ' ' MET . 32.5 m-20 -102.37 134.52 45.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.082 -1.834 . . . . 0.0 109.248 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.821 ' OG ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 m -112.36 120.66 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.948 . . . . 0.0 110.523 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 25.8 m-70 -95.23 129.11 42.47 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.778 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 8.3 m-30 -108.89 147.38 32.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.0 110.088 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 76' ' ' PHE . 9.3 t70 -76.88 112.16 13.18 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 103' ' ' GLU . 46.9 t0 -55.48 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.217 -0.927 . . . . 0.0 111.204 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' ASP . 1.9 m-20 -40.03 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 110.439 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 175.09 156.9 0.17 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.0 124.83 50.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.975 -1.078 . . . . 0.0 111.68 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TRP . . . . . 0.778 ' NE1' HG11 ' A' ' 117' ' ' VAL . 6.8 m0 -122.35 172.3 8.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 6.4 p -145.19 141.3 28.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.602 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 4.9 t-20 -103.26 27.99 6.76 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' SER . 8.8 t -142.05 25.89 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.468 -1.395 . . . . 0.0 110.626 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER 70.68 89.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.815 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.541 ' O ' ' CG2' ' A' ' 106' ' ' THR . . . 174.87 137.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.471 -0.768 . . . . 0.0 109.156 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.59 -149.04 0.27 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.859 -1.151 . . . . 0.0 108.651 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.619 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -65.17 -34.71 79.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.81 -1.181 . . . . 0.0 108.097 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER 75.38 124.73 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 110.393 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -66.55 -35.02 79.2 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.158 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -68.69 -43.29 76.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -178.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.89 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -64.58 -62.46 1.57 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.771 -1.205 . . . . 0.0 109.562 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.778 HG11 ' NE1' ' A' ' 105' ' ' TRP . 18.1 m -44.12 -46.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.209 -0.932 . . . . 0.0 109.61 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -62.49 -47.85 82.17 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.955 -1.091 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -48.36 -63.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.583 -0.698 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -46.62 -54.18 10.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.206 -0.934 . . . . 0.0 109.521 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.34 -18.81 65.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.963 -1.086 . . . . 0.0 108.254 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -81.89 -8.22 59.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -97.03 -37.89 4.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 -74.19 -47.41 35.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.33 -27.09 0.95 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.173 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 10.8 mtt -79.29 7.99 6.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.271 -0.893 . . . . 0.0 109.822 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 -23.75 27.22 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 128' ' ' LEU . 3.0 mm? -53.54 141.57 25.04 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.337 -1.096 . . . . 0.0 108.986 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.04 -176.43 2.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 109.528 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -63.75 132.59 51.45 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -90.25 -115.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -159.41 -48.64 0.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.696 -1.253 . . . . 0.0 109.261 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 132' ' ' GLN . 0.9 OUTLIER -42.38 124.83 2.85 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.979 . . . . 0.0 109.718 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -78.37 108.01 2.4 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.093 1.862 . . . . 0.0 109.386 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 124.27 -13.83 7.87 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.33 157.66 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.379 -1.071 . . . . 0.0 110.352 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 137' ' ' LEU . 14.2 tp -63.13 -24.77 68.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.441 ' CE ' ' HG ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -102.7 12.92 35.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -61.57 149.2 84.87 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.702 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 36.6 Cg_endo -77.27 21.11 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.959 2.44 . . . . 0.0 110.917 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 141' ' ' ILE . 1.1 mt -142.46 145.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.888 -1.133 . . . . 0.0 110.396 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -69.34 148.07 50.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 144' ' ' TYR . 5.9 m -161.97 -33.46 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 42.9 t80 59.24 166.06 0.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.4 -0.813 . . . . 0.0 109.057 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.634 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 1.2 t -150.13 115.31 5.41 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.844 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -39.94 42.92 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.092 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 44.6 t-20 -73.25 -48.38 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.076 -1.015 . . . . 0.0 108.511 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 150' ' ' LEU . 39.7 t80 75.45 139.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.39 0.614 . . . . 0.0 109.68 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 1.6 tpt180 -155.65 -25.06 0.11 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.316 -0.865 . . . . 0.0 110.889 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.607 ' HG ' ' CZ ' ' A' ' 148' ' ' PHE . 6.2 mt 65.66 83.36 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -53.87 140.36 30.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.611 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 mt-30 -55.23 -35.3 64.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.355 -0.84 . . . . 0.0 108.994 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -47.01 -33.81 5.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.531 -1.356 . . . . 0.0 108.889 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -89.1 -28.42 20.11 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ILE . . . . . 0.611 ' CG2' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -71.03 -34.48 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 2.2 ttmt -73.29 -56.86 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.463 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -51.0 -37.29 36.06 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.49 -14.9 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -70.34 -57.13 5.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.334 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 13.1 mm-40 -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.759 -0.588 . . . . 0.0 109.474 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.465 HD13 ' HE3' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -73.4 -29.43 62.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -0.779 . . . . 0.0 111.024 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.558 ' CD2' HD11 ' A' ' 49' ' ' LEU . 42.4 m-85 -131.24 -51.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.471 -1.393 . . . . 0.0 109.174 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' ASN . 1.5 mmm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 53.48 -89.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 108.937 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.6 m-20 -148.45 -178.54 6.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.124 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -74.96 150.18 39.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.3 m-85 -127.87 165.55 29.52 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 35.0 Cg_endo -76.03 41.86 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.841 2.36 . . . . 0.0 112.031 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 71.79 -49.23 0.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.837 -1.165 . . . . 0.0 111.236 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -78.13 117.06 63.7 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.743 -1.223 . . . . 0.0 109.964 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 10' ' ' LYS . 32.2 Cg_endo -73.04 80.67 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.152 1.902 . . . . 0.0 108.84 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -30.88 134.05 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.375 0.607 . . . . 0.0 110.704 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.549 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -57.89 134.57 56.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 109.238 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.594 ' OD1' HD13 ' A' ' 161' ' ' LEU . 8.5 t70 -175.87 74.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -164.01 139.94 6.37 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.338 -0.851 . . . . 0.0 109.905 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 4.2 p-10 -53.98 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 5.1 mt-30 47.67 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.959 -1.088 . . . . 0.0 110.305 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.478 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -115.25 149.96 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.7 132.51 56.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.852 -1.155 . . . . 0.0 109.383 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CB ' HG13 ' A' ' 61' ' ' ILE . 44.0 p90 -140.49 151.92 45.2 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.252 -0.905 . . . . 0.0 109.902 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 18.4 tpt180 -150.75 119.71 6.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.759 . . . . 0.0 109.372 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.827 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -70.51 138.82 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.537 HG22 ' O ' ' A' ' 21' ' ' ILE . 27.8 mm -82.89 -5.47 9.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 172.79 105.67 0.19 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.827 ' CE1' HD13 ' A' ' 20' ' ' ILE . 3.8 m-30 -51.91 168.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.334 -1.098 . . . . 0.0 109.306 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.81 ' CG2' HD22 ' A' ' 27' ' ' LEU . 5.3 t -109.89 148.75 38.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.974 . . . . 0.0 109.762 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.3 Cg_endo -82.06 -36.39 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.883 2.389 . . . . 0.0 111.622 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 24' ' ' THR . 0.7 OUTLIER -42.43 -26.59 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.208 -0.933 . . . . 0.0 110.007 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.89 168.35 17.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.017 -1.052 . . . . 0.0 109.272 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CB ' ' OG1' ' A' ' 31' ' ' THR . 0.5 OUTLIER -57.4 147.79 57.29 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 108.787 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 29.6 Cg_endo -70.25 -45.85 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -69.61 -21.12 63.6 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 47.8 m -76.78 -50.06 14.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.138 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.05 ' HB ' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -55.33 -34.4 33.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.39 -39.88 92.31 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.043 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -44.43 27.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.33 -29.34 33.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.172 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.61 -44.09 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.305 -0.872 . . . . 0.0 108.96 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -61.01 -52.78 63.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -51.37 -58.56 5.91 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -45.32 -51.14 11.43 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -46.17 -50.23 15.91 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.327 -0.858 . . . . 0.0 110.003 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.71 -32.82 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.9 -1.125 . . . . 0.0 108.915 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.688 ' O ' HG12 ' A' ' 46' ' ' VAL . 4.7 m95 -100.54 -25.15 14.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -77.82 -18.25 56.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.094 -1.004 . . . . 0.0 108.39 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 43.7 t0 -71.46 -14.27 62.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.081 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 46' ' ' VAL . 3.7 p -102.92 10.7 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.284 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 9.2 t -178.13 148.15 0.63 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 109.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 34.6 Cg_endo -76.01 56.84 4.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.551 2.167 . . . . 0.0 110.393 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.965 HD23 ' CE1' ' A' ' 51' ' ' PHE . 9.2 tp -85.89 147.7 26.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.362 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -113.05 110.88 21.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.965 ' CE1' HD23 ' A' ' 49' ' ' LEU . 39.7 m-85 -97.01 141.78 29.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 109.478 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -132.42 125.09 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.27 140.35 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.534 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.38 -168.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.77 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -176.15 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -163.31 -32.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 110.199 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.54 27.9 17.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.9 OUTLIER 58.04 170.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -1.193 . . . . 0.0 109.161 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 54' ' ' ILE . . . -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.04 -1.038 . . . . 0.0 110.672 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CG ' ' CZ2' ' A' ' 11' ' ' TRP . 79.1 m-20 -58.91 -47.86 83.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -102.15 126.42 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 6.9 mtp -116.48 125.17 51.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 109.567 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' ILE . 2.6 mp -105.09 158.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.715 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.504 ' HB2' ' HB ' ' A' ' 21' ' ' ILE . 33.1 t30 178.85 -138.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.141 -0.974 . . . . 0.0 109.816 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.77 -174.77 2.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.875 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' ARG . . . -106.63 -19.34 9.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 37.8 mtt180 60.75 170.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -1.211 . . . . 0.0 110.46 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 75' ' ' PRO . 41.0 m0 -81.33 -42.81 19.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 0.0 109.15 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 44.9 mt-10 -75.85 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.839 . . . . 0.0 109.077 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 1.5 t-80 78.17 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 72' ' ' ASP . . . 120.68 -22.51 8.18 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 71' ' ' GLY . 7.3 m-20 -37.72 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.591 -0.947 . . . . 0.0 110.017 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.95 31.18 0.08 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -179.67 74.32 0.18 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.447 -1.031 . . . . 0.0 108.405 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 76' ' ' PHE . 32.5 Cg_endo -73.21 134.43 21.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.612 2.208 . . . . 0.0 111.847 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.5 p90 50.53 158.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.332 1.063 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 1.4 p-10 178.56 -29.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 51.74 -156.84 3.42 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 78' ' ' GLY . 3.5 mttp 43.56 -173.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.229 1.014 . . . . 0.0 110.517 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 81' ' ' GLY . 1.5 m-20 -67.15 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 41.06 -139.18 1.55 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -49.86 123.38 7.94 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 108.646 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 16.5 mt -111.74 -22.11 11.32 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.4 -178.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.67 ' HB3' H252 ' A' ' 800' ' ' I52 . 7.6 p-80 179.05 175.86 0.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.979 -1.075 . . . . 0.0 110.253 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.66 166.26 28.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 109.39 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.99 159.51 15.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.676 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -48.55 172.78 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.631 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 32.4 Cg_endo -73.69 137.98 25.76 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.119 1.879 . . . . 0.0 110.874 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' N ' ' HA3' ' A' ' 94' ' ' GLY . . . 175.77 -168.34 40.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.0 p -99.1 134.5 41.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 110.041 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.24 -82.46 0.66 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.481 ' HA ' ' OD2' ' A' ' 96' ' ' ASP . 0.9 OUTLIER -69.54 -41.37 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 110.205 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 90' ' ' GLY . . . -71.3 111.05 3.49 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.808 -1.186 . . . . 0.0 110.191 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 121.44 2.79 10.64 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.739 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 62' ' ' MET . 3.9 m-20 -95.96 140.02 31.32 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.415 -1.638 . . . . 0.0 109.865 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -121.3 142.62 49.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 59.5 m170 -114.76 130.71 56.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.809 . . . . 0.0 109.971 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -103.89 152.03 22.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' OD1' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -60.09 138.98 57.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.952 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -76.29 -78.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 8.5 t70 -66.04 91.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.016 -1.053 . . . . 0.0 110.672 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -159.81 -170.34 2.86 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.4 OUTLIER -138.38 82.69 1.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.705 -1.247 . . . . 0.0 110.867 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.32 130.62 42.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.08 -1.013 . . . . 0.0 109.449 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 110' ' ' ALA . 1.1 p -154.45 154.16 32.73 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.723 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.551 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 7.7 t30 -82.76 4.56 24.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 109' ' ' SER . 1.9 p -91.89 -145.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 108' ' ' THR . 6.3 t -89.9 37.99 0.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 106' ' ' THR . . . -64.14 -97.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 109.831 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -178.31 -46.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.061 -1.024 . . . . 0.0 109.639 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' OH ' ' CG ' ' A' ' 80' ' ' ASP . 94.4 m-85 -85.42 -36.32 20.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 109.176 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.851 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER 62.2 110.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -0.76 . . . . 0.0 110.591 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -50.86 -36.47 37.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 109.677 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.546 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.9 t80 -65.63 -35.9 82.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.674 HD12 ' OH ' ' A' ' 142' ' ' TYR . 2.1 tm? -80.58 -57.1 3.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.625 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.851 HG22 ' O ' ' A' ' 113' ' ' SER . 0.2 OUTLIER -50.42 -40.82 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.864 -1.148 . . . . 0.0 108.94 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -69.23 -49.52 55.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.857 . . . . 0.0 109.622 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -42.45 -59.78 1.74 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -49.18 -56.53 8.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.179 -0.95 . . . . 0.0 108.744 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.448 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 69.3 mm-40 -66.53 -11.99 55.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.53 -15.17 57.35 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CE ' ' A' ' 138' ' ' MET . . . -94.95 -42.04 3.91 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.593 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 5.0 m-70 -63.56 -49.16 74.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.11 . . . . 0.0 109.389 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -41.89 -26.39 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 124' ' ' HIS . 26.2 mmt -78.99 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.928 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . -157.91 -35.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.255 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.049 HD11 ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -46.25 149.72 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 109.579 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -129.29 163.06 26.5 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.593 ' CD2' ' HE2' ' A' ' 124' ' ' HIS . 25.5 m170 -44.28 137.41 3.56 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.064 -1.022 . . . . 0.0 109.228 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -112.89 11.9 19.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.23 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 0.5 OUTLIER 82.48 -24.8 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.21 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -66.49 124.89 89.43 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.67 -1.269 . . . . 0.0 109.737 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 141' ' ' ILE . 31.2 Cg_endo -72.58 -36.55 4.91 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.248 1.965 . . . . 0.0 110.555 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.49 11.07 47.17 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.23 174.69 7.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.999 -1.295 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.647 HD13 ' C36' ' A' ' 800' ' ' I52 . 22.7 tp -88.17 -35.81 17.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.526 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -83.81 7.25 18.52 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -55.39 154.7 11.19 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.839 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.97 21.66 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.906 2.404 . . . . 0.0 112.246 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -134.91 133.72 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.595 -1.316 . . . . 0.0 109.532 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.674 ' OH ' HD12 ' A' ' 116' ' ' LEU . 75.8 t80 -73.21 121.88 21.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 110.122 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -125.05 111.43 15.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.388 -0.82 . . . . 0.0 108.919 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -59.93 160.43 7.81 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.091 -1.006 . . . . 0.0 110.209 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.827 HG21 H392 ' A' ' 800' ' ' I52 . 2.8 p -99.09 83.0 2.81 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.659 -0.651 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -3.47 30.49 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.854 -1.154 . . . . 0.0 108.275 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -160.0 20.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.526 -0.734 . . . . 0.0 109.113 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 3.3 t80 36.24 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.463 -0.773 . . . . 0.0 110.529 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.52 ' O ' H381 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -118.65 132.57 56.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.334 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.457 ' HA ' HD23 ' A' ' 150' ' ' LEU . 50.8 mt -88.65 -163.41 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.384 -0.822 . . . . 0.0 109.838 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.0 p -167.12 131.43 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 109.648 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 155' ' ' ILE . 2.7 pt20 -59.63 -29.57 68.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 152' ' ' GLN . 4.0 m-20 -43.48 -37.62 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 107.956 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 158' ' ' ILE . 3.8 m-20 -85.42 -46.05 11.28 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.698 HD12 ' C ' ' A' ' 155' ' ' ILE . 0.9 OUTLIER -51.95 -33.69 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.681 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -56.77 4.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.83 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 1.049 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -57.04 -39.46 89.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.448 ' HA ' HD12 ' A' ' 158' ' ' ILE . 9.0 tp -78.17 -18.78 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -1.23 . . . . 0.0 109.788 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -72.78 -48.12 40.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.88 . . . . 0.0 108.925 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -74.37 -21.65 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.594 HD13 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -85.25 -15.86 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.784 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.476 ' CD2' HD13 ' A' ' 49' ' ' LEU . 6.0 m-85 -140.11 -93.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.42 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.75 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 1.003 ' H72' H241 ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.49 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.352 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.21 98.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -116.35 176.26 5.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.472 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -83.02 165.84 38.9 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 0.0 108.802 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 32.2 Cg_endo -74.18 -161.09 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.386 2.057 . . . . 0.0 109.919 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 14.9 ttp180 77.44 54.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.573 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 7' ' ' ARG . 6.0 mttp 60.52 144.59 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 36.3 Cg_endo -79.11 55.33 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.096 1.864 . . . . 0.0 108.965 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -62.34 -137.11 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.582 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -163.0 44.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.914 -1.116 . . . . 0.0 108.73 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.04 85.27 6.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -141.63 101.95 4.08 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 13' ' ' LYS . 7.7 m-20 -34.18 -85.71 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.894 -0.504 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -51.88 106.97 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 109.216 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CG2' HD11 ' A' ' 61' ' ' ILE . 3.3 mt -104.29 162.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 0.0 109.526 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.705 ' HB ' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -135.53 135.85 40.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -142.59 162.5 35.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.343 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.74 120.39 9.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.483 -0.76 . . . . 0.0 109.057 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.879 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -83.17 112.95 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.0 109.46 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' HG2' ' A' ' 62' ' ' MET . 7.7 mt -89.51 17.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 166.5 96.21 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CE1' HD13 ' A' ' 20' ' ' ILE . 20.3 m-85 -58.07 -114.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -1.074 . . . . 0.0 108.853 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.996 ' CG2' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -112.58 178.29 1.0 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.502 -1.374 . . . . 0.0 108.102 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 24' ' ' THR . 33.0 Cg_endo -76.57 -34.85 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.745 1.63 . . . . 0.0 112.324 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 24' ' ' THR . 5.6 t70 -158.64 81.73 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.768 -1.208 . . . . 0.0 112.191 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.996 HD22 ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -155.68 -178.98 7.68 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.184 -0.948 . . . . 0.0 108.737 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 1.3 m-20 -72.16 136.45 81.91 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 33' ' ' ASP . 26.8 Cg_endo -69.68 -30.88 21.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 106.444 -2.175 . . . . 0.0 106.444 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.17 -32.84 63.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.499 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 2.9 m -70.6 -62.65 1.31 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 23' ' ' TYR . 1.3 p -49.64 -43.28 18.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 3.0 t70 -64.85 -22.08 66.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.733 . . . . 0.0 109.109 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.3 t0 -78.38 -40.99 34.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.015 . . . . 0.0 110.174 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.595 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -57.52 -44.05 84.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.967 -1.083 . . . . 0.0 109.145 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 63' ' ' ILE . 75.2 m-85 -71.35 -48.57 49.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.27 -0.894 . . . . 0.0 108.637 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.31 -51.12 63.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 1.036 ' O ' HG22 ' A' ' 42' ' ' VAL . 61.3 mtp180 -67.18 -48.85 66.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.438 -0.789 . . . . 0.0 108.899 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . . . -41.98 -43.28 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.551 ' O ' ' CB ' ' A' ' 44' ' ' SER . 58.1 m-85 -68.52 -39.16 81.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ARG . 29.3 tt0 -71.56 -60.54 2.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.132 -0.98 . . . . 0.0 109.026 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 38' ' ' ARG . 1.7 m -46.18 -29.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.589 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 11.6 m95 -101.98 -19.0 15.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 11.2 t -88.7 -23.35 22.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.016 -1.053 . . . . 0.0 108.25 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -59.77 -12.56 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.716 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.7 p -110.62 19.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.003 . . . . 0.0 109.69 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 5.1 t -179.33 149.32 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.002 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 32.4 Cg_endo -76.0 57.82 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 110.486 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.65 HD11 ' CG ' ' A' ' 162' ' ' TYR . 18.8 mt -100.76 121.3 41.45 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.81 112.66 25.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 109.094 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 16' ' ' ILE . 56.3 m-85 -88.52 143.65 26.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.57 138.75 52.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.526 -0.734 . . . . 0.0 109.341 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -89.28 129.66 35.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.077 -1.014 . . . . 0.0 108.862 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.705 HD13 ' HB ' ' A' ' 17' ' ' THR . 2.5 pt -122.12 131.95 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 54' ' ' ILE . 4.4 p80 -60.32 -147.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.306 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -70.05 169.31 13.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.043 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.37 -147.29 18.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -83.03 150.91 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.253 . . . . 0.0 109.595 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.741 ' HB3' ' SD ' ' A' ' 62' ' ' MET . . . -160.91 150.4 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -77.88 -70.19 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 109.268 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -82.13 126.26 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.751 ' HG2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -120.96 115.83 23.94 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 4.6 mp -103.62 145.33 12.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.89 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 63.8 t30 -168.67 172.64 7.84 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 101' ' ' ASP . 31.2 p90 -119.94 160.77 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 109.842 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.71 128.87 1.73 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -96.9 -135.15 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 67' ' ' ARG . 1.6 t90 -49.92 -41.64 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.511 -1.368 . . . . 0.0 107.852 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' HIS . 2.8 tt0 -73.86 55.22 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 76' ' ' PHE . 4.1 t-160 -44.16 -50.63 8.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.175 -0.953 . . . . 0.0 109.27 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 18.11 44.98 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 72' ' ' ASP . 41.2 p-10 -151.47 28.04 0.65 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.349 -1.089 . . . . 0.0 109.892 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . 93.19 154.0 30.76 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.38 -0.914 . . . . 0.0 110.901 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.53 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 58.6 m-85 55.14 164.36 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 110.049 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 74' ' ' TYR . 34.4 Cg_endo -76.45 -159.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.004 1.803 . . . . 0.0 108.555 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.673 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 69.0 t80 177.54 168.86 0.65 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.9 -1.125 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 24.1 t70 50.63 40.61 24.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.705 -0.622 . . . . 0.0 110.345 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . -49.06 173.05 0.05 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.3 -2.32 . . . . 0.0 107.3 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 80' ' ' ASP . 1.1 ptmt -51.46 141.75 15.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.762 -1.434 . . . . 0.0 107.253 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 79' ' ' LYS . 21.2 t70 39.55 -111.21 0.11 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 25.85 -132.54 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 CA-C-O 121.432 0.462 . . . . 0.0 112.226 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.58 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -26.94 123.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.975 0.893 . . . . 0.0 111.914 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 73.5 mt -118.84 -28.6 5.54 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 172.51 146.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.511 -0.743 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.733 ' CB ' H241 ' A' ' 800' ' ' I52 . 24.4 p-80 -144.92 149.25 34.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.339 -0.851 . . . . 0.0 109.262 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 97' ' ' SER . . . -123.61 159.44 29.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.892 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.41 151.8 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.075 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.17 168.96 0.78 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 109.624 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.3 Cg_endo -78.6 152.23 25.89 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.773 2.315 . . . . 0.0 110.569 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 91' ' ' THR . . . 179.58 -103.1 0.17 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -162.59 78.51 0.48 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -1.093 . . . . 0.0 109.357 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.06 -103.1 0.29 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.87 -2.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -1.168 . . . . 0.0 109.32 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -75.6 143.2 29.99 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.843 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 76.34 -4.4 49.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 1.6 m-20 -101.03 134.8 43.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.942 -1.328 . . . . 0.0 108.68 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 16.4 t -130.86 127.64 38.98 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.576 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 46.0 m80 -89.78 145.27 25.31 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.422 -0.799 . . . . 0.0 109.109 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -116.58 160.29 20.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.001 -1.062 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 83' ' ' LEU . 3.5 m-20 -52.85 121.36 7.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 109.854 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 18.6 t0 -44.58 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' GLU . 35.3 m-20 -77.22 -128.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 83.92 -29.86 0.08 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 103' ' ' GLU . 16.0 tp 68.81 74.56 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.185 -0.947 . . . . 0.0 111.137 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.603 ' O ' ' HB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -94.0 163.19 13.59 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.96 HG23 ' N ' ' A' ' 108' ' ' THR . 9.7 t 171.48 -173.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.096 -1.002 . . . . 0.0 110.308 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.586 ' O ' ' OG1' ' A' ' 108' ' ' THR . 6.8 p-10 -50.19 -31.17 13.1 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.96 ' N ' HG23 ' A' ' 106' ' ' THR . 1.8 p 73.31 -110.89 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER 61.24 23.14 13.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 100.99 -3.707 . . . . 0.0 100.99 -168.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.446 ' N ' ' C ' ' A' ' 108' ' ' THR . . . -135.78 -45.26 0.66 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.318 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -158.39 -86.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.775 -0.578 . . . . 0.0 110.277 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.808 ' O ' HG21 ' A' ' 108' ' ' THR . 9.0 m-85 -121.16 126.64 50.21 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.669 ' OG ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.58 129.59 36.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 111.557 -178.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.595 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -57.09 -24.23 52.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.653 -0.654 . . . . 0.0 110.479 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 42' ' ' VAL . 1.7 t80 -73.64 -54.75 7.42 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.498 -1.376 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.8 HD21 ' CE1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -63.26 -51.0 67.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.926 -1.108 . . . . 0.0 109.144 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 118' ' ' ALA . 21.0 m -54.82 -53.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 109.907 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -66.91 -39.99 87.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.735 -1.228 . . . . 0.0 108.828 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 115' ' ' PHE . . . -47.6 -58.37 4.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.4 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 34.1 t60 -54.49 -42.6 70.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.157 . . . . 0.0 108.53 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 117' ' ' VAL . 54.2 mm-40 -71.73 -10.5 59.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.5 OUTLIER -87.28 -15.67 37.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.589 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -89.51 -45.6 4.59 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.02 -45.97 91.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.475 -1.015 . . . . 0.0 108.417 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.68 -19.11 2.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.315 -0.865 . . . . 0.0 109.162 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.1 mtt -100.97 -5.51 25.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 113.21 -35.57 4.5 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.522 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 127' ' ' GLY . 1.8 mt -37.0 146.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.494 -1.003 . . . . 0.0 110.237 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 138' ' ' MET . 0.3 OUTLIER -113.08 -179.48 3.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 109.713 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.761 ' CE1' H132 ' A' ' 800' ' ' I52 . 62.5 m170 -58.43 151.31 20.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -96.71 -177.73 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 0.0 109.519 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -13.24 6.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -101.05 142.36 24.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.94 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 32.5 Cg_endo -76.84 116.7 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.8 2.333 . . . . 0.0 109.564 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.81 -3.56 24.41 Favored Glycine 0 C--N 1.272 -2.989 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.782 ' O ' H352 ' A' ' 800' ' ' I52 . . . -67.77 -177.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.192 . . . . 0.0 109.772 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.54 ' CD1' H362 ' A' ' 800' ' ' I52 . 8.6 tp -96.06 -28.86 14.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 109.681 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -94.6 3.01 55.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.508 ' O ' ' H34' ' A' ' 800' ' ' I52 . . . -46.19 148.14 1.63 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.274 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.757 ' O ' HD13 ' A' ' 141' ' ' ILE . 36.5 Cg_endo -78.04 12.0 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.565 2.176 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.4 mm -133.64 155.69 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 0.0 110.262 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER -76.0 95.29 3.56 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.46 ' O ' H371 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -100.96 92.93 5.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 108.637 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.8 ' CE1' HD21 ' A' ' 116' ' ' LEU . 7.8 t80 -60.07 155.38 17.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.588 HG21 H393 ' A' ' 800' ' ' I52 . 0.1 OUTLIER -143.49 8.83 1.58 Allowed 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.626 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 144' ' ' TYR . 21.3 mtpt 52.6 -106.75 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.305 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 4.9 p-10 -56.94 -47.22 81.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.716 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.639 ' CD1' H393 ' A' ' 800' ' ' I52 . 5.8 t80 68.01 125.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.808 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -100.77 -70.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.61 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 4.0 tp 169.29 172.15 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -143.45 130.68 20.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.021 -1.049 . . . . 0.0 109.654 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.659 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 46.9 tt0 -54.63 -30.31 54.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' O ' HD21 ' A' ' 128' ' ' LEU . 51.5 m-20 -46.9 -41.61 16.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.577 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.552 ' OD1' ' CZ3' ' A' ' 43' ' ' TRP . 21.5 t0 -83.53 -36.14 24.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.659 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -63.57 -31.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 108.908 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -78.71 -44.72 22.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.55 -20.29 78.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.623 HG22 ' HA ' ' A' ' 155' ' ' ILE . 1.6 tp -93.9 -17.87 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 155' ' ' ILE . 2.9 pt20 -90.94 -31.48 16.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.081 . . . . 0.0 108.446 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 159' ' ' GLN . 2.0 mm-40 -86.94 -29.94 21.69 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.66 ' O ' HD13 ' A' ' 161' ' ' LEU . 0.2 OUTLIER -95.66 -28.11 14.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.65 ' CG ' HD11 ' A' ' 49' ' ' LEU . 2.1 m-85 -122.38 -91.28 0.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.452 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 158' ' ' ILE . . . . . . . . 0 N--CA 1.492 2.383 0 CA-C-O 118.036 -1.425 . . . . 0.0 109.756 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 0.782 H352 ' O ' ' A' ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' TYR . 24.8 mtm . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.18 0.514 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 75.17 123.0 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.981 0.896 . . . . 0.0 108.978 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.83 39.3 3.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' PHE . 9.4 m-85 -107.0 176.19 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.446 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 171.11 -54.46 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.456 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' HD3' ' CB ' ' A' ' 5' ' ' PHE . 39.1 Cg_endo -82.23 108.2 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.314 2.009 . . . . 0.0 111.846 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.01 44.37 1.03 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 148.69 34.84 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.729 -0.607 . . . . 0.0 109.88 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.7 Cg_endo -74.64 58.02 4.5 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.13 1.886 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 40.45 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -95.98 106.76 18.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.808 -1.182 . . . . 0.0 110.022 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.05 81.58 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.093 . . . . 0.0 110.102 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.75 153.1 48.54 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.261 -0.9 . . . . 0.0 109.309 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -79.44 -89.21 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.46 111.27 1.33 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.275 -0.891 . . . . 0.0 108.948 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.893 HD12 ' HE1' ' A' ' 51' ' ' PHE . 73.7 mt -119.59 145.67 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.444 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 22.8 p -121.06 140.06 52.46 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.591 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 61' ' ' ILE . 34.0 p90 -139.28 -179.44 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.9 ptm180 -159.34 140.45 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.792 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.7 mt -95.27 145.18 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 64' ' ' ASN . 28.0 mt -90.19 -5.53 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.792 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 147.54 109.79 0.57 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -66.29 -163.3 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.047 -1.267 . . . . 0.0 108.812 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.639 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -108.49 146.8 34.4 Favored Pre-proline 0 C--N 1.293 -1.853 0 O-C-N 121.51 -0.744 . . . . 0.0 109.257 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 26' ' ' ASP . 29.9 Cg_endo -73.13 -26.15 15.21 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.441 2.094 . . . . 0.0 110.42 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 24' ' ' THR . 10.0 p-10 -35.23 -35.43 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.414 0.626 . . . . 0.0 109.976 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -133.04 171.66 13.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.988 -1.07 . . . . 0.0 110.245 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 5.5 m-20 -51.63 148.16 10.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.559 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 32' ' ' VAL . 32.3 Cg_endo -69.98 -32.44 17.68 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 N-CA-C 105.688 -2.466 . . . . 0.0 105.688 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -78.33 -31.26 48.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.617 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 21.4 m -73.7 -52.62 12.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.883 -1.136 . . . . 0.0 108.45 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 23' ' ' TYR . 1.8 p -47.74 -41.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 5.3 m-20 -61.43 -39.12 89.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.693 -0.63 . . . . 0.0 109.669 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -61.21 -37.5 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.206 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.93 -28.6 38.06 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.908 . . . . 0.0 109.074 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.19 -24.95 19.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 108.892 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.36 63.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -39.21 73.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -57.32 -40.58 78.22 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -60.61 -45.72 92.94 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -74.95 -15.85 60.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.685 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 ' HZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -84.3 -27.95 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.811 -1.181 . . . . 0.0 109.057 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -104.96 -25.2 12.67 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.709 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' THR . 9.7 t -85.11 -23.27 28.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.396 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.748 ' OD1' HD11 ' A' ' 150' ' ' LEU . 3.4 p30 -60.04 -22.39 62.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.16 -0.962 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.643 HG13 ' OD1' ' A' ' 45' ' ' ASP . 10.8 m -99.07 16.63 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.999 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.563 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t -173.52 152.74 2.16 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.093 -1.004 . . . . 0.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 33.8 Cg_endo -74.91 45.65 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.985 2.457 . . . . 0.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.861 HD23 ' HZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -87.3 144.14 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.231 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 99.03 5.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.309 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.893 ' HE1' HD12 ' A' ' 16' ' ' ILE . 15.9 m-85 -93.38 133.16 36.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.884 -1.135 . . . . 0.0 110.047 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.54 164.98 13.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.795 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 2.3 mtp-105 -111.17 137.62 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 108.808 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 7.2 pt -145.34 134.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.017 -1.052 . . . . 0.0 109.658 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.31 42.53 2.72 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.21 -67.24 0.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.3 -0.875 . . . . 0.0 110.049 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . -99.16 50.25 1.19 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 68.09 162.72 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.299 -1.118 . . . . 0.0 109.932 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . -129.49 173.17 10.82 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -84.9 -57.08 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.12 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -95.87 148.42 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 0.0 109.874 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.524 ' CG ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -123.52 116.9 23.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.502 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' SER . 46.9 mt -115.62 140.51 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 108.908 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.747 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.9 p-10 -154.49 -148.67 0.25 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.686 -1.258 . . . . 0.0 110.36 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -136.59 174.98 10.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.896 -1.127 . . . . 0.0 110.604 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 101' ' ' ASP . . . -122.77 99.27 0.64 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 101' ' ' ASP . 5.4 mtm180 -90.08 -6.96 54.91 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -1.072 . . . . 0.0 110.459 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 177.46 -162.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' PRO . 5.8 pt-20 -83.76 67.27 9.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.741 -1.224 . . . . 0.0 111.033 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -49.74 -172.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.0 109.136 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . -64.58 -9.49 38.32 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.66 ' CB ' ' CE1' ' A' ' 70' ' ' HIS . 11.5 t0 -54.89 -169.99 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.021 -1.282 . . . . 0.0 108.396 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.37 -8.95 26.3 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.344 -1.407 . . . . 0.0 110.095 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CD1' HD11 ' A' ' 82' ' ' LEU . 11.7 m-85 -110.67 118.33 48.87 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.206 -1.173 . . . . 0.0 108.652 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -75.47 -176.43 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.045 1.83 . . . . 0.0 110.31 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 68' ' ' TRP . 38.3 p90 -78.69 140.86 38.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.552 -0.718 . . . . 0.0 109.107 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 9.5 p-10 -115.55 6.66 14.69 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.24 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 62.75 -167.68 19.95 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.265 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -43.16 167.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -1.064 . . . . 0.0 109.874 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' LYS . 71.6 m-20 41.15 -162.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.277 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 -146.94 50.77 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.302 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.485 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -47.77 107.1 0.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.481 -1.011 . . . . 0.0 108.997 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 15.4 mt -91.23 -15.37 29.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.023 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.5 158.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.524 -0.735 . . . . 0.0 109.024 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.531 ' HB3' H252 ' A' ' 800' ' ' I52 . 22.8 p-80 -156.83 146.38 20.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.981 -1.075 . . . . 0.0 109.915 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 97' ' ' SER . . . -128.86 161.55 29.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.357 -0.839 . . . . 0.0 109.714 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.1 166.0 10.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.759 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.41 166.93 38.16 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.515 -0.74 . . . . 0.0 109.084 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.759 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 33.1 Cg_endo -76.87 157.54 34.94 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.51 2.14 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.41 -102.32 0.16 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -150.87 90.95 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.255 . . . . 0.0 110.038 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.83 -73.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.41 -1.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -1.209 . . . . 0.0 110.026 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -76.39 139.91 24.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 73.82 67.78 1.71 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' OD1' ' CG ' ' A' ' 62' ' ' MET . 14.9 m-20 -160.8 117.02 2.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 109.01 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -117.02 157.39 25.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.466 -0.771 . . . . 0.0 109.861 -179.209 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -129.79 146.81 51.52 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m-85 -111.19 144.24 40.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.123 -0.986 . . . . 0.0 110.022 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -44.7 167.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.586 -1.321 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 5.1 t0 -97.43 -25.39 15.21 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -99.42 -144.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 178.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.4 OUTLIER 75.24 136.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.0 109.643 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -94.91 90.63 6.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.327 -0.858 . . . . 0.0 110.55 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.586 ' CB ' HD22 ' A' ' 114' ' ' LEU . 13.0 m0 -96.38 153.53 17.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.624 HG21 ' HB3' ' A' ' 110' ' ' ALA . 55.3 p -138.16 159.61 41.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.617 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 28.7 t-20 -112.73 4.37 17.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 0.0 109.148 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 108' ' ' THR . 9.7 t -139.6 48.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.6 p 45.62 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.89 -1.131 . . . . 0.0 109.874 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 106' ' ' THR . . . -136.13 -42.11 0.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.909 -1.119 . . . . 0.0 109.974 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -137.48 -77.31 0.39 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.5 m-30 -107.98 -102.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER 165.43 98.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.835 -1.166 . . . . 0.0 110.633 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.586 HD22 ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -52.12 -35.24 47.59 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.106 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HZ ' HG21 ' A' ' 42' ' ' VAL . 2.2 t80 -66.33 -43.25 86.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 110.005 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.708 ' CD2' H382 ' A' ' 800' ' ' I52 . 1.2 mt -59.41 -60.96 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.004 -1.06 . . . . 0.0 109.566 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.445 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.7 m -52.66 -38.19 26.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -61.74 -51.03 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -53.15 -49.5 66.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.493 -0.754 . . . . 0.0 109.144 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -46.44 -68.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 65.6 mm-40 -56.97 -21.14 28.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.217 -0.927 . . . . 0.0 108.834 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -74.4 -12.2 60.45 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.89 -47.43 2.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.535 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 0.6 OUTLIER -59.6 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -1.1 . . . . 0.0 109.57 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.48 22.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -0.754 . . . . 0.0 110.286 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 7.7 mtt -103.79 -10.65 18.11 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.692 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA3' HD22 ' A' ' 161' ' ' LEU . . . 128.75 -64.28 0.6 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.013 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 127' ' ' GLY . 15.0 mt -49.35 176.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -169.54 -172.64 1.48 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.719 0.771 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -49.82 114.01 0.97 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.763 0.792 . . . . 0.0 109.99 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 11.2 t -84.86 -77.53 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 131' ' ' SER . 52.3 tt0 161.03 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -57.88 133.1 83.28 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.715 -0.616 . . . . 0.0 109.632 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 29.2 Cg_endo -75.69 113.33 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.555 2.17 . . . . 0.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.53 -13.77 20.61 Favored Glycine 0 C--N 1.272 -2.983 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.74 158.82 12.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.884 -1.362 . . . . 0.0 109.706 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.03 HD13 H381 ' A' ' 800' ' ' I52 . 11.7 tp -70.47 -20.41 62.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.024 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -100.05 2.06 42.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.376 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -70.19 156.69 91.44 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.232 -0.918 . . . . 0.0 110.015 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.457 ' HB3' ' H92' ' A' ' 800' ' ' I52 . 34.3 Cg_endo -77.14 64.65 7.85 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.858 2.372 . . . . 0.0 110.986 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.539 ' O ' ' N27' ' A' ' 800' ' ' I52 . 0.0 OUTLIER -159.53 -157.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.261 -0.9 . . . . 0.0 109.625 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -165.69 119.03 1.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 109.823 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' TYR . 52.8 m -138.26 95.87 3.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 109.259 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.615 ' HA ' HD11 ' A' ' 116' ' ' LEU . 21.8 t80 -45.39 158.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.793 -1.192 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.519 HG21 H393 ' A' ' 800' ' ' I52 . 1.3 t -152.01 123.92 8.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -48.52 122.46 5.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.195 . . . . 0.0 108.578 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.505 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 7.5 m-20 58.96 -95.34 0.05 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.253 -0.905 . . . . 0.0 108.56 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 42' ' ' VAL . 1.2 p90 177.72 142.88 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.088 -1.007 . . . . 0.0 109.657 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -107.82 -10.83 15.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.892 -1.13 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.748 HD11 ' OD1' ' A' ' 45' ' ' ASP . 1.5 mt 66.57 139.34 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.74 122.76 48.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.584 ' HA ' HG23 ' A' ' 155' ' ' ILE . 5.3 tt0 -50.01 -53.11 28.89 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.09 0.471 . . . . 0.0 109.954 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -42.32 -29.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -90.62 -29.29 17.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.024 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 151' ' ' SER . 0.9 OUTLIER -73.49 -30.43 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.434 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -88.25 -43.3 11.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -64.24 -25.62 69.88 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -85.45 -47.47 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.379 . . . . 0.0 109.078 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.522 ' N ' HG23 ' A' ' 158' ' ' ILE . 38.2 mt-30 -52.02 -31.22 28.74 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 109.624 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.02 -28.71 22.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.264 -0.897 . . . . 0.0 109.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.504 HD22 ' HA3' ' A' ' 127' ' ' GLY . 0.1 OUTLIER -89.35 -16.08 31.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CZ ' HD21 ' A' ' 49' ' ' LEU . 1.8 m-85 -126.54 -47.37 1.57 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.812 -1.18 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.503 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 1.03 H381 HD13 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.278 0.561 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 3' ' ' ASN . 46.7 p90 -84.44 -173.1 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.49 -0.756 . . . . 0.0 109.524 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.603 ' HB2' ' CD1' ' A' ' 2' ' ' TYR . 1.5 t30 49.59 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.04 -33.79 16.2 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.02 -1.05 . . . . 0.0 110.259 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.573 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER 178.83 -55.96 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.909 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 5' ' ' PHE . 32.7 Cg_endo -79.45 159.32 25.76 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.087 1.858 . . . . 0.0 110.67 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -71.4 0.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.693 -0.629 . . . . 0.0 109.348 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -99.04 141.87 23.63 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 109.891 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.62 82.24 2.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.913 1.742 . . . . 0.0 108.784 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -51.99 175.6 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.195 -0.941 . . . . 0.0 108.843 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.408 ' CH2' ' HB3' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -66.1 140.37 58.23 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 109.79 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -61.46 165.53 4.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 108.549 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.641 ' HD2' ' CD1' ' A' ' 162' ' ' TYR . 5.6 mmtp -118.75 -175.7 2.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.536 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' HD12 ' A' ' 49' ' ' LEU . 1.9 m120 61.96 141.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.336 -0.852 . . . . 0.0 109.175 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . 2.5 mt-30 45.04 76.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.859 -1.151 . . . . 0.0 109.683 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 49' ' ' LEU . 20.6 mt -110.73 136.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 108.886 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 52' ' ' SER . 0.2 OUTLIER -120.09 136.56 54.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.409 -0.807 . . . . 0.0 111.382 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CD1' HD11 ' A' ' 63' ' ' ILE . 34.3 p90 -149.61 153.07 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.969 . . . . 0.0 110.304 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HD2' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.77 138.9 44.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.523 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -80.24 121.4 33.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 19' ' ' ARG . 33.8 mm -67.33 -2.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.469 -0.769 . . . . 0.0 109.77 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 23' ' ' TYR . . . 144.15 84.44 0.07 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.791 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -51.19 169.42 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 1.2 t -85.31 149.07 51.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.059 -1.651 . . . . 0.0 109.276 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' LEU . 36.2 Cg_endo -79.09 -21.5 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.331 2.021 . . . . 0.0 109.85 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' PRO . 74.4 m-20 -40.64 -25.06 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.133 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 27' ' ' LEU . 1.4 pt? -133.76 173.83 11.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.675 -1.266 . . . . 0.0 110.798 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 3.0 m-20 -48.66 138.3 12.11 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 108.862 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.551 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.3 Cg_endo -69.03 -33.66 18.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 N-CA-C 107.331 -1.834 . . . . 0.0 107.331 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 pt-20 -79.01 -26.88 43.22 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 20.8 m -74.15 -50.83 17.68 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.66 -36.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.993 0.901 . . . . 0.0 108.643 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.87 -24.72 59.78 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.66 -41.66 68.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -53.19 -38.89 63.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' HG21 ' A' ' 63' ' ' ILE . 26.9 m-85 -74.12 -26.75 60.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -52.66 9.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -34.47 72.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -62.9 -46.78 86.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.44 -0.788 . . . . 0.0 109.206 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -53.39 -34.72 58.79 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -83.01 -12.3 57.37 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -73.38 -32.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.828 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -102.82 -51.02 3.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.599 -0.688 . . . . 0.0 109.718 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 10.0 t -53.76 -33.17 54.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 109.157 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 41' ' ' GLN . 1.2 t70 -54.78 -33.3 61.22 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.599 -0.688 . . . . 0.0 109.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 46' ' ' VAL . 12.1 p -106.06 23.42 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.036 -1.04 . . . . 0.0 110.694 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.441 HG22 ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -173.13 153.87 2.54 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.665 -1.272 . . . . 0.0 110.115 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' CD ' ' OXT' ' A' ' 163' ' ' GLY . 37.3 Cg_endo -79.77 12.78 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.89 3.06 . . . . 0.0 110.723 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.2 tt -64.37 148.72 49.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.96 138.93 45.64 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.77 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 49' ' ' LEU . 26.6 m-85 -116.72 135.62 53.63 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.183 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.745 ' HB3' HG23 ' A' ' 17' ' ' THR . 9.4 t -128.59 118.67 23.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.059 -1.025 . . . . 0.0 110.322 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 18' ' ' TYR . 6.0 mtm180 -92.16 131.43 37.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.977 -1.077 . . . . 0.0 108.15 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.699 HD11 ' CB ' ' A' ' 59' ' ' ALA . 15.5 pt -126.6 148.31 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 109.536 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -109.38 -14.58 14.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.996 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -135.44 -167.39 2.0 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.953 -1.092 . . . . 0.0 109.941 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.86 -170.94 2.0 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 54' ' ' ILE . 1.9 tp10 -79.07 158.43 27.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.251 -1.146 . . . . 0.0 110.358 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.699 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -136.44 -160.38 1.05 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.447 -0.783 . . . . 0.0 108.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -134.22 -57.03 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.584 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.618 HG23 ' C ' ' A' ' 95' ' ' GLY . 2.5 mt -98.77 152.05 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.361 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtt -119.21 123.19 43.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.948 -1.095 . . . . 0.0 110.274 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.636 HD11 ' CD1' ' A' ' 18' ' ' TYR . 1.6 mp -117.78 142.21 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.634 -1.291 . . . . 0.0 109.968 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' OD1' ' C ' ' A' ' 63' ' ' ILE . 2.7 p-10 175.3 -174.69 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.439 -0.788 . . . . 0.0 110.189 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -89.96 -167.3 1.81 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.001 -1.062 . . . . 0.0 111.052 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 99' ' ' PHE . . . -149.3 49.66 0.57 Allowed Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -56.05 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -49.95 -57.28 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.981 . . . . 0.0 109.886 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 124.75 24.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.693 -0.63 . . . . 0.0 110.146 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.09 -70.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 133.74 -20.0 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -46.33 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.517 -0.99 . . . . 0.0 111.601 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.77 -2.02 65.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.88 77.59 18.51 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.967 -1.314 . . . . 0.0 110.172 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.27 139.33 18.65 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.51 2.14 . . . . 0.0 109.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.24 159.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.384 -0.822 . . . . 0.0 109.605 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.9 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.495 -0.753 . . . . 0.0 109.112 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.86 -154.92 19.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -69.4 167.28 16.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -1.068 . . . . 0.0 111.128 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.57 ' HA ' HD21 ' A' ' 83' ' ' LEU . 0.4 OUTLIER 41.42 -150.41 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 83' ' ' LEU . . . 54.42 -134.88 45.52 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 100' ' ' ASP . 4.7 tt -50.68 98.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.594 -0.945 . . . . 0.0 109.012 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 80' ' ' ASP . 1.3 mt -110.31 -28.45 8.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 108.934 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 121' ' ' GLU . . . -177.94 155.34 0.97 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 98' ' ' HIS . 4.8 p80 -152.21 174.48 13.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.768 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -144.76 144.11 31.01 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.428 -0.795 . . . . 0.0 109.874 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.6 156.91 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 108.739 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -65.67 173.32 2.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 110.195 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 37.5 Cg_endo -82.51 155.54 16.21 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.201 2.601 . . . . 0.0 110.67 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.52 -128.76 1.18 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.7 60.09 1.7 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.207 -1.173 . . . . 0.0 110.475 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.18 -67.8 0.44 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.543 ' O ' HG12 ' A' ' 93' ' ' VAL . 61.7 t -79.86 1.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.281 . . . . 0.0 108.36 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -78.89 134.82 14.46 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' HG23 ' A' ' 61' ' ' ILE . . . 84.04 91.95 0.72 Allowed Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.55 -0.97 . . . . 0.0 110.68 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.3 m-20 -160.99 120.33 2.61 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.975 -1.309 . . . . 0.0 108.754 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 3.1 p -110.25 130.01 55.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.052 0.93 . . . . 0.0 110.505 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 85' ' ' HIS . 29.5 m170 -119.36 148.9 42.67 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 109.333 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.7 m-30 -112.48 147.05 37.35 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 0.0 109.833 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.684 ' HB2' HD23 ' A' ' 82' ' ' LEU . 3.6 t70 -81.13 114.92 20.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 67' ' ' ARG . 18.5 t70 -57.37 -95.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.75 -0.78 . . . . 0.0 108.92 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 101' ' ' ASP . 47.2 m-20 21.67 -93.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 120.706 0.288 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 102' ' ' ASP . 2.5 mp0 -41.95 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.933 -1.104 . . . . 0.0 110.094 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.596 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 2.0 tp -106.2 101.08 10.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.883 . . . . 0.0 109.696 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' THR . 12.1 m95 -103.11 147.27 27.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.363 -0.835 . . . . 0.0 110.034 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.655 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 p -159.02 -159.68 0.79 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.315 -0.866 . . . . 0.0 110.02 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -149.1 70.0 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -168.2 -99.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.467 ' H ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -142.67 59.82 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.774 -1.204 . . . . 0.0 109.613 178.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.93 -24.13 0.76 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.246 -0.908 . . . . 0.0 110.972 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.596 ' ND2' ' O ' ' A' ' 104' ' ' LEU . 2.6 t-20 -169.57 -153.66 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.739 -1.226 . . . . 0.0 108.968 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -67.74 -167.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.798 -1.189 . . . . 0.0 108.436 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.5 t -105.36 117.61 34.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.904 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -53.24 -22.51 6.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.86 0.838 . . . . 0.0 108.753 179.107 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.543 ' C ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -76.07 -38.49 57.02 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.595 HD12 ' CZ ' ' A' ' 142' ' ' TYR . 2.3 tm? -64.72 -55.13 21.88 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.409 -0.807 . . . . 0.0 109.716 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 118' ' ' ALA . 2.4 m -53.67 -51.06 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 117' ' ' VAL . . . -57.29 -51.48 69.2 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.938 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.4 -58.25 3.47 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.953 0.882 . . . . 0.0 109.333 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.805 ' HB2' ' H34' ' A' ' 800' ' ' I52 . 84.9 t60 -42.81 -67.62 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 84' ' ' ALA . 44.1 mm-40 -62.25 -21.95 65.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CG ' ' CZ2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -74.43 -5.54 43.07 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -98.08 -48.54 1.88 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.471 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 97.0 m-70 -60.79 -42.61 97.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.53 -16.5 38.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.922 . . . . 0.0 109.209 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.5 ' SD ' ' OH ' ' A' ' 162' ' ' TYR . 44.2 mtt -84.62 15.82 3.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 100.95 -73.26 0.39 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.788 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' GLY . 15.7 mt -32.44 145.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.997 -0.708 . . . . 0.0 111.184 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.85 -179.66 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.815 -1.178 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -49.08 135.47 16.13 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.2 p -93.35 -152.16 0.32 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.16 -4.66 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.746 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -81.97 134.44 49.75 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.905 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.93 113.15 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.465 2.11 . . . . 0.0 111.007 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.07 -5.32 42.06 Favored Glycine 0 C--N 1.268 -3.199 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . . . -54.13 162.04 1.12 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.682 -0.893 . . . . 0.0 109.64 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.762 HD13 H382 ' A' ' 800' ' ' I52 . 19.0 tp -67.32 -34.3 77.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.547 -0.721 . . . . 0.0 109.085 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.416 ' HE1' ' OD1' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -107.34 28.09 8.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.514 -0.741 . . . . 0.0 110.398 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -78.19 164.27 57.61 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.773 -1.204 . . . . 0.0 109.112 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 35.2 Cg_endo -73.5 15.74 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.269 2.646 . . . . 0.0 112.39 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.411 ' O ' ' H30' ' A' ' 800' ' ' I52 . 1.0 OUTLIER -137.93 139.59 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.853 -1.155 . . . . 0.0 109.507 -179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.595 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 62.9 t80 -76.79 129.58 36.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 144' ' ' TYR . 6.2 m -150.06 84.77 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.982 -1.074 . . . . 0.0 108.472 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.565 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 75.4 t80 -42.37 164.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.633 -0.667 . . . . 0.0 109.339 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.838 ' HB ' H371 ' A' ' 800' ' ' I52 . 1.7 t -111.5 119.05 37.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 110.604 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -44.83 104.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.825 . . . . 0.0 108.848 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 146' ' ' LYS . 70.1 m-20 68.81 -79.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.854 ' CE1' HD23 ' A' ' 150' ' ' LEU . 24.1 t80 171.14 113.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.037 -1.039 . . . . 0.0 108.95 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 14.1 ttt85 -133.02 -20.7 2.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 110.214 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.854 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 71.98 -160.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -163.42 126.71 2.71 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.731 -1.231 . . . . 0.0 108.985 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.585 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 4.7 mm-40 -45.51 -44.07 12.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.25 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' GLN . 41.9 t0 -45.57 -36.4 4.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.654 -1.218 . . . . 0.0 108.357 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' OD1' ' HE1' ' A' ' 138' ' ' MET . 29.2 t0 -86.51 -30.89 21.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.634 -0.667 . . . . 0.0 109.479 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.685 HD12 ' C ' ' A' ' 155' ' ' ILE . 0.6 OUTLIER -70.48 -37.56 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 108.805 178.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -72.82 -43.1 63.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.84 48.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.687 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -54.47 -42.95 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.365 . . . . 0.0 109.534 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.425 ' N ' HG23 ' A' ' 158' ' ' ILE . 7.3 mm-40 -65.4 -43.15 91.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 109.589 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 69.3 mm-40 -57.73 -22.98 49.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.741 -1.225 . . . . 0.0 108.468 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.469 ' HB3' ' HD1' ' A' ' 162' ' ' TYR . 3.8 mm? -98.96 -64.5 1.03 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.584 0.707 . . . . 0.0 109.318 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.792 ' CE2' HD13 ' A' ' 49' ' ' LEU . 21.9 p90 -151.64 85.27 1.3 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.45 ' OXT' ' CD ' ' A' ' 48' ' ' PRO . . . . . . . . 0 N--CA 1.494 2.543 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.662 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 1.056 H251 ' H61' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.259 0.552 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.612 ' O ' ' CG ' ' A' ' 2' ' ' TYR . 0.7 OUTLIER -153.27 83.16 1.19 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -102.94 31.28 4.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.151 -0.968 . . . . 0.0 109.849 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -79.72 125.35 29.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 109.577 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -68.13 155.74 91.43 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.164 -0.96 . . . . 0.0 108.984 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -79.26 157.3 26.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.452 2.102 . . . . 0.0 110.131 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 9.0 mmt180 -88.95 -1.67 58.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 62.43 144.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.998 . . . . 0.0 108.979 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.51 82.63 2.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.058 1.839 . . . . 0.0 108.848 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 9.8 mttp -54.33 164.45 0.68 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 3.0 m95 -71.54 130.99 42.61 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 11.8 p-10 167.92 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.36 -0.837 . . . . 0.0 109.383 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.64 32.0 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 13' ' ' LYS . 4.6 t-20 72.28 -62.97 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.146 -0.971 . . . . 0.0 108.951 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 50' ' ' ARG . 21.3 mt-30 -78.94 103.23 8.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.517 -0.739 . . . . 0.0 109.297 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.552 HD13 ' N ' ' A' ' 16' ' ' ILE . 0.9 OUTLIER -101.06 162.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 108.577 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.45 133.96 48.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 110.043 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 7.3 p90 -145.99 157.69 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . 3.4 tmm_? -148.76 136.82 20.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 0.0 109.927 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 23' ' ' TYR . 5.8 mt -86.6 144.97 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 62' ' ' MET . 11.6 mm -107.67 -38.85 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 0.0 110.074 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.02 96.23 0.14 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.755 ' CG ' HG11 ' A' ' 32' ' ' VAL . 2.5 m-85 -55.31 179.02 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.353 -1.086 . . . . 0.0 109.1 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.563 HG22 HD11 ' A' ' 27' ' ' LEU . 5.0 t -105.05 150.59 38.93 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 109.437 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.2 Cg_endo -81.27 -33.04 0.79 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.727 2.285 . . . . 0.0 111.238 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' PRO . 36.5 m-20 -39.48 -27.16 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.68 -0.637 . . . . 0.0 110.105 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' HB ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -135.16 -178.15 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 110.04 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 1.1 m-20 -73.62 151.97 89.37 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.511 -0.743 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.557 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.7 Cg_endo -74.1 -30.12 9.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 N-CA-C 106.254 -2.248 . . . . 0.0 106.254 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 2.6 mm-40 -78.11 -30.41 49.45 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 107' ' ' ASN . 2.4 m -76.45 -50.68 13.46 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.755 HG11 ' CG ' ' A' ' 23' ' ' TYR . 1.4 p -54.92 -41.43 57.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.26 -23.97 62.08 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 2.7 t70 -81.39 -34.5 31.61 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.528 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.8 m-85 -73.21 -47.95 39.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -46.24 -51.15 14.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.993 . . . . 0.0 108.609 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' VAL . 9.3 mtm180 -55.19 -50.44 69.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.013 -1.054 . . . . 0.0 108.439 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -53.41 -44.36 68.68 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 44' ' ' SER . 49.6 t80 -51.25 -40.25 58.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 108.732 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 3.0 tt0 -86.77 -24.03 25.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -68.74 -33.33 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.147 -0.97 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.787 ' HE1' HD21 ' A' ' 137' ' ' LEU . 1.9 m95 -103.22 -22.3 13.75 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.208 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 27.5 t -85.9 -19.61 30.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.8 m-20 -64.6 -15.12 60.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.516 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.1 p -113.65 17.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.404 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -173.04 147.56 1.53 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 120.466 -1.396 . . . . 0.0 111.037 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' THR . 36.4 Cg_endo -78.52 46.78 2.23 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.773 2.316 . . . . 0.0 110.067 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD23 ' HE1' ' A' ' 51' ' ' PHE . 1.7 mp -76.55 160.16 29.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -130.41 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.866 ' HE1' HD23 ' A' ' 49' ' ' LEU . 5.4 m-30 -66.57 139.41 57.91 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' THR . 8.1 t -130.89 101.66 5.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.244 -0.91 . . . . 0.0 109.835 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -81.03 144.08 32.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.745 HD13 ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -113.29 158.87 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 43.1 m-70 -106.75 -14.65 14.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.04 -175.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.046 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.34 63.65 0.83 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 177.35 153.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.482 -1.01 . . . . 0.0 109.527 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 54' ' ' ILE . . . 176.45 143.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -62.53 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.793 HG23 ' O ' ' A' ' 95' ' ' GLY . 22.9 mt -87.59 156.51 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.983 ' HG2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -165.83 136.05 3.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.126 -0.984 . . . . 0.0 109.931 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.39 144.56 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 109.668 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -164.19 -167.14 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.325 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.464 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -117.2 166.73 11.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.74 -24.99 7.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 65' ' ' PHE . 54.1 mtp180 47.91 -150.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.177 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -91.12 -72.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 0.0 109.412 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -62.42 99.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.621 -0.675 . . . . 0.0 110.481 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.29 -160.28 0.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.86 -33.26 1.89 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.74 72.18 10.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.431 -1.04 . . . . 0.0 108.492 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' TYR . . . 112.95 -113.29 3.15 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER 163.33 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.21 -1.17 . . . . 0.0 109.827 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 74' ' ' TYR . 36.8 Cg_endo -79.26 137.69 13.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.246 1.964 . . . . 0.0 110.235 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 76' ' ' PHE . 24.7 p90 -71.63 138.05 48.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.617 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 p-10 -75.31 -2.29 27.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.555 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 57.41 -114.91 5.99 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.5 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 78' ' ' GLY . 5.4 mttt -41.65 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.057 -0.673 . . . . 0.0 110.78 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 79' ' ' LYS . 10.1 m-20 -25.18 -93.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 80' ' ' ASP . . . 38.6 -130.35 1.79 Allowed Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 9.7 tt -54.51 109.37 0.49 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.1 mt -107.94 -29.29 9.1 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 171.77 155.93 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.903 -1.123 . . . . 0.0 110.899 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.424 ' HB3' H252 ' A' ' 800' ' ' I52 . 1.9 p80 -146.36 -162.74 1.59 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 97' ' ' SER . . . -160.73 145.81 14.36 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -92.77 156.29 17.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.841 -1.162 . . . . 0.0 109.976 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.8 164.01 55.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.1 Cg_endo -79.35 154.55 24.68 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.002 2.468 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.49 60.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.78 92.56 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -1.084 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.82 -62.81 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 93' ' ' VAL . 2.4 t -58.19 153.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.267 . . . . 0.0 109.748 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 98.2 141.08 11.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.793 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 95.83 -45.78 1.96 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' MET . 4.1 p30 -73.26 125.22 27.27 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.188 -1.183 . . . . 0.0 109.724 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.511 ' OG ' ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -131.65 136.28 47.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.314 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 9.5 m80 -98.93 143.38 29.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . 13.8 m-85 -113.9 141.83 46.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.565 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' CZ3' ' A' ' 105' ' ' TRP . 5.4 t70 -51.91 135.43 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -98.23 -16.86 19.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.871 -1.143 . . . . 0.0 109.592 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.83 -16.92 60.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.534 ' OE2' HD23 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -75.49 158.23 32.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 111' ' ' ASN . 8.4 tp -109.09 95.61 5.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 99' ' ' PHE . 10.3 m0 -102.33 141.51 35.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.216 -0.927 . . . . 0.0 110.222 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.805 HG21 ' HB3' ' A' ' 110' ' ' ALA . 1.5 p -133.51 -160.28 1.04 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.972 -1.08 . . . . 0.0 110.006 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 31' ' ' THR . 0.2 OUTLIER -134.59 2.25 3.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.826 . . . . 0.0 109.99 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.08 -60.5 1.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.098 . . . . 0.0 109.359 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.6 p -165.26 -91.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.324 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.805 ' HB3' HG21 ' A' ' 106' ' ' THR . . . 43.6 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.865 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' A' ' 104' ' ' LEU . 60.8 t30 -110.55 -104.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.95 -124.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.794 -1.191 . . . . 0.0 109.456 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -171.99 117.24 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.356 -1.465 . . . . 0.0 111.219 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -45.95 -43.48 14.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.643 -0.66 . . . . 0.0 110.078 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.6 t80 -58.91 -44.52 91.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.388 -0.82 . . . . 0.0 109.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.5 OUTLIER -59.2 -67.14 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.422 -0.798 . . . . 0.0 109.766 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.5 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.1 m -51.08 -42.93 25.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.435 -0.791 . . . . 0.0 108.985 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -52.64 -46.94 67.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.861 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -54.48 -59.02 5.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.376 -0.828 . . . . 0.0 110.007 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.74 ' HB2' ' H34' ' A' ' 800' ' ' I52 . 77.3 t60 -43.55 -65.05 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.655 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 99' ' ' PHE . 68.1 mm-40 -62.84 -12.95 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 0.0 109.341 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.1 m-85 -80.92 -10.8 59.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.108 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.597 ' HA3' ' CZ2' ' A' ' 43' ' ' TRP . . . -103.68 -41.29 2.19 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 120' ' ' HIS . 9.5 m80 -61.02 -42.93 99.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -1.117 . . . . 0.0 109.104 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -37.56 -32.36 0.05 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.391 0.615 . . . . 0.0 109.532 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.867 ' HE1' HD12 ' A' ' 158' ' ' ILE . 4.1 mtm -69.89 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.87 . . . . 0.0 109.476 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.47 -30.87 0.05 OUTLIER Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' O ' ' HE1' ' A' ' 138' ' ' MET . 0.5 OUTLIER -49.9 153.82 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.538 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 130' ' ' HIS . 4.0 mt-10 -113.44 -177.53 3.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.157 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 129' ' ' GLU . 18.6 m170 -44.72 172.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 110.142 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 p -123.58 -152.23 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 -17.36 2.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.321 -0.862 . . . . 0.0 110.99 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 151.32 54.21 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.72 -1.237 . . . . 0.0 109.251 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.8 -38.7 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.398 2.065 . . . . 0.0 110.686 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.09 6.81 69.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.57 163.31 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 110.03 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 1.109 HD13 H382 ' A' ' 800' ' ' I52 . 16.7 tp -89.12 -28.5 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 110.233 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 139' ' ' ALA . 37.0 mtp -101.53 15.01 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.909 -1.119 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -43.15 153.72 0.34 Allowed Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.934 ' O ' HD13 ' A' ' 141' ' ' ILE . 35.2 Cg_endo -79.09 -1.11 11.32 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.205 1.937 . . . . 0.0 110.21 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.5 mm -131.28 154.46 40.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.66 139.36 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 110.16 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.649 ' HB ' ' H31' ' A' ' 800' ' ' I52 . 1.9 m -129.52 -41.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 110.37 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.849 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.5 OUTLIER 68.42 147.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.558 ' HB ' H371 ' A' ' 800' ' ' I52 . 6.4 t -120.65 138.13 54.09 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -83.11 0.15 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.119 -0.988 . . . . 0.0 111.003 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 1.5 p-10 -88.19 21.43 2.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.824 -1.173 . . . . 0.0 109.391 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 148' ' ' PHE . 1.6 t80 60.14 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.112 -0.993 . . . . 0.0 109.133 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -121.06 -10.8 8.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.437 -0.789 . . . . 0.0 109.247 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 tp 59.32 -144.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 109.274 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 155' ' ' ILE . 1.1 p -178.41 129.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.563 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.7 mm100 -53.76 -35.17 61.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.896 -0.502 . . . . 0.0 110.053 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 152' ' ' GLN . 2.9 m-20 -42.87 -47.7 5.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 109.304 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -79.37 -45.26 19.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.454 -0.779 . . . . 0.0 109.177 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 151' ' ' SER . 0.5 OUTLIER -50.86 -28.47 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.0 108.661 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -57.44 3.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 0.0 109.553 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.41 -36.41 53.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' HE1' ' A' ' 126' ' ' MET . 6.7 tp -75.28 -30.09 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.378 -1.072 . . . . 0.0 109.1 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.57 67.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.479 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 -28.38 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.406 0.622 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -19.62 20.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.658 -0.651 . . . . 0.0 110.136 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 49' ' ' LEU . 41.6 m-85 -140.3 -75.05 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.406 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 1.109 H382 HD13 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 59.65 53.93 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.437 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -127.18 132.85 50.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.815 . . . . 0.0 110.477 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.659 ' CE1' HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -100.73 113.35 65.63 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 110.38 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 33.0 Cg_endo -76.45 155.52 36.36 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.909 2.406 . . . . 0.0 110.904 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.561 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 13.7 mtp85 72.68 -109.09 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 89' ' ' PRO . 0.6 OUTLIER -83.73 109.74 20.42 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 109.516 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 31.7 Cg_endo -72.15 58.76 2.93 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.809 1.673 . . . . 0.0 110.261 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 22.17 -94.25 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.384 0.612 . . . . 0.0 111.936 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.568 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 176.0 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.462 -0.774 . . . . 0.0 109.24 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -44.57 158.39 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -114.81 144.65 43.17 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.471 -0.768 . . . . 0.0 109.448 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' O ' HD23 ' A' ' 49' ' ' LEU . 68.0 m-80 43.26 -82.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' LYS . 2.9 mt-30 -71.4 106.89 4.08 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 17' ' ' THR . 2.2 mm -114.05 -178.33 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.034 -1.041 . . . . 0.0 110.133 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -140.33 137.83 34.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CB ' HG13 ' A' ' 61' ' ' ILE . 43.2 p90 -145.38 162.89 36.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.115 -0.99 . . . . 0.0 109.569 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 58' ' ' GLU . 19.9 ttp85 -159.42 124.33 4.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -0.896 . . . . 0.0 109.684 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.892 HG21 ' CD1' ' A' ' 23' ' ' TYR . 4.0 mt -85.25 116.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.7 mt -73.62 0.3 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.981 -1.074 . . . . 0.0 109.836 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 151.64 103.64 0.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.892 ' CD1' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.74 -153.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -1.178 . . . . 0.0 109.365 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.528 HG22 HG21 ' A' ' 32' ' ' VAL . 1.4 t -105.13 147.63 34.84 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.202 -0.936 . . . . 0.0 110.521 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 37.5 Cg_endo -78.89 -32.91 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.157 2.571 . . . . 0.0 111.178 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' PRO . 71.7 m-20 -41.1 -34.73 0.47 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.698 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -121.03 176.95 5.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.967 -1.083 . . . . 0.0 109.231 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 4.6 m-20 -63.04 154.49 77.06 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.012 -1.055 . . . . 0.0 108.348 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.9 Cg_endo -72.3 -33.33 9.22 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.1 -26.41 33.62 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.885 HG21 ' HA ' ' A' ' 107' ' ' ASN . 1.4 m -71.79 -51.84 20.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.6 -33.74 40.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -70.35 -24.23 62.94 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 55.2 t0 -73.7 -39.19 64.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.296 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.726 ' HB3' HD23 ' A' ' 114' ' ' LEU . . . -53.25 -60.83 2.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.477 ' CE2' HD21 ' A' ' 114' ' ' LEU . 78.3 m-85 -53.42 -42.5 67.12 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -49.2 -38.96 27.74 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' VAL . 1.2 mtp180 -74.48 -46.84 36.99 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -56.35 -36.15 68.46 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -65.61 -40.99 93.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 1.3 mt-30 -81.69 -9.42 59.65 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -94.26 -27.84 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.133 -0.979 . . . . 0.0 109.63 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.804 ' HZ3' HD13 ' A' ' 158' ' ' ILE . 1.7 m95 -102.67 -21.16 14.16 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 109.887 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' THR . 6.2 t -95.2 -26.25 16.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.255 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -67.43 -4.54 11.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.918 HG23 HG22 ' A' ' 47' ' ' THR . 15.1 m -108.1 -8.2 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.705 -1.247 . . . . 0.0 109.614 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -153.16 163.53 23.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.999 -1.063 . . . . 0.0 108.424 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.2 Cg_endo -76.66 57.16 5.47 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.067 1.845 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.805 HD11 ' CE2' ' A' ' 162' ' ' TYR . 2.6 mt -93.66 125.5 38.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.546 -0.721 . . . . 0.0 109.241 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 4.9 mmm180 -112.26 90.81 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 89.4 m-85 -77.05 148.83 35.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.953 -1.092 . . . . 0.0 109.842 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' THR . 51.5 m -132.11 111.85 11.82 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.84 138.44 54.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.352 -0.843 . . . . 0.0 108.998 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.779 ' H ' HD13 ' A' ' 54' ' ' ILE . 0.2 OUTLIER -133.58 164.99 33.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.608 ' O ' ' N ' ' A' ' 57' ' ' GLY . 87.7 m-70 -132.03 165.35 24.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.258 -0.901 . . . . 0.0 109.697 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 0.3 OUTLIER 55.36 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 55' ' ' HIS . . . -46.3 156.53 0.52 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 1.7 mt-10 -66.55 161.2 23.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.92 -1.341 . . . . 0.0 110.47 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -124.47 148.57 47.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.587 -0.696 . . . . 0.0 109.381 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' CD2' ' A' ' 11' ' ' TRP . 10.3 t0 -70.03 -54.48 13.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.996 -1.065 . . . . 0.0 109.398 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.802 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -103.54 122.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.195 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 3.5 mtt -105.49 139.82 39.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.959 -1.088 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.438 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 2.9 mt -123.32 128.61 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.023 -1.048 . . . . 0.0 108.616 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -153.95 -147.1 0.21 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.101 -0.999 . . . . 0.0 109.782 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -177.85 -178.55 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.899 -1.126 . . . . 0.0 110.314 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 101' ' ' ASP . . . 139.21 178.95 16.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -160.87 161.74 31.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.286 -1.126 . . . . 0.0 109.786 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 57.04 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 108.517 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.5 pp20? -61.65 124.53 20.95 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-80 173.45 -57.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 77.55 -12.76 13.82 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 71' ' ' GLY . 6.0 m-20 -42.18 -24.68 0.05 Allowed 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.016 -1.285 . . . . 0.0 110.274 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 128.31 13.14 2.67 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.548 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 14.8 p90 -154.76 90.85 3.04 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 120.834 -1.392 . . . . 0.0 109.287 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 36.0 Cg_endo -78.35 -171.88 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.598 2.199 . . . . 0.0 110.957 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 26.6 m-85 61.08 170.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 0.0 109.235 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 78' ' ' GLY . 1.3 t70 172.63 -34.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . 31.72 -157.77 0.0 OUTLIER Glycine 0 N--CA 1.5 2.957 0 CA-C-O 121.682 0.601 . . . . 0.0 111.933 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 80' ' ' ASP . 6.3 mttt -72.8 162.45 29.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.688 -0.889 . . . . 0.0 110.957 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 79' ' ' LYS . 9.7 p-10 27.96 -138.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.199 0.523 . . . . 0.0 111.208 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 83' ' ' LEU . . . 44.51 -116.93 1.84 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -42.68 97.53 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 81' ' ' GLY . 1.7 mt -114.3 -21.41 10.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.567 -1.333 . . . . 0.0 109.392 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.09 150.09 0.94 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.143 -0.973 . . . . 0.0 110.178 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.588 ' CE1' ' CE1' ' A' ' 74' ' ' TYR . 1.1 p80 -144.04 -179.98 6.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.81 162.06 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.115 -0.99 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.07 168.7 10.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.673 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.8 148.32 64.72 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.547 -0.721 . . . . 0.0 109.357 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 28.8 Cg_endo -75.87 136.73 19.03 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.709 2.272 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.505 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 145.21 122.79 1.56 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.387 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER 56.25 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.704 . . . . 0.0 110.954 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 33.14 -92.21 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -45.65 160.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -1.124 . . . . 0.0 108.743 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 126.58 151.1 7.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 60.82 13.41 32.67 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.651 -1.499 . . . . 0.0 109.434 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 62' ' ' MET . 1.6 m-20 -97.09 116.2 28.86 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.552 -1.558 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.614 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 33.8 m -114.65 156.36 24.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.724 -0.61 . . . . 0.0 109.941 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 97' ' ' SER . 1.9 m80 -148.79 139.01 22.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 32.6 m-85 -104.61 179.24 4.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.172 0.987 . . . . 0.0 112.165 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' OD2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -58.64 161.98 4.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.866 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.611 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 13.2 t0 -94.02 -4.83 48.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -170.12 79.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.0 109.023 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -137.09 -8.54 1.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.476 -1.39 . . . . 0.0 111.599 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD13 ' H ' ' A' ' 105' ' ' TRP . 0.2 OUTLIER 76.66 141.5 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.188 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.608 ' H ' HD13 ' A' ' 104' ' ' LEU . 26.0 m-90 -149.01 -50.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.017 -1.052 . . . . 0.0 110.288 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 114' ' ' LEU . 35.8 p -138.13 -89.21 0.24 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 117.905 -1.518 . . . . 0.0 113.171 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.885 ' HA ' HG21 ' A' ' 31' ' ' THR . 28.8 t-20 52.92 19.26 1.28 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -175.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 106' ' ' THR . 30.3 p 50.49 37.63 16.35 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.356 1.074 . . . . 0.0 110.039 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -168.07 31.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 105' ' ' TRP . . . -98.12 179.97 4.58 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.463 0.649 . . . . 0.0 111.967 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -120.98 -13.31 8.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.523 ' O ' ' CB ' ' A' ' 113' ' ' SER . 1.2 m-85 -107.59 -42.4 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.939 -1.101 . . . . 0.0 108.475 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 105' ' ' TRP . 0.3 OUTLIER 81.01 93.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.927 0.87 . . . . 0.0 110.925 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.743 ' H ' HG23 ' A' ' 106' ' ' THR . 13.2 tp -37.67 -41.83 0.52 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.739 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.5 t80 -55.29 -45.1 76.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.893 . . . . 0.0 109.9 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.627 HD21 H352 ' A' ' 800' ' ' I52 . 1.0 OUTLIER -68.66 -58.69 3.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.448 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 118' ' ' ALA . 32.9 m -59.08 -42.37 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.006 -1.059 . . . . 0.0 109.432 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.645 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -59.06 -41.55 88.23 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.384 0.612 . . . . 0.0 109.4 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.32 69.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.492 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -54.64 -33.61 60.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 0.0 108.821 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -86.04 -24.61 26.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.167 -0.958 . . . . 0.0 109.151 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 118' ' ' ALA . 1.4 m-85 -71.91 -10.92 60.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -101.71 -37.92 3.33 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -63.54 -50.23 70.37 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.21 -1.171 . . . . 0.0 108.597 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 95' ' ' GLY . . . -61.18 -13.45 18.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.739 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 22.9 mmm -81.26 10.87 4.85 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.089 -1.007 . . . . 0.0 108.985 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 88.64 -54.96 4.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 128' ' ' LEU . 14.7 mt -42.8 142.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.343 -1.093 . . . . 0.0 110.166 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' HIS . 19.6 pt-20 -108.98 175.61 5.4 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' GLU . 45.4 m80 -44.24 167.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.143 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 m -115.6 -80.53 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.005 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 177.11 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 145.79 97.36 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -75.83 -35.44 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.256 1.971 . . . . 0.0 108.567 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.34 13.7 62.97 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.65 149.43 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -1.081 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.879 ' CD1' H351 ' A' ' 800' ' ' I52 . 14.3 tp -72.93 -16.16 61.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.519 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 7.3 mmt -112.45 27.87 9.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.95 154.49 93.62 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.743 -0.598 . . . . 0.0 109.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.25 4.14 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.79 2.327 . . . . 0.0 111.413 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 141' ' ' ILE . 1.0 OUTLIER -131.99 151.06 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.887 -1.133 . . . . 0.0 109.747 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 144' ' ' TYR . 30.1 t80 -63.96 120.96 12.96 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 144' ' ' TYR . 7.6 m -124.07 53.61 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.042 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.618 ' CD2' ' N ' ' A' ' 145' ' ' THR . 75.2 t80 -44.39 170.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.393 -0.817 . . . . 0.0 109.318 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.721 ' CG2' H382 ' A' ' 800' ' ' I52 . 1.6 t 179.64 113.3 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.064 -1.022 . . . . 0.0 109.455 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 23.0 ttpt -59.7 167.31 2.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.907 -1.121 . . . . 0.0 108.943 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 3.9 t-20 71.3 -54.83 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.086 . . . . 0.0 110.591 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 68.74 143.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.165 -0.96 . . . . 0.0 109.58 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 80.1 mtp85 -134.11 -86.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 108.922 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 2.1 mt 160.29 152.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.987 -1.071 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 155' ' ' ILE . 10.4 p -119.83 129.02 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 109.885 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.636 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.5 mt-30 -65.39 -32.55 74.25 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -44.46 -38.28 3.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -86.54 -38.41 17.22 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.542 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -62.7 -29.77 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 108.718 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -63.9 1.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 110.236 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -51.64 -39.97 47.05 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.804 HD13 ' HZ3' ' A' ' 43' ' ' TRP . 9.9 tp -70.17 -40.98 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.612 -0.934 . . . . 0.0 109.461 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 1.8 mm-40 -70.6 -20.55 62.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.257 -0.902 . . . . 0.0 108.809 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -87.14 -27.91 22.79 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.176 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.659 HD21 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -93.53 -19.99 20.69 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 109.808 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 49' ' ' LEU . 25.6 m-85 -113.59 -8.06 13.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.602 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 0.879 H351 ' CD1' ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -98.46 38.28 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.59 44.76 2.62 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.234 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.69 38.0 2.37 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.552 ' O ' ' NH1' ' A' ' 7' ' ' ARG . 13.1 m-85 -130.55 84.29 59.57 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 7' ' ' ARG . 36.7 Cg_endo -78.95 0.75 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.533 2.156 . . . . 0.0 110.743 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -54.58 -166.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.126 -0.984 . . . . 0.0 109.682 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' N ' ' HG2' ' A' ' 7' ' ' ARG . 2.9 mttt -88.79 158.04 48.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.028 -1.045 . . . . 0.0 109.548 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 8' ' ' LYS . 35.4 Cg_endo -78.01 57.28 6.06 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.501 2.134 . . . . 0.0 108.699 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HD3' ' HG2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -64.61 -171.04 0.06 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CH2' ' OD2' ' A' ' 60' ' ' ASP . 5.9 m95 -107.6 -105.58 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.0 109.199 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' OD1' HD11 ' A' ' 161' ' ' LEU . 13.5 m-20 61.34 22.95 13.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.81 -1.181 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HD2' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -94.3 166.74 11.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 109.709 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' ILE . 4.2 m120 -82.54 -88.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 110.262 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' CG ' ' A' ' 15' ' ' GLN . 3.5 pt20 -52.45 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.772 -1.205 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 17' ' ' THR . 10.9 mt -102.72 167.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.342 -0.849 . . . . 0.0 110.602 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.611 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.64 131.51 43.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.159 -0.963 . . . . 0.0 109.837 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.521 ' HA ' HG13 ' A' ' 61' ' ' ILE . 9.3 p90 -133.7 163.93 28.34 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.996 . . . . 0.0 110.53 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' A' ' 55' ' ' HIS . 19.1 ttt180 -159.05 132.4 7.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 109.754 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.671 HD13 ' OD1' ' A' ' 33' ' ' ASP . 6.0 mt -93.26 131.25 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.75 -20.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 159.76 113.15 0.32 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -84.27 -168.36 2.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.409 -1.054 . . . . 0.0 108.225 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 27' ' ' LEU . 0.7 OUTLIER -105.1 149.66 37.89 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.817 -1.177 . . . . 0.0 109.475 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -78.31 -28.75 4.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.67 2.247 . . . . 0.0 110.061 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.671 ' OD1' HG22 ' A' ' 106' ' ' THR . 1.8 p30 -38.88 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.017 HD13 ' HA ' ' A' ' 106' ' ' THR . 2.0 pt? -129.11 157.45 41.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.109 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 1.6 m-20 -40.75 138.89 1.23 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.602 -0.687 . . . . 0.0 109.169 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -70.87 -39.91 4.0 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 N-CA-C 107.021 -1.953 . . . . 0.0 107.021 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.4 pt-20 -72.88 -22.55 60.74 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.553 ' HB ' ' CB ' ' A' ' 28' ' ' ASP . 5.7 m -80.01 -51.36 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.357 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.787 ' CG2' HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 -39.14 53.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.671 ' OD1' HD13 ' A' ' 20' ' ' ILE . 4.8 m-20 -78.76 -29.9 45.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 11.6 t70 -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.727 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.622 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -43.28 -55.37 4.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.468 -0.77 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 25.1 m-85 -54.99 -42.58 72.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.65 -0.656 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.88 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.865 . . . . 0.0 109.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -47.93 -37.68 14.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.788 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -63.14 -47.71 81.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.6 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -52.4 -33.04 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 2.1 tt0 -82.39 -16.03 50.58 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.601 -0.687 . . . . 0.0 109.348 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.795 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -72.54 -36.43 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.921 -1.112 . . . . 0.0 110.167 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.795 ' CD1' HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.29 -24.52 12.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 28.2 t -77.63 -17.67 57.53 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.176 -0.952 . . . . 0.0 108.964 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 8.0 t70 -65.77 -17.67 64.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 110.097 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 46' ' ' VAL . 13.6 p -110.31 19.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 3.8 t -173.74 149.79 1.62 Allowed Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.069 -1.02 . . . . 0.0 108.805 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -81.03 47.12 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.885 2.39 . . . . 0.0 110.811 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 51' ' ' PHE . 0.6 OUTLIER -81.25 147.2 30.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.405 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -122.78 124.06 42.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.353 -0.842 . . . . 0.0 108.93 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.644 ' CZ ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 m-85 -102.23 144.37 30.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.662 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -118.9 119.68 35.07 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -87.84 141.9 28.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 109.159 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 ' CB ' ' A' ' 59' ' ' ALA . 4.5 pt -141.22 -169.01 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 109.778 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.421 ' O ' ' CZ ' ' A' ' 19' ' ' ARG . 16.4 p-80 -159.08 -33.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 109.191 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -115.31 157.86 23.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.18 -0.95 . . . . 0.0 109.18 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.18 11.26 78.82 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.16 158.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.419 -1.048 . . . . 0.0 109.066 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.867 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -128.13 143.66 51.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.88 -1.138 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 11' ' ' TRP . 1.6 m-20 -51.58 -59.24 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 109.072 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -98.6 129.66 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.062 . . . . 0.0 108.583 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.459 ' SD ' ' OD1' ' A' ' 96' ' ' ASP . 1.5 mtp -125.1 116.61 22.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.563 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.95 155.4 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.51 -0.744 . . . . 0.0 109.129 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.5 p30 179.3 -172.15 0.16 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.014 -1.054 . . . . 0.0 109.986 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -134.07 170.54 15.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.472 -0.768 . . . . 0.0 109.108 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -179.64 114.73 0.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -55.14 -149.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.722 -0.87 . . . . 0.0 110.894 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.4 p90 -48.96 -51.13 32.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.813 -1.179 . . . . 0.0 109.792 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 1.1 mt-10 -43.69 -69.21 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 15.1 t60 73.32 -73.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.43 -0.793 . . . . 0.0 110.608 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.33 9.96 9.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -170.66 68.5 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.252 -1.146 . . . . 0.0 109.971 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.49 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 117.59 179.25 17.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.81 76.29 14.03 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.431 -1.04 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HB2' ' CD2' ' A' ' 82' ' ' LEU . 29.7 Cg_endo -74.78 -84.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.39 2.06 . . . . 0.0 108.425 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 68' ' ' TRP . 24.1 t80 59.52 -100.12 0.1 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.435 -0.791 . . . . 0.0 110.567 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 75.69 -53.96 0.63 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.989 -1.07 . . . . 0.0 108.357 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 77' ' ' ASP . . . 101.83 -148.23 17.71 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HA ' ' OE2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -57.66 161.75 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 108.972 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 39.05 -147.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.434 -0.791 . . . . 0.0 110.028 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 51.46 -146.21 12.16 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.639 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 3.5 tp -40.56 112.93 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.927 . . . . 0.0 109.71 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 10.1 mt -108.63 -19.26 13.49 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.344 -0.848 . . . . 0.0 109.891 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 163.98 163.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 98' ' ' HIS . 6.3 p-80 -153.92 177.4 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.935 -1.103 . . . . 0.0 109.979 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.47 156.39 48.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.08 163.2 12.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.066 -1.022 . . . . 0.0 109.609 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -83.67 157.34 64.26 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.102 -0.999 . . . . 0.0 109.706 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' A' ' 10' ' ' LYS . 37.6 Cg_endo -76.81 147.56 27.56 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.462 2.108 . . . . 0.0 109.597 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 161.26 45.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.261 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 71.3 142.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -1.129 . . . . 0.0 109.72 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 35.97 -102.53 0.02 OUTLIER Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.73 119.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.158 -1.201 . . . . 0.0 108.171 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . 133.15 146.1 5.5 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.736 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 79.18 2.98 88.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.459 ' OD1' ' SD ' ' A' ' 62' ' ' MET . 1.3 m-20 -107.85 130.41 55.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.197 -1.178 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 85' ' ' HIS . 0.7 OUTLIER -122.67 133.53 54.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 109.535 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.537 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 5.8 m80 -111.89 134.21 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 109.065 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.651 ' HB2' ' CD2' ' A' ' 65' ' ' PHE . 6.1 m-85 -103.76 141.95 35.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 110.63 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.82 146.03 53.61 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 66' ' ' GLY . 16.6 m-20 -89.64 -112.27 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 101' ' ' ASP . 5.1 m-20 36.03 -160.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER 34.97 -124.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.437 -0.789 . . . . 0.0 110.349 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 15.1 tp -177.62 134.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.047 -1.033 . . . . 0.0 108.713 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.682 ' N ' ' CD1' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -126.25 124.51 40.53 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.971 -1.081 . . . . 0.0 110.449 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 1.017 ' HA ' HD13 ' A' ' 27' ' ' LEU . 4.1 p -147.03 -160.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.145 -0.972 . . . . 0.0 111.275 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.436 ' O ' ' CG ' ' A' ' 107' ' ' ASN . 36.7 t30 -108.21 18.81 20.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.391 -0.818 . . . . 0.0 110.782 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -37.15 2.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.435 -1.416 . . . . 0.0 110.168 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -178.68 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 36.26 -94.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.699 -0.626 . . . . 0.0 109.821 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 105' ' ' TRP . 1.1 m-20 -85.23 -80.98 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 108.597 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.443 ' HB3' ' OH ' ' A' ' 142' ' ' TYR . 40.8 m-85 -157.42 40.44 0.3 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.0 OUTLIER 61.92 108.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.414 -0.804 . . . . 0.0 109.863 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -40.14 -39.39 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 109.848 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 57.4 t80 -59.44 -46.51 88.54 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.146 -0.971 . . . . 0.0 109.803 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.875 HD12 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -67.6 -54.44 19.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.569 -0.707 . . . . 0.0 109.814 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.599 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 14.2 m -58.78 -50.25 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.837 -1.164 . . . . 0.0 109.499 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.82 -43.29 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.505 -0.747 . . . . 0.0 110.07 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.17 -51.02 63.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.608 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 51.9 t60 -55.75 -61.37 2.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.954 -1.091 . . . . 0.0 109.234 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HB2' ' HZ ' ' A' ' 99' ' ' PHE . 67.1 mm-40 -63.9 -11.21 25.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.545 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -88.16 -18.76 28.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.776 -1.203 . . . . 0.0 108.032 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.38 -43.8 9.18 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -69.82 -43.24 72.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.31 -32.07 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 64.9 mtt -72.97 -80.65 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.03 -40.32 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.77 155.96 7.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.377 -1.072 . . . . 0.0 111.019 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -173.4 2.24 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 138' ' ' MET . 45.7 m170 -52.39 144.19 13.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.55 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -123.75 20.17 9.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 1.2 tp60 54.07 -156.17 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER 66.37 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -72.72 -41.17 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.311 2.007 . . . . 0.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.86 9.44 52.44 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -75.73 153.73 36.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.051 -1.264 . . . . 0.0 110.14 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.67 HD13 H382 ' A' ' 800' ' ' I52 . 14.4 tp -85.6 -21.64 28.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -111.97 28.3 8.88 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.76 76.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.32 9.29 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.933 1.755 . . . . 0.0 110.719 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 142' ' ' TYR . 56.3 mt -122.75 -99.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.008 -1.057 . . . . 0.0 109.366 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.3 t80 179.46 144.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 0.0 110.158 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.568 ' O ' H352 ' A' ' 800' ' ' I52 . 1.6 m -137.46 84.47 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 0.0 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -55.28 161.09 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.82 137.62 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.643 -0.661 . . . . 0.0 110.28 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.086 -1.009 . . . . 0.0 108.595 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 148' ' ' PHE . 42.8 t-20 -51.69 -29.91 19.99 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.496 ' O ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 59.45 134.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 1.8 tpt180 -113.45 -15.49 12.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.069 -1.019 . . . . 0.0 110.454 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER 84.13 -24.84 0.14 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 155' ' ' ILE . 97.6 p 55.99 132.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.937 0.875 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.64 ' O ' HG13 ' A' ' 155' ' ' ILE . 55.8 mt-30 -73.31 -24.4 60.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -49.76 -40.83 42.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 158' ' ' ILE . 1.4 t70 -83.18 -43.64 15.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 152' ' ' GLN . 1.2 pp -51.08 -34.23 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 157' ' ' GLY . 8.2 tmtt? -73.15 -48.02 38.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.113 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' N ' ' HD3' ' A' ' 156' ' ' LYS . . . -72.11 -53.95 8.62 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.723 HD11 ' CE2' ' A' ' 162' ' ' TYR . 10.3 tp -45.61 -51.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -1.183 . . . . 0.0 110.181 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.613 ' N ' HG23 ' A' ' 158' ' ' ILE . 5.4 mt-30 -57.61 -56.93 15.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.681 -1.262 . . . . 0.0 109.144 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.53 -25.92 0.31 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.644 -0.66 . . . . 0.0 110.402 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 12' ' ' ASP . 16.6 tp -97.02 -56.53 2.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 109.42 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 158' ' ' ILE . 15.7 m-30 -77.9 -77.38 0.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.901 -1.124 . . . . 0.0 108.682 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.452 ' OXT' ' HG2' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.635 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 0.766 H251 ' H61' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' CB ' ' A' ' 2' ' ' TYR . 5.0 mtm . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.167 0.508 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.469 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 75.71 -177.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.9 23.19 12.22 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' O ' ' CD2' ' A' ' 5' ' ' PHE . 55.4 m-85 55.41 -124.29 2.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.211 -0.931 . . . . 0.0 109.295 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' CD2' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 179.76 -58.57 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.676 -1.265 . . . . 0.0 109.861 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 5' ' ' PHE . 32.2 Cg_endo -72.73 124.2 9.56 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.085 1.857 . . . . 0.0 110.635 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.82 19.53 4.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 108.853 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -96.52 143.74 26.65 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.77 57.16 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 N-CA-C 108.017 -1.571 . . . . 0.0 108.017 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -57.96 165.53 1.8 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 13.0 m95 -84.4 72.58 10.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 5.9 m-20 -122.58 62.94 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 109.558 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 49' ' ' LEU . 5.0 mtmt -124.63 -163.55 1.18 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.998 -1.064 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -109.77 -34.9 6.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.83 . . . . 0.0 108.82 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -94.14 97.7 10.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.497 0.665 . . . . 0.0 109.844 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.94 169.04 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.758 -1.214 . . . . 0.0 108.63 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -138.79 134.61 33.66 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.162 -0.961 . . . . 0.0 108.503 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 18.0 p90 -135.28 145.18 47.28 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.077 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HB2' HG13 ' A' ' 54' ' ' ILE . 2.2 tpt180 -151.21 125.37 9.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' N ' ' HD2' ' A' ' 19' ' ' ARG . 1.2 mt -85.56 124.04 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.874 -1.141 . . . . 0.0 109.049 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 64' ' ' ASN . 24.0 mm -53.76 -27.29 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.911 -1.118 . . . . 0.0 109.261 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 162.38 86.24 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.908 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CG ' HG11 ' A' ' 32' ' ' VAL . 1.3 p90 -46.73 177.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.567 -0.961 . . . . 0.0 109.203 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -87.94 140.72 31.1 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 0.0 109.941 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -80.09 -23.5 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.632 2.221 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . 12.0 t0 -39.83 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.894 -0.504 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -132.51 170.85 14.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.768 -1.207 . . . . 0.0 110.34 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.576 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 65.7 m-20 -42.64 133.93 2.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.371 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -68.67 -31.03 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' HA ' ' OE1' ' A' ' 30' ' ' GLU . 5.6 mm-40 -76.02 -34.49 59.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.576 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 17.5 m -69.69 -52.55 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.422 -1.311 . . . . 0.0 108.038 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -55.66 -38.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -74.22 -31.27 62.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 22.7 t70 -64.36 -33.77 76.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -50.52 -47.91 57.27 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -71.36 -25.71 62.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -63.9 -64.55 0.86 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -53.76 -39.93 65.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.919 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -58.9 -51.12 71.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.4 t80 -44.19 -49.22 9.21 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 22.4 tt0 -70.49 -26.27 63.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -60.9 -33.83 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 108.509 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.919 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -103.04 -55.36 2.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.725 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -49.08 -35.12 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 3.6 t0 -62.96 -28.77 70.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.401 -0.812 . . . . 0.0 110.596 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.8 p -108.72 9.68 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -149.74 133.63 8.84 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.52 29.96 0.46 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.764 2.309 . . . . 0.0 111.358 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -85.57 141.39 29.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.652 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -101.38 121.7 42.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.854 -1.154 . . . . 0.0 109.44 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -94.78 143.2 26.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.741 -0.599 . . . . 0.0 109.449 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -124.47 141.39 52.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.852 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -99.43 162.39 13.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.942 -1.099 . . . . 0.0 108.847 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.821 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.86 164.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.707 -1.197 . . . . 0.0 110.02 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 6.1 p-80 -145.97 38.64 1.09 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.415 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 55' ' ' HIS . 0.4 OUTLIER 169.04 166.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.427 -0.795 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . 75.2 -81.14 0.94 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.557 ' O ' HD12 ' A' ' 54' ' ' ILE . 1.3 tp10 178.33 166.24 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -1.004 . . . . 0.0 108.856 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -138.89 146.78 41.55 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 109.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.59 -57.76 6.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.02 -1.05 . . . . 0.0 108.745 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -93.46 116.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 120.839 -1.163 . . . . 0.0 109.223 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 4.8 mtm -113.06 114.01 26.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.582 -0.699 . . . . 0.0 109.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.1 mp -98.77 153.14 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.139 -0.975 . . . . 0.0 109.839 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 97' ' ' SER . 20.8 p-10 -174.64 -171.47 0.57 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 34.5 p90 -116.21 -171.9 2.08 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' A' ' 98' ' ' HIS . . . -164.64 116.2 0.69 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HD3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.73 -169.65 2.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -1.171 . . . . 0.0 108.876 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -16.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.472 -0.767 . . . . 0.0 109.92 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HG3' ' HD3' ' A' ' 67' ' ' ARG . 12.9 mt-10 -76.55 -105.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.05 . . . . 0.0 110.813 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 1.2 t-80 56.28 -158.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.862 -1.149 . . . . 0.0 108.751 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.57 38.11 0.23 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD1' ' CD2' ' A' ' 70' ' ' HIS . 1.3 m-20 -75.86 4.19 8.58 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.468 -1.019 . . . . 0.0 110.283 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.6 -42.4 2.32 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 16.0 p90 -103.19 160.61 25.64 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.303 . . . . 0.0 110.601 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -78.85 142.05 17.39 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.974 2.45 . . . . 0.0 111.287 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.603 ' HE2' ' HE2' ' A' ' 98' ' ' HIS . 9.1 m-85 -58.34 146.76 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 109.654 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.23 2.66 8.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.641 -0.662 . . . . 0.0 109.953 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.04 -161.58 41.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 163.72 13.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.016 -1.285 . . . . 0.0 109.438 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 53.72 -170.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 108.698 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 66.71 -144.32 45.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.487 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' HG ' H251 ' A' ' 800' ' ' I52 . 0.3 OUTLIER -38.25 127.02 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.722 -0.869 . . . . 0.0 110.461 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -113.59 -23.98 9.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . -179.65 162.74 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.717 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.45 167.81 25.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.98 48.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -0.903 . . . . 0.0 110.039 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -81.83 169.68 16.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.951 -1.093 . . . . 0.0 109.858 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' CD1' ' A' ' 11' ' ' TRP . 35.6 Cg_endo -79.47 140.62 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.078 2.519 . . . . 0.0 111.009 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.54 -43.19 1.54 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.9 p -73.17 159.06 34.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.416 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 -16.86 63.28 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 93' ' ' VAL . 74.4 t -103.66 0.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -1.23 . . . . 0.0 109.168 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.52 159.4 20.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 77.91 -6.37 48.7 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -91.14 130.05 37.07 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.712 -1.463 . . . . 0.0 108.607 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 17.8 m -122.13 142.55 50.28 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.53 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.603 ' HE2' ' HE2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -116.13 122.24 44.49 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 108.856 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 26.8 m-85 -98.39 145.22 26.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' OE1' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -46.91 163.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 108.933 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 105' ' ' TRP . 34.3 t70 -117.61 -18.1 9.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.982 -1.074 . . . . 0.0 108.924 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -81.84 -31.41 31.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.127 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' OE1' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -67.13 161.58 24.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 110.651 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -106.02 106.58 17.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.722 -0.611 . . . . 0.0 109.465 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -116.15 122.74 45.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.0 108.908 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 110' ' ' ALA . 1.2 p -149.13 151.3 34.14 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.803 -1.186 . . . . 0.0 110.574 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.78 68.59 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.058 . . . . 0.0 110.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -172.63 77.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.459 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 108' ' ' THR . 2.4 p 45.67 75.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.464 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 106' ' ' THR . . . -155.77 -158.19 0.79 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -73.47 -114.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 110.471 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -62.15 146.45 50.57 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.067 -1.021 . . . . 0.0 109.843 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 106' ' ' THR . 3.5 m -110.02 110.34 21.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 110.448 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.69 HD22 ' CG2' ' A' ' 32' ' ' VAL . 2.1 tp -39.42 -45.62 1.53 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 110.521 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 3.7 t80 -54.83 -46.17 74.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -62.65 -72.12 0.14 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 118' ' ' ALA . 17.4 m -45.21 -49.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.528 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -54.08 -46.31 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.04 -1.038 . . . . 0.0 109.888 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -50.72 -58.82 4.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.721 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.431 ' CD2' ' CD2' ' A' ' 124' ' ' HIS . 37.6 t60 -42.68 -57.52 2.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.502 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.4 -16.4 62.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.954 -1.091 . . . . 0.0 109.546 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.701 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -81.98 -3.46 54.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 108.24 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.13 -41.38 1.41 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.431 ' CD2' ' CD2' ' A' ' 120' ' ' HIS . 31.4 m-70 -64.09 -32.01 73.42 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.38 -26.7 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 109.36 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 6.84 46.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 109.747 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.67 -8.65 78.7 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.609 HD21 ' HA3' ' A' ' 157' ' ' GLY . 5.7 mt -44.73 151.36 0.29 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 110.438 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -111.6 176.05 5.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -80.46 169.95 17.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.152 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -115.07 -22.97 9.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 131' ' ' SER . 9.3 mm100 82.99 -21.72 0.27 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.691 -0.631 . . . . 0.0 110.707 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -74.66 152.41 87.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.877 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.26 -39.54 3.82 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.5 2.134 . . . . 0.0 110.356 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.33 2.14 62.95 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.99 149.09 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -1.214 . . . . 0.0 110.18 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.916 HD13 H362 ' A' ' 800' ' ' I52 . 18.1 tp -80.38 -23.25 40.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.188 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' CE1' ' A' ' 120' ' ' HIS . 1.1 mpt? -109.87 26.22 10.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -58.73 164.85 3.68 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.178 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 34.4 Cg_endo -78.69 17.18 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.465 2.11 . . . . 0.0 111.195 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 142' ' ' TYR . 15.5 mt -140.66 162.11 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.787 -1.196 . . . . 0.0 110.07 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 16.7 t80 -91.68 118.84 31.02 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -108.8 -48.81 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 58.7 t80 60.93 165.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.067 -1.021 . . . . 0.0 109.999 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.584 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 152.6 30.12 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.659 -0.651 . . . . 0.0 109.271 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 6.8 tptm -92.03 -11.62 35.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 148' ' ' PHE . 12.2 m-80 -126.53 -91.98 0.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 150' ' ' LEU . 6.2 t80 156.93 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.13 -0.981 . . . . 0.0 109.724 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -150.95 -40.53 0.12 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.288 -0.883 . . . . 0.0 110.364 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 148' ' ' PHE . 9.6 tp 65.6 144.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.018 -1.051 . . . . 0.0 109.495 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -114.84 131.56 56.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 12.3 tt0 -48.95 -22.66 0.9 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -48.6 78.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.888 -1.132 . . . . 0.0 108.088 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -73.58 -33.77 64.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.665 HD12 ' O ' ' A' ' 155' ' ' ILE . 0.5 OUTLIER -70.17 -27.53 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.365 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -76.56 -46.62 25.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 110.455 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.609 ' HA3' HD21 ' A' ' 128' ' ' LEU . . . -71.64 -23.12 78.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 159' ' ' GLN . 6.5 tp -81.0 -39.74 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.838 -1.389 . . . . 0.0 108.449 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -68.61 -22.45 64.44 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -86.13 -25.06 25.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.465 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -80.02 -22.23 42.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.497 ' CG ' HD11 ' A' ' 49' ' ' LEU . 30.3 m-85 -120.3 -69.05 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 108.999 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 0.916 H362 HD13 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.455 0.645 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 10.5 t80 -101.08 -29.94 11.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.11 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -102.16 -167.04 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 109.001 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -141.02 108.1 5.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.821 -1.174 . . . . 0.0 109.465 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 51.59 81.85 0.25 Allowed Pre-proline 0 C--N 1.303 -1.414 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.491 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.92 41.58 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.229 1.953 . . . . 0.0 110.821 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -142.32 -154.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.046 -1.034 . . . . 0.0 109.845 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 7' ' ' ARG . 5.4 mttt -176.98 163.28 1.54 Allowed Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 109.731 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' LYS . 36.3 Cg_endo -79.87 66.78 8.77 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.149 1.899 . . . . 0.0 108.632 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 9.1 mtpt -41.7 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.562 -0.711 . . . . 0.0 109.615 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER 174.86 45.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.929 -1.107 . . . . 0.0 110.354 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.485 ' HB3' ' CE1' ' A' ' 162' ' ' TYR . 12.9 p-10 -144.57 84.52 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.467 -1.395 . . . . 0.0 111.329 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -115.95 49.11 1.14 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.034 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 9.8 m-20 65.34 -69.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' LYS . 4.2 mt-30 -80.67 110.35 16.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.995 -1.066 . . . . 0.0 109.103 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.1 mm -104.18 164.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -128.2 137.55 52.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' ILE . 13.2 p90 -149.15 154.3 38.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.043 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.88 ' HB2' HG23 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -147.53 125.43 11.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.847 . . . . 0.0 109.865 -178.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.4 mt -86.02 124.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 64' ' ' ASN . 2.8 mt -74.18 3.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.89 -1.131 . . . . 0.0 110.43 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 145.42 112.56 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -61.63 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.113 -1.228 . . . . 0.0 107.788 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 27' ' ' LEU . 1.8 t -106.84 137.38 19.48 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.858 -1.151 . . . . 0.0 108.121 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.59 -24.74 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.206 1.938 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.26 -24.83 3.14 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.763 -0.586 . . . . 0.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -138.47 177.0 8.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.878 -1.139 . . . . 0.0 111.002 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 32' ' ' VAL . 74.8 m-20 -53.87 129.51 56.45 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.649 -0.657 . . . . 0.0 110.436 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.764 ' HA ' HG23 ' A' ' 32' ' ' VAL . 27.0 Cg_endo -73.79 -33.65 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 N-CA-C 105.394 -2.579 . . . . 0.0 105.394 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.72 -36.24 82.36 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.7 m -66.27 -71.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -41.32 -28.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 0.0 108.981 178.024 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -72.47 -38.37 68.23 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' THR . 24.2 t0 -79.89 -58.57 3.11 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . . . -36.77 -39.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.642 0.734 . . . . 0.0 109.034 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 63' ' ' ILE . 3.6 m-85 -68.26 -65.78 0.65 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -44.52 -51.02 9.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.773 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -59.26 -52.5 65.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -43.91 -52.57 6.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -46.38 -40.91 12.79 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.505 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' ARG . 0.1 OUTLIER -71.56 -20.33 62.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.546 -0.721 . . . . 0.0 110.591 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -86.47 -32.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.259 -1.526 . . . . 0.0 109.196 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.6 ' CH2' ' HA2' ' A' ' 123' ' ' GLY . 3.7 m95 -91.13 -19.01 23.56 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.626 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 28.9 t -91.37 -23.04 20.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 8.4 m-20 -65.34 -5.55 7.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.245 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' HB ' ' A' ' 155' ' ' ILE . 12.2 p -120.49 4.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.535 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 7.9 t -159.08 149.05 15.16 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.598 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -79.11 49.59 3.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.337 2.025 . . . . 0.0 109.856 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' A' ' 162' ' ' TYR . 4.8 tp -93.67 150.56 20.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.3 -0.875 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -122.95 136.79 54.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 109.073 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 51' ' ' PHE . 6.7 m-85 -112.56 149.72 32.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.929 -1.107 . . . . 0.0 110.183 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -125.11 126.68 45.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.208 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 6.0 mtm-85 -77.97 126.73 31.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 108.481 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.88 HG23 ' HB2' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.64 141.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.223 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.405 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -72.44 -145.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.53 -174.13 4.1 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 108.636 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.63 42.64 4.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.43 160.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -1.041 . . . . 0.0 109.203 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -153.46 148.94 27.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -53.55 -59.97 3.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 108.802 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -104.57 124.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 74.9 mtp -111.96 113.88 26.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 110.987 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 64' ' ' ASN . 1.6 mp -102.71 159.7 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.648 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.8 p-10 174.99 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.445 -0.784 . . . . 0.0 109.397 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -115.41 175.67 5.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.175 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.63 90.88 0.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -71.87 -145.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 108.059 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 67' ' ' ARG . 5.4 m95 -63.22 -147.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.485 -1.385 . . . . 0.0 108.648 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 47.79 -143.54 0.4 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.03 -1.044 . . . . 0.0 109.927 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.02 156.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -130.72 23.94 4.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.3 74.95 0.09 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.462 -1.022 . . . . 0.0 108.99 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 63.48 -87.51 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' CD1' ' N ' ' A' ' 74' ' ' TYR . 3.1 m-85 -108.71 117.98 52.87 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.294 -1.121 . . . . 0.0 108.713 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.52 158.38 40.19 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.68 1.586 . . . . 0.0 109.916 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 17.8 t80 62.64 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 80.95 -46.17 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.15 -157.56 23.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -57.31 165.5 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -1.163 . . . . 0.0 108.826 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 3.3 m-20 43.69 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.229 -0.919 . . . . 0.0 111.135 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 61.17 -142.32 48.4 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' HB3' ' OD2' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -40.08 106.83 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.655 -0.909 . . . . 0.0 109.347 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 mt -111.21 -26.92 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 165.05 152.93 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.385 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.677 ' HA ' ' H2 ' ' A' ' 800' ' ' I52 . 34.1 p80 -152.24 177.05 10.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.411 -0.806 . . . . 0.0 108.961 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.22 155.92 46.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 108.775 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 156.22 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 110.078 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -72.27 162.47 73.58 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 30.2 Cg_endo -73.75 136.76 23.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.807 2.338 . . . . 0.0 111.112 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.66 -165.82 28.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -86.48 117.96 25.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -1.086 . . . . 0.0 110.339 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.64 -89.81 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.6 ' O ' HG23 ' A' ' 93' ' ' VAL . 32.6 m -71.32 119.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.082 -1.246 . . . . 0.0 109.065 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.39 158.65 8.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.75 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 67.27 6.9 42.42 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' MET . 2.7 m-20 -97.98 140.83 31.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -1.194 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.8 131.15 25.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.02 . . . . 0.0 109.769 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 1.9 m170 -106.32 135.5 47.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.029 -1.044 . . . . 0.0 109.309 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 58.9 m-85 -96.52 158.83 15.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.457 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -55.43 129.42 38.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.698 -0.627 . . . . 0.0 109.683 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.14 -70.27 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 22.3 p-10 -60.7 86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 110.592 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -179.48 179.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.8 tp -119.32 100.77 7.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.906 -1.121 . . . . 0.0 109.385 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.761 ' O ' HD23 ' A' ' 27' ' ' LEU . 24.4 m0 -112.45 173.91 6.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.246 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 105' ' ' TRP . 0.5 OUTLIER 179.62 162.65 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.969 -1.082 . . . . 0.0 110.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.565 ' HB3' HG23 ' A' ' 31' ' ' THR . 45.7 t30 -104.84 21.74 16.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 109.869 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -124.01 -179.7 4.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.512 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 108' ' ' THR . 8.1 t -66.69 69.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.377 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 106' ' ' THR . . . -160.41 115.96 2.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.424 -0.798 . . . . 0.0 109.104 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.96 -150.3 0.26 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.443 -0.786 . . . . 0.0 108.984 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HD2' ' CD1' ' A' ' 105' ' ' TRP . 42.3 m-85 -67.88 -147.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.094 . . . . 0.0 108.4 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 106' ' ' THR . 22.4 t -148.71 98.64 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.061 -1.024 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -35.69 -57.97 0.63 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.384 -0.822 . . . . 0.0 111.286 -179.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' C ' ' CD1' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -49.66 -40.57 40.25 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.168 -0.958 . . . . 0.0 109.792 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.013 HD11 ' H33' ' A' ' 800' ' ' I52 . 3.0 tm? -70.36 -55.14 9.83 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 110.521 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 118' ' ' ALA . 35.7 m -58.36 -48.63 84.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 O-C-N 120.437 -1.414 . . . . 0.0 108.057 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -46.56 -52.37 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.94 -1.1 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.03 -54.53 6.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 108.605 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.552 ' CE1' ' HE2' ' A' ' 138' ' ' MET . 43.8 t60 -46.48 -64.63 0.71 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.102 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.506 ' HA ' ' OE1' ' A' ' 121' ' ' GLU . 66.3 mm-40 -63.23 -15.34 56.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.772 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.6 m-85 -82.12 -10.61 59.13 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.6 ' HA2' ' CH2' ' A' ' 43' ' ' TRP . . . -99.31 -48.38 1.71 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.435 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 12.8 m-70 -55.93 -40.54 73.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -1.07 . . . . 0.0 108.856 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.31 -4.66 18.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.465 -0.772 . . . . 0.0 109.554 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.482 ' HG2' ' OH ' ' A' ' 162' ' ' TYR . 26.7 mtt -103.04 -14.84 16.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 0.0 110.902 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.22 -11.67 12.91 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.677 -1.264 . . . . 0.0 110.678 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD12 ' CH2' ' A' ' 43' ' ' TRP . 30.9 mt -81.07 138.53 35.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.897 -1.355 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.39 178.27 4.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 138' ' ' MET . 50.4 m170 -55.53 148.28 16.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 0.0 110.247 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.4 p -112.39 -173.14 2.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -108.03 -14.46 14.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.004 -1.06 . . . . 0.0 109.715 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -70.04 134.72 87.46 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 133' ' ' ASP . 33.2 Cg_endo -79.51 109.84 2.55 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 123.056 2.504 . . . . 0.0 110.115 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.78 -2.77 17.48 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.11 170.7 1.53 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.353 -1.086 . . . . 0.0 109.406 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.875 HD13 H362 ' A' ' 800' ' ' I52 . 8.3 tp -84.68 -25.86 28.15 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.782 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.597 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 2.9 mmt -97.79 4.23 49.84 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.989 -1.069 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -41.69 156.75 0.22 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.13 2.37 7.71 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.426 2.084 . . . . 0.0 111.574 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.46 160.94 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.915 -1.116 . . . . 0.0 108.196 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.557 ' O ' ' CB ' ' A' ' 143' ' ' THR . 75.0 t80 -56.52 -82.28 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.563 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.557 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 3.2 m 81.59 -33.56 0.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.039 -1.038 . . . . 0.0 111.792 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.532 ' O ' H352 ' A' ' 800' ' ' I52 . 3.0 t80 71.59 175.23 0.29 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.686 -1.259 . . . . 0.0 109.426 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.916 ' HA ' H372 ' A' ' 800' ' ' I52 . 4.6 p -85.34 4.28 35.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 109.119 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.602 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 46.99 47.73 15.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.232 -0.917 . . . . 0.0 110.435 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.4 t30 89.16 21.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.619 ' N ' ' OG1' ' A' ' 145' ' ' THR . 48.7 t80 52.34 164.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 109.938 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.567 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 165.2 -22.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.61 -178.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.535 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 69.01 123.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 108.881 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.62 134.99 49.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.032 -1.042 . . . . 0.0 110.668 -178.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 0.8 OUTLIER -50.61 -19.99 1.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.38 -56.06 26.78 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.688 -1.257 . . . . 0.0 108.055 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.638 ' OD2' HD23 ' A' ' 137' ' ' LEU . 4.2 t0 -68.46 -32.13 71.91 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.68 HD12 ' C ' ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.29 -37.39 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.603 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 155' ' ' ILE . 8.4 tmtt? -61.73 -49.32 76.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.304 -0.873 . . . . 0.0 109.39 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -68.25 -39.83 87.84 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 155' ' ' ILE . 2.7 tp -66.17 -17.65 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.841 -1.388 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 163' ' ' GLY . 66.0 mt-30 -87.82 -49.02 7.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.092 . . . . 0.0 109.282 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -13.63 62.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 0.0 109.278 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -101.76 -42.3 6.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.839 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' A' ' 49' ' ' LEU . 21.8 m-30 -107.17 -13.21 15.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.794 -1.191 . . . . 0.0 110.312 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 1.013 ' H33' HD11 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptt? . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.16 132.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.321 -0.862 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.66 -161.59 1.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 5' ' ' PHE . 4.3 t80 -102.12 26.76 7.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.114 -0.991 . . . . 0.0 108.697 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 4' ' ' PHE . 25.5 m-85 42.86 84.31 0.19 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 109.32 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.33 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.569 2.179 . . . . 0.0 110.364 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER 44.35 -165.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.247 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -44.74 161.86 0.22 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.441 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 10' ' ' LYS . 36.7 Cg_endo -80.49 55.09 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.378 2.052 . . . . 0.0 107.58 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' A' ' 89' ' ' PRO . 0.1 OUTLIER 60.35 128.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' LYS . 14.6 m95 -37.5 110.64 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.56 -0.712 . . . . 0.0 110.338 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.7 p-10 -128.81 54.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -108.84 -167.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.287 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -108.57 -41.7 4.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.023 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 19.3 mt-30 -92.92 116.77 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.071 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -111.45 161.07 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.039 -1.038 . . . . 0.0 109.595 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.3 p -131.69 126.07 33.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.397 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 34.1 p90 -137.05 148.53 46.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.768 ' HG2' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.33 140.85 29.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.075 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.2 mp -92.89 161.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -108.38 -39.72 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . -161.58 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.222 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.966 ' CE1' HD13 ' A' ' 20' ' ' ILE . 15.5 m-85 -45.74 172.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -1.183 . . . . 0.0 108.962 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.587 ' CG2' HD11 ' A' ' 27' ' ' LEU . 9.9 t -97.98 145.41 29.74 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 34.2 Cg_endo -78.29 -28.69 4.47 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.313 2.009 . . . . 0.0 111.22 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.496 ' OD2' HG22 ' A' ' 106' ' ' THR . 3.9 t70 -41.56 -28.49 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.868 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -133.33 179.68 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.037 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.722 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -73.6 152.27 89.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.245 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 32' ' ' VAL . 26.5 Cg_endo -67.08 -32.61 34.02 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.872 2.381 . . . . 0.0 105.971 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.48 -31.95 71.6 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 107' ' ' ASN . 1.4 m -72.84 -69.39 0.42 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.97 -31.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.452 -0.78 . . . . 0.0 109.052 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 4.6 t0 -79.84 -33.05 40.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 31' ' ' THR . 21.7 t70 -78.93 -44.88 21.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 108.589 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 114' ' ' LEU . . . -44.62 -48.9 10.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 17.1 m-30 -71.44 -44.99 63.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.405 -0.81 . . . . 0.0 108.934 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -51.37 -54.17 29.09 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -53.32 -42.47 66.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.796 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -56.54 -49.67 74.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' A' ' 44' ' ' SER . 10.1 t80 -47.22 -33.76 5.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -86.81 -24.05 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.712 -0.617 . . . . 0.0 109.72 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -59.59 -35.34 58.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.258 -0.902 . . . . 0.0 108.851 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.796 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -105.96 -49.66 3.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.454 -0.779 . . . . 0.0 110.104 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 48.2 t -53.83 -21.7 8.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.178 -0.951 . . . . 0.0 110.639 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 6.2 m-20 -67.12 -13.89 62.38 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.878 HG23 HG23 ' A' ' 47' ' ' THR . 32.8 m -122.01 -20.83 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 0.0 110.434 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.878 HG23 HG23 ' A' ' 46' ' ' VAL . 54.0 p -122.58 143.8 40.77 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 109.405 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.05 57.99 4.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.097 1.864 . . . . 0.0 108.945 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 162' ' ' TYR . 3.0 mm? -84.64 144.84 28.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.904 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.462 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 9.3 tpm_? -116.6 66.64 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 108.778 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 47.2 m-85 -59.5 148.68 32.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 108.92 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.4 t -139.32 106.65 5.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.522 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 2.3 ptt85 -76.6 126.57 31.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 108.752 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.88 HD11 ' HA ' ' A' ' 59' ' ' ALA . 6.3 pt -117.95 166.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.937 -1.102 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 55' ' ' HIS . 9.7 p80 -154.01 70.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.071 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.44 6.01 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.725 -1.235 . . . . 0.0 109.824 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 58' ' ' GLU . . . 106.76 32.72 3.5 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 172.18 158.35 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.178 -1.189 . . . . 0.0 109.701 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.88 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . 178.95 143.04 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.764 . . . . 0.0 109.034 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.56 -57.38 9.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.077 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 95' ' ' GLY . 9.8 mt -90.51 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.169 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.605 ' C ' HD12 ' A' ' 63' ' ' ILE . 2.7 mtt -147.35 118.2 7.62 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.813 . . . . 0.0 109.776 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.813 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.0 mp -105.82 148.95 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 5.8 t30 176.44 -156.25 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.225 -0.922 . . . . 0.0 109.274 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -127.43 171.21 11.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.905 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.52 86.52 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.016 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 68' ' ' TRP . 1.4 ptt85 -78.26 -160.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.099 -1.236 . . . . 0.0 109.686 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.541 ' CE3' ' C ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -42.95 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.256 -0.903 . . . . 0.0 110.562 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -36.74 95.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.58 -0.7 . . . . 0.0 110.374 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' TRP . 2.2 t-80 -168.57 -61.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 76.77 -2.66 58.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 74' ' ' TYR . 4.1 p-10 -56.1 83.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.155 -1.203 . . . . 0.0 110.13 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 61.18 -75.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 72' ' ' ASP . 24.3 m-85 -100.69 137.11 19.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.274 . . . . 0.0 110.146 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.15 -157.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.576 2.184 . . . . 0.0 109.221 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -80.63 140.66 35.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.134 . . . . 0.0 109.153 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 40.2 p-10 -116.19 -15.6 11.05 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.05 -154.43 33.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' ASP . 1.1 mttt -47.25 154.6 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -1.171 . . . . 0.0 110.843 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' LYS . 15.6 m-20 49.5 -177.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.621 -0.674 . . . . 0.0 110.18 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 76.39 -144.97 31.24 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 28.6 tp -40.27 116.61 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.493 -1.004 . . . . 0.0 110.022 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD23 ' OE1' ' A' ' 103' ' ' GLU . 57.8 mt -112.02 -28.16 8.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 176.47 147.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 109.771 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -150.16 179.52 8.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -148.13 158.23 43.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.0 108.993 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.46 155.73 18.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.226 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -55.51 155.14 10.75 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.579 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.514 ' CG ' ' HE2' ' A' ' 10' ' ' LYS . 33.5 Cg_endo -75.2 141.41 26.03 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.761 2.307 . . . . 0.0 110.436 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.9 177.48 48.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.96 114.18 15.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.237 . . . . 0.0 109.236 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.78 -85.51 0.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.16 156.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -1.131 . . . . 0.0 108.928 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 109.69 156.22 16.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 74.83 -0.54 57.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -98.83 137.83 36.84 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.872 -1.369 . . . . 0.0 109.118 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -132.26 130.85 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.905 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -111.66 133.79 53.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.312 -0.867 . . . . 0.0 108.828 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 3.7 m-30 -95.95 159.8 14.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.544 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CB ' ' OE1' ' A' ' 103' ' ' GLU . 1.6 t70 -58.83 136.81 57.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 109.359 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.92 -9.2 58.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.229 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.5 -42.19 12.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.786 . . . . 0.0 109.742 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.612 ' OE1' HD23 ' A' ' 83' ' ' LEU . 3.1 mp0 -72.7 140.93 48.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.74 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 104' ' ' LEU . 1.1 mp -105.21 128.18 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.427 -0.795 . . . . 0.0 109.277 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.609 ' CZ2' ' HB2' ' A' ' 99' ' ' PHE . 1.9 m-90 -101.01 166.56 10.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.847 ' HA ' HD23 ' A' ' 27' ' ' LEU . 82.6 p -149.46 -168.3 3.07 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.056 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.579 ' HB3' HG23 ' A' ' 31' ' ' THR . 8.1 p-10 -135.2 6.33 3.32 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.128 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 109' ' ' SER . 11.1 t -139.22 -152.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.237 -0.915 . . . . 0.0 109.98 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.91 108.77 18.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.4 -0.813 . . . . 0.0 108.87 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.8 -97.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.262 -0.899 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -120.79 -78.05 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.069 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -100.92 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.127 -0.983 . . . . 0.0 109.073 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -164.61 114.63 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 32' ' ' VAL . 8.4 tp -50.16 -70.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.5 -0.75 . . . . 0.0 110.318 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' LEU . 8.0 t80 -39.5 -27.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.427 -0.795 . . . . 0.0 110.173 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.559 ' CD1' ' H31' ' A' ' 800' ' ' I52 . 1.0 OUTLIER -78.57 -71.6 0.42 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.836 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 118' ' ' ALA . 14.6 m -52.46 -42.43 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.917 -1.115 . . . . 0.0 109.154 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.88 -45.92 78.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.69 68.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.229 -0.919 . . . . 0.0 108.87 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 137' ' ' LEU . 24.0 t60 -60.52 -54.06 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 110.104 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 124' ' ' HIS . 73.5 mm-40 -69.05 -53.36 20.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.133 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.622 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 13.4 m-85 -49.59 -24.09 1.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.955 -1.091 . . . . 0.0 108.47 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.45 -27.53 24.74 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 2.1 m-70 -76.3 -48.23 20.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.689 -0.889 . . . . 0.0 109.183 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -42.88 -27.49 0.19 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.609 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -71.9 -98.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.782 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.58 29.14 0.19 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.76 144.84 24.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.742 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -119.96 151.78 38.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 138' ' ' MET . 12.2 m-70 -51.29 117.6 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 110.015 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -88.76 -80.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.082 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 131' ' ' SER . 5.6 tt0 177.03 -34.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.625 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -43.0 139.6 2.13 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.105 -0.997 . . . . 0.0 110.138 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.54 -38.86 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.431 2.088 . . . . 0.0 109.812 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.15 17.48 53.36 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 133' ' ' ASP . . . -85.09 149.42 25.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.066 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.923 HD22 H362 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -75.76 -10.99 59.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.583 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 0.8 OUTLIER -106.42 11.96 30.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -75.92 154.83 84.96 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.913 -1.117 . . . . 0.0 108.955 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.78 9.19 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.755 2.303 . . . . 0.0 111.477 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.663 HD12 ' H ' ' A' ' 141' ' ' ILE . 0.1 OUTLIER -134.63 137.79 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 109.307 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.583 ' OH ' ' CD1' ' A' ' 144' ' ' TYR . 2.9 t80 -84.78 128.72 34.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.424 -0.798 . . . . 0.0 110.186 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' TYR . 96.2 m -122.16 100.26 6.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CD1' ' OH ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -40.21 149.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -0.808 . . . . 0.0 110.26 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.908 HG21 H392 ' A' ' 800' ' ' I52 . 6.1 t -149.56 102.88 3.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -16.93 32.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.442 -0.786 . . . . 0.0 110.269 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 148' ' ' PHE . 1.1 t30 -95.25 -19.62 19.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.766 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.648 ' CE1' ' CG2' ' A' ' 42' ' ' VAL . 9.4 t80 49.2 104.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.701 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -121.32 -20.69 6.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 109.209 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 149' ' ' ARG . 15.5 tp 66.47 147.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.555 ' CB ' ' OD1' ' A' ' 153' ' ' ASP . 3.7 m -114.97 138.58 50.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 109.889 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.64 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 19.6 tt0 -49.09 -31.42 7.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 110.533 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.555 ' OD1' ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -46.3 -50.03 16.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.565 -1.334 . . . . 0.0 108.638 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -75.17 -31.33 60.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.474 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.69 -26.05 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 108.991 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -74.85 -53.57 8.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.252 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -59.32 -41.07 96.71 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 47' ' ' THR . 0.6 OUTLIER -75.78 -22.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -1.232 . . . . 0.0 109.751 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.572 ' NE2' HD13 ' A' ' 155' ' ' ILE . 36.6 mt-30 -79.25 -42.21 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 108.931 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.17 -22.86 15.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.805 ' HB3' HD21 ' A' ' 49' ' ' LEU . 17.6 m-85 -130.61 -24.99 2.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.589 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 0.923 H362 HD22 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.229 0.538 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.24 -33.35 6.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.285 -0.885 . . . . 0.0 109.828 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -61.57 150.09 37.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -114.4 110.58 20.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.534 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.55 106.47 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.343 -0.848 . . . . 0.0 109.474 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.6 136.59 19.41 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.628 2.219 . . . . 0.0 111.187 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.74 -163.74 0.67 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.516 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.0 158.48 52.99 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.199 -0.938 . . . . 0.0 110.501 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 8' ' ' LYS . 35.2 Cg_endo -75.51 58.21 5.13 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.283 1.989 . . . . 0.0 108.988 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HE3' HD13 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -55.6 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.551 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 172.05 42.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 16.1 p-10 -130.35 99.76 5.13 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLN . 2.4 mtmt -120.92 34.52 5.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.43 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.9 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.097 -1.002 . . . . 0.0 108.586 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.598 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt-30 -86.94 104.93 16.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.277 -0.89 . . . . 0.0 108.672 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 mt -112.84 153.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -115.19 148.41 39.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' A' ' 61' ' ' ILE . 15.9 p90 -151.94 155.24 37.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.932 . . . . 0.0 109.797 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -148.84 133.48 17.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.746 -179.495 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 22' ' ' GLY . 4.3 mt -96.17 124.85 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.917 -1.114 . . . . 0.0 108.834 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 62' ' ' MET . 2.8 mp -76.74 -1.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 0.0 109.474 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.764 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 157.71 100.81 0.17 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.438 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.746 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.88 -163.52 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -94.58 148.35 34.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.94 -1.1 . . . . 0.0 108.94 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' LEU . 35.1 Cg_endo -83.59 -29.11 1.16 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.559 2.839 . . . . 0.0 110.603 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -41.96 -26.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.57 -0.706 . . . . 0.0 109.528 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -129.4 166.03 20.36 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.266 -0.896 . . . . 0.0 109.613 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -58.63 147.95 68.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.492 -0.755 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 32' ' ' VAL . 28.9 Cg_endo -67.64 -34.85 24.04 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 106.131 -2.296 . . . . 0.0 106.131 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.58 -28.33 60.88 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 2.9 m -72.88 -63.42 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.746 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -45.92 -39.54 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.557 -0.714 . . . . 0.0 109.354 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 19.5 t0 -67.56 -29.84 69.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.1 t70 -61.39 -50.52 72.55 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.84 -39.38 5.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 109.317 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 85.5 m-85 -73.11 -36.2 66.7 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.687 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -56.0 -57.59 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 108.516 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' ALA . 2.7 mtm180 -61.34 -51.61 68.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.768 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -45.23 -48.99 12.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 28.6 t80 -49.99 -44.74 51.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 108.879 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 8.1 tt0 -79.87 -19.13 49.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 109.912 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -62.58 -36.08 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.028 -1.045 . . . . 0.0 108.502 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.768 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -108.42 -46.67 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.725 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -51.33 -20.3 1.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.053 . . . . 0.0 110.042 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.2 m-20 -64.92 -10.31 27.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 110.473 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 43' ' ' TRP . 2.6 m -111.15 -18.88 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.991 -1.068 . . . . 0.0 109.861 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.555 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -131.67 155.03 81.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 108.846 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 31.8 Cg_endo -77.84 49.15 2.85 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.748 2.298 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -76.38 162.5 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.932 0.873 . . . . 0.0 111.182 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 1.1 tpt180 -138.4 116.73 11.92 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HE1' HD22 ' A' ' 49' ' ' LEU . 3.3 m-85 -99.9 136.66 39.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.749 -1.219 . . . . 0.0 109.399 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -123.05 100.84 7.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.1 tmt_? -80.39 135.79 36.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.882 -1.136 . . . . 0.0 109.451 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -111.12 163.47 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.506 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -119.75 -29.33 5.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -0.962 . . . . 0.0 108.961 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.65 98.65 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.41 -173.31 32.92 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.68 161.96 25.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.271 . . . . 0.0 110.394 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . . . -143.71 153.11 42.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 108.978 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -77.12 -49.35 15.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.931 -1.106 . . . . 0.0 109.313 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.99 131.28 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 21' ' ' ILE . 4.3 ttm -116.35 115.81 26.58 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.149 -0.969 . . . . 0.0 109.2 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 9.3 mt -108.5 148.38 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.085 -1.01 . . . . 0.0 109.689 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 29.3 t30 177.93 159.79 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' A' ' 67' ' ' ARG . 35.7 p90 -83.32 175.16 10.09 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 108.665 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 68' ' ' TRP . . . -113.39 -27.17 3.71 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.614 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 62.7 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -1.228 . . . . 0.0 109.813 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 36.1 t-105 -165.35 -56.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.843 -1.16 . . . . 0.0 109.331 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.55 74.16 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.645 -0.66 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -106.86 -66.39 1.02 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 84.96 -10.39 63.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 3.2 m-20 -62.65 73.4 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.509 -0.995 . . . . 0.0 108.893 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 59.84 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -86.28 138.25 34.42 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.122 -1.223 . . . . 0.0 109.644 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.66 -175.06 2.54 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.405 2.07 . . . . 0.0 110.29 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -76.35 150.87 36.8 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.12 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD2' ' HA3' ' A' ' 81' ' ' GLY . 20.3 p-10 -115.07 -14.18 11.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 72.33 -92.12 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 80' ' ' ASP . 5.0 mttt -45.75 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.56 -0.964 . . . . 0.0 109.379 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -25.69 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.436 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 33.26 -139.24 0.1 Allowed Glycine 0 N--CA 1.502 3.093 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 81' ' ' GLY . 33.8 tp -37.18 118.67 0.63 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.885 . . . . 0.0 110.098 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' CE2' ' A' ' 112' ' ' TYR . 6.9 mt -105.2 -26.44 12.05 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . 170.5 175.94 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 109.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 55.5 p-80 -177.62 149.08 0.6 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.898 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB2' ' OG ' ' A' ' 97' ' ' SER . . . -132.35 175.62 9.12 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.63 156.87 26.29 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.09 -178.98 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 38.1 Cg_endo -80.57 144.36 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 11' ' ' TRP . . . -174.16 -172.2 39.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.659 HG22 ' N ' ' A' ' 92' ' ' GLY . 21.3 m -67.13 -96.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -1.04 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.659 ' N ' HG22 ' A' ' 91' ' ' THR . . . -70.09 -81.21 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 94' ' ' GLY . 31.6 t -61.9 172.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -1.143 . . . . 0.0 108.888 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 93' ' ' VAL . . . 96.92 150.94 27.46 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 62.07 9.67 22.95 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.343 -1.093 . . . . 0.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.53 ' CG ' ' CB ' ' A' ' 62' ' ' MET . 32.5 m-20 -102.37 134.52 45.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.082 -1.834 . . . . 0.0 109.248 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.821 ' OG ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 m -112.36 120.66 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.948 . . . . 0.0 110.523 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 8.1 m80 -95.23 129.11 42.47 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.778 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 8.3 m-30 -108.89 147.38 32.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.0 110.088 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 76' ' ' PHE . 9.3 t70 -76.88 112.16 13.18 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 103' ' ' GLU . 46.9 t0 -55.48 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.217 -0.927 . . . . 0.0 111.204 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' ASP . 1.9 m-20 -40.03 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 110.439 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 175.09 156.9 0.17 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.0 124.83 50.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.975 -1.078 . . . . 0.0 111.68 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TRP . . . . . 0.778 ' NE1' HG11 ' A' ' 117' ' ' VAL . 6.8 m0 -122.35 172.3 8.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 6.4 p -145.19 141.3 28.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.602 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 4.9 t-20 -103.26 27.99 6.76 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' SER . 8.8 t -142.05 25.89 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.468 -1.395 . . . . 0.0 110.626 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER 70.68 89.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.815 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.541 ' O ' ' CG2' ' A' ' 106' ' ' THR . . . 174.87 137.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.471 -0.768 . . . . 0.0 109.156 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.59 -149.04 0.27 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.859 -1.151 . . . . 0.0 108.651 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.619 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -65.17 -34.71 79.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.81 -1.181 . . . . 0.0 108.097 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER 75.38 124.73 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 110.393 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -66.55 -35.02 79.2 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.158 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -68.69 -43.29 76.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -178.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.89 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -64.58 -62.46 1.57 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.771 -1.205 . . . . 0.0 109.562 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.778 HG11 ' NE1' ' A' ' 105' ' ' TRP . 18.1 m -44.12 -46.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.209 -0.932 . . . . 0.0 109.61 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -62.49 -47.85 82.17 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.955 -1.091 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -48.36 -63.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.583 -0.698 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -46.62 -54.18 10.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.206 -0.934 . . . . 0.0 109.521 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.34 -18.81 65.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.963 -1.086 . . . . 0.0 108.254 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -81.89 -8.22 59.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -97.03 -37.89 4.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.468 ' CE1' ' CD2' ' A' ' 130' ' ' HIS . 55.3 m-70 -74.19 -47.41 35.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.33 -27.09 0.95 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.173 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 10.8 mtt -79.29 7.99 6.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.271 -0.893 . . . . 0.0 109.822 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 -23.75 27.22 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 128' ' ' LEU . 3.0 mm? -53.54 141.57 25.04 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.337 -1.096 . . . . 0.0 108.986 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.04 -176.43 2.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 109.528 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CD2' ' CE1' ' A' ' 124' ' ' HIS . 24.6 m170 -63.75 132.59 51.45 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -90.25 -115.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -159.41 -48.64 0.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.696 -1.253 . . . . 0.0 109.261 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 132' ' ' GLN . 0.9 OUTLIER -42.38 124.83 2.85 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.979 . . . . 0.0 109.718 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -78.37 108.01 2.4 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.093 1.862 . . . . 0.0 109.386 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 124.27 -13.83 7.87 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.601 ' O ' ' H33' ' A' ' 800' ' ' I52 . . . -57.33 157.66 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.379 -1.071 . . . . 0.0 110.352 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.862 ' HB2' H382 ' A' ' 800' ' ' I52 . 14.2 tp -63.13 -24.77 68.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.441 ' CE ' ' HG ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -102.7 12.92 35.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -61.57 149.2 84.87 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.702 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 36.6 Cg_endo -77.27 21.11 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.959 2.44 . . . . 0.0 110.917 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 141' ' ' ILE . 1.1 mt -142.46 145.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.888 -1.133 . . . . 0.0 110.396 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -69.34 148.07 50.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 144' ' ' TYR . 5.9 m -161.97 -33.46 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 42.9 t80 59.24 166.06 0.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.4 -0.813 . . . . 0.0 109.057 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.634 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 1.2 t -150.13 115.31 5.41 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.844 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -39.94 42.92 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.092 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 44.6 t-20 -73.25 -48.38 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.076 -1.015 . . . . 0.0 108.511 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 150' ' ' LEU . 39.7 t80 75.45 139.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.39 0.614 . . . . 0.0 109.68 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 1.6 tpt180 -155.65 -25.06 0.11 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.316 -0.865 . . . . 0.0 110.889 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.607 ' HG ' ' CZ ' ' A' ' 148' ' ' PHE . 6.2 mt 65.66 83.36 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -53.87 140.36 30.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.611 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 mt-30 -55.23 -35.3 64.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.355 -0.84 . . . . 0.0 108.994 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -47.01 -33.81 5.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.531 -1.356 . . . . 0.0 108.889 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -89.1 -28.42 20.11 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ILE . . . . . 0.611 ' CG2' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -71.03 -34.48 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 2.2 ttmt -73.29 -56.86 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.463 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -51.0 -37.29 36.06 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.49 -14.9 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -70.34 -57.13 5.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.334 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 13.1 mm-40 -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.759 -0.588 . . . . 0.0 109.474 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.465 HD13 ' HE3' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -73.4 -29.43 62.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -0.779 . . . . 0.0 111.024 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.558 ' CD2' HD11 ' A' ' 49' ' ' LEU . 42.4 m-85 -131.24 -51.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.471 -1.393 . . . . 0.0 109.174 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 800' ' ' I52 . . . . . 1.051 ' H72' ' H20' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.375 0.607 . . . . 0.0 110.704 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.549 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -57.89 134.57 56.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 109.238 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.594 ' OD1' HD13 ' A' ' 161' ' ' LEU . 8.5 t70 -175.87 74.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -164.01 139.94 6.37 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.338 -0.851 . . . . 0.0 109.905 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 4.2 p-10 -53.98 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 5.1 mt-30 47.67 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.959 -1.088 . . . . 0.0 110.305 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.478 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -115.25 149.96 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.7 132.51 56.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.852 -1.155 . . . . 0.0 109.383 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CB ' HG13 ' A' ' 61' ' ' ILE . 44.0 p90 -140.49 151.92 45.2 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.252 -0.905 . . . . 0.0 109.902 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 18.4 tpt180 -150.75 119.71 6.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.759 . . . . 0.0 109.372 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.827 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -70.51 138.82 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 27.8 mm -82.89 -5.47 9.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 172.79 105.67 0.19 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.827 ' CE1' HD13 ' A' ' 20' ' ' ILE . 3.8 m-30 -51.91 168.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.334 -1.098 . . . . 0.0 109.306 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.81 ' CG2' HD22 ' A' ' 27' ' ' LEU . 5.3 t -109.89 148.75 38.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.974 . . . . 0.0 109.762 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.3 Cg_endo -82.06 -36.39 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.883 2.389 . . . . 0.0 111.622 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 24' ' ' THR . 0.7 OUTLIER -42.43 -26.59 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.208 -0.933 . . . . 0.0 110.007 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.89 168.35 17.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.017 -1.052 . . . . 0.0 109.272 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CB ' ' OG1' ' A' ' 31' ' ' THR . 0.5 OUTLIER -57.4 147.79 57.29 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 108.787 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 29.6 Cg_endo -70.25 -45.85 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -69.61 -21.12 63.6 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 47.8 m -76.78 -50.06 14.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.138 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.05 ' HB ' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -55.33 -34.4 33.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.39 -39.88 92.31 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.043 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -44.43 27.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.33 -29.34 33.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.172 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.61 -44.09 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.305 -0.872 . . . . 0.0 108.96 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -61.01 -52.78 63.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -51.37 -58.56 5.91 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -45.32 -51.14 11.43 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -46.17 -50.23 15.91 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.327 -0.858 . . . . 0.0 110.003 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.71 -32.82 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.9 -1.125 . . . . 0.0 108.915 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.688 ' O ' HG12 ' A' ' 46' ' ' VAL . 4.7 m95 -100.54 -25.15 14.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -77.82 -18.25 56.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.094 -1.004 . . . . 0.0 108.39 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 43.7 t0 -71.46 -14.27 62.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.081 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.729 ' O ' HG22 ' A' ' 46' ' ' VAL . 3.7 p -102.92 10.7 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.284 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 9.2 t -178.13 148.15 0.63 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 109.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 34.6 Cg_endo -76.01 56.84 4.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.551 2.167 . . . . 0.0 110.393 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.965 HD23 ' CE1' ' A' ' 51' ' ' PHE . 9.2 tp -85.89 147.7 26.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.362 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -113.05 110.88 21.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.965 ' CE1' HD23 ' A' ' 49' ' ' LEU . 39.7 m-85 -97.01 141.78 29.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 109.478 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -132.42 125.09 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.27 140.35 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.534 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.38 -168.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.77 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -176.15 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -163.31 -32.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 110.199 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.54 27.9 17.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.9 OUTLIER 58.04 170.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -1.193 . . . . 0.0 109.161 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 54' ' ' ILE . . . -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.04 -1.038 . . . . 0.0 110.672 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CG ' ' CZ2' ' A' ' 11' ' ' TRP . 79.1 m-20 -58.91 -47.86 83.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -102.15 126.42 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 6.9 mtp -116.48 125.17 51.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 109.567 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' ILE . 2.6 mp -105.09 158.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.715 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.539 ' ND2' ' HB ' ' A' ' 21' ' ' ILE . 3.2 t-20 178.85 -138.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.141 -0.974 . . . . 0.0 109.816 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.77 -174.77 2.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.875 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' ARG . . . -106.63 -19.34 9.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 37.8 mtt180 60.75 170.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -1.211 . . . . 0.0 110.46 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 75' ' ' PRO . 41.0 m0 -81.33 -42.81 19.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 0.0 109.15 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 44.9 mt-10 -75.85 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.839 . . . . 0.0 109.077 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 1.5 t-80 78.17 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 72' ' ' ASP . . . 120.68 -22.51 8.18 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 71' ' ' GLY . 7.3 m-20 -37.72 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.591 -0.947 . . . . 0.0 110.017 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.95 31.18 0.08 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -179.67 74.32 0.18 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.447 -1.031 . . . . 0.0 108.405 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 76' ' ' PHE . 32.5 Cg_endo -73.21 134.43 21.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.612 2.208 . . . . 0.0 111.847 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.5 p90 50.53 158.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.332 1.063 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 1.4 p-10 178.56 -29.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 51.74 -156.84 3.42 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 78' ' ' GLY . 3.5 mttp 43.56 -173.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.229 1.014 . . . . 0.0 110.517 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 81' ' ' GLY . 1.5 m-20 -67.15 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 41.06 -139.18 1.55 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -49.86 123.38 7.94 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 108.646 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 16.5 mt -111.74 -22.11 11.32 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.4 -178.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.481 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 7.6 p-80 179.05 175.86 0.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.979 -1.075 . . . . 0.0 110.253 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.66 166.26 28.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 109.39 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.99 159.51 15.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.676 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -48.55 172.78 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.631 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 32.4 Cg_endo -73.69 137.98 25.76 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.119 1.879 . . . . 0.0 110.874 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' N ' ' HA3' ' A' ' 94' ' ' GLY . . . 175.77 -168.34 40.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.0 p -99.1 134.5 41.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 110.041 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.24 -82.46 0.66 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.481 ' HA ' ' OD2' ' A' ' 96' ' ' ASP . 0.9 OUTLIER -69.54 -41.37 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 110.205 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 90' ' ' GLY . . . -71.3 111.05 3.49 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.808 -1.186 . . . . 0.0 110.191 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 121.44 2.79 10.64 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.739 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 62' ' ' MET . 3.9 m-20 -95.96 140.02 31.32 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.415 -1.638 . . . . 0.0 109.865 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -121.3 142.62 49.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 59.5 m170 -114.76 130.71 56.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.809 . . . . 0.0 109.971 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -103.89 152.03 22.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' OD1' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -60.09 138.98 57.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.952 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -76.29 -78.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 8.5 t70 -66.04 91.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.016 -1.053 . . . . 0.0 110.672 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -159.81 -170.34 2.86 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.4 OUTLIER -138.38 82.69 1.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.705 -1.247 . . . . 0.0 110.867 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.32 130.62 42.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.08 -1.013 . . . . 0.0 109.449 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 110' ' ' ALA . 1.1 p -154.45 154.16 32.73 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.723 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.551 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 7.7 t30 -82.76 4.56 24.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 109' ' ' SER . 1.9 p -91.89 -145.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 108' ' ' THR . 6.3 t -89.9 37.99 0.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 106' ' ' THR . . . -64.14 -97.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 109.831 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -178.31 -46.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.061 -1.024 . . . . 0.0 109.639 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.441 ' OH ' ' CG ' ' A' ' 80' ' ' ASP . 94.4 m-85 -85.42 -36.32 20.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 109.176 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.851 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER 62.2 110.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -0.76 . . . . 0.0 110.591 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -50.86 -36.47 37.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 109.677 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.546 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.9 t80 -65.63 -35.9 82.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.674 HD12 ' OH ' ' A' ' 142' ' ' TYR . 2.1 tm? -80.58 -57.1 3.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.625 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.851 HG22 ' O ' ' A' ' 113' ' ' SER . 0.2 OUTLIER -50.42 -40.82 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.864 -1.148 . . . . 0.0 108.94 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -69.23 -49.52 55.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.857 . . . . 0.0 109.622 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -42.45 -59.78 1.74 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -49.18 -56.53 8.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.179 -0.95 . . . . 0.0 108.744 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 69.3 mm-40 -66.53 -11.99 55.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.53 -15.17 57.35 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CE ' ' A' ' 138' ' ' MET . . . -94.95 -42.04 3.91 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.665 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 5.0 m-70 -63.56 -49.16 74.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.11 . . . . 0.0 109.389 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -41.89 -26.39 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 124' ' ' HIS . 26.2 mmt -78.99 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.928 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . -157.91 -35.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.255 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 1.049 HD11 ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -46.25 149.72 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 109.579 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -129.29 163.06 26.5 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.665 ' CD2' ' HE2' ' A' ' 124' ' ' HIS . 25.5 m170 -44.28 137.41 3.56 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.064 -1.022 . . . . 0.0 109.228 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -112.89 11.9 19.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.23 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 0.5 OUTLIER 82.48 -24.8 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.21 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -66.49 124.89 89.43 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.67 -1.269 . . . . 0.0 109.737 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 141' ' ' ILE . 31.2 Cg_endo -72.58 -36.55 4.91 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.248 1.965 . . . . 0.0 110.555 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.49 11.07 47.17 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.23 174.69 7.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.999 -1.295 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 22.7 tp -88.17 -35.81 17.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.526 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -83.81 7.25 18.52 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -55.39 154.7 11.19 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.839 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.97 21.66 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.906 2.404 . . . . 0.0 112.246 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -134.91 133.72 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.595 -1.316 . . . . 0.0 109.532 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.674 ' OH ' HD12 ' A' ' 116' ' ' LEU . 75.8 t80 -73.21 121.88 21.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 110.122 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -125.05 111.43 15.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.388 -0.82 . . . . 0.0 108.919 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -59.93 160.43 7.81 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.091 -1.006 . . . . 0.0 110.209 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.8 p -99.09 83.0 2.81 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.659 -0.651 . . . . 0.0 110.493 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -3.47 30.49 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.854 -1.154 . . . . 0.0 108.275 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -160.0 20.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.526 -0.734 . . . . 0.0 109.113 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 3.3 t80 36.24 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.463 -0.773 . . . . 0.0 110.529 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.65 132.57 56.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.334 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 150' ' ' LEU . 50.8 mt -88.65 -163.41 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.384 -0.822 . . . . 0.0 109.838 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.0 p -167.12 131.43 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 109.648 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 155' ' ' ILE . 2.7 pt20 -59.63 -29.57 68.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 152' ' ' GLN . 4.0 m-20 -43.48 -37.62 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 107.956 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 158' ' ' ILE . 3.8 m-20 -85.42 -46.05 11.28 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.698 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.9 OUTLIER -51.95 -33.69 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.681 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -56.77 4.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.83 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 1.049 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -57.04 -39.46 89.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.448 ' HA ' HD12 ' A' ' 158' ' ' ILE . 9.0 tp -78.17 -18.78 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -1.23 . . . . 0.0 109.788 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -72.78 -48.12 40.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.88 . . . . 0.0 108.925 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -74.37 -21.65 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.594 HD13 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -85.25 -15.86 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.784 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.476 ' CD2' HD13 ' A' ' 49' ' ' LEU . 6.0 m-85 -140.11 -93.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.42 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.75 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.582 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -163.0 44.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.914 -1.116 . . . . 0.0 108.73 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.04 85.27 6.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -141.63 101.95 4.08 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 13' ' ' LYS . 7.7 m-20 -34.18 -85.71 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.894 -0.504 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -51.88 106.97 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 109.216 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CG2' HD11 ' A' ' 61' ' ' ILE . 3.3 mt -104.29 162.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 0.0 109.526 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.705 ' HB ' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -135.53 135.85 40.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -142.59 162.5 35.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.343 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.74 120.39 9.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.483 -0.76 . . . . 0.0 109.057 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.879 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -83.17 112.95 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.0 109.46 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' HG2' ' A' ' 62' ' ' MET . 7.7 mt -89.51 17.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 166.5 96.21 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CE1' HD13 ' A' ' 20' ' ' ILE . 20.3 m-85 -58.07 -114.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -1.074 . . . . 0.0 108.853 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.996 ' CG2' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -112.58 178.29 1.0 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.502 -1.374 . . . . 0.0 108.102 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 24' ' ' THR . 33.0 Cg_endo -76.57 -34.85 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.745 1.63 . . . . 0.0 112.324 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 24' ' ' THR . 5.6 t70 -158.64 81.73 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.768 -1.208 . . . . 0.0 112.191 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.996 HD22 ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -155.68 -178.98 7.68 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.184 -0.948 . . . . 0.0 108.737 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 1.3 m-20 -72.16 136.45 81.91 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 33' ' ' ASP . 26.8 Cg_endo -69.68 -30.88 21.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 106.444 -2.175 . . . . 0.0 106.444 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.17 -32.84 63.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.499 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 2.9 m -70.6 -62.65 1.31 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 23' ' ' TYR . 1.3 p -49.64 -43.28 18.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 3.0 t70 -64.85 -22.08 66.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.733 . . . . 0.0 109.109 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.3 t0 -78.38 -40.99 34.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.015 . . . . 0.0 110.174 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.595 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -57.52 -44.05 84.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.967 -1.083 . . . . 0.0 109.145 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 63' ' ' ILE . 75.2 m-85 -71.35 -48.57 49.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.27 -0.894 . . . . 0.0 108.637 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.31 -51.12 63.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 1.036 ' O ' HG22 ' A' ' 42' ' ' VAL . 61.3 mtp180 -67.18 -48.85 66.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.438 -0.789 . . . . 0.0 108.899 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . . . -41.98 -43.28 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.551 ' O ' ' CB ' ' A' ' 44' ' ' SER . 58.1 m-85 -68.52 -39.16 81.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ARG . 3.3 tt0 -71.56 -60.54 2.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.132 -0.98 . . . . 0.0 109.026 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 38' ' ' ARG . 1.7 m -46.18 -29.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.589 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 11.6 m95 -101.98 -19.0 15.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 11.2 t -88.7 -23.35 22.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.016 -1.053 . . . . 0.0 108.25 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -59.77 -12.56 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.716 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.7 p -110.62 19.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.003 . . . . 0.0 109.69 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 5.1 t -179.33 149.32 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.002 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 32.4 Cg_endo -76.0 57.82 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 110.486 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.65 HD11 ' CG ' ' A' ' 162' ' ' TYR . 18.8 mt -100.76 121.3 41.45 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.81 112.66 25.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 109.094 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 16' ' ' ILE . 56.3 m-85 -88.52 143.65 26.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.57 138.75 52.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.526 -0.734 . . . . 0.0 109.341 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -89.28 129.66 35.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.077 -1.014 . . . . 0.0 108.862 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.705 HD13 ' HB ' ' A' ' 17' ' ' THR . 2.5 pt -122.12 131.95 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 54' ' ' ILE . 4.4 p80 -60.32 -147.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.306 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -70.05 169.31 13.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.043 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.37 -147.29 18.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -83.03 150.91 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.253 . . . . 0.0 109.595 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.741 ' HB3' ' SD ' ' A' ' 62' ' ' MET . . . -160.91 150.4 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -77.88 -70.19 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 109.268 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -82.13 126.26 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.751 ' HG2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -120.96 115.83 23.94 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 4.6 mp -103.62 145.33 12.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.89 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 63.8 t30 -168.67 172.64 7.84 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 101' ' ' ASP . 31.2 p90 -119.94 160.77 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 109.842 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.71 128.87 1.73 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -96.9 -135.15 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 67' ' ' ARG . 1.6 t90 -49.92 -41.64 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.511 -1.368 . . . . 0.0 107.852 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' HIS . 2.8 tt0 -73.86 55.22 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 76' ' ' PHE . 4.1 t-160 -44.16 -50.63 8.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.175 -0.953 . . . . 0.0 109.27 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 18.11 44.98 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 72' ' ' ASP . 41.2 p-10 -151.47 28.04 0.65 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.349 -1.089 . . . . 0.0 109.892 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . 93.19 154.0 30.76 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.38 -0.914 . . . . 0.0 110.901 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.53 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 58.6 m-85 55.14 164.36 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 110.049 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 74' ' ' TYR . 34.4 Cg_endo -76.45 -159.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.004 1.803 . . . . 0.0 108.555 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.673 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 69.0 t80 177.54 168.86 0.65 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.9 -1.125 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.609 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 24.1 t70 50.63 40.61 24.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.705 -0.622 . . . . 0.0 110.345 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . -49.06 173.05 0.05 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.3 -2.32 . . . . 0.0 107.3 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 80' ' ' ASP . 1.1 ptmt -51.46 141.75 15.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.762 -1.434 . . . . 0.0 107.253 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 79' ' ' LYS . 21.2 t70 39.55 -111.21 0.11 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 25.85 -132.54 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 CA-C-O 121.432 0.462 . . . . 0.0 112.226 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.58 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -26.94 123.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.975 0.893 . . . . 0.0 111.914 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 73.5 mt -118.84 -28.6 5.54 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 172.51 146.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.511 -0.743 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.673 ' CE1' ' CE1' ' A' ' 76' ' ' PHE . 24.4 p-80 -144.92 149.25 34.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.339 -0.851 . . . . 0.0 109.262 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 97' ' ' SER . . . -123.61 159.44 29.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.892 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.41 151.8 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.075 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.17 168.96 0.78 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 109.624 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.3 Cg_endo -78.6 152.23 25.89 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.773 2.315 . . . . 0.0 110.569 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 91' ' ' THR . . . 179.58 -103.1 0.17 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -162.59 78.51 0.48 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -1.093 . . . . 0.0 109.357 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.06 -103.1 0.29 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.87 -2.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -1.168 . . . . 0.0 109.32 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -75.6 143.2 29.99 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.843 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 76.34 -4.4 49.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 1.6 m-20 -101.03 134.8 43.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.942 -1.328 . . . . 0.0 108.68 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 16.4 t -130.86 127.64 38.98 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.576 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 46.0 m80 -89.78 145.27 25.31 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.422 -0.799 . . . . 0.0 109.109 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -116.58 160.29 20.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.001 -1.062 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' CG ' ' OD1' ' A' ' 77' ' ' ASP . 3.5 m-20 -52.85 121.36 7.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 109.854 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 18.6 t0 -44.58 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' GLU . 35.3 m-20 -77.22 -128.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 83.92 -29.86 0.08 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 103' ' ' GLU . 16.0 tp 68.81 74.56 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.185 -0.947 . . . . 0.0 111.137 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.603 ' O ' ' HB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -94.0 163.19 13.59 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.96 HG23 ' N ' ' A' ' 108' ' ' THR . 9.7 t 171.48 -173.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.096 -1.002 . . . . 0.0 110.308 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.586 ' O ' ' OG1' ' A' ' 108' ' ' THR . 6.8 p-10 -50.19 -31.17 13.1 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.96 ' N ' HG23 ' A' ' 106' ' ' THR . 1.8 p 73.31 -110.89 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER 61.24 23.14 13.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 100.99 -3.707 . . . . 0.0 100.99 -168.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.446 ' N ' ' C ' ' A' ' 108' ' ' THR . . . -135.78 -45.26 0.66 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.318 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -158.39 -86.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.775 -0.578 . . . . 0.0 110.277 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.808 ' O ' HG21 ' A' ' 108' ' ' THR . 9.0 m-85 -121.16 126.64 50.21 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.669 ' OG ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.58 129.59 36.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 111.557 -178.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.595 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -57.09 -24.23 52.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.653 -0.654 . . . . 0.0 110.479 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 42' ' ' VAL . 1.7 t80 -73.64 -54.75 7.42 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.498 -1.376 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.8 HD21 ' CE1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -63.26 -51.0 67.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.926 -1.108 . . . . 0.0 109.144 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 118' ' ' ALA . 21.0 m -54.82 -53.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 109.907 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -66.91 -39.99 87.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.735 -1.228 . . . . 0.0 108.828 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 115' ' ' PHE . . . -47.6 -58.37 4.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.496 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 34.1 t60 -54.49 -42.6 70.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.157 . . . . 0.0 108.53 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 117' ' ' VAL . 54.2 mm-40 -71.73 -10.5 59.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.5 OUTLIER -87.28 -15.67 37.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.589 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -89.51 -45.6 4.59 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.496 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 1.5 m-70 -62.02 -45.97 91.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.475 -1.015 . . . . 0.0 108.417 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.68 -19.11 2.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.315 -0.865 . . . . 0.0 109.162 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.1 mtt -100.97 -5.51 25.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 113.21 -35.57 4.5 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.522 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 127' ' ' GLY . 1.8 mt -37.0 146.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.494 -1.003 . . . . 0.0 110.237 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 138' ' ' MET . 0.3 OUTLIER -113.08 -179.48 3.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 109.713 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.444 ' CD2' ' HE2' ' A' ' 124' ' ' HIS . 62.5 m170 -58.43 151.31 20.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -96.71 -177.73 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 0.0 109.519 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -13.24 6.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -101.05 142.36 24.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.94 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 32.5 Cg_endo -76.84 116.7 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.8 2.333 . . . . 0.0 109.564 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.81 -3.56 24.41 Favored Glycine 0 C--N 1.272 -2.989 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.77 -177.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.192 . . . . 0.0 109.772 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.508 HD21 ' CZ2' ' A' ' 43' ' ' TRP . 8.6 tp -96.06 -28.86 14.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 109.681 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -94.6 3.01 55.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -46.19 148.14 1.63 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.274 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.757 ' O ' HD13 ' A' ' 141' ' ' ILE . 36.5 Cg_endo -78.04 12.0 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.565 2.176 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.4 mm -133.64 155.69 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 0.0 110.262 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER -76.0 95.29 3.56 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.96 92.93 5.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 108.637 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.8 ' CE1' HD21 ' A' ' 116' ' ' LEU . 7.8 t80 -60.07 155.38 17.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -143.49 8.83 1.58 Allowed 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.626 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 144' ' ' TYR . 21.3 mtpt 52.6 -106.75 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.305 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 4.9 p-10 -56.94 -47.22 81.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.716 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.61 ' CZ ' HD12 ' A' ' 150' ' ' LEU . 5.8 t80 68.01 125.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.808 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -100.77 -70.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.61 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 4.0 tp 169.29 172.15 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -143.45 130.68 20.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.021 -1.049 . . . . 0.0 109.654 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.659 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 46.9 tt0 -54.63 -30.31 54.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.43 ' O ' HD21 ' A' ' 128' ' ' LEU . 51.5 m-20 -46.9 -41.61 16.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.577 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.552 ' OD1' ' CZ3' ' A' ' 43' ' ' TRP . 21.5 t0 -83.53 -36.14 24.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.659 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -63.57 -31.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 108.908 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -78.71 -44.72 22.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.55 -20.29 78.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.623 HG22 ' HA ' ' A' ' 155' ' ' ILE . 1.6 tp -93.9 -17.87 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 155' ' ' ILE . 2.9 pt20 -90.94 -31.48 16.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.081 . . . . 0.0 108.446 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 159' ' ' GLN . 2.0 mm-40 -86.94 -29.94 21.69 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -95.66 -28.11 14.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.65 ' CG ' HD11 ' A' ' 49' ' ' LEU . 2.1 m-85 -122.38 -91.28 0.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.452 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 158' ' ' ILE . . . . . . . . 0 N--CA 1.492 2.383 0 CA-C-O 118.036 -1.425 . . . . 0.0 109.756 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -95.98 106.76 18.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.808 -1.182 . . . . 0.0 110.022 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.05 81.58 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.093 . . . . 0.0 110.102 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.75 153.1 48.54 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.261 -0.9 . . . . 0.0 109.309 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -79.44 -89.21 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.46 111.27 1.33 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.275 -0.891 . . . . 0.0 108.948 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.893 HD12 ' HE1' ' A' ' 51' ' ' PHE . 73.7 mt -119.59 145.67 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.444 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 22.8 p -121.06 140.06 52.46 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.591 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 61' ' ' ILE . 34.0 p90 -139.28 -179.44 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.9 ptm180 -159.34 140.45 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.792 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.7 mt -95.27 145.18 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 64' ' ' ASN . 28.0 mt -90.19 -5.53 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.792 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 147.54 109.79 0.57 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -66.29 -163.3 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.047 -1.267 . . . . 0.0 108.812 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.639 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -108.49 146.8 34.4 Favored Pre-proline 0 C--N 1.293 -1.853 0 O-C-N 121.51 -0.744 . . . . 0.0 109.257 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 26' ' ' ASP . 29.9 Cg_endo -73.13 -26.15 15.21 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.441 2.094 . . . . 0.0 110.42 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 24' ' ' THR . 10.0 p-10 -35.23 -35.43 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.414 0.626 . . . . 0.0 109.976 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -133.04 171.66 13.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.988 -1.07 . . . . 0.0 110.245 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 5.5 m-20 -51.63 148.16 10.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.559 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 32' ' ' VAL . 32.3 Cg_endo -69.98 -32.44 17.68 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 N-CA-C 105.688 -2.466 . . . . 0.0 105.688 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -78.33 -31.26 48.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.617 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 21.4 m -73.7 -52.62 12.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.883 -1.136 . . . . 0.0 108.45 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 23' ' ' TYR . 1.8 p -47.74 -41.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 5.3 m-20 -61.43 -39.12 89.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.693 -0.63 . . . . 0.0 109.669 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -61.21 -37.5 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.206 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.93 -28.6 38.06 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.908 . . . . 0.0 109.074 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.19 -24.95 19.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 108.892 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.36 63.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -39.21 73.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -57.32 -40.58 78.22 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -60.61 -45.72 92.94 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -74.95 -15.85 60.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.685 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 ' HZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -84.3 -27.95 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.811 -1.181 . . . . 0.0 109.057 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -104.96 -25.2 12.67 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.709 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' THR . 9.7 t -85.11 -23.27 28.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.396 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.748 ' OD1' HD11 ' A' ' 150' ' ' LEU . 3.4 p30 -60.04 -22.39 62.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.16 -0.962 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.643 HG13 ' OD1' ' A' ' 45' ' ' ASP . 10.8 m -99.07 16.63 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.999 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.563 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t -173.52 152.74 2.16 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.093 -1.004 . . . . 0.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 33.8 Cg_endo -74.91 45.65 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.985 2.457 . . . . 0.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.861 HD23 ' HZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -87.3 144.14 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.231 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 99.03 5.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.309 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.893 ' HE1' HD12 ' A' ' 16' ' ' ILE . 15.9 m-85 -93.38 133.16 36.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.884 -1.135 . . . . 0.0 110.047 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.54 164.98 13.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.795 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.573 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 2.3 mtp-105 -111.17 137.62 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 108.808 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 7.2 pt -145.34 134.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.017 -1.052 . . . . 0.0 109.658 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.31 42.53 2.72 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.21 -67.24 0.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.3 -0.875 . . . . 0.0 110.049 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . -99.16 50.25 1.19 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 68.09 162.72 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.299 -1.118 . . . . 0.0 109.932 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . -129.49 173.17 10.82 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -84.9 -57.08 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.12 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -95.87 148.42 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 0.0 109.874 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.524 ' CG ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -123.52 116.9 23.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.502 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' SER . 46.9 mt -115.62 140.51 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 108.908 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.747 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.9 p-10 -154.49 -148.67 0.25 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.686 -1.258 . . . . 0.0 110.36 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -136.59 174.98 10.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.896 -1.127 . . . . 0.0 110.604 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 101' ' ' ASP . . . -122.77 99.27 0.64 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 101' ' ' ASP . 5.4 mtm180 -90.08 -6.96 54.91 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -1.072 . . . . 0.0 110.459 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 177.46 -162.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' PRO . 5.8 pt-20 -83.76 67.27 9.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.741 -1.224 . . . . 0.0 111.033 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -49.74 -172.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.0 109.136 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . -64.58 -9.49 38.32 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.66 ' CB ' ' CE1' ' A' ' 70' ' ' HIS . 11.5 t0 -54.89 -169.99 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.021 -1.282 . . . . 0.0 108.396 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.37 -8.95 26.3 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.344 -1.407 . . . . 0.0 110.095 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CD1' HD11 ' A' ' 82' ' ' LEU . 11.7 m-85 -110.67 118.33 48.87 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.206 -1.173 . . . . 0.0 108.652 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -75.47 -176.43 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.045 1.83 . . . . 0.0 110.31 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 68' ' ' TRP . 38.3 p90 -78.69 140.86 38.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.552 -0.718 . . . . 0.0 109.107 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 9.5 p-10 -115.55 6.66 14.69 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.24 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 62.75 -167.68 19.95 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.265 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -43.16 167.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -1.064 . . . . 0.0 109.874 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' LYS . 71.6 m-20 41.15 -162.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.277 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 -146.94 50.77 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.302 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.485 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -47.77 107.1 0.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.481 -1.011 . . . . 0.0 108.997 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 15.4 mt -91.23 -15.37 29.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.023 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.5 158.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.524 -0.735 . . . . 0.0 109.024 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -156.83 146.38 20.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.981 -1.075 . . . . 0.0 109.915 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 97' ' ' SER . . . -128.86 161.55 29.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.357 -0.839 . . . . 0.0 109.714 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.1 166.0 10.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.759 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.41 166.93 38.16 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.515 -0.74 . . . . 0.0 109.084 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.759 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 33.1 Cg_endo -76.87 157.54 34.94 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.51 2.14 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.41 -102.32 0.16 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -150.87 90.95 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.255 . . . . 0.0 110.038 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.83 -73.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.41 -1.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -1.209 . . . . 0.0 110.026 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -76.39 139.91 24.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 73.82 67.78 1.71 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.524 ' OD1' ' CG ' ' A' ' 62' ' ' MET . 14.9 m-20 -160.8 117.02 2.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 109.01 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -117.02 157.39 25.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.466 -0.771 . . . . 0.0 109.861 -179.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -129.79 146.81 51.52 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m-85 -111.19 144.24 40.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.123 -0.986 . . . . 0.0 110.022 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -44.7 167.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.586 -1.321 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.539 ' O ' ' OD1' ' A' ' 101' ' ' ASP . 5.1 t0 -97.43 -25.39 15.21 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -99.42 -144.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 178.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.4 OUTLIER 75.24 136.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.0 109.643 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -94.91 90.63 6.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.327 -0.858 . . . . 0.0 110.55 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.586 ' CB ' HD22 ' A' ' 114' ' ' LEU . 13.0 m0 -96.38 153.53 17.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.624 HG21 ' HB3' ' A' ' 110' ' ' ALA . 55.3 p -138.16 159.61 41.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.617 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 9.4 t30 -112.73 4.37 17.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 0.0 109.148 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 108' ' ' THR . 9.7 t -139.6 48.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.6 p 45.62 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.89 -1.131 . . . . 0.0 109.874 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 106' ' ' THR . . . -136.13 -42.11 0.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.909 -1.119 . . . . 0.0 109.974 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -137.48 -77.31 0.39 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.5 m-30 -107.98 -102.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER 165.43 98.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.835 -1.166 . . . . 0.0 110.633 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.586 HD22 ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -52.12 -35.24 47.59 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.106 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HZ ' HG21 ' A' ' 42' ' ' VAL . 2.2 t80 -66.33 -43.25 86.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 110.005 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.615 HD11 ' HA ' ' A' ' 144' ' ' TYR . 1.2 mt -59.41 -60.96 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.004 -1.06 . . . . 0.0 109.566 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.445 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.7 m -52.66 -38.19 26.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -61.74 -51.03 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -53.15 -49.5 66.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.493 -0.754 . . . . 0.0 109.144 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -46.44 -68.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 65.6 mm-40 -56.97 -21.14 28.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.217 -0.927 . . . . 0.0 108.834 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -74.4 -12.2 60.45 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.89 -47.43 2.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.982 ' HE2' ' CE1' ' A' ' 130' ' ' HIS . 0.6 OUTLIER -59.6 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -1.1 . . . . 0.0 109.57 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.48 22.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -0.754 . . . . 0.0 110.286 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 7.7 mtt -103.79 -10.65 18.11 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.692 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA3' HD22 ' A' ' 161' ' ' LEU . . . 128.75 -64.28 0.6 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.013 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 127' ' ' GLY . 15.0 mt -49.35 176.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -169.54 -172.64 1.48 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.719 0.771 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.982 ' CE1' ' HE2' ' A' ' 124' ' ' HIS . 23.0 m80 -49.82 114.01 0.97 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.763 0.792 . . . . 0.0 109.99 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 11.2 t -84.86 -77.53 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 131' ' ' SER . 52.3 tt0 161.03 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -57.88 133.1 83.28 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.715 -0.616 . . . . 0.0 109.632 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 29.2 Cg_endo -75.69 113.33 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.555 2.17 . . . . 0.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.53 -13.77 20.61 Favored Glycine 0 C--N 1.272 -2.983 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.74 158.82 12.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.884 -1.362 . . . . 0.0 109.706 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.672 HD21 ' HB1' ' A' ' 119' ' ' ALA . 11.7 tp -70.47 -20.41 62.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.024 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -100.05 2.06 42.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.376 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -70.19 156.69 91.44 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.232 -0.918 . . . . 0.0 110.015 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.442 ' C ' ' CG1' ' A' ' 141' ' ' ILE . 34.3 Cg_endo -77.14 64.65 7.85 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.858 2.372 . . . . 0.0 110.986 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.442 ' CG1' ' C ' ' A' ' 140' ' ' PRO . 0.0 OUTLIER -159.53 -157.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.261 -0.9 . . . . 0.0 109.625 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -165.69 119.03 1.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 109.823 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' TYR . 52.8 m -138.26 95.87 3.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 109.259 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.615 ' HA ' HD11 ' A' ' 116' ' ' LEU . 21.8 t80 -45.39 158.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.793 -1.192 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 145' ' ' THR . 1.3 t -152.01 123.92 8.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -48.52 122.46 5.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.195 . . . . 0.0 108.578 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.505 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 7.5 m-20 58.96 -95.34 0.05 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.253 -0.905 . . . . 0.0 108.56 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 42' ' ' VAL . 1.2 p90 177.72 142.88 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.088 -1.007 . . . . 0.0 109.657 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -107.82 -10.83 15.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.892 -1.13 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.748 HD11 ' OD1' ' A' ' 45' ' ' ASP . 1.5 mt 66.57 139.34 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.74 122.76 48.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.584 ' HA ' HG23 ' A' ' 155' ' ' ILE . 5.3 tt0 -50.01 -53.11 28.89 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.09 0.471 . . . . 0.0 109.954 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -42.32 -29.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -90.62 -29.29 17.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 151' ' ' SER . 0.9 OUTLIER -73.49 -30.43 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.434 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -88.25 -43.3 11.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -64.24 -25.62 69.88 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -85.45 -47.47 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.379 . . . . 0.0 109.078 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.522 ' N ' HG23 ' A' ' 158' ' ' ILE . 14.6 mt-30 -52.02 -31.22 28.74 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 109.624 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.02 -28.71 22.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.264 -0.897 . . . . 0.0 109.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.504 HD22 ' HA3' ' A' ' 127' ' ' GLY . 0.1 OUTLIER -89.35 -16.08 31.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CZ ' HD21 ' A' ' 49' ' ' LEU . 1.8 m-85 -126.54 -47.37 1.57 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.812 -1.18 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.503 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.408 ' CH2' ' HB3' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -66.1 140.37 58.23 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 109.79 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -61.46 165.53 4.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 108.549 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.641 ' HD2' ' CD1' ' A' ' 162' ' ' TYR . 5.6 mmtp -118.75 -175.7 2.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.536 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' HD12 ' A' ' 49' ' ' LEU . 1.9 m120 61.96 141.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.336 -0.852 . . . . 0.0 109.175 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . 2.5 mt-30 45.04 76.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.859 -1.151 . . . . 0.0 109.683 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 49' ' ' LEU . 20.6 mt -110.73 136.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 108.886 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 52' ' ' SER . 0.2 OUTLIER -120.09 136.56 54.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.409 -0.807 . . . . 0.0 111.382 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CD1' HD11 ' A' ' 63' ' ' ILE . 34.3 p90 -149.61 153.07 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.969 . . . . 0.0 110.304 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HD2' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.77 138.9 44.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.523 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -80.24 121.4 33.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 19' ' ' ARG . 33.8 mm -67.33 -2.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.469 -0.769 . . . . 0.0 109.77 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 23' ' ' TYR . . . 144.15 84.44 0.07 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.791 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -51.19 169.42 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 1.2 t -85.31 149.07 51.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.059 -1.651 . . . . 0.0 109.276 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' LEU . 36.2 Cg_endo -79.09 -21.5 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.331 2.021 . . . . 0.0 109.85 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' PRO . 74.4 m-20 -40.64 -25.06 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.133 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.692 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.4 pt? -133.76 173.83 11.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.675 -1.266 . . . . 0.0 110.798 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 3.0 m-20 -48.66 138.3 12.11 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 108.862 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.551 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.3 Cg_endo -69.03 -33.66 18.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 N-CA-C 107.331 -1.834 . . . . 0.0 107.331 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 pt-20 -79.01 -26.88 43.22 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 20.8 m -74.15 -50.83 17.68 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.66 -36.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.993 0.901 . . . . 0.0 108.643 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.87 -24.72 59.78 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.66 -41.66 68.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -53.19 -38.89 63.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' HG21 ' A' ' 63' ' ' ILE . 26.9 m-85 -74.12 -26.75 60.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -52.66 9.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -34.47 72.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -62.9 -46.78 86.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.44 -0.788 . . . . 0.0 109.206 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -53.39 -34.72 58.79 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -83.01 -12.3 57.37 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -73.38 -32.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.828 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -102.82 -51.02 3.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.599 -0.688 . . . . 0.0 109.718 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 10.0 t -53.76 -33.17 54.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 109.157 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 41' ' ' GLN . 1.2 t70 -54.78 -33.3 61.22 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.599 -0.688 . . . . 0.0 109.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 46' ' ' VAL . 12.1 p -106.06 23.42 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.036 -1.04 . . . . 0.0 110.694 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.441 HG22 ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -173.13 153.87 2.54 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.665 -1.272 . . . . 0.0 110.115 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' CD ' ' OXT' ' A' ' 163' ' ' GLY . 37.3 Cg_endo -79.77 12.78 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.89 3.06 . . . . 0.0 110.723 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.2 tt -64.37 148.72 49.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.96 138.93 45.64 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.77 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 49' ' ' LEU . 26.6 m-85 -116.72 135.62 53.63 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.183 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.745 ' HB3' HG23 ' A' ' 17' ' ' THR . 9.4 t -128.59 118.67 23.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.059 -1.025 . . . . 0.0 110.322 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 18' ' ' TYR . 6.0 mtm180 -92.16 131.43 37.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.977 -1.077 . . . . 0.0 108.15 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.699 HD11 ' CB ' ' A' ' 59' ' ' ALA . 15.5 pt -126.6 148.31 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 109.536 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -109.38 -14.58 14.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.996 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -135.44 -167.39 2.0 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.953 -1.092 . . . . 0.0 109.941 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.86 -170.94 2.0 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 54' ' ' ILE . 1.9 tp10 -79.07 158.43 27.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.251 -1.146 . . . . 0.0 110.358 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.699 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -136.44 -160.38 1.05 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.447 -0.783 . . . . 0.0 108.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -134.22 -57.03 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.584 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.618 HG23 ' C ' ' A' ' 95' ' ' GLY . 2.5 mt -98.77 152.05 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.361 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtt -119.21 123.19 43.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.948 -1.095 . . . . 0.0 110.274 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.636 HD11 ' CD1' ' A' ' 18' ' ' TYR . 1.6 mp -117.78 142.21 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.634 -1.291 . . . . 0.0 109.968 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.461 ' OD1' ' C ' ' A' ' 63' ' ' ILE . 2.7 p-10 175.3 -174.69 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.439 -0.788 . . . . 0.0 110.189 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -89.96 -167.3 1.81 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.001 -1.062 . . . . 0.0 111.052 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 99' ' ' PHE . . . -149.3 49.66 0.57 Allowed Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -56.05 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -49.95 -57.28 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.981 . . . . 0.0 109.886 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 124.75 24.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.693 -0.63 . . . . 0.0 110.146 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.09 -70.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 133.74 -20.0 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -46.33 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.517 -0.99 . . . . 0.0 111.601 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.77 -2.02 65.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.88 77.59 18.51 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.967 -1.314 . . . . 0.0 110.172 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.27 139.33 18.65 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.51 2.14 . . . . 0.0 109.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.24 159.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.384 -0.822 . . . . 0.0 109.605 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.9 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.495 -0.753 . . . . 0.0 109.112 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.86 -154.92 19.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -69.4 167.28 16.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -1.068 . . . . 0.0 111.128 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.57 ' HA ' HD21 ' A' ' 83' ' ' LEU . 0.4 OUTLIER 41.42 -150.41 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 83' ' ' LEU . . . 54.42 -134.88 45.52 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 100' ' ' ASP . 4.7 tt -50.68 98.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.594 -0.945 . . . . 0.0 109.012 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 80' ' ' ASP . 1.3 mt -110.31 -28.45 8.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 108.934 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 121' ' ' GLU . . . -177.94 155.34 0.97 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.508 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 4.8 p80 -152.21 174.48 13.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.768 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -144.76 144.11 31.01 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.428 -0.795 . . . . 0.0 109.874 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.6 156.91 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 108.739 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -65.67 173.32 2.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 110.195 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 37.5 Cg_endo -82.51 155.54 16.21 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.201 2.601 . . . . 0.0 110.67 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.52 -128.76 1.18 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.7 60.09 1.7 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.207 -1.173 . . . . 0.0 110.475 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.18 -67.8 0.44 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 93' ' ' VAL . 61.7 t -79.86 1.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.281 . . . . 0.0 108.36 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -78.89 134.82 14.46 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' HG23 ' A' ' 61' ' ' ILE . . . 84.04 91.95 0.72 Allowed Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.55 -0.97 . . . . 0.0 110.68 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.3 m-20 -160.99 120.33 2.61 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.975 -1.309 . . . . 0.0 108.754 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 3.1 p -110.25 130.01 55.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.052 0.93 . . . . 0.0 110.505 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.508 ' ND1' ' NE2' ' A' ' 85' ' ' HIS . 29.5 m170 -119.36 148.9 42.67 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 109.333 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.7 m-30 -112.48 147.05 37.35 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 0.0 109.833 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.684 ' HB2' HD23 ' A' ' 82' ' ' LEU . 3.6 t70 -81.13 114.92 20.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 67' ' ' ARG . 18.5 t70 -57.37 -95.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.75 -0.78 . . . . 0.0 108.92 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 101' ' ' ASP . 47.2 m-20 21.67 -93.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 120.706 0.288 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 102' ' ' ASP . 2.5 mp0 -41.95 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.933 -1.104 . . . . 0.0 110.094 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 2.0 tp -106.2 101.08 10.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.883 . . . . 0.0 109.696 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' THR . 12.1 m95 -103.11 147.27 27.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.363 -0.835 . . . . 0.0 110.034 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.655 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 p -159.02 -159.68 0.79 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.315 -0.866 . . . . 0.0 110.02 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.1 70.0 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -168.2 -99.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.467 ' H ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -142.67 59.82 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.774 -1.204 . . . . 0.0 109.613 178.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.93 -24.13 0.76 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.246 -0.908 . . . . 0.0 110.972 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -169.57 -153.66 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.739 -1.226 . . . . 0.0 108.968 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -67.74 -167.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.798 -1.189 . . . . 0.0 108.436 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.5 t -105.36 117.61 34.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.904 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -53.24 -22.51 6.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.86 0.838 . . . . 0.0 108.753 179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -76.07 -38.49 57.02 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.595 HD12 ' CZ ' ' A' ' 142' ' ' TYR . 2.3 tm? -64.72 -55.13 21.88 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.409 -0.807 . . . . 0.0 109.716 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 118' ' ' ALA . 2.4 m -53.67 -51.06 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 117' ' ' VAL . . . -57.29 -51.48 69.2 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.938 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.4 -58.25 3.47 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.953 0.882 . . . . 0.0 109.333 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.436 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 84.9 t60 -42.81 -67.62 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 84' ' ' ALA . 44.1 mm-40 -62.25 -21.95 65.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CG ' ' CZ2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -74.43 -5.54 43.07 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -98.08 -48.54 1.88 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.436 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 97.0 m-70 -60.79 -42.61 97.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.53 -16.5 38.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.922 . . . . 0.0 109.209 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.5 ' SD ' ' OH ' ' A' ' 162' ' ' TYR . 44.2 mtt -84.62 15.82 3.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 100.95 -73.26 0.39 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.788 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' GLY . 15.7 mt -32.44 145.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.997 -0.708 . . . . 0.0 111.184 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.85 -179.66 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.815 -1.178 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -49.08 135.47 16.13 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.2 p -93.35 -152.16 0.32 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.16 -4.66 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.746 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -81.97 134.44 49.75 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.905 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.93 113.15 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.465 2.11 . . . . 0.0 111.007 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.07 -5.32 42.06 Favored Glycine 0 C--N 1.268 -3.199 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . . . -54.13 162.04 1.12 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.682 -0.893 . . . . 0.0 109.64 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.404 HD23 ' OD2' ' A' ' 154' ' ' ASP . 19.0 tp -67.32 -34.3 77.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.547 -0.721 . . . . 0.0 109.085 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.416 ' HE1' ' OD1' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -107.34 28.09 8.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.514 -0.741 . . . . 0.0 110.398 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -78.19 164.27 57.61 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.773 -1.204 . . . . 0.0 109.112 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 35.2 Cg_endo -73.5 15.74 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.269 2.646 . . . . 0.0 112.39 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -137.93 139.59 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.853 -1.155 . . . . 0.0 109.507 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.595 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 62.9 t80 -76.79 129.58 36.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 144' ' ' TYR . 6.2 m -150.06 84.77 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.982 -1.074 . . . . 0.0 108.472 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.565 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 75.4 t80 -42.37 164.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.633 -0.667 . . . . 0.0 109.339 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.507 ' O ' ' CE2' ' A' ' 144' ' ' TYR . 1.7 t -111.5 119.05 37.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 110.604 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -44.83 104.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.825 . . . . 0.0 108.848 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 146' ' ' LYS . 70.1 m-20 68.81 -79.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.854 ' CE1' HD23 ' A' ' 150' ' ' LEU . 24.1 t80 171.14 113.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.037 -1.039 . . . . 0.0 108.95 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 14.1 ttt85 -133.02 -20.7 2.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 110.214 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.854 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 71.98 -160.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -163.42 126.71 2.71 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.731 -1.231 . . . . 0.0 108.985 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.585 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 4.7 mm-40 -45.51 -44.07 12.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.25 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' GLN . 41.9 t0 -45.57 -36.4 4.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.654 -1.218 . . . . 0.0 108.357 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.416 ' OD1' ' HE1' ' A' ' 138' ' ' MET . 29.2 t0 -86.51 -30.89 21.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.634 -0.667 . . . . 0.0 109.479 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.685 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -70.48 -37.56 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 108.805 178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -72.82 -43.1 63.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.84 48.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.687 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -54.47 -42.95 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.365 . . . . 0.0 109.534 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.425 ' N ' HG23 ' A' ' 158' ' ' ILE . 7.3 mm-40 -65.4 -43.15 91.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 109.589 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 69.3 mm-40 -57.73 -22.98 49.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.741 -1.225 . . . . 0.0 108.468 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.469 ' HB3' ' HD1' ' A' ' 162' ' ' TYR . 3.8 mm? -98.96 -64.5 1.03 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.584 0.707 . . . . 0.0 109.318 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.792 ' CE2' HD13 ' A' ' 49' ' ' LEU . 21.9 p90 -151.64 85.27 1.3 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.45 ' OXT' ' CD ' ' A' ' 48' ' ' PRO . . . . . . . . 0 N--CA 1.494 2.543 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.662 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 9.8 mttp . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 121.358 0.599 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 3.0 m95 -71.54 130.99 42.61 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 11.8 p-10 167.92 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.36 -0.837 . . . . 0.0 109.383 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.64 32.0 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 72.28 -62.97 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.146 -0.971 . . . . 0.0 108.951 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 50' ' ' ARG . 21.3 mt-30 -78.94 103.23 8.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.517 -0.739 . . . . 0.0 109.297 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.9 OUTLIER -101.06 162.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 108.577 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.45 133.96 48.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 110.043 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 7.3 p90 -145.99 157.69 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . 3.4 tmm_? -148.76 136.82 20.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 0.0 109.927 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 23' ' ' TYR . 5.8 mt -86.6 144.97 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 62' ' ' MET . 11.6 mm -107.67 -38.85 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 0.0 110.074 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.02 96.23 0.14 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.755 ' CG ' HG11 ' A' ' 32' ' ' VAL . 2.5 m-85 -55.31 179.02 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.353 -1.086 . . . . 0.0 109.1 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.563 HG22 HD11 ' A' ' 27' ' ' LEU . 5.0 t -105.05 150.59 38.93 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 109.437 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.2 Cg_endo -81.27 -33.04 0.79 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.727 2.285 . . . . 0.0 111.238 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' PRO . 36.5 m-20 -39.48 -27.16 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.68 -0.637 . . . . 0.0 110.105 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' HB ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -135.16 -178.15 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 110.04 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 1.1 m-20 -73.62 151.97 89.37 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.511 -0.743 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.557 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.7 Cg_endo -74.1 -30.12 9.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 N-CA-C 106.254 -2.248 . . . . 0.0 106.254 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 2.6 mm-40 -78.11 -30.41 49.45 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 107' ' ' ASN . 2.4 m -76.45 -50.68 13.46 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.755 HG11 ' CG ' ' A' ' 23' ' ' TYR . 1.4 p -54.92 -41.43 57.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.26 -23.97 62.08 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 2.7 t70 -81.39 -34.5 31.61 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.528 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.8 m-85 -73.21 -47.95 39.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -46.24 -51.15 14.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.993 . . . . 0.0 108.609 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' VAL . 9.3 mtm180 -55.19 -50.44 69.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.013 -1.054 . . . . 0.0 108.439 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -53.41 -44.36 68.68 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 44' ' ' SER . 49.6 t80 -51.25 -40.25 58.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 108.732 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 3.0 tt0 -86.77 -24.03 25.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -68.74 -33.33 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.147 -0.97 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.787 ' HE1' HD21 ' A' ' 137' ' ' LEU . 1.9 m95 -103.22 -22.3 13.75 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.208 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 27.5 t -85.9 -19.61 30.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.8 m-20 -64.6 -15.12 60.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.516 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.652 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.1 p -113.65 17.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.404 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -173.04 147.56 1.53 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 120.466 -1.396 . . . . 0.0 111.037 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 36.4 Cg_endo -78.52 46.78 2.23 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.773 2.316 . . . . 0.0 110.067 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.866 HD23 ' HE1' ' A' ' 51' ' ' PHE . 1.7 mp -76.55 160.16 29.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -130.41 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.866 ' HE1' HD23 ' A' ' 49' ' ' LEU . 5.4 m-30 -66.57 139.41 57.91 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' THR . 8.1 t -130.89 101.66 5.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.244 -0.91 . . . . 0.0 109.835 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -81.03 144.08 32.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.745 HD13 ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -113.29 158.87 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 43.1 m-70 -106.75 -14.65 14.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.04 -175.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.046 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.34 63.65 0.83 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 177.35 153.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.482 -1.01 . . . . 0.0 109.527 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 54' ' ' ILE . . . 176.45 143.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -62.53 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.793 HG23 ' O ' ' A' ' 95' ' ' GLY . 22.9 mt -87.59 156.51 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.983 ' HG2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -165.83 136.05 3.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.126 -0.984 . . . . 0.0 109.931 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.39 144.56 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 109.668 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -164.19 -167.14 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.325 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.464 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -117.2 166.73 11.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.74 -24.99 7.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 65' ' ' PHE . 54.1 mtp180 47.91 -150.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.177 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -91.12 -72.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 0.0 109.412 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -62.42 99.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.621 -0.675 . . . . 0.0 110.481 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.29 -160.28 0.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.86 -33.26 1.89 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.74 72.18 10.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.431 -1.04 . . . . 0.0 108.492 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' TYR . . . 112.95 -113.29 3.15 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER 163.33 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.21 -1.17 . . . . 0.0 109.827 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 74' ' ' TYR . 36.8 Cg_endo -79.26 137.69 13.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.246 1.964 . . . . 0.0 110.235 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 24.7 p90 -71.63 138.05 48.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.617 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 p-10 -75.31 -2.29 27.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.555 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 57.41 -114.91 5.99 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.5 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 78' ' ' GLY . 5.4 mttt -41.65 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.057 -0.673 . . . . 0.0 110.78 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 79' ' ' LYS . 10.1 m-20 -25.18 -93.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 80' ' ' ASP . . . 38.6 -130.35 1.79 Allowed Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 9.7 tt -54.51 109.37 0.49 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.1 mt -107.94 -29.29 9.1 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 171.77 155.93 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.903 -1.123 . . . . 0.0 110.899 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.427 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 1.9 p80 -146.36 -162.74 1.59 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 97' ' ' SER . . . -160.73 145.81 14.36 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -92.77 156.29 17.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.841 -1.162 . . . . 0.0 109.976 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.8 164.01 55.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.1 Cg_endo -79.35 154.55 24.68 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.002 2.468 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.49 60.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.78 92.56 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -1.084 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.82 -62.81 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 93' ' ' VAL . 2.4 t -58.19 153.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.267 . . . . 0.0 109.748 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 98.2 141.08 11.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.793 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 95.83 -45.78 1.96 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' MET . 4.1 p30 -73.26 125.22 27.27 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.188 -1.183 . . . . 0.0 109.724 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.511 ' OG ' ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -131.65 136.28 47.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.314 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 9.5 m80 -98.93 143.38 29.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . 13.8 m-85 -113.9 141.83 46.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.565 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' CZ3' ' A' ' 105' ' ' TRP . 5.4 t70 -51.91 135.43 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -98.23 -16.86 19.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.871 -1.143 . . . . 0.0 109.592 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.83 -16.92 60.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.534 ' OE2' HD23 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -75.49 158.23 32.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 111' ' ' ASN . 8.4 tp -109.09 95.61 5.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 99' ' ' PHE . 10.3 m0 -102.33 141.51 35.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.216 -0.927 . . . . 0.0 110.222 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.805 HG21 ' HB3' ' A' ' 110' ' ' ALA . 1.5 p -133.51 -160.28 1.04 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.972 -1.08 . . . . 0.0 110.006 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 31' ' ' THR . 0.2 OUTLIER -134.59 2.25 3.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.826 . . . . 0.0 109.99 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.08 -60.5 1.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.098 . . . . 0.0 109.359 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.6 p -165.26 -91.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.324 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.805 ' HB3' HG21 ' A' ' 106' ' ' THR . . . 43.6 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.865 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' A' ' 104' ' ' LEU . 60.8 t30 -110.55 -104.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.95 -124.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.794 -1.191 . . . . 0.0 109.456 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -171.99 117.24 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.356 -1.465 . . . . 0.0 111.219 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -45.95 -43.48 14.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.643 -0.66 . . . . 0.0 110.078 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.6 t80 -58.91 -44.52 91.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.388 -0.82 . . . . 0.0 109.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.5 OUTLIER -59.2 -67.14 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.422 -0.798 . . . . 0.0 109.766 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.5 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.1 m -51.08 -42.93 25.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.435 -0.791 . . . . 0.0 108.985 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -52.64 -46.94 67.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.861 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -54.48 -59.02 5.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.376 -0.828 . . . . 0.0 110.007 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 124' ' ' HIS . 77.3 t60 -43.55 -65.05 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.655 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 99' ' ' PHE . 68.1 mm-40 -62.84 -12.95 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 0.0 109.341 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.1 m-85 -80.92 -10.8 59.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.108 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.597 ' HA3' ' CZ2' ' A' ' 43' ' ' TRP . . . -103.68 -41.29 2.19 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 120' ' ' HIS . 9.5 m80 -61.02 -42.93 99.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -1.117 . . . . 0.0 109.104 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -37.56 -32.36 0.05 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.391 0.615 . . . . 0.0 109.532 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.867 ' HE1' HD12 ' A' ' 158' ' ' ILE . 4.1 mtm -69.89 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.87 . . . . 0.0 109.476 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.47 -30.87 0.05 OUTLIER Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.429 ' O ' ' HE1' ' A' ' 138' ' ' MET . 0.5 OUTLIER -49.9 153.82 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.538 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 130' ' ' HIS . 4.0 mt-10 -113.44 -177.53 3.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.157 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 129' ' ' GLU . 18.6 m170 -44.72 172.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 110.142 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 p -123.58 -152.23 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 -17.36 2.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.321 -0.862 . . . . 0.0 110.99 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 151.32 54.21 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.72 -1.237 . . . . 0.0 109.251 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.8 -38.7 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.398 2.065 . . . . 0.0 110.686 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.09 6.81 69.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.57 163.31 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 110.03 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.787 HD21 ' HE1' ' A' ' 43' ' ' TRP . 16.7 tp -89.12 -28.5 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 110.233 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 139' ' ' ALA . 37.0 mtp -101.53 15.01 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.909 -1.119 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -43.15 153.72 0.34 Allowed Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.934 ' O ' HD13 ' A' ' 141' ' ' ILE . 35.2 Cg_endo -79.09 -1.11 11.32 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.205 1.937 . . . . 0.0 110.21 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.5 mm -131.28 154.46 40.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.66 139.36 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 110.16 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 144' ' ' TYR . 1.9 m -129.52 -41.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 110.37 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.849 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.5 OUTLIER 68.42 147.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.4 t -120.65 138.13 54.09 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -83.11 0.15 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.119 -0.988 . . . . 0.0 111.003 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 1.5 p-10 -88.19 21.43 2.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.824 -1.173 . . . . 0.0 109.391 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 148' ' ' PHE . 1.6 t80 60.14 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.112 -0.993 . . . . 0.0 109.133 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -121.06 -10.8 8.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.437 -0.789 . . . . 0.0 109.247 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 tp 59.32 -144.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 109.274 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 155' ' ' ILE . 1.1 p -178.41 129.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.563 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 23.3 mm-40 -53.76 -35.17 61.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.896 -0.502 . . . . 0.0 110.053 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 152' ' ' GLN . 2.9 m-20 -42.87 -47.7 5.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 109.304 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -79.37 -45.26 19.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.454 -0.779 . . . . 0.0 109.177 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 151' ' ' SER . 0.5 OUTLIER -50.86 -28.47 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.0 108.661 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -57.44 3.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 0.0 109.553 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.41 -36.41 53.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' HE1' ' A' ' 126' ' ' MET . 6.7 tp -75.28 -30.09 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.378 -1.072 . . . . 0.0 109.1 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.57 67.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.479 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 -28.38 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.406 0.622 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -19.62 20.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.658 -0.651 . . . . 0.0 110.136 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 49' ' ' LEU . 41.6 m-85 -140.3 -75.05 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.406 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.795 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 CA-C-O 121.384 0.612 . . . . 0.0 111.936 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.568 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 176.0 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.462 -0.774 . . . . 0.0 109.24 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -44.57 158.39 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -114.81 144.65 43.17 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.471 -0.768 . . . . 0.0 109.448 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.43 ' O ' HD23 ' A' ' 49' ' ' LEU . 68.0 m-80 43.26 -82.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' LYS . 2.9 mt-30 -71.4 106.89 4.08 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 17' ' ' THR . 2.2 mm -114.05 -178.33 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.034 -1.041 . . . . 0.0 110.133 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -140.33 137.83 34.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CB ' HG13 ' A' ' 61' ' ' ILE . 43.2 p90 -145.38 162.89 36.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.115 -0.99 . . . . 0.0 109.569 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 58' ' ' GLU . 19.9 ttp85 -159.42 124.33 4.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -0.896 . . . . 0.0 109.684 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.892 HG21 ' CD1' ' A' ' 23' ' ' TYR . 4.0 mt -85.25 116.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.7 mt -73.62 0.3 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.981 -1.074 . . . . 0.0 109.836 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 151.64 103.64 0.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.892 ' CD1' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.74 -153.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -1.178 . . . . 0.0 109.365 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.528 HG22 HG21 ' A' ' 32' ' ' VAL . 1.4 t -105.13 147.63 34.84 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.202 -0.936 . . . . 0.0 110.521 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 37.5 Cg_endo -78.89 -32.91 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.157 2.571 . . . . 0.0 111.178 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' PRO . 71.7 m-20 -41.1 -34.73 0.47 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.698 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -121.03 176.95 5.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.967 -1.083 . . . . 0.0 109.231 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 4.6 m-20 -63.04 154.49 77.06 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.012 -1.055 . . . . 0.0 108.348 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.9 Cg_endo -72.3 -33.33 9.22 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.1 -26.41 33.62 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.885 HG21 ' HA ' ' A' ' 107' ' ' ASN . 1.4 m -71.79 -51.84 20.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.6 -33.74 40.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -70.35 -24.23 62.94 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 55.2 t0 -73.7 -39.19 64.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.296 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.726 ' HB3' HD23 ' A' ' 114' ' ' LEU . . . -53.25 -60.83 2.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.477 ' CE2' HD21 ' A' ' 114' ' ' LEU . 78.3 m-85 -53.42 -42.5 67.12 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -49.2 -38.96 27.74 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' VAL . 1.2 mtp180 -74.48 -46.84 36.99 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -56.35 -36.15 68.46 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -65.61 -40.99 93.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 1.3 mt-30 -81.69 -9.42 59.65 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -94.26 -27.84 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.133 -0.979 . . . . 0.0 109.63 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.804 ' HZ3' HD13 ' A' ' 158' ' ' ILE . 1.7 m95 -102.67 -21.16 14.16 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 109.887 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' THR . 6.2 t -95.2 -26.25 16.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.255 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -67.43 -4.54 11.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.918 HG23 HG22 ' A' ' 47' ' ' THR . 15.1 m -108.1 -8.2 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.705 -1.247 . . . . 0.0 109.614 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -153.16 163.53 23.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.999 -1.063 . . . . 0.0 108.424 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.2 Cg_endo -76.66 57.16 5.47 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.067 1.845 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.805 HD11 ' CE2' ' A' ' 162' ' ' TYR . 2.6 mt -93.66 125.5 38.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.546 -0.721 . . . . 0.0 109.241 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 4.9 mmm180 -112.26 90.81 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 89.4 m-85 -77.05 148.83 35.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.953 -1.092 . . . . 0.0 109.842 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' THR . 51.5 m -132.11 111.85 11.82 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.84 138.44 54.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.352 -0.843 . . . . 0.0 108.998 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -133.58 164.99 33.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.608 ' O ' ' N ' ' A' ' 57' ' ' GLY . 87.7 m-70 -132.03 165.35 24.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.258 -0.901 . . . . 0.0 109.697 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.51 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.3 OUTLIER 55.36 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 55' ' ' HIS . . . -46.3 156.53 0.52 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 1.7 mt-10 -66.55 161.2 23.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.92 -1.341 . . . . 0.0 110.47 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -124.47 148.57 47.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.587 -0.696 . . . . 0.0 109.381 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' CD2' ' A' ' 11' ' ' TRP . 10.3 t0 -70.03 -54.48 13.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.996 -1.065 . . . . 0.0 109.398 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.802 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -103.54 122.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.195 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 3.5 mtt -105.49 139.82 39.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.959 -1.088 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.438 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 2.9 mt -123.32 128.61 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.023 -1.048 . . . . 0.0 108.616 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.95 -147.1 0.21 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.101 -0.999 . . . . 0.0 109.782 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -177.85 -178.55 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.899 -1.126 . . . . 0.0 110.314 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 101' ' ' ASP . . . 139.21 178.95 16.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -160.87 161.74 31.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.286 -1.126 . . . . 0.0 109.786 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 57.04 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 108.517 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.5 pp20? -61.65 124.53 20.95 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-80 173.45 -57.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 77.55 -12.76 13.82 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 71' ' ' GLY . 6.0 m-20 -42.18 -24.68 0.05 Allowed 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.016 -1.285 . . . . 0.0 110.274 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 128.31 13.14 2.67 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.548 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.601 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 14.8 p90 -154.76 90.85 3.04 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 120.834 -1.392 . . . . 0.0 109.287 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 36.0 Cg_endo -78.35 -171.88 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.598 2.199 . . . . 0.0 110.957 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 26.6 m-85 61.08 170.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 0.0 109.235 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 78' ' ' GLY . 1.3 t70 172.63 -34.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . 31.72 -157.77 0.0 OUTLIER Glycine 0 N--CA 1.5 2.957 0 CA-C-O 121.682 0.601 . . . . 0.0 111.933 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 80' ' ' ASP . 6.3 mttt -72.8 162.45 29.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.688 -0.889 . . . . 0.0 110.957 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 79' ' ' LYS . 9.7 p-10 27.96 -138.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.199 0.523 . . . . 0.0 111.208 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 83' ' ' LEU . . . 44.51 -116.93 1.84 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.553 ' O ' ' OD2' ' A' ' 100' ' ' ASP . 0.2 OUTLIER -42.68 97.53 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 81' ' ' GLY . 1.7 mt -114.3 -21.41 10.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.567 -1.333 . . . . 0.0 109.392 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.09 150.09 0.94 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.143 -0.973 . . . . 0.0 110.178 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.588 ' CE1' ' CE1' ' A' ' 74' ' ' TYR . 1.1 p80 -144.04 -179.98 6.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.81 162.06 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.115 -0.99 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.07 168.7 10.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.673 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.8 148.32 64.72 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.547 -0.721 . . . . 0.0 109.357 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 28.8 Cg_endo -75.87 136.73 19.03 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.709 2.272 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.505 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 145.21 122.79 1.56 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.387 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER 56.25 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.704 . . . . 0.0 110.954 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 33.14 -92.21 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -45.65 160.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -1.124 . . . . 0.0 108.743 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.481 ' O ' ' OD1' ' A' ' 96' ' ' ASP . . . 126.58 151.1 7.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 60.82 13.41 32.67 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.651 -1.499 . . . . 0.0 109.434 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 62' ' ' MET . 1.6 m-20 -97.09 116.2 28.86 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.552 -1.558 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.614 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 33.8 m -114.65 156.36 24.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.724 -0.61 . . . . 0.0 109.941 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 97' ' ' SER . 1.9 m80 -148.79 139.01 22.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 32.6 m-85 -104.61 179.24 4.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.172 0.987 . . . . 0.0 112.165 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.553 ' OD2' ' O ' ' A' ' 82' ' ' LEU . 0.3 OUTLIER -58.64 161.98 4.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.866 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.611 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 13.2 t0 -94.02 -4.83 48.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -170.12 79.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.0 109.023 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -137.09 -8.54 1.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.476 -1.39 . . . . 0.0 111.599 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD13 ' H ' ' A' ' 105' ' ' TRP . 0.2 OUTLIER 76.66 141.5 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.188 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.608 ' H ' HD13 ' A' ' 104' ' ' LEU . 26.0 m-90 -149.01 -50.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.017 -1.052 . . . . 0.0 110.288 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 114' ' ' LEU . 35.8 p -138.13 -89.21 0.24 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 117.905 -1.518 . . . . 0.0 113.171 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.885 ' HA ' HG21 ' A' ' 31' ' ' THR . 28.8 t-20 52.92 19.26 1.28 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -175.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 106' ' ' THR . 30.3 p 50.49 37.63 16.35 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.356 1.074 . . . . 0.0 110.039 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -168.07 31.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 105' ' ' TRP . . . -98.12 179.97 4.58 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.463 0.649 . . . . 0.0 111.967 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -120.98 -13.31 8.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.523 ' O ' ' CB ' ' A' ' 113' ' ' SER . 1.2 m-85 -107.59 -42.4 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.939 -1.101 . . . . 0.0 108.475 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 105' ' ' TRP . 0.3 OUTLIER 81.01 93.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.927 0.87 . . . . 0.0 110.925 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.743 ' H ' HG23 ' A' ' 106' ' ' THR . 13.2 tp -37.67 -41.83 0.52 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.739 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.5 t80 -55.29 -45.1 76.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.893 . . . . 0.0 109.9 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.409 HD12 ' CE1' ' A' ' 142' ' ' TYR . 1.0 OUTLIER -68.66 -58.69 3.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.448 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 118' ' ' ALA . 32.9 m -59.08 -42.37 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.006 -1.059 . . . . 0.0 109.432 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.645 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -59.06 -41.55 88.23 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.384 0.612 . . . . 0.0 109.4 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.32 69.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.492 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -54.64 -33.61 60.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 0.0 108.821 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -86.04 -24.61 26.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.167 -0.958 . . . . 0.0 109.151 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 118' ' ' ALA . 1.4 m-85 -71.91 -10.92 60.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -101.71 -37.92 3.33 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -63.54 -50.23 70.37 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.21 -1.171 . . . . 0.0 108.597 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 95' ' ' GLY . . . -61.18 -13.45 18.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.739 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 22.9 mmm -81.26 10.87 4.85 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.089 -1.007 . . . . 0.0 108.985 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 88.64 -54.96 4.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 128' ' ' LEU . 14.7 mt -42.8 142.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.343 -1.093 . . . . 0.0 110.166 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' HIS . 19.6 pt-20 -108.98 175.61 5.4 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' GLU . 45.4 m80 -44.24 167.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.143 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 m -115.6 -80.53 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.005 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 177.11 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 145.79 97.36 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -75.83 -35.44 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.256 1.971 . . . . 0.0 108.567 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.34 13.7 62.97 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.65 149.43 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -1.081 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.486 HD12 ' O ' ' A' ' 137' ' ' LEU . 14.3 tp -72.93 -16.16 61.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.519 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 7.3 mmt -112.45 27.87 9.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.95 154.49 93.62 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.743 -0.598 . . . . 0.0 109.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.25 4.14 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.79 2.327 . . . . 0.0 111.413 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 141' ' ' ILE . 1.0 OUTLIER -131.99 151.06 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.887 -1.133 . . . . 0.0 109.747 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 144' ' ' TYR . 30.1 t80 -63.96 120.96 12.96 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 144' ' ' TYR . 7.6 m -124.07 53.61 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.042 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.618 ' CD2' ' N ' ' A' ' 145' ' ' THR . 75.2 t80 -44.39 170.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.393 -0.817 . . . . 0.0 109.318 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.618 ' N ' ' CD2' ' A' ' 144' ' ' TYR . 1.6 t 179.64 113.3 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.064 -1.022 . . . . 0.0 109.455 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 23.0 ttpt -59.7 167.31 2.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.907 -1.121 . . . . 0.0 108.943 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 3.9 t-20 71.3 -54.83 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.086 . . . . 0.0 110.591 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 68.74 143.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.165 -0.96 . . . . 0.0 109.58 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 80.1 mtp85 -134.11 -86.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 108.922 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 2.1 mt 160.29 152.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.987 -1.071 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 155' ' ' ILE . 10.4 p -119.83 129.02 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 109.885 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.636 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.5 mt-30 -65.39 -32.55 74.25 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -44.46 -38.28 3.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -86.54 -38.41 17.22 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.542 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -62.7 -29.77 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 108.718 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -63.9 1.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 110.236 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -51.64 -39.97 47.05 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.804 HD13 ' HZ3' ' A' ' 43' ' ' TRP . 9.9 tp -70.17 -40.98 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.612 -0.934 . . . . 0.0 109.461 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 1.8 mm-40 -70.6 -20.55 62.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.257 -0.902 . . . . 0.0 108.809 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -87.14 -27.91 22.79 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.176 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.457 ' CD1' ' HD3' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -93.53 -19.99 20.69 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 109.808 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 49' ' ' LEU . 25.6 m-85 -113.59 -8.06 13.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HD3' ' HG2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.484 1.263 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CH2' ' OD2' ' A' ' 60' ' ' ASP . 5.9 m95 -107.6 -105.58 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.0 109.199 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' OD1' HD11 ' A' ' 161' ' ' LEU . 13.5 m-20 61.34 22.95 13.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.81 -1.181 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HD2' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -94.3 166.74 11.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 109.709 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' ILE . 4.2 m120 -82.54 -88.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 110.262 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 15' ' ' GLN . 3.5 pt20 -52.45 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.772 -1.205 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 17' ' ' THR . 10.9 mt -102.72 167.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.342 -0.849 . . . . 0.0 110.602 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.611 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.64 131.51 43.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.159 -0.963 . . . . 0.0 109.837 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.521 ' HA ' HG13 ' A' ' 61' ' ' ILE . 9.3 p90 -133.7 163.93 28.34 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.996 . . . . 0.0 110.53 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' A' ' 55' ' ' HIS . 19.1 ttt180 -159.05 132.4 7.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 109.754 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.671 HD13 ' OD1' ' A' ' 33' ' ' ASP . 6.0 mt -93.26 131.25 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.75 -20.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 159.76 113.15 0.32 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -84.27 -168.36 2.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.409 -1.054 . . . . 0.0 108.225 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 27' ' ' LEU . 0.7 OUTLIER -105.1 149.66 37.89 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.817 -1.177 . . . . 0.0 109.475 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -78.31 -28.75 4.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.67 2.247 . . . . 0.0 110.061 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.671 ' OD1' HG22 ' A' ' 106' ' ' THR . 1.8 p30 -38.88 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.017 HD13 ' HA ' ' A' ' 106' ' ' THR . 2.0 pt? -129.11 157.45 41.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.109 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 1.6 m-20 -40.75 138.89 1.23 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.602 -0.687 . . . . 0.0 109.169 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -70.87 -39.91 4.0 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 N-CA-C 107.021 -1.953 . . . . 0.0 107.021 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.4 pt-20 -72.88 -22.55 60.74 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.553 ' HB ' ' CB ' ' A' ' 28' ' ' ASP . 5.7 m -80.01 -51.36 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.357 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.787 ' CG2' HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 -39.14 53.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.671 ' OD1' HD13 ' A' ' 20' ' ' ILE . 4.8 m-20 -78.76 -29.9 45.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 11.6 t70 -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.727 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.622 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -43.28 -55.37 4.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.468 -0.77 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 25.1 m-85 -54.99 -42.58 72.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.65 -0.656 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.88 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.865 . . . . 0.0 109.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -47.93 -37.68 14.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.788 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -63.14 -47.71 81.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.6 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -52.4 -33.04 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 2.1 tt0 -82.39 -16.03 50.58 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.601 -0.687 . . . . 0.0 109.348 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.795 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -72.54 -36.43 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.921 -1.112 . . . . 0.0 110.167 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.795 ' CD1' HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.29 -24.52 12.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 28.2 t -77.63 -17.67 57.53 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.176 -0.952 . . . . 0.0 108.964 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 8.0 t70 -65.77 -17.67 64.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 110.097 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 46' ' ' VAL . 13.6 p -110.31 19.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 3.8 t -173.74 149.79 1.62 Allowed Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.069 -1.02 . . . . 0.0 108.805 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -81.03 47.12 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.885 2.39 . . . . 0.0 110.811 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 51' ' ' PHE . 0.6 OUTLIER -81.25 147.2 30.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.405 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -122.78 124.06 42.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.353 -0.842 . . . . 0.0 108.93 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.644 ' CZ ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 m-85 -102.23 144.37 30.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.662 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -118.9 119.68 35.07 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -87.84 141.9 28.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 109.159 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 ' CB ' ' A' ' 59' ' ' ALA . 4.5 pt -141.22 -169.01 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 109.778 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.421 ' O ' ' CZ ' ' A' ' 19' ' ' ARG . 4.6 p80 -159.08 -33.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 109.191 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -115.31 157.86 23.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.18 -0.95 . . . . 0.0 109.18 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.18 11.26 78.82 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.16 158.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.419 -1.048 . . . . 0.0 109.066 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.867 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -128.13 143.66 51.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.88 -1.138 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 11' ' ' TRP . 1.6 m-20 -51.58 -59.24 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 109.072 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -98.6 129.66 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.062 . . . . 0.0 108.583 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.459 ' SD ' ' OD1' ' A' ' 96' ' ' ASP . 1.5 mtp -125.1 116.61 22.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.563 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.95 155.4 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.51 -0.744 . . . . 0.0 109.129 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.5 p30 179.3 -172.15 0.16 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.014 -1.054 . . . . 0.0 109.986 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -134.07 170.54 15.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.472 -0.768 . . . . 0.0 109.108 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -179.64 114.73 0.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -55.14 -149.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.722 -0.87 . . . . 0.0 110.894 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.4 p90 -48.96 -51.13 32.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.813 -1.179 . . . . 0.0 109.792 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 1.1 mt-10 -43.69 -69.21 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 15.1 t60 73.32 -73.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.43 -0.793 . . . . 0.0 110.608 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.33 9.96 9.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -170.66 68.5 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.252 -1.146 . . . . 0.0 109.971 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.49 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 117.59 179.25 17.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.81 76.29 14.03 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.431 -1.04 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HB2' ' CD2' ' A' ' 82' ' ' LEU . 29.7 Cg_endo -74.78 -84.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.39 2.06 . . . . 0.0 108.425 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 68' ' ' TRP . 24.1 t80 59.52 -100.12 0.1 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.435 -0.791 . . . . 0.0 110.567 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 75.69 -53.96 0.63 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.989 -1.07 . . . . 0.0 108.357 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 77' ' ' ASP . . . 101.83 -148.23 17.71 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HA ' ' OE2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -57.66 161.75 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 108.972 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 39.05 -147.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.434 -0.791 . . . . 0.0 110.028 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 51.46 -146.21 12.16 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.639 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 3.5 tp -40.56 112.93 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.927 . . . . 0.0 109.71 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 10.1 mt -108.63 -19.26 13.49 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.344 -0.848 . . . . 0.0 109.891 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 163.98 163.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 98' ' ' HIS . 6.3 p-80 -153.92 177.4 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.935 -1.103 . . . . 0.0 109.979 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.47 156.39 48.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.08 163.2 12.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.066 -1.022 . . . . 0.0 109.609 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.547 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -83.67 157.34 64.26 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.102 -0.999 . . . . 0.0 109.706 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' A' ' 10' ' ' LYS . 37.6 Cg_endo -76.81 147.56 27.56 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.462 2.108 . . . . 0.0 109.597 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 161.26 45.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.261 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 71.3 142.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -1.129 . . . . 0.0 109.72 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 35.97 -102.53 0.02 OUTLIER Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.73 119.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.158 -1.201 . . . . 0.0 108.171 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . 133.15 146.1 5.5 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.736 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 79.18 2.98 88.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.459 ' OD1' ' SD ' ' A' ' 62' ' ' MET . 1.3 m-20 -107.85 130.41 55.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.197 -1.178 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 85' ' ' HIS . 0.7 OUTLIER -122.67 133.53 54.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 109.535 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.537 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 5.8 m80 -111.89 134.21 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 109.065 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.651 ' HB2' ' CD2' ' A' ' 65' ' ' PHE . 6.1 m-85 -103.76 141.95 35.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 110.63 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.82 146.03 53.61 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 66' ' ' GLY . 16.6 m-20 -89.64 -112.27 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 101' ' ' ASP . 5.1 m-20 36.03 -160.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER 34.97 -124.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.437 -0.789 . . . . 0.0 110.349 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 15.1 tp -177.62 134.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.047 -1.033 . . . . 0.0 108.713 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -126.25 124.51 40.53 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.971 -1.081 . . . . 0.0 110.449 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 1.017 ' HA ' HD13 ' A' ' 27' ' ' LEU . 4.1 p -147.03 -160.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.145 -0.972 . . . . 0.0 111.275 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 107' ' ' ASN . 36.7 t30 -108.21 18.81 20.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.391 -0.818 . . . . 0.0 110.782 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -37.15 2.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.435 -1.416 . . . . 0.0 110.168 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -178.68 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 36.26 -94.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.699 -0.626 . . . . 0.0 109.821 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 105' ' ' TRP . 1.1 m-20 -85.23 -80.98 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 108.597 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.443 ' HB3' ' OH ' ' A' ' 142' ' ' TYR . 40.8 m-85 -157.42 40.44 0.3 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.0 OUTLIER 61.92 108.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.414 -0.804 . . . . 0.0 109.863 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -40.14 -39.39 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 109.848 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 57.4 t80 -59.44 -46.51 88.54 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.146 -0.971 . . . . 0.0 109.803 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.875 HD12 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -67.6 -54.44 19.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.569 -0.707 . . . . 0.0 109.814 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.599 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 14.2 m -58.78 -50.25 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.837 -1.164 . . . . 0.0 109.499 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.82 -43.29 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.505 -0.747 . . . . 0.0 110.07 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.17 -51.02 63.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.608 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.44 ' CE1' ' HE2' ' A' ' 130' ' ' HIS . 51.9 t60 -55.75 -61.37 2.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.954 -1.091 . . . . 0.0 109.234 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HB2' ' HZ ' ' A' ' 99' ' ' PHE . 67.1 mm-40 -63.9 -11.21 25.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.545 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -88.16 -18.76 28.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.776 -1.203 . . . . 0.0 108.032 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.38 -43.8 9.18 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.439 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -69.82 -43.24 72.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.31 -32.07 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 64.9 mtt -72.97 -80.65 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.03 -40.32 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.77 155.96 7.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.377 -1.072 . . . . 0.0 111.019 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -173.4 2.24 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 138' ' ' MET . 45.7 m170 -52.39 144.19 13.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.55 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -123.75 20.17 9.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 1.2 tp60 54.07 -156.17 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER 66.37 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -72.72 -41.17 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.311 2.007 . . . . 0.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.86 9.44 52.44 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -75.73 153.73 36.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.051 -1.264 . . . . 0.0 110.14 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.496 ' O ' HD12 ' A' ' 137' ' ' LEU . 14.4 tp -85.6 -21.64 28.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -111.97 28.3 8.88 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.76 76.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.32 9.29 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.933 1.755 . . . . 0.0 110.719 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 142' ' ' TYR . 56.3 mt -122.75 -99.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.008 -1.057 . . . . 0.0 109.366 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.3 t80 179.46 144.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 0.0 110.158 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 m -137.46 84.47 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 0.0 109.32 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -55.28 161.09 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.82 137.62 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.643 -0.661 . . . . 0.0 110.28 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.086 -1.009 . . . . 0.0 108.595 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 148' ' ' PHE . 42.8 t-20 -51.69 -29.91 19.99 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.496 ' O ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 59.45 134.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 1.8 tpt180 -113.45 -15.49 12.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.069 -1.019 . . . . 0.0 110.454 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER 84.13 -24.84 0.14 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 155' ' ' ILE . 97.6 p 55.99 132.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.937 0.875 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.64 ' O ' HG13 ' A' ' 155' ' ' ILE . 55.8 mt-30 -73.31 -24.4 60.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -49.76 -40.83 42.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 158' ' ' ILE . 1.4 t70 -83.18 -43.64 15.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 152' ' ' GLN . 1.2 pp -51.08 -34.23 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 157' ' ' GLY . 8.2 tmtt? -73.15 -48.02 38.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.113 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' N ' ' HD3' ' A' ' 156' ' ' LYS . . . -72.11 -53.95 8.62 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.723 HD11 ' CE2' ' A' ' 162' ' ' TYR . 10.3 tp -45.61 -51.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -1.183 . . . . 0.0 110.181 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.613 ' N ' HG23 ' A' ' 158' ' ' ILE . 5.4 mt-30 -57.61 -56.93 15.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.681 -1.262 . . . . 0.0 109.144 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.53 -25.92 0.31 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.644 -0.66 . . . . 0.0 110.402 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 12' ' ' ASP . 16.6 tp -97.02 -56.53 2.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 109.42 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 158' ' ' ILE . 15.7 m-30 -77.9 -77.38 0.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.901 -1.124 . . . . 0.0 108.682 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.452 ' OXT' ' HG2' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.635 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mttt . . . . . 0 N--CA 1.478 0.925 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 13.0 m95 -84.4 72.58 10.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 5.9 m-20 -122.58 62.94 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 109.558 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 49' ' ' LEU . 5.0 mtmt -124.63 -163.55 1.18 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.998 -1.064 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -109.77 -34.9 6.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.83 . . . . 0.0 108.82 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -94.14 97.7 10.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.497 0.665 . . . . 0.0 109.844 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.94 169.04 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.758 -1.214 . . . . 0.0 108.63 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -138.79 134.61 33.66 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.162 -0.961 . . . . 0.0 108.503 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 18.0 p90 -135.28 145.18 47.28 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.077 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HB2' HG13 ' A' ' 54' ' ' ILE . 2.2 tpt180 -151.21 125.37 9.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' N ' ' HD2' ' A' ' 19' ' ' ARG . 1.2 mt -85.56 124.04 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.874 -1.141 . . . . 0.0 109.049 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 64' ' ' ASN . 24.0 mm -53.76 -27.29 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.911 -1.118 . . . . 0.0 109.261 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 162.38 86.24 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.908 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CG ' HG11 ' A' ' 32' ' ' VAL . 1.3 p90 -46.73 177.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.567 -0.961 . . . . 0.0 109.203 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -87.94 140.72 31.1 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 0.0 109.941 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -80.09 -23.5 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.632 2.221 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . 12.0 t0 -39.83 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.894 -0.504 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -132.51 170.85 14.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.768 -1.207 . . . . 0.0 110.34 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.576 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 65.7 m-20 -42.64 133.93 2.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.371 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -68.67 -31.03 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 30' ' ' GLU . 5.6 mm-40 -76.02 -34.49 59.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.576 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 17.5 m -69.69 -52.55 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.422 -1.311 . . . . 0.0 108.038 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -55.66 -38.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -74.22 -31.27 62.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 22.7 t70 -64.36 -33.77 76.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -50.52 -47.91 57.27 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -71.36 -25.71 62.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -63.9 -64.55 0.86 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -53.76 -39.93 65.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.919 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -58.9 -51.12 71.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.4 t80 -44.19 -49.22 9.21 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 22.4 tt0 -70.49 -26.27 63.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -60.9 -33.83 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 108.509 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.919 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -103.04 -55.36 2.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.725 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -49.08 -35.12 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 3.6 t0 -62.96 -28.77 70.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.401 -0.812 . . . . 0.0 110.596 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.8 p -108.72 9.68 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -149.74 133.63 8.84 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.52 29.96 0.46 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.764 2.309 . . . . 0.0 111.358 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -85.57 141.39 29.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.652 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -101.38 121.7 42.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.854 -1.154 . . . . 0.0 109.44 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -94.78 143.2 26.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.741 -0.599 . . . . 0.0 109.449 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -124.47 141.39 52.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.852 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -99.43 162.39 13.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.942 -1.099 . . . . 0.0 108.847 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.821 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.86 164.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.707 -1.197 . . . . 0.0 110.02 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.1 p80 -145.97 38.64 1.09 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.415 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 55' ' ' HIS . 0.4 OUTLIER 169.04 166.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.427 -0.795 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . 75.2 -81.14 0.94 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.557 ' O ' HD12 ' A' ' 54' ' ' ILE . 1.3 tp10 178.33 166.24 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -1.004 . . . . 0.0 108.856 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -138.89 146.78 41.55 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 109.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.59 -57.76 6.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.02 -1.05 . . . . 0.0 108.745 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -93.46 116.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 120.839 -1.163 . . . . 0.0 109.223 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 4.8 mtm -113.06 114.01 26.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.582 -0.699 . . . . 0.0 109.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.1 mp -98.77 153.14 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.139 -0.975 . . . . 0.0 109.839 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 97' ' ' SER . 20.8 p-10 -174.64 -171.47 0.57 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 34.5 p90 -116.21 -171.9 2.08 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' A' ' 98' ' ' HIS . . . -164.64 116.2 0.69 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HD3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.73 -169.65 2.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -1.171 . . . . 0.0 108.876 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -16.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.472 -0.767 . . . . 0.0 109.92 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HG3' ' HD3' ' A' ' 67' ' ' ARG . 12.9 mt-10 -76.55 -105.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.05 . . . . 0.0 110.813 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 1.2 t-80 56.28 -158.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.862 -1.149 . . . . 0.0 108.751 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.57 38.11 0.23 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD1' ' CD2' ' A' ' 70' ' ' HIS . 1.3 m-20 -75.86 4.19 8.58 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.468 -1.019 . . . . 0.0 110.283 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.6 -42.4 2.32 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 16.0 p90 -103.19 160.61 25.64 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.303 . . . . 0.0 110.601 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -78.85 142.05 17.39 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.974 2.45 . . . . 0.0 111.287 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.603 ' HE2' ' HE2' ' A' ' 98' ' ' HIS . 9.1 m-85 -58.34 146.76 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 109.654 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 80' ' ' ASP . 10.9 p-10 -74.23 2.66 8.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.641 -0.662 . . . . 0.0 109.953 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.04 -161.58 41.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 163.72 13.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.016 -1.285 . . . . 0.0 109.438 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.462 ' O ' ' OD2' ' A' ' 77' ' ' ASP . 61.1 m-20 53.72 -170.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 108.698 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 66.71 -144.32 45.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.487 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 81' ' ' GLY . 0.3 OUTLIER -38.25 127.02 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.722 -0.869 . . . . 0.0 110.461 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -113.59 -23.98 9.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . -179.65 162.74 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.717 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.45 167.81 25.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.98 48.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -0.903 . . . . 0.0 110.039 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -81.83 169.68 16.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.951 -1.093 . . . . 0.0 109.858 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' CD1' ' A' ' 11' ' ' TRP . 35.6 Cg_endo -79.47 140.62 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.078 2.519 . . . . 0.0 111.009 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.54 -43.19 1.54 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.9 p -73.17 159.06 34.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.416 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 -16.86 63.28 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 93' ' ' VAL . 74.4 t -103.66 0.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -1.23 . . . . 0.0 109.168 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.52 159.4 20.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 77.91 -6.37 48.7 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -91.14 130.05 37.07 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.712 -1.463 . . . . 0.0 108.607 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 17.8 m -122.13 142.55 50.28 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.53 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.603 ' HE2' ' HE2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -116.13 122.24 44.49 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 108.856 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 26.8 m-85 -98.39 145.22 26.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' OE1' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -46.91 163.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 108.933 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 105' ' ' TRP . 34.3 t70 -117.61 -18.1 9.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.982 -1.074 . . . . 0.0 108.924 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -81.84 -31.41 31.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.127 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.436 ' OE1' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -67.13 161.58 24.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 110.651 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -106.02 106.58 17.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.722 -0.611 . . . . 0.0 109.465 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -116.15 122.74 45.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.0 108.908 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 110' ' ' ALA . 1.2 p -149.13 151.3 34.14 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.803 -1.186 . . . . 0.0 110.574 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.78 68.59 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.058 . . . . 0.0 110.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -172.63 77.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.459 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 108' ' ' THR . 2.4 p 45.67 75.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.464 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 106' ' ' THR . . . -155.77 -158.19 0.79 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -73.47 -114.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 110.471 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -62.15 146.45 50.57 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.067 -1.021 . . . . 0.0 109.843 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 106' ' ' THR . 3.5 m -110.02 110.34 21.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 110.448 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.69 HD22 ' CG2' ' A' ' 32' ' ' VAL . 2.1 tp -39.42 -45.62 1.53 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 110.521 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 3.7 t80 -54.83 -46.17 74.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -62.65 -72.12 0.14 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 118' ' ' ALA . 17.4 m -45.21 -49.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.528 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -54.08 -46.31 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.04 -1.038 . . . . 0.0 109.888 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -50.72 -58.82 4.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.721 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 124' ' ' HIS . 37.6 t60 -42.68 -57.52 2.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.502 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.4 -16.4 62.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.954 -1.091 . . . . 0.0 109.546 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.701 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -81.98 -3.46 54.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 108.24 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.13 -41.38 1.41 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.538 ' NE2' ' NE2' ' A' ' 120' ' ' HIS . 31.4 m-70 -64.09 -32.01 73.42 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.38 -26.7 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 109.36 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 6.84 46.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 109.747 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.67 -8.65 78.7 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.609 HD21 ' HA3' ' A' ' 157' ' ' GLY . 5.7 mt -44.73 151.36 0.29 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 110.438 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -111.6 176.05 5.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -80.46 169.95 17.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.152 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -115.07 -22.97 9.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 131' ' ' SER . 9.3 mm100 82.99 -21.72 0.27 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.691 -0.631 . . . . 0.0 110.707 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -74.66 152.41 87.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.877 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.26 -39.54 3.82 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.5 2.134 . . . . 0.0 110.356 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.33 2.14 62.95 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.99 149.09 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -1.214 . . . . 0.0 110.18 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.431 HD12 ' O ' ' A' ' 137' ' ' LEU . 18.1 tp -80.38 -23.25 40.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.188 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' CE1' ' A' ' 120' ' ' HIS . 1.1 mpt? -109.87 26.22 10.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -58.73 164.85 3.68 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.178 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 34.4 Cg_endo -78.69 17.18 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.465 2.11 . . . . 0.0 111.195 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 142' ' ' TYR . 15.5 mt -140.66 162.11 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.787 -1.196 . . . . 0.0 110.07 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 16.7 t80 -91.68 118.84 31.02 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -108.8 -48.81 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 58.7 t80 60.93 165.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.067 -1.021 . . . . 0.0 109.999 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.584 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 152.6 30.12 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.659 -0.651 . . . . 0.0 109.271 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 6.8 tptm -92.03 -11.62 35.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 148' ' ' PHE . 12.2 m-80 -126.53 -91.98 0.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 150' ' ' LEU . 6.2 t80 156.93 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.13 -0.981 . . . . 0.0 109.724 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -150.95 -40.53 0.12 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.288 -0.883 . . . . 0.0 110.364 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 148' ' ' PHE . 9.6 tp 65.6 144.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.018 -1.051 . . . . 0.0 109.495 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -114.84 131.56 56.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 12.3 tt0 -48.95 -22.66 0.9 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -48.6 78.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.888 -1.132 . . . . 0.0 108.088 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -73.58 -33.77 64.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -70.17 -27.53 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.365 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -76.56 -46.62 25.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 110.455 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.609 ' HA3' HD21 ' A' ' 128' ' ' LEU . . . -71.64 -23.12 78.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 159' ' ' GLN . 6.5 tp -81.0 -39.74 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.838 -1.389 . . . . 0.0 108.449 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -68.61 -22.45 64.44 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -86.13 -25.06 25.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -80.02 -22.23 42.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.497 ' CG ' HD11 ' A' ' 49' ' ' LEU . 30.3 m-85 -120.3 -69.05 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 108.999 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 9.1 mtpt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER 174.86 45.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.929 -1.107 . . . . 0.0 110.354 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.485 ' HB3' ' CE1' ' A' ' 162' ' ' TYR . 12.9 p-10 -144.57 84.52 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.467 -1.395 . . . . 0.0 111.329 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -115.95 49.11 1.14 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 9.8 m-20 65.34 -69.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' LYS . 4.2 mt-30 -80.67 110.35 16.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.995 -1.066 . . . . 0.0 109.103 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.1 mm -104.18 164.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -128.2 137.55 52.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' ILE . 13.2 p90 -149.15 154.3 38.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.043 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.88 ' HB2' HG23 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -147.53 125.43 11.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.847 . . . . 0.0 109.865 -178.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.4 mt -86.02 124.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 64' ' ' ASN . 2.8 mt -74.18 3.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.89 -1.131 . . . . 0.0 110.43 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 145.42 112.56 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.625 ' N ' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -61.63 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.113 -1.228 . . . . 0.0 107.788 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 27' ' ' LEU . 1.8 t -106.84 137.38 19.48 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.858 -1.151 . . . . 0.0 108.121 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.59 -24.74 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.206 1.938 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.26 -24.83 3.14 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.763 -0.586 . . . . 0.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -138.47 177.0 8.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.878 -1.139 . . . . 0.0 111.002 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 32' ' ' VAL . 74.8 m-20 -53.87 129.51 56.45 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.649 -0.657 . . . . 0.0 110.436 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.764 ' HA ' HG23 ' A' ' 32' ' ' VAL . 27.0 Cg_endo -73.79 -33.65 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 N-CA-C 105.394 -2.579 . . . . 0.0 105.394 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.72 -36.24 82.36 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.7 m -66.27 -71.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -41.32 -28.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 0.0 108.981 178.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -72.47 -38.37 68.23 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' THR . 24.2 t0 -79.89 -58.57 3.11 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . . . -36.77 -39.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.642 0.734 . . . . 0.0 109.034 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 63' ' ' ILE . 3.6 m-85 -68.26 -65.78 0.65 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -44.52 -51.02 9.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.773 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -59.26 -52.5 65.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -43.91 -52.57 6.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -46.38 -40.91 12.79 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -71.56 -20.33 62.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.546 -0.721 . . . . 0.0 110.591 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -86.47 -32.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.259 -1.526 . . . . 0.0 109.196 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.6 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 3.7 m95 -91.13 -19.01 23.56 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.626 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 28.9 t -91.37 -23.04 20.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 8.4 m-20 -65.34 -5.55 7.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.245 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' HB ' ' A' ' 155' ' ' ILE . 12.2 p -120.49 4.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.535 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 7.9 t -159.08 149.05 15.16 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.598 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -79.11 49.59 3.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.337 2.025 . . . . 0.0 109.856 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' A' ' 162' ' ' TYR . 4.8 tp -93.67 150.56 20.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.3 -0.875 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -122.95 136.79 54.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 109.073 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 51' ' ' PHE . 6.7 m-85 -112.56 149.72 32.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.929 -1.107 . . . . 0.0 110.183 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -125.11 126.68 45.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.208 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' CZ ' ' HB2' ' A' ' 53' ' ' ARG . 6.0 mtm-85 -77.97 126.73 31.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 108.481 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.88 HG23 ' HB2' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.64 141.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.223 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.509 ' CD2' ' N ' ' A' ' 55' ' ' HIS . 4.5 m170 -72.44 -145.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.53 -174.13 4.1 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 108.636 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.63 42.64 4.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.43 160.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -1.041 . . . . 0.0 109.203 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.502 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -153.46 148.94 27.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -53.55 -59.97 3.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 108.802 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -104.57 124.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 74.9 mtp -111.96 113.88 26.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 110.987 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 64' ' ' ASN . 1.6 mp -102.71 159.7 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.648 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.8 p-10 174.99 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.445 -0.784 . . . . 0.0 109.397 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -115.41 175.67 5.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.175 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.63 90.88 0.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -71.87 -145.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 108.059 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 67' ' ' ARG . 5.4 m95 -63.22 -147.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.485 -1.385 . . . . 0.0 108.648 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 47.79 -143.54 0.4 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.03 -1.044 . . . . 0.0 109.927 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.426 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 0.1 OUTLIER 68.02 156.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -130.72 23.94 4.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.3 74.95 0.09 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.462 -1.022 . . . . 0.0 108.99 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 63.48 -87.51 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 3.1 m-85 -108.71 117.98 52.87 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.294 -1.121 . . . . 0.0 108.713 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.52 158.38 40.19 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.68 1.586 . . . . 0.0 109.916 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 17.8 t80 62.64 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 80.95 -46.17 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.15 -157.56 23.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -57.31 165.5 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -1.163 . . . . 0.0 108.826 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 3.3 m-20 43.69 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.229 -0.919 . . . . 0.0 111.135 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 61.17 -142.32 48.4 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.46 ' HB3' ' OD2' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -40.08 106.83 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.655 -0.909 . . . . 0.0 109.347 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 mt -111.21 -26.92 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 165.05 152.93 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.385 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -152.24 177.05 10.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.411 -0.806 . . . . 0.0 108.961 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.22 155.92 46.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 108.775 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 156.22 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 110.078 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -72.27 162.47 73.58 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 30.2 Cg_endo -73.75 136.76 23.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.807 2.338 . . . . 0.0 111.112 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.66 -165.82 28.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -86.48 117.96 25.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -1.086 . . . . 0.0 110.339 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.64 -89.81 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 93' ' ' VAL . 32.6 m -71.32 119.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.082 -1.246 . . . . 0.0 109.065 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.39 158.65 8.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.75 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 67.27 6.9 42.42 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' MET . 2.7 m-20 -97.98 140.83 31.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -1.194 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.8 131.15 25.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.02 . . . . 0.0 109.769 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CD2' ' N ' ' A' ' 98' ' ' HIS . 1.9 m170 -106.32 135.5 47.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.029 -1.044 . . . . 0.0 109.309 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 58.9 m-85 -96.52 158.83 15.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.457 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -55.43 129.42 38.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.698 -0.627 . . . . 0.0 109.683 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.14 -70.27 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 22.3 p-10 -60.7 86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 110.592 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -179.48 179.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.532 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 63.8 tp -119.32 100.77 7.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.906 -1.121 . . . . 0.0 109.385 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.761 ' O ' HD23 ' A' ' 27' ' ' LEU . 24.4 m0 -112.45 173.91 6.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.246 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 105' ' ' TRP . 0.5 OUTLIER 179.62 162.65 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.969 -1.082 . . . . 0.0 110.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.565 ' HB3' HG23 ' A' ' 31' ' ' THR . 2.1 t-20 -104.84 21.74 16.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 109.869 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -124.01 -179.7 4.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.512 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 108' ' ' THR . 8.1 t -66.69 69.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.377 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 106' ' ' THR . . . -160.41 115.96 2.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.424 -0.798 . . . . 0.0 109.104 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t-20 64.96 -150.3 0.26 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.443 -0.786 . . . . 0.0 108.984 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HD2' ' CD1' ' A' ' 105' ' ' TRP . 42.3 m-85 -67.88 -147.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.094 . . . . 0.0 108.4 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 106' ' ' THR . 22.4 t -148.71 98.64 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.061 -1.024 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -35.69 -57.97 0.63 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.384 -0.822 . . . . 0.0 111.286 -179.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -49.66 -40.57 40.25 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.168 -0.958 . . . . 0.0 109.792 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' C ' HD13 ' A' ' 116' ' ' LEU . 3.0 tm? -70.36 -55.14 9.83 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 110.521 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 118' ' ' ALA . 35.7 m -58.36 -48.63 84.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 O-C-N 120.437 -1.414 . . . . 0.0 108.057 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -46.56 -52.37 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.94 -1.1 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.03 -54.53 6.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 108.605 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.475 ' CE1' ' HA ' ' A' ' 138' ' ' MET . 43.8 t60 -46.48 -64.63 0.71 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.102 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 66.3 mm-40 -63.23 -15.34 56.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.772 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.6 m-85 -82.12 -10.61 59.13 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.6 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -99.31 -48.38 1.71 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.503 ' CD2' ' HE1' ' A' ' 138' ' ' MET . 12.8 m-70 -55.93 -40.54 73.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -1.07 . . . . 0.0 108.856 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.31 -4.66 18.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.465 -0.772 . . . . 0.0 109.554 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.482 ' HG2' ' OH ' ' A' ' 162' ' ' TYR . 26.7 mtt -103.04 -14.84 16.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 0.0 110.902 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.22 -11.67 12.91 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.677 -1.264 . . . . 0.0 110.678 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.512 HD12 ' CH2' ' A' ' 43' ' ' TRP . 30.9 mt -81.07 138.53 35.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.897 -1.355 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.39 178.27 4.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 138' ' ' MET . 50.4 m170 -55.53 148.28 16.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 0.0 110.247 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.4 p -112.39 -173.14 2.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -108.03 -14.46 14.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.004 -1.06 . . . . 0.0 109.715 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -70.04 134.72 87.46 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 133' ' ' ASP . 33.2 Cg_endo -79.51 109.84 2.55 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 123.056 2.504 . . . . 0.0 110.115 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.78 -2.77 17.48 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.11 170.7 1.53 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.353 -1.086 . . . . 0.0 109.406 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.7 HD12 ' O ' ' A' ' 137' ' ' LEU . 8.3 tp -84.68 -25.86 28.15 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.782 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.597 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 2.9 mmt -97.79 4.23 49.84 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.989 -1.069 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -41.69 156.75 0.22 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.13 2.37 7.71 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.426 2.084 . . . . 0.0 111.574 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.46 160.94 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.915 -1.116 . . . . 0.0 108.196 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.557 ' O ' ' CB ' ' A' ' 143' ' ' THR . 75.0 t80 -56.52 -82.28 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.563 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.557 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 3.2 m 81.59 -33.56 0.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.039 -1.038 . . . . 0.0 111.792 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.491 ' CB ' ' O ' ' A' ' 143' ' ' THR . 3.0 t80 71.59 175.23 0.29 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.686 -1.259 . . . . 0.0 109.426 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.619 ' OG1' ' N ' ' A' ' 148' ' ' PHE . 4.6 p -85.34 4.28 35.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 109.119 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.602 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 46.99 47.73 15.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.232 -0.917 . . . . 0.0 110.435 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.4 t30 89.16 21.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.619 ' N ' ' OG1' ' A' ' 145' ' ' THR . 48.7 t80 52.34 164.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 109.938 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.567 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 165.2 -22.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.61 -178.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.535 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 69.01 123.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 108.881 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.62 134.99 49.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.032 -1.042 . . . . 0.0 110.668 -178.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 0.4 OUTLIER -50.61 -19.99 1.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.38 -56.06 26.78 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.688 -1.257 . . . . 0.0 108.055 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.638 ' OD2' HD23 ' A' ' 137' ' ' LEU . 4.2 t0 -68.46 -32.13 71.91 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.68 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.29 -37.39 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.603 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 155' ' ' ILE . 8.4 tmtt? -61.73 -49.32 76.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.304 -0.873 . . . . 0.0 109.39 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -68.25 -39.83 87.84 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 155' ' ' ILE . 2.7 tp -66.17 -17.65 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.841 -1.388 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 163' ' ' GLY . 66.0 mt-30 -87.82 -49.02 7.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.092 . . . . 0.0 109.282 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -13.63 62.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 0.0 109.278 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -101.76 -42.3 6.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.839 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' A' ' 49' ' ' LEU . 21.8 m-30 -107.17 -13.21 15.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.794 -1.191 . . . . 0.0 110.312 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' A' ' 89' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.484 1.245 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' LYS . 14.6 m95 -37.5 110.64 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.56 -0.712 . . . . 0.0 110.338 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.7 p-10 -128.81 54.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -108.84 -167.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.287 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -108.57 -41.7 4.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.023 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HG2' ' HG2' ' A' ' 50' ' ' ARG . 19.3 mt-30 -92.92 116.77 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.071 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -111.45 161.07 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.039 -1.038 . . . . 0.0 109.595 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.3 p -131.69 126.07 33.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.397 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 34.1 p90 -137.05 148.53 46.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.768 ' HG2' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.33 140.85 29.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.075 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.2 mp -92.89 161.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -108.38 -39.72 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . -161.58 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.222 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.966 ' CE1' HD13 ' A' ' 20' ' ' ILE . 15.5 m-85 -45.74 172.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -1.183 . . . . 0.0 108.962 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.587 ' CG2' HD11 ' A' ' 27' ' ' LEU . 9.9 t -97.98 145.41 29.74 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 34.2 Cg_endo -78.29 -28.69 4.47 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.313 2.009 . . . . 0.0 111.22 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.496 ' OD2' HG22 ' A' ' 106' ' ' THR . 3.9 t70 -41.56 -28.49 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.868 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -133.33 179.68 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.037 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.722 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -73.6 152.27 89.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.245 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 32' ' ' VAL . 26.5 Cg_endo -67.08 -32.61 34.02 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.872 2.381 . . . . 0.0 105.971 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.48 -31.95 71.6 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 107' ' ' ASN . 1.4 m -72.84 -69.39 0.42 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.97 -31.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.452 -0.78 . . . . 0.0 109.052 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 4.6 t0 -79.84 -33.05 40.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 31' ' ' THR . 21.7 t70 -78.93 -44.88 21.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 108.589 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 114' ' ' LEU . . . -44.62 -48.9 10.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 17.1 m-30 -71.44 -44.99 63.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.405 -0.81 . . . . 0.0 108.934 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -51.37 -54.17 29.09 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -53.32 -42.47 66.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.796 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -56.54 -49.67 74.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' A' ' 44' ' ' SER . 10.1 t80 -47.22 -33.76 5.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -86.81 -24.05 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.712 -0.617 . . . . 0.0 109.72 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -59.59 -35.34 58.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.258 -0.902 . . . . 0.0 108.851 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.796 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -105.96 -49.66 3.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.454 -0.779 . . . . 0.0 110.104 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 48.2 t -53.83 -21.7 8.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.178 -0.951 . . . . 0.0 110.639 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 6.2 m-20 -67.12 -13.89 62.38 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.878 HG23 HG23 ' A' ' 47' ' ' THR . 32.8 m -122.01 -20.83 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 0.0 110.434 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.878 HG23 HG23 ' A' ' 46' ' ' VAL . 54.0 p -122.58 143.8 40.77 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 109.405 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.05 57.99 4.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.097 1.864 . . . . 0.0 108.945 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 162' ' ' TYR . 3.0 mm? -84.64 144.84 28.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.904 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.462 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 9.3 tpm_? -116.6 66.64 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 108.778 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 47.2 m-85 -59.5 148.68 32.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 108.92 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.4 t -139.32 106.65 5.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.522 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 2.3 ptt85 -76.6 126.57 31.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 108.752 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.88 HD11 ' HA ' ' A' ' 59' ' ' ALA . 6.3 pt -117.95 166.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.937 -1.102 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 55' ' ' HIS . 9.7 p80 -154.01 70.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.071 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.44 6.01 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.725 -1.235 . . . . 0.0 109.824 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 58' ' ' GLU . . . 106.76 32.72 3.5 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 172.18 158.35 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.178 -1.189 . . . . 0.0 109.701 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.88 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . 178.95 143.04 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.764 . . . . 0.0 109.034 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.56 -57.38 9.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.077 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 95' ' ' GLY . 9.8 mt -90.51 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.169 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.605 ' C ' HD12 ' A' ' 63' ' ' ILE . 2.7 mtt -147.35 118.2 7.62 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.813 . . . . 0.0 109.776 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.813 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.0 mp -105.82 148.95 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 5.8 t30 176.44 -156.25 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.225 -0.922 . . . . 0.0 109.274 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -127.43 171.21 11.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.905 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.52 86.52 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.016 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 68' ' ' TRP . 1.4 ptt85 -78.26 -160.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.099 -1.236 . . . . 0.0 109.686 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.541 ' C ' ' CE3' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -42.95 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.256 -0.903 . . . . 0.0 110.562 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -36.74 95.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.58 -0.7 . . . . 0.0 110.374 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' TRP . 2.2 t-80 -168.57 -61.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 76.77 -2.66 58.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 74' ' ' TYR . 4.1 p-10 -56.1 83.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.155 -1.203 . . . . 0.0 110.13 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 61.18 -75.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 72' ' ' ASP . 24.3 m-85 -100.69 137.11 19.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.274 . . . . 0.0 110.146 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.15 -157.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.576 2.184 . . . . 0.0 109.221 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -80.63 140.66 35.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.134 . . . . 0.0 109.153 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 40.2 p-10 -116.19 -15.6 11.05 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.05 -154.43 33.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' ASP . 1.1 mttt -47.25 154.6 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -1.171 . . . . 0.0 110.843 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' LYS . 15.6 m-20 49.5 -177.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.621 -0.674 . . . . 0.0 110.18 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 76.39 -144.97 31.24 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 28.6 tp -40.27 116.61 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.493 -1.004 . . . . 0.0 110.022 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.612 HD23 ' OE1' ' A' ' 103' ' ' GLU . 57.8 mt -112.02 -28.16 8.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 176.47 147.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 109.771 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -150.16 179.52 8.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -148.13 158.23 43.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.0 108.993 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.46 155.73 18.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.226 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -55.51 155.14 10.75 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.579 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.514 ' CG ' ' HE2' ' A' ' 10' ' ' LYS . 33.5 Cg_endo -75.2 141.41 26.03 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.761 2.307 . . . . 0.0 110.436 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.9 177.48 48.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.96 114.18 15.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.237 . . . . 0.0 109.236 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.78 -85.51 0.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.16 156.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -1.131 . . . . 0.0 108.928 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 109.69 156.22 16.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 74.83 -0.54 57.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -98.83 137.83 36.84 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.872 -1.369 . . . . 0.0 109.118 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -132.26 130.85 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.905 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -111.66 133.79 53.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.312 -0.867 . . . . 0.0 108.828 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 3.7 m-30 -95.95 159.8 14.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.544 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CB ' ' OE1' ' A' ' 103' ' ' GLU . 1.6 t70 -58.83 136.81 57.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 109.359 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.92 -9.2 58.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.229 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.5 -42.19 12.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.786 . . . . 0.0 109.742 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.612 ' OE1' HD23 ' A' ' 83' ' ' LEU . 3.1 mp0 -72.7 140.93 48.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.74 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 104' ' ' LEU . 1.1 mp -105.21 128.18 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.427 -0.795 . . . . 0.0 109.277 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.609 ' CZ2' ' HB2' ' A' ' 99' ' ' PHE . 1.9 m-90 -101.01 166.56 10.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.847 ' HA ' HD23 ' A' ' 27' ' ' LEU . 82.6 p -149.46 -168.3 3.07 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.056 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.579 ' HB3' HG23 ' A' ' 31' ' ' THR . 2.6 p30 -135.2 6.33 3.32 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.128 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 109' ' ' SER . 11.1 t -139.22 -152.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.237 -0.915 . . . . 0.0 109.98 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.91 108.77 18.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.4 -0.813 . . . . 0.0 108.87 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.8 -97.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.262 -0.899 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.79 -78.05 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.069 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -100.92 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.127 -0.983 . . . . 0.0 109.073 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -164.61 114.63 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 32' ' ' VAL . 8.4 tp -50.16 -70.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.5 -0.75 . . . . 0.0 110.318 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' LEU . 8.0 t80 -39.5 -27.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.427 -0.795 . . . . 0.0 110.173 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 114' ' ' LEU . 1.0 OUTLIER -78.57 -71.6 0.42 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.836 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 118' ' ' ALA . 14.6 m -52.46 -42.43 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.917 -1.115 . . . . 0.0 109.154 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.88 -45.92 78.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.69 68.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.229 -0.919 . . . . 0.0 108.87 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 137' ' ' LEU . 24.0 t60 -60.52 -54.06 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 110.104 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 124' ' ' HIS . 73.5 mm-40 -69.05 -53.36 20.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.133 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.622 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 13.4 m-85 -49.59 -24.09 1.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.955 -1.091 . . . . 0.0 108.47 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.45 -27.53 24.74 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 2.1 m-70 -76.3 -48.23 20.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.689 -0.889 . . . . 0.0 109.183 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -42.88 -27.49 0.19 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.609 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -71.9 -98.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.782 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.58 29.14 0.19 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.76 144.84 24.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.742 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -119.96 151.78 38.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 138' ' ' MET . 12.2 m-70 -51.29 117.6 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 110.015 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -88.76 -80.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.082 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 131' ' ' SER . 5.6 tt0 177.03 -34.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.625 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -43.0 139.6 2.13 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.105 -0.997 . . . . 0.0 110.138 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.54 -38.86 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.431 2.088 . . . . 0.0 109.812 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.15 17.48 53.36 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 133' ' ' ASP . . . -85.09 149.42 25.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.066 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.575 HD12 ' HA ' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -75.76 -10.99 59.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.583 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 0.8 OUTLIER -106.42 11.96 30.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -75.92 154.83 84.96 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.913 -1.117 . . . . 0.0 108.955 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.78 9.19 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.755 2.303 . . . . 0.0 111.477 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.663 ' H ' HD12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -134.63 137.79 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 109.307 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.583 ' OH ' ' CD1' ' A' ' 144' ' ' TYR . 2.9 t80 -84.78 128.72 34.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.424 -0.798 . . . . 0.0 110.186 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' TYR . 96.2 m -122.16 100.26 6.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CD1' ' OH ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -40.21 149.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -0.808 . . . . 0.0 110.26 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.633 ' O ' HG23 ' A' ' 145' ' ' THR . 6.1 t -149.56 102.88 3.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -16.93 32.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.442 -0.786 . . . . 0.0 110.269 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 148' ' ' PHE . 1.1 t30 -95.25 -19.62 19.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.766 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.648 ' CE1' ' CG2' ' A' ' 42' ' ' VAL . 9.4 t80 49.2 104.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.701 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -121.32 -20.69 6.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 109.209 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 149' ' ' ARG . 15.5 tp 66.47 147.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.555 ' CB ' ' OD1' ' A' ' 153' ' ' ASP . 3.7 m -114.97 138.58 50.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 109.889 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.64 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 19.6 tt0 -49.09 -31.42 7.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 110.533 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.555 ' OD1' ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -46.3 -50.03 16.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.565 -1.334 . . . . 0.0 108.638 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -75.17 -31.33 60.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.474 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.69 -26.05 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 108.991 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -74.85 -53.57 8.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.252 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -59.32 -41.07 96.71 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 47' ' ' THR . 0.6 OUTLIER -75.78 -22.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -1.232 . . . . 0.0 109.751 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.572 ' NE2' HD13 ' A' ' 155' ' ' ILE . 36.6 mt-30 -79.25 -42.21 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 108.931 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.17 -22.86 15.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.805 ' HB3' HD21 ' A' ' 49' ' ' LEU . 17.6 m-85 -130.61 -24.99 2.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.589 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HE3' HD13 ' A' ' 161' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.551 ' HA ' ' CE3' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 172.05 42.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.551 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 16.1 p-10 -130.35 99.76 5.13 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLN . 2.4 mtmt -120.92 34.52 5.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.43 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.9 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.097 -1.002 . . . . 0.0 108.586 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.598 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt-30 -86.94 104.93 16.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.277 -0.89 . . . . 0.0 108.672 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 mt -112.84 153.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -115.19 148.41 39.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' A' ' 61' ' ' ILE . 15.9 p90 -151.94 155.24 37.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.932 . . . . 0.0 109.797 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -148.84 133.48 17.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.746 -179.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 22' ' ' GLY . 4.3 mt -96.17 124.85 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.917 -1.114 . . . . 0.0 108.834 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 62' ' ' MET . 2.8 mp -76.74 -1.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 0.0 109.474 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.764 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 157.71 100.81 0.17 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.438 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.746 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.88 -163.52 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -94.58 148.35 34.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.94 -1.1 . . . . 0.0 108.94 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' LEU . 35.1 Cg_endo -83.59 -29.11 1.16 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.559 2.839 . . . . 0.0 110.603 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -41.96 -26.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.57 -0.706 . . . . 0.0 109.528 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -129.4 166.03 20.36 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.266 -0.896 . . . . 0.0 109.613 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -58.63 147.95 68.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.492 -0.755 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 32' ' ' VAL . 28.9 Cg_endo -67.64 -34.85 24.04 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 106.131 -2.296 . . . . 0.0 106.131 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.58 -28.33 60.88 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 2.9 m -72.88 -63.42 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.746 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -45.92 -39.54 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.557 -0.714 . . . . 0.0 109.354 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 19.5 t0 -67.56 -29.84 69.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.1 t70 -61.39 -50.52 72.55 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.84 -39.38 5.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 109.317 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 85.5 m-85 -73.11 -36.2 66.7 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.687 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -56.0 -57.59 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 108.516 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' ALA . 2.7 mtm180 -61.34 -51.61 68.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.768 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -45.23 -48.99 12.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 28.6 t80 -49.99 -44.74 51.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 108.879 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 8.1 tt0 -79.87 -19.13 49.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 109.912 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -62.58 -36.08 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.028 -1.045 . . . . 0.0 108.502 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.768 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -108.42 -46.67 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.725 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -51.33 -20.3 1.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.053 . . . . 0.0 110.042 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.2 m-20 -64.92 -10.31 27.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 110.473 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 43' ' ' TRP . 2.6 m -111.15 -18.88 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.991 -1.068 . . . . 0.0 109.861 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.555 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -131.67 155.03 81.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 108.846 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 31.8 Cg_endo -77.84 49.15 2.85 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.748 2.298 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.581 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -76.38 162.5 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.932 0.873 . . . . 0.0 111.182 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 1.1 tpt180 -138.4 116.73 11.92 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HE1' HD22 ' A' ' 49' ' ' LEU . 3.3 m-85 -99.9 136.66 39.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.749 -1.219 . . . . 0.0 109.399 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -123.05 100.84 7.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.1 tmt_? -80.39 135.79 36.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.882 -1.136 . . . . 0.0 109.451 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -111.12 163.47 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.506 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -119.75 -29.33 5.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -0.962 . . . . 0.0 108.961 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.65 98.65 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.41 -173.31 32.92 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.68 161.96 25.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.271 . . . . 0.0 110.394 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . . . -143.71 153.11 42.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 108.978 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -77.12 -49.35 15.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.931 -1.106 . . . . 0.0 109.313 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.99 131.28 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 21' ' ' ILE . 4.3 ttm -116.35 115.81 26.58 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.149 -0.969 . . . . 0.0 109.2 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 9.3 mt -108.5 148.38 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.085 -1.01 . . . . 0.0 109.689 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 29.3 t30 177.93 159.79 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' A' ' 67' ' ' ARG . 35.7 p90 -83.32 175.16 10.09 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 108.665 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 68' ' ' TRP . . . -113.39 -27.17 3.71 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.614 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 62.7 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -1.228 . . . . 0.0 109.813 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TRP . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 36.1 t-105 -165.35 -56.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.843 -1.16 . . . . 0.0 109.331 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.55 74.16 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.645 -0.66 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -106.86 -66.39 1.02 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 84.96 -10.39 63.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 3.2 m-20 -62.65 73.4 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.509 -0.995 . . . . 0.0 108.893 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 59.84 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -86.28 138.25 34.42 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.122 -1.223 . . . . 0.0 109.644 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.66 -175.06 2.54 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.405 2.07 . . . . 0.0 110.29 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -76.35 150.87 36.8 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.12 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD2' ' HA3' ' A' ' 81' ' ' GLY . 20.3 p-10 -115.07 -14.18 11.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 72.33 -92.12 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 80' ' ' ASP . 5.0 mttt -45.75 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.56 -0.964 . . . . 0.0 109.379 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -25.69 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.436 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 33.26 -139.24 0.1 Allowed Glycine 0 N--CA 1.502 3.093 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 81' ' ' GLY . 33.8 tp -37.18 118.67 0.63 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.885 . . . . 0.0 110.098 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' CE2' ' A' ' 112' ' ' TYR . 6.9 mt -105.2 -26.44 12.05 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . 170.5 175.94 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 109.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 55.5 p-80 -177.62 149.08 0.6 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.898 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB2' ' OG ' ' A' ' 97' ' ' SER . . . -132.35 175.62 9.12 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.63 156.87 26.29 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.09 -178.98 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 38.1 Cg_endo -80.57 144.36 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 11' ' ' TRP . . . -174.16 -172.2 39.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.659 HG22 ' N ' ' A' ' 92' ' ' GLY . 21.3 m -67.13 -96.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -1.04 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.659 ' N ' HG22 ' A' ' 91' ' ' THR . . . -70.09 -81.21 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 94' ' ' GLY . 31.6 t -61.9 172.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -1.143 . . . . 0.0 108.888 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 93' ' ' VAL . . . 96.92 150.94 27.46 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 62.07 9.67 22.95 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.343 -1.093 . . . . 0.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.53 ' CG ' ' CB ' ' A' ' 62' ' ' MET . 32.5 m-20 -102.37 134.52 45.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.082 -1.834 . . . . 0.0 109.248 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.821 ' OG ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 m -112.36 120.66 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.948 . . . . 0.0 110.523 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 8.1 m80 -95.23 129.11 42.47 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.778 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 8.3 m-30 -108.89 147.38 32.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.0 110.088 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 76' ' ' PHE . 9.3 t70 -76.88 112.16 13.18 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 103' ' ' GLU . 46.9 t0 -55.48 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.217 -0.927 . . . . 0.0 111.204 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' ASP . 1.9 m-20 -40.03 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 110.439 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 175.09 156.9 0.17 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.0 124.83 50.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.975 -1.078 . . . . 0.0 111.68 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TRP . . . . . 0.778 ' NE1' HG11 ' A' ' 117' ' ' VAL . 6.8 m0 -122.35 172.3 8.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 6.4 p -145.19 141.3 28.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.602 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 4.9 t-20 -103.26 27.99 6.76 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' SER . 8.8 t -142.05 25.89 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.468 -1.395 . . . . 0.0 110.626 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER 70.68 89.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.815 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.541 ' O ' ' CG2' ' A' ' 106' ' ' THR . . . 174.87 137.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.471 -0.768 . . . . 0.0 109.156 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.59 -149.04 0.27 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.859 -1.151 . . . . 0.0 108.651 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.619 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -65.17 -34.71 79.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.81 -1.181 . . . . 0.0 108.097 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER 75.38 124.73 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 110.393 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -66.55 -35.02 79.2 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.158 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -68.69 -43.29 76.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -178.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.89 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -64.58 -62.46 1.57 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.771 -1.205 . . . . 0.0 109.562 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.778 HG11 ' NE1' ' A' ' 105' ' ' TRP . 18.1 m -44.12 -46.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.209 -0.932 . . . . 0.0 109.61 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -62.49 -47.85 82.17 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.955 -1.091 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -48.36 -63.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.583 -0.698 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -46.62 -54.18 10.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.206 -0.934 . . . . 0.0 109.521 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.34 -18.81 65.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.963 -1.086 . . . . 0.0 108.254 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -81.89 -8.22 59.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -97.03 -37.89 4.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.468 ' CE1' ' CD2' ' A' ' 130' ' ' HIS . 55.3 m-70 -74.19 -47.41 35.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.33 -27.09 0.95 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.173 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 10.8 mtt -79.29 7.99 6.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.271 -0.893 . . . . 0.0 109.822 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 -23.75 27.22 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.54 ' CD2' ' N ' ' A' ' 128' ' ' LEU . 3.0 mm? -53.54 141.57 25.04 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.337 -1.096 . . . . 0.0 108.986 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.04 -176.43 2.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 109.528 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CD2' ' CE1' ' A' ' 124' ' ' HIS . 24.6 m170 -63.75 132.59 51.45 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -90.25 -115.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -159.41 -48.64 0.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.696 -1.253 . . . . 0.0 109.261 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 132' ' ' GLN . 0.9 OUTLIER -42.38 124.83 2.85 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.979 . . . . 0.0 109.718 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -78.37 108.01 2.4 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.093 1.862 . . . . 0.0 109.386 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 124.27 -13.83 7.87 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -57.33 157.66 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.379 -1.071 . . . . 0.0 110.352 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 137' ' ' LEU . 14.2 tp -63.13 -24.77 68.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.441 ' CE ' ' HG ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -102.7 12.92 35.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -61.57 149.2 84.87 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.702 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 36.6 Cg_endo -77.27 21.11 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.959 2.44 . . . . 0.0 110.917 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 141' ' ' ILE . 1.1 mt -142.46 145.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.888 -1.133 . . . . 0.0 110.396 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -69.34 148.07 50.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 144' ' ' TYR . 5.9 m -161.97 -33.46 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 42.9 t80 59.24 166.06 0.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.4 -0.813 . . . . 0.0 109.057 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.634 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 1.2 t -150.13 115.31 5.41 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.844 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -39.94 42.92 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.092 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 44.6 t-20 -73.25 -48.38 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.076 -1.015 . . . . 0.0 108.511 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 150' ' ' LEU . 39.7 t80 75.45 139.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.39 0.614 . . . . 0.0 109.68 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 1.6 tpt180 -155.65 -25.06 0.11 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.316 -0.865 . . . . 0.0 110.889 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.607 ' HG ' ' CZ ' ' A' ' 148' ' ' PHE . 6.2 mt 65.66 83.36 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -53.87 140.36 30.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.611 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 mt-30 -55.23 -35.3 64.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.355 -0.84 . . . . 0.0 108.994 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -47.01 -33.81 5.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.531 -1.356 . . . . 0.0 108.889 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -89.1 -28.42 20.11 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ILE . . . . . 0.611 ' CG2' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -71.03 -34.48 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 2.2 ttmt -73.29 -56.86 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.463 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -51.0 -37.29 36.06 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.49 -14.9 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -70.34 -57.13 5.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 13.1 mm-40 -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.759 -0.588 . . . . 0.0 109.474 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.465 HD13 ' HE3' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -73.4 -29.43 62.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -0.779 . . . . 0.0 111.024 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.558 ' CD2' HD11 ' A' ' 49' ' ' LEU . 42.4 m-85 -131.24 -51.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.471 -1.393 . . . . 0.0 109.174 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 3' ' ' ASN . 1.5 mmm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 53.48 -89.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.209 -0.932 . . . . 0.0 108.937 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 1' ' ' MET . 1.6 m-20 -148.45 -178.54 6.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.495 -0.753 . . . . 0.0 109.124 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -74.96 150.18 39.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.349 -0.845 . . . . 0.0 109.505 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 2.3 m-85 -127.87 165.55 29.52 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.806 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 35.0 Cg_endo -76.03 41.86 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.841 2.36 . . . . 0.0 112.031 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 71.79 -49.23 0.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.837 -1.165 . . . . 0.0 111.236 178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -78.13 117.06 63.7 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.743 -1.223 . . . . 0.0 109.964 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 10' ' ' LYS . 32.2 Cg_endo -73.04 80.67 1.8 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.152 1.902 . . . . 0.0 108.84 178.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -30.88 134.05 0.07 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.375 0.607 . . . . 0.0 110.704 -178.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.549 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER -57.89 134.57 56.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 109.238 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.594 ' OD1' HD13 ' A' ' 161' ' ' LEU . 8.5 t70 -175.87 74.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.458 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -164.01 139.94 6.37 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.338 -0.851 . . . . 0.0 109.905 -179.321 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 4.2 p-10 -53.98 -173.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 14' ' ' ASN . 5.1 mt-30 47.67 98.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.959 -1.088 . . . . 0.0 110.305 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.478 ' HA ' ' NZ ' ' A' ' 13' ' ' LYS . 0.6 OUTLIER -115.25 149.96 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.212 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.1 OUTLIER -118.7 132.51 56.16 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.852 -1.155 . . . . 0.0 109.383 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.525 ' CB ' HG13 ' A' ' 61' ' ' ILE . 44.0 p90 -140.49 151.92 45.2 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.252 -0.905 . . . . 0.0 109.902 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.435 ' HD3' ' O ' ' A' ' 54' ' ' ILE . 18.4 tpt180 -150.75 119.71 6.67 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.485 -0.759 . . . . 0.0 109.372 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.827 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -70.51 138.82 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 179.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' ND2' ' A' ' 64' ' ' ASN . 27.8 mm -82.89 -5.47 9.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.619 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 172.79 105.67 0.19 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.247 -1.454 . . . . 0.0 110.657 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.827 ' CE1' HD13 ' A' ' 20' ' ' ILE . 3.8 m-30 -51.91 168.15 0.09 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.334 -1.098 . . . . 0.0 109.306 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.81 ' CG2' HD22 ' A' ' 27' ' ' LEU . 5.3 t -109.89 148.75 38.88 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.974 . . . . 0.0 109.762 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.3 Cg_endo -82.06 -36.39 0.3 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.883 2.389 . . . . 0.0 111.622 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.525 ' OD1' ' CG2' ' A' ' 24' ' ' THR . 0.7 OUTLIER -42.43 -26.59 0.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.208 -0.933 . . . . 0.0 110.007 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.05 HD21 ' HB ' ' A' ' 32' ' ' VAL . 0.3 OUTLIER -130.89 168.35 17.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.017 -1.052 . . . . 0.0 109.272 -179.879 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.532 ' CB ' ' OG1' ' A' ' 31' ' ' THR . 0.5 OUTLIER -57.4 147.79 57.29 Favored Pre-proline 0 C--N 1.301 -1.501 0 O-C-N 121.169 -0.957 . . . . 0.0 108.787 179.105 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.439 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 29.6 Cg_endo -70.25 -45.85 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.811 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -69.61 -21.12 63.6 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 47.8 m -76.78 -50.06 14.43 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.08 -1.048 . . . . 0.0 109.138 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.05 ' HB ' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -55.33 -34.4 33.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 178.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -61.39 -39.88 92.31 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.043 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.78 -44.43 27.6 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.423 -0.798 . . . . 0.0 109.447 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.549 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -53.33 -29.34 33.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -0.862 . . . . 0.0 109.172 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.61 -44.09 16.22 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.305 -0.872 . . . . 0.0 108.96 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -61.01 -52.78 63.56 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 39' ' ' ALA . 0.1 OUTLIER -51.37 -58.56 5.91 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.716 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -45.32 -51.14 11.43 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 44' ' ' SER . 0.1 OUTLIER -46.17 -50.23 15.91 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -71.92 -24.48 61.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.327 -0.858 . . . . 0.0 110.003 179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.716 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -64.71 -32.82 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.9 -1.125 . . . . 0.0 108.915 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.688 ' O ' HG12 ' A' ' 46' ' ' VAL . 4.7 m95 -100.54 -25.15 14.28 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 40' ' ' PHE . 0.2 OUTLIER -77.82 -18.25 56.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.094 -1.004 . . . . 0.0 108.39 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 43.7 t0 -71.46 -14.27 62.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.39 -0.819 . . . . 0.0 109.081 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.729 HG22 ' O ' ' A' ' 46' ' ' VAL . 3.7 p -102.92 10.7 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.284 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.525 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 9.2 t -178.13 148.15 0.63 Allowed Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.316 -0.865 . . . . 0.0 109.13 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 34.6 Cg_endo -76.01 56.84 4.97 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.551 2.167 . . . . 0.0 110.393 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.965 HD23 ' CE1' ' A' ' 51' ' ' PHE . 9.2 tp -85.89 147.7 26.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.313 -0.867 . . . . 0.0 109.362 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.1 mmt-85 -113.05 110.88 21.21 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.367 -0.833 . . . . 0.0 109.052 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.965 ' CE1' HD23 ' A' ' 49' ' ' LEU . 39.7 m-85 -97.01 141.78 29.76 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.23 -0.919 . . . . 0.0 109.478 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -132.42 125.09 29.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.056 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.27 140.35 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.534 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -124.38 -168.73 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.77 179.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -176.15 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -163.31 -32.83 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 0.0 110.199 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.54 27.9 17.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.44 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.9 OUTLIER 58.04 170.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.173 -1.193 . . . . 0.0 109.161 -179.883 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.936 ' HB2' HD11 ' A' ' 54' ' ' ILE . . . -136.13 154.81 50.87 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.04 -1.038 . . . . 0.0 110.672 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CG ' ' CZ2' ' A' ' 11' ' ' TRP . 79.1 m-20 -58.91 -47.86 83.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.868 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.4 OUTLIER -102.15 126.42 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 6.9 mtp -116.48 125.17 51.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.945 -1.097 . . . . 0.0 109.567 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.473 ' HB ' ' HA ' ' A' ' 20' ' ' ILE . 2.6 mp -105.09 158.34 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 110.715 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.539 ' ND2' ' HB ' ' A' ' 21' ' ' ILE . 3.2 t-20 178.85 -138.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 O-C-N 121.141 -0.974 . . . . 0.0 109.816 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -121.77 -174.77 2.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.955 -1.091 . . . . 0.0 109.875 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 67' ' ' ARG . . . -106.63 -19.34 9.86 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 37.8 mtt180 60.75 170.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.142 -1.211 . . . . 0.0 110.46 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.489 ' O ' ' CB ' ' A' ' 75' ' ' PRO . 41.0 m0 -81.33 -42.81 19.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.503 -0.748 . . . . 0.0 109.15 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.501 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 44.9 mt-10 -75.85 -96.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.357 -0.839 . . . . 0.0 109.077 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.501 ' CB ' ' O ' ' A' ' 69' ' ' GLU . 1.5 t-80 78.17 -80.06 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.281 -0.887 . . . . 0.0 110.42 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' C ' ' A' ' 72' ' ' ASP . . . 120.68 -22.51 8.18 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 71' ' ' GLY . 7.3 m-20 -37.72 -90.1 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.591 -0.947 . . . . 0.0 110.017 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.95 31.18 0.08 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -179.67 74.32 0.18 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.447 -1.031 . . . . 0.0 108.405 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.59 ' O ' ' CG ' ' A' ' 76' ' ' PHE . 32.5 Cg_endo -73.21 134.43 21.07 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.612 2.208 . . . . 0.0 111.847 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.59 ' CG ' ' O ' ' A' ' 75' ' ' PRO . 4.5 p90 50.53 158.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.332 1.063 . . . . 0.0 111.193 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 76' ' ' PHE . 1.4 p-10 178.56 -29.39 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.529 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 51.74 -156.84 3.42 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 78' ' ' GLY . 3.5 mttp 43.56 -173.56 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 122.229 1.014 . . . . 0.0 110.517 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' O ' ' C ' ' A' ' 81' ' ' GLY . 1.5 m-20 -67.15 -95.85 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 41.06 -139.18 1.55 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -49.86 123.38 7.94 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.441 -1.035 . . . . 0.0 108.646 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.607 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 16.5 mt -111.74 -22.11 11.32 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.4 -178.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.769 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.67 ' HB3' H252 ' A' ' 800' ' ' I52 . 7.6 p-80 179.05 175.86 0.61 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.979 -1.075 . . . . 0.0 110.253 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.66 166.26 28.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.378 -0.826 . . . . 0.0 109.39 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.439 ' O ' ' O ' ' A' ' 88' ' ' ALA . 0.1 OUTLIER -93.99 159.51 15.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.161 -0.962 . . . . 0.0 109.676 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.857 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -48.55 172.78 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.245 -0.909 . . . . 0.0 108.631 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.857 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 32.4 Cg_endo -73.69 137.98 25.76 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.119 1.879 . . . . 0.0 110.874 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' N ' ' HA3' ' A' ' 94' ' ' GLY . . . 175.77 -168.34 40.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.0 p -99.1 134.5 41.84 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 110.041 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.24 -82.46 0.66 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.481 ' HA ' ' OD2' ' A' ' 96' ' ' ASP . 0.9 OUTLIER -69.54 -41.37 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -1.145 . . . . 0.0 110.205 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.524 ' HA3' ' N ' ' A' ' 90' ' ' GLY . . . -71.3 111.05 3.49 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.808 -1.186 . . . . 0.0 110.191 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 121.44 2.79 10.64 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.65 -1.262 . . . . 0.0 110.739 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HA ' ' O ' ' A' ' 62' ' ' MET . 3.9 m-20 -95.96 140.02 31.32 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.415 -1.638 . . . . 0.0 109.865 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 85' ' ' HIS . 0.0 OUTLIER -121.3 142.62 49.78 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 59.5 m170 -114.76 130.71 56.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.405 -0.809 . . . . 0.0 109.971 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -103.89 152.03 22.43 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.244 -0.91 . . . . 0.0 109.36 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' OD1' ' HG ' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -60.09 138.98 57.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.007 -1.058 . . . . 0.0 108.952 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -76.29 -78.56 0.12 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.366 -0.834 . . . . 0.0 109.644 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' O ' ' OE1' ' A' ' 103' ' ' GLU . 8.5 t70 -66.04 91.16 0.15 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.016 -1.053 . . . . 0.0 110.672 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.577 ' CB ' ' CZ2' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -159.81 -170.34 2.86 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.56 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.4 OUTLIER -138.38 82.69 1.92 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.705 -1.247 . . . . 0.0 110.867 -178.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.577 ' CZ2' ' CB ' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -95.32 130.62 42.03 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.08 -1.013 . . . . 0.0 109.449 179.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.714 ' OG1' ' HB2' ' A' ' 110' ' ' ALA . 1.1 p -154.45 154.16 32.73 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.081 -1.047 . . . . 0.0 110.723 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.551 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 7.7 t30 -82.76 4.56 24.71 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 109' ' ' SER . 1.9 p -91.89 -145.28 0.2 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.223 -0.923 . . . . 0.0 109.177 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.42 ' N ' ' OG1' ' A' ' 108' ' ' THR . 6.3 t -89.9 37.99 0.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.071 -1.018 . . . . 0.0 108.88 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.714 ' HB2' ' OG1' ' A' ' 106' ' ' THR . . . -64.14 -97.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.334 -0.854 . . . . 0.0 109.831 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -178.31 -46.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.061 -1.024 . . . . 0.0 109.639 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.441 ' OH ' ' CG ' ' A' ' 80' ' ' ASP . 94.4 m-85 -85.42 -36.32 20.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.104 -0.997 . . . . 0.0 109.176 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.851 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.0 OUTLIER 62.2 110.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.484 -0.76 . . . . 0.0 110.591 179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.1 OUTLIER -50.86 -36.47 37.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.217 -0.927 . . . . 0.0 109.677 179.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.546 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.9 t80 -65.63 -35.9 82.14 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.836 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.674 HD12 ' OH ' ' A' ' 142' ' ' TYR . 2.1 tm? -80.58 -57.1 3.73 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.625 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.851 HG22 ' O ' ' A' ' 113' ' ' SER . 0.2 OUTLIER -50.42 -40.82 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.864 -1.148 . . . . 0.0 108.94 179.29 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -69.23 -49.52 55.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.857 . . . . 0.0 109.622 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -42.45 -59.78 1.74 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.111 -0.993 . . . . 0.0 109.187 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.7 t60 -49.18 -56.53 8.93 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.179 -0.95 . . . . 0.0 108.744 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.448 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 69.3 mm-40 -66.53 -11.99 55.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.559 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -80.53 -15.17 57.35 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' HA3' ' CE ' ' A' ' 138' ' ' MET . . . -94.95 -42.04 3.91 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.634 -1.787 . . . . 0.0 108.634 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.593 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 5.0 m-70 -63.56 -49.16 74.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.314 -1.11 . . . . 0.0 109.389 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -41.89 -26.39 0.08 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.437 -0.79 . . . . 0.0 109.506 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 124' ' ' HIS . 26.2 mmt -78.99 -96.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.928 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . -157.91 -35.53 0.02 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 119.624 -1.274 . . . . 0.0 110.255 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.049 HD11 ' HA3' ' A' ' 157' ' ' GLY . 0.2 OUTLIER -46.25 149.72 0.7 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.978 -1.307 . . . . 0.0 109.579 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' O ' ' C ' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -129.29 163.06 26.5 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.593 ' CD2' ' HE2' ' A' ' 124' ' ' HIS . 25.5 m170 -44.28 137.41 3.56 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.064 -1.022 . . . . 0.0 109.228 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 132' ' ' GLN . 1.0 OUTLIER -112.89 11.9 19.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.108 -0.995 . . . . 0.0 110.23 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 131' ' ' SER . 0.5 OUTLIER 82.48 -24.8 0.17 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.596 -0.69 . . . . 0.0 111.21 178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -66.49 124.89 89.43 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.67 -1.269 . . . . 0.0 109.737 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.558 ' HA ' HD11 ' A' ' 141' ' ' ILE . 31.2 Cg_endo -72.58 -36.55 4.91 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.248 1.965 . . . . 0.0 110.555 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -81.49 11.07 47.17 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -92.23 174.69 7.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.999 -1.295 . . . . 0.0 109.936 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.647 HD13 ' C36' ' A' ' 800' ' ' I52 . 22.7 tp -88.17 -35.81 17.18 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.526 ' CE ' ' HA3' ' A' ' 123' ' ' GLY . 0.2 OUTLIER -83.81 7.25 18.52 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -55.39 154.7 11.19 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.358 -0.839 . . . . 0.0 109.497 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.97 21.66 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.906 2.404 . . . . 0.0 112.246 -179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -134.91 133.72 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.595 -1.316 . . . . 0.0 109.532 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.674 ' OH ' HD12 ' A' ' 116' ' ' LEU . 75.8 t80 -73.21 121.88 21.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.581 -0.699 . . . . 0.0 110.122 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.3 m -125.05 111.43 15.36 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.388 -0.82 . . . . 0.0 108.919 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -59.93 160.43 7.81 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.091 -1.006 . . . . 0.0 110.209 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.827 HG21 H392 ' A' ' 800' ' ' I52 . 2.8 p -99.09 83.0 2.81 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.659 -0.651 . . . . 0.0 110.493 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -3.47 30.49 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.854 -1.154 . . . . 0.0 108.275 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.463 ' O ' ' C ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -160.0 20.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.526 -0.734 . . . . 0.0 109.113 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.478 ' CZ ' ' CG2' ' A' ' 42' ' ' VAL . 3.3 t80 36.24 94.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.463 -0.773 . . . . 0.0 110.529 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.52 ' O ' H381 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -118.65 132.57 56.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.334 179.271 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.457 HD23 ' HA ' ' A' ' 150' ' ' LEU . 50.8 mt -88.65 -163.41 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.384 -0.822 . . . . 0.0 109.838 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 2.0 p -167.12 131.43 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 109.648 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.633 ' O ' HG13 ' A' ' 155' ' ' ILE . 2.7 pt20 -59.63 -29.57 68.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 0.0 109.198 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 152' ' ' GLN . 4.0 m-20 -43.48 -37.62 2.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.784 -1.198 . . . . 0.0 107.956 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 158' ' ' ILE . 3.8 m-20 -85.42 -46.05 11.28 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.698 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.9 OUTLIER -51.95 -33.69 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 108.681 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -56.77 4.38 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.446 -0.784 . . . . 0.0 109.83 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 1.049 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -57.04 -39.46 89.7 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.448 ' HA ' HD12 ' A' ' 158' ' ' ILE . 9.0 tp -78.17 -18.78 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.109 -1.23 . . . . 0.0 109.788 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 163' ' ' GLY . 0.0 OUTLIER -72.78 -48.12 40.89 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.291 -0.88 . . . . 0.0 108.925 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -74.37 -21.65 59.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.091 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.594 HD13 ' OD1' ' A' ' 12' ' ' ASP . 0.2 OUTLIER -85.25 -15.86 42.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.309 -0.869 . . . . 0.0 109.784 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.476 ' CD2' HD13 ' A' ' 49' ' ' LEU . 6.0 m-85 -140.11 -93.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.42 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.31 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.75 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 1.003 ' H72' H241 ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -58.49 -94.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -0.962 . . . . 0.0 109.352 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.21 98.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 0.0 110.211 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -116.35 176.26 5.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.472 ' HB2' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -83.02 165.84 38.9 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 0.0 108.802 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.541 ' O ' ' CB ' ' A' ' 7' ' ' ARG . 32.2 Cg_endo -74.18 -161.09 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 C-N-CA 122.386 2.057 . . . . 0.0 109.919 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.541 ' CB ' ' O ' ' A' ' 6' ' ' PRO . 14.9 ttp180 77.44 54.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.908 . . . . 0.0 109.573 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 7' ' ' ARG . 6.0 mttp 60.52 144.59 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.331 -0.856 . . . . 0.0 109.789 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 90' ' ' GLY . 36.3 Cg_endo -79.11 55.33 5.57 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.096 1.864 . . . . 0.0 108.965 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.425 ' O ' ' O ' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -62.34 -137.11 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.582 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER -163.0 44.18 0.12 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.914 -1.116 . . . . 0.0 108.73 179.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -81.04 85.27 6.31 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.353 -0.842 . . . . 0.0 109.325 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.558 ' HD2' ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -141.63 101.95 4.08 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.207 -0.933 . . . . 0.0 109.315 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' C ' ' O ' ' A' ' 13' ' ' LYS . 7.7 m-20 -34.18 -85.71 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.894 -0.504 . . . . 0.0 110.009 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -51.88 106.97 0.16 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.851 -1.156 . . . . 0.0 109.216 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.628 ' CG2' HD11 ' A' ' 61' ' ' ILE . 3.3 mt -104.29 162.84 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.04 -1.037 . . . . 0.0 109.526 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.705 ' HB ' HD13 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -135.53 135.85 40.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.1 OUTLIER -142.59 162.5 35.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.101 -0.999 . . . . 0.0 110.343 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -145.74 120.39 9.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.483 -0.76 . . . . 0.0 109.057 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.879 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.7 mp -83.17 112.95 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.0 109.46 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.751 HD11 ' HG2' ' A' ' 62' ' ' MET . 7.7 mt -89.51 17.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.602 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 166.5 96.21 0.11 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.879 ' CE1' HD13 ' A' ' 20' ' ' ILE . 20.3 m-85 -58.07 -114.33 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.374 -1.074 . . . . 0.0 108.853 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.996 ' CG2' HD22 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -112.58 178.29 1.0 Allowed Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.502 -1.374 . . . . 0.0 108.102 179.236 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' HD2' HG23 ' A' ' 24' ' ' THR . 33.0 Cg_endo -76.57 -34.85 2.35 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.745 1.63 . . . . 0.0 112.324 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.694 ' H ' HG23 ' A' ' 24' ' ' THR . 5.6 t70 -158.64 81.73 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.768 -1.208 . . . . 0.0 112.191 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.996 HD22 ' CG2' ' A' ' 24' ' ' THR . 0.3 OUTLIER -155.68 -178.98 7.68 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.184 -0.948 . . . . 0.0 108.737 177.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 1.3 m-20 -72.16 136.45 81.91 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.507 ' O ' ' HB3' ' A' ' 33' ' ' ASP . 26.8 Cg_endo -69.68 -30.88 21.94 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 N-CA-C 106.444 -2.175 . . . . 0.0 106.444 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -74.17 -32.84 63.26 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.499 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 2.9 m -70.6 -62.65 1.31 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.821 HG21 ' HB3' ' A' ' 23' ' ' TYR . 1.3 p -49.64 -43.28 18.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 3.0 t70 -64.85 -22.08 66.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.528 -0.733 . . . . 0.0 109.109 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.3 t0 -78.38 -40.99 34.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.075 -1.015 . . . . 0.0 110.174 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.595 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -57.52 -44.05 84.78 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.967 -1.083 . . . . 0.0 109.145 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.466 ' CZ ' HG21 ' A' ' 63' ' ' ILE . 75.2 m-85 -71.35 -48.57 49.48 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.27 -0.894 . . . . 0.0 108.637 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -53.31 -51.12 63.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 1.036 ' O ' HG22 ' A' ' 42' ' ' VAL . 61.3 mtp180 -67.18 -48.85 66.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.438 -0.789 . . . . 0.0 108.899 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.599 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . . . -41.98 -43.28 3.09 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.551 ' O ' ' CB ' ' A' ' 44' ' ' SER . 58.1 m-85 -68.52 -39.16 81.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.276 -0.89 . . . . 0.0 109.09 179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 38' ' ' ARG . 3.3 tt0 -71.56 -60.54 2.18 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.132 -0.98 . . . . 0.0 109.026 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.036 HG22 ' O ' ' A' ' 38' ' ' ARG . 1.7 m -46.18 -29.43 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.33 -0.856 . . . . 0.0 109.321 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.589 ' CH2' ' CA ' ' A' ' 123' ' ' GLY . 11.6 m95 -101.98 -19.0 15.4 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.0 110.101 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 11.2 t -88.7 -23.35 22.99 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.016 -1.053 . . . . 0.0 108.25 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -59.77 -12.56 7.51 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.716 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.761 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.7 p -110.62 19.42 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.096 -1.003 . . . . 0.0 109.69 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.519 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 5.1 t -179.33 149.32 0.56 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.002 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 32.4 Cg_endo -76.0 57.82 5.31 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.321 2.014 . . . . 0.0 110.486 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.65 HD11 ' CG ' ' A' ' 162' ' ' TYR . 18.8 mt -100.76 121.3 41.45 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -106.81 112.66 25.74 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.975 -1.078 . . . . 0.0 109.094 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 16' ' ' ILE . 56.3 m-85 -88.52 143.65 26.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.428 -0.795 . . . . 0.0 109.528 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.57 138.75 52.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.526 -0.734 . . . . 0.0 109.341 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -89.28 129.66 35.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.077 -1.014 . . . . 0.0 108.862 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.705 HD13 ' HB ' ' A' ' 17' ' ' THR . 2.5 pt -122.12 131.95 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.142 -0.974 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 54' ' ' ILE . 4.4 p80 -60.32 -147.56 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.271 -0.893 . . . . 0.0 109.306 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' N ' ' CG ' ' A' ' 55' ' ' HIS . 0.3 OUTLIER -70.05 169.31 13.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.277 -0.889 . . . . 0.0 109.043 179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 114.37 -147.29 18.78 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.447 ' O ' HD12 ' A' ' 54' ' ' ILE . 0.0 OUTLIER -83.03 150.91 26.05 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.253 . . . . 0.0 109.595 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.741 ' HB3' ' SD ' ' A' ' 62' ' ' MET . . . -160.91 150.4 17.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.536 -0.727 . . . . 0.0 109.261 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.4 OUTLIER -77.88 -70.19 0.5 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.116 -0.99 . . . . 0.0 109.268 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.843 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -82.13 126.26 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.751 ' HG2' HD11 ' A' ' 21' ' ' ILE . 1.0 OUTLIER -120.96 115.83 23.94 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.268 -0.895 . . . . 0.0 109.182 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.466 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 4.6 mp -103.62 145.33 12.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.394 -0.816 . . . . 0.0 109.89 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' O ' ' HA ' ' A' ' 98' ' ' HIS . 63.8 t30 -168.67 172.64 7.84 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.125 -0.984 . . . . 0.0 109.345 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.472 ' HB2' ' HA ' ' A' ' 101' ' ' ASP . 31.2 p90 -119.94 160.77 22.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.147 -0.971 . . . . 0.0 109.842 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.71 128.87 1.73 Allowed Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.23 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -96.9 -135.15 0.24 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.405 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.402 ' C ' ' O ' ' A' ' 67' ' ' ARG . 1.6 t90 -49.92 -41.64 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.511 -1.368 . . . . 0.0 107.852 179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.406 ' O ' ' C ' ' A' ' 70' ' ' HIS . 2.8 tt0 -73.86 55.22 0.53 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 76' ' ' PHE . 4.1 t-160 -44.16 -50.63 8.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.175 -0.953 . . . . 0.0 109.27 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.96 18.11 44.98 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.76 -1.736 . . . . 0.0 108.76 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 72' ' ' ASP . 41.2 p-10 -151.47 28.04 0.65 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.349 -1.089 . . . . 0.0 109.892 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 74' ' ' TYR . . . 93.19 154.0 30.76 Favored Glycine 0 N--CA 1.494 2.522 0 C-N-CA 120.38 -0.914 . . . . 0.0 110.901 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.53 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 58.6 m-85 55.14 164.36 0.06 OUTLIER Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.473 -1.016 . . . . 0.0 110.049 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 74' ' ' TYR . 34.4 Cg_endo -76.45 -159.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.004 1.803 . . . . 0.0 108.555 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.673 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 69.0 t80 177.54 168.86 0.65 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.9 -1.125 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.609 ' N ' ' CD2' ' A' ' 76' ' ' PHE . 24.1 t70 50.63 40.61 24.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.705 -0.622 . . . . 0.0 110.345 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . -49.06 173.05 0.05 OUTLIER Glycine 0 N--CA 1.488 2.133 0 N-CA-C 107.3 -2.32 . . . . 0.0 107.3 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' O ' ' C ' ' A' ' 80' ' ' ASP . 1.1 ptmt -51.46 141.75 15.09 Favored 'General case' 0 C--N 1.309 -1.179 0 O-C-N 120.762 -1.434 . . . . 0.0 107.253 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.485 ' C ' ' O ' ' A' ' 79' ' ' LYS . 21.2 t70 39.55 -111.21 0.11 Allowed 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 25.85 -132.54 0.03 OUTLIER Glycine 0 N--CA 1.496 2.682 0 CA-C-O 121.432 0.462 . . . . 0.0 112.226 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.58 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -26.94 123.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.975 0.893 . . . . 0.0 111.914 -179.107 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.593 HD22 ' CZ2' ' A' ' 105' ' ' TRP . 73.5 mt -118.84 -28.6 5.54 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 172.51 146.54 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.511 -0.743 . . . . 0.0 109.343 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.733 ' CB ' H241 ' A' ' 800' ' ' I52 . 24.4 p-80 -144.92 149.25 34.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.339 -0.851 . . . . 0.0 109.262 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.489 ' CB ' ' HB2' ' A' ' 97' ' ' SER . . . -123.61 159.44 29.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.971 . . . . 0.0 109.892 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.41 151.8 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 110.075 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.794 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.17 168.96 0.78 Allowed Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.364 -0.835 . . . . 0.0 109.624 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.794 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.3 Cg_endo -78.6 152.23 25.89 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.773 2.315 . . . . 0.0 110.569 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 91' ' ' THR . . . 179.58 -103.1 0.17 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 90' ' ' GLY . 0.5 OUTLIER -162.59 78.51 0.48 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.342 -1.093 . . . . 0.0 109.357 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 144.06 -103.1 0.29 Allowed Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.6 t -74.87 -2.78 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.214 -1.168 . . . . 0.0 109.32 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.521 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -75.6 143.2 29.99 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.843 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 76.34 -4.4 49.15 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 1.6 m-20 -101.03 134.8 43.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.942 -1.328 . . . . 0.0 108.68 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.489 ' HB2' ' CB ' ' A' ' 86' ' ' ALA . 16.4 t -130.86 127.64 38.98 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.197 -0.939 . . . . 0.0 109.805 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.576 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 46.0 m80 -89.78 145.27 25.31 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.422 -0.799 . . . . 0.0 109.109 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -116.58 160.29 20.89 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.001 -1.062 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.484 ' OD2' ' HA ' ' A' ' 83' ' ' LEU . 3.5 m-20 -52.85 121.36 7.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.402 -0.811 . . . . 0.0 109.854 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 67' ' ' ARG . 18.6 t0 -44.58 -86.42 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.306 -0.871 . . . . 0.0 109.366 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 103' ' ' GLU . 35.3 m-20 -77.22 -128.43 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.562 ' CB ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 83.92 -29.86 0.08 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 103' ' ' GLU . 16.0 tp 68.81 74.56 0.26 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.185 -0.947 . . . . 0.0 111.137 178.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.603 ' O ' ' HB ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -94.0 163.19 13.59 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.96 HG23 ' N ' ' A' ' 108' ' ' THR . 9.7 t 171.48 -173.82 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.096 -1.002 . . . . 0.0 110.308 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.586 ' O ' ' OG1' ' A' ' 108' ' ' THR . 6.8 p-10 -50.19 -31.17 13.1 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 174.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.96 ' N ' HG23 ' A' ' 106' ' ' THR . 1.8 p 73.31 -110.89 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 173.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.43 ' CB ' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER 61.24 23.14 13.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 100.99 -3.707 . . . . 0.0 100.99 -168.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.446 ' N ' ' C ' ' A' ' 108' ' ' THR . . . -135.78 -45.26 0.66 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.852 -1.522 . . . . 0.0 108.318 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -158.39 -86.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.775 -0.578 . . . . 0.0 110.277 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.808 ' O ' HG21 ' A' ' 108' ' ' THR . 9.0 m-85 -121.16 126.64 50.21 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.176 -0.952 . . . . 0.0 110.263 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.669 ' OG ' HD22 ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.58 129.59 36.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 111.557 -178.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.595 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.2 OUTLIER -57.09 -24.23 52.54 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.653 -0.654 . . . . 0.0 110.479 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.826 ' CE1' HG21 ' A' ' 42' ' ' VAL . 1.7 t80 -73.64 -54.75 7.42 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 120.498 -1.376 . . . . 0.0 110.425 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.8 HD21 ' CE1' ' A' ' 144' ' ' TYR . 0.4 OUTLIER -63.26 -51.0 67.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.926 -1.108 . . . . 0.0 109.144 -179.585 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.606 HG23 ' N ' ' A' ' 118' ' ' ALA . 21.0 m -54.82 -53.74 29.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.148 -0.97 . . . . 0.0 109.907 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.606 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -66.91 -39.99 87.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.735 -1.228 . . . . 0.0 108.828 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 115' ' ' PHE . . . -47.6 -58.37 4.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.293 -0.879 . . . . 0.0 109.479 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.4 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 34.1 t60 -54.49 -42.6 70.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.848 -1.157 . . . . 0.0 108.53 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 117' ' ' VAL . 54.2 mm-40 -71.73 -10.5 59.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 118' ' ' ALA . 0.5 OUTLIER -87.28 -15.67 37.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.589 ' CA ' ' CH2' ' A' ' 43' ' ' TRP . . . -89.51 -45.6 4.59 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -62.02 -45.97 91.26 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.475 -1.015 . . . . 0.0 108.417 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -52.68 -19.11 2.15 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.315 -0.865 . . . . 0.0 109.162 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 23.1 mtt -100.97 -5.51 25.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.357 -0.839 . . . . 0.0 109.73 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.457 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 113.21 -35.57 4.5 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 119.701 -1.238 . . . . 0.0 110.522 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.457 ' C ' ' O ' ' A' ' 127' ' ' GLY . 1.8 mt -37.0 146.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.494 -1.003 . . . . 0.0 110.237 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 138' ' ' MET . 0.3 OUTLIER -113.08 -179.48 3.66 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.369 -0.832 . . . . 0.0 109.713 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.761 ' CE1' H132 ' A' ' 800' ' ' I52 . 62.5 m170 -58.43 151.31 20.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.535 -0.728 . . . . 0.0 110.184 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 52.4 p -96.71 -177.73 4.01 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.52 -0.737 . . . . 0.0 109.519 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.97 -13.24 6.89 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.328 -0.858 . . . . 0.0 109.808 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.495 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.2 OUTLIER -101.05 142.36 24.46 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.957 . . . . 0.0 109.94 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.495 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 32.5 Cg_endo -76.84 116.7 4.3 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.8 2.333 . . . . 0.0 109.564 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 113.81 -3.56 24.41 Favored Glycine 0 C--N 1.272 -2.989 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.782 ' O ' H352 ' A' ' 800' ' ' I52 . . . -67.77 -177.85 0.85 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.173 -1.192 . . . . 0.0 109.772 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.54 ' CD1' H362 ' A' ' 800' ' ' I52 . 8.6 tp -96.06 -28.86 14.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.908 . . . . 0.0 109.681 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.481 ' HB3' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -94.6 3.01 55.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.142 -0.974 . . . . 0.0 109.706 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.508 ' O ' ' H34' ' A' ' 800' ' ' I52 . . . -46.19 148.14 1.63 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.274 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.757 ' O ' HD13 ' A' ' 141' ' ' ILE . 36.5 Cg_endo -78.04 12.0 2.14 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.565 2.176 . . . . 0.0 111.021 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.757 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.4 mm -133.64 155.69 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.987 -1.07 . . . . 0.0 110.262 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.541 ' C ' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER -76.0 95.29 3.56 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.46 ' O ' H371 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -100.96 92.93 5.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.966 . . . . 0.0 108.637 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.8 ' CE1' HD21 ' A' ' 116' ' ' LEU . 7.8 t80 -60.07 155.38 17.16 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.151 -0.968 . . . . 0.0 109.917 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.588 HG21 H393 ' A' ' 800' ' ' I52 . 0.1 OUTLIER -143.49 8.83 1.58 Allowed 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.626 179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.575 ' HG3' ' CE2' ' A' ' 144' ' ' TYR . 21.3 mtpt 52.6 -106.75 0.3 Allowed 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.187 -0.946 . . . . 0.0 110.305 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.533 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 4.9 p-10 -56.94 -47.22 81.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.935 -1.103 . . . . 0.0 110.716 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.639 ' CD1' H393 ' A' ' 800' ' ' I52 . 5.8 t80 68.01 125.81 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.522 -0.736 . . . . 0.0 110.808 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.489 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 0.0 OUTLIER -100.77 -70.3 0.74 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.732 -1.211 . . . . 0.0 107.732 178.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.61 HD12 ' CZ ' ' A' ' 148' ' ' PHE . 4.0 tp 169.29 172.15 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.506 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.1 OUTLIER -143.45 130.68 20.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.021 -1.049 . . . . 0.0 109.654 -179.272 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.659 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 46.9 tt0 -54.63 -30.31 54.65 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.446 -0.784 . . . . 0.0 109.273 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' O ' HD21 ' A' ' 128' ' ' LEU . 51.5 m-20 -46.9 -41.61 16.17 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.861 -1.149 . . . . 0.0 108.577 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.552 ' OD1' ' CZ3' ' A' ' 43' ' ' TRP . 21.5 t0 -83.53 -36.14 24.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.244 -0.91 . . . . 0.0 109.279 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.659 ' CG1' ' HA ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -63.57 -31.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 108.908 179.568 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -78.71 -44.72 22.9 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.55 -20.29 78.59 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.623 HG22 ' HA ' ' A' ' 155' ' ' ILE . 1.6 tp -93.9 -17.87 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.24 -1.153 . . . . 0.0 109.249 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 155' ' ' ILE . 2.9 pt20 -90.94 -31.48 16.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.97 -1.081 . . . . 0.0 108.446 178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 159' ' ' GLN . 2.0 mm-40 -86.94 -29.94 21.69 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.66 HD13 ' O ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -95.66 -28.11 14.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 109.102 179.116 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.65 ' CG ' HD11 ' A' ' 49' ' ' LEU . 2.1 m-85 -122.38 -91.28 0.56 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.452 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 158' ' ' ILE . . . . . . . . 0 N--CA 1.492 2.383 0 CA-C-O 118.036 -1.425 . . . . 0.0 109.756 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 0.782 H352 ' O ' ' A' ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.491 ' O ' ' HB2' ' A' ' 2' ' ' TYR . 24.8 mtm . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.18 0.514 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 75.17 123.0 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.981 0.896 . . . . 0.0 108.978 -179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -116.83 39.3 3.24 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' PHE . 9.4 m-85 -107.0 176.19 5.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.49 -0.756 . . . . 0.0 110.446 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER 171.11 -54.46 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.452 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.456 -178.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.615 ' HD3' ' CB ' ' A' ' 5' ' ' PHE . 39.1 Cg_endo -82.23 108.2 1.75 Allowed 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.314 2.009 . . . . 0.0 111.846 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.01 44.37 1.03 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.03 148.69 34.84 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.729 -0.607 . . . . 0.0 109.88 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 10' ' ' LYS . 34.7 Cg_endo -74.64 58.02 4.5 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.13 1.886 . . . . 0.0 109.242 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.528 ' HG3' ' HG3' ' A' ' 89' ' ' PRO . 0.0 OUTLIER 40.45 -162.03 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -95.98 106.76 18.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.808 -1.182 . . . . 0.0 110.022 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.05 81.58 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.952 -1.093 . . . . 0.0 110.102 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.75 153.1 48.54 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.261 -0.9 . . . . 0.0 109.309 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -79.44 -89.21 0.06 Allowed 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.48 -0.763 . . . . 0.0 109.444 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -59.46 111.27 1.33 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.275 -0.891 . . . . 0.0 108.948 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.893 HD12 ' HE1' ' A' ' 51' ' ' PHE . 73.7 mt -119.59 145.67 25.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.078 -1.014 . . . . 0.0 109.444 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.573 ' HB ' ' CD1' ' A' ' 54' ' ' ILE . 22.8 p -121.06 140.06 52.46 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.591 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.513 ' HB3' HG13 ' A' ' 61' ' ' ILE . 34.0 p90 -139.28 -179.44 5.88 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 1.9 ptm180 -159.34 140.45 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.792 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.7 mt -95.27 145.18 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.93 . . . . 0.0 110.206 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.747 HD12 ' HB3' ' A' ' 64' ' ' ASN . 28.0 mt -90.19 -5.53 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.894 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.792 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 147.54 109.79 0.57 Allowed Glycine 0 N--CA 1.483 1.778 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -66.29 -163.3 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.047 -1.267 . . . . 0.0 108.812 -179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.639 HG23 ' OD1' ' A' ' 26' ' ' ASP . 0.4 OUTLIER -108.49 146.8 34.4 Favored Pre-proline 0 C--N 1.293 -1.853 0 O-C-N 121.51 -0.744 . . . . 0.0 109.257 -179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' C ' ' A' ' 26' ' ' ASP . 29.9 Cg_endo -73.13 -26.15 15.21 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.441 2.094 . . . . 0.0 110.42 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 24' ' ' THR . 10.0 p-10 -35.23 -35.43 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.414 0.626 . . . . 0.0 109.976 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -133.04 171.66 13.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.988 -1.07 . . . . 0.0 110.245 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 5.5 m-20 -51.63 148.16 10.14 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.394 -0.816 . . . . 0.0 109.559 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' O ' HG12 ' A' ' 32' ' ' VAL . 32.3 Cg_endo -69.98 -32.44 17.68 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 N-CA-C 105.688 -2.466 . . . . 0.0 105.688 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -78.33 -31.26 48.64 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.617 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 21.4 m -73.7 -52.62 12.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.883 -1.136 . . . . 0.0 108.45 178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 23' ' ' TYR . 1.8 p -47.74 -41.18 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 29' ' ' PRO . 5.3 m-20 -61.43 -39.12 89.63 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.693 -0.63 . . . . 0.0 109.669 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -61.21 -37.5 83.23 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.206 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -53.93 -28.6 38.06 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.246 -0.908 . . . . 0.0 109.074 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -91.19 -24.95 19.77 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 108.892 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.36 63.29 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.83 -39.21 73.15 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -57.32 -40.58 78.22 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -60.61 -45.72 92.94 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -74.95 -15.85 60.66 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.685 -179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 ' HZ ' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -84.3 -27.95 7.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 120.811 -1.181 . . . . 0.0 109.057 -179.274 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -104.96 -25.2 12.67 Favored 'General case' 0 C--N 1.297 -1.681 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.709 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 47' ' ' THR . 9.7 t -85.11 -23.27 28.54 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 109.396 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.748 ' OD1' HD11 ' A' ' 150' ' ' LEU . 3.4 p30 -60.04 -22.39 62.6 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.16 -0.962 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.643 HG13 ' OD1' ' A' ' 45' ' ' ASP . 10.8 m -99.07 16.63 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.999 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.563 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 1.3 t -173.52 152.74 2.16 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.093 -1.004 . . . . 0.0 110.051 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 33.8 Cg_endo -74.91 45.65 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.985 2.457 . . . . 0.0 110.339 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.861 HD23 ' HZ ' ' A' ' 51' ' ' PHE . 0.9 OUTLIER -87.3 144.14 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.153 -0.967 . . . . 0.0 109.231 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.44 99.03 5.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.191 -0.943 . . . . 0.0 109.309 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.893 ' HE1' HD12 ' A' ' 16' ' ' ILE . 15.9 m-85 -93.38 133.16 36.92 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.884 -1.135 . . . . 0.0 110.047 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.54 164.98 13.51 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.686 -0.634 . . . . 0.0 109.795 179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.573 ' HB2' ' CZ ' ' A' ' 53' ' ' ARG . 2.3 mtp-105 -111.17 137.62 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.314 -0.867 . . . . 0.0 108.808 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' ' HB ' ' A' ' 17' ' ' THR . 7.2 pt -145.34 134.58 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.017 -1.052 . . . . 0.0 109.658 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -135.31 42.53 2.72 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -130.21 -67.24 0.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.3 -0.875 . . . . 0.0 110.049 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . -99.16 50.25 1.19 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 57' ' ' GLY . 0.1 OUTLIER 68.09 162.72 0.2 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.299 -1.118 . . . . 0.0 109.932 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.537 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . -129.49 173.17 10.82 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' CB ' ' O ' ' A' ' 17' ' ' THR . 1.0 OUTLIER -84.9 -57.08 3.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 110.12 -179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -95.87 148.42 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.068 -1.02 . . . . 0.0 109.874 -179.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.524 ' CG ' ' OD1' ' A' ' 96' ' ' ASP . 0.3 OUTLIER -123.52 116.9 23.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.0 109.502 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 97' ' ' SER . 46.9 mt -115.62 140.51 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 108.908 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.747 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.9 p-10 -154.49 -148.67 0.25 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.686 -1.258 . . . . 0.0 110.36 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.588 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -136.59 174.98 10.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.896 -1.127 . . . . 0.0 110.604 -179.021 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 101' ' ' ASP . . . -122.77 99.27 0.64 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 101' ' ' ASP . 5.4 mtm180 -90.08 -6.96 54.91 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.378 -1.072 . . . . 0.0 110.459 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 177.46 -162.15 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 75' ' ' PRO . 5.8 pt-20 -83.76 67.27 9.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.741 -1.224 . . . . 0.0 111.033 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -49.74 -172.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.448 -0.782 . . . . 0.0 109.136 178.9 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . -64.58 -9.49 38.32 Favored Glycine 0 N--CA 1.493 2.487 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.506 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.66 ' CB ' ' CE1' ' A' ' 70' ' ' HIS . 11.5 t0 -54.89 -169.99 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.021 -1.282 . . . . 0.0 108.396 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.37 -8.95 26.3 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.344 -1.407 . . . . 0.0 110.095 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CD1' HD11 ' A' ' 82' ' ' LEU . 11.7 m-85 -110.67 118.33 48.87 Favored Pre-proline 0 C--N 1.302 -1.457 0 O-C-N 121.206 -1.173 . . . . 0.0 108.652 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -75.47 -176.43 2.95 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.045 1.83 . . . . 0.0 110.31 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 68' ' ' TRP . 38.3 p90 -78.69 140.86 38.29 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.552 -0.718 . . . . 0.0 109.107 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 9.5 p-10 -115.55 6.66 14.69 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.363 -0.836 . . . . 0.0 109.24 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 62.75 -167.68 19.95 Favored Glycine 0 N--CA 1.498 2.809 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.265 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -43.16 167.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -1.064 . . . . 0.0 109.874 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 79' ' ' LYS . 71.6 m-20 41.15 -162.01 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.277 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.98 -146.94 50.77 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.302 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.485 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 0.0 OUTLIER -47.77 107.1 0.11 Allowed 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.481 -1.011 . . . . 0.0 108.997 -179.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 15.4 mt -91.23 -15.37 29.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.124 -0.985 . . . . 0.0 109.023 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.613 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 169.5 158.95 0.06 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.524 -0.735 . . . . 0.0 109.024 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.531 ' HB3' H252 ' A' ' 800' ' ' I52 . 22.8 p-80 -156.83 146.38 20.6 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.981 -1.075 . . . . 0.0 109.915 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.682 ' HB2' ' HB3' ' A' ' 97' ' ' SER . . . -128.86 161.55 29.56 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.357 -0.839 . . . . 0.0 109.714 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.1 166.0 10.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.334 -0.854 . . . . 0.0 110.946 -179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.759 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.41 166.93 38.16 Favored Pre-proline 0 N--CA 1.485 1.309 0 O-C-N 121.515 -0.74 . . . . 0.0 109.084 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.759 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 33.1 Cg_endo -76.87 157.54 34.94 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 122.51 2.14 . . . . 0.0 110.257 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -178.41 -102.32 0.16 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.8 m -150.87 90.95 1.66 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.067 -1.255 . . . . 0.0 110.038 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 105.83 -73.21 0.22 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.5 t -77.41 -1.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.145 -1.209 . . . . 0.0 110.026 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -76.39 139.91 24.64 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.946 -1.662 . . . . 0.0 108.946 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 61' ' ' ILE . . . 73.82 67.78 1.71 Allowed Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.524 ' OD1' ' CG ' ' A' ' 62' ' ' MET . 14.9 m-20 -160.8 117.02 2.28 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.428 -1.042 . . . . 0.0 109.01 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.682 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 0.0 OUTLIER -117.02 157.39 25.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.466 -0.771 . . . . 0.0 109.861 -179.209 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -129.79 146.81 51.52 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 34.6 m-85 -111.19 144.24 40.67 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.123 -0.986 . . . . 0.0 110.022 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.548 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -44.7 167.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.586 -1.321 . . . . 0.0 109.308 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.539 ' OD1' ' O ' ' A' ' 101' ' ' ASP . 5.1 t0 -97.43 -25.39 15.21 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 0.5 OUTLIER -99.42 -144.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.09 178.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.548 ' HG3' ' HB3' ' A' ' 100' ' ' ASP . 0.4 OUTLIER 75.24 136.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.266 -0.896 . . . . 0.0 109.643 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -94.91 90.63 6.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.327 -0.858 . . . . 0.0 110.55 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.586 ' CB ' HD22 ' A' ' 114' ' ' LEU . 13.0 m0 -96.38 153.53 17.77 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.624 HG21 ' HB3' ' A' ' 110' ' ' ALA . 55.3 p -138.16 159.61 41.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.908 -1.12 . . . . 0.0 111.229 -179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.617 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 9.4 t30 -112.73 4.37 17.05 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.439 -0.788 . . . . 0.0 109.148 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 108' ' ' THR . 9.7 t -139.6 48.7 1.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.232 -0.917 . . . . 0.0 110.531 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 93.6 p 45.62 81.34 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.89 -1.131 . . . . 0.0 109.874 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 106' ' ' THR . . . -136.13 -42.11 0.65 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.909 -1.119 . . . . 0.0 109.974 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -137.48 -77.31 0.39 Allowed 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.506 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.5 m-30 -107.98 -102.0 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.4 OUTLIER 165.43 98.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.835 -1.166 . . . . 0.0 110.633 178.437 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.586 HD22 ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -52.12 -35.24 47.59 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.106 179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.814 ' HZ ' HG21 ' A' ' 42' ' ' VAL . 2.2 t80 -66.33 -43.25 86.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.092 -1.005 . . . . 0.0 110.005 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.708 ' CD2' H382 ' A' ' 800' ' ' I52 . 1.2 mt -59.41 -60.96 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.004 -1.06 . . . . 0.0 109.566 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.445 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.7 m -52.66 -38.19 26.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 121.262 -0.899 . . . . 0.0 109.404 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 122' ' ' PHE . . . -61.74 -51.03 70.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.636 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -53.15 -49.5 66.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.493 -0.754 . . . . 0.0 109.144 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -46.44 -68.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 65.6 mm-40 -56.97 -21.14 28.0 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.217 -0.927 . . . . 0.0 108.834 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.615 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 0.2 OUTLIER -74.4 -12.2 60.45 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -96.89 -47.43 2.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.535 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 0.6 OUTLIER -59.6 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.329 -1.1 . . . . 0.0 109.57 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -70.38 -4.48 22.54 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.494 -0.754 . . . . 0.0 110.286 -179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 7.7 mtt -103.79 -10.65 18.11 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.07 -1.019 . . . . 0.0 109.692 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.504 ' HA3' HD22 ' A' ' 161' ' ' LEU . . . 128.75 -64.28 0.6 Allowed Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.582 -1.294 . . . . 0.0 110.013 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 127' ' ' GLY . 15.0 mt -49.35 176.04 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 109.289 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -169.54 -172.64 1.48 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.719 0.771 . . . . 0.0 109.405 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -49.82 114.01 0.97 Allowed 'General case' 0 C--N 1.294 -1.824 0 CA-C-O 121.763 0.792 . . . . 0.0 109.99 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.555 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 11.2 t -84.86 -77.53 0.28 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 131' ' ' SER . 52.3 tt0 161.03 -29.8 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.419 ' OD1' ' HD2' ' A' ' 134' ' ' PRO . 0.4 OUTLIER -57.88 133.1 83.28 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.715 -0.616 . . . . 0.0 109.632 -179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.419 ' HD2' ' OD1' ' A' ' 133' ' ' ASP . 29.2 Cg_endo -75.69 113.33 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.555 2.17 . . . . 0.0 110.045 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.53 -13.77 20.61 Favored Glycine 0 C--N 1.272 -2.983 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.534 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.74 158.82 12.01 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.884 -1.362 . . . . 0.0 109.706 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.03 HD13 H381 ' A' ' 800' ' ' I52 . 11.7 tp -70.47 -20.41 62.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.024 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -100.05 2.06 42.97 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.983 -1.073 . . . . 0.0 109.376 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -70.19 156.69 91.44 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.232 -0.918 . . . . 0.0 110.015 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.457 ' HB3' ' H92' ' A' ' 800' ' ' I52 . 34.3 Cg_endo -77.14 64.65 7.85 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.858 2.372 . . . . 0.0 110.986 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.539 ' O ' ' N27' ' A' ' 800' ' ' I52 . 0.0 OUTLIER -159.53 -157.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.261 -0.9 . . . . 0.0 109.625 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -165.69 119.03 1.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.11 -0.994 . . . . 0.0 109.823 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 144' ' ' TYR . 52.8 m -138.26 95.87 3.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.247 -0.908 . . . . 0.0 109.259 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.615 ' HA ' HD11 ' A' ' 116' ' ' LEU . 21.8 t80 -45.39 158.32 0.08 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.793 -1.192 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.519 HG21 H393 ' A' ' 800' ' ' I52 . 1.3 t -152.01 123.92 8.03 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 145' ' ' THR . 0.0 OUTLIER -48.52 122.46 5.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.787 -1.195 . . . . 0.0 108.578 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.505 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 7.5 m-20 58.96 -95.34 0.05 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.253 -0.905 . . . . 0.0 108.56 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.523 ' CD2' HG23 ' A' ' 42' ' ' VAL . 1.2 p90 177.72 142.88 0.09 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.088 -1.007 . . . . 0.0 109.657 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -107.82 -10.83 15.49 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.892 -1.13 . . . . 0.0 109.364 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.748 HD11 ' OD1' ' A' ' 45' ' ' ASP . 1.5 mt 66.57 139.34 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -111.74 122.76 48.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.97 -1.081 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.584 ' HA ' HG23 ' A' ' 155' ' ' ILE . 5.3 tt0 -50.01 -53.11 28.89 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.09 0.471 . . . . 0.0 109.954 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.7 OUTLIER -42.32 -29.04 0.23 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.805 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -90.62 -29.29 17.87 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.024 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 151' ' ' SER . 0.9 OUTLIER -73.49 -30.43 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.434 ' N ' HG13 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -88.25 -43.3 11.68 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -64.24 -25.62 69.88 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.805 HG22 ' O ' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -85.45 -47.47 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.855 -1.379 . . . . 0.0 109.078 179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.522 ' N ' HG23 ' A' ' 158' ' ' ILE . 14.6 mt-30 -52.02 -31.22 28.74 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.946 -1.096 . . . . 0.0 109.624 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -87.02 -28.71 22.46 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.264 -0.897 . . . . 0.0 109.15 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.504 HD22 ' HA3' ' A' ' 127' ' ' GLY . 0.1 OUTLIER -89.35 -16.08 31.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 110.045 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CZ ' HD21 ' A' ' 49' ' ' LEU . 1.8 m-85 -126.54 -47.37 1.57 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.812 -1.18 . . . . 0.0 110.052 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 CA-C-O 117.964 -1.464 . . . . 0.0 109.503 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 1.03 H381 HD13 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.278 0.561 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.603 ' CD1' ' HB2' ' A' ' 3' ' ' ASN . 46.7 p90 -84.44 -173.1 4.53 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.49 -0.756 . . . . 0.0 109.524 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.603 ' HB2' ' CD1' ' A' ' 2' ' ' TYR . 1.5 t30 49.59 93.13 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -178.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.04 -33.79 16.2 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.02 -1.05 . . . . 0.0 110.259 -178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.573 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 0.3 OUTLIER 178.83 -55.96 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.367 -0.833 . . . . 0.0 109.909 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 5' ' ' PHE . 32.7 Cg_endo -79.45 159.32 25.76 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.087 1.858 . . . . 0.0 110.67 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.07 -71.4 0.33 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.693 -0.629 . . . . 0.0 109.348 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -99.04 141.87 23.63 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 120.821 -1.175 . . . . 0.0 109.891 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -75.62 82.24 2.16 Favored 'Trans proline' 0 C--N 1.302 -1.896 0 C-N-CA 121.913 1.742 . . . . 0.0 108.784 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.1 mmtm -51.99 175.6 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 O-C-N 121.195 -0.941 . . . . 0.0 108.843 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.408 ' CH2' ' HB3' ' A' ' 60' ' ' ASP . 0.3 OUTLIER -66.1 140.37 58.23 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.229 -0.92 . . . . 0.0 109.79 179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -61.46 165.53 4.72 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.232 -0.917 . . . . 0.0 108.549 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.641 ' HD2' ' CD1' ' A' ' 162' ' ' TYR . 5.6 mmtp -118.75 -175.7 2.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.536 -179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.458 ' H ' HD12 ' A' ' 49' ' ' LEU . 1.9 m120 61.96 141.3 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.336 -0.852 . . . . 0.0 109.175 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . 2.5 mt-30 45.04 76.14 0.09 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.859 -1.151 . . . . 0.0 109.683 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' CD1' HD11 ' A' ' 49' ' ' LEU . 20.6 mt -110.73 136.76 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -0.846 . . . . 0.0 108.886 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.745 HG23 ' HB3' ' A' ' 52' ' ' SER . 0.2 OUTLIER -120.09 136.56 54.55 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.409 -0.807 . . . . 0.0 111.382 -178.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.636 ' CD1' HD11 ' A' ' 63' ' ' ILE . 34.3 p90 -149.61 153.07 36.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.969 . . . . 0.0 110.304 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.76 ' HD2' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -134.77 138.9 44.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -0.886 . . . . 0.0 109.523 179.559 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.647 HD12 ' CD2' ' A' ' 23' ' ' TYR . 0.7 OUTLIER -80.24 121.4 33.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.76 HD13 ' HD2' ' A' ' 19' ' ' ARG . 33.8 mm -67.33 -2.76 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.469 -0.769 . . . . 0.0 109.77 178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 23' ' ' TYR . . . 144.15 84.44 0.07 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.791 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -51.19 169.42 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 178.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.482 ' OG1' ' HD2' ' A' ' 25' ' ' PRO . 1.2 t -85.31 149.07 51.47 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 120.059 -1.651 . . . . 0.0 109.276 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' LEU . 36.2 Cg_endo -79.09 -21.5 9.28 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.331 2.021 . . . . 0.0 109.85 -178.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 25' ' ' PRO . 74.4 m-20 -40.64 -25.06 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.133 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.692 ' H ' HD23 ' A' ' 27' ' ' LEU . 1.4 pt? -133.76 173.83 11.1 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.675 -1.266 . . . . 0.0 110.798 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 3.0 m-20 -48.66 138.3 12.11 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.233 -0.917 . . . . 0.0 108.862 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.551 ' O ' HG12 ' A' ' 32' ' ' VAL . 31.3 Cg_endo -69.03 -33.66 18.84 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 N-CA-C 107.331 -1.834 . . . . 0.0 107.331 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.435 ' HG3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 pt-20 -79.01 -26.88 43.22 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.542 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 20.8 m -74.15 -50.83 17.68 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.791 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -54.66 -36.26 35.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.993 0.901 . . . . 0.0 108.643 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.87 -24.72 59.78 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -71.66 -41.66 68.48 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.531 ' HA ' ' HB2' ' A' ' 115' ' ' PHE . . . -53.19 -38.89 63.23 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' HG21 ' A' ' 63' ' ' ILE . 26.9 m-85 -74.12 -26.75 60.51 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.12 -52.66 9.66 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -34.47 72.33 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.828 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -62.9 -46.78 86.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.44 -0.788 . . . . 0.0 109.206 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -53.39 -34.72 58.79 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' O ' ' CB ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -83.01 -12.3 57.37 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 178.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.579 HG12 ' CE2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -73.38 -32.76 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.327 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.828 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 1.0 OUTLIER -102.82 -51.02 3.38 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.599 -0.688 . . . . 0.0 109.718 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 10.0 t -53.76 -33.17 54.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.151 -0.968 . . . . 0.0 109.157 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' CB ' ' O ' ' A' ' 41' ' ' GLN . 1.2 t70 -54.78 -33.3 61.22 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.599 -0.688 . . . . 0.0 109.622 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 46' ' ' VAL . 12.1 p -106.06 23.42 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 O-C-N 121.036 -1.04 . . . . 0.0 110.694 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.441 HG22 ' C ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -173.13 153.87 2.54 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.665 -1.272 . . . . 0.0 110.115 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' CD ' ' OXT' ' A' ' 163' ' ' GLY . 37.3 Cg_endo -79.77 12.78 2.31 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 123.89 3.06 . . . . 0.0 110.723 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.792 HD13 ' CE2' ' A' ' 162' ' ' TYR . 4.2 tt -64.37 148.72 49.79 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.96 138.93 45.64 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.77 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.693 ' CE2' HD22 ' A' ' 49' ' ' LEU . 26.6 m-85 -116.72 135.62 53.63 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.183 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.745 ' HB3' HG23 ' A' ' 17' ' ' THR . 9.4 t -128.59 118.67 23.37 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.059 -1.025 . . . . 0.0 110.322 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 18' ' ' TYR . 6.0 mtm180 -92.16 131.43 37.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.977 -1.077 . . . . 0.0 108.15 179.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.699 HD11 ' CB ' ' A' ' 59' ' ' ALA . 15.5 pt -126.6 148.31 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.614 -1.304 . . . . 0.0 109.536 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.423 ' CD2' ' N ' ' A' ' 55' ' ' HIS . 0.2 OUTLIER -109.38 -14.58 14.41 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.996 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -135.44 -167.39 2.0 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 120.953 -1.092 . . . . 0.0 109.941 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.86 -170.94 2.0 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.542 ' O ' ' CD1' ' A' ' 54' ' ' ILE . 1.9 tp10 -79.07 158.43 27.83 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.251 -1.146 . . . . 0.0 110.358 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.699 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -136.44 -160.38 1.05 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.447 -0.783 . . . . 0.0 108.911 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER -134.22 -57.03 0.86 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.584 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.618 HG23 ' C ' ' A' ' 95' ' ' GLY . 2.5 mt -98.77 152.05 4.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.361 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.0 mtt -119.21 123.19 43.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.948 -1.095 . . . . 0.0 110.274 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.636 HD11 ' CD1' ' A' ' 18' ' ' TYR . 1.6 mp -117.78 142.21 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.634 -1.291 . . . . 0.0 109.968 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.461 ' OD1' ' C ' ' A' ' 63' ' ' ILE . 2.7 p-10 175.3 -174.69 0.09 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.439 -0.788 . . . . 0.0 110.189 179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -89.96 -167.3 1.81 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.001 -1.062 . . . . 0.0 111.052 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 99' ' ' PHE . . . -149.3 49.66 0.57 Allowed Glycine 0 N--CA 1.5 2.945 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 0.0 OUTLIER -56.05 -170.44 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.945 -1.326 . . . . 0.0 109.501 179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.4 t90 -49.95 -57.28 7.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.131 -0.981 . . . . 0.0 109.886 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.5 124.75 24.08 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.693 -0.63 . . . . 0.0 110.146 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -175.09 -70.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 72' ' ' ASP . . . 133.74 -20.0 4.14 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.036 -1.225 . . . . 0.0 110.036 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -46.33 -177.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.517 -0.99 . . . . 0.0 111.601 -179.407 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -93.77 -2.02 65.27 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -141.88 77.59 18.51 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 120.967 -1.314 . . . . 0.0 110.172 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -77.27 139.33 18.65 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.51 2.14 . . . . 0.0 109.649 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.24 159.89 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.384 -0.822 . . . . 0.0 109.605 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -178.9 -31.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.495 -0.753 . . . . 0.0 109.112 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.86 -154.92 19.64 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -69.4 167.28 16.89 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.384 -1.068 . . . . 0.0 111.128 -179.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.57 ' HA ' HD21 ' A' ' 83' ' ' LEU . 0.4 OUTLIER 41.42 -150.41 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.498 ' O ' HD12 ' A' ' 83' ' ' LEU . . . 54.42 -134.88 45.52 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 109.871 -1.292 . . . . 0.0 109.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.684 HD23 ' HB2' ' A' ' 100' ' ' ASP . 4.7 tt -50.68 98.34 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.594 -0.945 . . . . 0.0 109.012 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.57 HD21 ' HA ' ' A' ' 80' ' ' ASP . 1.3 mt -110.31 -28.45 8.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 108.934 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 121' ' ' GLU . . . -177.94 155.34 0.97 Allowed 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 98' ' ' HIS . 4.8 p80 -152.21 174.48 13.7 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.014 -1.054 . . . . 0.0 109.768 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -144.76 144.11 31.01 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.428 -0.795 . . . . 0.0 109.874 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -85.6 156.91 20.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 108.739 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.926 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -65.67 173.32 2.07 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.079 -1.013 . . . . 0.0 110.195 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.926 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 37.5 Cg_endo -82.51 155.54 16.21 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 123.201 2.601 . . . . 0.0 110.67 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.52 -128.76 1.18 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.7 60.09 1.7 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.207 -1.173 . . . . 0.0 110.475 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 143.18 -67.8 0.44 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 93' ' ' VAL . 61.7 t -79.86 1.24 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.022 -1.281 . . . . 0.0 108.36 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . -78.89 134.82 14.46 Favored Glycine 0 N--CA 1.477 1.413 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.618 ' C ' HG23 ' A' ' 61' ' ' ILE . . . 84.04 91.95 0.72 Allowed Glycine 0 N--CA 1.491 2.36 0 O-C-N 121.55 -0.97 . . . . 0.0 110.68 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' O ' ' HA ' ' A' ' 86' ' ' ALA . 7.3 m-20 -160.99 120.33 2.61 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 120.975 -1.309 . . . . 0.0 108.754 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 63' ' ' ILE . 3.1 p -110.25 130.01 55.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.052 0.93 . . . . 0.0 110.505 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 85' ' ' HIS . 29.5 m170 -119.36 148.9 42.67 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.464 -0.772 . . . . 0.0 109.333 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 66' ' ' GLY . 11.7 m-30 -112.48 147.05 37.35 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.566 -0.709 . . . . 0.0 109.833 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.684 ' HB2' HD23 ' A' ' 82' ' ' LEU . 3.6 t70 -81.13 114.92 20.29 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.548 ' HB3' ' HG2' ' A' ' 67' ' ' ARG . 18.5 t70 -57.37 -95.31 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.75 -0.78 . . . . 0.0 108.92 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 101' ' ' ASP . 47.2 m-20 21.67 -93.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-O 120.706 0.288 . . . . 0.0 111.272 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 102' ' ' ASP . 2.5 mp0 -41.95 161.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.933 -1.104 . . . . 0.0 110.094 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.446 ' O ' ' OD1' ' A' ' 111' ' ' ASN . 2.0 tp -106.2 101.08 10.59 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.883 . . . . 0.0 109.696 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.461 ' O ' HG22 ' A' ' 106' ' ' THR . 12.1 m95 -103.11 147.27 27.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.363 -0.835 . . . . 0.0 110.034 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.655 ' HA ' HD13 ' A' ' 27' ' ' LEU . 2.2 p -159.02 -159.68 0.79 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.315 -0.866 . . . . 0.0 110.02 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.1 70.0 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.429 -0.795 . . . . 0.0 109.733 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.467 HG23 ' H ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -168.2 -99.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.467 ' H ' HG23 ' A' ' 108' ' ' THR . 0.1 OUTLIER -142.67 59.82 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.774 -1.204 . . . . 0.0 109.613 178.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.93 -24.13 0.76 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.246 -0.908 . . . . 0.0 110.972 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.446 ' OD1' ' O ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -169.57 -153.66 0.11 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.739 -1.226 . . . . 0.0 108.968 -179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -67.74 -167.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.798 -1.189 . . . . 0.0 108.436 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.5 t -105.36 117.61 34.45 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.378 -0.826 . . . . 0.0 109.904 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.736 HD13 ' O ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -53.24 -22.51 6.96 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-O 121.86 0.838 . . . . 0.0 108.753 179.107 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -76.07 -38.49 57.02 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.595 HD12 ' CZ ' ' A' ' 142' ' ' TYR . 2.3 tm? -64.72 -55.13 21.88 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.409 -0.807 . . . . 0.0 109.716 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.507 HG23 ' H ' ' A' ' 118' ' ' ALA . 2.4 m -53.67 -51.06 46.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.507 ' H ' HG23 ' A' ' 117' ' ' VAL . . . -57.29 -51.48 69.2 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.39 -0.819 . . . . 0.0 108.938 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.461 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.4 -58.25 3.47 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 121.953 0.882 . . . . 0.0 109.333 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.805 ' HB2' ' H34' ' A' ' 800' ' ' I52 . 84.9 t60 -42.81 -67.62 0.26 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.601 0.715 . . . . 0.0 109.194 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.553 ' HG3' ' HB1' ' A' ' 84' ' ' ALA . 44.1 mm-40 -62.25 -21.95 65.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 0.0 109.053 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.51 ' CG ' ' CZ2' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -74.43 -5.54 43.07 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -98.08 -48.54 1.88 Allowed Glycine 0 N--CA 1.482 1.705 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.471 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 97.0 m-70 -60.79 -42.61 97.91 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -60.53 -16.5 38.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.226 -0.922 . . . . 0.0 109.209 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.5 ' SD ' ' OH ' ' A' ' 162' ' ' TYR . 44.2 mtt -84.62 15.82 3.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.449 -0.782 . . . . 0.0 110.098 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 100.95 -73.26 0.39 Allowed Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.353 -1.403 . . . . 0.0 109.788 179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.455 ' C ' ' O ' ' A' ' 127' ' ' GLY . 15.7 mt -32.44 145.25 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.997 -0.708 . . . . 0.0 111.184 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -110.85 -179.66 3.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.815 -1.178 . . . . 0.0 109.397 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -49.08 135.47 16.13 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 77.2 p -93.35 -152.16 0.32 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.458 -0.776 . . . . 0.0 109.907 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -133.16 -4.66 3.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.506 -0.746 . . . . 0.0 109.642 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -81.97 134.44 49.75 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.238 -0.914 . . . . 0.0 109.905 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.93 113.15 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.465 2.11 . . . . 0.0 111.007 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 105.07 -5.32 42.06 Favored Glycine 0 C--N 1.268 -3.199 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 139' ' ' ALA . . . -54.13 162.04 1.12 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.682 -0.893 . . . . 0.0 109.64 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.762 HD13 H382 ' A' ' 800' ' ' I52 . 19.0 tp -67.32 -34.3 77.08 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.547 -0.721 . . . . 0.0 109.085 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.416 ' HE1' ' OD1' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -107.34 28.09 8.44 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.514 -0.741 . . . . 0.0 110.398 -179.217 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.725 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -78.19 164.27 57.61 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.773 -1.204 . . . . 0.0 109.112 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.725 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 35.2 Cg_endo -73.5 15.74 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 123.269 2.646 . . . . 0.0 112.39 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.411 ' O ' ' H30' ' A' ' 800' ' ' I52 . 1.0 OUTLIER -137.93 139.59 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.853 -1.155 . . . . 0.0 109.507 -179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.595 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 62.9 t80 -76.79 129.58 36.48 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.106 -0.996 . . . . 0.0 109.918 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 144' ' ' TYR . 6.2 m -150.06 84.77 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.982 -1.074 . . . . 0.0 108.472 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.565 ' CD1' ' HG ' ' A' ' 116' ' ' LEU . 75.4 t80 -42.37 164.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.633 -0.667 . . . . 0.0 109.339 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.838 ' HB ' H371 ' A' ' 800' ' ' I52 . 1.7 t -111.5 119.05 37.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.054 -1.029 . . . . 0.0 110.604 -178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER -44.83 104.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.381 -0.825 . . . . 0.0 108.848 -179.812 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 146' ' ' LYS . 70.1 m-20 68.81 -79.15 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.274 -0.891 . . . . 0.0 109.574 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.854 ' CE1' HD23 ' A' ' 150' ' ' LEU . 24.1 t80 171.14 113.88 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.037 -1.039 . . . . 0.0 108.95 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 14.1 ttt85 -133.02 -20.7 2.17 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.577 -0.702 . . . . 0.0 110.214 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.854 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 71.98 -160.53 0.12 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.486 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -163.42 126.71 2.71 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.731 -1.231 . . . . 0.0 108.985 -179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.585 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 4.7 mm-40 -45.51 -44.07 12.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.394 -0.816 . . . . 0.0 109.25 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 152' ' ' GLN . 41.9 t0 -45.57 -36.4 4.64 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 118.654 -1.218 . . . . 0.0 108.357 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' OD1' ' HE1' ' A' ' 138' ' ' MET . 29.2 t0 -86.51 -30.89 21.62 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.634 -0.667 . . . . 0.0 109.479 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.685 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.6 OUTLIER -70.48 -37.56 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.087 -1.008 . . . . 0.0 108.805 178.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -72.82 -43.1 63.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.821 -179.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -67.43 -49.84 48.44 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.687 HD11 ' OH ' ' A' ' 162' ' ' TYR . 0.5 OUTLIER -54.47 -42.95 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.879 -1.365 . . . . 0.0 109.534 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.425 ' N ' HG23 ' A' ' 158' ' ' ILE . 7.3 mm-40 -65.4 -43.15 91.51 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.817 -1.177 . . . . 0.0 109.589 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 156' ' ' LYS . 69.3 mm-40 -57.73 -22.98 49.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.741 -1.225 . . . . 0.0 108.468 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.469 ' HB3' ' HD1' ' A' ' 162' ' ' TYR . 3.8 mm? -98.96 -64.5 1.03 Allowed 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.584 0.707 . . . . 0.0 109.318 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.792 ' CE2' HD13 ' A' ' 49' ' ' LEU . 21.9 p90 -151.64 85.27 1.3 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.45 ' OXT' ' CD ' ' A' ' 48' ' ' PRO . . . . . . . . 0 N--CA 1.494 2.543 0 CA-C-O 118.037 -1.424 . . . . 0.0 109.662 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 1.056 ' H61' H251 ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.259 0.552 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.612 ' CG ' ' O ' ' A' ' 2' ' ' TYR . 0.7 OUTLIER -153.27 83.16 1.19 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -102.94 31.28 4.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.151 -0.968 . . . . 0.0 109.849 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -79.72 125.35 29.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.097 -1.002 . . . . 0.0 109.577 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -68.13 155.74 91.43 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.164 -0.96 . . . . 0.0 108.984 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -79.26 157.3 26.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.452 2.102 . . . . 0.0 110.131 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 9.0 mmt180 -88.95 -1.67 58.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.492 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' HB2' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER 62.43 144.14 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.998 . . . . 0.0 108.979 -179.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.51 82.63 2.22 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.058 1.839 . . . . 0.0 108.848 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' O ' ' OD1' ' A' ' 12' ' ' ASP . 9.8 mttp -54.33 164.45 0.68 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.366 -0.833 . . . . 0.0 109.939 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 3.0 m95 -71.54 130.99 42.61 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 11.8 p-10 167.92 99.41 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.36 -0.837 . . . . 0.0 109.383 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -161.64 32.0 0.13 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.301 -0.874 . . . . 0.0 109.493 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 48' ' ' PRO . 0.1 OUTLIER 72.28 -62.97 0.45 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.146 -0.971 . . . . 0.0 108.951 -179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.554 ' HA ' ' O ' ' A' ' 50' ' ' ARG . 21.3 mt-30 -78.94 103.23 8.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.517 -0.739 . . . . 0.0 109.297 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.552 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.9 OUTLIER -101.06 162.4 3.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 108.577 179.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.2 OUTLIER -128.45 133.96 48.64 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.06 -1.025 . . . . 0.0 110.043 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 7.3 p90 -145.99 157.69 43.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.504 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' HB2' ' CB ' ' A' ' 59' ' ' ALA . 3.4 tmm_? -148.76 136.82 20.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 0.0 109.927 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.638 HD13 ' CZ ' ' A' ' 23' ' ' TYR . 5.8 mt -86.6 144.97 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 62' ' ' MET . 11.6 mm -107.67 -38.85 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.069 -1.019 . . . . 0.0 110.074 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.02 96.23 0.14 Allowed Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.755 ' CG ' HG11 ' A' ' 32' ' ' VAL . 2.5 m-85 -55.31 179.02 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.353 -1.086 . . . . 0.0 109.1 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.563 HG22 HD11 ' A' ' 27' ' ' LEU . 5.0 t -105.05 150.59 38.93 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.081 -1.012 . . . . 0.0 109.437 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 36.2 Cg_endo -81.27 -33.04 0.79 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.727 2.285 . . . . 0.0 111.238 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 25' ' ' PRO . 36.5 m-20 -39.48 -27.16 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.68 -0.637 . . . . 0.0 110.105 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.662 HD13 ' HB ' ' A' ' 32' ' ' VAL . 0.6 OUTLIER -135.16 -178.15 4.97 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 110.04 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 1.1 m-20 -73.62 151.97 89.37 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.511 -0.743 . . . . 0.0 110.268 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.557 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.7 Cg_endo -74.1 -30.12 9.18 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 N-CA-C 106.254 -2.248 . . . . 0.0 106.254 177.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 2.6 mm-40 -78.11 -30.41 49.45 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.538 ' CG2' ' HB2' ' A' ' 107' ' ' ASN . 2.4 m -76.45 -50.68 13.46 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.755 HG11 ' CG ' ' A' ' 23' ' ' TYR . 1.4 p -54.92 -41.43 57.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.7 OUTLIER -71.26 -23.97 62.08 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 2.7 t70 -81.39 -34.5 31.61 Favored 'General case' 0 N--CA 1.485 1.296 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -31.21 72.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.112 -0.993 . . . . 0.0 108.528 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.409 ' O ' ' C ' ' A' ' 37' ' ' ALA . 5.8 m-85 -73.21 -47.95 39.19 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -0.87 . . . . 0.0 108.974 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -46.24 -51.15 14.96 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.993 . . . . 0.0 108.609 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' O ' ' N ' ' A' ' 42' ' ' VAL . 9.3 mtm180 -55.19 -50.44 69.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.013 -1.054 . . . . 0.0 108.439 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.542 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -53.41 -44.36 68.68 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.533 ' O ' ' CB ' ' A' ' 44' ' ' SER . 49.6 t80 -51.25 -40.25 58.45 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.209 -0.932 . . . . 0.0 108.732 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 3.0 tt0 -86.77 -24.03 25.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.484 -0.76 . . . . 0.0 109.847 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -68.74 -33.33 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.147 -0.97 . . . . 0.0 109.846 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.787 ' HE1' HD21 ' A' ' 137' ' ' LEU . 1.9 m95 -103.22 -22.3 13.75 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.58 -0.7 . . . . 0.0 109.208 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 27.5 t -85.9 -19.61 30.28 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 109.16 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.8 m-20 -64.6 -15.12 60.63 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.364 -0.835 . . . . 0.0 109.516 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 46' ' ' VAL . 7.1 p -113.65 17.73 7.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.44 -0.788 . . . . 0.0 109.404 -179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -173.04 147.56 1.53 Allowed Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 120.466 -1.396 . . . . 0.0 111.037 -179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.517 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 36.4 Cg_endo -78.52 46.78 2.23 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.773 2.316 . . . . 0.0 110.067 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.866 HD23 ' HE1' ' A' ' 51' ' ' PHE . 1.7 mp -76.55 160.16 29.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.0 110.386 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -130.41 84.41 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.866 ' HE1' HD23 ' A' ' 49' ' ' LEU . 5.4 m-30 -66.57 139.41 57.91 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.636 -1.29 . . . . 0.0 108.997 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' THR . 8.1 t -130.89 101.66 5.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.244 -0.91 . . . . 0.0 109.835 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 55' ' ' HIS . 0.0 OUTLIER -81.03 144.08 32.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.85 -1.156 . . . . 0.0 109.099 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.745 HD13 ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -113.29 158.87 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 -179.796 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.634 ' CE1' ' NH1' ' A' ' 53' ' ' ARG . 43.1 m-70 -106.75 -14.65 14.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.125 -0.984 . . . . 0.0 109.302 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.04 -175.37 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.307 -0.871 . . . . 0.0 109.046 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.34 63.65 0.83 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.486 -1.846 . . . . 0.0 108.486 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 54' ' ' ILE . 0.6 OUTLIER 177.35 153.91 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.482 -1.01 . . . . 0.0 109.527 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 54' ' ' ILE . . . 176.45 143.66 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.462 -0.774 . . . . 0.0 109.175 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.17 -62.53 1.61 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.793 HG23 ' O ' ' A' ' 95' ' ' GLY . 22.9 mt -87.59 156.51 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.983 ' HG2' HD11 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -165.83 136.05 3.52 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.126 -0.984 . . . . 0.0 109.931 -179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.39 144.56 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.237 -0.914 . . . . 0.0 109.668 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.516 ' OD1' ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -164.19 -167.14 1.25 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.264 -0.898 . . . . 0.0 109.325 179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.464 ' CD1' ' HD2' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -117.2 166.73 11.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 109.629 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -102.74 -24.99 7.85 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 65' ' ' PHE . 54.1 mtp180 47.91 -150.38 0.14 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.38 -1.071 . . . . 0.0 110.177 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.436 ' O ' ' O ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -91.12 -72.57 0.57 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.041 -1.037 . . . . 0.0 109.412 -179.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 mp0 -62.42 99.95 0.16 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.621 -0.675 . . . . 0.0 110.481 -179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -127.29 -160.28 0.99 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -113.86 -33.26 1.89 Allowed Glycine 0 N--CA 1.485 1.904 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -83.74 72.18 10.37 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.431 -1.04 . . . . 0.0 108.492 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 74' ' ' TYR . . . 112.95 -113.29 3.15 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER 163.33 -52.46 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.21 -1.17 . . . . 0.0 109.827 178.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 74' ' ' TYR . 36.8 Cg_endo -79.26 137.69 13.59 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.246 1.964 . . . . 0.0 110.235 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.463 ' CD1' ' O ' ' A' ' 76' ' ' PHE . 24.7 p90 -71.63 138.05 48.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.108 -0.995 . . . . 0.0 108.617 179.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 3.4 p-10 -75.31 -2.29 27.56 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.351 -0.843 . . . . 0.0 109.555 -179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.525 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 57.41 -114.91 5.99 Favored Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.5 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.525 ' O ' ' O ' ' A' ' 78' ' ' GLY . 5.4 mttt -41.65 172.51 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 122.057 -0.673 . . . . 0.0 110.78 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.52 ' C ' ' O ' ' A' ' 79' ' ' LYS . 10.1 m-20 -25.18 -93.17 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 80' ' ' ASP . . . 38.6 -130.35 1.79 Allowed Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.521 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 9.7 tt -54.51 109.37 0.49 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.1 mt -107.94 -29.29 9.1 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.603 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 171.77 155.93 0.08 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.903 -1.123 . . . . 0.0 110.899 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.424 ' HB3' H252 ' A' ' 800' ' ' I52 . 1.9 p80 -146.36 -162.74 1.59 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.493 -0.755 . . . . 0.0 110.29 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 97' ' ' SER . . . -160.73 145.81 14.36 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.47 ' O ' ' HA2' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -92.77 156.29 17.11 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.841 -1.162 . . . . 0.0 109.976 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.611 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -79.8 164.01 55.42 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.317 -0.865 . . . . 0.0 109.977 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.611 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 36.1 Cg_endo -79.35 154.55 24.68 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.002 2.468 . . . . 0.0 110.338 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 161.49 60.07 0.02 OUTLIER Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.78 92.56 0.08 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -1.084 . . . . 0.0 109.383 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.82 -62.81 4.13 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.41 ' H ' HG23 ' A' ' 93' ' ' VAL . 2.4 t -58.19 153.12 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.046 -1.267 . . . . 0.0 109.748 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 98.2 141.08 11.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.793 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 95.83 -45.78 1.96 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' MET . 4.1 p30 -73.26 125.22 27.27 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.188 -1.183 . . . . 0.0 109.724 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.511 ' OG ' ' CE1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -131.65 136.28 47.59 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.314 -179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CD2' ' OD1' ' A' ' 64' ' ' ASN . 9.5 m80 -98.93 143.38 29.29 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 105' ' ' TRP . 13.8 m-85 -113.9 141.83 46.87 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.299 -0.875 . . . . 0.0 109.565 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.515 ' O ' ' CZ3' ' A' ' 105' ' ' TRP . 5.4 t70 -51.91 135.43 30.33 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -98.23 -16.86 19.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.871 -1.143 . . . . 0.0 109.592 -179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -75.83 -16.92 60.01 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.534 ' OE2' HD23 ' A' ' 83' ' ' LEU . 0.4 OUTLIER -75.49 158.23 32.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.154 -0.966 . . . . 0.0 110.074 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 111' ' ' ASN . 8.4 tp -109.09 95.61 5.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.477 -0.764 . . . . 0.0 109.705 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 99' ' ' PHE . 10.3 m0 -102.33 141.51 35.05 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.216 -0.927 . . . . 0.0 110.222 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.805 HG21 ' HB3' ' A' ' 110' ' ' ALA . 1.5 p -133.51 -160.28 1.04 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.972 -1.08 . . . . 0.0 110.006 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.538 ' HB2' ' CG2' ' A' ' 31' ' ' THR . 0.2 OUTLIER -134.59 2.25 3.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.379 -0.826 . . . . 0.0 109.99 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.08 -60.5 1.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.944 -1.098 . . . . 0.0 109.359 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.483 ' O ' ' N ' ' A' ' 111' ' ' ASN . 3.6 p -165.26 -91.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.324 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.805 ' HB3' HG21 ' A' ' 106' ' ' THR . . . 43.6 -95.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.937 . . . . 0.0 109.865 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.483 ' HB2' HD23 ' A' ' 104' ' ' LEU . 60.8 t30 -110.55 -104.63 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.774 -1.204 . . . . 0.0 109.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.95 -124.17 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.794 -1.191 . . . . 0.0 109.456 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.405 ' OG ' ' HB2' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -171.99 117.24 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.356 -1.465 . . . . 0.0 111.219 -179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.554 HD23 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -45.95 -43.48 14.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.643 -0.66 . . . . 0.0 110.078 179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.637 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.6 t80 -58.91 -44.52 91.26 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.388 -0.82 . . . . 0.0 109.862 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.849 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.5 OUTLIER -59.2 -67.14 0.4 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.422 -0.798 . . . . 0.0 109.766 -179.139 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.5 HG11 ' NE1' ' A' ' 105' ' ' TRP . 19.1 m -51.08 -42.93 25.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.435 -0.791 . . . . 0.0 108.985 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.467 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -52.64 -46.94 67.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.332 -0.855 . . . . 0.0 108.861 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -54.48 -59.02 5.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.376 -0.828 . . . . 0.0 110.007 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.74 ' HB2' ' H34' ' A' ' 800' ' ' I52 . 77.3 t60 -43.55 -65.05 0.54 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.655 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 99' ' ' PHE . 68.1 mm-40 -62.84 -12.95 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 0.0 109.341 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.1 m-85 -80.92 -10.8 59.68 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.108 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.597 ' HA3' ' CZ2' ' A' ' 43' ' ' TRP . . . -103.68 -41.29 2.19 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.597 ' CE1' ' CE1' ' A' ' 120' ' ' HIS . 9.5 m80 -61.02 -42.93 99.4 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -1.117 . . . . 0.0 109.104 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.467 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -37.56 -32.36 0.05 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.391 0.615 . . . . 0.0 109.532 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.867 ' HE1' HD12 ' A' ' 158' ' ' ILE . 4.1 mtm -69.89 -82.15 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.309 -0.87 . . . . 0.0 109.476 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -178.47 -30.87 0.05 OUTLIER Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.429 ' O ' ' HE1' ' A' ' 138' ' ' MET . 0.5 OUTLIER -49.9 153.82 1.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -1.174 . . . . 0.0 109.538 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.479 ' O ' ' O ' ' A' ' 130' ' ' HIS . 4.0 mt-10 -113.44 -177.53 3.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.212 -0.93 . . . . 0.0 109.157 179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.479 ' O ' ' O ' ' A' ' 129' ' ' GLU . 18.6 m170 -44.72 172.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.633 -0.667 . . . . 0.0 110.142 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 9.8 p -123.58 -152.23 0.51 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.144 -0.972 . . . . 0.0 110.38 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.3 -17.36 2.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.321 -0.862 . . . . 0.0 110.99 -179.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.08 151.32 54.21 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.72 -1.237 . . . . 0.0 109.251 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -72.8 -38.7 2.88 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.398 2.065 . . . . 0.0 110.686 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -83.09 6.81 69.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -66.57 163.31 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 110.03 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 1.109 HD13 H382 ' A' ' 800' ' ' I52 . 16.7 tp -89.12 -28.5 20.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 110.233 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.444 ' O ' ' C ' ' A' ' 139' ' ' ALA . 37.0 mtp -101.53 15.01 30.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.909 -1.119 . . . . 0.0 109.221 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -43.15 153.72 0.34 Allowed Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.934 ' O ' HD13 ' A' ' 141' ' ' ILE . 35.2 Cg_endo -79.09 -1.11 11.32 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 C-N-CA 122.205 1.937 . . . . 0.0 110.21 -179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.934 HD13 ' O ' ' A' ' 140' ' ' PRO . 5.5 mm -131.28 154.46 40.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.82 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -65.66 139.36 58.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.0 110.16 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.649 ' HB ' ' H31' ' A' ' 800' ' ' I52 . 1.9 m -129.52 -41.98 1.33 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.493 -0.755 . . . . 0.0 110.37 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.849 ' HA ' HD11 ' A' ' 116' ' ' LEU . 0.5 OUTLIER 68.42 147.71 0.06 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.558 ' HB ' H371 ' A' ' 800' ' ' I52 . 6.4 t -120.65 138.13 54.09 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.69 -83.11 0.15 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.119 -0.988 . . . . 0.0 111.003 -178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 1.5 p-10 -88.19 21.43 2.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.824 -1.173 . . . . 0.0 109.391 -179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.523 ' C ' ' CD1' ' A' ' 148' ' ' PHE . 1.6 t80 60.14 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.112 -0.993 . . . . 0.0 109.133 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 6.4 mtt180 -121.06 -10.8 8.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.437 -0.789 . . . . 0.0 109.247 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.5 tp 59.32 -144.74 0.55 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.431 -0.793 . . . . 0.0 109.274 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.647 ' O ' HG23 ' A' ' 155' ' ' ILE . 1.1 p -178.41 129.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.004 -1.06 . . . . 0.0 109.855 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.563 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 23.3 mm-40 -53.76 -35.17 61.0 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.896 -0.502 . . . . 0.0 110.053 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 152' ' ' GLN . 2.9 m-20 -42.87 -47.7 5.65 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.121 -0.987 . . . . 0.0 109.304 -179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 43' ' ' TRP . 0.4 OUTLIER -79.37 -45.26 19.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.454 -0.779 . . . . 0.0 109.177 179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.647 HG23 ' O ' ' A' ' 151' ' ' SER . 0.5 OUTLIER -50.86 -28.47 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.307 -0.87 . . . . 0.0 108.661 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -57.44 3.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.279 -0.888 . . . . 0.0 109.553 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -53.41 -36.41 53.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.867 HD12 ' HE1' ' A' ' 126' ' ' MET . 6.7 tp -75.28 -30.09 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.378 -1.072 . . . . 0.0 109.1 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -25.57 67.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.06 -1.025 . . . . 0.0 108.479 178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -86.41 -28.38 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.406 0.622 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.02 -19.62 20.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.658 -0.651 . . . . 0.0 110.136 -178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.795 ' CD2' HD11 ' A' ' 49' ' ' LEU . 41.6 m-85 -140.3 -75.05 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 0.0 109.406 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 1.109 H382 HD13 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 tpt . . . . . 0 N--CA 1.496 1.847 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 59.65 53.93 4.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 109.437 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -127.18 132.85 50.4 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.815 . . . . 0.0 110.477 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.659 ' CE1' HD21 ' A' ' 161' ' ' LEU . 0.1 OUTLIER -100.73 113.35 65.63 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.0 110.38 -179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 7' ' ' ARG . 33.0 Cg_endo -76.45 155.52 36.36 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.909 2.406 . . . . 0.0 110.904 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.561 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 13.7 mtp85 72.68 -109.09 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.365 -0.834 . . . . 0.0 109.472 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 89' ' ' PRO . 0.6 OUTLIER -83.73 109.74 20.42 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 120.97 -1.081 . . . . 0.0 109.516 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 31.7 Cg_endo -72.15 58.76 2.93 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.809 1.673 . . . . 0.0 110.261 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 22.17 -94.25 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 CA-C-O 121.384 0.612 . . . . 0.0 111.936 179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.568 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 176.0 -160.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.462 -0.774 . . . . 0.0 109.24 -178.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.584 ' HB2' HG23 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -44.57 158.39 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.161 -0.962 . . . . 0.0 110.302 -179.229 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.669 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -114.81 144.65 43.17 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.471 -0.768 . . . . 0.0 109.448 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.43 ' O ' HD23 ' A' ' 49' ' ' LEU . 68.0 m-80 43.26 -82.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.669 ' N ' ' O ' ' A' ' 13' ' ' LYS . 2.9 mt-30 -71.4 106.89 4.08 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.316 -0.865 . . . . 0.0 109.15 178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 17' ' ' THR . 2.2 mm -114.05 -178.33 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.034 -1.041 . . . . 0.0 110.133 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.638 ' H ' HG22 ' A' ' 16' ' ' ILE . 0.5 OUTLIER -140.33 137.83 34.43 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.518 ' CB ' HG13 ' A' ' 61' ' ' ILE . 43.2 p90 -145.38 162.89 36.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.115 -0.99 . . . . 0.0 109.569 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' NH2' ' HA ' ' A' ' 58' ' ' GLU . 19.9 ttp85 -159.42 124.33 4.06 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.267 -0.896 . . . . 0.0 109.684 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.892 HG21 ' CD1' ' A' ' 23' ' ' TYR . 4.0 mt -85.25 116.53 28.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.64 HG22 ' O ' ' A' ' 21' ' ' ILE . 3.7 mt -73.62 0.3 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.981 -1.074 . . . . 0.0 109.836 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.677 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 151.64 103.64 0.26 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.892 ' CD1' HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -68.74 -153.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.198 -1.178 . . . . 0.0 109.365 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.528 HG22 HG21 ' A' ' 32' ' ' VAL . 1.4 t -105.13 147.63 34.84 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 121.202 -0.936 . . . . 0.0 110.521 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 26' ' ' ASP . 37.5 Cg_endo -78.89 -32.91 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.157 2.571 . . . . 0.0 111.178 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 25' ' ' PRO . 71.7 m-20 -41.1 -34.73 0.47 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.636 -0.665 . . . . 0.0 110.698 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 107' ' ' ASN . 0.1 OUTLIER -121.03 176.95 5.32 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.967 -1.083 . . . . 0.0 109.231 -179.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HB2' ' HB ' ' A' ' 31' ' ' THR . 4.6 m-20 -63.04 154.49 77.06 Favored Pre-proline 0 N--CA 1.486 1.364 0 O-C-N 121.012 -1.055 . . . . 0.0 108.348 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' O ' HG12 ' A' ' 32' ' ' VAL . 30.9 Cg_endo -72.3 -33.33 9.22 Favored 'Trans proline' 0 C--N 1.296 -2.207 0 N-CA-C 106.672 -2.088 . . . . 0.0 106.672 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -82.1 -26.41 33.62 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.885 HG21 ' HA ' ' A' ' 107' ' ' ASN . 1.4 m -71.79 -51.84 20.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.883 HG11 ' CB ' ' A' ' 23' ' ' TYR . 0.3 OUTLIER -56.6 -33.74 40.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 0.2 OUTLIER -70.35 -24.23 62.94 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 55.2 t0 -73.7 -39.19 64.53 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.198 -1.001 . . . . 0.0 109.296 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.726 ' HB3' HD23 ' A' ' 114' ' ' LEU . . . -53.25 -60.83 2.79 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.477 ' CE2' HD21 ' A' ' 114' ' ' LEU . 78.3 m-85 -53.42 -42.5 67.12 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -49.2 -38.96 27.74 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 42' ' ' VAL . 1.2 mtp180 -74.48 -46.84 36.99 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -56.35 -36.15 68.46 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 40' ' ' PHE . 0.9 OUTLIER -65.61 -40.99 93.22 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 1.3 mt-30 -81.69 -9.42 59.65 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.334 -0.854 . . . . 0.0 109.882 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -94.26 -27.84 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.133 -0.979 . . . . 0.0 109.63 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.804 ' HZ3' HD13 ' A' ' 158' ' ' ILE . 1.7 m95 -102.67 -21.16 14.16 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.545 -0.722 . . . . 0.0 109.887 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.466 ' O ' ' O ' ' A' ' 47' ' ' THR . 6.2 t -95.2 -26.25 16.06 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.55 -0.719 . . . . 0.0 109.255 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -67.43 -4.54 11.51 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.222 -0.924 . . . . 0.0 110.196 -179.798 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.918 HG23 HG22 ' A' ' 47' ' ' THR . 15.1 m -108.1 -8.2 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 O-C-N 120.705 -1.247 . . . . 0.0 109.614 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.918 HG22 HG23 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -153.16 163.53 23.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.999 -1.063 . . . . 0.0 108.424 178.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.5 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.2 Cg_endo -76.66 57.16 5.47 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 122.067 1.845 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.805 HD11 ' CE2' ' A' ' 162' ' ' TYR . 2.6 mt -93.66 125.5 38.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.546 -0.721 . . . . 0.0 109.241 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 15' ' ' GLN . 4.9 mmm180 -112.26 90.81 3.44 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.934 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 89.4 m-85 -77.05 148.83 35.93 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.953 -1.092 . . . . 0.0 109.842 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' THR . 51.5 m -132.11 111.85 11.82 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.458 -0.776 . . . . 0.0 109.893 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -68.84 138.44 54.75 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.352 -0.843 . . . . 0.0 108.998 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.779 HD13 ' H ' ' A' ' 54' ' ' ILE . 0.2 OUTLIER -133.58 164.99 33.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.953 -1.092 . . . . 0.0 109.34 179.012 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.608 ' O ' ' N ' ' A' ' 57' ' ' GLY . 87.7 m-70 -132.03 165.35 24.18 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.258 -0.901 . . . . 0.0 109.697 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 0.3 OUTLIER 55.36 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -179.08 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.608 ' N ' ' O ' ' A' ' 55' ' ' HIS . . . -46.3 156.53 0.52 Allowed Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.419 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 1.7 mt-10 -66.55 161.2 23.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.92 -1.341 . . . . 0.0 110.47 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -124.47 148.57 47.59 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.587 -0.696 . . . . 0.0 109.381 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' CD2' ' A' ' 11' ' ' TRP . 10.3 t0 -70.03 -54.48 13.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.996 -1.065 . . . . 0.0 109.398 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.802 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -103.54 122.47 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.511 -0.743 . . . . 0.0 109.195 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.5 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 3.5 mtt -105.49 139.82 39.52 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.959 -1.088 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.438 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 2.9 mt -123.32 128.61 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.023 -1.048 . . . . 0.0 108.616 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.95 -147.1 0.21 Allowed 'General case' 0 N--CA 1.482 1.141 0 O-C-N 121.101 -0.999 . . . . 0.0 109.782 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 101' ' ' ASP . 0.1 OUTLIER -177.85 -178.55 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.899 -1.126 . . . . 0.0 110.314 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 101' ' ' ASP . . . 139.21 178.95 16.96 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.488 ' O ' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -160.87 161.74 31.94 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.286 -1.126 . . . . 0.0 109.786 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER 57.04 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.193 -0.942 . . . . 0.0 108.517 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.488 ' N ' ' O ' ' A' ' 67' ' ' ARG . 1.5 pp20? -61.65 124.53 20.95 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.317 -0.864 . . . . 0.0 108.802 179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-80 173.45 -57.0 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 77.55 -12.76 13.82 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 71' ' ' GLY . 6.0 m-20 -42.18 -24.68 0.05 Allowed 'General case' 0 C--N 1.31 -1.135 0 O-C-N 121.016 -1.285 . . . . 0.0 110.274 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 128.31 13.14 2.67 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 119.406 -1.378 . . . . 0.0 110.548 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.601 ' O ' ' CG ' ' A' ' 74' ' ' TYR . 14.8 p90 -154.76 90.85 3.04 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 120.834 -1.392 . . . . 0.0 109.287 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' O ' ' HB2' ' A' ' 76' ' ' PHE . 36.0 Cg_endo -78.35 -171.88 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.598 2.199 . . . . 0.0 110.957 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' HB2' ' A' ' 77' ' ' ASP . 26.6 m-85 61.08 170.87 0.1 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 0.0 109.235 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' O ' ' A' ' 78' ' ' GLY . 1.3 t70 172.63 -34.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' O ' ' O ' ' A' ' 77' ' ' ASP . . . 31.72 -157.77 0.0 OUTLIER Glycine 0 N--CA 1.5 2.957 0 CA-C-O 121.682 0.601 . . . . 0.0 111.933 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.497 ' O ' ' C ' ' A' ' 80' ' ' ASP . 6.3 mttt -72.8 162.45 29.48 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.688 -0.889 . . . . 0.0 110.957 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.497 ' C ' ' O ' ' A' ' 79' ' ' LYS . 9.7 p-10 27.96 -138.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.199 0.523 . . . . 0.0 111.208 178.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 83' ' ' LEU . . . 44.51 -116.93 1.84 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' A' ' 77' ' ' ASP . 0.2 OUTLIER -42.68 97.53 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' A' ' 81' ' ' GLY . 1.7 mt -114.3 -21.41 10.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.567 -1.333 . . . . 0.0 109.392 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.09 150.09 0.94 Allowed 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.143 -0.973 . . . . 0.0 110.178 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.588 ' CE1' ' CE1' ' A' ' 74' ' ' TYR . 1.1 p80 -144.04 -179.98 6.84 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.239 -0.913 . . . . 0.0 109.171 178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -165.81 162.06 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.115 -0.99 . . . . 0.0 110.167 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -98.07 168.7 10.1 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.285 -0.884 . . . . 0.0 110.673 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.8 148.32 64.72 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.547 -0.721 . . . . 0.0 109.357 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.479 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 28.8 Cg_endo -75.87 136.73 19.03 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.709 2.272 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.505 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . 145.21 122.79 1.56 Allowed Glycine 0 N--CA 1.486 2.022 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.387 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.512 ' O ' ' N ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER 56.25 115.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 122.004 -0.704 . . . . 0.0 110.954 179.439 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 33.14 -92.21 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -45.65 160.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -1.124 . . . . 0.0 108.743 -179.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 89' ' ' PRO . . . 126.58 151.1 7.73 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.802 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 60.82 13.41 32.67 Favored Glycine 0 N--CA 1.489 2.186 0 O-C-N 120.651 -1.499 . . . . 0.0 109.434 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.5 ' HA ' ' H ' ' A' ' 62' ' ' MET . 1.6 m-20 -97.09 116.2 28.86 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.552 -1.558 . . . . 0.0 109.661 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.614 ' O ' ' CD2' ' A' ' 98' ' ' HIS . 33.8 m -114.65 156.36 24.88 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.724 -0.61 . . . . 0.0 109.941 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 97' ' ' SER . 1.9 m80 -148.79 139.01 22.35 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' O ' ' HB2' ' A' ' 65' ' ' PHE . 32.6 m-85 -104.61 179.24 4.33 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.172 0.987 . . . . 0.0 112.165 -177.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.499 ' OD2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -58.64 161.98 4.26 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.866 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.611 ' HA ' ' CD2' ' A' ' 65' ' ' PHE . 13.2 t0 -94.02 -4.83 48.84 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.652 -0.655 . . . . 0.0 110.829 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -170.12 79.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.225 -0.922 . . . . 0.0 109.023 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -137.09 -8.54 1.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.476 -1.39 . . . . 0.0 111.599 -178.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD13 ' H ' ' A' ' 105' ' ' TRP . 0.2 OUTLIER 76.66 141.5 0.07 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.993 -1.067 . . . . 0.0 110.188 179.483 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.608 ' H ' HD13 ' A' ' 104' ' ' LEU . 26.0 m-90 -149.01 -50.44 0.15 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.017 -1.052 . . . . 0.0 110.288 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 114' ' ' LEU . 35.8 p -138.13 -89.21 0.24 Allowed 'General case' 0 C--N 1.291 -1.967 0 C-N-CA 117.905 -1.518 . . . . 0.0 113.171 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.885 ' HA ' HG21 ' A' ' 31' ' ' THR . 28.8 t-20 52.92 19.26 1.28 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 -175.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.473 ' N ' ' C ' ' A' ' 106' ' ' THR . 30.3 p 50.49 37.63 16.35 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.356 1.074 . . . . 0.0 110.039 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -168.07 31.91 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 105' ' ' TRP . . . -98.12 179.97 4.58 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-O 121.463 0.649 . . . . 0.0 111.967 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -120.98 -13.31 8.62 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.326 -0.859 . . . . 0.0 109.669 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.523 ' O ' ' CB ' ' A' ' 113' ' ' SER . 1.2 m-85 -107.59 -42.4 4.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.939 -1.101 . . . . 0.0 108.475 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 105' ' ' TRP . 0.3 OUTLIER 81.01 93.24 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.927 0.87 . . . . 0.0 110.925 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.743 ' H ' HG23 ' A' ' 106' ' ' THR . 13.2 tp -37.67 -41.83 0.52 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.739 178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.607 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 1.5 t80 -55.29 -45.1 76.23 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -0.893 . . . . 0.0 109.9 -179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.627 HD21 H352 ' A' ' 800' ' ' I52 . 1.0 OUTLIER -68.66 -58.69 3.87 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.189 -0.944 . . . . 0.0 110.448 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 118' ' ' ALA . 32.9 m -59.08 -42.37 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.006 -1.059 . . . . 0.0 109.432 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.645 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -59.06 -41.55 88.23 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.384 0.612 . . . . 0.0 109.4 -179.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -57.23 -51.32 69.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.356 -0.84 . . . . 0.0 109.492 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.7 t60 -54.64 -33.61 60.89 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 0.0 108.821 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -86.04 -24.61 26.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.167 -0.958 . . . . 0.0 109.151 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 118' ' ' ALA . 1.4 m-85 -71.91 -10.92 60.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 126' ' ' MET . . . -101.71 -37.92 3.33 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.487 -1.845 . . . . 0.0 108.487 178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -63.54 -50.23 70.37 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.21 -1.171 . . . . 0.0 108.597 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.556 ' HB1' ' HA2' ' A' ' 95' ' ' GLY . . . -61.18 -13.45 18.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.481 -0.888 . . . . 0.0 108.739 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.526 ' HB2' ' O ' ' A' ' 123' ' ' GLY . 22.9 mmm -81.26 10.87 4.85 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.089 -1.007 . . . . 0.0 108.985 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 128' ' ' LEU . . . 88.64 -54.96 4.14 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' A' ' 128' ' ' LEU . 14.7 mt -42.8 142.79 0.81 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.343 -1.093 . . . . 0.0 110.166 -179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' HIS . 19.6 pt-20 -108.98 175.61 5.4 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' GLU . 45.4 m80 -44.24 167.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.191 -0.943 . . . . 0.0 109.143 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 5.7 m -115.6 -80.53 0.6 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.005 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 177.11 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.175 -0.953 . . . . 0.0 110.137 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 145.79 97.36 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.269 -0.894 . . . . 0.0 110.142 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -75.83 -35.44 2.58 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.256 1.971 . . . . 0.0 108.567 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -89.34 13.7 62.97 Favored Glycine 0 N--CA 1.484 1.869 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -75.65 149.43 38.18 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.362 -1.081 . . . . 0.0 109.753 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.879 ' CD1' H351 ' A' ' 800' ' ' I52 . 14.3 tp -72.93 -16.16 61.55 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 7.3 mmt -112.45 27.87 9.26 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -67.95 154.49 93.62 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.743 -0.598 . . . . 0.0 109.477 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.25 4.14 7.07 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.79 2.327 . . . . 0.0 111.413 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.41 ' O ' HD12 ' A' ' 141' ' ' ILE . 1.0 OUTLIER -131.99 151.06 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.887 -1.133 . . . . 0.0 109.747 -179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.586 ' CE2' ' HB2' ' A' ' 144' ' ' TYR . 30.1 t80 -63.96 120.96 12.96 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.274 -0.891 . . . . 0.0 109.978 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.486 ' O ' ' O ' ' A' ' 144' ' ' TYR . 7.6 m -124.07 53.61 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.546 -0.721 . . . . 0.0 110.042 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.618 ' CD2' ' N ' ' A' ' 145' ' ' THR . 75.2 t80 -44.39 170.84 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.393 -0.817 . . . . 0.0 109.318 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.721 ' CG2' H382 ' A' ' 800' ' ' I52 . 1.6 t 179.64 113.3 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.064 -1.022 . . . . 0.0 109.455 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 23.0 ttpt -59.7 167.31 2.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.907 -1.121 . . . . 0.0 108.943 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 3.9 t-20 71.3 -54.83 0.66 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.962 -1.086 . . . . 0.0 110.591 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.444 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER 68.74 143.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.165 -0.96 . . . . 0.0 109.58 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.529 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 80.1 mtp85 -134.11 -86.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 108.922 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 2.1 mt 160.29 152.65 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.987 -1.071 . . . . 0.0 109.358 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.66 ' O ' HG23 ' A' ' 155' ' ' ILE . 10.4 p -119.83 129.02 54.22 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.018 -1.051 . . . . 0.0 109.885 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.636 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 7.5 mt-30 -65.39 -32.55 74.25 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -44.46 -38.28 3.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 158' ' ' ILE . 0.9 OUTLIER -86.54 -38.41 17.22 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.542 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.66 HG23 ' O ' ' A' ' 151' ' ' SER . 0.8 OUTLIER -62.7 -29.77 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.319 -0.863 . . . . 0.0 108.718 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.67 -63.9 1.31 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.626 -0.671 . . . . 0.0 110.236 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -51.64 -39.97 47.05 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.804 HD13 ' HZ3' ' A' ' 43' ' ' TRP . 9.9 tp -70.17 -40.98 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.612 -0.934 . . . . 0.0 109.461 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.49 ' N ' ' CG2' ' A' ' 158' ' ' ILE . 1.8 mm-40 -70.6 -20.55 62.75 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.257 -0.902 . . . . 0.0 108.809 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -87.14 -27.91 22.79 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.162 -0.961 . . . . 0.0 109.176 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.659 HD21 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -93.53 -19.99 20.69 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.777 . . . . 0.0 109.808 -179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.805 ' CE2' HD11 ' A' ' 49' ' ' LEU . 25.6 m-85 -113.59 -8.06 13.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.394 -0.816 . . . . 0.0 109.8 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.602 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 0.879 H351 ' CD1' ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -98.46 38.28 1.37 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.008 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -123.59 44.76 2.62 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.234 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -108.69 38.0 2.37 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.215 -0.928 . . . . 0.0 109.727 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.552 ' O ' ' NH1' ' A' ' 7' ' ' ARG . 13.1 m-85 -130.55 84.29 59.57 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 110.072 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' A' ' 7' ' ' ARG . 36.7 Cg_endo -78.95 0.75 9.74 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.533 2.156 . . . . 0.0 110.743 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.552 ' NH1' ' O ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -54.58 -166.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.126 -0.984 . . . . 0.0 109.682 -179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' N ' ' HG2' ' A' ' 7' ' ' ARG . 2.9 mttt -88.79 158.04 48.24 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.028 -1.045 . . . . 0.0 109.548 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 8' ' ' LYS . 35.4 Cg_endo -78.01 57.28 6.06 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.501 2.134 . . . . 0.0 108.699 179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' HD3' ' HG2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -64.61 -171.04 0.06 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -179.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.567 ' CH2' ' OD2' ' A' ' 60' ' ' ASP . 5.9 m95 -107.6 -105.58 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.948 -1.095 . . . . 0.0 109.199 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' OD1' HD11 ' A' ' 161' ' ' LEU . 13.5 m-20 61.34 22.95 13.25 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.81 -1.181 . . . . 0.0 109.548 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HD2' HG13 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -94.3 166.74 11.94 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.196 -0.94 . . . . 0.0 109.709 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.422 ' O ' ' N ' ' A' ' 16' ' ' ILE . 4.2 m120 -82.54 -88.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.377 -0.827 . . . . 0.0 110.262 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' CG ' ' O ' ' A' ' 15' ' ' GLN . 3.5 pt20 -52.45 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.772 -1.205 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 17' ' ' THR . 10.9 mt -102.72 167.96 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.342 -0.849 . . . . 0.0 110.602 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.611 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -131.64 131.51 43.26 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.159 -0.963 . . . . 0.0 109.837 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.521 ' HA ' HG13 ' A' ' 61' ' ' ILE . 9.3 p90 -133.7 163.93 28.34 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.996 . . . . 0.0 110.53 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' CZ ' ' O ' ' A' ' 55' ' ' HIS . 19.1 ttt180 -159.05 132.4 7.24 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.43 -0.794 . . . . 0.0 109.754 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.671 HD13 ' OD1' ' A' ' 33' ' ' ASP . 6.0 mt -93.26 131.25 40.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mm -72.75 -20.32 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.199 -0.938 . . . . 0.0 110.126 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 159.76 113.15 0.32 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -84.27 -168.36 2.13 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.409 -1.054 . . . . 0.0 108.225 178.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.558 HG23 ' CD2' ' A' ' 27' ' ' LEU . 0.7 OUTLIER -105.1 149.66 37.89 Favored Pre-proline 0 N--CA 1.493 1.725 0 O-C-N 120.817 -1.177 . . . . 0.0 109.475 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -78.31 -28.75 4.4 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.67 2.247 . . . . 0.0 110.061 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.671 ' OD1' HG22 ' A' ' 106' ' ' THR . 1.8 p30 -38.88 -28.27 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.039 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.017 HD13 ' HA ' ' A' ' 106' ' ' THR . 2.0 pt? -129.11 157.45 41.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.926 -1.109 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.553 ' CB ' ' HB ' ' A' ' 31' ' ' THR . 1.6 m-20 -40.75 138.89 1.23 Allowed Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.602 -0.687 . . . . 0.0 109.169 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -70.87 -39.91 4.0 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 N-CA-C 107.021 -1.953 . . . . 0.0 107.021 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 34' ' ' ASP . 13.4 pt-20 -72.88 -22.55 60.74 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.553 ' HB ' ' CB ' ' A' ' 28' ' ' ASP . 5.7 m -80.01 -51.36 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.357 178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.787 ' CG2' HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 -39.14 53.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.671 ' OD1' HD13 ' A' ' 20' ' ' ILE . 4.8 m-20 -78.76 -29.9 45.4 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 11.6 t70 -59.35 -43.64 92.77 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.115 -0.991 . . . . 0.0 108.727 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.622 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -43.28 -55.37 4.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.468 -0.77 . . . . 0.0 109.198 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 25.1 m-85 -54.99 -42.58 72.66 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.65 -0.656 . . . . 0.0 109.42 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.88 -65.88 0.52 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.317 -0.865 . . . . 0.0 109.03 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' HB3' ' CD1' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -47.93 -37.68 14.86 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.788 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -63.14 -47.71 81.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.415 -0.803 . . . . 0.0 109.471 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.6 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -52.4 -33.04 41.83 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 2.1 tt0 -82.39 -16.03 50.58 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.601 -0.687 . . . . 0.0 109.348 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.795 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -72.54 -36.43 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.921 -1.112 . . . . 0.0 110.167 -179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.795 ' CD1' HG13 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -105.29 -24.52 12.68 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 40' ' ' PHE . 28.2 t -77.63 -17.67 57.53 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.176 -0.952 . . . . 0.0 108.964 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 8.0 t70 -65.77 -17.67 64.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 0.0 110.097 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 46' ' ' VAL . 13.6 p -110.31 19.95 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 3.8 t -173.74 149.79 1.62 Allowed Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.069 -1.02 . . . . 0.0 108.805 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -81.03 47.12 2.47 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.885 2.39 . . . . 0.0 110.811 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.644 ' CD2' ' CZ ' ' A' ' 51' ' ' PHE . 0.6 OUTLIER -81.25 147.2 30.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.147 -0.97 . . . . 0.0 109.405 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -122.78 124.06 42.46 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.353 -0.842 . . . . 0.0 108.93 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.644 ' CZ ' ' CD2' ' A' ' 49' ' ' LEU . 45.4 m-85 -102.23 144.37 30.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.167 -0.958 . . . . 0.0 109.662 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.6 OUTLIER -118.9 119.68 35.07 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' NH1' ' HG3' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -87.84 141.9 28.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.214 -0.929 . . . . 0.0 109.159 -179.513 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 ' CB ' ' A' ' 59' ' ' ALA . 4.5 pt -141.22 -169.01 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.28 -0.888 . . . . 0.0 109.778 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.421 ' O ' ' CZ ' ' A' ' 19' ' ' ARG . 4.6 p80 -159.08 -33.22 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.515 -0.741 . . . . 0.0 109.191 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -115.31 157.86 23.21 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.18 -0.95 . . . . 0.0 109.18 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.18 11.26 78.82 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.16 158.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.419 -1.048 . . . . 0.0 109.066 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.867 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -128.13 143.66 51.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.88 -1.138 . . . . 0.0 110.489 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD2' ' CH2' ' A' ' 11' ' ' TRP . 1.6 m-20 -51.58 -59.24 4.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.416 -0.802 . . . . 0.0 109.072 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.736 HG22 ' O ' ' A' ' 95' ' ' GLY . 1.0 OUTLIER -98.6 129.66 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.0 -1.062 . . . . 0.0 108.583 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.459 ' SD ' ' OD1' ' A' ' 96' ' ' ASP . 1.5 mtp -125.1 116.61 22.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.014 -1.054 . . . . 0.0 110.563 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.95 155.4 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.51 -0.744 . . . . 0.0 109.129 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.5 p30 179.3 -172.15 0.16 Allowed 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.014 -1.054 . . . . 0.0 109.986 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.668 ' CD2' ' CZ3' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -134.07 170.54 15.5 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.472 -0.768 . . . . 0.0 109.108 -179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -179.64 114.73 0.45 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' GLY . 0.3 OUTLIER -55.14 -149.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.722 -0.87 . . . . 0.0 110.894 -179.332 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 76' ' ' PHE . 14.4 p90 -48.96 -51.13 32.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.813 -1.179 . . . . 0.0 109.792 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' HIS . 1.1 mt-10 -43.69 -69.21 0.14 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 15.1 t60 73.32 -73.4 0.1 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.43 -0.793 . . . . 0.0 110.608 178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 118.33 9.96 9.12 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.762 -1.209 . . . . 0.0 110.085 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -170.66 68.5 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.252 -1.146 . . . . 0.0 109.971 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.49 ' C ' ' HD3' ' A' ' 75' ' ' PRO . . . 117.59 179.25 17.46 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -118.81 76.29 14.03 Favored Pre-proline 0 C--N 1.301 -1.509 0 O-C-N 121.431 -1.04 . . . . 0.0 108.987 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.639 ' HB2' ' CD2' ' A' ' 82' ' ' LEU . 29.7 Cg_endo -74.78 -84.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.39 2.06 . . . . 0.0 108.425 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 68' ' ' TRP . 24.1 t80 59.52 -100.12 0.1 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.435 -0.791 . . . . 0.0 110.567 177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 75.69 -53.96 0.63 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.989 -1.07 . . . . 0.0 108.357 -178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.493 ' N ' ' CG ' ' A' ' 77' ' ' ASP . . . 101.83 -148.23 17.71 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HA ' ' OE2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -57.66 161.75 3.47 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.054 -1.262 . . . . 0.0 108.972 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.426 ' C ' ' O ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER 39.05 -147.41 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.434 -0.791 . . . . 0.0 110.028 -179.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.494 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 51.46 -146.21 12.16 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.639 ' CD2' ' HB2' ' A' ' 75' ' ' PRO . 3.5 tp -40.56 112.93 0.32 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.624 -0.927 . . . . 0.0 109.71 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.715 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 10.1 mt -108.63 -19.26 13.49 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.344 -0.848 . . . . 0.0 109.891 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.715 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 163.98 163.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.235 -0.916 . . . . 0.0 109.418 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.5 ' NE2' ' HB2' ' A' ' 98' ' ' HIS . 6.3 p-80 -153.92 177.4 11.07 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.935 -1.103 . . . . 0.0 109.979 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -137.47 156.39 48.21 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.08 163.2 12.4 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.066 -1.022 . . . . 0.0 109.609 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.547 ' O ' ' HA2' ' A' ' 94' ' ' GLY . . . -83.67 157.34 64.26 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.102 -0.999 . . . . 0.0 109.706 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.5 ' HG2' ' HD3' ' A' ' 10' ' ' LYS . 37.6 Cg_endo -76.81 147.56 27.56 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.462 2.108 . . . . 0.0 109.597 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 91' ' ' THR . . . 161.26 45.15 0.02 OUTLIER Glycine 0 N--CA 1.489 2.203 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.261 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 90' ' ' GLY . 0.7 OUTLIER 71.3 142.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.281 -1.129 . . . . 0.0 109.72 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' THR . . . 35.97 -102.53 0.02 OUTLIER Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -48.73 119.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.158 -1.201 . . . . 0.0 108.171 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 88' ' ' ALA . . . 133.15 146.1 5.5 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.736 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 79.18 2.98 88.14 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.459 ' OD1' ' SD ' ' A' ' 62' ' ' MET . 1.3 m-20 -107.85 130.41 55.0 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.197 -1.178 . . . . 0.0 109.583 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.496 ' HB3' ' O ' ' A' ' 85' ' ' HIS . 0.7 OUTLIER -122.67 133.53 54.51 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.468 -0.77 . . . . 0.0 109.535 -179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.537 ' HB2' ' CE1' ' A' ' 70' ' ' HIS . 5.8 m80 -111.89 134.21 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.035 -1.041 . . . . 0.0 109.065 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.651 ' HB2' ' CD2' ' A' ' 65' ' ' PHE . 6.1 m-85 -103.76 141.95 35.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 110.63 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -62.82 146.03 53.61 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 66' ' ' GLY . 16.6 m-20 -89.64 -112.27 0.07 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' O ' ' O ' ' A' ' 101' ' ' ASP . 5.1 m-20 36.03 -160.05 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 102' ' ' ASP . 0.6 OUTLIER 34.97 -124.11 0.11 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.437 -0.789 . . . . 0.0 110.349 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 15.1 tp -177.62 134.33 0.17 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.047 -1.033 . . . . 0.0 108.713 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.682 ' CD1' ' N ' ' A' ' 105' ' ' TRP . 0.0 OUTLIER -126.25 124.51 40.53 Favored 'General case' 0 N--CA 1.508 2.436 0 O-C-N 120.971 -1.081 . . . . 0.0 110.449 -178.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 1.017 ' HA ' HD13 ' A' ' 27' ' ' LEU . 4.1 p -147.03 -160.6 1.18 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.145 -0.972 . . . . 0.0 111.275 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.436 ' CG ' ' O ' ' A' ' 107' ' ' ASN . 36.7 t30 -108.21 18.81 20.68 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.391 -0.818 . . . . 0.0 110.782 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.56 -37.15 2.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.435 -1.416 . . . . 0.0 110.168 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 111' ' ' ASN . 0.1 OUTLIER -178.68 -86.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 0.0 109.616 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 109' ' ' SER . . . 36.26 -94.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.699 -0.626 . . . . 0.0 109.821 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.518 ' HB2' ' HA ' ' A' ' 105' ' ' TRP . 1.1 m-20 -85.23 -80.98 0.2 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 108.597 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.443 ' HB3' ' OH ' ' A' ' 142' ' ' TYR . 40.8 m-85 -157.42 40.44 0.3 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.0 OUTLIER 61.92 108.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.414 -0.804 . . . . 0.0 109.863 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HB3' ' CB ' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -40.14 -39.39 0.9 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 109.848 179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.446 ' CD1' ' HB3' ' A' ' 38' ' ' ARG . 57.4 t80 -59.44 -46.51 88.54 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.146 -0.971 . . . . 0.0 109.803 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.875 HD12 ' CE2' ' A' ' 142' ' ' TYR . 0.2 OUTLIER -67.6 -54.44 19.76 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.569 -0.707 . . . . 0.0 109.814 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.599 ' CG2' ' HA ' ' A' ' 114' ' ' LEU . 14.2 m -58.78 -50.25 79.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.837 -1.164 . . . . 0.0 109.499 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.82 -43.29 76.81 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.505 -0.747 . . . . 0.0 110.07 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.17 -51.02 63.37 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.608 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 51.9 t60 -55.75 -61.37 2.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.954 -1.091 . . . . 0.0 109.234 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.419 ' HB2' ' HZ ' ' A' ' 99' ' ' PHE . 67.1 mm-40 -63.9 -11.21 25.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.93 . . . . 0.0 109.862 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.545 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 0.8 OUTLIER -88.16 -18.76 28.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.776 -1.203 . . . . 0.0 108.032 179.136 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.38 -43.8 9.18 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 107.178 -2.369 . . . . 0.0 107.178 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 130' ' ' HIS . 0.4 OUTLIER -69.82 -43.24 72.42 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.31 -32.07 2.92 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 122' ' ' PHE . 64.9 mtt -72.97 -80.65 0.07 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -172.03 -40.32 0.04 OUTLIER Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.356 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.77 155.96 7.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.377 -1.072 . . . . 0.0 111.019 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.22 -173.4 2.24 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.302 -0.874 . . . . 0.0 109.697 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.518 ' CD2' ' O ' ' A' ' 138' ' ' MET . 45.7 m170 -52.39 144.19 13.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.621 -0.674 . . . . 0.0 109.55 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 3.9 p -123.75 20.17 9.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.485 -0.759 . . . . 0.0 109.632 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 136' ' ' ALA . 1.2 tp60 54.07 -156.17 0.21 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.281 -0.887 . . . . 0.0 109.325 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 0.6 OUTLIER 66.37 134.99 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -72.72 -41.17 1.64 Allowed 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.311 2.007 . . . . 0.0 110.361 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.86 9.44 52.44 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.686 ' HB2' ' HB3' ' A' ' 133' ' ' ASP . . . -75.73 153.73 36.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.051 -1.264 . . . . 0.0 110.14 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.67 HD13 H382 ' A' ' 800' ' ' I52 . 14.4 tp -85.6 -21.64 28.38 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.518 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -111.97 28.3 8.88 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.293 -0.879 . . . . 0.0 109.841 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -62.01 152.76 76.31 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.32 9.29 2.89 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.933 1.755 . . . . 0.0 110.719 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 142' ' ' TYR . 56.3 mt -122.75 -99.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.008 -1.057 . . . . 0.0 109.366 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.875 ' CE2' HD12 ' A' ' 116' ' ' LEU . 1.3 t80 179.46 144.45 0.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 0.0 110.158 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.568 ' O ' H352 ' A' ' 800' ' ' I52 . 1.6 m -137.46 84.47 2.05 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.463 -0.773 . . . . 0.0 109.32 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -55.28 161.09 1.96 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.56 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 176.82 137.62 0.06 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.643 -0.661 . . . . 0.0 110.28 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.8 -69.82 0.73 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.086 -1.009 . . . . 0.0 108.595 178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 148' ' ' PHE . 42.8 t-20 -51.69 -29.91 19.99 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.496 ' O ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER 59.45 134.46 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.549 ' O ' ' CB ' ' A' ' 150' ' ' LEU . 1.8 tpt180 -113.45 -15.49 12.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.069 -1.019 . . . . 0.0 110.454 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.549 ' CB ' ' O ' ' A' ' 149' ' ' ARG . 0.3 OUTLIER 84.13 -24.84 0.14 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.596 -0.69 . . . . 0.0 109.325 -179.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.629 ' O ' HG23 ' A' ' 155' ' ' ILE . 97.6 p 55.99 132.64 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.937 0.875 . . . . 0.0 110.26 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.64 ' O ' HG13 ' A' ' 155' ' ' ILE . 55.8 mt-30 -73.31 -24.4 60.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.266 -0.896 . . . . 0.0 108.619 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 151' ' ' SER . 0.0 OUTLIER -49.76 -40.83 42.49 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 158' ' ' ILE . 1.4 t70 -83.18 -43.64 15.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 152' ' ' GLN . 1.2 pp -51.08 -34.23 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 157' ' ' GLY . 8.2 tmtt? -73.15 -48.02 38.98 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.113 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' N ' ' HD3' ' A' ' 156' ' ' LYS . . . -72.11 -53.95 8.62 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.723 HD11 ' CE2' ' A' ' 162' ' ' TYR . 10.3 tp -45.61 -51.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -1.183 . . . . 0.0 110.181 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.613 ' N ' HG23 ' A' ' 158' ' ' ILE . 5.4 mt-30 -57.61 -56.93 15.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.681 -1.262 . . . . 0.0 109.144 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -44.53 -25.92 0.31 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.644 -0.66 . . . . 0.0 110.402 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.492 HD11 ' OD1' ' A' ' 12' ' ' ASP . 16.6 tp -97.02 -56.53 2.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.147 -0.971 . . . . 0.0 109.42 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.723 ' CE2' HD11 ' A' ' 158' ' ' ILE . 15.7 m-30 -77.9 -77.38 0.16 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.901 -1.124 . . . . 0.0 108.682 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.452 ' OXT' ' HG2' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.635 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 0.766 ' H61' H251 ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' ' CB ' ' A' ' 2' ' ' TYR . 5.0 mtm . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.167 0.508 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.469 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.2 OUTLIER 75.71 -177.36 0.14 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 0.0 109.307 -179.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 59.9 23.19 12.22 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.269 -0.894 . . . . 0.0 109.585 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.615 ' O ' ' CD2' ' A' ' 5' ' ' PHE . 55.4 m-85 55.41 -124.29 2.06 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.211 -0.931 . . . . 0.0 109.295 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.615 ' CD2' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER 179.76 -58.57 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.676 -1.265 . . . . 0.0 109.861 -179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HD3' ' CB ' ' A' ' 5' ' ' PHE . 32.2 Cg_endo -72.73 124.2 9.56 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.085 1.857 . . . . 0.0 110.635 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.82 19.53 4.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.313 -0.867 . . . . 0.0 108.853 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -96.52 143.74 26.65 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 179.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -76.77 57.16 5.54 Favored 'Trans proline' 0 C--N 1.301 -1.94 0 N-CA-C 108.017 -1.571 . . . . 0.0 108.017 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -57.96 165.53 1.8 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.59 ' CD1' ' HB3' ' A' ' 89' ' ' PRO . 13.0 m95 -84.4 72.58 10.59 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.989 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' N ' ' OD1' ' A' ' 12' ' ' ASP . 5.9 m-20 -122.58 62.94 0.97 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.587 -0.695 . . . . 0.0 109.558 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.843 ' O ' HD21 ' A' ' 49' ' ' LEU . 5.0 mtmt -124.63 -163.55 1.18 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.998 -1.064 . . . . 0.0 109.649 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -109.77 -34.9 6.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.83 . . . . 0.0 108.82 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 15' ' ' GLN . 0.6 OUTLIER -94.14 97.7 10.47 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.497 0.665 . . . . 0.0 109.844 -179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.3 mm -100.94 169.04 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 120.758 -1.214 . . . . 0.0 108.63 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -138.79 134.61 33.66 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.162 -0.961 . . . . 0.0 108.503 179.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 18.0 p90 -135.28 145.18 47.28 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.077 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.511 ' HB2' HG13 ' A' ' 54' ' ' ILE . 2.2 tpt180 -151.21 125.37 9.31 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' N ' ' HD2' ' A' ' 19' ' ' ARG . 1.2 mt -85.56 124.04 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.874 -1.141 . . . . 0.0 109.049 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 64' ' ' ASN . 24.0 mm -53.76 -27.29 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.911 -1.118 . . . . 0.0 109.261 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . 162.38 86.24 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 C-N-CA 119.498 -1.334 . . . . 0.0 109.908 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' CG ' HG11 ' A' ' 32' ' ' VAL . 1.3 p90 -46.73 177.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.567 -0.961 . . . . 0.0 109.203 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -87.94 140.72 31.1 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 120.807 -1.183 . . . . 0.0 109.941 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' LEU . 33.9 Cg_endo -80.09 -23.5 6.46 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.632 2.221 . . . . 0.0 109.762 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 25' ' ' PRO . 12.0 t0 -39.83 -27.52 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.894 -0.504 . . . . 0.0 110.093 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 HD22 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -132.51 170.85 14.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.768 -1.207 . . . . 0.0 110.34 179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.576 ' HB2' ' CB ' ' A' ' 31' ' ' THR . 65.7 m-20 -42.64 133.93 2.82 Favored Pre-proline 0 N--CA 1.487 1.411 0 O-C-N 121.513 -0.742 . . . . 0.0 109.371 179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.537 ' O ' HG12 ' A' ' 32' ' ' VAL . 29.5 Cg_endo -68.67 -31.03 27.03 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 N-CA-C 106.656 -2.094 . . . . 0.0 106.656 179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 30' ' ' GLU . 5.6 mm-40 -76.02 -34.49 59.69 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 177.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.576 ' CB ' ' HB2' ' A' ' 28' ' ' ASP . 17.5 m -69.69 -52.55 24.62 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 118.422 -1.311 . . . . 0.0 108.038 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.69 ' CG2' HD22 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -55.66 -38.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD2' ' CE2' ' A' ' 23' ' ' TYR . 0.4 OUTLIER -74.22 -31.27 62.55 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 22.7 t70 -64.36 -33.77 76.62 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.541 ' CB ' ' HB3' ' A' ' 114' ' ' LEU . . . -50.52 -47.91 57.27 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -71.36 -25.71 62.49 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 34' ' ' ASP . . . -63.9 -64.55 0.86 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -53.76 -39.93 65.78 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.919 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -58.9 -51.12 71.4 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.506 ' O ' ' HB3' ' A' ' 44' ' ' SER . 6.4 t80 -44.19 -49.22 9.21 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' ASP . 22.4 tt0 -70.49 -26.27 63.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 110.032 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -60.9 -33.83 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.041 -1.037 . . . . 0.0 108.509 179.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.919 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.8 OUTLIER -103.04 -55.36 2.43 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.725 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.506 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -49.08 -35.12 15.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.112 -0.993 . . . . 0.0 110.093 -179.032 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 3.6 t0 -62.96 -28.77 70.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.401 -0.812 . . . . 0.0 110.596 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 46' ' ' VAL . 7.8 p -108.72 9.68 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.83 -1.169 . . . . 0.0 109.103 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -149.74 133.63 8.84 Favored Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.52 29.96 0.46 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.764 2.309 . . . . 0.0 111.358 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.843 HD21 ' O ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -85.57 141.39 29.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.02 -1.05 . . . . 0.0 109.652 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.509 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -101.38 121.7 42.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.854 -1.154 . . . . 0.0 109.44 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -94.78 143.2 26.65 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.741 -0.599 . . . . 0.0 109.449 -179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -124.47 141.39 52.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 0.0 109.852 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -99.43 162.39 13.06 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.942 -1.099 . . . . 0.0 108.847 179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.821 HD11 ' CB ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.86 164.78 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 118.707 -1.197 . . . . 0.0 110.02 178.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 2.1 p80 -145.97 38.64 1.09 Allowed 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.415 -179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 55' ' ' HIS . 0.4 OUTLIER 169.04 166.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.427 -0.795 . . . . 0.0 109.819 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 58' ' ' GLU . . . 75.2 -81.14 0.94 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.557 ' O ' HD12 ' A' ' 54' ' ' ILE . 1.3 tp10 178.33 166.24 0.79 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.494 -1.004 . . . . 0.0 108.856 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.821 ' CB ' HD11 ' A' ' 54' ' ' ILE . . . -138.89 146.78 41.55 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.105 -0.997 . . . . 0.0 109.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.59 -57.76 6.57 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.02 -1.05 . . . . 0.0 108.745 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.6 OUTLIER -93.46 116.96 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 120.839 -1.163 . . . . 0.0 109.223 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.517 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 4.8 mtm -113.06 114.01 26.24 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.582 -0.699 . . . . 0.0 109.208 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 63' ' ' ILE . 4.1 mp -98.77 153.14 4.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.139 -0.975 . . . . 0.0 109.839 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 97' ' ' SER . 20.8 p-10 -174.64 -171.47 0.57 Allowed 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.154 -0.966 . . . . 0.0 109.922 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 99' ' ' PHE . 34.5 p90 -116.21 -171.9 2.08 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.487 ' HA3' ' CD2' ' A' ' 98' ' ' HIS . . . -164.64 116.2 0.69 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 119.383 -1.389 . . . . 0.0 110.443 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HD3' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -88.73 -169.65 2.62 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.209 -1.171 . . . . 0.0 108.876 179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -16.53 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.472 -0.767 . . . . 0.0 109.92 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HG3' ' HD3' ' A' ' 67' ' ' ARG . 12.9 mt-10 -76.55 -105.68 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.019 -1.05 . . . . 0.0 110.813 -178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.459 ' CD2' ' OD1' ' A' ' 72' ' ' ASP . 1.2 t-80 56.28 -158.34 0.24 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.862 -1.149 . . . . 0.0 108.751 -178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -167.57 38.11 0.23 Allowed Glycine 0 N--CA 1.488 2.103 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.459 ' OD1' ' CD2' ' A' ' 70' ' ' HIS . 1.3 m-20 -75.86 4.19 8.58 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.468 -1.019 . . . . 0.0 110.283 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 95.6 -42.4 2.32 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.889 -1.148 . . . . 0.0 110.889 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 16.0 p90 -103.19 160.61 25.64 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 120.986 -1.303 . . . . 0.0 110.601 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 74' ' ' TYR . 36.5 Cg_endo -78.85 142.05 17.39 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 122.974 2.45 . . . . 0.0 111.287 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.603 ' HE2' ' HE2' ' A' ' 98' ' ' HIS . 9.1 m-85 -58.34 146.76 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.209 -0.932 . . . . 0.0 109.654 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -74.23 2.66 8.62 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.641 -0.662 . . . . 0.0 109.953 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.04 -161.58 41.78 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 163.72 13.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.016 -1.285 . . . . 0.0 109.438 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 53.72 -170.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 108.698 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.421 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 66.71 -144.32 45.18 Favored Glycine 0 N--CA 1.494 2.52 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.487 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' HG ' H251 ' A' ' 800' ' ' I52 . 0.3 OUTLIER -38.25 127.02 1.37 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.722 -0.869 . . . . 0.0 110.461 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 0.8 OUTLIER -113.59 -23.98 9.47 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . -179.65 162.74 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.717 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -149.45 167.81 25.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -133.72 142.98 48.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.255 -0.903 . . . . 0.0 110.039 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -81.83 169.68 16.59 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.257 -0.902 . . . . 0.0 109.591 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.98 151.92 70.99 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 120.951 -1.093 . . . . 0.0 109.858 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.59 ' HB3' ' CD1' ' A' ' 11' ' ' TRP . 35.6 Cg_endo -79.47 140.62 15.25 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.078 2.519 . . . . 0.0 111.009 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.54 -43.19 1.54 Allowed Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 43.9 p -73.17 159.06 34.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.375 -1.074 . . . . 0.0 109.416 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.34 -16.86 63.28 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 93' ' ' VAL . 74.4 t -103.66 0.73 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -1.23 . . . . 0.0 109.168 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -59.52 159.4 20.94 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 77.91 -6.37 48.7 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 96' ' ' ASP . 0.8 OUTLIER -91.14 130.05 37.07 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.712 -1.463 . . . . 0.0 108.607 179.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.484 ' O ' ' OD1' ' A' ' 64' ' ' ASN . 17.8 m -122.13 142.55 50.28 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.3 -0.875 . . . . 0.0 109.53 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.603 ' HE2' ' HE2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -116.13 122.24 44.49 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.32 -0.862 . . . . 0.0 108.856 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 26.8 m-85 -98.39 145.22 26.94 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.436 ' OD2' ' OE1' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -46.91 163.58 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.145 -0.972 . . . . 0.0 108.933 179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.493 ' HA ' ' CZ2' ' A' ' 105' ' ' TRP . 34.3 t70 -117.61 -18.1 9.79 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.982 -1.074 . . . . 0.0 108.924 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -81.84 -31.41 31.67 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.127 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.436 ' OE1' ' OD2' ' A' ' 100' ' ' ASP . 0.3 OUTLIER -67.13 161.58 24.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.445 -0.784 . . . . 0.0 110.651 -178.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 tp -106.02 106.58 17.15 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.722 -0.611 . . . . 0.0 109.465 -179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -116.15 122.74 45.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.0 108.908 -179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 110' ' ' ALA . 1.2 p -149.13 151.3 34.14 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.803 -1.186 . . . . 0.0 110.574 -179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -111.78 68.59 0.67 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.006 -1.058 . . . . 0.0 110.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.442 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.1 OUTLIER -172.63 77.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.276 -0.89 . . . . 0.0 109.459 179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 108' ' ' THR . 2.4 p 45.67 75.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.464 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 106' ' ' THR . . . -155.77 -158.19 0.79 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -73.47 -114.2 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.0 110.471 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -62.15 146.45 50.57 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 121.067 -1.021 . . . . 0.0 109.843 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 106' ' ' THR . 3.5 m -110.02 110.34 21.22 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.463 -0.773 . . . . 0.0 110.448 -178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.69 HD22 ' CG2' ' A' ' 32' ' ' VAL . 2.1 tp -39.42 -45.62 1.53 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.59 -0.694 . . . . 0.0 110.521 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.471 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 3.7 t80 -54.83 -46.17 74.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.922 -1.111 . . . . 0.0 108.497 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.853 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -62.65 -72.12 0.14 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.41 -0.806 . . . . 0.0 109.697 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.528 HG23 ' N ' ' A' ' 118' ' ' ALA . 17.4 m -45.21 -49.89 2.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.232 -0.918 . . . . 0.0 110.014 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.528 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -54.08 -46.31 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.04 -1.038 . . . . 0.0 109.888 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.456 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -50.72 -58.82 4.97 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.961 -1.087 . . . . 0.0 109.721 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.431 ' CD2' ' CD2' ' A' ' 124' ' ' HIS . 37.6 t60 -42.68 -57.52 2.69 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.502 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.4 -16.4 62.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.954 -1.091 . . . . 0.0 109.546 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.701 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.6 OUTLIER -81.98 -3.46 54.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 0.0 108.24 178.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.13 -41.38 1.41 Allowed Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.942 -2.063 . . . . 0.0 107.942 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.431 ' CD2' ' CD2' ' A' ' 120' ' ' HIS . 31.4 m-70 -64.09 -32.01 73.42 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -47.38 -26.7 1.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.506 -0.746 . . . . 0.0 109.36 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.02 6.84 46.51 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.175 -0.953 . . . . 0.0 109.747 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 88.67 -8.65 78.7 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.609 HD21 ' HA3' ' A' ' 157' ' ' GLY . 5.7 mt -44.73 151.36 0.29 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.194 -1.18 . . . . 0.0 110.438 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 27.3 mp0 -111.6 176.05 5.18 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -80.46 169.95 17.02 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.324 -0.86 . . . . 0.0 110.152 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.8 OUTLIER -115.07 -22.97 9.25 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.526 -0.734 . . . . 0.0 109.785 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.542 ' HB2' ' O ' ' A' ' 131' ' ' SER . 9.3 mm100 82.99 -21.72 0.27 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.691 -0.631 . . . . 0.0 110.707 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 0.6 OUTLIER -74.66 152.41 87.24 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.877 -178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.26 -39.54 3.82 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.5 2.134 . . . . 0.0 110.356 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.33 2.14 62.95 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.99 149.09 34.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.136 -1.214 . . . . 0.0 110.18 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.916 HD13 H362 ' A' ' 800' ' ' I52 . 18.1 tp -80.38 -23.25 40.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.507 -0.746 . . . . 0.0 109.188 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.43 ' HA ' ' CE1' ' A' ' 120' ' ' HIS . 1.1 mpt? -109.87 26.22 10.9 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.608 ' HB1' ' HD2' ' A' ' 140' ' ' PRO . . . -58.73 164.85 3.68 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.305 -0.872 . . . . 0.0 109.178 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 139' ' ' ALA . 34.4 Cg_endo -78.69 17.18 1.16 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.465 2.11 . . . . 0.0 111.195 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 142' ' ' TYR . 15.5 mt -140.66 162.11 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.787 -1.196 . . . . 0.0 110.07 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.635 ' CZ ' HD12 ' A' ' 116' ' ' LEU . 16.7 t80 -91.68 118.84 31.02 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.477 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 144' ' ' TYR . 0.2 OUTLIER -108.8 -48.81 3.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.479 -0.763 . . . . 0.0 110.281 -178.917 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.853 ' HA ' HD11 ' A' ' 116' ' ' LEU . 58.7 t80 60.93 165.87 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.067 -1.021 . . . . 0.0 109.999 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.584 ' N ' ' CG ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -154.69 152.6 30.12 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.659 -0.651 . . . . 0.0 109.271 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 146' ' ' LYS . 6.8 tptm -92.03 -11.62 35.42 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.573 ' O ' ' CB ' ' A' ' 148' ' ' PHE . 12.2 m-80 -126.53 -91.98 0.51 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.657 ' CZ ' ' HB2' ' A' ' 150' ' ' LEU . 6.2 t80 156.93 149.36 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.13 -0.981 . . . . 0.0 109.724 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -150.95 -40.53 0.12 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.288 -0.883 . . . . 0.0 110.364 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.657 ' HB2' ' CZ ' ' A' ' 148' ' ' PHE . 9.6 tp 65.6 144.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.018 -1.051 . . . . 0.0 109.495 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -114.84 131.56 56.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.887 . . . . 0.0 109.64 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.586 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 12.3 tt0 -48.95 -22.66 0.9 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.278 -0.889 . . . . 0.0 109.638 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.48 -48.6 78.79 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.888 -1.132 . . . . 0.0 108.088 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -73.58 -33.77 64.8 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.665 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -70.17 -27.53 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.181 -0.95 . . . . 0.0 109.365 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.502 ' HA ' ' HG2' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -76.56 -46.62 25.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.345 -0.847 . . . . 0.0 110.455 -179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.609 ' HA3' HD21 ' A' ' 128' ' ' LEU . . . -71.64 -23.12 78.43 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 159' ' ' GLN . 6.5 tp -81.0 -39.74 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.838 -1.389 . . . . 0.0 108.449 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 156' ' ' LYS . 0.9 OUTLIER -68.61 -22.45 64.44 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.491 ' N ' ' HG3' ' A' ' 159' ' ' GLN . 0.8 OUTLIER -86.13 -25.06 25.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.465 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 161' ' ' LEU . 0.1 OUTLIER -80.02 -22.23 42.67 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.497 ' CG ' HD11 ' A' ' 49' ' ' LEU . 30.3 m-85 -120.3 -69.05 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 0.0 108.999 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 0.916 H362 HD13 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' CG ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.455 0.645 . . . . 0.0 110.274 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 2' ' ' TYR . 10.5 t80 -101.08 -29.94 11.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.065 -1.022 . . . . 0.0 109.11 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -102.16 -167.04 1.35 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.301 -0.874 . . . . 0.0 109.001 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -141.02 108.1 5.46 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.821 -1.174 . . . . 0.0 109.465 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 51.59 81.85 0.25 Allowed Pre-proline 0 C--N 1.303 -1.414 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.491 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -77.92 41.58 1.03 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.229 1.953 . . . . 0.0 110.821 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -142.32 -154.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.046 -1.034 . . . . 0.0 109.845 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' CG ' ' O ' ' A' ' 7' ' ' ARG . 5.4 mttt -176.98 163.28 1.54 Allowed Pre-proline 0 N--CA 1.498 1.949 0 O-C-N 120.879 -1.138 . . . . 0.0 109.731 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' LYS . 36.3 Cg_endo -79.87 66.78 8.77 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.149 1.899 . . . . 0.0 108.632 178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.596 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 9.1 mtpt -41.7 -93.07 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.562 -0.711 . . . . 0.0 109.615 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.596 ' CG ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER 174.86 45.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.929 -1.107 . . . . 0.0 110.354 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.485 ' HB3' ' CE1' ' A' ' 162' ' ' TYR . 12.9 p-10 -144.57 84.52 1.74 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.467 -1.395 . . . . 0.0 111.329 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -115.95 49.11 1.14 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.034 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 9.8 m-20 65.34 -69.63 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' LYS . 4.2 mt-30 -80.67 110.35 16.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.995 -1.066 . . . . 0.0 109.103 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 52' ' ' SER . 1.1 mm -104.18 164.72 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.126 -0.984 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.595 ' O ' ' CG1' ' A' ' 61' ' ' ILE . 0.1 OUTLIER -128.2 137.55 52.09 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.758 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.634 ' O ' HG22 ' A' ' 54' ' ' ILE . 13.2 p90 -149.15 154.3 38.97 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 110.043 -178.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.88 ' HB2' HG23 ' A' ' 54' ' ' ILE . 0.6 OUTLIER -147.53 125.43 11.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.346 -0.847 . . . . 0.0 109.865 -178.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 22' ' ' GLY . 3.4 mt -86.02 124.58 40.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 64' ' ' ASN . 2.8 mt -74.18 3.94 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 120.89 -1.131 . . . . 0.0 110.43 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.618 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 145.42 112.56 0.79 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -61.63 -161.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.113 -1.228 . . . . 0.0 107.788 179.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 HG23 HD11 ' A' ' 27' ' ' LEU . 1.8 t -106.84 137.38 19.48 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.858 -1.151 . . . . 0.0 108.121 178.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -76.59 -24.74 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.206 1.938 . . . . 0.0 110.254 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.26 -24.83 3.14 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.763 -0.586 . . . . 0.0 110.159 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 105' ' ' TRP . 1.0 OUTLIER -138.47 177.0 8.21 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.878 -1.139 . . . . 0.0 111.002 -178.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.652 ' O ' HG22 ' A' ' 32' ' ' VAL . 74.8 m-20 -53.87 129.51 56.45 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.649 -0.657 . . . . 0.0 110.436 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.764 ' HA ' HG23 ' A' ' 32' ' ' VAL . 27.0 Cg_endo -73.79 -33.65 6.18 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 N-CA-C 105.394 -2.579 . . . . 0.0 105.394 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -62.72 -36.24 82.36 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 34' ' ' ASP . 1.7 m -66.27 -71.48 0.19 Allowed 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 177.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.764 HG23 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -41.32 -28.79 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.388 -0.82 . . . . 0.0 108.981 178.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 31' ' ' THR . 0.5 OUTLIER -72.47 -38.37 68.23 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.578 ' N ' ' O ' ' A' ' 31' ' ' THR . 24.2 t0 -79.89 -58.57 3.11 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.529 ' HB2' ' HB2' ' A' ' 107' ' ' ASN . . . -36.77 -39.4 0.21 Allowed 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.642 0.734 . . . . 0.0 109.034 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HE2' HG21 ' A' ' 63' ' ' ILE . 3.6 m-85 -68.26 -65.78 0.65 Allowed 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -44.52 -51.02 9.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.969 . . . . 0.0 109.773 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 41' ' ' GLN . 0.8 OUTLIER -59.26 -52.5 65.4 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.22 -0.925 . . . . 0.0 110.079 -179.269 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -43.91 -52.57 6.77 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 44' ' ' SER . 0.2 OUTLIER -46.38 -40.91 12.79 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -71.56 -20.33 62.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.546 -0.721 . . . . 0.0 110.591 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 39' ' ' ALA . 0.4 OUTLIER -86.47 -32.54 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.259 -1.526 . . . . 0.0 109.196 -179.874 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.6 ' CH2' ' HA2' ' A' ' 123' ' ' GLY . 3.7 m95 -91.13 -19.01 23.56 Favored 'General case' 0 N--CA 1.499 2.001 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.626 ' HB2' ' CE1' ' A' ' 40' ' ' PHE . 28.9 t -91.37 -23.04 20.19 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 41' ' ' GLN . 8.4 m-20 -65.34 -5.55 7.66 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.245 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.665 ' CG2' ' HB ' ' A' ' 155' ' ' ILE . 12.2 p -120.49 4.8 6.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.535 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 7.9 t -159.08 149.05 15.16 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.598 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 36.8 Cg_endo -79.11 49.59 3.21 Favored 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 122.337 2.025 . . . . 0.0 109.856 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' A' ' 162' ' ' TYR . 4.8 tp -93.67 150.56 20.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.3 -0.875 . . . . 0.0 109.75 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 -122.95 136.79 54.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 109.073 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 51' ' ' PHE . 6.7 m-85 -112.56 149.72 32.33 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.929 -1.107 . . . . 0.0 110.183 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.4 OUTLIER -125.11 126.68 45.7 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.324 -0.86 . . . . 0.0 110.208 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 53' ' ' ARG . 6.0 mtm-85 -77.97 126.73 31.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.194 -0.941 . . . . 0.0 108.481 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.88 HG23 ' HB2' ' A' ' 19' ' ' ARG . 0.9 OUTLIER -113.64 141.07 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.175 -0.953 . . . . 0.0 109.223 -179.706 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.509 ' N ' ' CD2' ' A' ' 55' ' ' HIS . 4.5 m170 -72.44 -145.14 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -79.53 -174.13 4.1 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.183 -0.948 . . . . 0.0 108.636 178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 93.63 42.64 4.13 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 64.43 160.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.43 -1.041 . . . . 0.0 109.203 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.502 ' CB ' ' HB3' ' A' ' 19' ' ' ARG . . . -153.46 148.94 27.23 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.37 -0.831 . . . . 0.0 109.475 -179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 0.2 OUTLIER -53.55 -59.97 3.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.238 -0.914 . . . . 0.0 108.802 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -104.57 124.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 106.949 -1.501 . . . . 0.0 106.949 178.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.48 ' O ' ' HA ' ' A' ' 96' ' ' ASP . 74.9 mtp -111.96 113.88 26.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.746 -1.221 . . . . 0.0 110.987 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.489 ' CG2' ' N ' ' A' ' 64' ' ' ASN . 1.6 mp -102.71 159.7 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.648 ' HB3' HD12 ' A' ' 21' ' ' ILE . 7.8 p-10 174.99 -168.79 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.175 0 O-C-N 121.445 -0.784 . . . . 0.0 109.397 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -115.41 175.67 5.41 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 0.0 109.175 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.63 90.88 0.27 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' O ' ' O ' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -71.87 -145.99 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.257 -1.143 . . . . 0.0 108.059 179.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.405 ' O ' ' O ' ' A' ' 67' ' ' ARG . 5.4 m95 -63.22 -147.11 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.485 -1.385 . . . . 0.0 108.648 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 47.79 -143.54 0.4 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.03 -1.044 . . . . 0.0 109.927 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 68.02 156.47 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . -130.72 23.94 4.4 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.3 74.95 0.09 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.462 -1.022 . . . . 0.0 108.99 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 63.48 -87.51 0.06 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.584 -1.806 . . . . 0.0 108.584 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' N ' ' CD1' ' A' ' 74' ' ' TYR . 3.1 m-85 -108.71 117.98 52.87 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.294 -1.121 . . . . 0.0 108.713 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.52 158.38 40.19 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.68 1.586 . . . . 0.0 109.916 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.524 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 17.8 t80 62.64 -87.49 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.48 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.524 ' CB ' ' O ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER 80.95 -46.17 0.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.58 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.15 -157.56 23.38 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 ptmt -57.31 165.5 1.43 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.223 -1.163 . . . . 0.0 108.826 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 80' ' ' ASP . 3.3 m-20 43.69 -165.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.229 -0.919 . . . . 0.0 111.135 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 82' ' ' LEU . . . 61.17 -142.32 48.4 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.46 ' HB3' ' OD2' ' A' ' 77' ' ' ASP . 0.9 OUTLIER -40.08 106.83 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.655 -0.909 . . . . 0.0 109.347 179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.701 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 1.8 mt -111.21 -26.92 8.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.124 -0.985 . . . . 0.0 109.603 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.701 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 165.05 152.93 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.414 -0.804 . . . . 0.0 109.385 -179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.677 ' HA ' ' H2 ' ' A' ' 800' ' ' I52 . 34.1 p80 -152.24 177.05 10.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.411 -0.806 . . . . 0.0 108.961 179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -140.22 155.92 46.7 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.174 -0.954 . . . . 0.0 108.775 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 156.22 16.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.317 -0.865 . . . . 0.0 110.078 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.624 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -72.27 162.47 73.58 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.624 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 30.2 Cg_endo -73.75 136.76 23.72 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.807 2.338 . . . . 0.0 111.112 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.66 -165.82 28.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.5 m -86.48 117.96 25.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.354 -1.086 . . . . 0.0 110.339 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.64 -89.81 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 93' ' ' VAL . 32.6 m -71.32 119.11 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.082 -1.246 . . . . 0.0 109.065 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.39 158.65 8.08 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.75 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 67.27 6.9 42.42 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' MET . 2.7 m-20 -97.98 140.83 31.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.171 -1.194 . . . . 0.0 109.836 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.8 131.15 25.13 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.067 -1.02 . . . . 0.0 109.769 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.557 ' N ' ' CD2' ' A' ' 98' ' ' HIS . 1.9 m170 -106.32 135.5 47.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.029 -1.044 . . . . 0.0 109.309 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 118' ' ' ALA . 58.9 m-85 -96.52 158.83 15.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.375 -0.828 . . . . 0.0 110.457 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CG ' ' HA ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -55.43 129.42 38.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.698 -0.627 . . . . 0.0 109.683 179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -94.14 -70.27 0.71 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 22.3 p-10 -60.7 86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.25 -0.906 . . . . 0.0 110.592 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -179.48 179.14 0.63 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.123 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.532 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 63.8 tp -119.32 100.77 7.52 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.906 -1.121 . . . . 0.0 109.385 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.761 ' O ' HD23 ' A' ' 27' ' ' LEU . 24.4 m0 -112.45 173.91 6.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.246 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.716 HG22 ' C ' ' A' ' 105' ' ' TRP . 0.5 OUTLIER 179.62 162.65 0.93 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.969 -1.082 . . . . 0.0 110.165 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.565 ' HB3' HG23 ' A' ' 31' ' ' THR . 2.1 t-20 -104.84 21.74 16.44 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.357 -0.839 . . . . 0.0 109.869 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.5 ' O ' ' N ' ' A' ' 110' ' ' ALA . 0.0 OUTLIER -124.01 -179.7 4.51 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.512 179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.454 ' N ' ' OG1' ' A' ' 108' ' ' THR . 8.1 t -66.69 69.06 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.377 -179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 106' ' ' THR . . . -160.41 115.96 2.3 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.424 -0.798 . . . . 0.0 109.104 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 104' ' ' LEU . 3.9 t-20 64.96 -150.3 0.26 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.443 -0.786 . . . . 0.0 108.984 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.48 ' HD2' ' CD1' ' A' ' 105' ' ' TRP . 42.3 m-85 -67.88 -147.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.949 -1.094 . . . . 0.0 108.4 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 106' ' ' THR . 22.4 t -148.71 98.64 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.061 -1.024 . . . . 0.0 109.715 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 106' ' ' THR . 0.1 OUTLIER -35.69 -57.97 0.63 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.384 -0.822 . . . . 0.0 111.286 -179.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 115' ' ' PHE . 0.1 OUTLIER -49.66 -40.57 40.25 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.168 -0.958 . . . . 0.0 109.792 -178.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.013 HD11 ' H33' ' A' ' 800' ' ' I52 . 3.0 tm? -70.36 -55.14 9.83 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.554 -0.716 . . . . 0.0 110.521 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 118' ' ' ALA . 35.7 m -58.36 -48.63 84.53 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 O-C-N 120.437 -1.414 . . . . 0.0 108.057 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 99' ' ' PHE . . . -46.56 -52.37 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.94 -1.1 . . . . 0.0 109.064 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 122' ' ' PHE . . . -45.03 -54.53 6.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 108.605 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.552 ' CE1' ' HE2' ' A' ' 138' ' ' MET . 43.8 t60 -46.48 -64.63 0.71 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.102 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.506 ' OE1' ' HA ' ' A' ' 121' ' ' GLU . 66.3 mm-40 -63.23 -15.34 56.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.049 -1.032 . . . . 0.0 109.772 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 119' ' ' ALA . 1.6 m-85 -82.12 -10.61 59.13 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.6 ' HA2' ' CH2' ' A' ' 43' ' ' TRP . . . -99.31 -48.38 1.71 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.435 ' CD2' ' O1 ' ' A' ' 800' ' ' I52 . 12.8 m-70 -55.93 -40.54 73.27 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.381 -1.07 . . . . 0.0 108.856 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -69.31 -4.66 18.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.465 -0.772 . . . . 0.0 109.554 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.482 ' HG2' ' OH ' ' A' ' 162' ' ' TYR . 26.7 mtt -103.04 -14.84 16.29 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.276 -0.89 . . . . 0.0 110.902 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 118.22 -11.67 12.91 Favored Glycine 0 N--CA 1.499 2.86 0 O-C-N 120.677 -1.264 . . . . 0.0 110.678 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.512 HD12 ' CH2' ' A' ' 43' ' ' TRP . 30.9 mt -81.07 138.53 35.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.897 -1.355 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.39 178.27 4.36 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.156 -0.965 . . . . 0.0 109.746 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 138' ' ' MET . 50.4 m170 -55.53 148.28 16.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.386 -0.821 . . . . 0.0 110.247 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 39.4 p -112.39 -173.14 2.18 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -108.03 -14.46 14.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.004 -1.06 . . . . 0.0 109.715 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -70.04 134.72 87.46 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 133' ' ' ASP . 33.2 Cg_endo -79.51 109.84 2.55 Favored 'Trans proline' 0 C--N 1.318 -1.053 0 C-N-CA 123.056 2.504 . . . . 0.0 110.115 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.78 -2.77 17.48 Favored Glycine 0 C--N 1.273 -2.963 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.11 170.7 1.53 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.353 -1.086 . . . . 0.0 109.406 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.875 HD13 H362 ' A' ' 800' ' ' I52 . 8.3 tp -84.68 -25.86 28.15 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.782 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.597 ' O ' ' CD2' ' A' ' 130' ' ' HIS . 2.9 mmt -97.79 4.23 49.84 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 120.989 -1.069 . . . . 0.0 110.865 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.462 ' C ' ' O ' ' A' ' 138' ' ' MET . . . -41.69 156.75 0.22 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 120.978 -1.076 . . . . 0.0 109.31 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.13 2.37 7.71 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.426 2.084 . . . . 0.0 111.574 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.46 160.94 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.915 -1.116 . . . . 0.0 108.196 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.557 ' O ' ' CB ' ' A' ' 143' ' ' THR . 75.0 t80 -56.52 -82.28 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.563 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.557 ' CB ' ' O ' ' A' ' 142' ' ' TYR . 3.2 m 81.59 -33.56 0.1 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.039 -1.038 . . . . 0.0 111.792 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.532 ' O ' H352 ' A' ' 800' ' ' I52 . 3.0 t80 71.59 175.23 0.29 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.686 -1.259 . . . . 0.0 109.426 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.916 ' HA ' H372 ' A' ' 800' ' ' I52 . 4.6 p -85.34 4.28 35.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.107 -0.996 . . . . 0.0 109.119 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.602 ' O ' ' CB ' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 46.99 47.73 15.7 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.232 -0.917 . . . . 0.0 110.435 179.42 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 146' ' ' LYS . 2.4 t30 89.16 21.04 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.619 ' N ' ' OG1' ' A' ' 145' ' ' THR . 48.7 t80 52.34 164.82 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.591 0.71 . . . . 0.0 109.938 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.567 ' N ' ' CG ' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 165.2 -22.78 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.123 -0.986 . . . . 0.0 109.61 -178.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.535 HD23 ' CE1' ' A' ' 148' ' ' PHE . 0.2 OUTLIER 69.01 123.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.227 -0.921 . . . . 0.0 108.881 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -107.62 134.99 49.82 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.032 -1.042 . . . . 0.0 110.668 -178.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 0.4 OUTLIER -50.61 -19.99 1.07 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -57.38 -56.06 26.78 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.688 -1.257 . . . . 0.0 108.055 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.638 ' OD2' HD23 ' A' ' 137' ' ' LEU . 4.2 t0 -68.46 -32.13 71.91 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.276 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.68 ' C ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.29 -37.39 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.235 -0.916 . . . . 0.0 108.603 179.461 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 155' ' ' ILE . 8.4 tmtt? -61.73 -49.32 76.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.304 -0.873 . . . . 0.0 109.39 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -68.25 -39.83 87.84 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 110.08 -1.208 . . . . 0.0 110.08 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 155' ' ' ILE . 2.7 tp -66.17 -17.65 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.841 -1.388 . . . . 0.0 110.359 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.453 ' O ' ' N ' ' A' ' 163' ' ' GLY . 66.0 mt-30 -87.82 -49.02 7.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.092 . . . . 0.0 109.282 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.13 -13.63 62.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.45 -0.781 . . . . 0.0 109.278 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 157' ' ' GLY . 0.1 OUTLIER -101.76 -42.3 6.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.839 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' A' ' 49' ' ' LEU . 21.8 m-30 -107.17 -13.21 15.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.794 -1.191 . . . . 0.0 110.312 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.366 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 1.013 ' H33' HD11 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ptt? . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 67.16 132.35 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.321 -0.862 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.66 -161.59 1.34 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.413 -0.804 . . . . 0.0 109.001 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' O ' ' C ' ' A' ' 5' ' ' PHE . 4.3 t80 -102.12 26.76 7.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.114 -0.991 . . . . 0.0 108.697 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 4' ' ' PHE . 25.5 m-85 42.86 84.31 0.19 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.475 -0.766 . . . . 0.0 109.32 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.33 -85.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.569 2.179 . . . . 0.0 110.364 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.1 OUTLIER 44.35 -165.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.247 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 7' ' ' ARG . 0.0 OUTLIER -44.74 161.86 0.22 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.567 -0.708 . . . . 0.0 109.441 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 10' ' ' LYS . 36.7 Cg_endo -80.49 55.09 5.52 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.378 2.052 . . . . 0.0 107.58 178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.514 ' HE2' ' CG ' ' A' ' 89' ' ' PRO . 0.1 OUTLIER 60.35 128.25 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.473 ' C ' ' O ' ' A' ' 10' ' ' LYS . 14.6 m95 -37.5 110.64 0.13 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.56 -0.712 . . . . 0.0 110.338 -178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 1.7 p-10 -128.81 54.44 1.78 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.354 -0.841 . . . . 0.0 109.691 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -108.84 -167.59 1.24 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.348 -0.845 . . . . 0.0 109.287 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' N ' ' A' ' 14' ' ' ASN . 0.5 OUTLIER -108.57 -41.7 4.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.311 -0.868 . . . . 0.0 109.023 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.462 ' HG2' ' HG2' ' A' ' 50' ' ' ARG . 19.3 mt-30 -92.92 116.77 29.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.071 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 52' ' ' SER . 0.5 OUTLIER -111.45 161.07 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.039 -1.038 . . . . 0.0 109.595 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 52' ' ' SER . 4.3 p -131.69 126.07 33.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 109.397 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 53' ' ' ARG . 34.1 p90 -137.05 148.53 46.85 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.608 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.768 ' HG2' ' HB3' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -144.33 140.85 29.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.075 179.575 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.966 HD13 ' CE1' ' A' ' 23' ' ' TYR . 2.2 mp -92.89 161.45 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 0.0 109.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -108.38 -39.72 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.214 -0.929 . . . . 0.0 109.412 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 23' ' ' TYR . . . -161.58 94.12 0.12 Allowed Glycine 0 N--CA 1.488 2.143 0 C-N-CA 119.336 -1.412 . . . . 0.0 110.222 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.966 ' CE1' HD13 ' A' ' 20' ' ' ILE . 15.5 m-85 -45.74 172.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -1.183 . . . . 0.0 108.962 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.587 ' CG2' HD11 ' A' ' 27' ' ' LEU . 9.9 t -97.98 145.41 29.74 Favored Pre-proline 0 C--N 1.302 -1.477 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.429 ' HD2' ' OG1' ' A' ' 24' ' ' THR . 34.2 Cg_endo -78.29 -28.69 4.47 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 C-N-CA 122.313 2.009 . . . . 0.0 111.22 -178.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.496 ' OD2' HG22 ' A' ' 106' ' ' THR . 3.9 t70 -41.56 -28.49 0.13 Allowed 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.649 -0.657 . . . . 0.0 109.868 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 106' ' ' THR . 0.4 OUTLIER -133.33 179.68 6.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.077 -1.014 . . . . 0.0 110.037 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.722 ' O ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -73.6 152.27 89.48 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.356 -0.84 . . . . 0.0 111.245 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.773 ' HA ' HG23 ' A' ' 32' ' ' VAL . 26.5 Cg_endo -67.08 -32.61 34.02 Favored 'Trans proline' 0 C--N 1.316 -1.137 0 C-N-CA 122.872 2.381 . . . . 0.0 105.971 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -68.48 -31.95 71.6 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 175.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.579 HG23 ' HB3' ' A' ' 107' ' ' ASN . 1.4 m -72.84 -69.39 0.42 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.836 HG13 HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -40.97 -31.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.452 -0.78 . . . . 0.0 109.052 178.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 33' ' ' ASP . 4.6 t0 -79.84 -33.05 40.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 108.981 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.575 ' N ' ' O ' ' A' ' 31' ' ' THR . 21.7 t70 -78.93 -44.88 21.67 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.917 . . . . 0.0 108.589 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' A' ' 114' ' ' LEU . . . -44.62 -48.9 10.46 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 17.1 m-30 -71.44 -44.99 63.81 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.405 -0.81 . . . . 0.0 108.934 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 40' ' ' PHE . . . -51.37 -54.17 29.09 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -53.32 -42.47 66.72 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.796 ' HB1' ' CH2' ' A' ' 43' ' ' TRP . . . -56.54 -49.67 74.11 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.492 ' O ' ' HB3' ' A' ' 44' ' ' SER . 10.1 t80 -47.22 -33.76 5.74 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.457 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -86.81 -24.05 25.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.712 -0.617 . . . . 0.0 109.72 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.674 HG13 ' CD1' ' A' ' 43' ' ' TRP . 0.3 OUTLIER -59.59 -35.34 58.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.258 -0.902 . . . . 0.0 108.851 -179.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.796 ' CH2' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -105.96 -49.66 3.34 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.454 -0.779 . . . . 0.0 110.104 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.492 ' HB3' ' O ' ' A' ' 40' ' ' PHE . 48.2 t -53.83 -21.7 8.11 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.178 -0.951 . . . . 0.0 110.639 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 6.2 m-20 -67.12 -13.89 62.38 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.154 -0.966 . . . . 0.0 110.138 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.878 HG23 HG23 ' A' ' 47' ' ' THR . 32.8 m -122.01 -20.83 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 0.0 110.434 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.878 HG23 HG23 ' A' ' 46' ' ' VAL . 54.0 p -122.58 143.8 40.77 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.938 -1.101 . . . . 0.0 109.405 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -74.05 57.99 4.08 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.097 1.864 . . . . 0.0 108.945 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.805 HD21 ' HB3' ' A' ' 162' ' ' TYR . 3.0 mm? -84.64 144.84 28.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.904 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.462 ' HG2' ' HG2' ' A' ' 15' ' ' GLN . 9.3 tpm_? -116.6 66.64 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 108.778 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 49' ' ' LEU . 47.2 m-85 -59.5 148.68 32.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.309 -0.869 . . . . 0.0 108.92 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' THR . 3.4 t -139.32 106.65 5.52 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 110.522 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 18' ' ' TYR . 2.3 ptt85 -76.6 126.57 31.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.977 -1.077 . . . . 0.0 108.752 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.88 HD11 ' HA ' ' A' ' 59' ' ' ALA . 6.3 pt -117.95 166.37 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.937 -1.102 . . . . 0.0 109.794 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 55' ' ' HIS . 9.7 p80 -154.01 70.76 0.83 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.31 -0.869 . . . . 0.0 110.071 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.44 6.01 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.725 -1.235 . . . . 0.0 109.824 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.517 ' O ' ' CG ' ' A' ' 58' ' ' GLU . . . 106.76 32.72 3.5 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.517 ' CG ' ' O ' ' A' ' 57' ' ' GLY . 0.6 OUTLIER 172.18 158.35 0.1 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.178 -1.189 . . . . 0.0 109.701 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.88 ' HA ' HD11 ' A' ' 54' ' ' ILE . . . 178.95 143.04 0.12 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.477 -0.764 . . . . 0.0 109.034 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -51.56 -57.38 9.25 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.404 -0.81 . . . . 0.0 109.077 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.88 HG23 ' O ' ' A' ' 95' ' ' GLY . 9.8 mt -90.51 153.91 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.169 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.605 ' C ' HD12 ' A' ' 63' ' ' ILE . 2.7 mtt -147.35 118.2 7.62 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.398 -0.813 . . . . 0.0 109.776 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.813 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.0 mp -105.82 148.95 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.185 -0.947 . . . . 0.0 109.327 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' OD1' ' HB ' ' A' ' 21' ' ' ILE . 5.8 t30 176.44 -156.25 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.249 0 O-C-N 121.225 -0.922 . . . . 0.0 109.274 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -127.43 171.21 11.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.289 -0.882 . . . . 0.0 108.905 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -143.52 86.52 0.18 Allowed Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.016 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 68' ' ' TRP . 1.4 ptt85 -78.26 -160.0 0.19 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.099 -1.236 . . . . 0.0 109.686 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.541 ' C ' ' CE3' ' A' ' 68' ' ' TRP . 0.0 OUTLIER -42.95 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.256 -0.903 . . . . 0.0 110.562 -179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' TRP . 0.6 OUTLIER -36.74 95.23 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.58 -0.7 . . . . 0.0 110.374 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' TRP . 2.2 t-80 -168.57 -61.58 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 76.77 -2.66 58.72 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 74' ' ' TYR . 4.1 p-10 -56.1 83.03 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.255 0 O-C-N 121.155 -1.203 . . . . 0.0 110.13 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 61.18 -75.32 0.01 OUTLIER Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 72' ' ' ASP . 24.3 m-85 -100.69 137.11 19.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.035 -1.274 . . . . 0.0 110.146 -179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -78.15 -157.99 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.576 2.184 . . . . 0.0 109.221 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -80.63 140.66 35.59 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.134 . . . . 0.0 109.153 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 82' ' ' LEU . 40.2 p-10 -116.19 -15.6 11.05 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.05 -154.43 33.6 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' ASP . 1.1 mttt -47.25 154.6 0.38 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.21 -1.171 . . . . 0.0 110.843 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 79' ' ' LYS . 15.6 m-20 49.5 -177.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.621 -0.674 . . . . 0.0 110.18 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 76.39 -144.97 31.24 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 77' ' ' ASP . 28.6 tp -40.27 116.61 0.69 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.493 -1.004 . . . . 0.0 110.022 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.612 HD23 ' OE1' ' A' ' 103' ' ' GLU . 57.8 mt -112.02 -28.16 8.12 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 83' ' ' LEU . . . 176.47 147.98 0.11 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.304 -0.872 . . . . 0.0 109.771 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.438 ' O ' ' HA ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -150.16 179.52 8.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.952 . . . . 0.0 110.014 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 96' ' ' ASP . . . -148.13 158.23 43.95 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.484 -0.76 . . . . 0.0 108.993 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.46 155.73 18.22 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.226 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.523 ' O ' ' CA ' ' A' ' 94' ' ' GLY . . . -55.51 155.14 10.75 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.906 . . . . 0.0 109.579 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.514 ' CG ' ' HE2' ' A' ' 10' ' ' LYS . 33.5 Cg_endo -75.2 141.41 26.03 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.761 2.307 . . . . 0.0 110.436 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 179.9 177.48 48.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -76.96 114.18 15.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.237 . . . . 0.0 109.236 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 99.78 -85.51 0.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.16 156.3 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.278 -1.131 . . . . 0.0 108.928 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.523 ' CA ' ' O ' ' A' ' 88' ' ' ALA . . . 109.69 156.22 16.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG23 ' A' ' 61' ' ' ILE . . . 74.83 -0.54 57.11 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -98.83 137.83 36.84 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.872 -1.369 . . . . 0.0 109.118 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 86' ' ' ALA . 0.6 OUTLIER -132.26 130.85 41.45 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.302 -0.874 . . . . 0.0 109.905 -179.532 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.9 m80 -111.66 133.79 53.67 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.312 -0.867 . . . . 0.0 108.828 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.609 ' HB2' ' CZ2' ' A' ' 105' ' ' TRP . 3.7 m-30 -95.95 159.8 14.79 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.544 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.483 ' CB ' ' OE1' ' A' ' 103' ' ' GLU . 1.6 t70 -58.83 136.81 57.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 109.359 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -83.92 -9.2 58.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.229 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.5 -42.19 12.95 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.442 -0.786 . . . . 0.0 109.742 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.612 ' OE1' HD23 ' A' ' 83' ' ' LEU . 3.1 mp0 -72.7 140.93 48.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.74 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 104' ' ' LEU . 1.1 mp -105.21 128.18 53.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.427 -0.795 . . . . 0.0 109.277 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.609 ' CZ2' ' HB2' ' A' ' 99' ' ' PHE . 1.9 m-90 -101.01 166.56 10.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.847 ' HA ' HD23 ' A' ' 27' ' ' LEU . 82.6 p -149.46 -168.3 3.07 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.056 -179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.579 ' HB3' HG23 ' A' ' 31' ' ' THR . 2.6 p30 -135.2 6.33 3.32 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.564 -0.71 . . . . 0.0 109.128 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 109' ' ' SER . 11.1 t -139.22 -152.53 0.42 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.237 -0.915 . . . . 0.0 109.98 -179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 108' ' ' THR . 0.0 OUTLIER -86.91 108.77 18.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.4 -0.813 . . . . 0.0 108.87 179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -159.8 -97.95 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.262 -0.899 . . . . 0.0 109.188 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.79 -78.05 0.59 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.112 -0.992 . . . . 0.0 109.069 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.501 ' HB3' ' HA ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -100.92 -156.15 0.54 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.127 -0.983 . . . . 0.0 109.073 179.381 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 106' ' ' THR . 0.5 OUTLIER -164.61 114.63 1.17 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.965 -1.084 . . . . 0.0 110.123 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.73 ' CD2' HG12 ' A' ' 32' ' ' VAL . 8.4 tp -50.16 -70.24 0.09 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.5 -0.75 . . . . 0.0 110.318 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.447 ' C ' ' O ' ' A' ' 114' ' ' LEU . 8.0 t80 -39.5 -27.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.427 -0.795 . . . . 0.0 110.173 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.559 ' CD1' ' H31' ' A' ' 800' ' ' I52 . 1.0 OUTLIER -78.57 -71.6 0.42 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.081 -1.012 . . . . 0.0 109.836 -179.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 118' ' ' ALA . 14.6 m -52.46 -42.43 38.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 120.917 -1.115 . . . . 0.0 109.154 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -55.88 -45.92 78.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.386 -0.821 . . . . 0.0 109.302 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.68 -35.69 68.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.229 -0.919 . . . . 0.0 108.87 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.575 ' HA ' HD12 ' A' ' 137' ' ' LEU . 24.0 t60 -60.52 -54.06 50.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.631 -0.668 . . . . 0.0 110.104 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.525 ' HA ' ' HB2' ' A' ' 124' ' ' HIS . 73.5 mm-40 -69.05 -53.36 20.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 110.133 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.622 ' CB ' ' CZ2' ' A' ' 43' ' ' TRP . 13.4 m-85 -49.59 -24.09 1.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.955 -1.091 . . . . 0.0 108.47 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -88.45 -27.53 24.74 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.208 -1.957 . . . . 0.0 108.208 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.525 ' HB2' ' HA ' ' A' ' 121' ' ' GLU . 2.1 m-70 -76.3 -48.23 20.85 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.689 -0.889 . . . . 0.0 109.183 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 124' ' ' HIS . . . -42.88 -27.49 0.19 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.609 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.417 ' N ' ' O ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -71.9 -98.92 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.782 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -166.58 29.14 0.19 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.76 144.84 24.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -1.12 . . . . 0.0 109.742 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -119.96 151.78 38.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 138' ' ' MET . 12.2 m-70 -51.29 117.6 2.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.345 -0.847 . . . . 0.0 110.015 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 132' ' ' GLN . 0.3 OUTLIER -88.76 -80.51 0.29 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.082 179.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 131' ' ' SER . 5.6 tt0 177.03 -34.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.264 -0.898 . . . . 0.0 110.058 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.625 ' O ' ' HB2' ' A' ' 139' ' ' ALA . 0.2 OUTLIER -43.0 139.6 2.13 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.105 -0.997 . . . . 0.0 110.138 -179.188 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -73.54 -38.86 2.25 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.431 2.088 . . . . 0.0 109.812 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.15 17.48 53.36 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' A' ' 133' ' ' ASP . . . -85.09 149.42 25.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.345 -1.091 . . . . 0.0 110.066 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.923 HD22 H362 ' A' ' 800' ' ' I52 . 0.0 OUTLIER -75.76 -10.99 59.9 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.583 ' O ' ' CG ' ' A' ' 130' ' ' HIS . 0.8 OUTLIER -106.42 11.96 30.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 110.272 -179.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 133' ' ' ASP . . . -75.92 154.83 84.96 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.913 -1.117 . . . . 0.0 108.955 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.78 9.19 2.75 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.755 2.303 . . . . 0.0 111.477 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.663 ' H ' HD12 ' A' ' 141' ' ' ILE . 0.1 OUTLIER -134.63 137.79 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.957 -1.089 . . . . 0.0 109.307 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.583 ' OH ' ' CD1' ' A' ' 144' ' ' TYR . 2.9 t80 -84.78 128.72 34.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.424 -0.798 . . . . 0.0 110.186 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.448 ' N ' ' CD1' ' A' ' 142' ' ' TYR . 96.2 m -122.16 100.26 6.87 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.583 ' CD1' ' OH ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -40.21 149.8 0.07 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.408 -0.808 . . . . 0.0 110.26 -179.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.908 HG21 H392 ' A' ' 800' ' ' I52 . 6.1 t -149.56 102.88 3.22 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -16.93 32.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.442 -0.786 . . . . 0.0 110.269 -178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 148' ' ' PHE . 1.1 t30 -95.25 -19.62 19.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.963 -1.086 . . . . 0.0 108.766 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.648 ' CE1' ' CG2' ' A' ' 42' ' ' VAL . 9.4 t80 49.2 104.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.578 -0.701 . . . . 0.0 110.15 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -121.32 -20.69 6.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 109.209 179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 149' ' ' ARG . 15.5 tp 66.47 147.46 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.555 ' CB ' ' OD1' ' A' ' 153' ' ' ASP . 3.7 m -114.97 138.58 50.67 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.129 -0.982 . . . . 0.0 109.889 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.64 ' HA ' ' CG1' ' A' ' 155' ' ' ILE . 19.6 tt0 -49.09 -31.42 7.92 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.443 -0.786 . . . . 0.0 110.533 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.555 ' OD1' ' CB ' ' A' ' 151' ' ' SER . 0.1 OUTLIER -46.3 -50.03 16.74 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.565 -1.334 . . . . 0.0 108.638 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -75.17 -31.33 60.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.928 . . . . 0.0 109.474 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.651 ' O ' HD12 ' A' ' 155' ' ' ILE . 0.5 OUTLIER -69.69 -26.05 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 108.991 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -74.85 -53.57 8.86 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.0 109.252 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 161' ' ' LEU . . . -59.32 -41.07 96.71 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.647 HG12 HG21 ' A' ' 47' ' ' THR . 0.6 OUTLIER -75.78 -22.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.105 -1.232 . . . . 0.0 109.751 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.572 ' NE2' HD13 ' A' ' 155' ' ' ILE . 36.6 mt-30 -79.25 -42.21 26.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.053 -1.029 . . . . 0.0 108.931 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -74.25 -19.63 60.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.428 -0.795 . . . . 0.0 109.207 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.435 ' O ' ' CD1' ' A' ' 162' ' ' TYR . 0.2 OUTLIER -100.17 -22.86 15.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 109.98 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.805 ' HB3' HD21 ' A' ' 49' ' ' LEU . 17.6 m-85 -130.61 -24.99 2.42 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.862 -1.149 . . . . 0.0 110.273 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.336 0 CA-C-O 118.015 -1.436 . . . . 0.0 109.589 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 0.923 H362 HD22 ' A' ' 137' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.229 0.538 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -111.24 -33.35 6.47 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.285 -0.885 . . . . 0.0 109.828 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -61.57 150.09 37.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.184 -0.947 . . . . 0.0 110.388 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -114.4 110.58 20.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.491 -0.756 . . . . 0.0 109.534 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 62.55 106.47 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 121.343 -0.848 . . . . 0.0 109.474 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.6 136.59 19.41 Favored 'Trans proline' 0 C--N 1.317 -1.112 0 C-N-CA 122.628 2.219 . . . . 0.0 111.187 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.74 -163.74 0.67 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.516 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -87.0 158.48 52.99 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.199 -0.938 . . . . 0.0 110.501 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 8' ' ' LYS . 35.2 Cg_endo -75.51 58.21 5.13 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.283 1.989 . . . . 0.0 108.988 178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HE3' HD13 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -55.6 -81.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.551 ' CE3' ' HA ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 172.05 42.91 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 12' ' ' ASP . 16.1 p-10 -130.35 99.76 5.13 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.562 ' O ' ' N ' ' A' ' 15' ' ' GLN . 2.4 mtmt -120.92 34.52 5.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.922 -1.111 . . . . 0.0 110.43 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.9 -76.1 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.097 -1.002 . . . . 0.0 108.586 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.598 ' HA ' ' HB3' ' A' ' 50' ' ' ARG . 1.3 mt-30 -86.94 104.93 16.73 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.277 -0.89 . . . . 0.0 108.672 178.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 19.1 mt -112.84 153.62 14.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 52' ' ' SER . 0.0 OUTLIER -115.19 148.41 39.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.339 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CB ' HG13 ' A' ' 61' ' ' ILE . 15.9 p90 -151.94 155.24 37.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.932 . . . . 0.0 109.797 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 0.1 OUTLIER -148.84 133.48 17.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.746 -179.495 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.764 HG22 ' H ' ' A' ' 22' ' ' GLY . 4.3 mt -96.17 124.85 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.917 -1.114 . . . . 0.0 108.834 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.635 HD11 ' HG2' ' A' ' 62' ' ' MET . 2.8 mp -76.74 -1.43 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.967 -1.083 . . . . 0.0 109.474 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.764 ' H ' HG22 ' A' ' 20' ' ' ILE . . . 157.71 100.81 0.17 Allowed Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.985 -1.102 . . . . 0.0 110.438 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.746 ' CG ' HG11 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -69.88 -163.52 0.06 Allowed 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.486 -1.302 . . . . 0.0 107.486 178.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -94.58 148.35 34.76 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.94 -1.1 . . . . 0.0 108.94 178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.461 ' O ' ' N ' ' A' ' 27' ' ' LEU . 35.1 Cg_endo -83.59 -29.11 1.16 Allowed 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.559 2.839 . . . . 0.0 110.603 -179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -41.96 -26.49 0.09 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.57 -0.706 . . . . 0.0 109.528 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD21 ' O ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -129.4 166.03 20.36 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.266 -0.896 . . . . 0.0 109.613 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.437 ' HB2' ' OG1' ' A' ' 31' ' ' THR . 8.5 m-20 -58.63 147.95 68.58 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.492 -0.755 . . . . 0.0 110.37 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 32' ' ' VAL . 28.9 Cg_endo -67.64 -34.85 24.04 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 N-CA-C 106.131 -2.296 . . . . 0.0 106.131 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -74.58 -28.33 60.88 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.602 ' CG2' ' HB3' ' A' ' 107' ' ' ASN . 2.9 m -72.88 -63.42 1.17 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.746 HG11 ' CG ' ' A' ' 23' ' ' TYR . 0.8 OUTLIER -45.92 -39.54 3.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.557 -0.714 . . . . 0.0 109.354 179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.43 ' N ' ' CG1' ' A' ' 32' ' ' VAL . 19.5 t0 -67.56 -29.84 69.32 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.569 ' N ' ' O ' ' A' ' 31' ' ' THR . 1.1 t70 -61.39 -50.52 72.55 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -44.84 -39.38 5.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.677 -0.64 . . . . 0.0 109.317 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 32' ' ' VAL . 85.5 m-85 -73.11 -36.2 66.7 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.687 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 34' ' ' ASP . . . -56.0 -57.59 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 108.516 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' ALA . 2.7 mtm180 -61.34 -51.61 68.09 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.768 ' HB1' ' CZ2' ' A' ' 43' ' ' TRP . . . -45.23 -48.99 12.69 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 43' ' ' TRP . 28.6 t80 -49.99 -44.74 51.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 108.879 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' ASP . 8.1 tt0 -79.87 -19.13 49.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 109.912 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -62.58 -36.08 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.028 -1.045 . . . . 0.0 108.502 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.768 ' CZ2' ' HB1' ' A' ' 39' ' ' ALA . 0.0 OUTLIER -108.42 -46.67 3.65 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.725 178.82 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.5 t -51.33 -20.3 1.65 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.016 -1.053 . . . . 0.0 110.042 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 1.2 m-20 -64.92 -10.31 27.92 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.103 -0.998 . . . . 0.0 110.473 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 43' ' ' TRP . 2.6 m -111.15 -18.88 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.991 -1.068 . . . . 0.0 109.861 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.555 ' OG1' ' HD2' ' A' ' 48' ' ' PRO . 0.1 OUTLIER -131.67 155.03 81.95 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.307 -0.871 . . . . 0.0 108.846 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.555 ' HD2' ' OG1' ' A' ' 47' ' ' THR . 31.8 Cg_endo -77.84 49.15 2.85 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.748 2.298 . . . . 0.0 110.319 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD22 ' HE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -76.38 162.5 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.932 0.873 . . . . 0.0 111.182 -179.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.598 ' HB3' ' HA ' ' A' ' 15' ' ' GLN . 1.1 tpt180 -138.4 116.73 11.92 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.581 ' HE1' HD22 ' A' ' 49' ' ' LEU . 3.3 m-85 -99.9 136.66 39.48 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.749 -1.219 . . . . 0.0 109.399 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' THR . 0.4 OUTLIER -123.05 100.84 7.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.468 ' HB2' ' CE1' ' A' ' 18' ' ' TYR . 4.1 tmt_? -80.39 135.79 36.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.882 -1.136 . . . . 0.0 109.451 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.691 HD13 ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -111.12 163.47 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.171 -0.955 . . . . 0.0 109.506 -179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -119.75 -29.33 5.04 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.161 -0.962 . . . . 0.0 108.961 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -141.65 98.65 3.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.403 -0.811 . . . . 0.0 109.353 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 154.41 -173.31 32.92 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -79.68 161.96 25.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.039 -1.271 . . . . 0.0 110.394 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 19' ' ' ARG . . . -143.71 153.11 42.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 108.978 179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -77.12 -49.35 15.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.931 -1.106 . . . . 0.0 109.313 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.88 HG22 ' O ' ' A' ' 95' ' ' GLY . 0.0 OUTLIER -94.99 131.28 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.381 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.635 ' HG2' HD11 ' A' ' 21' ' ' ILE . 4.3 ttm -116.35 115.81 26.58 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.149 -0.969 . . . . 0.0 109.2 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 9.3 mt -108.5 148.38 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.085 -1.01 . . . . 0.0 109.689 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 65' ' ' PHE . 29.3 t30 177.93 159.79 0.49 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.151 -0.968 . . . . 0.0 109.699 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.614 ' CE1' ' HG3' ' A' ' 67' ' ' ARG . 35.7 p90 -83.32 175.16 10.09 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.302 -0.874 . . . . 0.0 108.665 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 68' ' ' TRP . . . -113.39 -27.17 3.71 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.614 ' HG3' ' CE1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER 62.7 -77.85 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.113 -1.228 . . . . 0.0 109.813 179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.504 ' O ' ' N ' ' A' ' 70' ' ' HIS . 36.1 t-105 -165.35 -56.08 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.843 -1.16 . . . . 0.0 109.331 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.55 74.16 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.645 -0.66 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.504 ' N ' ' O ' ' A' ' 68' ' ' TRP . 0.9 OUTLIER -106.86 -66.39 1.02 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.192 -0.943 . . . . 0.0 110.188 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 73' ' ' GLY . . . 84.96 -10.39 63.08 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 -179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.474 ' HB2' ' CD2' ' A' ' 70' ' ' HIS . 3.2 m-20 -62.65 73.4 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.085 0 O-C-N 121.509 -0.995 . . . . 0.0 108.893 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 71' ' ' GLY . . . 59.84 -84.96 0.02 OUTLIER Glycine 0 N--CA 1.485 1.937 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 72' ' ' ASP . 0.4 OUTLIER -86.28 138.25 34.42 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.122 -1.223 . . . . 0.0 109.644 -179.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 74' ' ' TYR . 35.9 Cg_endo -78.66 -175.06 2.54 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.405 2.07 . . . . 0.0 110.29 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 100' ' ' ASP . 0.1 OUTLIER -76.35 150.87 36.8 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.497 -0.752 . . . . 0.0 109.12 179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.441 ' OD2' ' HA3' ' A' ' 81' ' ' GLY . 20.3 p-10 -115.07 -14.18 11.82 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 79' ' ' LYS . . . 72.33 -92.12 0.57 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' O ' ' C ' ' A' ' 80' ' ' ASP . 5.0 mttt -45.75 173.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.56 -0.964 . . . . 0.0 109.379 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -25.69 -98.02 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 116.7 -0.227 . . . . 0.0 111.436 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' A' ' 83' ' ' LEU . . . 33.26 -139.24 0.1 Allowed Glycine 0 N--CA 1.502 3.093 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.469 ' C ' ' O ' ' A' ' 81' ' ' GLY . 33.8 tp -37.18 118.67 0.63 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.695 -0.885 . . . . 0.0 110.098 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.618 ' CD2' ' CE2' ' A' ' 112' ' ' TYR . 6.9 mt -105.2 -26.44 12.05 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.778 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . 170.5 175.94 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.221 -0.924 . . . . 0.0 109.819 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 98' ' ' HIS . 55.5 p-80 -177.62 149.08 0.6 Allowed 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.898 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.821 ' HB2' ' OG ' ' A' ' 97' ' ' SER . . . -132.35 175.62 9.12 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.36 -0.837 . . . . 0.0 109.457 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.63 156.87 26.29 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 1.024 ' HB1' ' HD2' ' A' ' 89' ' ' PRO . . . -57.09 -178.98 0.09 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 110.253 -179.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 1.024 ' HD2' ' HB1' ' A' ' 88' ' ' ALA . 38.1 Cg_endo -80.57 144.36 15.75 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 C-N-CA 122.61 2.207 . . . . 0.0 109.636 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.454 ' O ' ' CZ2' ' A' ' 11' ' ' TRP . . . -174.16 -172.2 39.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.659 HG22 ' N ' ' A' ' 92' ' ' GLY . 21.3 m -67.13 -96.0 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.432 -1.04 . . . . 0.0 110.311 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.659 ' N ' HG22 ' A' ' 91' ' ' THR . . . -70.09 -81.21 0.25 Allowed Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.602 HG12 ' N ' ' A' ' 94' ' ' GLY . 31.6 t -61.9 172.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.256 -1.143 . . . . 0.0 108.888 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.602 ' N ' HG12 ' A' ' 93' ' ' VAL . . . 96.92 150.94 27.46 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 61' ' ' ILE . . . 62.07 9.67 22.95 Favored Glycine 0 N--CA 1.492 2.381 0 O-C-N 121.343 -1.093 . . . . 0.0 110.558 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.53 ' CG ' ' CB ' ' A' ' 62' ' ' MET . 32.5 m-20 -102.37 134.52 45.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.082 -1.834 . . . . 0.0 109.248 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.821 ' OG ' ' HB2' ' A' ' 86' ' ' ALA . 1.5 m -112.36 120.66 42.46 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.184 -0.948 . . . . 0.0 110.523 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 85' ' ' HIS . 8.1 m80 -95.23 129.11 42.47 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.778 ' CD1' ' HB1' ' A' ' 84' ' ' ALA . 8.3 m-30 -108.89 147.38 32.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.0 110.088 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 76' ' ' PHE . 9.3 t70 -76.88 112.16 13.18 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 103' ' ' GLU . 46.9 t0 -55.48 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.217 -0.927 . . . . 0.0 111.204 -178.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 101' ' ' ASP . 1.9 m-20 -40.03 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.108 -0.995 . . . . 0.0 110.439 -178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 101' ' ' ASP . 0.0 OUTLIER 175.09 156.9 0.17 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.0 124.83 50.76 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.975 -1.078 . . . . 0.0 111.68 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TRP . . . . . 0.778 ' NE1' HG11 ' A' ' 117' ' ' VAL . 6.8 m0 -122.35 172.3 8.42 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.646 -0.659 . . . . 0.0 110.1 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 110' ' ' ALA . 6.4 p -145.19 141.3 28.57 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.037 -1.039 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.602 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 4.9 t-20 -103.26 27.99 6.76 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 109' ' ' SER . 8.8 t -142.05 25.89 1.89 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.468 -1.395 . . . . 0.0 110.626 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 110' ' ' ALA . 0.9 OUTLIER 70.68 89.3 0.1 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 108.815 -179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.541 ' O ' ' CG2' ' A' ' 106' ' ' THR . . . 174.87 137.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.471 -0.768 . . . . 0.0 109.156 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.59 -149.04 0.27 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.859 -1.151 . . . . 0.0 108.651 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.619 ' HB3' ' CD1' ' A' ' 105' ' ' TRP . 0.5 OUTLIER -65.17 -34.71 79.03 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.81 -1.181 . . . . 0.0 108.097 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.599 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.7 OUTLIER 75.38 124.73 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.542 -0.724 . . . . 0.0 110.393 179.136 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.575 ' CD2' ' CB ' ' A' ' 105' ' ' TRP . 0.1 OUTLIER -66.55 -35.02 79.2 Favored 'General case' 0 N--CA 1.499 2.025 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.158 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -68.69 -43.29 76.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.189 -0.944 . . . . 0.0 110.259 -178.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.89 HD11 ' HA ' ' A' ' 144' ' ' TYR . 0.0 OUTLIER -64.58 -62.46 1.57 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.771 -1.205 . . . . 0.0 109.562 -179.147 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.778 HG11 ' NE1' ' A' ' 105' ' ' TRP . 18.1 m -44.12 -46.78 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.209 -0.932 . . . . 0.0 109.61 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.503 ' N ' HG23 ' A' ' 117' ' ' VAL . . . -62.49 -47.85 82.17 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.955 -1.091 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.463 ' O ' ' N ' ' A' ' 122' ' ' PHE . . . -48.36 -63.62 1.03 Allowed 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.583 -0.698 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -46.62 -54.18 10.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.206 -0.934 . . . . 0.0 109.521 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -66.34 -18.81 65.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.963 -1.086 . . . . 0.0 108.254 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.535 ' CD1' ' CH2' ' A' ' 43' ' ' TRP . 0.7 OUTLIER -81.89 -8.22 59.66 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 128' ' ' LEU . . . -97.03 -37.89 4.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 178.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.468 ' CE1' ' CD2' ' A' ' 130' ' ' HIS . 55.3 m-70 -74.19 -47.41 35.77 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -46.33 -27.09 0.95 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.173 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.499 ' HG2' ' CZ ' ' A' ' 162' ' ' TYR . 10.8 mtt -79.29 7.99 6.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.271 -0.893 . . . . 0.0 109.822 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.79 -23.75 27.22 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.54 ' N ' ' CD2' ' A' ' 128' ' ' LEU . 3.0 mm? -53.54 141.57 25.04 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.337 -1.096 . . . . 0.0 108.986 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -110.04 -176.43 2.99 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 109.528 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.468 ' CD2' ' CE1' ' A' ' 124' ' ' HIS . 24.6 m170 -63.75 132.59 51.45 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 4.9 p -90.25 -115.22 0.07 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.439 ' O ' ' C ' ' A' ' 133' ' ' ASP . 0.4 OUTLIER -159.41 -48.64 0.05 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.696 -1.253 . . . . 0.0 109.261 179.575 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 132' ' ' GLN . 0.9 OUTLIER -42.38 124.83 2.85 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.134 -0.979 . . . . 0.0 109.718 179.515 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -78.37 108.01 2.4 Favored 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.093 1.862 . . . . 0.0 109.386 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 124.27 -13.83 7.87 Favored Glycine 0 C--N 1.271 -3.037 0 N-CA-C 108.742 -1.743 . . . . 0.0 108.742 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.601 ' O ' ' H33' ' A' ' 800' ' ' I52 . . . -57.33 157.66 6.28 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.379 -1.071 . . . . 0.0 110.352 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.862 ' HB2' H382 ' A' ' 800' ' ' I52 . 14.2 tp -63.13 -24.77 68.05 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.441 ' CE ' ' HG ' ' A' ' 137' ' ' LEU . 0.0 OUTLIER -102.7 12.92 35.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 140' ' ' PRO . . . -61.57 149.2 84.87 Favored Pre-proline 0 N--CA 1.487 1.406 0 C-N-CA 119.258 -0.977 . . . . 0.0 109.702 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 139' ' ' ALA . 36.6 Cg_endo -77.27 21.11 0.63 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.959 2.44 . . . . 0.0 110.917 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 141' ' ' ILE . 1.1 mt -142.46 145.48 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.888 -1.133 . . . . 0.0 110.396 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -69.34 148.07 50.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 144' ' ' TYR . 5.9 m -161.97 -33.46 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.084 -1.01 . . . . 0.0 109.704 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . 0.89 ' HA ' HD11 ' A' ' 116' ' ' LEU . 42.9 t80 59.24 166.06 0.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.4 -0.813 . . . . 0.0 109.057 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.634 ' N ' ' CD1' ' A' ' 144' ' ' TYR . 1.2 t -150.13 115.31 5.41 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.245 -0.91 . . . . 0.0 109.844 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.71 -39.94 42.92 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.092 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.544 ' O ' ' HB3' ' A' ' 148' ' ' PHE . 44.6 t-20 -73.25 -48.38 35.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.076 -1.015 . . . . 0.0 108.511 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 150' ' ' LEU . 39.7 t80 75.45 139.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.39 0.614 . . . . 0.0 109.68 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.51 ' O ' ' HB2' ' A' ' 150' ' ' LEU . 1.6 tpt180 -155.65 -25.06 0.11 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.316 -0.865 . . . . 0.0 110.889 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.607 ' HG ' ' CZ ' ' A' ' 148' ' ' PHE . 6.2 mt 65.66 83.36 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 155' ' ' ILE . 0.0 OUTLIER -53.87 140.36 30.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 110.172 -178.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.611 ' HA ' ' CG2' ' A' ' 155' ' ' ILE . 5.3 mt-30 -55.23 -35.3 64.78 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.355 -0.84 . . . . 0.0 108.994 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 152' ' ' GLN . 0.6 OUTLIER -47.01 -33.81 5.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.531 -1.356 . . . . 0.0 108.889 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -89.1 -28.42 20.11 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ILE . . . . . 0.611 ' CG2' ' HA ' ' A' ' 152' ' ' GLN . 0.8 OUTLIER -71.03 -34.48 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 179.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 159' ' ' GLN . 2.2 ttmt -73.29 -56.86 4.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.541 -0.724 . . . . 0.0 109.564 178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.463 ' HA3' HD11 ' A' ' 128' ' ' LEU . . . -51.0 -37.29 36.06 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.115 -1.194 . . . . 0.0 110.115 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -83.49 -14.9 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.34 -1.094 . . . . 0.0 109.441 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 156' ' ' LYS . 0.6 OUTLIER -70.34 -57.13 5.18 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.334 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.454 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 13.1 mm-40 -64.22 -40.19 95.54 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.759 -0.588 . . . . 0.0 109.474 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.465 HD13 ' HE3' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -73.4 -29.43 62.59 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.454 -0.779 . . . . 0.0 111.024 -178.243 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.558 ' CD2' HD11 ' A' ' 49' ' ' LEU . 42.4 m-85 -131.24 -51.47 1.02 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.471 -1.393 . . . . 0.0 109.174 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 159' ' ' GLN . . . . . . . . 0 N--CA 1.482 1.752 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' I52 . . . . . 1.051 ' H20' ' H72' ' A' ' 800' ' ' I52 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_